cell_line_id,drug_id,response,predictions
MOLP-8,11612883,2.388158793316403,1.8795438056978957
MDST8,654092,-1.4293910300938224,0.021181795207106276
RKO,52947716,-6.611161073849914,-1.3170898640284792
RKO,56963564,0.5825206420774123,-0.06971921725343157
Granta-519,107970,1.5911312599666134,1.8763152164585868
HEL,12003241,-0.3954740832299299,-1.1195613170419618
SK-HEP-1,445091,4.514173662724111,4.390166792326124
SK-CO-1,vorinostat-carboplatin (1-1 mol-mol),2.626947191906058,3.2689894642660096
SU-DHL-1,JQ-1-vorinostat (2-1 mol-mol),1.047000957100153,0.8612468873816771
PaTu 8902,selumetinib-navitoclax (8-1 mol-mol),2.7909772109313677,1.613591741427276
HCC15,24775005,4.257174534281358,3.6508815715108955
HuP-T3,6450551,3.7588607556856006,2.982555745006789
SaOS-2,72376,-1.862865015628177,-1.882428004733093
HARA [Human squamous cell lung carcinoma],9911830,2.811378702432749,2.535875616775684
Panc 02.03,3062316,2.5231792980774,1.0781292081598064
MOLP-8,6918837,-6.2821371699611515,-4.204412735257027
SW48,1242560,3.5610164041067645,3.616841984866111
RCC10RGB,3062316,3.7206614033239833,0.6195061028586155
IA-LM,25262965,-3.1838216959830796,-1.5644194111627032
BICR 22,3038522,1.9324211832044784,2.95643605305162
SW1573,4096211,3.236722527011662,2.3687607003873397
LS180,navitoclax-pluripotin (1-1 mol-mol),-0.4771322903655018,-0.5731449412522879
NCI-H2452,2733526,3.4563089712221,3.785519212332784
WM115,44197249,3.814304480361476,4.432983929191935
HARA [Human squamous cell lung carcinoma],ISOX-bortezomib (250-1 mol-mol),0.5382016887520487,0.5442329533477962
Granta-519,JQ-1-UNC0638 (2-1 mol-mol),-1.2323689665878552,0.19452298741801222
SW948,216345,3.8478701746280506,3.564960354166294
RKN,2858523,3.2318364946727653,3.152556128401005
HARA [Human squamous cell lung carcinoma],11507802,1.3937860028408913,1.768024183642117
LCLC-97TM1,17759555,4.8791087487812606,3.4633299020149746
ALL-SIL,24771867,-3.516684419884963,-1.6316849343357254
WM115,11455910,0.9860510612095932,1.1969922718672972
MOLP-8,11485656,1.8270206697288176,1.595893119742482
MOLM-13,9866186,-0.4750218873797177,-0.05870778775619611
Daudi,445091,3.707432883595851,3.6479303743631557
RERF-LC-MS,9907093,3.840365222907794,4.312802844020506
LCLC-97TM1,selumetinib-decitabine (4-1 mol-mol),4.710076676704391,3.052213993133718
IA-LM,49836020,4.225846480888235,2.7832775511664276
IA-LM,JQ-1-navitoclax (2-1 mol-mol),0.4623829149690596,0.5204253884279977
HuP-T3,445643,4.0158423100173986,3.962723366815975
RKO,5351362,1.5688417029382893,1.0484206721276919
SU-DHL-1,25262965,-0.1887460090186497,-2.1246957459445794
MOLP-8,3552672,2.5417747800161483,2.1157775534424466
Daudi,selumetinib-UNC0638 (4-1 mol-mol),2.5339399670169827,3.1169508291865737
HCC15,24771867,-1.1106317715549263,2.836164673874429
HARA [Human squamous cell lung carcinoma],16115403,-4.2638303939611335,-4.2244166812664075
COR-L95,25161177,5.647598761093448,3.7505571192371576
BFTC-909,16219061,3.736019824418232,3.47437677065746
LCLC-97TM1,3503,2.904492448420953,2.4649172775926984
RKN,5287620,-2.679516494579474,-2.011580048658739
IA-LM,5281321,-0.2514769440259956,-2.1132375571650157
SK-HEP-1,24964624,3.121305411780932,2.5481385363120252
SaOS-2,9884685,-0.6485333929619777,0.7064050628162805
MOLP-8,44566777,0.3680572795114795,-0.13760466997929607
K-562,3081361,1.217245739162405,2.0735882539358053
HuP-T3,53392493,2.0684681956337654,2.6742170882577856
SW48,11404337,-1.6842588085779022,-0.4504375245541442
RKO,24771867,6.323343540042099,-0.9821023933380236
MDST8,11497983,4.366208744407351,4.1066011642805424
Daudi,6918638,-1.8107043721369585,-0.44864810776170444
RERF-LC-MS,107970,3.001301355490032,2.3354038731442817
NCI-H2452,56963564,2.315469414243469,0.7789099768208237
MOLP-8,JQ-1-UNC0638 (2-1 mol-mol),-1.954296009625891,0.5992717495268042
MOLM-13,4259181,-1.5110532495146267,-0.42491546037951733
RERF-LC-MS,5566,3.05978093065268,3.0454573492231445
HEL,44607531,1.529117499700861,1.1656399479588615
BFTC-909,25262965,-1.7887871070762158,-0.7550222951802732
ML-1 [Human thyroid carcinoma],26596,-0.6105391992480588,-0.9917454268699238
BICR 31,46191454,1.7584497327325264,1.4150790292862014
UACC-812,426756,4.999419351863596,4.207788664532146
SW1271,9911463,3.695583497273472,3.9466707355408306
COR-L105,219104,4.205860409291191,3.9131214454109022
MOLP-8,46943432,-0.8980695552897974,0.7447399704111035
MOLM-13,11626560,-0.3289224093786886,0.6655075275530584
SU-DHL-1,73707398,0.2992121771474305,1.197866467304079
HCC15,doxorubicin-navitoclax (2-1 mol-mol),-1.4188615279170478,-0.8073943778688433
HCC1500,9907093,4.182225492860836,3.9929695621108454
SW1573,JQ-1-vorinostat (2-1 mol-mol),2.32143209708559,1.2811393091717047
LS180,serdemetan-SCH-529074 (1-1 mol-mol),1.4143670518957836,2.0889217243352247
NCI-H1568,5746,-0.0019321539800122,1.1285565599915035
SW1271,navitoclax-birinapant (1-1 mol-mol),0.1602834101021188,1.1363088405563355
HEL,10385095,1.0320529067741009,0.8478098139780259
P31/FUJ,374536,-2.654779926412406,0.8577509633045376
KU-19-19,119607,4.136898976237774,5.181194372741187
HCC1500,11656518,1.3375266797474916,1.1117472199238931
NCI-H1568,44819697,-2.651253194329211,-0.39518614758368537
COR-L105,6918328,0.8369476830507139,0.2813136014406533
PaTu 8988t,1750826,2.46453979570572,-1.1152411791239674
NCI-H1568,vorinostat-navitoclax (4-1 mol-mol),0.9474025116898376,1.2002261818714106
HCC1500,6438330,2.8683818740810088,2.237378589987861
HEL,11214940,0.9295508638766669,1.3527188211999563
HCC15,104842,-2.640027553911029,-2.489907256913245
BICR 22,53495165,-1.022289455565369,0.2783862760966518
SK-HEP-1,JQ-1-vorinostat (2-1 mol-mol),1.4434630535263555,1.3508070632607598
SW948,11167602,-0.1815305116238505,2.1384903328701212
SaOS-2,119607,5.401113896800015,5.205366430114059
SW1271,444795,4.935671262335122,4.515724359417935
LS411N,107970,2.4864618038552724,2.2967611513165425
RERF-LC-MS,3025944,4.157794890121567,4.32246853518251
IGROV-1,5282054,3.614574021382022,3.7632632060097833
MOLP-8,5284373,1.9803114216772224,1.8957631400253951
SW1271,46907787,1.639327018501732,2.5285516483647994
K-562,tretinoin-carboplatin (2-1 mol-mol),5.512334561910439,3.551828209422699
IA-LM,carboplatin-UNC0638 (2-1 mol-mol),4.065848381548882,3.1214018206976792
ALL-SIL,5351362,0.9273092220520184,0.97580313212081
MDST8,docetaxel-tanespimycin (2-1 mol-mol),-2.250770682375198,-2.4632567280642634
LCLC-97TM1,54618164,4.1848187977728,4.077380077605199
SK-HEP-1,123631,3.617013696107864,2.338838543289743
LS180,1641662,3.031869457755623,3.4686351568161773
LCLC-97TM1,46199207,3.402623883365983,3.172562459371641
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.41122118675425556
ALL-SIL,168312962,1.491579787235829,0.5378511896444391
IGROV-1,135398516,1.9751898057484376,2.407258726324599
SK-OV-3,4261,3.2658157069367615,1.7345508238685232
Panc 02.03,11707110,-0.717341284128793,-0.35492282340978193
P31/FUJ,4261,-0.12536828191131,0.4516454099940772
Daudi,53481919,2.490259403593742,3.258343727228283
MDST8,navitoclax-birinapant (1-1 mol-mol),-0.9553214738186762,1.0553679513390397
ML-1 [Human thyroid carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),2.9053104812744186,1.9288976058485283
SW1573,12003241,-0.6702221198842615,-0.9787545178616017
COR-L95,11238147,1.8523673489534709,2.55382264429317
SW48,452548,-3.152923699933953,0.4375222613809484
ALL-SIL,46224516,1.508509192124363,1.7788892609082325
COR-L105,selumetinib-MK-2206 (8-1 mol-mol),1.6265269022274589,2.4542457265117825
HARA [Human squamous cell lung carcinoma],46199207,3.289640650109998,3.188045673608847
UACC-812,docetaxel-tanespimycin (2-1 mol-mol),-4.467025086254145,-3.050575427074088
ML-1 [Human thyroid carcinoma],24856436,-1.6469735215058778,0.7507906362020661
Daudi,6918837,-6.333799665630375,-4.405984969392919
K-562,57330099,5.557476297558147,3.7623259484043685
MOLM-13,3038522,-2.559283473550591,2.072057436173514
BICR 31,tanespimycin-bortezomib (250-1 mol-mol),0.0232172753211841,-0.2952468640939966
SU-DHL-6,9903786,1.8029536633965553,1.9895433316195679
Daudi,151289,0.3893937359913983,0.3704516424841114
MOLP-8,51037431,3.96461280344528,2.942814007974809
BICR 31,11152667,-0.7818812516610519,-0.5084451768890229
LS180,46907787,-0.2837252988913812,1.7074185530653736
PaTu 8902,16725315,5.393152185048805,4.3659358841587235
Panc 02.03,6914657,-4.005158687469553,-3.797578584944619
HuP-T3,54613361,5.307179038572215,0.07575214066547685
PaTu 8902,107970,2.826401466277882,2.363163648248765
RKO,25183872,-1.1635703485572924,-1.0865307782814424
RCC10RGB,135659046,5.776465120313546,3.8205581603067493
BICR 31,16725315,5.360398456728244,4.337775069924838
IA-LM,216239,1.6797579071033788,2.190238694430639
LCLC-97TM1,selumetinib-navitoclax (8-1 mol-mol),3.8256626967827385,1.7651161165496156
COR-L105,6610216,4.21117605455994,4.395568669029215
COR-L105,10427712,4.508625829006449,4.328091782028808
NCI-H2452,6610355,4.992583267176856,4.632682150165798
PaTu 8988t,11364421,0.0778741703331701,-1.574739789331239
RKN,3552672,1.948192158503618,2.828368772322475
Granta-519,46174525,4.2506809125564615,3.1927444628014667
SW1271,44819697,-0.8585090240358869,-0.38809907256356807
WM115,44486219,4.206639028474801,4.302738595300591
MOLP-8,6918736,-3.613498069188207,-1.9799604082104503
LS411N,navitoclax-pluripotin (1-1 mol-mol),0.0808011312818899,-0.7660343669998692
LS411N,49836020,4.501659667614969,2.986247897282453
WM115,9927531,5.125567810288171,4.887996399482409
SW1271,24797083,1.5469513987685792,1.4088831522680905
HCC1500,1566236,1.5057997400762737,2.4332607287468333
SK-OV-3,serdemetan-SCH-529074 (1-1 mol-mol),2.3877296872918334,2.1747420545192946
LCLC-97TM1,5566,3.3253657103683976,2.7761460818014583
NCI-H1568,1242560,2.6554382745340046,3.4951707517187485
RKO,11717001,3.92417498432234,3.8907743700585256
SW1271,11612883,2.3755529899406604,2.826653652559487
Daudi,11396600,1.6595042173405945,2.6156971100245396
P31/FUJ,60700,-1.8341903870446763,-1.7568739374162545
MOLM-13,JQ-1-MK-0752 (1-1 mol-mol),-1.5133138249776965,0.18055722195611681
BFTC-909,sirolimus-bortezomib (250-1 mol-mol),1.9272227302236649,0.9062316071491222
ML-1 [Human thyroid carcinoma],2858523,3.273643216387516,3.0684979545160296
IGROV-1,3552672,2.134472496867482,2.7370039775952177
Granta-519,637858,1.0013506713179747,0.8774933497639836
RERF-LC-MS,24753719,5.208830602571573,4.42261963497326
BICR 22,10385095,0.7738978245677988,1.4363491653371974
IA-LM,216468,5.467489395679956,1.1712220026499136
HARA [Human squamous cell lung carcinoma],46398810,2.9743064800682912,2.6666310459742295
ML-1 [Human thyroid carcinoma],JQ-1-navitoclax (2-1 mol-mol),0.5559974390910295,1.2780727494511948
SK-HEP-1,5738263,4.7811273930471065,3.436611665064378
SU-DHL-1,44632017,-0.1440136540504316,1.0734959632498804
HEL,selumetinib-navitoclax (8-1 mol-mol),-0.2593426680751931,0.4942069663323913
PaTu 8902,11152667,1.2355675895718252,-0.3289025631027163
RCC10RGB,53245473,3.741106102916085,2.8716357624632214
RERF-LC-MS,637858,3.156110522031532,2.1154693845378296
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,2.0805385282103837
HuP-T3,selumetinib-MK-2206 (8-1 mol-mol),2.743935040601299,2.074991244105167
MOLP-8,23635314,-4.658988245687028,-3.05562203410464
HCC1500,241158,4.347158152842418,3.765731770345361
NCI-H1568,16065773,2.3280951044534923,2.4061339552081895
COR-L105,24771867,3.297975412837562,3.034426334943319
COR-L105,11625818,4.2515796910784385,4.504664373762324
RERF-LC-MS,JQ-1-MK-0752 (1-1 mol-mol),3.600892214686445,1.996248187849683
IGROV-1,2841722,3.834853118277962,4.330888227480542
SaOS-2,51039095,1.985897726070115,2.5727554448299115
LS180,navitoclax-sorafenib (1-1 mol-mol),3.51212583776398,1.6847085613057933
COR-L105,44589607,3.154557065472522,3.174586820894591
HARA [Human squamous cell lung carcinoma],54626689,4.600126869473187,4.581242655811406
LS411N,9911463,4.267700407985282,3.4084661292663276
IGROV-1,4378219,2.016502068118561,2.604238177266439
Daudi,135659046,3.1156448500687923,3.201320909745888
KU-19-19,16722836,2.3762239171314894,1.7613429583636733
IGROV-1,10410894,3.2660402181528263,3.325012124443796
Panc 02.03,49793307,-1.288996397670963,-2.543287174018648
HuP-T3,SNX-2112-bortezomib (250-1 mol-mol),0.0780901353743998,-1.1344128383453573
MOLM-13,3136844,3.815118683612459,3.5314844053005108
MOLP-8,6914657,-3.275680842626438,-4.157211711870213
K-562,9887053,4.062685534067952,2.7287817897244167
ML-1 [Human thyroid carcinoma],16038120,1.3266996549374028,1.120878336765134
NCI-H1568,52947716,-4.502411459776945,-0.8484172101320051
BFTC-909,11178236,-2.4757289909406683,-3.377783968674609
Daudi,6610355,3.6984054922795906,3.886950823555324
HuP-T3,10184653,2.026243337908569,1.132930739898552
IA-LM,36462,3.5803800151684384,2.040347872251365
SU-DHL-6,46907787,-0.6700724490980451,-0.5313500877892805
HCC15,10231331,4.227224330005602,1.884462344155577
LS180,135398516,1.9815935031047112,2.2167396351996875
MDST8,53495165,-1.6914230136545845,0.9403999694962326
SW48,135411,0.1882785626851766,0.6462332029372138
COR-L105,11485656,1.8131666015075352,2.4770940801154904
HCC15,1239801,5.074899811919598,4.129239176147154
SK-CO-1,11497983,-2.036472499029009,4.076416305520415
Granta-519,2742550,3.255820788990773,3.204070206284218
ALL-SIL,16720766,-0.6951675656481376,-0.6019165475328744
COR-L105,11175137,3.2551565890936165,2.7600687100322996
RCC10RGB,decitabine-navitoclax (2-1 mol-mol),2.143538063867694,1.78897223653444
BICR 22,ISOX-bortezomib (250-1 mol-mol),1.660291867951594,0.9203777570103061
IGROV-1,409805,5.990596261907717,4.89259548539791
Panc 02.03,11485656,5.602754460209725,2.4348057145474447
Granta-519,54619267,3.910643053444693,3.409103471169169
COR-L95,navitoclax-gemcitabine (1-1 mol-mol),-4.597005855092225,-1.47307049929028
BICR 22,6252,-0.1324642168432157,1.3529301328512497
MDST8,11404337,0.5498361952050128,-0.1330239880022823
SaOS-2,60750,-3.1697993298632183,-2.194393517495439
SW948,11717001,4.275182691709766,3.9809879591660753
MDST8,11175137,2.5746086097463974,2.4126058939720862
IGROV-1,322968,4.140599241163106,3.654466365130304
HCC1500,1242560,3.704354238917139,3.4851785158619957
MOLM-13,9911830,-0.5537570191991712,1.7165463132120038
COR-L105,16038120,1.5247864010803889,1.4131971038646243
COR-L105,45279963,3.905008730311125,3.900498760313261
WM115,148198,-2.543343591950365,-3.2610774096562767
IGROV-1,2749,2.0319044408234954,1.9489893106872416
K-562,4477,-0.1635303329058878,0.5672607355817743
SK-HEP-1,25227462,1.4628952719758763,0.7233348276584763
Panc 02.03,23582824,1.3457270338170706,0.8812592409264601
SK-HEP-1,241158,4.116654148222159,3.8360289109704593
SK-CO-1,168313047,0.9150038640573646,2.6369869251837756
Granta-519,9823820,3.571742016367909,2.30986571565372
SK-CO-1,159324,2.1120355222347738,2.823360862780116
SK-CO-1,10385095,1.4661007046294967,1.5725945776333248
NCI-H2452,71304818,2.7948147605911218,2.568372649532044
MOLP-8,4578,4.125075782233611,3.7407433891391917
NCI-H2452,11455910,0.7111396076654327,1.4332080964735088
HARA [Human squamous cell lung carcinoma],6917907,-4.425737266076785,-5.237657135583304
LS180,10074640,3.3464344717087333,3.121851332853243
MDST8,71466578,3.80352554053155,4.317278934376513
LS411N,6184667,3.0967158778150465,2.456708244139162
SW948,11317348,1.1175502037929408,1.6209568478670142
MDST8,119607,4.705186592802013,5.184163255471811
SW48,11507802,0.6466338181730511,1.3282239345972382
IA-LM,alisertib-navitoclax (2-1 mol-mol),-2.012462769104639,0.05327379341419112
WM115,5702613,3.6693021536028367,3.0678105728850626
SK-CO-1,23725625,2.337747507524157,5.04573437666747
K-562,2749,1.8349792189296796,1.217132719580742
IA-LM,3825829,4.571991496451351,3.4058733466834434
KU-19-19,104842,-1.861779032385676,-2.362072369444112
SK-HEP-1,12001922,2.448252559355595,2.1377805437116217
HEL,135440466,1.1488755358131115,1.9513276772870671
Panc 02.03,6918328,1.3018368822202735,0.16586682184360285
SaOS-2,72734382,4.901362762899978,4.8893642274907245
HuP-T3,135421197,1.625440100707307,1.9434316515935957
HCC1500,3384730,2.626558190955656,3.1875948357846267
IGROV-1,51037431,5.669320749085174,3.0023447794814695
BFTC-909,4917,2.929839520827846,3.2068690896590715
WM115,637858,1.77843641117838,2.1376583411848427
MDST8,44589607,2.007770745404649,2.885574873986213
LCLC-97TM1,5282054,3.1900504557345664,3.4167673126182567
HuP-T3,46199207,3.4499209547515433,3.277830431785949
BICR 31,25262965,-3.4333038857773093,-0.8161314621971815
LCLC-97TM1,6914657,-1.7973267784986633,-3.776364665684383
MOLM-13,9823820,-0.5140029045699521,2.063201246097959
RCC10RGB,327653,3.228661308812885,3.265443500690318
NCI-H1568,4705,2.022283964907955,3.301061472276369
SW948,selumetinib-MK-2206 (8-1 mol-mol),-0.5060345185709773,1.969818234689405
RKO,6914657,-2.9196237708628505,-4.256428627708426
WM115,72734382,5.455243998512052,4.758972614310281
SW48,46398810,2.2376864399879,2.4547845117888625
LS411N,2945648,3.381909997555915,2.475667902036614
LS411N,JQ-1-UNC0638 (2-1 mol-mol),1.029472619372517,1.140216754595498
SaOS-2,selumetinib-PLX-4032 (8-1 mol-mol),4.990111037976576,3.512404517870894
ALL-SIL,421610,2.937759224643201,2.5501613985735636
COR-L95,11404337,0.1032061359669597,-0.5561039253586274
WM115,11427553,3.734660617826416,2.9451435699691215
HCC15,122327,4.313110702061898,4.685054873935138
Daudi,9444,3.424690286905087,3.2326215466429424
Granta-519,4521392,4.382822475618979,3.7218999966839736
SW48,31703,-4.626106549902408,-0.9478168335850055
RKN,10127622,5.371150210721622,3.68259721081949
ALL-SIL,71466445,2.2002248480614925,2.3478324665193737
MDST8,656346,0.9697505348816438,1.1759928687920753
Daudi,71680916,3.7291665773697,3.6674215892743383
HEL,135398516,1.4688857829361923,1.0981836066501935
HARA [Human squamous cell lung carcinoma],168312962,2.6720428895447412,1.8791384887707037
P31/FUJ,9936388,-7.166815071220185,-5.415093229659151
HARA [Human squamous cell lung carcinoma],42611257,3.5357302300548716,3.361543380948949
HCC15,11625818,4.624206979967606,4.605734335693604
LCLC-97TM1,42611257,3.4642891468760957,3.361324128333344
LCLC-97TM1,5311,1.9621633752287055,1.3972852375262526
RERF-LC-MS,52912189,3.970931922009392,2.542636045478803
BICR 22,9915743,0.3047863731286212,-0.30715109863617585
Granta-519,11612883,3.2575401906490895,1.6939599038599216
LCLC-97TM1,vorinostat-carboplatin (1-1 mol-mol),3.53516680468747,2.6501427392317525
NCI-H2452,3543504,4.306818718463235,4.684150304881161
SK-CO-1,676352,2.6575015884388704,2.1466777249649143
COR-L105,docetaxel-tanespimycin (2-1 mol-mol),0.3286281168811693,-2.393065553433946
RKN,71304818,2.008207131108322,2.4615424396551226
IGROV-1,67156097,0.1763939852409119,-0.495033863841221
IGROV-1,51039095,1.7163430299301403,2.7558741339724393
P31/FUJ,JQ-1-MK-0752 (1-1 mol-mol),-0.1535880671922636,0.12649921693206187
IGROV-1,72193861,2.0623829231433293,1.6893216371814324
Daudi,tretinoin-navitoclax (4-1 mol-mol),3.599991807714322,0.7847951149536952
NCI-H1568,11167602,1.5259281753697294,2.3867605614272347
NCI-H1568,52912189,3.4016367932827563,2.358359007071944
SU-DHL-1,107985,-3.306496987383706,-3.574407547402986
P31/FUJ,73707386,2.311695228129917,2.536192208655631
WM115,9884685,-1.925323313513864,0.5104784700583304
SaOS-2,16722836,0.8662367041162377,1.74732581805142
PaTu 8902,46843906,4.340257675131653,3.3057899055317996
BFTC-909,656346,-0.1018552101429806,1.0899256643298976
COR-L95,54618305,4.5292428127427575,4.222216502397108
PaTu 8988t,selumetinib-MK-2206 (8-1 mol-mol),3.0176221561167096,2.0656598624916573
Daudi,24772860,-3.9771177154169304,-2.7776710270417326
BFTC-909,9911463,4.114346930944119,3.933394888821857
LCLC-97TM1,44197249,3.7483906325702545,3.1699739470025987
BFTC-909,6918837,-1.9878509916437357,-2.199949159505562
RERF-LC-MS,24797083,0.2985814331764478,1.4992953172315833
P31/FUJ,135928012,4.893710575363991,3.9372711772264437
P31/FUJ,53232,3.343897726239282,2.3459927978525017
K-562,navitoclax-MST-312 (1-1 mol-mol),0.8745280332695038,0.37032100562227754
MOLP-8,25062766,1.6722099464266416,1.7463841312055601
PaTu 8902,JQ-1-vorinostat (2-1 mol-mol),2.024407809701968,1.1493547158645394
ALL-SIL,tanespimycin-bortezomib (250-1 mol-mol),0.6461816419253308,-0.8287728527946783
SK-CO-1,262093,3.1807391377127376,2.9947134682948957
LS180,72376,-2.8322202153843703,-2.125901324834037
SK-CO-1,carboplatin-etoposide (40-17 mol-mol),1.570074747334896,2.6709313876540364
KU-19-19,6918328,0.0154884073180988,0.09732283236865351
SK-HEP-1,107985,-2.2891993358893856,-3.479513631286177
PaTu 8988t,216239,1.832862266271042,2.3608258804980693
SW1573,vorinostat-navitoclax (4-1 mol-mol),1.892054443323453,0.9278696472618556
PaTu 8902,156414,2.7243668654536206,1.4190983535030923
Daudi,16659841,2.946181230411034,2.4538642765615264
LS180,123631,2.1427319304120624,2.2935933434282174
BFTC-909,10385095,0.9839595624316404,1.4341252156371818
NCI-H1568,241158,1.943489424131273,3.7479144710659846
UACC-812,44589607,1.3537953197929582,2.9699362573469976
Granta-519,11960529,3.2261057296158593,3.3159930735877134
LCLC-97TM1,25062766,2.2139494005881293,2.1087912408979657
LCLC-97TM1,5291,3.6350350305332424,3.6289454437985227
MOLM-13,44491742,3.7695621371445975,3.656381247625646
P31/FUJ,3025986,-2.3655111331800067,-1.4833395760416082
PaTu 8988t,2749,1.558615062570056,1.9598990360112871
IGROV-1,2113511,5.982902824257526,5.555446635169906
Daudi,54639126,5.221444108043,2.5170003894278716
HuP-T3,selumetinib-PLX-4032 (8-1 mol-mol),4.085577653340594,3.3104940092432322
HCC15,9868037,2.5640614102548556,3.5027394267768983
PaTu 8902,6918837,-2.118913626513807,-2.651789338361281
ALL-SIL,23725625,2.2136327630148736,3.246813968625564
COR-L105,11455910,0.425998653780944,1.5305759430648596
K-562,16013152,3.768503882504226,3.4947316741101715
Daudi,67156097,-2.7448600083467163,-2.352674632089019
SW48,6610216,4.461301788418361,4.201224102722326
BICR 22,11977753,-1.1105881150796446,-1.3922128488904313
Daudi,753704,2.787779434331829,4.034107144438793
COR-L105,46943432,2.471907312248233,2.771581614725464
IA-LM,16736978,1.926640001137528,1.5687778158983954
IGROV-1,176870,1.8349827429681411,3.2001250642415484
SK-CO-1,148198,-1.1611262776602205,-3.17031947560686
HARA [Human squamous cell lung carcinoma],219104,4.732621852676119,3.9625821696604806
IGROV-1,46943432,4.105714883822214,2.3538219799527678
LS411N,168312962,3.224541058203402,1.179823318868517
LS411N,1641662,3.6634193785306337,3.164341127047445
HEL,vorinostat-navitoclax (4-1 mol-mol),-0.226382947191329,0.008046051454804228
LCLC-97TM1,26596,-2.266692800551727,-1.4228746130609151
HEL,151289,0.2321343459174182,0.5650689714700177
Daudi,1285940,3.7558538743643792,2.566728502873928
MOLP-8,2749,1.3302247490678565,1.0410136012890236
RERF-LC-MS,10427712,4.250983789220692,4.3631678314576225
WM115,16725315,4.630500047502962,4.319574077563711
Granta-519,9840324,5.864872193260208,5.574624869371934
HuP-T3,25262965,3.989652761156405,-1.0924305136183396
NCI-H2452,11719255,2.41462187851326,3.603991831192572
COR-L105,1641662,3.72017777917812,3.7369969803199616
SaOS-2,89928392,1.2892186505806515,1.4256540834997906
LS411N,969516,3.2917111714105647,2.259255508898717
Panc 02.03,carboplatin-etoposide (40-17 mol-mol),3.971241945633474,3.1742326188111925
NCI-H2452,327653,3.049758242791241,3.2503101840740998
LS180,4521392,3.9983682640735094,4.283922623225106
IA-LM,2113511,5.955012720035456,5.349251260155532
HCC15,11167602,2.587200682435675,2.4240236116828577
RCC10RGB,9911830,4.5526597563763795,2.9008740957221164
P31/FUJ,168312962,2.530788243280419,0.335116256273267
ML-1 [Human thyroid carcinoma],136227331,5.904689393841422,4.111086535355554
ML-1 [Human thyroid carcinoma],11609586,2.006327876020203,2.976805415324658
Granta-519,9933475,1.54115480203428,1.2714711329038708
HuP-T3,73707398,1.153693297692098,1.3587120954303153
SaOS-2,409805,5.764413924489168,4.721478907213539
KU-19-19,984333,-0.867877464903324,0.7835519915663286
HARA [Human squamous cell lung carcinoma],5351362,1.123570314509272,1.6776882350110716
LCLC-97TM1,selumetinib-PLX-4032 (8-1 mol-mol),3.0304859741823944,3.3119385933517744
P31/FUJ,navitoclax-pluripotin (1-1 mol-mol),-1.7547710657643,-2.2812543155515286
SW48,6918837,-4.354568378072889,-2.7911073593717117
LCLC-97TM1,16741245,5.12826814210941,3.5733006584133005
NCI-H2452,11507802,3.578778888517491,1.8811352805773356
HEL,11175137,3.15338888234114,1.6871297168497146
BICR 22,60750,-4.532323865382038,-1.344749887054672
Granta-519,44491742,4.018752292224149,3.734262895339052
SK-HEP-1,12003241,-1.7510835313415607,-1.1043718811553043
SU-DHL-6,36314,1.1358641594844867,-2.8620929868519123
HuP-T3,11152667,0.3145958176635,-0.2660954740062319
Granta-519,15547703,2.599412791530534,2.637698113279468
IA-LM,25126798,4.097105087874825,3.6793693481579317
MOLP-8,119182,-1.11255726511749,-1.7764558750632065
BICR 31,65064,5.259646525120305,4.94747372621035
COR-L105,6917907,-5.504495586582428,-4.833144942551112
LCLC-97TM1,11238147,1.840896458617422,2.8044342276359853
HEL,51039095,2.698396554100347,2.153648435848242
PaTu 8902,44185566,2.9137350944736653,2.50748173871419
Daudi,53495165,-3.885820769064659,-1.9659821329351805
BICR 31,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7385932494474976,3.997712522104117
MOLP-8,439501,-2.9296652389863267,-2.427001156230575
Panc 02.03,4259181,2.0313571914007604,0.5042737922645648
PaTu 8902,126941,-2.2828817630557228,-2.48127835341013
RKN,5328940,2.201806852003849,1.6695893271790938
PaTu 8988t,SNX-2112-bortezomib (250-1 mol-mol),-1.5745385961478635,-0.9106637807404171
HARA [Human squamous cell lung carcinoma],piperlongumine-MST-312 (1-1 mol-mol),1.5629845870291592,1.8048573150887801
COR-L95,246676,4.317733637680926,3.9405526335592795
K-562,135928012,4.4390204871751004,3.9510901874448194
MOLP-8,56946209,-6.528820954061854,-4.789294887529203
SW948,selumetinib-decitabine (4-1 mol-mol),0.3455932815007744,1.6966487543294593
COR-L105,135421197,1.9442341701951136,2.1811585141157677
HARA [Human squamous cell lung carcinoma],374536,3.8012573814376567,2.813757271143717
IA-LM,selumetinib-MK-2206 (8-1 mol-mol),3.1087327611966185,1.8318724934944612
ML-1 [Human thyroid carcinoma],56649450,4.029501942502391,3.3711270659126176
RCC10RGB,5280436,4.525748645562069,3.6332410687660803
NCI-H1568,31703,-1.6950574450364193,-0.5854124137542749
SW1271,148198,-2.630785543453804,-2.9944387533484824
Granta-519,11964036,1.5223427206827596,0.04126954365355937
MOLM-13,16725315,3.788691115651132,3.6478637120602633
Panc 02.03,1716436,3.766168811644757,3.192647792327459
SaOS-2,JQ-1-UNC0638 (2-1 mol-mol),1.2943206739427773,1.790660185164288
K-562,1566236,1.8179642124055264,1.8009835188339949
RCC10RGB,409805,6.020159348453613,5.0404880491677355
HuP-T3,navitoclax-MST-312 (1-1 mol-mol),0.8342028342455182,0.9838124362436399
HCC1500,11175137,2.755904594476177,2.749344212137763
HCC1500,11494412,1.8019649514762912,1.641646934926258
HCC15,10127622,3.735977541508184,3.736903003845697
HARA [Human squamous cell lung carcinoma],4096211,1.410240196225579,2.2263555718285004
SK-HEP-1,168312962,-1.3309808369359073,2.0814472493510494
COR-L105,24180719,3.693037976394381,3.5279093837988413
Daudi,46943432,0.8866201698678313,0.8572044170256313
HCC15,BRD-K27188169-navitoclax (2-1 mol-mol),-0.2430288225821102,2.1648743750803483
Granta-519,24180125,1.2477770260094014,2.24947367817669
RKN,9967941,2.6996754619948065,3.6510032770542544
RKN,135398516,1.9656218312143572,2.451230504188921
KU-19-19,16115403,-3.194116920729502,-3.7267533143703777
SW948,56949517,5.5880132005349505,3.9375516411689504
NCI-H1568,44632017,0.9967277604489184,1.3209802732318496
COR-L95,11175137,2.52315362607855,2.3802642532034586
NCI-H1568,676352,1.7505105304855018,2.066848632561306
NCI-H2452,126941,-2.0674603287446964,-2.838480261963006
NCI-H2452,4477,0.2060981637085811,0.6608141929153696
SaOS-2,vorinostat-navitoclax (4-1 mol-mol),1.3300754000959574,0.9270161993128125
LS411N,vorinostat-carboplatin (1-1 mol-mol),2.115093899053651,1.9412656629055507
BICR 31,11647372,2.8607835505972035,1.178324481170684
WM115,52912189,2.2242444616857417,2.3763557284419927
COR-L105,2729026,3.0417945234466863,2.7234358803141667
COR-L95,65064,3.24172080303354,4.359309470676519
IGROV-1,54613361,1.0826132998561049,-0.2774295051341273
NCI-H1568,53232,2.5527200815554587,2.9520832478263745
IGROV-1,9884685,-0.088911709267569,0.5980159059769895
HARA [Human squamous cell lung carcinoma],104842,-3.702627319243614,-2.599494261269803
SW948,16720766,3.3510678765666517,0.18595697703061853
ALL-SIL,135928012,2.5698772014589992,3.7912287850015156
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.5234453959586867
COR-L95,56946209,-6.902335125637694,-4.327575586959695
IA-LM,49867926,4.185996432673056,3.6901484819985364
SW948,11625818,3.962309646097391,3.802641271480293
IA-LM,4259181,2.3536383664390734,-0.28815100025201545
NCI-H1568,4259181,0.5766231269303183,0.19003031736336135
SW948,6438330,3.286047925562068,2.201783597398879
P31/FUJ,15547703,2.950164329068843,2.599709214717676
COR-L95,1750826,-0.7485912803642704,-1.4545422685579155
HEL,51037431,1.91843497941606,2.7464157012236283
BICR 22,vorinostat-navitoclax (4-1 mol-mol),0.9224898382798205,0.5955425205041146
Granta-519,462382,0.1364457210972633,0.3639346897589253
LCLC-97TM1,11719255,2.8064116850649774,3.1821106287726235
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-1.2974237520868712
MOLP-8,1242560,2.9421278446513393,2.987958138331578
WM115,9911463,2.5241618652619007,3.8507501544304894
RKO,3025986,-0.6013959236761957,-1.1952613016218216
PaTu 8902,5335621,4.440333682211631,4.610361369377426
NCI-H2452,19582717,3.9299005055458793,4.47889861812443
NCI-H2452,171352865,2.832902682703541,3.1537160502817727
COR-L105,5566,3.258554573596101,3.0726908400171196
BFTC-909,11647372,1.2423847125416496,1.2924962449617456
Daudi,3503,0.8148417795144576,1.8741477911674098
COR-L105,25183872,-0.7403581245059931,-0.39890914087804286
ALL-SIL,375860,-1.552794194023853,-0.7437199946657348
HuP-T3,72193861,3.3106720937076233,1.9914562607897128
NCI-H1568,ISOX-bortezomib (250-1 mol-mol),0.1016439372832729,0.663660730001847
SW1271,6438330,2.1351654373433764,1.9017490289860506
SU-DHL-6,25262965,-2.983432395440536,-2.6010230824277563
SU-DHL-1,serdemetan-SCH-529074 (1-1 mol-mol),1.762662031403703,1.622532499989954
BICR 22,JQ-1-UNC0638 (2-1 mol-mol),1.3883099593452988,1.4399686609512563
SU-DHL-1,44489367,4.533806271256096,4.6637869660632285
MDST8,31703,-1.4422735490012837,-0.6912936683755073
ML-1 [Human thyroid carcinoma],568763,0.2556406277244685,0.7222238899119787
IA-LM,10302451,4.177351274859187,2.9329218724192487
SW48,11214940,3.1705360221414134,2.078858159835151
RCC10RGB,10074640,3.4095283906874956,3.174025431233779
HCC1500,carboplatin-UNC0638 (2-1 mol-mol),3.485346920824326,3.2800028253926525
COR-L105,25227462,0.5095099099095757,1.0861590981863627
COR-L95,66577038,3.0490878420221934,2.737446874765323
LS180,46191454,1.5509574675684803,1.455223816060592
RCC10RGB,65064,5.251967206688168,4.937586423362988
IGROV-1,72376,-2.111352545322758,-1.665119875909995
MOLM-13,89183176,2.661461024404157,2.9324355524375547
LCLC-97TM1,doxorubicin-navitoclax (2-1 mol-mol),-1.1891183752031609,-0.8567688866551929
RKO,3384730,1.0492755436091918,1.7832365424216992
SW948,11656518,-0.9054812480406104,1.5050147989057916
ALL-SIL,2949965,1.286096946783907,2.106821323194083
ML-1 [Human thyroid carcinoma],selumetinib-tretinoin (2-1 mol-mol),1.8296865613090936,3.2183591634847937
RERF-LC-MS,selumetinib-BRD-A02303741 (4-1 mol-mol),3.278081284431068,4.10309720404393
K-562,5287620,-0.244838249137823,-2.3600266839103043
Granta-519,3825829,3.4773445434270243,3.186284007991955
MOLP-8,10385095,0.909191851453096,1.067446632344304
COR-L95,135928012,3.4969711227856397,3.954252511551861
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.622759622413082
UACC-812,25161177,3.457735095549926,3.7573253123281267
SK-HEP-1,11178236,-5.847785565222589,-3.469709521702868
SW1573,16741245,2.047879460545898,3.8211428691807923
K-562,vorinostat-navitoclax (4-1 mol-mol),0.9167311998987592,0.7472443148722077
K-562,89183176,3.981701702250952,3.329239938659875
P31/FUJ,9915743,-0.8907797257006451,0.05376490499790398
WM115,3503,1.3325075362119865,2.4665773857383417
PaTu 8988t,44202524,3.9754310935930968,2.183791561989541
SW948,9952709,2.6604018004594514,2.392944462298743
Granta-519,56946209,-6.359988120178517,-5.137511488566852
NCI-H1568,navitoclax-piperlongumine (1-1 mol-mol),1.526760839095053,1.8774607552349643
Daudi,613000,1.9882519691431488,2.0400010620619855
RERF-LC-MS,374536,3.716253113618047,2.619299690119994
LS180,72734382,4.032476699930466,4.5826188354928306
Daudi,1566236,1.0534301581716357,1.4567964894029537
BFTC-909,9868037,3.24226767674478,3.4545836571241906
HuP-T3,107985,-4.90392348596967,-3.4084712273747364
BICR 22,crizotinib-PLX-4032 (2-1 mol-mol),2.04605335326416,1.9318861521038193
IGROV-1,168312962,3.022863957843741,1.8401221727298573
IGROV-1,3081361,0.99973562532788,2.17246431964548
BFTC-909,5311,1.6846521587280363,1.531218565900587
NCI-H2452,2841722,4.2339337769073175,4.380436999973569
NCI-H1568,navitoclax-gemcitabine (1-1 mol-mol),-4.7036832419339865,-0.7068421412024822
RERF-LC-MS,5278396,3.382202757419261,3.5919996166112678
COR-L95,44607531,1.1147625805359247,1.2037224837249496
SaOS-2,135440466,1.1747227113697256,2.069669304786023
RCC10RGB,285033,2.114091727684993,-1.3726181127874697
SW1573,448949,2.6434946381292703,2.0160826331522417
SK-CO-1,11964036,1.41955554287601,1.3970692338055515
SK-HEP-1,24901704,5.545234809796251,3.525899025903754
RERF-LC-MS,71751553,4.213964581210796,4.424740064295277
SW1573,11178236,-2.507507612037206,-3.3318535809408587
HCC15,6450551,1.6627728253820353,2.8939979802331894
SU-DHL-1,54619267,3.144461009217004,3.802168151185327
P31/FUJ,11626560,0.2148563033664798,0.7563348559853216
COR-L105,119607,5.370152891195211,5.342835925220276
NCI-H2452,11427553,2.818972077820031,2.8030315223864575
HuP-T3,2871966,0.5817483683031975,0.5124870772032764
Granta-519,439501,-6.00499370561019,-2.5770373322026425
RCC10RGB,JQ-1-UNC0638 (2-1 mol-mol),2.5689754136574425,2.094565825867445
SW948,navitoclax-sorafenib (1-1 mol-mol),1.76041571963915,1.413573647004931
BICR 22,2945648,3.5832925483527625,2.846806987591446
NCI-H1568,11228183,4.140816994678141,2.5105258512755295
COR-L95,89928392,1.3878824566143364,1.1203072561204288
BICR 22,2871966,0.0284401826322965,1.167212367146662
HEL,46199207,2.3973871372245372,2.9290098491139793
HCC1500,52912189,2.5783780690097857,2.428988374563082
KU-19-19,52947716,-4.518413756843173,0.0023026615253119776
ML-1 [Human thyroid carcinoma],5280436,5.01828711367565,3.5791874703800666
NCI-H1568,7326481,2.864470016727109,3.11318396928177
RKN,53232,2.2291100881655037,2.7829565307651514
KU-19-19,4477,-0.0533500132034658,0.44344728106387643
SK-OV-3,107970,2.5604111984812152,2.4048585264894045
BICR 22,1242560,3.7933374150058015,3.4912580231371275
ALL-SIL,5738263,2.854339564213428,2.7091011814083306
HEL,5329102,1.6539669706420914,1.3225415815646295
LS411N,selumetinib-BRD-A02303741 (4-1 mol-mol),3.2423717644429577,2.7305858710289983
SaOS-2,3854666,0.6354016080385003,1.8125919077222579
P31/FUJ,107985,-4.114404549725097,-3.8339118040171014
SK-HEP-1,54619267,4.307302877095537,4.216318955491398
MOLP-8,11213558,1.2108381509164672,1.2732698591000464
LS180,6914657,-4.58065814502937,-4.020793319639729
HEL,71466380,3.121887792191312,3.8243263831504324
COR-L105,25154868,4.769445801979145,4.540931343621811
LCLC-97TM1,25105715,3.527934306265534,3.280910480053811
SW1271,16013152,5.485365595141675,4.144080618182593
ALL-SIL,1750826,-2.8707446972397483,-2.9376774383948527
SW48,44632017,-0.021210675828241,1.2827317581253317
NCI-H1568,4578,4.166510450069308,4.111143042826652
SW948,24180125,1.460789729891403,2.273213919177789
COR-L105,25161177,3.712985248467103,4.279096419145804
P31/FUJ,57519531,1.451496749892495,1.5541758758843611
ALL-SIL,6918837,-4.772645295536399,-4.737009815819688
RKO,16720766,-1.2722083569090707,-0.04189157826921756
Daudi,11707110,2.6257952816009498,1.294340572506629
PaTu 8988t,24785538,3.127280515757933,1.6167551233191597
PaTu 8988t,selumetinib-vorinostat (8-1 mol-mol),4.764605515620316,2.535242838782691
HEL,46174525,3.393297616528365,3.218814725411039
MDST8,17759555,5.018522859633252,3.833592119123776
SW1271,53392493,2.79081275696651,2.6726440237592226
COR-L95,carboplatin-UNC0638 (2-1 mol-mol),3.064030034312791,3.159181386028462
SU-DHL-1,9927531,2.969590320438058,4.489756738328648
Daudi,445455,3.7530002864178416,4.046569872719797
SW948,24951314,0.7675285489701543,0.7710470271450022
IA-LM,JQ-1-carboplatin (1-1 mol-mol),4.993034474620053,0.287903025582555
SK-CO-1,9866186,-0.7388742913087788,1.0068267808953326
RERF-LC-MS,60700,0.497286081450591,0.2420157292593487
BFTC-909,11364421,-5.034674750215906,-1.8191579160728653
SW1573,49766530,-2.79322841384178,-0.5121179644604936
COR-L105,vorinostat-carboplatin (1-1 mol-mol),4.069993227019241,3.2764540135390785
MDST8,25126798,3.890491738661291,3.981787870389636
HCC1500,3543504,4.272332537756205,4.47643692168914
COR-L95,25062766,3.209944577871265,2.1018644641425883
ML-1 [Human thyroid carcinoma],5351362,1.4214743835970418,1.843411137905453
SK-CO-1,44632017,0.9847861620501556,1.347741664859997
NCI-H2452,navitoclax-piperlongumine (1-1 mol-mol),2.2697751233857058,2.0759965828827642
NCI-H2452,445455,4.8000860101003235,4.776016715265692
ML-1 [Human thyroid carcinoma],446155,2.0206180645356766,2.6541521648257937
HuP-T3,439501,-2.469428626730465,-1.9909323640233587
RERF-LC-MS,9884685,0.4531053665233772,0.8761390409672114
RKO,5281321,1.9988379902215376,-2.188001933013663
NCI-H2452,10410894,4.350169635958685,3.374562054437654
HuP-T3,24951314,1.4235135044150102,1.520701752429661
SaOS-2,71466445,4.363709574185696,3.8441160851744542
BICR 31,44185566,3.0664042381745946,2.731479425920654
NCI-H1568,11625818,3.359978935972883,4.580865298107812
BICR 31,3552672,2.13577451695998,2.6061607482164124
P31/FUJ,decitabine-carboplatin (1-1 mol-mol),1.8939659397992608,0.38107884405963494
HARA [Human squamous cell lung carcinoma],11640390,3.0925981241806983,3.4612238191942906
ML-1 [Human thyroid carcinoma],55283,2.9349831464401936,2.7211322141220764
LCLC-97TM1,119182,-0.294501899208461,-0.544405403559389
ALL-SIL,52947716,-0.7216046839402591,-3.237871772175286
RKO,11640390,5.295981617059328,2.418216128262859
RKO,25150857,2.5785304193211247,1.6145589108246248
RKO,erlotinib-PLX-4032 (2-1 mol-mol),3.5689359084165124,2.8163632204427085
ALL-SIL,1716436,3.0252724323132374,2.4859685334298436
RCC10RGB,262093,2.8343922904091134,2.94377223248936
HARA [Human squamous cell lung carcinoma],135411,-0.5831763791629045,0.8876980577210972
SK-HEP-1,439501,-2.4482777943885856,-1.8329962735145355
RKN,71466380,6.199959456698308,4.5096251300968815
HARA [Human squamous cell lung carcinoma],19582717,3.08314824082211,4.184482838534471
RERF-LC-MS,1242560,3.610791422912421,3.637637220878921
SK-CO-1,ISOX-bortezomib (250-1 mol-mol),-0.2509608033573304,0.6870676407715692
Panc 02.03,66577038,3.3089612685646985,3.049235416804676
LCLC-97TM1,52947716,-3.0616129604635565,-0.937262070015377
SU-DHL-1,20959075,-3.3128713931491087,-2.714777228859253
BICR 22,2113511,7.552062733189383,5.584633161897929
SW948,25126798,3.357341035223679,3.779215407065883
HEL,3854666,0.8085723321900852,0.7518846006687244
HCC15,168313047,3.1265794948701338,2.434564510988581
WM115,107985,-2.5041726579949857,-3.401716906403887
WM115,42611257,-0.3600732192588895,2.8180573306842804
HCC15,60700,-1.3823438115431317,-0.428819988946033
COR-L95,alisertib-navitoclax (2-1 mol-mol),-1.2067075871406427,-0.7925754372703353
PaTu 8902,navitoclax-MST-312 (1-1 mol-mol),2.8235677032410873,1.0253620639348469
SW48,60750,-4.2221568193195225,-2.0164889814298035
NCI-H1568,262093,2.8880881470868585,3.0983740637265607
PaTu 8902,53392493,3.316041661234319,2.846431318551438
Granta-519,11647372,1.7523915142224398,0.20448629650435063
SK-HEP-1,8515,5.0523689066797495,3.9666664814484935
SW1271,decitabine-navitoclax (2-1 mol-mol),4.244493551272361,1.8384917813842874
LS180,702558,5.586038369213652,5.065022206024361
IGROV-1,15983966,1.7101486625531308,-0.9147466255119435
SK-CO-1,6505803,-2.970063061644963,-0.7270560319518203
SaOS-2,navitoclax-piperlongumine (1-1 mol-mol),1.6017048786640289,1.5019721286486618
PaTu 8988t,11485656,1.82057121616084,2.4050272373853545
KU-19-19,2874250,6.302627434426347,4.212568588866875
MOLM-13,11175137,0.3158641445144168,1.7491518857963848
WM115,644241,2.021542714802758,2.325517249367436
SW48,52947716,1.8444935422046616,-0.6510182943335043
NCI-H1568,10302451,3.040030486332468,3.181525522160178
COR-L95,44185566,2.2555949878605484,2.234213298047776
LS411N,16725315,5.1123164266785714,3.824684441727357
BICR 22,25195348,4.085059979970886,3.3876718875248657
SaOS-2,5311281,0.944453452900516,2.2609362261425727
SW1271,613753,3.197731710568041,3.1847544274784725
IA-LM,9840324,5.344700856558617,5.5272252519077405
LCLC-97TM1,439501,-2.367039612081251,-1.8516476136032896
LS180,9825149,2.508714096118433,2.058819451225452
COR-L105,9911830,1.908645944756667,2.677322491950108
Granta-519,25126798,3.857539921377872,3.2629217527645547
K-562,11238147,1.4367734907149323,2.008609414200729
SK-CO-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6721111669479054,-0.8029587328046568
IGROV-1,4705,3.3098412390054603,3.225659534639573
RERF-LC-MS,1716436,4.437154842045929,3.0086817757848703
COR-L95,6918638,0.5429028056483723,-0.15580095789313625
BICR 22,11507802,1.0844954054416946,1.9045230329552825
Daudi,54626689,2.8292455243221264,4.25207855696409
COR-L105,148124,3.589067174421039,-1.0032954826666498
HEL,selumetinib-JQ-1 (4-1 mol-mol),-0.6322408734916383,0.09089848566047934
IGROV-1,9825149,2.5588021380929553,2.154405046246967
LS180,2113511,7.0742493322433955,5.524834431481537
MOLP-8,16038120,-1.6086793301450355,0.1353862834373254
KU-19-19,67291369,2.2261044123877656,2.8900774628365955
COR-L105,carboplatin-etoposide (40-17 mol-mol),5.23047829437091,3.13398397461574
HARA [Human squamous cell lung carcinoma],6505803,-0.6058988133854029,-0.6335686530502795
MDST8,navitoclax-gemcitabine (1-1 mol-mol),0.2783653553106409,-1.3461215362568584
Granta-519,44462760,4.300929542453815,2.5799214151908334
MDST8,tretinoin-navitoclax (4-1 mol-mol),1.0614057430446846,2.6814848359180594
KU-19-19,17755052,6.06318579738538,1.9705564876743333
MDST8,11214940,-0.3312007430689519,1.670181548118804
SaOS-2,57519531,1.7793183342968584,2.4810071985842357
BFTC-909,erlotinib-PLX-4032 (2-1 mol-mol),4.45664321306644,3.071600449356525
LCLC-97TM1,44493528,4.18527882332477,4.194100043494671
LS180,decitabine-navitoclax (2-1 mol-mol),3.265284502098727,2.134798532406692
SW48,10231331,-2.95597966611556,2.0488766378415217
SW948,24797083,1.9027092264791332,1.3461980487127332
IGROV-1,11238147,2.1723642292765084,3.0742671027762407
COR-L95,17755052,2.817022282186957,1.4900977783321798
LS180,25126798,3.79328534931886,3.667422789074599
IGROV-1,71304818,2.4878074097553378,2.4835682188186397
SK-HEP-1,10302451,4.165168773877425,3.364124290738523
HCC15,25102847,1.68346873279249,2.40617772920072
SK-OV-3,15983966,-3.6834707194333927,-0.8567160772618359
HCC1500,54143018,1.195335139641603,0.8755759576579938
COR-L105,11364421,-0.5536252833264237,-0.8000991253182786
RKN,148198,-1.0178445286580065,-3.260175081212195
KU-19-19,400769,-0.482585358097733,-0.6735179290270129
COR-L105,7326481,3.3886978035876547,3.142901787844128
COR-L105,44819697,1.466179589978979,0.005411043821233775
SW1271,5281672,5.179464513143849,4.494358769189954
PaTu 8988t,3634881,3.651211463421112,3.3265514120653803
IA-LM,11404337,0.4340662777154989,-0.4793577223186447
NCI-H1568,5287969,-2.4053225408736405,-1.5932504553478806
ML-1 [Human thyroid carcinoma],60750,0.2716917716617745,-1.922429338987512
COR-L105,54619267,4.07987987500145,4.105493108533683
SK-OV-3,9907093,4.994966956142975,4.2748745395585885
ALL-SIL,11167602,0.1759872916057691,1.6437428724992418
MOLM-13,49836020,-0.1965532240483963,2.908969034760419
HCC15,52947716,3.127529556956005,0.16618495312815224
SW1573,4261,3.544037815747042,1.6932260104966543
MOLM-13,6184667,1.666374934082413,2.0452324156411263
SK-HEP-1,3854666,3.0622551399292264,2.3701070033282705
Granta-519,241158,3.1692083740262373,2.4699754573966333
MOLP-8,5978,-7.284134927472065,-2.957200917391276
LS180,10302451,1.4669812473297774,2.551027474501686
RKO,16065773,3.3120716405166615,2.2083434233765824
MOLM-13,24964624,0.892926396159225,0.6106150385855857
KU-19-19,11427553,3.4053411651543035,3.0290780354711644
SK-CO-1,44137675,3.0714779264964074,3.4952622306733487
P31/FUJ,6852167,1.016015239887951,1.7261513461618136
HCC1500,5351362,1.2955308259083285,1.426767016964422
ML-1 [Human thyroid carcinoma],11964036,2.920411614995081,1.4694838898829239
MOLM-13,252682,7.80657372951634,6.279717895983745
HARA [Human squamous cell lung carcinoma],57330099,4.527264318285619,3.892157485281084
HCC1500,44607530,1.2894809747133489,1.5308801841454538
SW1271,3025944,4.184087558749553,4.243621030835857
HCC15,44493528,4.34604946513687,4.419756197855359
P31/FUJ,6918736,-1.9353169891324984,-2.3789907781292494
ML-1 [Human thyroid carcinoma],168313016,5.516575315061805,5.0449533792566505
K-562,24856436,0.0017034666231649,-0.22501112463467596
LS180,216468,-0.2416288368660945,3.105639205143734
SU-DHL-6,11507802,0.7208159532280615,0.4187805671435993
SW948,5291,4.046310039203204,3.5737338216072403
ML-1 [Human thyroid carcinoma],46398810,2.1486791434985344,2.649538002561007
HCC15,11152667,0.1037945221143532,-0.3514774480485238
K-562,selumetinib-GDC-0941 (4-1 mol-mol),2.3648746020483284,1.2050932325151595
Daudi,piperlongumine-MST-312 (1-1 mol-mol),0.9306925214047892,1.1414806489547826
SaOS-2,49766530,0.3706728408995327,-0.5734650398275712
SU-DHL-1,168313016,5.361416197440646,4.570245591803075
HCC15,168312962,2.4994502868710677,1.6395891541557672
IGROV-1,24797083,1.5319862293819655,1.2853330235387879
WM115,71751553,4.133313051647094,4.448351679203075
SW1271,24951314,2.0404240106098723,1.4739469017805036
Granta-519,SNX-2112-bortezomib (250-1 mol-mol),-3.1352941908416243,-2.933756561917591
SaOS-2,676352,2.2074841133021432,2.0692459795106104
P31/FUJ,322968,1.4419696378870497,2.451673110204722
SU-DHL-1,10127622,2.7675483211751466,2.989626384798445
COR-L105,44137675,1.808161252080405,3.7851344953246437
PaTu 8988t,11625818,4.482422780967983,4.696404968768357
HARA [Human squamous cell lung carcinoma],156414,2.353598180094054,1.3659813528617
Panc 02.03,16038120,1.606654693103348,1.2079545730877441
BICR 22,3854666,0.9977305103930704,2.136282678940759
Daudi,46398810,1.6020476162665716,1.9637963547112356
COR-L95,984333,1.162546188419483,0.37913136326531377
WM115,1317464,3.7806694387813753,2.9354462751048604
K-562,71680916,4.727537128358906,3.9502979692512326
BICR 31,25183872,-0.4870171412848909,-0.5591327187361633
COR-L105,11626560,2.2911739511823503,1.9107739150200347
SW1271,9936388,2.2656701786136315,-1.3892936994739697
MOLM-13,135421197,0.945680487717708,1.277389207169766
SK-HEP-1,136227924,3.6301481247272287,3.198449179000605
K-562,375860,-0.3542925626582329,-0.48402687581099796
SK-OV-3,9887053,4.42879128381072,4.179495811387134
LS180,9936388,-5.017955750811216,-1.6285522766742528
SW48,9935249,1.3330175828473068,2.6438734375765645
SW1271,11214940,1.5931636594582963,1.7301555839736045
BICR 31,serdemetan-SCH-529074 (1-1 mol-mol),3.0027631707479467,2.1973233572390085
RKO,67156097,-1.3338800856316015,-1.7438171067938557
LCLC-97TM1,51039095,2.799665973949055,2.7347731950795118
MOLM-13,54143018,-1.3895840664016086,-0.6382333860181366
Granta-519,5738263,2.4520737989935246,2.531644469970095
SW1271,2828334,6.430891789984985,6.207482580915358
COR-L105,salermide-PLX-4032 (12-1 mol-mol),5.562133960836907,4.8746465208281675
HCC15,3136844,4.306118753112888,4.530954253399005
IGROV-1,54454,2.453541831966438,2.6891884160166946
BICR 22,9935249,5.2884064452137585,2.9056392944620315
BICR 22,72376,-2.4643814155147634,-2.0725152993679683
HARA [Human squamous cell lung carcinoma],71304818,2.9544117211144147,2.549946468087301
ML-1 [Human thyroid carcinoma],selumetinib-MK-2206 (8-1 mol-mol),-0.7620404937141786,2.167845322464799
SK-OV-3,25022340,0.9085118587340768,2.8056684648227974
HARA [Human squamous cell lung carcinoma],11167602,3.2969276962649823,2.381714353290205
P31/FUJ,11238147,2.0504580426090286,2.0193377644353503
NCI-H2452,44607531,1.7526351480007742,1.7256742897174921
SW48,selumetinib-navitoclax (8-1 mol-mol),-2.7874089121789662,1.8947982680809545
WM115,119607,3.834781850796951,5.49397224890583
IGROV-1,71466445,2.3758001916617797,3.9937131644943182
SaOS-2,54618164,4.337585482929099,4.045806451662501
SaOS-2,46843906,2.56299568717197,2.824956736249972
SW1573,navitoclax-sorafenib (1-1 mol-mol),1.0822173392973782,1.6040450871264822
LCLC-97TM1,2841722,4.284298549740087,4.122300432560426
LS411N,36462,3.380504085081747,1.726988913574879
COR-L95,637858,1.3348673917451612,1.5902048709222243
HuP-T3,10113978,4.191114511390656,3.465608380980139
Daudi,selumetinib-vorinostat (8-1 mol-mol),1.8930359660265372,1.83378405825622
MOLM-13,24772860,-4.1681928866236415,-3.0144018865271986
WM115,9823820,4.472944540337913,4.085716583896656
MOLM-13,3676137,4.483658238026924,4.0813674193427625
MOLP-8,49766530,-0.668776240648524,-1.7605971969133634
SW1271,107970,2.3235168881670285,2.389934458107262
PaTu 8988t,16065773,3.154821962511545,2.3141011973029806
Daudi,tretinoin-carboplatin (2-1 mol-mol),4.019264736178175,3.1700810792503105
SK-OV-3,JQ-1-UNC0638 (2-1 mol-mol),4.235651526458717,1.9605503292703674
Panc 02.03,selumetinib-UNC0638 (4-1 mol-mol),4.3993780952510955,2.670123292784132
RERF-LC-MS,selumetinib-PLX-4032 (8-1 mol-mol),2.4830780225250413,3.4117339323665306
NCI-H2452,11364421,-0.8742390414707,-1.250136567478973
NCI-H2452,4788,5.30317679490816,5.677536707792678
P31/FUJ,11396600,3.188193103342261,2.7769968996743195
SW48,2130404,2.4705566813277215,3.2441756129029256
SU-DHL-6,322968,0.8712022459195665,1.995104874275085
BICR 22,107985,-3.867593954539223,-3.6568330256707977
COR-L105,46215462,2.588599789838095,2.1626539678766523
PaTu 8988t,5287969,-2.0890298278516513,-1.7262144290319512
SaOS-2,9866186,1.0217998308229927,0.7853919254487021
SW948,16065773,2.2305150921307653,2.3054292679576913
RERF-LC-MS,tretinoin-carboplatin (2-1 mol-mol),4.86238533641819,4.932132113218283
WM115,10127622,-0.9383410403940764,2.6511274346457867
WM115,2733526,4.043531113233861,3.7274510607187636
PaTu 8902,49850262,5.593248228762752,3.748482575804293
HCC1500,54613361,2.498230028210423,-0.19494232523552665
SaOS-2,ISOX-bortezomib (250-1 mol-mol),1.126416426166952,0.4057608335066686
Daudi,5746,-2.3170879531966273,-0.051401602528706014
MDST8,6610355,3.7892287954147457,4.764582511091088
SK-OV-3,219104,6.736269406359778,3.8124736344790624
MOLP-8,49793307,-5.094504062696007,-4.261706549868566
NCI-H1568,54626689,4.298451601405369,4.6376887570192205
IGROV-1,156414,1.4212019235656712,1.5898150563786748
Daudi,4477,-0.8111056564008632,0.6299450248224197
K-562,135398738,1.706304792848783,2.4732762386716574
MOLM-13,57330099,4.105312173478173,3.571980306919564
SW1271,42642645,0.8738549597199083,0.7735637405394588
SK-CO-1,tanespimycin-bortezomib (250-1 mol-mol),-1.8128298123800823,-0.8093075291729582
NCI-H1568,decitabine-carboplatin (1-1 mol-mol),4.2821372470380545,4.394509186650382
ML-1 [Human thyroid carcinoma],selumetinib-vorinostat (8-1 mol-mol),1.7610539005616883,2.485643053113075
Granta-519,16725315,3.130545070245978,3.5560901027091543
ML-1 [Human thyroid carcinoma],73707386,3.645367416812384,2.9504251399423684
RKO,3854666,1.2691133577357363,0.8878582678531325
SaOS-2,119182,-1.602754826097209,-0.3462160450153805
ML-1 [Human thyroid carcinoma],49793307,-2.0238665574613024,-1.8164229199388462
Granta-519,9843750,4.294258272153345,3.1716871782301923
MDST8,5329102,2.639161266907228,2.0582611983392316
Daudi,selumetinib-JQ-1 (4-1 mol-mol),0.1373274073902578,-0.2260555397988378
SW48,36314,-6.6979677874770065,-1.859051249080836
RKO,9825149,2.459088339864112,2.1067931202228136
MOLM-13,9911463,2.5287579203643986,3.105189125934173
RERF-LC-MS,44566777,0.4059341966526995,0.970652113841222
SK-OV-3,10184653,1.9718742380811307,1.1409643813696808
HCC1500,16219061,2.7461663809715375,3.0430327983413523
SK-HEP-1,9926054,1.934364320328667,2.0862789852985513
IGROV-1,24901704,3.0789156375765936,3.402002404617141
BICR 31,9933475,1.7480026685414405,2.027940132045169
COR-L95,3552672,1.407232830890507,2.236412139763679
NCI-H2452,ISOX-bortezomib (250-1 mol-mol),1.6045376494936,0.6361972638690616
COR-L105,66577038,3.4359280481345755,2.8991674245540655
COR-L105,24753719,4.356648297258706,4.456706651556796
ALL-SIL,24978538,-2.389127379896269,-0.7072359195155823
SU-DHL-1,3025986,-2.176216514163443,-1.3905681242207297
IA-LM,3062316,1.9598487648076035,0.6899228608277661
MOLP-8,448949,2.0087568721459146,1.4227710489918906
HCC15,89928392,2.045660123087396,2.0177817724153146
SK-CO-1,16720766,-0.9325558438762483,0.7594102979743657
IGROV-1,11485656,1.900409616013456,2.4004944477385313
HCC15,44137675,4.493981948720765,3.486526888903534
SaOS-2,5284373,3.659507244236858,2.916569630389157
COR-L95,44589607,1.7004659608333377,2.4013544884653384
PaTu 8988t,16659841,4.413190590676007,3.8973493421089795
MDST8,5311,1.1196330054843209,1.5985533690945244
HARA [Human squamous cell lung carcinoma],3825829,3.0637384073868787,4.066890623281472
K-562,168313200,4.769830643466651,2.8578898090160654
SU-DHL-1,36314,4.070517798024083,-1.6567830289158456
COR-L95,219104,2.3748233222255144,3.2605853850481226
Granta-519,44566777,1.2837383493022634,-0.33992288876773974
WM115,45279963,3.6868070952026506,3.915129506746772
HuP-T3,10127622,4.169685865232827,3.494974660141882
SaOS-2,54454,3.299905279612609,2.518446960318078
COR-L105,71466445,5.452991683251573,4.2275225228628495
SK-HEP-1,crizotinib-PLX-4032 (2-1 mol-mol),2.841663753001873,1.9803631684905907
COR-L105,19582717,3.403236730524823,4.566937771236624
K-562,11625818,4.129982389727392,3.7889851045351777
LCLC-97TM1,3384730,2.793888789676347,2.5919952213972226
BICR 31,4917,3.733916426719056,2.930159545122542
PaTu 8902,54619267,4.2510877724746585,4.080147596927585
ALL-SIL,25102847,-0.1309610459144975,2.002227076451928
MOLM-13,23939,5.7894293981406,3.3418711446071927
COR-L95,2828334,5.963676169995917,5.992414706257467
PaTu 8988t,44137675,4.243997881661858,3.6740282379991656
HARA [Human squamous cell lung carcinoma],675434,4.319126364052166,4.543486219185404
SW948,5978,-3.22198817122066,-1.6874509000175824
RKN,375860,0.0559819210079563,-0.07232840487176272
NCI-H1568,49836020,3.1231470101883336,2.403643436474792
NCI-H1568,12001922,1.1909466973303815,1.8705587355611897
HuP-T3,135411,0.8125735513868637,0.8770997036033612
NCI-H1568,119607,3.825066299684422,5.289612268234086
WM115,9825149,1.8328544820090609,2.061925550217226
WM115,104842,-0.2362637011987665,-2.301382833945272
P31/FUJ,327653,2.543614095842417,2.5229861082846363
RKO,11396600,3.504834935214814,2.626909441963818
SK-CO-1,135440466,-1.3303352220830715,2.332267977487686
HCC1500,sirolimus-bortezomib (250-1 mol-mol),0.0140631270051885,0.7455166100469967
P31/FUJ,23635314,-1.6494447832357666,-2.885592344269615
RERF-LC-MS,carboplatin-etoposide (40-17 mol-mol),1.469978322286411,3.043476556444034
SW1271,46215462,2.0233113088179406,1.8338514843967428
MOLP-8,969516,1.8716619229833695,2.197361594722363
K-562,135999136,3.657737204061429,2.498719109007875
SW1271,9866186,1.0057234740027048,0.9813117241360142
BICR 31,5278396,4.450921628721945,3.611804410514405
HuP-T3,462382,0.4397112913332706,0.5532844821058833
SW48,44202524,0.7134579720144102,1.975587499638427
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-1.3420938634621882
HARA [Human squamous cell lung carcinoma],6610216,4.810637550807952,4.379735077959341
LCLC-97TM1,3025944,4.079230434060959,4.195782620500891
SW48,46174525,4.111785915347283,4.5143982622989425
HCC15,11396600,3.725702968544969,3.8512714467813565
SaOS-2,2949965,2.5764816921436067,2.8504760686888266
COR-L95,selumetinib-navitoclax (8-1 mol-mol),1.0752689694736437,1.4906446670290663
NCI-H1568,10296883,3.9462373745058863,4.029990218183613
COR-L105,SNX-2112-bortezomib (250-1 mol-mol),-1.6644703388391169,-1.0008256267438282
Panc 02.03,216345,4.682043945218969,4.191479464243016
Daudi,26596,-3.612902475241139,-2.5112318242322025
NCI-H2452,262093,3.2163720661137942,3.054886050292866
PaTu 8902,9936388,2.1491039356268966,-1.1392072894288738
SaOS-2,4477,0.5134457679146515,0.5971744403591974
RERF-LC-MS,4096211,1.8582313750529689,2.000352706221341
SK-HEP-1,53232,2.505434368946379,2.8214801536209886
SaOS-2,crizotinib-PLX-4032 (2-1 mol-mol),1.6526017036303646,1.9359307194146538
KU-19-19,439501,-2.2192304341921205,-1.8607251130721598
SW48,11222830,1.1015320686905217,1.6278893585929084
P31/FUJ,71680916,4.420716560192731,3.820918350457469
IGROV-1,73707398,0.8848064516600974,1.3471493808954313
BICR 31,176870,3.2718013899021607,3.031855501927848
PaTu 8902,72193861,3.6637635590803384,1.6447338823613222
SW48,10427712,4.323791553226545,4.22408962398893
HuP-T3,5470400,-0.4965810223867313,-0.38704866591064124
BFTC-909,3385,6.578023483143935,4.4593696218878485
LS411N,5278396,4.113687735714835,3.103639968070674
WM115,carboplatin-etoposide (40-17 mol-mol),5.807621476943687,2.6151006312901175
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.682467064015046
P31/FUJ,36462,-0.6599401629031103,-0.3413880087540085
IA-LM,24964624,2.660053298461781,1.6098187361628415
Granta-519,4477,0.7960263088071861,0.5869736162361506
WM115,675434,4.127717546006753,4.542298978330311
SW48,2708,3.1864056833879726,4.929808037819745
P31/FUJ,11964036,1.0580497047985076,0.4462742642656744
SK-CO-1,4096211,1.2314360568652074,2.2798251704659505
Granta-519,24748573,3.0643863299071668,1.2148576078945938
HCC1500,salermide-PLX-4032 (12-1 mol-mol),5.277831355050616,4.693260760319897
MDST8,6918736,-3.3936356144084066,-1.270147052786233
IGROV-1,3062316,-2.2361832227909075,0.9176604980527842
Daudi,136227331,3.813653547789358,3.637216343229566
MDST8,3385,6.506797592159471,4.007745425388924
MOLP-8,3101542,4.39402228569031,1.523015711889013
PaTu 8988t,19582717,5.440280671607156,4.313839333772607
ALL-SIL,54618771,-0.3818526805852408,-0.040303587045873134
SW948,9911463,3.099005262739027,3.293260371651765
NCI-H1568,navitoclax-pluripotin (1-1 mol-mol),-0.6791877741589081,-0.4564755457448586
HEL,4259181,-1.3539346499127438,-0.24804291920533428
Panc 02.03,702558,5.477624163348055,5.390788255171742
RCC10RGB,9911463,4.415558893727306,3.8874544440918233
P31/FUJ,2828334,6.241721397046506,5.502398354282736
BFTC-909,53232,2.9810373365160316,2.6766139988881754
KU-19-19,1750826,-1.6748688873644846,-1.0713571746747659
WM115,54454,3.1744679186495963,2.7843795529718314
LS180,5329102,2.7428602070947266,2.097014562739866
K-562,25102847,1.0686863962440132,2.099785534703993
NCI-H2452,51039095,3.311280338748592,2.993195317220746
SaOS-2,107985,-4.209612864808627,-3.4862534667060885
RERF-LC-MS,24180719,3.6010609924552455,3.5741061705460297
P31/FUJ,9967941,3.859476565836545,3.1978237240613088
ALL-SIL,19582717,3.9660864037028793,2.979247280068189
BICR 31,448949,3.395825088667814,2.118640008749264
IGROV-1,9926054,1.8111808945519428,2.0021356496637677
MOLM-13,44632017,0.3571286974750209,0.6829192764889249
RKO,984333,1.1849980625737155,0.5095875402071612
BICR 31,tretinoin-carboplatin (2-1 mol-mol),5.271330190091957,4.952607376254178
LS180,5311281,2.3621140012684014,2.1879944950345713
IGROV-1,5328940,0.347812751869877,1.864613497105911
SU-DHL-1,126941,-4.504729002827146,-2.690404014407836
LS180,49850262,4.041689005821524,3.7601463624430824
RKO,selumetinib-GDC-0941 (4-1 mol-mol),1.3988498652301435,0.7788628332315548
SW48,10113978,2.97157913395206,3.3876691413633693
COR-L95,227681,2.232633220711044,2.9721046163372438
P31/FUJ,carboplatin-etoposide (40-17 mol-mol),0.2579285765316561,0.01150776433052218
SW1271,65064,3.2018268639765908,4.826842185598863
Daudi,2733487,3.89488184101632,5.2999009187377
MDST8,4096211,1.945430248625456,2.1486362702499524
MOLM-13,56963564,-0.6687647359934185,-0.36217270480780867
HEL,navitoclax-birinapant (1-1 mol-mol),-0.6071790485634636,0.13984811402916944
Daudi,216468,0.1519487612341026,0.8242416761062661
COR-L105,11494412,3.277457630260471,1.9070059173659997
BICR 31,31703,-0.4867862372580436,-0.7736805507860628
P31/FUJ,49793307,-4.015617000908982,-4.304825989308231
ALL-SIL,6450551,-1.4599471288533186,1.1385928522390905
LS411N,selumetinib-JQ-1 (4-1 mol-mol),-0.8055713738039206,0.0058080994519189135
SW1271,36462,1.4389686814792042,2.2140255338540142
IGROV-1,selumetinib-JQ-1 (4-1 mol-mol),0.7800599487705251,1.622759622413082
SW1271,17755052,4.188603356762487,2.0007392574453386
HARA [Human squamous cell lung carcinoma],9444,4.21141613858085,4.266145934296279
Granta-519,9967941,4.009641048767512,3.106689466801568
HCC1500,25105715,3.368057340132644,3.5220212128667288
Daudi,ISOX-bortezomib (250-1 mol-mol),-0.1612683603405773,0.01752908938424759
HEL,2858523,2.985624119180162,2.699020821193888
SaOS-2,3543504,4.845259948636094,4.373706701001829
HEL,71466578,3.2881122758034413,2.860016414098935
MOLM-13,44185566,-0.1979234147827578,1.4432755158258834
RKO,46215462,1.869666408515056,1.0153792785137505
PaTu 8988t,16720766,0.7633491404380248,0.7499019648974117
MDST8,17755052,0.7758841708349149,1.913855770664121
SW948,doxorubicin-navitoclax (2-1 mol-mol),-0.3830277458226139,-1.0126551349260213
Granta-519,16741245,4.459375532286075,3.4011783142950858
LCLC-97TM1,36462,0.8347023875377979,2.1618541519227303
HEL,24785538,4.025400084811953,0.3984623967365858
SU-DHL-1,piperlongumine-MST-312 (1-1 mol-mol),0.8193437205412945,1.6082840184970248
SK-CO-1,54613361,-1.1953747905350511,-0.00733634355830003
HCC1500,selumetinib-GDC-0941 (4-1 mol-mol),3.80127350150034,0.8465929954819018
Daudi,25105715,2.455657378323054,3.3167820912720765
SK-CO-1,3038522,3.74499401693701,3.0464047525151527
LS411N,11625818,4.428513603720294,3.5206238032972728
SW948,445643,4.022773961540602,3.8785330313517723
COR-L105,135984461,4.336047626093702,4.224433214835071
NCI-H1568,71466578,4.264938806787537,4.625362938534204
HuP-T3,11364421,1.6783982807514195,-0.9450309152089497
Daudi,49867926,3.659415180241599,3.0378495436775155
HARA [Human squamous cell lung carcinoma],navitoclax-pluripotin (1-1 mol-mol),-0.7875744304636512,-0.8106721620192476
SW948,11404337,1.0073661261070797,-0.1702455708563338
SU-DHL-6,5278396,3.0928075812605123,2.9347338144441384
SW48,JQ-1-vorinostat (2-1 mol-mol),0.3555995079043024,1.0218180165447834
PaTu 8988t,24964624,3.238300662516523,2.5762844375365948
Granta-519,135411,0.2246473977843227,-0.3245235180192283
LS411N,3025986,-2.0648766502168843,-0.7443795615823494
HEL,BRD-K58730230,4.651487565209977,3.0670684845550524
K-562,148124,-7.41486725283878,-3.6888897301695733
K-562,10302451,0.1323934402367818,2.866440601639499
K-562,1641662,2.591871767435193,2.849093014600819
ML-1 [Human thyroid carcinoma],54618164,4.279062995535924,4.253887609093425
Daudi,156422,2.1936092532092295,2.9193404802311096
BFTC-909,44491742,4.0640318167931255,4.397940536320663
PaTu 8988t,doxorubicin-navitoclax (2-1 mol-mol),-0.3664110079346409,-0.8702454001046234
MOLP-8,135398744,7.476327693514706,4.682300775024374
IGROV-1,54618164,4.2184521751950115,4.158250972031609
HCC1500,selumetinib-vorinostat (8-1 mol-mol),2.561295167839282,2.411759456906837
PaTu 8988t,4259181,-1.3402011211504403,0.31110135860939897
RCC10RGB,selumetinib-navitoclax (8-1 mol-mol),2.731385168920209,1.6723484422400399
KU-19-19,31703,-0.69897788572983,-0.5790884383367245
SK-HEP-1,5460769,6.10306620405049,3.0668979979572053
K-562,11404337,1.5978316825317844,-0.9511778152811384
NCI-H2452,9840324,6.282829349463256,5.891302980058097
HEL,JQ-1-carboplatin (1-1 mol-mol),-0.4400207777249079,-0.08110428500295437
KU-19-19,11214940,3.3843502872937106,2.3326798161136004
MOLM-13,3815108,3.4784839929418343,2.3840455323072804
IGROV-1,16065773,3.3717508464278585,2.474366898323353
Daudi,6252,0.2227136884944618,-1.7185039778291642
SK-OV-3,1641662,4.382504296977698,3.668329999887313
MOLP-8,11238147,1.6731293567937424,2.1456064934365915
K-562,44462760,3.6560426907742896,2.8037766791445278
RKO,9911463,3.963116579454927,3.216942242406519
KU-19-19,387447,-3.0100561484626738,-4.126975281747004
LS180,219104,3.901138037988577,3.6021200587208706
SaOS-2,selumetinib-UNC0638 (4-1 mol-mol),4.750362941139615,3.0049734043136893
LS180,11609586,3.254650235567635,2.8519147747909064
RKO,3025944,4.391654014934833,4.022496328538156
ML-1 [Human thyroid carcinoma],16720766,0.621696324806819,0.6846690309561885
SW1573,11640390,3.5338327701281176,3.494858674112379
ML-1 [Human thyroid carcinoma],6917907,-7.443362541349426,-3.468820364098529
NCI-H2452,navitoclax-pluripotin (1-1 mol-mol),-1.4411429928004444,-0.5323947000469661
LCLC-97TM1,2708,5.63991197078878,4.650657282659985
HuP-T3,262093,3.018266583248783,3.047138800405896
PaTu 8902,3503,3.0706473844938422,2.327814853919831
HCC15,6918328,-0.0257689511183662,0.16811836439078057
COR-L105,24797083,1.0360227961267732,1.634500114526864
P31/FUJ,9887053,2.876589254443052,2.8293168649556857
WM115,446155,1.535185995815247,2.6664054112513322
COR-L105,613753,3.1601590793812,3.267376903292684
LCLC-97TM1,tanespimycin-bortezomib (250-1 mol-mol),-0.5611743356408021,-0.907435771384839
IGROV-1,10385095,1.0670946713416192,1.239351522181285
NCI-H2452,6252,4.582294901932163,1.2572788900862153
MOLP-8,72193861,1.011292170776,0.28717289290395404
LS411N,JQ-1-vorinostat (2-1 mol-mol),0.7731890132640523,-0.21450392064110482
IGROV-1,26596,2.910298792762654,-0.8302108578930314
RERF-LC-MS,11640390,2.8932892314821927,3.740516016822937
SW1573,selumetinib-piperlongumine (8-1 mol-mol),4.823355107887568,3.076320583163365
ML-1 [Human thyroid carcinoma],9444,3.622178437751676,4.173946402985789
MOLP-8,carboplatin-etoposide (40-17 mol-mol),0.4522049028656168,1.5349719872622458
RKO,selumetinib-BRD-A02303741 (4-1 mol-mol),2.7729264296394276,3.316525161134997
SK-OV-3,168313047,2.892407732266751,2.4925112860819727
Daudi,9926054,1.7776420054693636,1.6417978613385562
COR-L105,2749,1.1758378373045044,2.207379857342332
SK-CO-1,6918837,-2.3986996753086305,-2.8554486906569934
IGROV-1,12003241,-2.0122972114546904,-1.278720281219491
HCC15,9866186,0.9811967871114916,0.97513548241655
MOLP-8,selumetinib-decitabine (4-1 mol-mol),-1.0628389373049278,0.8536492792695711
WM115,9887053,3.7520086754622657,4.187036463819721
COR-L105,9933475,1.7212192557919994,1.9139129638480978
MDST8,9967941,4.864965348465847,3.611572163731141
KU-19-19,5566,3.5813761109507154,3.0478612135557124
MDST8,navitoclax-pluripotin (1-1 mol-mol),-0.7687489339577367,-0.8465263785080286
ALL-SIL,168313016,2.945013463521221,3.7821985134206226
RKN,JQ-1-vorinostat (2-1 mol-mol),1.810431860868636,0.9389940380623468
LCLC-97TM1,216239,3.3274661005628636,2.234880276150687
UACC-812,9935249,3.1921366544842,2.8331628711004897
KU-19-19,46398810,3.059016393641159,2.7983355568047887
HCC15,selumetinib-vorinostat (8-1 mol-mol),1.4639379045779866,2.6157697512377958
Daudi,24901704,1.6931015271472445,2.415592435949494
UACC-812,navitoclax-sorafenib (1-1 mol-mol),2.1784288698451473,1.8109477913653345
SU-DHL-1,135440466,0.4118800450630493,1.9487480968950799
IGROV-1,5311,1.0068816368200209,1.466252680129331
RERF-LC-MS,5329102,2.8374518121885637,2.0834312175844283
LS180,selumetinib-UNC0638 (4-1 mol-mol),1.869156071766359,2.6784591721770523
Granta-519,10302451,3.667767303482806,2.580775155039721
HCC1500,alisertib-navitoclax (2-1 mol-mol),-1.6435253227103,0.23325415929562318
NCI-H1568,4096211,1.8643847121139272,2.216912662316332
ML-1 [Human thyroid carcinoma],11612883,2.523942692100722,2.9979630152196917
LS180,44487872,4.564049669792266,4.364111368235399
ALL-SIL,JQ-1-vorinostat (2-1 mol-mol),0.0034804556832889,-0.7822169163482564
SW948,135411,1.551236240082995,0.22243721264397628
PaTu 8988t,216345,4.148994433618168,4.056616954814991
LS180,9935249,3.57280690269837,2.8704572941286632
UACC-812,46926350,-4.425607795744521,-4.071192149572521
K-562,46224516,3.0237589268452396,2.055895832937379
SW948,16013152,4.211275799279611,3.2735063180579935
BICR 22,10074640,3.373223414806136,2.8702476491079496
Granta-519,54618164,3.794628352719798,3.5615456264356857
K-562,49793307,-5.346924391172112,-4.119069793926426
IGROV-1,54678924,1.4704159748793169,2.3038434160762593
COR-L105,selumetinib-tretinoin (2-1 mol-mol),2.682328410307197,3.927773280064054
IA-LM,24785538,2.950939703376364,0.31081306415120247
HARA [Human squamous cell lung carcinoma],5278396,3.775794457804869,3.501057102689391
ALL-SIL,262093,0.6753795238054565,1.5590775779307071
SK-HEP-1,49793307,-1.6219654789172164,-2.059219106092175
UACC-812,9915743,-6.921665690083625,0.24883967376689636
MOLP-8,24964624,0.5129160642166024,1.1935863863145613
SW48,16725315,4.089936042929296,4.163650037985686
P31/FUJ,25102847,1.6695774391929423,1.6852331572916401
MOLM-13,216468,0.0785275755512733,0.8436135254154151
HCC1500,135421197,1.2704457907642457,1.885432973339587
COR-L95,445643,4.015431140089913,3.892271202959471
Granta-519,9826308,-1.279512827450026,-0.21672556775427507
HARA [Human squamous cell lung carcinoma],9549297,1.8946305959472185,2.645775741421793
HCC15,44589607,3.4730057914725005,3.111114251614959
SK-CO-1,73707398,0.894037962240185,1.6341475021195573
RERF-LC-MS,46191454,1.934559197398404,1.9649740496680457
PaTu 8902,44491742,4.263402068757711,4.350777423752911
PaTu 8902,53481919,4.066569856261274,3.8000365112167547
HCC1500,4521392,5.662319691471263,4.274108925482737
BICR 22,11364421,-5.708558910936986,-1.1321456160830365
LCLC-97TM1,6610216,4.478615539127516,4.1029029652439855
BICR 22,52912189,1.443997008169696,2.6117982804335402
SW1271,11404337,-3.6050810245472382,-0.17347377283126472
IGROV-1,969516,2.460805405371151,2.7630238830920075
LS411N,25062766,1.7796504921777256,1.9148463565753442
IGROV-1,11977753,-2.2284230058029433,-1.260215750356114
SW48,JQ-1-UNC0638 (2-1 mol-mol),0.4200169651809782,1.3289887821751398
IA-LM,54618164,4.43488746250501,3.8318554775057185
SU-DHL-1,135398738,3.5570959576905983,3.8986017214385735
HCC1500,23725625,5.012282150953445,4.95406295307705
SW948,56973724,2.5267361451247647,2.36562230341416
COR-L105,2742550,3.8597521863519257,4.118088570869526
HCC1500,selumetinib-navitoclax (8-1 mol-mol),0.8768646792211049,2.1608148364619657
SW948,11485656,1.7814283284456571,1.7428905081279178
LS180,56963564,-0.4927248320174067,0.38627623628491364
RKO,9866186,0.3829002704071885,0.05294506664350691
Daudi,44202524,1.1056351253600936,1.206501642067423
NCI-H1568,11964036,0.8982081488420575,1.1541144230213423
MOLM-13,9915743,0.7456385275428815,0.11197841080104956
Panc 02.03,4788,6.040807258084593,5.704502596556226
SU-DHL-1,10410894,1.885737679840171,3.0716881183441473
WM115,3062316,1.2654694678882143,1.2174858439930534
HuP-T3,148198,-3.5090934063696153,-3.213874248402693
HCC1500,24748573,2.217224851211772,2.363821781460403
RKN,44185566,3.394049733904779,2.5889707516317184
WM115,73707371,4.316198918387243,4.831800338606646
HARA [Human squamous cell lung carcinoma],2749,1.5155233624959286,1.9840984355349756
COR-L95,119607,5.444677320305195,4.986943751905874
SW1271,3543504,5.279434126076659,4.308094904581747
RKN,613753,3.037549827357118,3.0615440410585752
MOLP-8,9933475,1.6461417731910544,1.7035748140621831
SU-DHL-1,374536,2.32669265560356,1.4372281222500585
NCI-H2452,11222830,1.0864314168284432,1.6150914855190999
BICR 31,16736978,1.5520316002325725,2.0386669162728692
BFTC-909,11656518,3.71751997684089,2.0649225126320037
SW48,49793307,-4.357023521296349,-2.998504463804308
HCC15,676352,2.734399334153108,2.312613670710714
K-562,9933475,1.5582186007451084,1.4930186317131757
COR-L105,1716436,2.5827881779858797,2.9514512173835787
MOLP-8,71751553,4.257415338539138,3.821512052045665
MOLP-8,11427553,-1.470461076327197,1.4965999714566873
HARA [Human squamous cell lung carcinoma],5329102,2.385019760073336,2.1288708750017644
HCC1500,65064,3.4319990575629484,4.9084412378668345
BICR 22,54678924,2.835542995017498,2.1288922013272633
SaOS-2,52947716,3.1327874038156636,-0.12708270692762524
RERF-LC-MS,327653,4.17889189356682,3.445824392013208
RERF-LC-MS,216468,3.2358353560937267,3.5001430167687717
LS180,637858,2.1359320280537704,1.986825139191739
ALL-SIL,navitoclax-PLX-4032 (1-1 mol-mol),-1.20714893159784,-0.42282089057309724
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,3.0941272405417704
HCC15,25154868,4.699010678354358,4.3676976589022205
BFTC-909,1716436,3.115342072857748,3.106914641513206
WM115,208908,3.0871953707393662,1.8985182719429512
COR-L95,5287969,-1.974656124599848,-1.861745043087312
MOLP-8,9907093,3.7363465424365567,3.56127017030581
RCC10RGB,5738263,4.593697299478501,3.612623835016423
SU-DHL-1,446155,1.7989638936827528,2.196716019818641
Granta-519,51037431,4.032962229357369,2.7656237266357255
BFTC-909,24771867,4.730369684143592,2.277424360029376
SW1271,9926054,1.9992649208496855,1.9924053088470364
IA-LM,46843906,4.034671652936036,1.8868135227651315
PaTu 8902,3634881,3.736044150449037,3.302363671304965
HARA [Human squamous cell lung carcinoma],5311281,2.4258881489706217,2.438892107718224
COR-L105,89928392,1.7234999745886912,1.8544202121422475
Panc 02.03,6917907,-5.450554920776264,-4.543676635449869
ALL-SIL,216345,2.7239648031314108,3.0390721313773748
Granta-519,5311281,1.2060114833285496,1.7809476925528616
RKN,25150857,2.829513348324473,2.4476613214974576
RERF-LC-MS,702558,6.005509402748126,5.415544098834931
Granta-519,44202524,0.8355806814666445,1.1971607002123499
IGROV-1,65064,4.920352624378345,4.924549691286046
HCC15,82146,4.430619158397189,3.8609285309847716
IGROV-1,135984461,4.285945029851472,3.995341846936626
SW1573,tretinoin-navitoclax (4-1 mol-mol),3.744579099862024,2.562099653168119
RKN,25183872,-1.1518449365963386,-0.8047040628770751
SW1271,6450551,2.703162256598128,2.6537064000431214
COR-L95,SNX-2112-bortezomib (250-1 mol-mol),-1.5926355912839212,-1.728804973945515
RKN,656346,1.677354805367284,1.0206331925045524
MOLP-8,3503,1.781914224283778,1.9193113266012338
COR-L105,2828334,6.248355208389406,6.133586216769019
BFTC-909,docetaxel-tanespimycin (2-1 mol-mol),0.450361572300305,-2.5202716608404163
MOLP-8,135875424,3.0291075959050233,3.2077599361881077
HCC15,24748573,2.004363812639911,2.187392857912172
RERF-LC-MS,selumetinib-MK-2206 (8-1 mol-mol),2.1861340415515076,2.3815031849347363
HARA [Human squamous cell lung carcinoma],89928392,1.691456490518517,1.6270363371730183
IGROV-1,56649450,0.515518984822669,3.379362097082248
KU-19-19,9444,4.28834999434395,4.367817198985519
Granta-519,3552672,2.198733357723822,2.2384200244740784
SW948,66577038,2.9537896679300655,2.607724679929567
NCI-H2452,119607,5.591396796149955,5.404425701695448
RKN,selumetinib-tretinoin (2-1 mol-mol),7.09288474093864,3.681603948521225
HuP-T3,2729026,2.9922624267509317,2.781552710415299
SK-HEP-1,71466578,6.341226391578653,4.670674863165939
Daudi,24785538,-0.3082535888445589,0.6869706080952673
IGROV-1,5280436,3.2616766817665086,3.4717384785243475
RERF-LC-MS,7251185,3.4578262740878976,2.894447693296324
HCC15,156414,2.365134958139565,1.7339599188707289
BICR 22,piperlongumine-MST-312 (1-1 mol-mol),1.342404351806,1.9920355149605264
BICR 31,10127622,3.719060323270891,3.5149570672683956
SaOS-2,15547703,3.066966974063678,3.293636616875786
Daudi,decitabine-carboplatin (1-1 mol-mol),0.1639659484946293,0.3052403561683292
HCC15,alisertib-navitoclax (2-1 mol-mol),-2.6533611611755177,0.6435865027497671
SU-DHL-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.028973070586865,3.7391057866868405
SU-DHL-1,3689413,-2.511818154735677,-0.15136387517797661
COR-L105,56946209,-4.798718381888378,-3.7796791352932457
IGROV-1,5978,-1.5618214380165825,-2.1082377770197516
BFTC-909,11222830,1.7098036316197358,1.5546790749359982
IGROV-1,216239,2.21703825410177,2.2046778875390554
MDST8,135440466,3.3221976295713342,2.5180599934553385
P31/FUJ,44632017,0.6534437162154956,0.8997840566523729
IGROV-1,219104,3.803083685328391,3.602359067716997
SaOS-2,637858,1.716758511666406,2.0495115663023085
WM115,crizotinib-PLX-4032 (2-1 mol-mol),-0.0688201401017855,1.827468930466476
COR-L95,24753719,4.203119149122614,4.0180416011298465
HCC1500,3025944,3.928139296588046,4.208889900306648
Panc 02.03,56946209,-4.513446270471167,-3.676713911937816
HuP-T3,25126798,3.926602492728053,3.903581166691515
PaTu 8988t,3011155,4.341218756124128,4.0970935818219605
SW48,20959075,-3.67297247887529,-2.7513127900271406
HCC1500,JQ-1-navitoclax (2-1 mol-mol),-0.2605650300766051,0.3470811284603004
BICR 22,44486219,3.936553836391045,4.38918437216286
RERF-LC-MS,6918736,-1.8242544668906209,-1.7213290379194541
NCI-H2452,selumetinib-PLX-4032 (8-1 mol-mol),3.036066268275686,3.77004274697093
RKO,44137675,4.282234128328841,2.882765380322225
IA-LM,11626560,2.8197095065502515,0.8975254320163263
SW948,2746,1.2183078272507333,2.296154459639798
NCI-H1568,168313200,3.516432771095034,2.9738107517148
IA-LM,262093,2.9896562434219627,2.063426613151464
MOLP-8,4261,-0.435327551985223,0.6802955002647073
HEL,2708,3.2519957529556716,3.3215715805149078
BICR 31,selumetinib-tretinoin (2-1 mol-mol),0.9632535907950592,3.320657510387629
LCLC-97TM1,erlotinib-PLX-4032 (2-1 mol-mol),2.856806725221915,2.6768992165220102
MOLM-13,51039095,-0.7255439577713276,2.1400336977803263
IGROV-1,426756,6.142776526139055,4.238726119138235
NCI-H2452,25154868,4.866167054223791,4.611161573043776
PaTu 8902,4705,3.6244040622068256,3.2451057912325947
ML-1 [Human thyroid carcinoma],25105715,3.821272786179671,3.3853230785315116
Daudi,135421197,0.2989842149032058,1.2234125340382027
IGROV-1,10427712,3.944243047938238,4.156186571093977
COR-L95,24978538,-1.547703636473998,0.5948483667445308
SaOS-2,52912189,2.036463757447864,2.7498831306858005
PaTu 8902,452548,0.9739796251952438,0.31842522732249995
IGROV-1,52912189,2.3966568144845666,2.481803248692849
SU-DHL-1,387447,-5.562438756444553,-4.74411537810715
HCC15,135398516,2.1695814103654696,2.1638416535603375
SK-CO-1,6610216,4.838209270425191,4.086749719704401
MOLM-13,5351362,0.6925875902125201,0.8247610038726667
HCC15,46191454,1.8626809755345697,1.8154584986760736
SW948,9825149,1.8114941973110277,1.9642145705078442
Daudi,54639665,4.383406013207389,2.9928928008550066
HEL,2828334,6.1216048061751795,5.639731721264927
BICR 22,71466445,3.433479198461154,3.841418091254173
ALL-SIL,9826308,-0.8056632694679019,-0.08950399476020808
NCI-H2452,57519531,1.3990882913061125,2.6125998708039053
BICR 22,54613361,0.4978505675466737,0.11243554073811288
SK-OV-3,135440466,2.5162908691834405,2.5010970068487026
SW48,JQ-1-MK-0752 (1-1 mol-mol),-0.7749163681319219,1.6212235471059906
SW48,6852167,2.2630322871527913,2.9751405492698253
RKO,11404337,-0.3534280477619294,-0.795049627572418
ALL-SIL,5291,-1.9713425457655045,2.6868295601375407
K-562,salermide-PLX-4032 (12-1 mol-mol),5.074335009677914,4.54824016018367
IGROV-1,24771867,1.9944882740161016,2.8956964841606574
MOLM-13,46224516,1.6904951862054391,1.7152143627607865
SW48,119607,5.387394946551996,5.1751341405035785
Panc 02.03,ISOX-bortezomib (250-1 mol-mol),1.22897027092613,0.7372413964339337
BICR 22,49836020,2.6142262300183305,2.3921548150207967
BICR 22,16720766,0.4876582946813295,1.033156300086752
HARA [Human squamous cell lung carcinoma],159324,3.9851922367796937,3.0553712123973655
SK-CO-1,123631,1.846760097113305,2.4747559817627542
BFTC-909,36462,4.374665451212183,2.2153014450891715
LS180,vorinostat-carboplatin (1-1 mol-mol),3.0396864380779327,3.182257140880744
RKO,5328940,1.7974237645790871,1.1179799734044844
RCC10RGB,ISOX-bortezomib (250-1 mol-mol),1.8255695347909304,0.8638174464537136
ALL-SIL,5281321,-2.461016259028612,-2.670752140572455
P31/FUJ,568763,-0.9310646254211032,-0.2700899689198197
HuP-T3,selumetinib-UNC0638 (4-1 mol-mol),3.11768337000848,2.9327295029583054
HCC15,crizotinib-PLX-4032 (2-1 mol-mol),0.980759868979001,1.8667854609449548
WM115,3081361,1.7542351340434374,2.4742983503270763
Panc 02.03,676352,3.0262590525496895,2.217926772678366
Panc 02.03,44462760,5.147948611944762,4.115937632947787
COR-L95,11228183,-1.8408108773608771,1.576248275754268
WM115,56973724,4.208743527700851,3.387866139458184
KU-19-19,vorinostat-carboplatin (1-1 mol-mol),2.5196906513135913,3.250958252634159
HEL,65628,4.10911337005638,3.3265766639482353
Daudi,11612883,1.1925703345745973,1.811931234541336
RCC10RGB,24856436,4.070420512574028,0.954545414322147
COR-L105,46199207,3.6604959991625825,3.255558007200024
Granta-519,25195348,3.9328442274761217,2.26550382809496
NCI-H1568,1750826,-3.116085482779225,-1.112510770372871
IA-LM,12001922,1.9531449792239188,1.9531229819737572
IGROV-1,19582717,6.764352444432722,4.229349084914892
HCC15,10113978,2.260363506948615,3.438316632382745
SK-HEP-1,10074640,3.7857764861964935,3.2858520489507463
PaTu 8988t,6918328,1.905296387062238,0.2978538662918156
HuP-T3,24785538,1.540895569713237,1.687734552635329
BICR 31,5281321,1.1837918014475457,-1.0774274460165296
MOLM-13,216345,0.0865178974102724,2.5350823235495583
HCC15,448949,2.8674184346568414,2.08109084515314
K-562,44566777,1.311822236929868,0.27719909941049886
HEL,452548,-1.769607447996444,-1.7584800469098594
SU-DHL-1,11507802,0.9378608618407872,1.5367533489355603
SU-DHL-6,2113511,5.89050983447184,4.63525872369272
SaOS-2,54613361,0.0035364978270003,-0.031821855280057446
SaOS-2,24748573,1.7294478830476196,2.139222770293022
HARA [Human squamous cell lung carcinoma],9868037,3.8920643368101713,3.2852253313024393
HuP-T3,49766530,1.2218451996302029,-0.6164707642339589
HEL,262093,2.3252232523203995,1.6296205882178065
SaOS-2,tretinoin-navitoclax (4-1 mol-mol),2.244909484198112,2.5371074855287956
MOLP-8,675434,3.835070621627746,4.042503429838732
RKN,16725315,3.256745916563384,4.051614443021209
RERF-LC-MS,5746,1.1068525081764873,1.4791710502445397
SaOS-2,11964036,0.5086023979470407,1.47926820641022
COR-L105,selumetinib-navitoclax (8-1 mol-mol),1.996235021345007,2.0789699168341538
LCLC-97TM1,126941,-2.218385477362075,-2.3888179014344275
HCC15,54618771,1.6567762934530044,1.337155438979376
RKO,2113511,4.623772297498578,5.356724479467687
RKN,9929138,7.419607622812729,5.516241429472317
HCC1500,5460769,5.1304942195737935,2.677184187362286
COR-L95,31703,-3.0462560513884203,-1.588845188966751
HCC1500,46224516,1.0534131743048871,2.3592647629749024
Panc 02.03,5328940,2.397017671249583,1.7523688526661516
LCLC-97TM1,11404337,-1.4043223473519348,-0.5837703637556956
HCC1500,42642645,1.451455976812008,1.1507624571514952
IGROV-1,51037431,5.669320749085174,3.0023447794814695
SW1573,107970,2.0608182724975266,2.297920416875096
SW948,46191454,4.338482378206047,1.412223767991898
Granta-519,11455910,0.302072347623865,0.35285945580201855
COR-L105,2113511,6.080993735084838,5.845875259219902
SW948,ISOX-bortezomib (250-1 mol-mol),0.2235113953706366,0.7516510755226667
IGROV-1,448949,2.098499309472767,2.0812100322419296
NCI-H1568,107970,1.680617581032042,2.4204944379284763
SK-OV-3,24797083,1.6169926593639932,1.5687904711074274
ML-1 [Human thyroid carcinoma],vorinostat-navitoclax (4-1 mol-mol),0.5480043604957033,1.439109207157056
SW948,selumetinib-BRD-A02303741 (4-1 mol-mol),-2.798210383310514,2.8784171473908065
IGROV-1,4259181,0.1937358171291443,0.20438500229701473
LS180,135875424,4.384751932486372,3.941478164694681
UACC-812,54765302,2.961863639252158,4.012890996094087
SW1271,49867926,6.0238397416149345,4.335743780000294
SU-DHL-1,3025944,3.851371371046294,4.079589796550911
SW48,9967941,4.423983829284398,3.48261464065699
SW1573,11609586,3.686627979451031,2.9789630570215233
Panc 02.03,16065773,3.1661848504472023,2.629829874283272
RCC10RGB,135421197,4.393109316582631,2.3168241035726114
IGROV-1,24785538,1.106246320450551,1.7895753786502815
HuP-T3,5278396,4.193223405360703,3.6066808385982365
IA-LM,24901704,3.940918836251392,2.5733813525784974
SK-HEP-1,11214940,1.8009666315936252,1.7007875558263625
K-562,11364421,-5.792707438494169,-4.011320148626756
LS411N,3384730,4.573317632228089,1.833145691966299
LCLC-97TM1,568763,-0.0784771886342085,0.582602228157539
HCC1500,9936388,-2.5304598124234365,-1.0923897731925283
HCC15,5311,0.7792586953300233,1.5942398247212333
SU-DHL-1,54686904,3.5039759810509676,2.5940338989088185
PaTu 8988t,11626560,2.010870886496287,1.9388155032445888
HuP-T3,2749,2.009482044490881,2.2799826119020095
RKO,60750,-2.2331483998906654,-2.3113552451171118
HCC15,5287620,-1.6098111318920385,-1.645141840921474
HEL,654092,-1.523294365181231,-0.8799773737526684
SK-HEP-1,71304818,1.6350171624170464,2.6037598790319096
SU-DHL-1,448949,1.2808073887625644,1.8212600653773579
K-562,5281321,0.5422415972342122,-2.1818600414447022
NCI-H1568,selumetinib-JQ-1 (4-1 mol-mol),2.397330498930178,1.740763036204809
LCLC-97TM1,5351362,1.316382729979947,1.4028378601416185
MOLP-8,5460769,1.8843864880791628,1.9420978816047287
SaOS-2,56963564,-0.1924881408966614,0.635475012019746
RKN,446155,3.7628691651204234,2.6355340993949863
HEL,doxorubicin-navitoclax (2-1 mol-mol),-1.6523771973343595,-2.36819914148555
NCI-H1568,16038120,0.8714631615296456,1.064118777228517
Daudi,25102847,1.3031740879242997,2.057558086919837
LS411N,25154868,4.929077040033465,4.071427830554863
SW1573,crizotinib-PLX-4032 (2-1 mol-mol),2.8041804107820796,2.117279910255732
ML-1 [Human thyroid carcinoma],54649381,4.324070376451948,4.038715207026534
LS411N,9915743,2.8294092926119028,0.6266230369709862
Panc 02.03,BRD-K55473186,4.513191364064351,4.245835857007447
SW1271,JQ-1-vorinostat (2-1 mol-mol),1.5175672893366323,1.2184614686542456
SK-HEP-1,selumetinib-navitoclax (8-1 mol-mol),3.029292695644022,2.241961156398128
SU-DHL-6,4917,2.9501994456287792,2.73130026621018
Daudi,16741245,3.410771008602035,3.390522015692804
MOLP-8,3062316,1.3489297980566397,0.6639687874140884
NCI-H2452,selumetinib-UNC0638 (4-1 mol-mol),4.804967854809725,3.5922281916862864
RERF-LC-MS,25183872,-0.4545636564638026,-0.49857195599307425
HEL,JQ-1-UNC0638 (2-1 mol-mol),-0.0647820501822815,0.41344553504649895
MOLP-8,60700,-2.8082015295780858,-1.396276420875095
NCI-H2452,637858,1.8545349692582156,2.226571087527698
LCLC-97TM1,11626560,0.938916298027116,1.459125230185136
HuP-T3,136227924,2.888640375816574,3.071016230525824
IA-LM,5284329,5.1954673618886655,2.950088187144222
RKO,104842,-2.5196749638548,-3.411235560895613
SaOS-2,11494412,0.4895123820960489,1.4458031296075862
IA-LM,9926054,3.212619063516659,1.8925652581070946
MOLM-13,doxorubicin-navitoclax (2-1 mol-mol),-5.382475006616194,-2.5203637625929187
MDST8,23635314,-2.200660522590374,-1.6272259292899478
SaOS-2,alisertib-navitoclax (2-1 mol-mol),-0.6198148244275179,0.37387599732346294
RKN,4261,1.529955054772996,1.694836214455281
SW48,11396600,3.829401994456863,3.7091731558308343
LS411N,JQ-1-navitoclax (2-1 mol-mol),0.3997266798331875,0.544120862684738
HCC1500,16659841,5.303826701580757,3.7014836977964154
HARA [Human squamous cell lung carcinoma],24901704,2.881552784728447,3.4714557499515855
BICR 31,JQ-1-vorinostat (2-1 mol-mol),1.378421076759701,1.2543579166933443
MOLP-8,10231331,1.2198029486879254,0.5864896508667343
COR-L95,16725315,5.004914745056217,3.862995909710747
HEL,16115403,-4.756245139541522,-4.357793616591161
WM115,11717001,-1.1241138002933555,3.7788435775950067
SaOS-2,11626560,1.1465195781021866,2.006530731586515
BFTC-909,9907093,4.635414583134371,4.217624715551743
HCC1500,66577038,2.9555971550997935,3.066843128865884
IA-LM,285033,0.5092837727748464,-2.004772943721508
IA-LM,4917,4.737499942891754,2.8900984306025195
BICR 22,44632017,0.9263322393180023,1.5380356512300188
RKN,navitoclax-pluripotin (1-1 mol-mol),0.1191364332542713,-1.108277567207411
HARA [Human squamous cell lung carcinoma],docetaxel-tanespimycin (2-1 mol-mol),-6.628155731353656,-3.1187615809788287
SW1573,89928392,2.032641459256584,1.800710645918904
MOLP-8,119607,5.472499710124238,4.390006588011997
COR-L105,46398810,3.2483226376094194,2.6436778719836265
HCC15,decitabine-navitoclax (2-1 mol-mol),0.0974547037094189,1.9904725624326192
HCC1500,135999136,4.086589117257826,3.7522369530857826
WM115,11497983,4.51521868458229,4.109056052368529
SK-HEP-1,46926350,-4.110479335135347,-4.030068808725115
RKO,322968,3.8471310775605216,2.412911408978877
LS180,25262965,-0.0916364033105869,-1.8509270794915065
HCC1500,246676,4.424448695399937,3.8362087162916123
COR-L105,104842,-0.9230389281504464,-2.3266477973718693
SK-HEP-1,navitoclax-piperlongumine (1-1 mol-mol),1.24584260367843,1.801306760176385
SK-CO-1,6610355,4.767157937449789,4.318735490515724
IGROV-1,676352,2.310492141650647,2.2718784709397224
SW48,262093,2.726859331273406,2.975743251501869
HCC15,55508,3.481008151195261,3.5037551962910825
HCC1500,2126,3.801078614960916,4.804205604787524
PaTu 8988t,24951314,3.0808050806085188,1.5847555146724608
RKN,11455910,3.815213247766997,1.1357047475875475
SW1573,3062316,2.075650426956439,1.1165096229718332
SK-HEP-1,5287620,-1.0463187584720948,-1.865989089219657
HARA [Human squamous cell lung carcinoma],25102847,2.0322740825170555,2.503004984342066
MOLP-8,24779724,4.381900106399647,3.4679052206847594
Panc 02.03,107985,-4.238430695688479,-3.640911134016055
IA-LM,322968,2.7570489193637018,2.713958201244704
K-562,448949,1.070656561881704,1.468573275422677
LS180,54649381,3.823257143411622,3.6801913098419994
IGROV-1,5281321,-1.4962463697398798,-1.0168400256543133
NCI-H1568,42642645,1.4281976900349445,0.8720744543112795
SK-HEP-1,selumetinib-GDC-0941 (4-1 mol-mol),2.75141710768083,1.5860324657589537
K-562,44185566,1.8580861510177096,1.92036255069707
SW48,637858,1.3097623359774897,2.171237629895573
SK-HEP-1,613753,3.3794099216210203,3.2727074557467724
ML-1 [Human thyroid carcinoma],selumetinib-piperlongumine (8-1 mol-mol),2.412069402111766,3.1608756499647286
COR-L105,11234052,4.539846823478364,4.065498300614307
IGROV-1,72193861,2.0623829231433293,1.6893216371814324
SW1271,3503,3.0280256153278606,2.239755605270964
NCI-H1568,57330099,4.373464200171548,4.398180928682831
MOLM-13,1750826,-3.2515027143289728,-2.8431817055138864
SW1271,11222830,1.3106603955640226,1.551040182556525
RERF-LC-MS,445091,4.218142840499499,4.317250052328115
BICR 31,3062316,-1.406162609577698,0.6279183621301773
HEL,25126798,0.3968700607761156,3.2069964292653315
COR-L95,5738263,2.419040765220329,3.0005182401487924
SK-CO-1,36462,0.7476665664464673,2.214428450958396
WM115,49766530,-0.6421157759153451,-0.014816677127582127
SW1271,ISOX-bortezomib (250-1 mol-mol),1.0601498198738095,0.6673929462886463
BFTC-909,46901937,4.445112058189045,3.0593122702862674
SW1271,136227331,4.376300443457216,3.8750538812729447
COR-L95,25262965,1.4716002732306153,-1.277403685976902
COR-L105,5281672,4.46136628199001,4.663559717962391
WM115,73707398,1.178086440828875,1.306517727010552
Granta-519,6852167,2.2648312753409887,1.371505645764657
RERF-LC-MS,46174525,5.020740506928848,4.529432376550253
SW48,navitoclax-PLX-4032 (1-1 mol-mol),2.4409762203438117,1.7208257006700418
RCC10RGB,44202524,4.922768729279552,2.8403262518857666
BFTC-909,BRD-K27188169,5.152610673434624,3.7805717838939303
ML-1 [Human thyroid carcinoma],44607530,1.6401891623478355,2.002897701135558
IA-LM,439501,-4.16745845294267,-2.177229871530057
RKN,25262965,-0.5506090189051945,-1.314264091092958
SW48,3385,1.919145280274203,3.974517855363904
RERF-LC-MS,12001922,2.43602915295576,2.0468514680993346
IGROV-1,568763,0.665047061839467,0.4825743529925577
P31/FUJ,10385095,1.5135865779060806,1.0337995506620445
HuP-T3,12001922,2.3367896101102907,1.9820725366490888
HCC1500,1641662,3.3816027924522487,3.431579999296589
HARA [Human squamous cell lung carcinoma],25195348,4.01900560130828,3.124425976856253
P31/FUJ,1242560,3.8275456086274127,2.949969471903458
NCI-H1568,57519531,1.3161148530355309,2.6107983804773562
SW1271,42611257,4.308869978455437,3.2869904546977877
Daudi,10184653,1.026270071695755,0.7054256097458235
K-562,2858523,2.745068324935018,2.644531846731903
IA-LM,crizotinib-PLX-4032 (2-1 mol-mol),2.5646441197957555,1.371964456105752
HARA [Human squamous cell lung carcinoma],11152667,-1.8717886502550631,-0.28229925801739275
BICR 22,12001922,2.2523981699696165,1.810317220504167
KU-19-19,tanespimycin-bortezomib (250-1 mol-mol),0.8089732350000719,-0.38151306628813086
UACC-812,5978,-2.554443854158195,-1.428332700802375
MOLP-8,753704,3.0200894206550877,4.121005305747005
ALL-SIL,5394,4.4345454375843625,3.470493877655594
RCC10RGB,navitoclax-PLX-4032 (1-1 mol-mol),2.769034348653669,1.674821991911833
WM115,selumetinib-navitoclax (8-1 mol-mol),-2.2824841087283954,1.92839438004879
NCI-H2452,44137675,2.6709050374584846,3.7659608210437328
BICR 31,52912189,2.5113420173615464,2.3474548040572314
WM115,72199292,4.562209520612744,0.34363590750794676
BICR 22,25154868,5.114547534217177,4.3382035795725615
SW48,25262965,-0.5589271325062998,-1.4983909466331715
IGROV-1,4705,3.3098412390054603,3.225659534639573
LS180,SNX-2112-bortezomib (250-1 mol-mol),-0.5067570232278682,-1.4957897643778242
COR-L95,11955716,-2.3894028875885778,-1.4020874758271744
BICR 31,241158,4.31214680273537,4.074649265021404
RCC10RGB,25062766,2.0619451400109265,2.29989138012867
HCC1500,25262965,-5.244904140838402,-1.199242042437094
PaTu 8988t,285033,-2.1993510069972215,-1.4685581564391825
PaTu 8988t,44566777,-0.8532538772982161,0.8481958349300407
SW948,71466445,3.954398511848749,2.8550817860255604
IGROV-1,6610216,4.310938387105607,4.401258219080982
PaTu 8902,11497983,4.394920409770125,4.216701002638153
SW48,11612883,0.3553002535249436,2.7117031131166187
SaOS-2,tanespimycin-bortezomib (250-1 mol-mol),-1.2470778221654188,-0.621464961942454
HEL,9868037,2.50949616555346,1.8301280998494383
HEL,11178236,-0.8324730036537664,-3.6805448794909164
RERF-LC-MS,60750,-4.1612389836176,-2.0238046204367834
Granta-519,carboplatin-etoposide (40-17 mol-mol),-0.2598184919405968,0.12385529852102478
SaOS-2,24901704,3.518814077302041,3.1447782046916224
COR-L95,6914657,-4.192308975603822,-4.84912445805326
COR-L105,262093,2.940873643596252,3.1078982521714913
LS180,44486219,4.325065743764261,4.084806982531771
RKN,10074640,3.313081701902331,3.2812713983821844
BFTC-909,5746,0.5111824642409613,1.338536585951542
K-562,8515,4.039482215632923,3.3493174280095896
PaTu 8988t,31703,0.1373281877500042,-0.8220469151560504
MDST8,135984461,4.124255066625015,3.6014958254591427
WM115,107970,1.780812210779262,2.313003644858175
HARA [Human squamous cell lung carcinoma],44507138,3.9193587835112,2.4320000305718277
IGROV-1,327653,3.667792542405671,3.197203138295692
P31/FUJ,89183176,3.539325961528454,3.31536430105359
RCC10RGB,6438330,2.9900078425794385,2.5319086143065155
RKN,5280436,4.161667428331563,3.3933942788479032
COR-L105,445455,4.3186388426275535,4.789225744313769
LS411N,24785538,0.7817075732213645,0.07927621720384734
Daudi,11152667,-2.9472151872913104,-1.8803988414089117
P31/FUJ,448949,2.0159916590055067,1.4086532820624418
Daudi,11609586,-0.3532025604686024,1.5578432674701006
SW948,46926350,-4.641976408237662,-3.528134271451039
SW1271,72193861,2.914678902909763,1.562943858746546
PaTu 8902,25126798,4.210533326596683,3.8030347699683364
COR-L105,11955716,-2.257823880116287,-1.7340302398729674
HCC15,46224516,2.679221759698836,2.7734045366617113
HCC15,135423438,2.37991378319322,2.65676107636504
Daudi,421610,1.7509728437935097,2.5770527542919357
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,2.3518487464889914
SaOS-2,11238147,2.85636627636287,2.874604949236665
IGROV-1,374536,0.7022324251593053,2.551184903752136
SU-DHL-1,51039095,1.7422871999086744,2.0572360133202583
IA-LM,72193861,3.820444995189443,0.3720180365234254
HEL,5738263,3.378820716395454,2.731629870365867
RCC10RGB,BRD9876-MK-1775 (4-1 mol-mol),3.486807022828034,1.0211121909659868
SW948,6852167,2.188206161672083,2.3087516955988914
K-562,71751553,5.367911183247371,3.9659238352429758
BFTC-909,71304818,3.116417285157316,2.5434006940971052
SW948,25227462,-0.2382390684396511,0.2274489911131655
SK-OV-3,637858,3.830307013284548,2.0223790184709687
RKN,49766530,-3.8574490235665584,-0.5657838338542247
NCI-H1568,9933475,1.8521331470520848,1.9797070460297923
BFTC-909,decitabine-navitoclax (2-1 mol-mol),5.107856917496857,2.1163202775433665
KU-19-19,17759555,3.7275461226555566,3.573692232344716
LS411N,44589607,3.372730635507476,2.045775919051847
RKO,vorinostat-carboplatin (1-1 mol-mol),4.42147496708757,2.100303555933496
SW1271,5278396,3.101008990901291,3.504290393856442
LCLC-97TM1,46398810,1.8633773855233131,2.2200393822030153
SK-CO-1,6852167,2.111498553552754,2.8519376566158177
SW1573,5479543,3.675213844165782,3.735073822891222
COR-L95,12003241,2.921570030601445,-0.8727209931595534
Panc 02.03,9911463,4.953148943637795,4.046609549398833
P31/FUJ,crizotinib-PLX-4032 (2-1 mol-mol),0.7828925550397006,1.0540522139686788
RERF-LC-MS,3384730,3.247206310046507,3.021977697964746
IGROV-1,51039095,1.7163430299301403,2.7558741339724393
KU-19-19,89928392,2.8864230284497747,1.731753154365699
SK-CO-1,216468,0.6363757446548435,3.2351657009545405
LCLC-97TM1,3038522,2.979698040139259,3.0098185887684967
BICR 22,6914657,-3.057028291966878,-3.6180267232068184
MDST8,3815108,3.655140825789689,2.751668889413841
HEL,11364421,-3.0976744543470067,-4.008900896310253
SW1573,10074640,3.956421484938757,3.12569167378034
LS180,6610355,3.640469161520063,4.27837846668136
Daudi,2858523,2.224035136584194,2.7129892767833756
BICR 22,135875424,4.925705128316808,3.7628950282257345
SK-OV-3,23582824,0.9299959314677436,0.8140559162275024
K-562,5282054,3.5952240521498062,2.660970562210734
NCI-H2452,44589607,3.0010828964799208,3.0911139914038874
LS180,638278,3.5544678930796656,2.842410538232836
MOLP-8,426756,3.5390437920539117,3.619510404343737
HARA [Human squamous cell lung carcinoma],11964036,1.505983259630614,1.5019237833245058
SaOS-2,selumetinib-MK-2206 (8-1 mol-mol),3.420103401204114,2.4388625504564088
SK-HEP-1,selumetinib-PLX-4032 (8-1 mol-mol),4.995301598954557,3.3203175753236693
BICR 31,71466380,5.422644788319504,4.558910505155616
PaTu 8988t,53392493,3.5279637137541524,2.6620197945951727
UACC-812,6610216,4.947422623598504,4.315780329777486
SW1271,16038120,0.5203426502283315,0.7915849513943287
IGROV-1,67156097,0.1763939852409119,-0.495033863841221
UACC-812,216239,2.3945159107119767,2.3720035177941283
HCC15,serdemetan-SCH-529074 (1-1 mol-mol),2.4880259252589543,2.259039705906776
ALL-SIL,36462,-1.376242093473402,-0.1854426371007623
BICR 31,1750826,0.6511109819152475,-1.012481503768408
IGROV-1,56649450,0.515518984822669,3.379362097082248
HARA [Human squamous cell lung carcinoma],66577038,3.5726698245106445,3.151693491870788
PaTu 8988t,6918837,-0.8891471976747255,-2.517622505882524
ML-1 [Human thyroid carcinoma],9936388,-4.434207119356507,-0.3699957918849956
NCI-H1568,2828334,5.9155051642717,6.270369240501488
MOLP-8,56973724,1.5171827826362807,1.9246000602892517
MOLP-8,2729026,2.779201693602774,2.235174154969387
P31/FUJ,753704,3.2802738483106766,4.029626323342183
SaOS-2,25183872,-0.102413301755783,-0.7082308291380741
NCI-H2452,decitabine-navitoclax (2-1 mol-mol),4.538424362545292,2.1438820435976877
LCLC-97TM1,9825149,1.404394440199107,2.140664576944351
WM115,9929138,6.7694003006369226,5.712721644852959
RERF-LC-MS,2746,3.2731211053052647,3.5653735371706397
COR-L95,5351362,0.837381680047442,1.3558564749771724
HCC15,ISOX-bortezomib (250-1 mol-mol),1.036560789961647,0.7121027136680455
RCC10RGB,3101542,4.48788654191394,3.1425401903720918
BICR 31,44566777,1.4466588952743178,0.759083107156389
WM115,5746,-0.962904812763719,1.319055527130332
HEL,9903786,1.206049982415758,1.8238257576730659
NCI-H1568,44486219,3.435494584556288,4.3533612234776164
SK-CO-1,124202324,2.795373404058925,2.135679372710859
MOLM-13,5329102,-5.212236525427112,1.2143084428439983
SaOS-2,10427712,4.893681366378875,4.337188964870137
SW48,409805,3.4729287041870127,4.79055812775642
HCC15,216345,4.3772403070959705,3.987531919025942
NCI-H2452,46215462,2.291566037713401,2.0317058677189435
SU-DHL-1,55283,1.0511806970329092,2.319336322978353
SW48,navitoclax-birinapant (1-1 mol-mol),1.0401381719181744,1.8208158595733916
HARA [Human squamous cell lung carcinoma],56946209,-3.7436646215458182,-3.9021020135020246
MDST8,24821094,3.627663013095859,2.4083510442422615
HCC15,9911463,3.642862209488471,3.7780950439724057
BICR 31,navitoclax-gemcitabine (1-1 mol-mol),3.844959889456845,-1.2296950537991922
SW948,11178236,-0.7120713487548671,-3.003905308942417
HCC1500,5329102,1.6369795361395487,2.2101502372901747
SU-DHL-1,11364421,-4.160715855029451,-2.0354624182895837
SU-DHL-1,176870,3.225718242496366,2.8093370511912044
WM115,2742550,3.774256401917875,3.9365618686424337
SW48,12003241,-0.9746028071684796,-1.355953222997828
NCI-H1568,11494412,0.631822071405162,1.89850275488982
WM115,25102847,1.9091464851380515,2.756925270580484
COR-L105,23725625,5.8274909459435165,5.145986507870434
Granta-519,9956119,4.186560294974692,2.589455998930948
COR-L95,72193861,1.6807669427950571,1.0759623007698138
IA-LM,6917907,0.442667441503668,-5.052964404628054
SW1573,53232,-0.4627324496874346,2.8328404028031455
Panc 02.03,19582717,5.117031119305748,4.502289022549108
RCC10RGB,227681,3.758665689171896,3.537060218221216
WM115,24901704,3.629786211252992,3.270409344470683
HARA [Human squamous cell lung carcinoma],4477,-0.0807211341972061,0.43811489619077904
K-562,637858,1.3097643671251342,0.9159590827697259
SW948,613753,3.0653891790249617,2.9188709730432265
Granta-519,9926054,1.8135939424605243,1.6826291050862343
SK-CO-1,55508,3.57241133457179,3.438128279801431
HCC1500,5426,4.174536858194301,3.3514695573222424
IGROV-1,4521392,5.131794979216607,4.320720021176094
UACC-812,6918878,3.827620339158657,2.8444136585860877
SaOS-2,sirolimus-bortezomib (250-1 mol-mol),1.8011935542733906,0.8984990688251062
KU-19-19,72193861,2.401782330602402,1.9955022199262193
WM115,5281321,0.1495893125543727,-1.0343280731291251
ML-1 [Human thyroid carcinoma],3038522,3.665928761402901,3.1335720245437
P31/FUJ,31703,-2.5575864334968976,-2.6202755896272407
HEL,decitabine-navitoclax (2-1 mol-mol),-1.4855622179945482,-0.6334222351024988
ALL-SIL,44589607,0.5481515481681011,1.5836993185952912
PaTu 8988t,11955716,-2.6731660557009267,-0.9552023869092012
IGROV-1,5738263,4.037832478240785,3.483939102133446
HARA [Human squamous cell lung carcinoma],126941,-2.554285063423382,-2.541914583722543
BFTC-909,650361,3.8112149600795706,3.586129812203465
SW948,16725315,5.2631267850751335,3.766118667983296
Panc 02.03,25102847,3.3458680072040603,2.585551968170737
BICR 31,216239,4.655547148927136,2.7070650432816956
SK-HEP-1,51039095,3.60670356936783,2.73142604011509
IGROV-1,9907093,2.687959785702283,4.035568642869007
ML-1 [Human thyroid carcinoma],126941,-2.044263255039902,-2.3305680604819212
LCLC-97TM1,49766530,0.6419783818490065,-0.8443978676906498
Granta-519,2113511,5.634502761977105,4.24889233251018
COR-L95,322968,2.331837213900703,3.1419672855910337
RKO,ISOX-bortezomib (250-1 mol-mol),0.9877489052510549,0.46168798174056663
SW48,60700,-1.9747801062936423,-0.24057174582328067
SaOS-2,46907787,1.5905885991562354,2.2725011290758594
LS411N,5311,1.0830647686053458,0.7917549488166142
NCI-H1568,5278396,3.684546625455108,3.5969494108078535
P31/FUJ,2858523,2.921593087757198,2.857961016916933
MOLP-8,25102847,1.798391543473315,2.0323647726727563
HCC15,57330099,4.175732386995395,4.191419785363816
LCLC-97TM1,16013152,5.423690206414697,3.747665685388635
SW1271,16065773,2.6188234772001886,2.5011666940894637
RERF-LC-MS,52947716,-5.597592816818683,0.6287359777442678
MOLM-13,11167602,-1.7638454235436123,1.3164056428125508
NCI-H2452,vorinostat-carboplatin (1-1 mol-mol),3.5311802496777576,3.165343340653923
Granta-519,3038522,1.8764454398289976,2.546881063762923
SW1573,54626689,3.958399976383255,4.756639900843422
K-562,445455,4.202279962055385,3.8841920237919867
SK-CO-1,25262965,-3.291258197582341,-1.3491908148127518
Granta-519,54618771,-0.1786557603441652,0.38705519475932204
ML-1 [Human thyroid carcinoma],216345,4.790115930225849,4.130601766278377
HuP-T3,42642645,1.566786855324099,1.0308380916914026
MOLM-13,44589607,2.917529465117915,1.7789453676053792
ML-1 [Human thyroid carcinoma],10385095,1.881738472046862,1.419214349582891
SU-DHL-6,753704,4.418086475877281,4.140790920445932
SU-DHL-6,6918837,-4.716152603392634,-4.893654301937315
P31/FUJ,46199207,2.4446101047156215,2.858033553963562
SaOS-2,156422,4.313289259132858,3.905890673251031
BFTC-909,5282054,4.21714099973987,3.702976885995227
RCC10RGB,9803433,4.221770064596342,4.743640174981738
Granta-519,UNC0638-navitoclax (1-1 mol-mol),-1.1089217343766455,-0.0010955662843603164
RKN,89183176,6.327700475537756,4.29564282769421
BFTC-909,16038120,1.74161234898449,1.0411696860805641
HCC1500,71466445,3.970736335461394,3.9206834524050667
Granta-519,25062766,1.8322611726564384,1.694332207940587
SK-OV-3,216345,4.761928129554225,4.163212563568257
Granta-519,11609586,-2.485330170292811,1.4161615153618268
SK-HEP-1,6918878,4.4325993547595655,3.0151889337598483
P31/FUJ,676352,1.6175160353980318,1.7358394875111096
UACC-812,25227462,-0.2916299121927669,0.1875109639397124
RERF-LC-MS,54596558,4.400747096440468,4.44929575791154
Daudi,9911830,-0.0057102646081846,1.8163078943021216
COR-L95,72376,-2.5853838467146493,-2.536092138139724
LCLC-97TM1,135875424,3.9585615026829823,3.645457244304157
P31/FUJ,49850262,2.7073676452568427,2.4035951335795316
HEL,10410894,1.686960620182283,2.7750368861698806
LS180,10127622,1.4423864514133429,3.219060391580237
LS411N,16038120,1.458068935835204,0.1838686674649587
ML-1 [Human thyroid carcinoma],136227924,2.8741817701449506,3.015627253013314
IGROV-1,11214940,1.360660548899077,2.1697628768355823
Panc 02.03,969516,3.806573436208542,2.9741816183698178
BICR 22,JQ-1-navitoclax (2-1 mol-mol),1.0465005615278271,0.9410707802138107
SW48,656346,-0.2718986936332406,0.9080285642759499
SW948,285033,-0.875487938395224,-2.0322416977707736
Panc 02.03,4261,3.516583077320981,1.8367529646969016
SW48,49766530,3.606492941369466,-0.21049416205123264
SW48,16038120,-1.7922421690180796,0.9540228488348533
RKN,navitoclax-MST-312 (1-1 mol-mol),0.5631499209413128,1.0948024198840398
ML-1 [Human thyroid carcinoma],46199207,3.5690585114534024,3.3042489404574296
WM115,2945648,2.5851994154769025,3.0213476012788645
BFTC-909,vorinostat-carboplatin (1-1 mol-mol),0.6014624935477999,3.0885657266517814
BICR 22,25227462,-3.180570489875023,0.1230252080649485
IGROV-1,5460769,1.6083174601829917,2.2094040803833557
K-562,753704,4.7227938780788525,4.047900909833437
K-562,ISOX-bortezomib (250-1 mol-mol),0.3376370593793573,0.2629882696170458
HuP-T3,4788,5.894927949545096,5.702964143253822
SK-OV-3,42642645,1.640931292575566,1.029723476658888
PaTu 8988t,11222830,1.761666424308375,1.6265141068420474
BFTC-909,448949,2.818327130228084,2.110396736721971
HEL,serdemetan-SCH-529074 (1-1 mol-mol),2.278758279722759,1.5062429891925513
WM115,5281672,6.287836255113029,4.568373109659161
Daudi,3384730,1.441294292217556,1.483697936011491
SaOS-2,navitoclax-pluripotin (1-1 mol-mol),-0.5587106095561101,-0.7827557563288151
LS180,6252,-0.5438897009285958,1.1378680203923255
SaOS-2,3025944,4.435896212894107,4.16081913827015
SaOS-2,25161177,4.43427627730954,3.8882693328111992
LS180,JQ-1-UNC0638 (2-1 mol-mol),0.673634242684319,1.2353870853181537
HARA [Human squamous cell lung carcinoma],6918328,1.494996835192892,0.24242920364033943
BFTC-909,11228183,3.298719229946038,2.1510253597570435
Panc 02.03,navitoclax-sorafenib (1-1 mol-mol),3.063115591562286,1.9662116520053032
Granta-519,135659046,3.900512348834848,3.0323785447507645
LS180,126941,-2.6871715133008385,-2.473388090035944
MOLM-13,3081361,0.9632978577503784,1.3997185310524882
WM115,9936388,-1.175666523167262,-0.09267731964236316
HARA [Human squamous cell lung carcinoma],119182,-1.5549760643936197,-0.6998058528167307
IGROV-1,15953870,2.712793598656007,3.610482035026306
RKN,10410894,1.511663597063748,2.94326685059041
IA-LM,6918638,0.61198230609435,0.4297865381592397
SW1271,56946209,-4.174123648346971,-3.801693016163276
BICR 22,67156097,-1.5899611273150889,-0.19782806074673506
SW1271,2749,2.846909316544141,2.022786947327574
KU-19-19,65628,4.405271017285275,4.430388227177666
MOLM-13,5566,2.591289759721003,2.693785764972053
HCC1500,89928392,1.0051530188155344,1.5855324966336248
SW948,25102847,1.6816963863778185,2.226279383553694
ALL-SIL,10427712,3.5706749567785625,3.6981802203648164
IGROV-1,2749,2.0319044408234954,1.9489893106872416
LS411N,selumetinib-piperlongumine (8-1 mol-mol),1.1466452951203283,1.977355602156004
HCC15,SNX-2112-bortezomib (250-1 mol-mol),-3.246727097806559,-0.9479160868432368
SaOS-2,1242560,3.6046854082724034,3.5298358945957813
RCC10RGB,123631,3.672101761387351,2.555099273659812
SaOS-2,JQ-1-MK-0752 (1-1 mol-mol),2.214313979092396,1.5921021213811561
SW48,carboplatin-etoposide (40-17 mol-mol),-0.9429596789262168,2.566524756533626
ML-1 [Human thyroid carcinoma],400769,0.4240275581269139,-0.3531352045510245
MOLM-13,23725625,2.3173082013566204,2.982849022911341
SK-CO-1,15547703,3.920131639479481,3.2815429063333155
SK-CO-1,navitoclax-pluripotin (1-1 mol-mol),-0.9841338872717872,-0.2651884881225755
SaOS-2,71729975,2.29546286795302,1.600136828625557
KU-19-19,12003241,-0.0608702413973226,-1.0183491217789324
SK-CO-1,568763,0.0338205510733868,0.6568908906189529
SU-DHL-1,984333,1.5848171755072842,0.2309683923389067
RERF-LC-MS,49766530,0.7744144603938863,-0.6261412303576871
SU-DHL-6,11152667,-4.5064226702829,-1.7056151534709516
HCC15,2130404,2.6093174666871293,3.5431726773780756
RKN,11626560,2.593417875894138,1.8915937422620899
NCI-H1568,navitoclax-MST-312 (1-1 mol-mol),0.8258625122307741,1.0135218124038383
Daudi,44137675,1.0044684727898117,2.8197733383058714
SW948,54619267,3.654776559833868,3.971854769862207
MOLP-8,selumetinib-UNC0638 (4-1 mol-mol),0.7931432464838661,2.341610700719574
RCC10RGB,4259181,1.719089746142662,0.5488312286348784
SU-DHL-1,9887053,2.0473441666614156,3.2149606798389017
SK-OV-3,9911463,4.2249846626647125,3.9566822596157176
HCC15,49766530,0.5190445493569186,-0.06199828684033805
Granta-519,3385,2.090684083959823,1.9120684857720223
RKO,54613361,0.2998145946125954,-0.24009443071969142
HEL,3384730,1.593743887858678,1.6349812435474487
NCI-H1568,11977753,-3.4091025242198696,-1.0882959014568871
SK-OV-3,285033,-0.1977879636486448,-1.9618217994267055
Daudi,3385,1.70419989930712,2.304646991445004
NCI-H1568,9825149,1.6639399446813206,2.344358860066315
IGROV-1,654092,-1.340387623873854,0.007952728577717512
SW1271,126941,-2.215477966101826,-2.394902878306546
IGROV-1,6852167,1.5305143027352028,3.019065602990417
HEL,11626560,1.0872099702081388,0.6582665395142888
SW948,126941,-3.436390914894009,-2.7741178921434475
RKN,107985,-3.0900461086436404,-3.2212026575360757
P31/FUJ,12001922,1.6134382673725098,1.376910251415005
Daudi,11404337,-3.064654238522792,-1.0998914803642172
SaOS-2,6438330,2.0981522234577064,2.116796321644854
LS411N,126941,-2.790198017582557,-2.6450542946604467
HCC1500,10302451,3.7658874637842135,2.96823897434293
BICR 31,4259181,2.3774772051226685,0.42403253875433466
MOLM-13,11656518,1.5202718128538335,0.5481460360051893
COR-L95,148124,-0.3758104123213183,-2.2879704849205345
MOLP-8,53232,1.5052202963885184,2.5168967957491826
NCI-H2452,3038522,3.3601174997652725,3.3240347861867856
HCC1500,erlotinib-PLX-4032 (2-1 mol-mol),3.588293308391856,3.012333254844593
SW948,16722836,1.2939108289094092,1.2326077143709875
HEL,439501,-2.350875236844296,-2.6116170822341225
NCI-H2452,445091,5.08182727911324,4.464885480145821
RKO,9840324,5.302067215897717,5.309357515445738
SaOS-2,44489675,3.960447273667139,4.086308991366992
ML-1 [Human thyroid carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),2.479159740244691,2.226832732926538
BICR 22,46901937,4.667354689676901,3.2380748287762824
LCLC-97TM1,2746,2.92478275020961,2.9494249243716526
P31/FUJ,selumetinib-JQ-1 (4-1 mol-mol),-1.737174960648273,-0.3551866315734455
Daudi,44491742,3.5549145676591314,3.779916297259991
BICR 31,374536,2.383890315264743,2.7036288548534135
NCI-H2452,17759555,4.398260875691204,3.7823387578266248
LS411N,25183872,0.0970121311419586,-0.6257015233454831
Panc 02.03,23725625,6.172373492037936,5.1552833934492845
Granta-519,65064,2.9178387202883735,4.10167457107997
COR-L105,11222830,1.704570553497338,1.780747980172865
NCI-H1568,5394,4.198509108960074,3.974561141444535
P31/FUJ,135984461,4.1454221372139894,2.906144804565137
K-562,49836020,4.414855158615189,2.978128301166222
HEL,4788,5.03605552733545,4.760703923966956
HEL,selumetinib-GDC-0941 (4-1 mol-mol),3.377819044796062,0.45471856633702146
LS411N,6610216,4.962940577428159,4.059627474553278
NCI-H1568,23635314,-3.8228905075414055,-1.8492009389928696
HCC1500,5328940,1.924598719414512,1.6241857025538704
BFTC-909,44589607,3.3115887945185496,3.0361129145555497
MOLM-13,5281321,-2.338854439084819,-2.6989856291183814
MOLP-8,71466380,3.4619880715079603,3.847084276168102
K-562,439501,-2.3563528898814905,-2.1988356437068712
LCLC-97TM1,44819697,0.4394946813834864,-0.2881771121153316
HCC1500,9956119,4.194319271525248,3.618428749808179
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.701286019602347
HCC1500,6505803,-1.3038553273576796,-0.5082741122809361
SK-CO-1,16038120,-1.5377645940979283,0.9464484450555364
MOLP-8,46398810,1.7248083632166018,1.9961081878194522
RKN,73707386,3.296207724675486,2.8408535031263233
HuP-T3,6918638,1.0959798369911515,0.9176201813328495
SK-CO-1,72734382,5.327408257337546,4.817020740387912
P31/FUJ,alisertib-navitoclax (2-1 mol-mol),-2.72541188794455,-1.5090035174593144
SU-DHL-1,23725625,3.354193732931358,4.547532585909168
SW948,4378219,2.7444419460246716,2.316859241153043
Granta-519,6610216,4.381057854502396,3.791280260390393
SaOS-2,25126798,4.16568157244383,3.998360069879679
MOLP-8,11719255,2.3085103352777057,2.3304475575357095
SU-DHL-1,969516,2.44648475018104,2.6733504027824124
HuP-T3,9884685,1.9355517940144655,0.7525159735878054
SU-DHL-1,54618164,3.660876980117255,3.8870255934218396
P31/FUJ,4788,5.1911977113578285,4.8020070097232495
IGROV-1,10074640,3.2681490579824426,3.088121446264488
LS180,46224516,3.8200366067107714,2.7025861536600924
K-562,24753719,4.107201496626299,3.4042035309029366
HCC1500,46926350,-3.99988450675712,-3.850294879633923
LS411N,11175137,2.6624545374598,2.3463423164377333
IGROV-1,71466578,4.017291197092763,4.298885128166112
Granta-519,10184653,0.998312657126817,0.7176500997653024
MDST8,selumetinib-MK-2206 (8-1 mol-mol),0.7033297936486181,2.364947076449944
MOLP-8,6918328,-3.583816044173495,-1.584222030383003
SW948,56649450,1.940604714075546,2.6016301352223805
BFTC-909,374536,2.594742723017773,2.6985480014878545
KU-19-19,44185566,3.361767971446376,2.7163787218678412
NCI-H2452,1750826,0.2631697114156899,-1.5279062678356956
LCLC-97TM1,24180719,3.1823264447338837,3.4695328822037754
SW1573,docetaxel-tanespimycin (2-1 mol-mol),2.3053158054818077,-2.7175526594495416
KU-19-19,navitoclax-piperlongumine (1-1 mol-mol),2.9388781180521124,1.9589682790707517
RKO,675434,4.252493680505022,4.245661738325356
RERF-LC-MS,vorinostat-navitoclax (4-1 mol-mol),1.7393887492524955,1.6055982742179729
HCC15,25105715,3.3758270019314147,3.546472164027565
HuP-T3,6610216,4.722811341582641,4.278897511918349
MOLP-8,156422,3.6985484587412394,2.9420501146810607
SK-HEP-1,6917907,-0.2672796642005143,-4.33441899240791
SW948,984333,0.954004982504914,0.5233496629820522
PaTu 8988t,51039095,3.672985699080835,2.617778597788936
Granta-519,selumetinib-BRD-A02303741 (4-1 mol-mol),7.197937797796196,3.2620483400568996
MOLM-13,10385095,0.2048351805935088,0.7619970448529524
WM115,2842253,4.366205978966029,5.57697173431442
NCI-H1568,navitoclax-birinapant (1-1 mol-mol),1.7942101393430023,1.403325659803935
IGROV-1,135423438,0.764137689665023,2.510268332774208
RKO,16725315,5.119694523443236,3.6109736900464746
MDST8,11609586,4.829072296940778,2.9280064602642626
COR-L95,7251185,1.1216187825494426,2.1466375816250807
RERF-LC-MS,51039095,3.2453184174795324,2.7707423162966727
P31/FUJ,17759555,3.626728737883383,3.3028883043412742
HCC1500,5113032,4.590685122922873,4.8016806586796426
P31/FUJ,16741245,4.043144814115882,3.651621937953384
HCC15,5746,0.6503914795852271,1.0771701958125746
RKO,10074640,2.8357111382750646,2.943224433873666
WM115,10322450,3.651827454662003,3.711357230659728
LS180,11404337,-0.0678179476465551,-0.3792574750882629
Daudi,46191454,-0.8094751773550651,0.21845239536728986
P31/FUJ,selumetinib-tretinoin (2-1 mol-mol),-0.8330243559244562,1.8856456947929234
P31/FUJ,44202524,1.0280075167408849,1.5815915773969882
ALL-SIL,44185566,1.0410692737439569,1.6443859748506826
PaTu 8902,54618164,4.284638344065584,4.16390993060361
COR-L95,46224516,1.2687748324677306,2.357642457556455
COR-L105,56949517,4.666554440626914,4.199055074843974
BICR 31,piperlongumine-MST-312 (1-1 mol-mol),1.564015805040982,1.8917870614586045
BICR 22,45279963,3.757910341256097,3.5340968902007703
HEL,9911463,3.4775133545177774,3.0894562740579805
HCC1500,navitoclax-PLX-4032 (1-1 mol-mol),-0.625964193644412,1.0851113417631495
BICR 22,JQ-1-MK-0752 (1-1 mol-mol),2.0389244155422577,1.7094628911337306
Granta-519,5287969,-2.420005986832857,-2.2041611180628977
IGROV-1,71466578,4.017291197092763,4.298885128166112
Daudi,1323703,3.9745876209629354,1.3746563720883658
COR-L95,9956119,3.960527548011759,3.494358129942597
SW48,15953870,2.1672009909649415,3.282943268109303
SW48,5278396,2.530949009900888,3.5589580117978046
WM115,10296883,3.9273376390568138,3.9082186315929595
NCI-H2452,10302451,4.286596307748033,3.268168931904498
SW948,9915743,1.1952390119197474,0.005043005371156057
SW1271,9903786,4.005340236032604,2.8552797882003587
LS411N,49793307,-3.1894754739686455,-3.2403581781823054
Daudi,126941,-4.413815937813151,-2.8950259294463403
SU-DHL-1,89183176,5.662525063156772,3.559768087911587
BICR 31,SNX-2112-bortezomib (250-1 mol-mol),-2.620347476140509,-1.1592092446711681
SK-CO-1,216239,2.5779715954988656,2.3424932184963962
SaOS-2,24889392,3.914866726590468,4.006610172428015
LS180,3025944,4.8838055311701805,4.076808810492196
SW48,11626560,-0.4765255311776857,1.8981915373539073
RKN,168313047,2.366456695786382,2.430128089400204
NCI-H1568,4788,5.820003751306211,5.583730184828666
RKN,65628,4.337575078598336,4.3066892901511045
LS411N,5311281,3.759327828108219,2.191878978831775
RKN,23725625,4.172652901782409,4.9692033920662215
BFTC-909,168312962,2.436518653578315,1.9903739105367533
K-562,56946209,-4.819463057676977,-4.603289865862368
K-562,navitoclax-piperlongumine (1-1 mol-mol),1.084720053726158,0.8414247134547612
Daudi,11647372,-0.1839602824658907,-0.07749877587378647
SW948,5479543,0.3482839273666757,2.8793824764814873
SU-DHL-1,11626560,-1.697644171575415,1.5339746781626218
BICR 22,71466380,4.042212978424107,4.480510815690469
HCC1500,selumetinib-UNC0638 (4-1 mol-mol),3.968035032331931,2.526279659449615
MOLP-8,BRD-A02303741-navitoclax (2-1 mol-mol),3.766843844868067,1.4583207626174686
MOLP-8,9967941,2.6295638429027206,3.21298769454982
SW1271,piperlongumine-MST-312 (1-1 mol-mol),2.322149279280664,1.8401352870461056
NCI-H2452,25183872,0.970145395005522,-0.8467090068018963
RCC10RGB,navitoclax-MST-312 (1-1 mol-mol),1.0881941253840328,0.9562067111976889
RERF-LC-MS,sirolimus-bortezomib (250-1 mol-mol),0.955955259392996,0.9789260106846688
HCC15,8515,2.8931769079597767,4.01919636001352
SK-HEP-1,7251185,3.0945137710223687,2.714764048368495
HuP-T3,3689413,-1.422602865458103,0.29638989318771075
HCC1500,2113511,4.626117550925971,5.476555554077546
HARA [Human squamous cell lung carcinoma],445091,4.978549366904043,4.562410016959286
SW1573,5351362,2.395315345585997,1.5126591887669878
SaOS-2,16725315,3.258166087647875,3.87046108306459
SK-HEP-1,44566777,0.1035402456781041,0.5505471900664822
ML-1 [Human thyroid carcinoma],9887053,4.856845998315694,4.307088761425416
NCI-H2452,54618771,2.226699645078912,1.6351390703270081
RKN,5329102,3.127163305072316,2.1616846986621967
BFTC-909,JQ-1-vorinostat (2-1 mol-mol),1.4357033395957943,1.0953433840356694
IGROV-1,selumetinib-MK-2206 (8-1 mol-mol),1.1145818568790276,2.3518487464889914
NCI-H1568,5287620,-3.0605655272876104,-1.822523803180325
IGROV-1,5329102,1.2794664511054334,2.0783120287897403
SU-DHL-1,71680916,6.473574001994787,4.75290058048294
COR-L105,25262965,-4.3344847799771,-1.1037909184040147
SW48,3503,2.2068347221848605,2.241536652662298
BICR 31,36462,3.088359748996336,2.495697331829682
SK-HEP-1,24753719,4.401042857593667,4.3042970551080035
RCC10RGB,navitoclax-gemcitabine (1-1 mol-mol),-0.0681716439191075,-0.80128565350263
IA-LM,16659841,3.92216274325252,2.4027180673085895
WM115,24771867,3.628628048718056,2.9821023319134046
SK-CO-1,67156097,0.6545128366700663,-0.12251441727680333
RKN,selumetinib-vorinostat (8-1 mol-mol),2.829001792073934,2.6497316936600246
SaOS-2,navitoclax-sorafenib (1-1 mol-mol),2.1552340524690843,1.5798068971115604
IGROV-1,71466380,4.863636874274779,4.333575199360522
HCC1500,selumetinib-piperlongumine (8-1 mol-mol),2.4825259194039173,2.744502463769196
Daudi,5281321,-4.970506938945455,-2.7946866325651665
BFTC-909,12003241,-0.8371396827795129,-1.03197838115156
SaOS-2,44185566,3.018169617675811,2.567658360682972
SW48,54619238,4.554849733994691,4.3472983024442415
Granta-519,25227462,-6.0432717278136066,-2.1856193488633573
HCC1500,72376,-0.7270592073375387,-1.7439358087068577
SK-OV-3,3689413,0.6002437290843657,-0.12146449723691573
HARA [Human squamous cell lung carcinoma],122327,4.478573115200279,4.716123371677902
COR-L105,71466380,4.962997689396809,4.554607551857246
K-562,56649450,4.352548214039191,2.631645377172733
ALL-SIL,2828334,5.780519190951295,5.500402945077067
MOLP-8,5746,-0.9490954024297016,0.006860487329899614
LS411N,9935249,3.5378716054356927,1.5372982387442247
KU-19-19,148198,-3.572091199224797,-3.221276640693351
Granta-519,navitoclax-piperlongumine (1-1 mol-mol),-0.8573381901716745,-0.4808801772009888
Granta-519,navitoclax-MST-312 (1-1 mol-mol),-0.2022371646874937,-0.4772183209857929
RERF-LC-MS,54619267,3.9836959677109354,4.235354933515927
RKO,piperlongumine-MST-312 (1-1 mol-mol),2.2495159802497864,1.1386837263926024
SK-CO-1,445455,4.388752059403359,4.423481731644156
ML-1 [Human thyroid carcinoma],42611257,2.85876832372032,3.3105349689134234
BFTC-909,6914657,-4.61933610547547,-3.7982572470232636
IGROV-1,54619267,3.9701367924453455,4.110513906289304
NCI-H2452,6918289,-3.5458030779688277,2.812182757471263
SW48,654092,0.3720639788768654,0.22417091268145628
LS180,10184653,1.1411409682713576,1.1095651256677106
SW1573,4259181,2.0061423198913766,0.4075603161889946
BICR 22,5978,-3.054007840707858,-0.9174007834619544
SK-CO-1,446155,2.509492168961503,3.003721777729419
HuP-T3,piperlongumine-MST-312 (1-1 mol-mol),1.4346079723069378,1.8874782487747177
MOLP-8,6917907,-6.199761218038622,-5.096211869432515
WM115,6610216,3.675624927368402,4.10422302770589
BICR 22,11964036,1.4111698106068242,1.467087008574702
IGROV-1,135440466,0.9791523710816318,2.302257172028229
SU-DHL-1,46224516,1.9664047258697153,2.241826562778633
ML-1 [Human thyroid carcinoma],656346,1.1399678324227185,1.219873590591943
NCI-H2452,156422,4.888821376667332,4.172308723940273
BICR 22,446155,3.7361559304721106,2.8799011826240553
BFTC-909,3038522,3.685618431455981,3.1715282540964553
RKO,46907787,4.104881837237831,0.562568994247743
IGROV-1,123631,1.7694522866439453,2.5492970450062677
LS411N,5280436,4.183720769167266,2.9944851318120955
HARA [Human squamous cell lung carcinoma],15983966,-4.087930187377121,-1.289783043000171
HEL,5311,0.0816485968486221,0.7421851654942322
SU-DHL-1,327653,2.51842673185387,2.8287221489594128
MOLM-13,8515,0.8268618162227004,3.039989903247754
MOLP-8,25183872,-1.6811002192977054,-1.9136382241616101
Granta-519,11228183,-2.3490545548585335,-0.01811120460063122
LS411N,sirolimus-bortezomib (250-1 mol-mol),1.8501035907850776,0.7230168861015733
SaOS-2,5470400,4.204063595869918,0.02910785324878452
BFTC-909,5738263,3.1091802601858185,3.4147626059765925
SK-CO-1,20959075,-3.269929661945314,-2.522848095292134
SK-OV-3,9956119,5.08600620496794,3.7797920108083183
WM115,tretinoin-navitoclax (4-1 mol-mol),3.8155470378280008,2.4657521857590967
BICR 31,5978,2.6862960741960693,-1.3266618058755435
RERF-LC-MS,375860,-0.2896823379882159,0.020214206812157364
SK-OV-3,selumetinib-piperlongumine (8-1 mol-mol),4.999927979817729,3.1717390424472827
COR-L105,44202524,4.8543272504702895,2.5447716562916782
MOLP-8,44137675,1.775364766844489,3.0578998265352495
IGROV-1,9907093,2.687959785702283,4.035568642869007
LCLC-97TM1,10385095,1.2595894653665305,1.4037059363676474
HCC1500,serdemetan-SCH-529074 (1-1 mol-mol),0.9549823890456136,2.039890049691309
P31/FUJ,3038522,3.230912995410489,2.57752912104433
PaTu 8988t,5281321,0.6032906637165831,-0.770133045675043
HEL,9866186,-1.054303819018661,0.08153320279206439
HCC15,carboplatin-etoposide (40-17 mol-mol),1.5999978710207647,2.8168625265435714
SW948,2708,5.7755473109613265,4.004285916678021
PaTu 8988t,3025944,4.261130932115319,4.212329403893963
SK-HEP-1,3689413,-2.4602386660304143,-0.0046847487434860495
SU-DHL-1,selumetinib-BRD-A02303741 (4-1 mol-mol),4.3225967046124065,3.30393654978418
ML-1 [Human thyroid carcinoma],24771867,3.392643461506865,2.9306806145023963
RKO,6252,0.5352436981906653,-0.8208840318035273
SU-DHL-1,4521392,5.192178694848648,4.303133215862307
Daudi,72376,-4.854665282210012,-3.4849093296059412
RKN,4259181,0.9508926940780028,0.2466517002992776
ML-1 [Human thyroid carcinoma],4096211,3.147888642031647,2.2879634926805394
HARA [Human squamous cell lung carcinoma],44819697,3.9048868362328264,-0.18177722156157297
SW1271,36314,-4.053350989931705,-1.3339886303847046
COR-L105,1750826,-1.9007119452090728,-0.8233652560580373
HuP-T3,salermide-PLX-4032 (12-1 mol-mol),5.718732466752557,4.808532115986404
Granta-519,46215462,0.9491023197189584,1.1357455276492445
SW1271,3676137,4.713113076263269,4.333760088932582
IA-LM,5278396,3.9030690758091904,3.2159333679336286
NCI-H2452,24775005,5.579264227156813,3.933066167073936
K-562,23635314,-4.3400265171433725,-3.2405879687325427
COR-L105,6852167,2.71981320036177,2.9988790383108164
Panc 02.03,16741245,4.354855972582246,3.9990512605552158
SU-DHL-1,2733487,6.186604270067288,6.219056643027525
Granta-519,26596,-3.6955660538224784,-2.6833298144067492
SW1271,JQ-1-UNC0638 (2-1 mol-mol),1.8151113798618133,1.867711135694568
ALL-SIL,176870,2.444675771693443,2.473741589249062
LCLC-97TM1,19582717,4.783105330370089,3.868638069162833
HuP-T3,119607,5.841541098284191,5.423054085577925
RKN,selumetinib-UNC0638 (4-1 mol-mol),3.946775123673676,3.313177416893217
P31/FUJ,637858,0.7903103947120294,0.9521575894476243
COR-L95,5329102,1.6379635813529434,1.977979719270887
BICR 31,5291,3.978522058600436,3.76428493572981
LS180,6852167,2.255231171645259,3.029797354303807
IA-LM,89928392,1.436934436501384,0.5484523355373576
RKO,docetaxel-tanespimycin (2-1 mol-mol),-5.095252166768177,-4.065720758354061
BICR 22,9903786,3.2901982519836213,2.637022922721375
SK-CO-1,3384730,3.2619898650330272,3.079466050303383
SW48,17755052,-0.4852421045975616,1.6460405220362642
COR-L105,568763,0.9810834095142736,0.5698307857545344
HCC1500,9866186,3.137309558941867,1.0679906596244164
HCC15,124202324,2.163317754038658,2.491009809607368
HCC1500,6917907,-5.345696307345718,-3.8312757987234614
HCC1500,23635314,-1.1425681705854864,-0.7468840138690486
Granta-519,126941,-4.311277898608593,-3.2436638144754615
SU-DHL-1,tretinoin-carboplatin (2-1 mol-mol),3.205630539300333,4.0996067870073505
SW948,24771867,-2.1331828785420166,-0.3502690738800709
HARA [Human squamous cell lung carcinoma],638278,3.613202989039307,3.131335554231448
LCLC-97TM1,10410894,3.7243046596553344,3.2264168693000563
COR-L95,11609586,-0.6075050167057128,2.464958557560334
MOLM-13,9952709,2.652499766566874,1.8340496557915358
HCC15,24951314,1.20775234306688,1.510793106549133
BFTC-909,11175137,1.859642091823866,2.562974349706011
PaTu 8988t,tanespimycin-bortezomib (250-1 mol-mol),-0.2002957463821567,-0.5875492007592896
SaOS-2,9444,4.299296809659387,4.286826575708528
Daudi,71576739,4.751042411789338,3.112801884858927
SU-DHL-1,6505803,-0.92520479323989,-1.0560715114740638
SU-DHL-1,11214940,-0.4959690036226346,1.7337070943132287
IA-LM,71466578,5.490140561499378,3.2796093387697
RERF-LC-MS,262093,3.104487938727744,3.015964981546677
SW1271,71466380,4.990835020791986,4.530005283212976
Panc 02.03,135411,0.8368106867561712,1.056340011757521
RERF-LC-MS,8515,3.770178660744851,4.001543746743596
HCC15,45100309,5.717971650422449,2.8839899661676656
COR-L95,54618771,1.9587299059916856,1.0820316473619171
LCLC-97TM1,16736978,1.4629436365964008,1.488647066657067
IGROV-1,9825149,2.5588021380929553,2.154405046246967
IGROV-1,227681,3.5439813498262347,3.366154483027893
RERF-LC-MS,44489675,3.7548789887197183,4.105451363615255
MOLP-8,3136844,3.797428854524256,3.588697354682306
COR-L95,5746,-1.1189080553056585,0.16150151567813897
BICR 22,135398516,2.7677082767193117,1.9608339433431166
KU-19-19,tanespimycin-gemcitabine (1-1 mol-mol),1.208542786585586,-0.35189571830972083
ALL-SIL,57330099,4.126515702027515,3.7590039206148913
SW48,135398738,2.3509294796071454,4.441971050283255
WM115,2113511,5.303490143807845,5.5989702764813964
Daudi,2729026,1.2833432455886875,2.315900181540902
P31/FUJ,100016,5.4217002529902185,5.084094710696379
IGROV-1,71466445,2.3758001916617797,3.9937131644943182
ALL-SIL,6918878,-0.682122479171039,0.508379508376925
Daudi,73707371,3.866210661620395,3.570185313883917
ML-1 [Human thyroid carcinoma],60700,-3.146668380067059,0.5523686716893355
SW48,11364421,-4.967269122022574,-1.8861190854979486
HCC15,selumetinib-JQ-1 (4-1 mol-mol),1.0945511889039805,1.8460932116909132
LS411N,135411,0.7383506227122603,0.2681116895245414
K-562,3634881,3.4419902111623473,2.5764499073582043
KU-19-19,969516,2.8919422545546043,2.9208707788685957
Daudi,135999136,4.063293138043838,2.3970496412608098
SU-DHL-1,12001922,1.0574025128990867,1.6942474138813837
HCC15,carboplatin-UNC0638 (2-1 mol-mol),3.871381279129182,3.24730844649579
MDST8,11427553,3.108888701151444,3.0064160286456576
COR-L95,navitoclax-pluripotin (1-1 mol-mol),-0.7248049337705845,-0.8803678081146856
HuP-T3,9840324,6.187364891887578,5.784660166056301
RERF-LC-MS,5281321,-2.2570738048063257,-1.2823742125076347
UACC-812,16725315,4.601797708491857,4.151670392127263
WM115,53481919,3.625694730030069,3.7054025385434617
WM115,3136844,4.4781621433894925,4.493914616504903
SK-HEP-1,135999136,5.290710201924687,3.990813286861756
SK-OV-3,72734382,4.397767647147488,4.796054487931549
SU-DHL-1,4096211,0.0680701310214702,1.927847651361067
SK-CO-1,2749,0.8616454488616467,2.168084324348873
COR-L105,4477,0.3499366832640422,0.6573992505310996
SW948,24785538,-1.2786696026485709,0.4267985878694788
BICR 22,25161177,4.685384367036766,4.141224734895611
Granta-519,11955716,-3.0537796337487064,-1.979587764203713
ALL-SIL,10127622,5.469150259822909,2.942937138890095
SK-CO-1,11238147,1.2924304468719774,3.0154594976064675
IGROV-1,11427553,2.926316692603687,2.734293662357305
BICR 22,54618164,4.171441086739322,3.978315116801219
BFTC-909,57519531,3.2286550647211025,2.5630555071700796
SaOS-2,1750826,-1.0374385524430834,-1.3466939452292306
SU-DHL-1,71466445,3.7763473385017994,2.3683243383627706
SW1271,6852167,3.737297660761554,2.876200180299745
SW948,9549297,1.722924191719054,2.1751880793141596
BICR 31,72376,-0.802396523967939,-1.8361073024536305
SK-HEP-1,56946209,-4.57873882670014,-3.65168539686655
RKO,24964624,3.0430796891613903,1.0455599547236996
NCI-H2452,54143018,0.9899128272921088,0.743531066210344
SU-DHL-6,60750,-4.821248170588626,-3.7042082240154564
HEL,44259,1.31343744649104,0.7704837738001588
MDST8,3038522,4.546677862508445,2.955497642335272
Daudi,72193861,0.2314245956601211,0.26623653959786664
NCI-H2452,4096211,2.487981551988898,2.349517918030172
LCLC-97TM1,carboplatin-etoposide (40-17 mol-mol),1.252125961208134,2.657541397021676
Daudi,208908,1.616008502166041,1.8046719756335947
LS411N,46191454,1.665967132338862,1.2140226936819514
Panc 02.03,262093,3.467425891303458,3.2183646070132004
COR-L95,462382,0.8255977399878551,0.41109621469437374
IGROV-1,16736978,0.1982875499977011,1.798022380124802
MDST8,107985,-3.301997074358414,-3.5843047882311208
COR-L105,navitoclax-gemcitabine (1-1 mol-mol),-0.9402734681791266,-0.8373034619421134
ML-1 [Human thyroid carcinoma],65064,4.907366569161651,5.142986301496043
RKO,54618164,4.0326978900214705,3.885888340222232
MOLP-8,5311,0.4432260076750803,0.5588084069160572
SK-HEP-1,5291,4.1108608913621545,3.6833628978787742
SaOS-2,107970,2.235066344736828,2.29864451126103
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,2.5942035294204455
Granta-519,6252,-5.172240666242431,-1.4914199479710826
IGROV-1,285033,-1.3538783590767758,-1.8503222902820722
RKO,serdemetan-SCH-529074 (1-1 mol-mol),2.0344925203933006,1.5305284082365305
NCI-H1568,46191454,1.7726304550427152,1.705371482332974
PaTu 8902,24856436,4.585148807200659,0.4543168108241311
WM115,5351362,0.9981168658111552,1.9620565786183903
IA-LM,387447,-4.406032561698067,-4.083573028317016
MOLM-13,656346,-0.3431029585418202,0.44478839009048493
COR-L105,637858,2.3247583240908405,2.1710108913525445
Daudi,448949,1.1283153338590814,1.2330594848306584
SW948,42642645,-0.386998084672917,0.1244527149980068
BFTC-909,JQ-1-carboplatin (1-1 mol-mol),5.2410563732595845,2.3527040934307504
HCC1500,52947716,-7.376885049387286,-1.4510479610269684
MDST8,439501,-2.351670240427255,-1.9243540075153986
RERF-LC-MS,25161177,4.303824118845859,4.161928391430457
SU-DHL-1,3634881,1.9377929493272257,3.0544654624924625
RKO,46398810,2.934390735401444,1.9880559937541002
BFTC-909,carboplatin-etoposide (40-17 mol-mol),3.649517561488253,2.7776028928939054
HCC15,159324,2.6315252421023536,3.173301625127343
PaTu 8988t,serdemetan-SCH-529074 (1-1 mol-mol),3.002094874495684,2.1077136218631396
HARA [Human squamous cell lung carcinoma],11612883,2.0711773248440783,2.5675047979579055
Daudi,2949965,1.2926680931891954,1.9833769945815627
RKO,23725625,3.9986828157613616,3.5220801971988123
HEL,16722836,0.561669465799647,0.7536531553713947
Panc 02.03,11175137,3.7353172411310696,2.68864226491235
KU-19-19,6918878,0.8609723302141853,3.2074957642636908
Granta-519,docetaxel-tanespimycin (2-1 mol-mol),-8.26947994699302,-4.695984751294545
SW48,3854666,0.5343434371102147,2.067834919061478
SK-HEP-1,11626560,2.7034566874481745,2.018055138018805
ML-1 [Human thyroid carcinoma],navitoclax-sorafenib (1-1 mol-mol),2.2930044306717954,1.838079512855253
NCI-H2452,3825829,3.8827569930751937,4.145705180498599
BFTC-909,126941,-2.0975077483758415,-2.382842470198152
NCI-H2452,24951314,1.9717681393720747,1.685480380173548
HCC15,54454,0.5186235809490349,2.6342081021441475
BICR 31,4096211,1.2121831781068038,2.2976172946324476
SK-CO-1,6914657,-1.8836208914019363,-3.7071847305218633
SW48,44493528,3.8128145383765992,4.134646543072973
COR-L95,BRD-A02303741-navitoclax (2-1 mol-mol),0.0270607892224954,1.3984772020503808
SW1271,168312962,3.6054980890180746,1.7415351000322097
HARA [Human squamous cell lung carcinoma],5566,3.127581032716584,3.011696164669773
Panc 02.03,135440466,3.0724615257354153,2.360033982732914
PaTu 8988t,navitoclax-piperlongumine (1-1 mol-mol),3.1694697801552025,1.778061825611427
BFTC-909,11427553,2.7610941057010754,2.772295598253336
LS411N,ISOX-bortezomib (250-1 mol-mol),0.5408045393266885,0.5813091648992362
SW1271,44493528,4.286060334293371,4.469645517910539
Granta-519,JQ-1-MK-0752 (1-1 mol-mol),-0.0004173872761687,0.35151590854718434
LS180,49836020,0.6204023867713871,2.812516858489281
HEL,148198,-3.399100076616297,-4.296161587945424
ML-1 [Human thyroid carcinoma],19582717,3.041392892734857,4.365153295648081
Granta-519,3543504,5.0961511485487705,3.379475922131092
HCC1500,3038522,2.0060085934463108,2.785484386147686
RKO,4917,3.097539294413192,2.9531860560307495
RCC10RGB,168312962,4.335962117924443,2.0236192023760426
SaOS-2,104842,-4.966916923279438,-2.907975376944277
Panc 02.03,753704,5.09544361232119,5.1287788174296205
PaTu 8988t,439501,-3.4446792284706347,-2.0477620112420136
LS180,5282054,4.115839158247494,3.688075837404395
IA-LM,5287620,-0.8479822353163541,-2.0826257834957302
RCC10RGB,6610216,4.531223922644925,4.359353720137797
SK-OV-3,vorinostat-carboplatin (1-1 mol-mol),3.580838266034329,3.110016962616713
HuP-T3,selumetinib-tretinoin (2-1 mol-mol),3.9566869559335585,2.980681945348897
SW1271,9911830,2.7072275961126997,2.3434307183861565
WM115,11719255,3.1992621528929166,3.4897157350773864
RCC10RGB,42642645,2.104174802814935,1.101363168026314
K-562,72376,-2.627875463605781,-3.244204358105141
KU-19-19,selumetinib-vorinostat (8-1 mol-mol),1.3262473417693337,2.72286569970019
HCC1500,9549297,1.8848953505663728,2.5082758861658236
HCC1500,44241473,4.374636754710865,4.740460970667866
HuP-T3,2708,5.229598766149438,5.069839794509179
P31/FUJ,9866186,-0.5408158091236333,0.00478405248019197
RERF-LC-MS,11657048,4.330866638894723,3.8883475965442056
HEL,119182,-2.1951032337756935,-2.59288559065059
RCC10RGB,10296883,4.350673741830848,3.9143014691766407
MDST8,10385095,1.2575537617816142,1.4367271007487048
SK-CO-1,23635314,-1.3218098525260824,-0.8594564881149508
BICR 22,72199289,4.441607504718354,3.2955385224114355
MOLP-8,9911830,1.992368688928045,2.0512560093019605
SW48,24772860,-4.097111396936187,-1.7715358141165674
COR-L105,8515,4.561371818511258,4.1194447214381675
IGROV-1,15547703,3.339928221860449,3.1793070164907213
SU-DHL-1,656346,-0.4085927723055031,0.8987915384446775
COR-L105,168313200,3.683873258385797,3.1179777382168536
Daudi,46224516,0.8162026590632436,2.2859700115196926
Granta-519,5287620,-2.8216901996678985,-2.148446065127646
P31/FUJ,JQ-1-vorinostat (2-1 mol-mol),-0.2741289026450685,-0.7075899374015994
UACC-812,11640390,4.086462739167014,3.073261738041466
K-562,17755052,3.8994339695870326,1.485633073593411
BICR 31,selumetinib-GDC-0941 (4-1 mol-mol),-0.0760223515380139,1.6557063239195875
LS180,656346,-0.0089884994203474,0.7917229379980654
LS411N,selumetinib-UNC0638 (4-1 mol-mol),2.4499191002493315,3.009743331627628
SU-DHL-1,5311281,2.996662642824561,2.08674611860163
RCC10RGB,25161177,5.612412997721579,4.262386520075622
K-562,3854666,0.2872946014041473,0.9474200903140315
P31/FUJ,9825149,2.400010374644864,1.7598628637297953
SW1271,11964036,1.1602803966527862,1.5586669434466294
LCLC-97TM1,176870,1.9757247403033509,2.9010360010056155
K-562,168313016,4.482960220744853,4.00700838321475
BICR 22,selumetinib-PLX-4032 (8-1 mol-mol),3.113612897977895,2.827990701453323
SW1573,285033,-0.3175288260868649,-1.2568475989202508
BICR 31,4788,6.181654669045445,5.745521443065478
LS411N,11404337,-0.9351547419605356,-0.5791124046530222
RERF-LC-MS,9967941,1.5454786965180345,3.8795190171099434
Granta-519,56973724,1.8473061894805545,1.5548613252451244
K-562,11507802,0.4095176942133114,0.6678934827089019
SW1271,1750826,-3.093550008900348,-1.5501726592589318
P31/FUJ,135398738,-0.0291234665218711,2.2271363614207322
WM115,5329102,1.7959886386080517,1.978622945516629
MOLM-13,5470400,-0.3466627309634489,0.14310772456112308
WM115,navitoclax-PLX-4032 (1-1 mol-mol),-0.9695757520165332,1.7090198524324762
Granta-519,44607531,0.7355881041308102,1.0502591908462282
RCC10RGB,5566,3.997570642857795,3.190336455311264
KU-19-19,24964624,3.8522438290321768,2.508630310995559
WM115,1641662,3.4019570651475557,3.732431452330017
BICR 22,5282054,4.223594396310054,3.6027321437224225
BICR 31,10231331,3.776464743887352,2.3088299357492446
RKO,3825829,4.017808531984142,3.271139910784935
Daudi,10322450,2.3131627402631905,3.1493257102415595
BICR 22,285033,-4.068757657270757,-1.4339368821837255
SU-DHL-1,5281321,-1.7372628502658949,-1.0206625873189288
RKO,5287620,-1.9975210326345276,-2.086898503438626
Panc 02.03,53232,6.367991743549877,2.7253097909184
SaOS-2,9826308,0.4955218987390744,0.4533070002792193
HuP-T3,10074640,3.8159838645365807,3.225508827510854
SW948,4259181,0.2292867461834122,-0.07504922532111832
HARA [Human squamous cell lung carcinoma],11222830,1.4006503885864872,1.665948209403907
IGROV-1,568763,0.665047061839467,0.4825743529925577
ALL-SIL,decitabine-carboplatin (1-1 mol-mol),-0.0286812837112609,-0.11299150676984687
MOLM-13,322968,2.556875190594409,2.1639235362799787
ALL-SIL,9903786,1.532435199339551,1.7825511939035714
SW1573,409805,6.568626512075582,4.962863863591855
LS180,1750826,1.061711606063746,-0.3808916620849934
HuP-T3,46191454,1.9484889201022677,1.6304331334036986
ML-1 [Human thyroid carcinoma],24901704,3.6288922396747743,3.403367256048646
HEL,216345,3.87635579429504,2.785946613425165
BICR 31,2749,2.2358137088107033,2.072140212597793
SaOS-2,3385,7.1536746080698395,4.433302586721678
WM115,11626560,1.643291568999912,1.7962725144731737
BFTC-909,selumetinib-GDC-0941 (4-1 mol-mol),1.742559417066922,1.6059403922347213
ML-1 [Human thyroid carcinoma],36462,0.3533243941090192,2.340971995334066
Granta-519,24964624,2.975569692960617,1.0210225973387244
HARA [Human squamous cell lung carcinoma],16038120,0.7093520184689783,1.1604874713189282
COR-L105,6918638,0.8528151020185122,0.8208127459608618
RCC10RGB,9825149,2.634802111166888,2.643151602384935
HCC1500,44493528,4.240662848371031,4.288028016611583
COR-L105,44489675,3.747818158649104,4.091224455015552
SK-CO-1,selumetinib-BRD-A02303741 (4-1 mol-mol),0.1356145956067642,2.9681612754482605
P31/FUJ,selumetinib-piperlongumine (8-1 mol-mol),0.6855922532418997,2.1072165494391495
BICR 31,2746,4.041774334142006,3.4407031060636775
MDST8,51037431,3.453193232905579,3.1942288642009604
K-562,676352,1.515837042857868,1.9672143087301937
LCLC-97TM1,73707386,3.587652793939767,2.7657685252698734
SK-CO-1,54618164,4.180915062416914,4.048229233512339
SaOS-2,5329102,1.942826181308244,2.024064937926093
SU-DHL-1,doxorubicin-navitoclax (2-1 mol-mol),-3.969153330724774,-1.7716336940004882
LCLC-97TM1,151289,0.9235530786043882,1.1227334973151104
BICR 22,400769,0.1100780529561809,-0.5101152249068044
Panc 02.03,docetaxel-tanespimycin (2-1 mol-mol),-0.6813802759264704,-1.9092392401521499
SK-CO-1,400769,-0.6897300489229926,-0.60708744968662
SW1271,56973724,2.58013716529859,3.191719500118517
LCLC-97TM1,2945648,2.6479910997037934,2.7450861910015116
SU-DHL-1,439501,-2.3864560258185916,-2.062215994496801
NCI-H1568,148198,-4.9953315451672005,-3.324665692385498
RKO,11507802,1.7455765117352984,0.6647799353738608
Panc 02.03,216239,3.7763245170365183,2.5516527073092603
HCC1500,9825149,1.9829642871568696,2.0130530215835307
NCI-H2452,53232,3.5381177646863837,2.736444931583355
MOLP-8,11494412,0.4734092912657368,0.4914260241681137
Granta-519,9911463,3.5000933341892733,3.083754861829438
SK-CO-1,10410894,3.775604170297083,3.2737930300141445
Granta-519,navitoclax-pluripotin (1-1 mol-mol),-1.5381813072816537,-2.0916220935770964
MDST8,5328940,2.138158341424683,1.8270370360193666
SaOS-2,1716436,3.427239396926117,3.106393532916657
HuP-T3,9887053,4.07990532641299,4.167234398654893
NCI-H1568,24772860,2.3104914540479324,-1.7060057649415485
LCLC-97TM1,135999136,4.356650968290631,3.6790195512094317
IGROV-1,4378219,2.016502068118561,2.604238177266439
BICR 22,46199207,3.899734747403315,3.1159382841920187
BICR 31,9915743,-0.3251640044425866,0.8554490721650133
NCI-H2452,613753,2.817247196569438,3.30423089541152
P31/FUJ,46174525,2.51911302821391,3.220011237693511
P31/FUJ,5335621,3.2282922271331613,3.7387797508348917
IGROV-1,5278396,3.119031774261392,3.6738007248476094
HuP-T3,16038120,1.51216352382263,1.1429278800547171
LCLC-97TM1,17755052,0.1986775459223547,1.5261436373401223
PaTu 8988t,66577038,3.1818565141070625,3.0961558574164925
PaTu 8988t,54618771,0.599962301527202,1.5912331664105657
SK-CO-1,46191454,1.747962727561699,1.6271281619413966
SW48,46907787,-1.5740012638710297,2.016513977062136
ALL-SIL,11485656,1.390704841990788,1.4999594952645987
RERF-LC-MS,selumetinib-piperlongumine (8-1 mol-mol),3.579320132644808,3.564184860694807
SK-CO-1,4788,5.843658659854095,5.640400867233869
IGROV-1,16725315,4.890680859998698,4.25019687846544
SW1271,24821094,3.627509655063773,2.7558113010729635
Daudi,navitoclax-pluripotin (1-1 mol-mol),-3.474702671481659,-1.9673212389314714
WM115,216468,3.848857711215856,3.4396037610481285
SaOS-2,24779724,4.377738848523283,4.159206065135734
HCC15,675434,4.852455641097197,4.497289479468974
SK-CO-1,46398810,2.9216967746168625,2.5012997839793596
LS180,JQ-1-vorinostat (2-1 mol-mol),0.4669519655203766,0.943782051447505
Panc 02.03,123631,3.5560371664842325,2.597327945556884
SK-CO-1,448949,1.9523830928265349,2.1115814293580555
RKO,285033,-2.0365968290915393,-2.7386075810418298
SW48,2749,0.8385534684858028,2.1417975050205182
IA-LM,navitoclax-gemcitabine (1-1 mol-mol),-0.1598122581920494,-0.9877408953284389
HCC1500,54618164,3.7944844711277264,4.132791861351413
Panc 02.03,2858523,3.458791746781272,3.0976680644221704
PaTu 8902,piperlongumine-MST-312 (1-1 mol-mol),2.709357535529884,1.8794456002198212
COR-L95,4261,0.3666433774913241,1.1217082428251919
HEL,126941,-3.7945695708983664,-3.0372954950094573
HCC1500,54596490,4.413271545106012,4.658647312766911
BFTC-909,375860,-1.1901103647211757,-0.08972028472953023
COR-L95,9866186,0.0204391385842873,0.8032174746591391
BICR 22,66577038,2.5300885228037813,2.5823017772224097
SW948,9826308,0.2428169991227084,0.1137661568645598
MOLM-13,73707440,5.976327057082507,3.8644683288913138
PaTu 8902,5291,3.72219732976082,3.7243482881969294
RERF-LC-MS,5470400,2.5584942331402623,-0.16099554447992376
SW1573,16725315,3.253832365815957,4.0264268899047355
SU-DHL-1,3552672,1.9257473882600096,2.660874183032821
HCC15,60750,0.68669542572171,-1.8090897156457328
SW48,5328940,0.1162920415883012,1.7012118547051147
PaTu 8988t,4378219,1.99751885903338,2.565209475179307
HEL,241158,3.370113308144609,2.5265700268300035
MOLP-8,53495165,-2.6639864548579535,-1.8049643950257248
LS411N,46943432,5.879073426568822,1.2029033186874982
LS180,ISOX-bortezomib (250-1 mol-mol),0.5409757723847333,0.8582616161504358
SK-HEP-1,selumetinib-UNC0638 (4-1 mol-mol),4.697700742307761,3.249281734063164
Panc 02.03,4521392,4.25988041093388,4.280196727601508
SW1271,5951923,6.143368489838077,4.235944748875689
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,3.7193984896208905
HARA [Human squamous cell lung carcinoma],44185566,2.9912273208606552,2.56071696988876
RERF-LC-MS,11717001,4.567893424272946,4.045393850382651
NCI-H1568,25102847,1.8020479238639409,2.4123752227101765
MOLM-13,44137675,1.768154079183361,2.6580358483905333
RKO,10427712,4.823698606341804,3.888960049857605
BICR 22,6852167,2.9570859917106533,2.9833661089163566
ALL-SIL,vorinostat-navitoclax (4-1 mol-mol),-1.3745471945547945,-0.5634955605139508
SW1271,124202324,3.327062905972079,2.4380280438539104
WM115,400769,0.2375153529743729,-0.32171540776737606
RKN,3038522,4.332475047921768,3.265795270082611
SW1271,4096211,3.040458805184357,2.1986901287027703
BICR 31,60700,1.4006980690412227,-0.14478935587384745
Granta-519,448949,1.64880276038625,1.128703255447167
HEL,11964036,0.787171767074348,0.2126090744214931
HARA [Human squamous cell lung carcinoma],11485656,2.214748392282881,2.4200714646364268
BICR 22,11485656,1.7887481250962165,2.3334550170830566
HEL,44202524,1.7623585771552046,1.6000586884126995
COR-L105,3503,2.4932686195421625,2.635638854321603
LS180,4788,5.917574515812926,5.566665990817016
IGROV-1,219104,3.803083685328391,3.602359067716997
IGROV-1,11152667,-1.4116509977729443,-0.2500706814436021
LCLC-97TM1,JQ-1-MK-0752 (1-1 mol-mol),0.5638595279312849,1.131783606116771
HuP-T3,11485656,3.0565489144797224,2.428299020688675
NCI-H1568,9907093,3.7800753982052697,4.275412628486183
LCLC-97TM1,10184653,1.174063194948861,1.1004006568630837
MDST8,16038120,1.9679009346440888,1.106410226408591
MDST8,navitoclax-PLX-4032 (1-1 mol-mol),-1.0125849451326647,1.5946730931041189
NCI-H1568,216239,1.54277692538335,2.194669559693298
LCLC-97TM1,5280436,3.0011603005672804,3.171312291820425
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,3.0941744319636317
Granta-519,5281321,-3.900138103622144,-2.5416810182513725
NCI-H2452,6917907,-3.4621989648593696,-5.145937538969251
HCC1500,135659046,2.9858139057826905,3.8285163640582685
P31/FUJ,3825829,3.1586120375796516,3.302338023726167
NCI-H1568,selumetinib-piperlongumine (8-1 mol-mol),3.9234194964704185,3.2217750522934008
SW1271,JQ-1-navitoclax (2-1 mol-mol),1.3503657606474289,0.8494978927178363
SK-HEP-1,7326481,2.0213225214426505,3.202684544508449
PaTu 8988t,JQ-1-navitoclax (2-1 mol-mol),1.798415555135888,0.8983558041621511
HCC1500,3634881,3.181593200231373,3.2944491264004427
HuP-T3,5311,2.274555641774389,1.6079302417870907
P31/FUJ,969516,2.490551298955204,2.1758819002947782
LCLC-97TM1,25183872,-1.9138026924081315,-0.9871340004555266
WM115,54619267,3.5599503094850244,4.147544823883175
HARA [Human squamous cell lung carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),3.6972893846800545,3.0033825531167873
SaOS-2,17755052,-0.5339241699834809,1.9482389140987528
SW948,decitabine-navitoclax (2-1 mol-mol),2.8681609289857155,0.8479398511148291
SaOS-2,19582717,4.316823865856345,4.051458763441181
COR-L105,25105715,3.731140483220641,3.508715871347289
SK-HEP-1,5278396,4.037206436677834,3.412352180290725
HCC15,erlotinib-PLX-4032 (2-1 mol-mol),4.047611661511117,3.202220673340143
COR-L105,6918837,-2.1114263163326177,-2.3265419923360096
IGROV-1,25262965,-3.18785020602057,-1.3673594181451358
HuP-T3,6505803,1.3238670991795596,-0.32786662093612967
NCI-H1568,11214940,1.6761106979183067,1.9411855747902131
HCC15,44543605,4.452652862359365,3.7574199753865605
SW48,46199207,2.9489751610364405,3.133399466435465
P31/FUJ,104842,-4.465734156959207,-4.207154056797055
MOLM-13,24180719,3.226510234308061,2.8846274902423605
HCC15,12003241,-1.0460858766179792,-0.9759562656962878
IGROV-1,10231331,1.9104831176724932,2.045162795987459
IGROV-1,107970,2.287061680908213,2.355101928482323
LCLC-97TM1,46907787,1.8795083111860824,1.5321790136489681
IGROV-1,5278396,3.119031774261392,3.6738007248476094
SK-CO-1,5329102,2.034917542642271,2.0166125608007404
SK-HEP-1,11152667,2.375581084403437,-0.16043552504543976
WM115,2126,3.806678244062894,4.698383689842458
SW1271,selumetinib-decitabine (4-1 mol-mol),1.699127774006886,3.0348239778744937
K-562,6918736,-3.666344542032524,-2.135907840846339
Granta-519,6450551,1.162651959279597,1.5239516423913095
NCI-H2452,5479543,3.804245584293823,3.9118968098704867
Daudi,11497983,1.6119133198716458,-0.600781719282694
WM115,4521392,4.32247006400087,4.336607440510786
MOLM-13,24901704,-2.733844077576574,2.072267819368867
Daudi,56973724,1.9677776982823123,1.6609136944154104
HCC1500,613753,3.153964202511791,3.103272475489394
Granta-519,5460769,2.1422187145203897,1.700453679598916
RCC10RGB,53495165,3.554009618530711,0.7356924936989061
PaTu 8902,3854666,4.137852419807088,2.384035233833687
Granta-519,151289,0.2062194994497177,0.4916607600444932
MOLP-8,5479543,3.0970965636903327,2.9751442652718367
LCLC-97TM1,4096211,1.6170661636178802,1.872992065106053
LCLC-97TM1,SNX-2112-bortezomib (250-1 mol-mol),-1.5766290939625012,-1.2072550492472047
SW48,9907093,2.826389946725867,3.8274369955099745
MOLP-8,5281672,3.2641398124752063,4.115246050189798
SW948,6610355,3.913576061403015,4.201595200696763
SU-DHL-1,5746,-2.2023974745237815,0.13631335397618582
MOLM-13,10410894,3.311191932806664,2.3614837507016886
SW1573,3384730,1.5192292760027193,2.8890382356182265
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,1.7240122877099449
NCI-H2452,54649381,5.966732082850981,4.0106161740786925
COR-L105,JQ-1-navitoclax (2-1 mol-mol),0.1739680576486409,1.0512088699009638
BFTC-909,9444,3.603329432205708,4.2261244403866
RERF-LC-MS,SNX-2112-bortezomib (250-1 mol-mol),-2.268317507970671,-1.1889284069681791
SW1271,9952709,3.6093754742197706,2.8809358953973248
IGROV-1,4788,5.801051990484709,5.585162461833021
K-562,3825829,2.9396673791475587,3.2238524384150002
COR-L105,53232,1.738169806280081,2.908860407835742
Daudi,25195348,1.3194617548918357,2.5380313970652177
NCI-H1568,46199207,1.8853593558521984,3.275801519273611
RCC10RGB,135440466,4.497503570362309,2.1240799856955856
SU-DHL-1,navitoclax-birinapant (1-1 mol-mol),1.3479254816656925,0.7739590304939982
NCI-H1568,3062316,1.133797551734723,1.1151457253439234
Panc 02.03,56649450,3.905458120664549,3.631705373914984
RKN,44589607,3.09715941328701,3.003997263579903
MOLM-13,568763,-0.9067431163570788,-0.4669941323945392
MOLP-8,444795,3.9342801961368417,3.202507172375567
RCC10RGB,navitoclax-piperlongumine (1-1 mol-mol),1.8990680206310235,1.0390796568912997
COR-L95,selumetinib-piperlongumine (8-1 mol-mol),2.799372777395438,2.832324084312541
COR-L105,vorinostat-navitoclax (4-1 mol-mol),0.9761778131002136,1.2858087610630864
IGROV-1,6918878,1.6706182189896102,2.8915080132850473
BFTC-909,piperlongumine-MST-312 (1-1 mol-mol),1.831832453388112,1.966813858351157
BICR 22,5280436,0.2666608642372045,3.4061879282483
BFTC-909,3081361,3.110656330811392,2.154692850559752
PaTu 8988t,45279963,4.21642269895433,3.6509465803704915
MDST8,613753,3.2461287764543085,2.912461729624308
LS411N,6917907,-5.419583860239815,-5.2393479553648925
HCC15,5335621,5.428336568471036,4.826275301785045
SW48,71466380,4.3724837890251935,4.402850749143936
SK-OV-3,66577038,3.416512813520814,3.147598155845978
RCC10RGB,49766530,-1.6086406954404375,-0.05607541060973243
HuP-T3,16722836,1.72068374216493,1.7758393229020297
MOLM-13,168313016,3.5509192860421592,3.601167979731709
SU-DHL-1,675434,3.83709506639581,4.182799240927298
P31/FUJ,9911463,3.6551866379259743,3.1147775466331113
P31/FUJ,445455,5.725867195241275,3.8485453228717375
MOLP-8,285033,-4.447286141218139,-2.989539020831255
RKN,107970,2.600341318615175,2.3179320463960194
IA-LM,4788,5.899787929501101,5.652592706323983
RKO,71680916,5.910552922648844,3.890901653119292
K-562,9825149,1.660902694463834,2.2498682457469887
RCC10RGB,4261,3.441062261939301,1.926807584202659
IGROV-1,387447,-3.9508602289798658,-4.352667549424805
WM115,54618164,3.776567993994872,4.070223775112698
LS180,44607531,1.744731406430345,1.3964433449680362
NCI-H2452,123631,2.1406097245383062,2.580366380740776
K-562,262093,3.1056763935044813,1.9844682202483614
MDST8,24180719,2.4870372971011374,3.127226594097461
WM115,66577038,2.911239385644133,2.853142642782262
SU-DHL-1,6918328,-0.7249486298416586,-1.2111623947639358
NCI-H2452,135999136,4.5117873079445205,4.072529813111397
ML-1 [Human thyroid carcinoma],9823820,3.655965927562111,4.111695817537914
PaTu 8902,11609586,3.6092581559147185,2.9819105361776637
IGROV-1,11497983,4.37450324471555,4.388835981305245
RKN,387447,-2.9807645129134066,-4.2422828518201925
LS180,6184667,4.288388758455988,2.93299055939075
RKO,JQ-1-vorinostat (2-1 mol-mol),0.9623246898976432,0.23508644263697354
NCI-H1568,5460769,1.1324377767406906,3.02780159083851
ML-1 [Human thyroid carcinoma],374536,-3.4857090018028956,2.5077972505354786
HuP-T3,3025986,0.0333046209415895,-0.7673264215054079
IGROV-1,11625818,2.877471533668122,4.6212406016969405
SaOS-2,122327,5.211292969638739,4.673082216297845
BICR 31,46943432,4.176233154169203,2.6223649127761424
HCC1500,10427712,5.196976599700856,4.285297943861526
K-562,9866186,0.7861847855254385,0.20990794129793533
RKO,10231331,2.816804700080647,1.1252074057585313
NCI-H1568,126941,-1.411149621431801,-2.371077932605876
HCC1500,9933475,1.9677534910437375,1.9687572485900244
ALL-SIL,53245473,2.8781179496967666,2.896526369171231
K-562,135423438,0.8826240773524879,1.381272078291154
BFTC-909,9956119,4.255413767268681,3.842616003625905
HCC1500,9884685,1.9086372211674376,0.7277048362147291
P31/FUJ,71304818,2.235751993715144,1.5269673428668877
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-0.8212174742821865
MOLP-8,5470400,0.1664110443814662,0.3031970370268915
ML-1 [Human thyroid carcinoma],9967941,2.6659391926085183,3.9780301356760854
SW48,44819697,-2.186530212001632,-0.4501592999953277
SW48,12001922,1.4259296039497584,1.865543553653998
NCI-H1568,24951314,0.6613293075425478,1.469261658395841
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.5931618348670695
SW1573,51039095,4.568767182944777,2.8865969613569042
BFTC-909,46224516,1.8849058086882595,2.716984477126201
SU-DHL-1,52947716,-4.8688827763192135,-2.5425491673425658
IGROV-1,262093,3.169376516915595,3.0391015200511866
MOLM-13,selumetinib-PLX-4032 (8-1 mol-mol),2.341131850097057,2.490238356586663
WM115,24821094,1.6911725066550027,3.260165437553862
COR-L105,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9364869385558905,3.641848715894878
SaOS-2,53325874,4.45514535643454,4.681833185796035
SaOS-2,4261,1.4562926555721387,1.6556483605717165
Daudi,selumetinib-BRD-A02303741 (4-1 mol-mol),4.766499662103581,3.6515135949018895
SK-CO-1,9907093,3.652313916117519,4.189047579355398
SaOS-2,613753,3.192322830330122,3.0859220727304404
BFTC-909,148198,-2.03933057080943,-3.0540504556226984
MOLM-13,49793307,-4.691237884437231,-4.4542379459248735
ML-1 [Human thyroid carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-2.7240522304333763,-0.6363616894692785
COR-L105,135411,0.974173137304268,0.8787976577811026
RERF-LC-MS,135411,0.496828330774242,0.8330426178313816
SK-OV-3,16725315,5.283554915030345,4.096577080264687
SK-CO-1,3854666,3.8596661393399927,2.4028342354621457
LS180,51039095,2.999333495393298,2.7686137799044173
RERF-LC-MS,135440466,2.007932851474071,2.181638197750111
SW1271,SNX-2112-bortezomib (250-1 mol-mol),-1.3790138823522573,-1.335680951501211
LS411N,446155,3.6642844723827266,2.5433666976064266
HCC15,72193861,-0.2523453521741511,1.7409642516939037
BFTC-909,52947716,3.1995758728854224,-0.0012648966898628222
SK-HEP-1,9933475,2.440596541444364,1.9279010479752279
MOLM-13,702558,4.671896667990455,3.785733299147412
P31/FUJ,375860,-1.2092771030706315,-0.525844060562049
Panc 02.03,57519531,5.330694472788803,2.8265006601071683
COR-L105,selumetinib-decitabine (4-1 mol-mol),2.222127008727221,3.9884780723930016
HCC1500,11238147,3.2515653100317023,2.998225847079171
RKO,11427553,3.456895276763714,1.2957895454945518
HARA [Human squamous cell lung carcinoma],24771867,-1.145662696893675,2.966319493411188
HCC15,9927531,3.758901572486559,4.659993786656384
Panc 02.03,107970,3.0394503344184214,2.415723287399809
BICR 22,6917907,-5.724798000333263,-4.12123539402877
P31/FUJ,219104,1.0946129740431632,2.294968284369483
MOLP-8,selumetinib-BRD-A02303741 (4-1 mol-mol),0.9308410221976412,3.7852675197499552
ML-1 [Human thyroid carcinoma],421610,2.367130129227347,3.397228019291136
P31/FUJ,SNX-2112-bortezomib (250-1 mol-mol),-3.0882098716957223,-2.7648397061738494
COR-L105,23582824,0.3539942370445449,0.9205811727357585
RERF-LC-MS,selumetinib-vorinostat (8-1 mol-mol),2.5829848762682865,2.6439318939569967
NCI-H1568,135999136,4.3721543597322405,4.075343815484373
HuP-T3,11404337,1.0495167124251128,-0.33049225781214225
MOLM-13,2729026,2.3347481789683564,2.2022248132039928
IGROV-1,9935249,3.330117761231163,3.054280232946636
IGROV-1,16038120,0.2864038103759729,1.2847241613095646
NCI-H2452,11167602,2.565240148317103,2.481841574726202
Granta-519,4788,5.939837006566146,4.703347136406859
HARA [Human squamous cell lung carcinoma],9935249,3.837366541191349,3.0553712123973655
Daudi,2842253,3.640131040983124,3.107122708317414
PaTu 8988t,9911463,4.367264855700764,3.966958968948991
IA-LM,613753,3.1957676281974328,2.949497606567304
HCC1500,168312962,0.9454061370050444,1.7211190284727875
Granta-519,52912189,-1.096728840522365,0.5081573338054874
K-562,67291369,1.5957287334193675,1.242304164688163
HuP-T3,1750826,-1.878047057258104,-1.051087171892308
RCC10RGB,24180125,2.398663234613943,3.2115231814040026
SW1271,5566,3.0013167075914344,3.026399556262027
P31/FUJ,126941,-4.476387704672624,-3.171165687327229
ML-1 [Human thyroid carcinoma],UNC0638-navitoclax (1-1 mol-mol),2.518264645027629,1.8950410489358964
HCC1500,44486219,3.883233561942222,4.359878287562098
SW1573,24964624,5.100144587499453,2.3853655091512773
LCLC-97TM1,crizotinib-PLX-4032 (2-1 mol-mol),1.007977471964547,1.4423434234005494
Daudi,42642645,-0.8700738631175318,-0.0687193348793845
COR-L95,carboplatin-etoposide (40-17 mol-mol),-0.214243666427535,1.4427209625143647
HARA [Human squamous cell lung carcinoma],5746,1.191361240850758,1.177911453564551
SW1271,969516,2.705669665349302,2.9095018077766146
COR-L95,6918837,-4.56092327324237,-3.711782762056836
SK-CO-1,25154868,4.619527339846263,4.412814422382265
RKO,159324,3.5523933893017583,1.4251830231645746
HCC1500,168313200,1.6452616775244175,2.722626592042811
IGROV-1,4788,5.801051990484709,5.585162461833021
KU-19-19,5746,1.6270456089520258,1.295489355327945
RERF-LC-MS,46398810,3.3112335021243977,2.679089023253195
IGROV-1,6438330,2.7487580937365683,2.4229052215791764
PaTu 8988t,123631,3.803217986992814,2.395069551851413
LCLC-97TM1,5278396,4.167561166456711,3.2610459410493666
WM115,71680916,4.535911767348542,4.863222642918115
NCI-H2452,322968,3.869715934392993,3.988601530996108
NCI-H1568,2708,3.449118605167301,5.065794583596389
Daudi,5470400,3.6690588756853706,0.42730693994206426
NCI-H1568,3038522,2.281352774411324,3.077330814303125
K-562,24951314,0.9405452740645998,0.4431598819107714
BICR 31,44137675,3.031084694210408,3.714950977766232
SaOS-2,82146,4.466197629976123,3.8556216274024284
ALL-SIL,BRD-A02303741-navitoclax (2-1 mol-mol),-0.9236991288199824,-0.14754068570463397
HuP-T3,5738263,4.055810266621769,3.392662652901539
COR-L95,11494412,1.7619372096243109,1.1723382098783746
Granta-519,11507802,0.4974969144595386,0.8713254424758118
WM115,2949965,2.619280368742809,2.859048814577974
HCC15,613753,3.363668001401703,3.403167645029668
HCC1500,107985,-3.8501888791364034,-3.3271989550247674
WM115,54678924,1.8194282087981308,2.279981244705626
Daudi,135398516,-0.2737475793919353,1.1530536293034317
PaTu 8902,5280436,5.000479378124589,3.48427924914377
RKN,439501,-1.5558449248177562,-2.1006744455925412
RCC10RGB,5287620,-0.3857243809023412,-1.6910215571411853
Daudi,5566,2.2518803351891616,2.829405829739196
COR-L105,31703,0.0245204691354453,-0.5583931518027763
LS180,44507138,3.917968702075208,2.2153844073172957
Daudi,11964036,0.3747037141940179,0.3181034609806685
K-562,16659841,3.212428083743772,2.667418037197911
MOLM-13,54618771,-0.6841479707721928,0.31601262518287593
NCI-H1568,49793307,-3.5648882234860895,-2.1647199258675793
SK-HEP-1,navitoclax-gemcitabine (1-1 mol-mol),-0.1291553978520299,-1.6514472225357912
BFTC-909,vorinostat-navitoclax (4-1 mol-mol),1.5579626952552863,1.1559576081603367
KU-19-19,selumetinib-decitabine (4-1 mol-mol),2.1660518976484853,3.881950225799077
SW1271,107985,-2.924919788256343,-3.248487001676468
COR-L95,2746,2.78697970441755,2.551663483715916
IGROV-1,104842,-1.6690343627553987,-2.86379947122396
COR-L95,16038120,0.5843691628917023,0.5984479397647359
HARA [Human squamous cell lung carcinoma],73707398,1.6371281450925783,1.5055082155119928
HCC1500,123631,1.5682585338280497,2.287218414090151
PaTu 8902,322968,4.547287257097872,3.919267977983336
HARA [Human squamous cell lung carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),2.4213259806317335,2.1824737206016698
Daudi,11167602,1.0022899570414256,1.6723128606064017
ALL-SIL,10074640,-0.3353589360570669,2.3883426654228233
COR-L95,57519531,1.325264870307383,2.057226068415122
LCLC-97TM1,46191454,0.3820919964810073,1.5387113799866452
ALL-SIL,439501,-2.349752310116714,-2.8487876237730476
IGROV-1,25126798,3.9275606774720817,3.8439692539812644
WM115,24753719,4.6734048968266775,4.358550650000638
HCC15,36314,-6.084589216701663,-1.8370863309076344
HEL,16720766,-1.3120587580234824,-0.48215174850343273
SU-DHL-1,11222830,1.179409628644554,1.5111613013334957
HuP-T3,3634881,3.0028113890745707,3.3737421464103945
K-562,5738263,2.3545721599917027,2.774948125837464
SK-CO-1,16725315,3.5012946679092853,4.3314726425684125
RKN,327653,3.2518035953304434,3.1776028307082527
RKO,24772860,-3.046302255649564,-2.6498116416393667
HARA [Human squamous cell lung carcinoma],1750826,2.2891380116234616,-0.9435370553486156
NCI-H1568,piperlongumine-MST-312 (1-1 mol-mol),1.2489252589958966,1.9654096008552924
SK-CO-1,15953870,2.1343083972614725,3.538095010047482
BICR 22,71751553,4.276876209585518,4.250426679191769
K-562,24964624,2.9615918690112717,1.4093927869815053
RKO,11222830,1.6656419736189183,1.36163154729442
RCC10RGB,25105715,3.76392637454814,3.4738742653885284
ALL-SIL,54618164,3.625474128679928,3.6028650612841373
HARA [Human squamous cell lung carcinoma],25183872,-0.077265330214196,-0.6049481748667949
SU-DHL-1,49793307,-4.256389272054101,-3.622771855509865
SK-HEP-1,9915743,2.4580731883892293,1.2223574025226442
SaOS-2,10410894,2.56650375580144,3.260107981003969
ML-1 [Human thyroid carcinoma],9926054,2.0491703403306056,2.0572851912333956
COR-L95,44491742,4.146782751375218,4.057770184608077
SK-OV-3,44137675,2.687297746540291,3.645556766119461
SU-DHL-1,4477,-0.6876815909262691,0.4483288195311944
RKN,5311,1.8833679583763572,1.4779189017477554
COR-L105,11640390,3.408966388045623,3.7854410534314873
RCC10RGB,637858,2.3286326267725084,2.215039981349502
HARA [Human squamous cell lung carcinoma],16722836,2.4020375260133595,1.7166957914849261
ML-1 [Human thyroid carcinoma],54454,2.7684179569761422,2.820873946259848
NCI-H1568,serdemetan-SCH-529074 (1-1 mol-mol),1.1632168234026012,2.0578743165872213
SU-DHL-1,6852167,2.266746993939426,2.169005505395307
HARA [Human squamous cell lung carcinoma],2945648,3.3865607820212316,3.065399173053276
HuP-T3,49793307,-5.3581383477853555,-2.264105415004802
SK-CO-1,5282054,3.655593178279643,3.8168516135790207
RKO,2841722,4.522769482159767,3.6652063316564307
Granta-519,65628,2.6603144373939154,2.974562171205743
SU-DHL-1,637858,0.6782178889909583,1.7029223443468677
RKN,9911830,3.6623648245681744,2.510965078165409
ALL-SIL,tretinoin-navitoclax (4-1 mol-mol),0.1560826957318693,-0.13147463710449273
MDST8,ISOX-bortezomib (250-1 mol-mol),1.0361241685592786,0.610441549966648
BICR 22,9884685,0.2149660223226223,0.886744295433637
COR-L105,46907787,0.7742744471044445,2.6572180442243187
RCC10RGB,navitoclax-sorafenib (1-1 mol-mol),2.209619948834929,1.5348992426696955
RKO,54618771,2.3159310195777985,1.0764300038892844
HCC1500,6450551,2.2317386689521816,2.7036262838122496
BICR 22,10296883,3.888864516393213,3.588759686979384
Daudi,10302451,1.2926011902861492,2.5845074473034595
Daudi,tanespimycin-gemcitabine (1-1 mol-mol),-4.635562978503933,-2.49615196670034
SaOS-2,JQ-1-carboplatin (1-1 mol-mol),1.527244446829994,2.279255488853246
Granta-519,216239,2.502983600228736,1.9378382419728504
RERF-LC-MS,selumetinib-JQ-1 (4-1 mol-mol),1.7940148785234815,1.8574385894604724
NCI-H2452,4521392,4.554150979099382,4.327118652021608
IGROV-1,123631,1.7694522866439453,2.5492970450062677
IGROV-1,5566,3.174346862827938,3.0552492016577304
MDST8,72193861,1.790495642839322,2.0065640526646873
COR-L95,400769,-0.6446482680437077,-0.6380004078469859
SaOS-2,5287620,-1.8033063725700844,-2.1799402092291063
COR-L95,6917907,-5.619348954097505,-5.272475783071723
WM115,9840324,5.544544164897635,5.877177653436137
COR-L105,selumetinib-UNC0638 (4-1 mol-mol),1.9595144972930605,3.4223714986989764
SW948,10322450,3.138867511839475,3.1607884798404995
K-562,25126798,3.746183025237492,3.33831835605423
LS180,5335621,4.412574333730147,4.6655316709773755
SK-CO-1,9911830,2.5560928673864676,2.421369191162081
BICR 31,selumetinib-vorinostat (8-1 mol-mol),3.0204654665417237,2.4253974400008538
SK-CO-1,9825149,2.4273154495027147,1.9946807362052825
HuP-T3,tretinoin-navitoclax (4-1 mol-mol),4.772875046445671,2.9091552911050833
KU-19-19,10074640,3.725362653690234,3.2558150292188786
NCI-H1568,24901704,3.012455129702266,3.447593265576296
PaTu 8902,216345,4.855612410794221,4.052062587553358
LCLC-97TM1,44202524,1.0559659544617075,2.22774374208698
MOLP-8,9884685,-1.6145757941110517,-0.38759124847745297
SaOS-2,11656518,3.53164758658959,1.8650797506986996
ALL-SIL,5280436,2.610850174870569,2.7552286389213005
ML-1 [Human thyroid carcinoma],10231331,4.187669502210677,2.136244209667096
HARA [Human squamous cell lung carcinoma],JQ-1-vorinostat (2-1 mol-mol),2.5839829159057848,0.9897295403497172
COR-L105,16659841,4.469572921203622,4.078861667162547
SW48,11625818,2.5740084903132914,4.259084475983326
COR-L95,135875424,3.0866900102445816,3.626785117910552
NCI-H2452,10074640,3.4255764700713685,3.239745082389421
SK-CO-1,60750,-4.4937571478067495,-1.2929884116301602
BICR 22,374536,2.9550889228261386,2.893340909901519
MOLP-8,2126,5.134995770793403,3.7612118739636924
NCI-H2452,5566,2.960608772215372,3.124688580944169
Daudi,54618771,-0.114332288085178,0.4010969813061979
NCI-H1568,44137675,2.485428235347338,3.61866870397855
BICR 31,24771867,6.325583215176513,3.053102181123655
HCC1500,135875424,3.5744445956281483,3.740196092569935
K-562,vorinostat-carboplatin (1-1 mol-mol),2.490945525629646,1.9630942585722075
IGROV-1,753704,6.461140333581179,5.155293803208196
SW48,11497983,-4.007853458767396,4.157035383318502
MOLM-13,25195348,1.114215790958376,2.5471015800418115
Daudi,441298,1.3514709590925575,2.118076556844453
SK-OV-3,124202324,3.0713957973247186,2.495390025072516
BFTC-909,23635314,-1.3241610546701814,-1.6488390121881296
COR-L95,71304818,2.943301589855332,2.2243905665938914
SW1271,44607530,2.17277245139498,1.942836341381746
RERF-LC-MS,219104,4.628133490361187,3.904281317793168
NCI-H2452,31703,-0.2834256058580119,-0.8535646367777207
Daudi,462382,-0.0525304302162242,0.3851376640176476
SU-DHL-1,25183872,-2.297532702486321,-1.9025101720334334
K-562,54618164,3.946994253297547,3.7351507434002102
SK-HEP-1,568763,1.0235069184223942,0.6680876593129952
SW48,docetaxel-tanespimycin (2-1 mol-mol),-8.123886258687621,-3.450380889831914
Daudi,BRD-A02303741-navitoclax (2-1 mol-mol),3.127125631555358,0.9579587663179047
Panc 02.03,2828334,6.385741192046609,6.173463256859802
HCC15,5702613,2.8473188935914835,2.7757301508586614
PaTu 8902,11625818,4.430115392870615,4.547951310158191
COR-L105,53392493,2.0389615313780256,2.8998788121111034
RKN,3062316,2.6330403907451863,0.6022973076124112
UACC-812,6505803,-4.59801553223132,-0.3826770374285608
UACC-812,16736978,0.0217391388778129,1.7098052691382488
BFTC-909,5278396,3.473037688340168,3.7539646610692983
SW948,73707398,1.7510146080607218,0.9039909356179345
BICR 22,107970,2.71438120007047,2.4650734578965214
SW1271,984333,0.5174855517327741,0.7598082416531953
IGROV-1,9967941,2.9735049794712545,3.5624708858291125
SW948,tanespimycin-bortezomib (250-1 mol-mol),-2.5529889563934693,-0.6655553809960755
SW948,135984461,4.375312800732864,3.2120195595551007
LS180,5280436,4.14000298943632,3.2604977147008616
MOLP-8,219104,2.0853040324344536,2.4175893314269756
MOLP-8,1716436,2.7387406442001287,2.711352287367742
MOLM-13,171352865,4.594115651620468,2.5451609101751926
KU-19-19,10127622,1.068304480617998,3.912906741541734
KU-19-19,5460769,4.3332822587900255,2.873493589275579
LS180,675434,4.417044491450032,4.2511917965613195
RERF-LC-MS,vorinostat-carboplatin (1-1 mol-mol),3.78748525663286,3.2548804496375574
SK-HEP-1,66577038,3.45712203265648,3.040642550664812
SW1271,3689413,-1.2412691685690602,-0.3702521148820037
COR-L95,10296883,4.074268886544182,3.652353023893161
HCC1500,5287620,-3.8084705838741306,-1.714597871717564
RCC10RGB,JQ-1-navitoclax (2-1 mol-mol),1.088443536961304,0.8746225052534361
WM115,serdemetan-SCH-529074 (1-1 mol-mol),1.0432203411705916,1.9687947591538326
SW948,vorinostat-navitoclax (4-1 mol-mol),1.0335682598311662,0.3223582159253897
SW1271,46843906,3.0036733058278298,2.982699044728347
SW1271,10184653,2.439662406391272,1.4189763782790923
SK-CO-1,31703,-2.259601900898513,-0.5058266095951989
COR-L105,10074640,3.626128603914542,3.1776204484721546
MOLP-8,11152667,-1.9226575172330305,-1.5550575040759873
SW948,56646779,5.261847054930003,2.781240351287713
MOLP-8,9825149,0.6088991704164435,1.4575191307506938
ALL-SIL,piperlongumine-MST-312 (1-1 mol-mol),1.1188007214876046,1.148970946012171
RKN,1641662,3.781184529562369,3.587912435528926
Daudi,1750826,-5.008838903624334,-2.9063350138408053
RERF-LC-MS,24856436,0.2419222597799965,0.6810581746194418
COR-L105,6184667,3.4155069342084916,3.092229707784189
HARA [Human squamous cell lung carcinoma],151289,0.6137813450564443,1.0935414862220314
MOLP-8,568763,-0.8505432933185847,0.0006278017549095355
Granta-519,piperlongumine-MST-312 (1-1 mol-mol),1.116794346695572,1.1720245247869443
SK-OV-3,54618771,2.5849230632376923,1.586994666886705
SW1271,135398516,2.256973153183445,2.1713167988154622
MOLM-13,44819697,-1.7672663076184636,-1.7185372852337206
LCLC-97TM1,24748573,2.1629406196043894,2.0471605833750885
NCI-H1568,10113978,1.8126489257310032,3.237390865338102
ALL-SIL,SNX-2112-bortezomib (250-1 mol-mol),-3.319111432428944,-3.066663611872917
COR-L95,1566236,1.7351682171374878,1.987828400617851
PaTu 8988t,54619267,4.243668204976347,4.193511917622129
BICR 31,73707398,2.635299985295534,1.463531383931478
P31/FUJ,24978538,-1.1674360999825653,-0.9190819736513748
HuP-T3,25227462,0.1487181406442073,0.5785999969551164
Daudi,439501,-2.973914496380735,-2.598578957912261
NCI-H1568,67156097,-1.7914617240991686,-0.5783785071643514
WM115,36314,3.85550299796777,-0.3851439171019655
MOLP-8,409805,3.552664043240888,3.9461813676607504
SW48,24753719,4.052743892866938,4.184649106048638
SW48,3825829,3.1303188593692854,3.83207268048468
PaTu 8988t,54613361,0.5051194448617704,0.2143349874872156
SK-CO-1,44493528,4.973545843770428,4.408283374193899
MOLP-8,44202524,1.1617664844294235,1.3339549524289414
P31/FUJ,11656518,-0.8295634521320199,0.6040201050107145
HARA [Human squamous cell lung carcinoma],11625818,4.840804819194981,4.4648326730661845
LS180,36314,2.4476112429633403,-1.523453733282186
SK-CO-1,119182,-2.3548964470523974,-0.4823448147923711
LS411N,72376,-2.6969507034435236,-2.8055316582606995
BICR 31,51037431,4.633533363663127,3.470167572492635
ML-1 [Human thyroid carcinoma],72376,-3.175400377997246,-1.5531169100774045
HCC1500,46907787,2.786329845885891,2.363501661993413
MOLP-8,2708,2.5820066460748015,3.677410428085771
HEL,10113978,2.6394190696879662,2.0015640959721144
HEL,1641662,3.192273244328466,2.814391346808201
LS411N,12001922,2.0246848718715604,1.8377331314495504
ALL-SIL,56963564,-1.2928564241979046,-0.16184740769503492
ALL-SIL,168313047,1.973173862571291,1.7766930695208236
COR-L95,3038522,2.051786867518871,2.9671605823230323
LS411N,25102847,2.9606059837222767,2.300381124531626
SW48,5566,2.216391660090734,2.8837726392391674
HARA [Human squamous cell lung carcinoma],637858,2.3831379320922728,2.006571371796161
SW48,6917907,-5.957551707769467,-5.30132515311777
RKN,246676,4.414592383854902,4.179524194542723
IGROV-1,285033,-1.3538783590767758,-1.8503222902820722
PaTu 8988t,11609586,2.9135578891851233,3.0679316811728166
P31/FUJ,19582717,2.23583270668625,2.907085920286695
SK-OV-3,71304818,3.289226671933847,2.6639652731510846
SW48,9903786,0.6824641791663469,2.5985072174924797
SW48,107985,-4.220376672084107,-3.5495225119311518
ALL-SIL,49836020,-3.56746653346715,2.9622006647763497
HARA [Human squamous cell lung carcinoma],24772860,-1.3203429479269333,-1.6575320202896666
MOLM-13,7326481,3.309466894819375,2.6180660476819355
PaTu 8988t,387447,-4.215036300164339,-3.6492188934051364
IGROV-1,10231331,1.9104831176724932,2.045162795987459
NCI-H1568,salermide-PLX-4032 (12-1 mol-mol),5.036103452561945,5.03090738232566
WM115,6852167,1.3860811523021286,2.9323575542590805
SW48,11175137,0.8049020199472112,2.686062176314175
NCI-H1568,6918837,-3.937828464321892,-2.619758445888902
ALL-SIL,409805,3.511042482554543,3.7408974157606663
BFTC-909,11485656,2.882750602975944,2.354432235121098
HCC1500,6610216,3.984830656845064,4.271437358862368
MDST8,46191454,-0.3052251724831438,1.9297091276390668
NCI-H2452,52947716,2.3907771066336543,0.069214577663032
COR-L95,135411,0.6709946332822974,0.46345870007116596
RERF-LC-MS,11497983,4.204546577264711,4.5394653339096696
MDST8,3025986,-2.3601391308628368,-0.43103504465573844
K-562,10113978,1.9599198523990544,2.3804518533132764
MDST8,66577038,3.4472401917824387,2.746810954686452
RCC10RGB,6917907,3.54732574828972,-3.941311648066147
SU-DHL-1,54618305,4.34503505735179,3.5739508577256167
RERF-LC-MS,selumetinib-navitoclax (8-1 mol-mol),2.77400767356552,2.2147582233324186
RERF-LC-MS,navitoclax-piperlongumine (1-1 mol-mol),3.552905574656644,1.7867200550099565
WM115,448949,1.6539360415615445,2.216174466421268
ALL-SIL,216239,1.0502640873271551,1.769913909531168
HuP-T3,docetaxel-tanespimycin (2-1 mol-mol),1.3630986120545014,-2.9352703637624735
IA-LM,53325874,6.131967715828746,3.470943381009316
ML-1 [Human thyroid carcinoma],16219061,3.525142786131821,3.4893911291693667
P31/FUJ,119182,-2.8125390579467244,-2.619863990598476
SU-DHL-1,11717001,3.585470860794662,3.2974513291289806
MOLP-8,168313016,3.7646553629166304,3.7583754439341033
ML-1 [Human thyroid carcinoma],11485656,3.567697107596816,2.4911254887276626
SW1271,9823820,4.369434873409536,4.242074766705994
SK-CO-1,51037431,2.025162533854422,3.4669287796988733
SW48,11964036,-0.90016316876993,1.4072333088570332
Granta-519,702558,4.9740995052838874,4.078833701244982
ALL-SIL,UNC0638-navitoclax (1-1 mol-mol),-1.2077799570565213,-0.4156211354388419
NCI-H1568,6918328,-2.169641972219076,0.05881165932356684
Daudi,637858,0.7785119720749748,0.8723783141097796
SW948,53495165,0.2015090818079991,-1.3821809461172745
SW1573,46398810,3.5765453048302933,2.565234682799279
MOLP-8,637858,0.6022882265593398,0.9425711315849911
NCI-H1568,3825829,3.749474944576795,4.152103013480151
MOLM-13,4788,4.00969340257961,5.00634003025812
SU-DHL-1,135398516,1.716785738144405,1.8782700902627918
HCC1500,2945648,3.001490751925554,2.709977948737114
SaOS-2,SNX-2112-bortezomib (250-1 mol-mol),-2.769432838518552,-1.331402491193114
HEL,46943432,0.8947528664895825,0.9270983384586178
RKN,3689413,-4.085525957083088,-0.3703236370817298
COR-L95,45279963,4.007720953160328,3.0937258736011137
LS180,11364421,-2.9792456594346945,-1.748020281790422
SW948,51039095,-2.1737453378627567,2.7943397913816326
HEL,135421197,2.810551353794614,1.3923128916196246
SK-OV-3,doxorubicin-navitoclax (2-1 mol-mol),-0.6082867931514424,-1.0604136240539368
HuP-T3,5351362,1.4959503226370765,1.5422463835827467
P31/FUJ,selumetinib-decitabine (4-1 mol-mol),-0.417260560947631,0.11982158340239638
SU-DHL-1,6623618,1.9512254956144048,2.1589137488035623
BICR 22,31703,-2.104947288409208,-0.5965748493423001
P31/FUJ,BRD-A02303741-navitoclax (2-1 mol-mol),0.458289206697817,-0.15551478800471327
IA-LM,17755052,4.247702528352723,1.7940062412660014
IGROV-1,17755052,-1.0246415273055465,1.7534076082839298
WM115,navitoclax-birinapant (1-1 mol-mol),2.982568846631371,1.7284549806037084
IGROV-1,3503,2.453392942972796,2.142733557141935
BICR 31,10302451,2.0763164615496232,2.775816326542755
COR-L95,JQ-1-vorinostat (2-1 mol-mol),1.1858087423050925,0.25263564388576504
MOLM-13,2841722,4.084965304911922,3.519675672658829
COR-L105,9549297,5.541569761250669,2.9864054496632315
COR-L95,4705,3.007858501345706,3.061110727265751
SK-HEP-1,54626689,5.252317432323977,4.6627707157355385
BICR 22,24964624,2.8366894332481127,2.3904469231661722
K-562,3384730,2.2830550335302555,1.6744565804464613
RKN,46224516,3.695788234754723,2.719616348449062
Panc 02.03,44607531,1.9299895981807216,1.5504542281811888
MOLM-13,11317348,-4.1893096196029465,0.9413146909001894
LS411N,60700,1.793788628592944,-0.5737070365728578
ALL-SIL,9967941,3.4348481015027628,3.172320504077718
SK-HEP-1,46907787,5.1061569205326505,2.441277807260275
RKN,5351362,2.529766574998156,1.4838343829115694
HuP-T3,31703,0.4675615226322689,-0.5291228249922917
SaOS-2,6610355,4.596244040557677,4.6897708265330795
BICR 31,25195348,4.130650271984148,3.3166036805165406
MOLP-8,73707438,3.908454567487333,3.859863052411265
MDST8,3503,3.3556251865549065,2.3538019153919247
COR-L95,439501,-1.1523844892623298,-1.8079353868784473
HARA [Human squamous cell lung carcinoma],selumetinib-piperlongumine (8-1 mol-mol),4.925037100159097,3.423887090296452
P31/FUJ,5281321,-2.503740446113486,-2.415785087927616
BICR 22,selumetinib-piperlongumine (8-1 mol-mol),3.0599254943264116,2.747286399834415
BICR 22,2729026,3.062923067871907,2.664941904244921
SW1573,51037431,1.8928004764191728,3.4368521378824295
ML-1 [Human thyroid carcinoma],285033,-2.470992399828971,-1.5240664802216306
RERF-LC-MS,16741245,3.282184197465347,3.9512565794827395
ML-1 [Human thyroid carcinoma],71466380,5.169213277707957,4.53707132610382
SK-HEP-1,11427553,3.604603983851784,3.1090003300511
SW948,alisertib-navitoclax (2-1 mol-mol),-1.9206127672365017,-0.056139589955336515
SaOS-2,36462,1.0480120523183942,2.1299162935446656
IGROV-1,124202324,2.2563058955522157,2.6103596601172416
P31/FUJ,54618771,-0.1557090961755644,0.30808935641216295
HCC15,6918837,-3.491973763742546,-2.4115361865629033
RERF-LC-MS,10302451,4.085913110869725,3.327030155496238
WM115,9866186,1.4274901944164853,1.2400798477073918
RCC10RGB,3634881,4.1231622503065495,3.312390598876442
MOLP-8,tretinoin-carboplatin (2-1 mol-mol),4.454701733266676,3.492746060994952
SK-OV-3,56946209,-2.3996417591607235,-3.967693858698385
Daudi,9907093,2.3595872536278977,3.3282263159821475
UACC-812,135421197,0.8848266315498433,1.8065342282344785
COR-L105,11707110,-2.3960237918310967,0.8341134577953653
NCI-H2452,crizotinib-PLX-4032 (2-1 mol-mol),2.3217431804401607,2.0966868048299228
RKN,selumetinib-GDC-0941 (4-1 mol-mol),1.8547441727402172,1.4433521359663992
BICR 22,5287620,-2.2777736835755076,-1.6577393934520632
HEL,135398738,1.3240045179008624,2.328381484712283
SK-CO-1,3825829,3.015639513793665,4.092677531602304
BFTC-909,135398516,3.047749913114312,2.3559688712487787
Granta-519,252682,6.242071482699392,6.192103493993621
RERF-LC-MS,piperlongumine-MST-312 (1-1 mol-mol),1.31949560405159,1.9355635736671388
SU-DHL-1,241158,1.6235055790866513,3.625258269689862
PaTu 8988t,8515,4.36808886077581,3.9124567428975867
NCI-H1568,44489675,3.7863062268563064,4.172026074667862
MDST8,135875424,6.383148165610491,3.7172439727537085
IA-LM,24771867,1.1290385026114922,-0.5652923348270966
PaTu 8902,12001922,1.8953174279693872,2.0207841694777677
HCC1500,8515,5.3989297102528715,4.036385000691859
MDST8,4259181,0.8851574645315519,0.5534922017795152
SK-OV-3,16038120,1.745962946040546,1.1643418911659702
SK-CO-1,25126798,3.6561952188996503,3.757952083651814
HCC1500,4261,0.9221319619811188,1.4040880106787106
WM115,613753,3.1291419252746877,3.3709748037559417
IGROV-1,6505803,-0.2382223795960626,-0.6184853298068745
KU-19-19,49766530,0.1366302187334878,-0.5827944955931148
BICR 22,11494412,0.8036857209518554,1.537218061340524
HCC1500,11955716,2.281516197797272,-0.9622315385635498
MOLP-8,71680916,4.479993680298279,3.903951384281156
ML-1 [Human thyroid carcinoma],3025944,4.339456842576773,4.327809416511382
BICR 22,15983966,-4.391384426150851,-0.5152203798528638
SK-HEP-1,selumetinib-tretinoin (2-1 mol-mol),6.787404934084747,3.4011030904553583
RERF-LC-MS,9866186,0.0636323256725951,0.8994563044474816
IGROV-1,54613361,1.0826132998561049,-0.2774295051341273
K-562,4259181,-0.7813149193344907,-0.38262284845790184
SW48,6438330,1.214777505056659,2.4033416780495664
LS180,54618305,4.3130332958468385,4.47029502437569
K-562,5746,1.9738407973257048,0.5451227452059163
COR-L95,3081361,3.577896308939448,2.392805099100079
KU-19-19,ISOX-bortezomib (250-1 mol-mol),0.6477518582997711,0.4650319740461874
MOLM-13,navitoclax-sorafenib (1-1 mol-mol),-4.200053856490793,0.5592568303893889
HARA [Human squamous cell lung carcinoma],2113511,5.545523050638764,5.42351806675705
NCI-H2452,alisertib-navitoclax (2-1 mol-mol),-1.045230676490147,1.055455450126869
K-562,53495165,-1.204911447319433,-1.8407014385502227
SK-CO-1,JQ-1-vorinostat (2-1 mol-mol),1.937629549480178,1.1436490857508845
HCC15,3676137,4.952150033317278,4.415474952825226
PaTu 8988t,46398810,3.220252132938068,2.6976154840158904
IA-LM,ISOX-bortezomib (250-1 mol-mol),0.3247346059672509,0.7297031067269047
BFTC-909,9927531,5.31835549136936,4.906098902482507
Panc 02.03,16722836,2.9028860212849565,1.9190547207479662
NCI-H1568,doxorubicin-navitoclax (2-1 mol-mol),-2.631367093813306,-0.8721287188829646
Granta-519,3011155,5.044202810550695,1.656842654081031
IGROV-1,3825829,4.144093606877803,3.9094427401008205
HARA [Human squamous cell lung carcinoma],11404337,-1.2743672881567891,-0.38806946722378877
P31/FUJ,sirolimus-bortezomib (250-1 mol-mol),0.0617669843942014,-1.4338662735611274
WM115,11238147,1.7518250261640556,2.9379826477951707
HEL,6610355,4.700351008256091,3.955146133160148
COR-L105,10410894,5.46795970795096,3.401084862993796
K-562,135421197,2.032823128578147,1.5376488096356677
HuP-T3,25105715,3.756943800954468,3.388179049938754
BICR 22,11717001,4.533318725499836,3.9103132298633314
ML-1 [Human thyroid carcinoma],168313047,1.965548883908303,2.423890156372154
BICR 22,176870,3.0604023761484154,2.48042728056029
COR-L105,9823820,3.977631180290917,3.9938489803831017
P31/FUJ,66577038,3.0536576112540916,2.5503139991807577
HuP-T3,11612883,3.639610964764467,2.893966454446154
PaTu 8988t,12001922,2.536714978511883,2.009247316565638
P31/FUJ,24771867,-2.604308550432203,-1.5494793909523024
P31/FUJ,3634881,2.159990781463395,2.433265904420221
SW1271,11640390,3.706316930576478,3.6012665956449452
Granta-519,984333,0.7513060576966085,-0.6542343091392536
COR-L95,46398810,2.3153378536205036,2.118510325855446
NCI-H2452,4259181,1.4154165902225178,0.23058910541158834
HCC15,docetaxel-tanespimycin (2-1 mol-mol),-6.454135481670954,-2.869823257021744
RERF-LC-MS,3503,1.2198018250646854,2.427045737490074
BFTC-909,168313047,1.967772312792883,2.349005551799555
NCI-H1568,49766530,-3.205306991379519,-0.2005440705592092
SW948,selumetinib-JQ-1 (4-1 mol-mol),-0.7293969321677569,0.30363193480713835
IGROV-1,44491742,4.406671418311328,4.1516122406261475
SaOS-2,54596490,5.687426160237218,4.333952603772511
Granta-519,46843906,0.846372381562089,1.2287105715429716
SK-OV-3,46398810,2.6339706660379205,2.6525991552518717
WM115,25154868,2.4497388117539773,4.562958750687326
K-562,navitoclax-gemcitabine (1-1 mol-mol),-0.2101297783462078,-2.1410287706738877
BICR 31,123631,1.818021308876907,2.4770237238120747
HuP-T3,60750,3.212181181151216,-2.073809509566373
WM115,71304818,2.065667497969779,2.539342758744701
SU-DHL-1,11964036,1.0253922980362349,1.3283861910121795
SW1271,9444,4.046685913234064,4.2657053892970795
IA-LM,1716436,3.827820678542469,2.828444947362373
HARA [Human squamous cell lung carcinoma],3854666,0.7328632401261175,2.200953323573664
Granta-519,selumetinib-decitabine (4-1 mol-mol),1.299817261369256,0.12388382674685289
SW48,44137675,1.8984167228990951,3.244338182744973
IGROV-1,11364421,-2.1205062036040982,-2.189977442033261
PaTu 8902,3465537,3.540732953494624,2.4940316261855213
HCC1500,54618771,1.4039271563223086,1.173796280364228
NCI-H1568,23725625,5.336887169251221,5.027226617086177
BICR 31,9936388,2.7244047649519074,-0.8740189289280899
IGROV-1,49850262,4.068828647042517,3.4771023029694934
HCC15,5280436,4.320878094694944,3.693666162714641
COR-L95,46215462,1.6156782364555438,1.7778180126859953
SW948,25022340,4.946878477600784,1.6161503672047755
P31/FUJ,3025944,3.8644283212627895,3.7955852248085744
SK-CO-1,5978,-3.732613512446313,-1.1912493290023263
LS411N,19582717,5.192972758226466,2.863714166203668
SaOS-2,26596,-1.8442798913702467,-0.8621050556012062
MOLM-13,6610216,4.131122051839403,3.8369457317523894
KU-19-19,3025944,4.41555498235696,4.226505406792576
HCC15,11497983,1.686538707374479,4.183920148740361
HCC1500,216468,3.3608861469702735,2.970773278441085
NCI-H2452,56649450,2.972344092085675,3.6737990730738947
SK-OV-3,25262965,0.4953902890441227,-0.804326976409174
HCC15,10184653,1.3258142209068642,1.7864685060599879
SU-DHL-1,3825829,2.249840075454991,3.6048377742447304
WM115,49867926,3.8689880289876446,4.274180581236309
K-562,285033,-3.792012978388577,-3.2270548970851918
Granta-519,53495165,-2.785106410212646,-1.7809478656141535
SU-DHL-1,5335621,3.5965276677583846,4.4028170469442625
NCI-H1568,1566236,1.6523344134899465,2.5245115985667828
HCC15,25195348,3.62058364960133,3.459386966013562
LCLC-97TM1,7326481,3.961997196958484,2.972908097444068
SU-DHL-1,JQ-1-UNC0638 (2-1 mol-mol),2.5998168320155712,0.5038625473157629
LS411N,9887053,4.348393626170801,2.9919338521075183
LS180,208908,2.3350670945107783,1.7647979311275606
IA-LM,54454,3.681506421747591,2.6717201563332407
RKN,4378219,1.9905206425028277,2.362778117054924
WM115,selumetinib-tretinoin (2-1 mol-mol),-1.0607687385354925,2.5941453071939002
ML-1 [Human thyroid carcinoma],2949965,3.680012286367402,2.871514262447942
IGROV-1,216345,3.498629789107092,3.901190610975039
SW948,5282054,2.5738720751419746,3.0636538443566717
PaTu 8902,66577038,3.2739824602509304,3.0784890588023837
COR-L105,1566236,2.352597865521479,2.4935192477001396
MDST8,selumetinib-piperlongumine (8-1 mol-mol),2.2463644977006423,2.5821703694726064
MOLM-13,46191454,-2.5774836063329905,0.028965838160600558
HCC15,72734382,4.010055800269774,4.711174799602762
SU-DHL-1,navitoclax-MST-312 (1-1 mol-mol),0.7019716882253797,0.4388448220743608
SaOS-2,53232,1.3253237607162072,2.6588197873720207
KU-19-19,9936388,2.972521935644637,-0.7043306047967502
BFTC-909,selumetinib-JQ-1 (4-1 mol-mol),1.1253035869238386,1.6357401758277994
PaTu 8988t,selumetinib-PLX-4032 (8-1 mol-mol),6.546714585900996,3.722328492804041
SU-DHL-6,445643,2.4790626422724107,3.4027795767505817
ML-1 [Human thyroid carcinoma],89183176,4.271882086089193,4.48978524097733
HCC1500,208908,1.6399748300125228,1.6921102501310683
P31/FUJ,4917,2.744589019426067,2.615582500077399
HuP-T3,241158,3.8412641522091144,4.087223124789549
SaOS-2,46224516,2.521923040225463,2.5557454831489017
LS180,54618771,0.643112685351952,1.0679782659308514
Daudi,23725625,2.2816125857144978,2.938142341034242
Panc 02.03,25227462,-1.0518848939229315,0.8073517811697704
WM115,462382,0.0353255606914336,0.28324368314491205
SaOS-2,135875424,3.0421388786055727,3.7717965203049073
Granta-519,10113978,3.360346958971763,2.171039303424358
SU-DHL-1,51037431,2.2415500634191763,3.0673908747946887
SW1271,135440466,1.7072517695379112,2.2194995251311638
BICR 31,208908,2.9880095911503983,1.930821410795955
NCI-H1568,11719255,3.5544275615483087,3.530889958604179
SU-DHL-1,4259181,-1.4222017445817885,0.24875548803717712
NCI-H1568,135984461,4.216726883570129,3.7709380705541884
Daudi,navitoclax-piperlongumine (1-1 mol-mol),0.8768236288563281,0.4675706021174395
K-562,25195348,2.6278567451650394,2.8574284995235915
SW948,6918638,-0.8188756331889222,0.32966703252739804
UACC-812,216345,3.8515167014354152,3.72235753875574
PaTu 8988t,446155,5.325372031764619,2.54963008098652
RERF-LC-MS,selumetinib-tretinoin (2-1 mol-mol),3.2790865080217397,3.6308961070936827
NCI-H1568,54618771,0.8004506686595156,1.3937178404958903
HCC15,9823820,3.975711917882334,4.080138297398598
RCC10RGB,9935249,3.9754060705766943,3.3484895253402267
SK-OV-3,3854666,3.321518045263264,2.326277059662792
Daudi,135928012,2.6114481479622516,3.8517594414431127
RERF-LC-MS,selumetinib-UNC0638 (4-1 mol-mol),2.6397170445300433,3.311874224908878
HCC1500,44491742,3.6723474636183537,4.447277968029857
K-562,54626689,4.3954029102592145,4.3868300001008365
SW948,11152667,-0.307089718187717,-0.8825754034023052
NCI-H1568,984333,0.7198134332239758,0.543742238073873
Granta-519,selumetinib-tretinoin (2-1 mol-mol),5.148474908350203,2.4130698359145697
IGROV-1,44507138,2.359177395411688,2.477946883719173
COR-L105,44566777,0.9614143121394376,0.8786133963169704
HCC1500,25126798,3.9309577641895137,3.708233236672757
LS411N,5470400,-0.4509258648896809,-0.3232517400017907
PaTu 8902,11427553,3.388107623793881,2.731598824913405
BICR 31,JQ-1-carboplatin (1-1 mol-mol),2.1121797103281876,2.371592307133357
LS411N,11364421,-0.88941081068058,-3.031483984182273
Panc 02.03,6918638,1.5939476449475074,0.6159823153540338
IA-LM,73707398,1.4255919606814562,0.8430792776904206
Granta-519,54613361,-0.5306815642640709,-1.2118061047696722
IGROV-1,176870,1.8349827429681411,3.2001250642415484
SK-OV-3,24821094,3.4952627197751744,2.9770480019503323
SaOS-2,5566,3.2892304449964125,3.0376483191455703
BFTC-909,44486219,4.380685277356905,4.405497062185577
SW1271,52947716,2.875834451056303,-0.4968799546582028
LS180,20959075,-3.038194424999374,-2.789499936959276
BICR 22,2708,5.160276397343071,4.936366269210065
LS411N,24856436,0.7977520405714393,0.258203293913371
RKO,3062316,2.656751778030552,1.1190117513284144
IGROV-1,2841722,3.834853118277962,4.330888227480542
SW948,9967941,3.223093544556301,3.3053744335028825
WM115,5291,3.6779708977342263,3.6440226012843624
ML-1 [Human thyroid carcinoma],262093,3.5917492591420737,3.056572589186482
NCI-H2452,11152667,-1.2581393219211725,-0.2669980547124551
SK-HEP-1,54454,2.662573207119838,2.5067448100548977
PaTu 8902,46398810,2.87785673961289,2.626660737560437
MOLM-13,4096211,0.3628379797080729,0.7339786439992896
SaOS-2,31703,-1.4545352226195103,-0.880461520606032
NCI-H2452,89928392,1.3829077368930702,1.7826129833815336
PaTu 8902,sirolimus-bortezomib (250-1 mol-mol),1.4421927553258482,0.706202590658188
SU-DHL-1,216468,2.865615091111303,2.1829390231603187
BFTC-909,5335621,5.263558209813896,4.740334003840787
IGROV-1,984333,0.6618578113050116,0.764374671670743
SaOS-2,53393127,5.00574224434263,3.9291958314423625
LS180,26596,-1.3053249122689552,-1.1902164071785677
PaTu 8902,216239,3.2515461693373946,2.3798101769467697
RERF-LC-MS,216239,1.5111459083459036,2.4356769258294735
IGROV-1,327653,3.667792542405671,3.197203138295692
MDST8,25062766,1.7641764997703038,1.9699144260760642
COR-L105,tanespimycin-bortezomib (250-1 mol-mol),0.350179088814853,-0.46692338219688007
SW948,9911830,2.1163810502856344,2.4864518923596997
SW948,25262965,-4.786935998048743,-1.3601033059541823
Granta-519,17755052,3.698735089058188,0.5708816316752455
HARA [Human squamous cell lung carcinoma],969516,2.3775549977258836,2.8896793005758115
SW1271,navitoclax-MST-312 (1-1 mol-mol),1.6729617215063168,0.9145558713750899
BICR 31,65628,4.368112552275168,4.5401884777430945
LS411N,1716436,3.6051806229528394,2.7195545244432218
HEL,31703,-1.5815868160580933,-2.498690533134321
ALL-SIL,46191454,0.8221974593607395,-0.2262156118757444
IGROV-1,46843906,3.392503571349757,2.978205429298456
MDST8,52912189,0.1558018738717314,2.6647254702107084
SK-HEP-1,73707398,1.730256970360003,1.5383185662444316
NCI-H2452,969516,2.821538204226011,3.0263972587679295
Daudi,9825149,1.5190393381512124,1.471590147149458
HEL,49766530,-2.395534265113236,-2.004277026977886
SU-DHL-1,445643,3.1136870030048116,3.6966565728408516
Granta-519,25102847,2.235988678650905,1.827498926319447
SU-DHL-1,8515,3.677486404661737,3.2984644366087794
SK-CO-1,decitabine-carboplatin (1-1 mol-mol),2.301340396249523,4.439833544179175
NCI-H1568,73707398,1.0000031751048108,1.400474465664339
RKN,44607531,3.612700906890815,1.574140944249783
RKO,448949,2.722052887717566,1.6859093710600006
SaOS-2,123631,3.143555798261004,2.0772433113677184
RERF-LC-MS,docetaxel-tanespimycin (2-1 mol-mol),-5.54075092456557,-2.690009246526842
HCC15,445455,6.40486213649735,4.696030556460333
ML-1 [Human thyroid carcinoma],54639126,4.430736107428324,3.6457941786857093
MOLM-13,16720766,-3.0154852550238473,-0.4684797189512486
SU-DHL-1,52912189,2.819399061651446,2.063049956543517
IGROV-1,6918328,-0.5330006254346346,0.022920153438830023
HARA [Human squamous cell lung carcinoma],67156097,-1.978765302962937,-0.7256418291273268
Granta-519,168312962,2.8455100129937447,0.722921871486287
RCC10RGB,24748573,3.544482176439233,2.201751192624018
NCI-H1568,71576739,4.4464222538448075,3.7123187456608315
IGROV-1,ISOX-bortezomib (250-1 mol-mol),0.8859012184952701,0.5234453959586867
MOLP-8,3025944,3.977744021049233,3.948471395633835
MDST8,navitoclax-sorafenib (1-1 mol-mol),0.2125187849150193,1.5407295101612053
SW48,3025944,3.8378875325919513,4.060216912138626
P31/FUJ,5460769,2.718083541162644,1.8952850199365547
PaTu 8902,56946209,-3.5225671286307585,-3.9058115375770655
IGROV-1,11964036,-0.1609353030421705,1.5217863950163235
HCC1500,327653,2.623652361439541,3.1407982571492505
BICR 22,11640390,3.3009766271386014,3.537853094137272
IGROV-1,400769,-0.5589612210030486,-0.6852695928865862
HuP-T3,24821094,3.9398095537443023,2.9299744349240417
HuP-T3,BRD-A02303741-navitoclax (2-1 mol-mol),4.136817383870447,2.66594426115565
RKN,54618771,1.93479648501244,1.4124632490275983
Daudi,BRD-A02303741-carboplatin (1-1 mol-mol),4.3065470056962765,3.9657980597288565
PaTu 8988t,73707398,1.170719580837983,1.2567690601748231
HARA [Human squamous cell lung carcinoma],10113978,3.460603354098383,3.4596659288589136
Panc 02.03,10231331,3.962628244123872,2.064308202275321
HCC1500,387447,-5.435802195710178,-3.658503904479937
K-562,25150857,2.2256112733235978,1.7735385536818316
COR-L95,135398516,3.161482452438301,1.7364440496755325
MOLP-8,46191454,-2.2442719810217984,0.6631266192049624
HEL,BRD-A02303741-navitoclax (2-1 mol-mol),-1.272488077546847,0.548930423071965
BICR 22,4259181,0.3497439952553443,0.43099195850925137
SU-DHL-1,49836020,5.336381428124731,2.3591372621297957
P31/FUJ,246676,3.344572915959865,3.8378319600109556
MOLP-8,UNC0638-navitoclax (1-1 mol-mol),1.623066033495539,0.7730048980515153
WM115,JQ-1-MK-0752 (1-1 mol-mol),1.4273161009607245,1.8814239854002477
WM115,carboplatin-UNC0638 (2-1 mol-mol),3.608353626656174,3.292176353863322
SK-CO-1,135875424,3.678629656731489,3.6292519461535386
SW948,3552672,1.903682389315955,2.2732877109640315
NCI-H1568,selumetinib-BRD-A02303741 (4-1 mol-mol),5.032258587314436,4.196443336165482
NCI-H2452,JQ-1-navitoclax (2-1 mol-mol),0.3722844908497442,1.2312859256689828
HCC15,selumetinib-decitabine (4-1 mol-mol),4.297917027036863,3.6186670798078966
P31/FUJ,6610355,3.438139996915945,4.046317603389205
NCI-H1568,446155,2.3736727750277455,2.7829911786022814
HCC15,107985,-2.9906891972859415,-3.3493449486129743
Daudi,6918328,-3.006382851838594,-1.1493586196926315
Daudi,25161177,4.237474374185298,3.4023834056649718
LS180,selumetinib-navitoclax (8-1 mol-mol),0.5338849490491672,1.4260981134045247
RCC10RGB,vorinostat-carboplatin (1-1 mol-mol),4.3210323450827275,3.1120728925988974
HCC1500,374536,2.8802619944250765,2.087862679646613
SU-DHL-1,400769,-1.357151076144479,-1.0332972178163637
MOLP-8,16725315,4.20287759788283,3.548866187675691
K-562,SNX-2112-bortezomib (250-1 mol-mol),-3.0816368014715434,-2.255315284181503
MDST8,24753719,4.799692184779076,4.316320362645753
Panc 02.03,25195348,3.9334722209588735,3.117562488471448
IA-LM,5328940,2.67230513268953,1.2745744485237396
HARA [Human squamous cell lung carcinoma],387447,-4.146769649621688,-4.2638871385229695
IGROV-1,JQ-1-carboplatin (1-1 mol-mol),1.3160451625502905,2.5942035294204455
Granta-519,676352,1.633141874861156,1.8008577526681122
HCC15,49793307,-2.657858659953827,-2.6034592042125153
K-562,16065773,1.923835638804153,2.020717948122539
RERF-LC-MS,23582824,0.1470987082457378,0.8555766654476095
SW948,9907093,4.923675844906718,3.7217808310956992
HuP-T3,374536,4.193584653265312,2.6263352030638516
WM115,11396600,2.8854117577089378,3.7343443020576252
IGROV-1,16722836,0.856484234547582,1.5172717269028286
LS411N,89183176,4.7846004508379085,3.242515148742482
LS411N,selumetinib-MK-2206 (8-1 mol-mol),1.1332062725089502,1.5414299844487738
HCC15,6917907,-3.7751611818797897,-4.431935590008178
NCI-H1568,637858,1.7833024505225796,1.9074609188087164
PaTu 8902,5329102,2.5341846500240246,1.9477715072977702
Daudi,54765302,2.540510911033338,3.5345680841481424
RERF-LC-MS,100016,6.56071523320666,6.272315067044958
NCI-H1568,387447,-3.95080818095812,-3.7979220278622927
HARA [Human squamous cell lung carcinoma],168313047,3.4416690801744574,2.4521676079957446
SaOS-2,11612883,2.0316436721768087,2.9318433325177455
SK-OV-3,135411,1.6318689765112546,0.8152524788980112
IGROV-1,208908,2.822483792004996,1.977071922207451
RKN,51037431,2.467401650082352,3.0291623055128047
MOLM-13,3025944,3.8428716966726992,3.965444482799049
PaTu 8902,135421197,2.3024316473658004,2.075599249156991
MDST8,969516,2.598297465814476,2.9566656011623267
MOLM-13,60750,-4.5529472050787545,-2.9328135843648018
SK-CO-1,selumetinib-GDC-0941 (4-1 mol-mol),-0.9815172513006872,1.1179430698330277
IGROV-1,9915743,-0.4757488934941289,0.9882468101910099
BICR 31,56946209,-4.213875977630207,-3.8666046746542624
MDST8,124202324,2.333625526818204,2.398140160447013
BFTC-909,46907787,2.3649992203474515,2.4762619180784005
Daudi,12003241,-4.903510386182724,-1.7500946503943466
PaTu 8902,969516,4.108056616445131,3.036740818191026
RKO,24951314,1.467797052763695,0.6342197298593178
SW48,439501,-2.266376314928653,-2.0411993387955927
IGROV-1,5311281,3.3250623444804206,2.095666863197373
BFTC-909,9825149,2.463033939289578,2.457053007438779
LS180,2858523,3.002923184305197,3.0767812904472693
HEL,decitabine-carboplatin (1-1 mol-mol),0.001071059904297,0.2282241941704454
ALL-SIL,selumetinib-navitoclax (8-1 mol-mol),-0.8393067870593486,0.3215048274420619
PaTu 8902,10074640,3.6154267469790304,3.179041984781293
LS180,135421197,1.2375553911833763,1.7692646754967378
ML-1 [Human thyroid carcinoma],3081361,2.035617561629102,2.467571377662807
HuP-T3,4259181,1.3598984416642497,0.48833976781682514
MOLM-13,9840324,5.573129737038137,5.556369883987635
NCI-H2452,docetaxel-tanespimycin (2-1 mol-mol),0.4791468482228301,-3.702343449141826
RCC10RGB,7251185,2.312506998895348,2.5895942012767663
LCLC-97TM1,23725625,2.954034200595367,4.695071624375206
RKO,24797083,0.8657042008278414,1.0875371034640096
RKN,selumetinib-piperlongumine (8-1 mol-mol),3.808395082066658,3.239091854406306
HARA [Human squamous cell lung carcinoma],45100309,5.833200435543825,2.823688028998709
ALL-SIL,24951314,0.1921049921473096,0.2812442345576747
NCI-H1568,tretinoin-navitoclax (4-1 mol-mol),4.46686431300974,2.374228365302881
K-562,16725315,4.409558206085648,3.4047056513715415
ML-1 [Human thyroid carcinoma],9825149,3.1128843906344117,2.3184687268787
SU-DHL-1,9915743,1.482861419138649,0.7234145634217208
SW1271,4917,2.7806051488376293,3.034695459827635
Granta-519,vorinostat-carboplatin (1-1 mol-mol),1.7690430171361815,1.8323965065311105
COR-L95,3062316,3.2830028596837217,1.580757416401817
MDST8,10074640,3.541716125988611,3.147301597965076
IGROV-1,44185566,2.2104732991243248,2.6023348867449156
SU-DHL-6,57519531,1.2127003418717253,1.5821117380161862
SK-CO-1,241158,4.831010946536929,3.992016662474883
SW948,46843906,2.6248020109336023,2.1615981867499374
RERF-LC-MS,6610216,4.063402980130349,4.367344735132497
RERF-LC-MS,46843906,4.323049782377064,3.3565385312872316
NCI-H1568,selumetinib-UNC0638 (4-1 mol-mol),2.7760221243911016,3.422411520462436
LCLC-97TM1,piperlongumine-MST-312 (1-1 mol-mol),1.3069230942291734,1.908467044037902
RCC10RGB,selumetinib-vorinostat (8-1 mol-mol),3.237241333738756,2.26906790541552
HCC15,24180719,4.303391195547382,3.5493067644217073
RKO,selumetinib-navitoclax (8-1 mol-mol),2.1856811512057885,1.2751979040848371
MOLP-8,6505803,0.6382990348001342,-1.0389856783032634
Daudi,5278396,2.816567405543214,3.1624756303001775
RKO,66577038,3.1469091340303637,2.5599435246840128
MOLP-8,54143018,0.5860183196437395,-0.4429703769670797
SaOS-2,24856436,0.4386880001360848,0.4316668086444324
BICR 31,9866186,1.254760755448308,0.7631945574445916
RCC10RGB,11257553,3.6405008146732434,1.3981711986101677
SW48,JQ-1-navitoclax (2-1 mol-mol),-0.920123495664676,0.7605568921083656
RKO,57330099,4.8516025997257275,3.9177297358648997
P31/FUJ,54649500,4.423311343715707,3.2728514863137885
SW948,10302451,4.082058519290096,2.984248398378473
WM115,2746,3.2273654457979957,3.4497264131822827
KU-19-19,654092,0.6096416345891582,-0.19344770304687744
PaTu 8988t,10296883,3.999790485906541,4.020391355761437
BICR 22,54143018,1.1733542553992964,0.5323195897403568
MDST8,71466445,2.0942740576673593,4.006054024003558
PaTu 8902,36462,3.471634301287976,2.0539934138866895
LS411N,44632017,5.0127460000138,0.9462703964954149
COR-L95,9911830,2.1813921058815553,2.4592792260701706
ALL-SIL,9911830,-2.857836139869332,1.7400188510185013
WM115,3465537,1.2344570371137795,2.6495263947709957
NCI-H2452,navitoclax-birinapant (1-1 mol-mol),2.13598555906201,1.666623466730976
SU-DHL-1,54454,0.0220955119836291,2.275805243671889
HARA [Human squamous cell lung carcinoma],9927531,4.552330692797245,4.925405628290545
MOLP-8,24821094,3.654707766369703,2.76687944938257
MOLP-8,6852167,0.8455390099609336,1.7271446256192982
Panc 02.03,11222830,1.865607722872823,1.7044593610356398
MDST8,2746,2.514425635914287,3.3634582786015983
Granta-519,1716436,2.7310795448836904,2.5694460591428196
Daudi,selumetinib-tretinoin (2-1 mol-mol),4.819941209079035,2.2564513716646672
RERF-LC-MS,11625818,4.251014876931036,4.434145606350073
P31/FUJ,4378219,1.2412027933720209,1.851908187175589
HCC15,3062316,2.729530034687651,1.0017305174446316
LS180,9903786,2.2166672873522857,2.2591925629355325
PaTu 8902,16065773,3.37985868216597,2.4404346253324074
LS411N,9911830,3.118029057589745,2.095299840674045
LCLC-97TM1,6438330,3.0238187505324885,2.260185566622688
KU-19-19,25062766,2.9321374053838807,2.2268380709057602
HCC1500,10074640,2.968051262406446,3.070903962225576
P31/FUJ,6505803,0.2535639265329721,-1.0235980270490592
NCI-H2452,387447,-3.2957708741809975,-3.986513357838096
MOLM-13,11228183,-2.7074565632423546,0.45214512830747383
SU-DHL-6,5566,0.7122829809928822,2.887211841841017
COR-L95,24785538,1.0654849938174582,1.0415666169075892
RERF-LC-MS,ISOX-bortezomib (250-1 mol-mol),0.403542566479009,0.7128402157632117
WM115,4578,4.221194502857287,4.593954792915311
COR-L105,4578,4.590840204947243,4.476747265338988
K-562,374536,0.780579010414565,1.3196751053997853
COR-L105,60700,0.1425021915553204,-0.11125829703526911
K-562,46926350,-4.162486097405079,-4.655395688478526
SW1573,4705,3.887877577681455,3.4884463261702923
LCLC-97TM1,637858,1.4157632634757724,1.8378745502421525
WM115,46926350,-4.284670953339827,-3.8909247218777687
RERF-LC-MS,15547703,2.8085711207925015,3.2507182741960423
NCI-H1568,11497983,3.872384435522252,4.3376767727796235
MDST8,4788,5.889593740712007,5.605779403614912
IGROV-1,8515,2.1861539315976053,3.9210971556900036
RKN,24772860,-0.333409077824626,-1.8588622241624675
PaTu 8988t,322968,4.849886698333752,3.77971672556805
RERF-LC-MS,16720766,0.5604118097796991,0.9182739159777071
SW948,6505803,-1.4287073835677784,-0.7060794368284415
BICR 22,462382,1.3729135623232431,0.839555279488188
LS180,322968,4.435040308321651,3.8656488089825816
SaOS-2,11152667,-0.1732170298835725,-0.1920027681931464
ML-1 [Human thyroid carcinoma],49846579,3.632639122540709,1.8410477006111805
HCC1500,227681,1.895909952215359,3.474912768622517
SU-DHL-1,57330099,3.736750567984075,3.727126812479357
PaTu 8902,crizotinib-PLX-4032 (2-1 mol-mol),2.4716529657314252,2.2134104293736985
COR-L95,11977753,-0.4790698517891548,-1.367042943384195
HARA [Human squamous cell lung carcinoma],6450551,1.1333007709837388,2.667750338350223
SW1573,11427553,4.057369297610019,2.7606931533248673
LS411N,selumetinib-decitabine (4-1 mol-mol),2.113542613262742,1.2113320172512505
LS180,12001922,1.7594619366424422,1.8369751244435408
SaOS-2,12001922,2.1147367002170494,1.8574038749930275
SU-DHL-1,3543504,3.7817510655567625,4.201306214464252
BICR 31,24901704,3.914024172074534,3.56094238596784
MOLM-13,5287620,-2.884996470216499,-1.9718245633214395
BICR 31,25102847,2.842271629600241,2.538484886022784
COR-L95,10113978,3.7452762075447104,2.90100326985858
LS180,selumetinib-GDC-0941 (4-1 mol-mol),-1.227348326224306,1.1224484031451738
MOLP-8,vorinostat-navitoclax (4-1 mol-mol),0.8660372331148116,0.44755538562410935
ML-1 [Human thyroid carcinoma],1750826,-1.3031865689994189,-1.3528827943766404
MOLP-8,decitabine-carboplatin (1-1 mol-mol),0.1349258094123646,0.7590957592198981
COR-L105,168312962,3.0410731046381065,2.1464873964852473
LCLC-97TM1,10322450,3.85878970197106,3.7093318289668367
HCC1500,25161177,4.357780519617112,4.0528161087203145
SK-CO-1,9967941,1.837567054996146,3.3921058578147534
COR-L95,5311,1.4789786210040632,1.2002494028766533
ML-1 [Human thyroid carcinoma],2733526,3.914729894927785,3.7661397324256374
LCLC-97TM1,72193861,0.688846554638978,1.3455584667586649
SW48,4096211,0.1208358665406906,2.0673109875576783
LS411N,135875424,4.300305751936665,3.3295388919512874
SK-CO-1,42642645,0.466262192383588,1.1174852908443214
IGROV-1,1566236,2.765820903157784,2.2679726393806345
HCC15,10410894,4.508285516741203,3.2495602466941818
IGROV-1,6450551,2.579641476451469,2.791652771434821
IGROV-1,452548,0.0422661560146271,0.5073440220821008
COR-L95,216345,3.729430833860697,3.5283300831188926
Daudi,navitoclax-gemcitabine (1-1 mol-mol),-4.251556973738435,-2.7203053773544417
LS180,2945648,3.723684880750219,3.097422132532238
RKO,9936388,0.8183869926163714,-4.6046923281602785
HuP-T3,10231331,2.6811135289001236,1.8398686811258163
PaTu 8902,44493528,4.360494725244959,4.361205313927931
Panc 02.03,45279963,4.323488067826322,3.9005631840073445
MDST8,BRD-K27188169-navitoclax (2-1 mol-mol),-1.2819787508049554,2.512873471003864
BFTC-909,44507138,2.8704731321552734,2.7136417738849934
ALL-SIL,49766530,-2.347000417785464,-2.1918159088855744
SU-DHL-1,6918289,4.3249644726818275,0.6852569673582597
NCI-H2452,54626689,4.879011133008654,4.5792463747601655
HCC1500,4917,1.9149154714535184,2.9790863953491873
LCLC-97TM1,15547703,3.011827246330581,3.1344581322785077
MOLM-13,71304818,2.1544936448447873,1.8782524975811754
SU-DHL-1,4917,2.4666047815714154,2.9681235181711254
NCI-H2452,56946209,-3.558178980562316,-3.8558764212049437
RKN,1750826,-6.055252220387113,-1.3080802213214684
RKO,25105715,3.388469834531371,3.1847865083054954
RCC10RGB,46191454,4.887818963424851,1.663370580758854
LS411N,3815108,3.549037613932863,2.43263063117639
HEL,56946209,-4.040477533762366,-4.742983870680339
BICR 22,122327,5.571410232221064,4.614890098409099
BFTC-909,969516,2.723005004244225,2.8957208744309604
KU-19-19,selumetinib-JQ-1 (4-1 mol-mol),-0.4288095691894706,1.8126163765615688
RKO,24856436,0.2423564692967549,0.05594610985583472
SU-DHL-6,5746,-1.2123840023346684,-0.45416590769885473
SU-DHL-1,135411,-2.10627226052293,0.4716546187632764
SK-OV-3,1716436,3.636442167288748,3.0228877809959265
IGROV-1,44543605,3.88270235241076,4.033192162507925
K-562,6914657,-3.91828110768511,-4.90103979488479
HARA [Human squamous cell lung carcinoma],9866186,-0.525705997781229,0.8887067450830677
NCI-H2452,25262965,-3.6663688304344695,-1.2736379216777522
HARA [Human squamous cell lung carcinoma],navitoclax-MST-312 (1-1 mol-mol),0.8639589641874816,0.9751948143353684
MOLM-13,11404337,-1.791363376051536,-1.1072956424760116
RKO,36462,3.4370564574699185,1.2924923785543532
IGROV-1,446155,3.750396425244744,2.783767196769109
COR-L95,72734382,4.117898969233179,4.126648817277182
K-562,11396600,3.7562155275673415,2.8583626700311817
LCLC-97TM1,4705,3.0319662392534057,2.9795706642944464
Daudi,2130404,3.4806417402967993,2.092584109268573
UACC-812,vorinostat-navitoclax (4-1 mol-mol),1.8866466886365112,1.139813336297389
MDST8,327653,3.1544218347658375,2.7860365648084784
SK-CO-1,11656518,0.968890652064466,1.6189691996199946
K-562,5311281,3.9022564066083967,2.101482799656683
ALL-SIL,carboplatin-etoposide (40-17 mol-mol),-0.158708138675103,0.25868457049056676
MOLP-8,selumetinib-PLX-4032 (8-1 mol-mol),1.1163083218110827,3.349554229469994
RKO,445091,4.342692134156949,3.913973858019633
MOLM-13,9935249,2.7939558009041283,1.110085680217314
SK-CO-1,selumetinib-navitoclax (8-1 mol-mol),-1.2361376975305869,1.9761337952781417
RCC10RGB,selumetinib-JQ-1 (4-1 mol-mol),3.398592660488386,1.8162433661659891
SU-DHL-1,124202324,2.3695119203399906,2.4876564923334077
COR-L105,9884685,2.6443959528770167,0.8303319762213163
BICR 31,10113978,4.990782635230478,3.5450327824768033
HEL,crizotinib-PLX-4032 (2-1 mol-mol),1.5778515450818191,1.098585816416244
MOLP-8,6610355,3.5622833697709178,3.9523934203068456
LCLC-97TM1,2749,2.4194398786749067,1.9154644139350123
Daudi,5311,0.1794409230409946,0.5658172831332964
HuP-T3,2113511,6.036487802507154,5.578142826970828
P31/FUJ,452548,-2.598049093653093,-2.26972433239112
SaOS-2,16065773,3.691866894593861,2.286164562879606
RERF-LC-MS,65064,5.274588293813746,5.01146171695591
HuP-T3,89928392,1.747135585577409,1.5912178012180942
P31/FUJ,56963564,-0.6738396792941169,-0.49136597281381517
LS180,5746,0.8609008276830991,1.135622714179484
BICR 22,11707110,-2.2145574606059912,0.2952229378732578
Daudi,9952709,2.2307089742515713,1.9406997448899752
SW48,3543504,4.30466926238752,4.485363366603511
SW48,11427553,0.5193301330840923,2.6857123816044335
WM115,56649450,1.7070260970326938,3.6340676745938807
IGROV-1,89928392,1.4824233552493276,1.4487890830188563
SW1271,72376,-1.909620961604672,-1.478092345254547
SaOS-2,5278396,3.8495121754699686,3.5741000064875372
K-562,42642645,-0.9952706094252596,-0.009042603283216415
Panc 02.03,446155,2.721578883226381,2.9246818200125606
RERF-LC-MS,44462760,4.251912039026111,4.121294858335828
BFTC-909,3503,3.411270469206907,2.208748944551465
MOLM-13,104842,-5.846939346357726,-4.214517808425675
K-562,11656518,1.1460195934444493,1.0696619980131303
HCC15,76446078,6.244123044550032,3.947909428313177
COR-L95,6438330,1.555078701387849,1.9913737132342684
COR-L95,9926054,2.0133423062539726,1.6555553523323172
BICR 31,462382,1.217928478873545,0.5042569673296027
UACC-812,46199207,3.606176782545976,3.099134044880308
SW1271,16725315,3.214819296898604,4.045141912099678
BICR 22,3385,1.594485383262216,3.5302287224689444
HEL,11234052,1.6482548628813194,3.0450228286882264
SW1271,49793307,-1.6735159246770874,-2.141003419724099
HEL,3025944,4.107185950107739,3.5971187027691602
SK-CO-1,1641662,2.678789461404506,3.564393205099311
RKN,71680916,6.446363106372924,4.952985128489592
IA-LM,25183872,-0.4633226224219731,-0.6826249222433005
IGROV-1,6918837,-2.9804518885508635,-2.8213036805172034
HEL,252682,5.808471376099282,6.367453604212017
SU-DHL-1,sirolimus-bortezomib (250-1 mol-mol),0.2178646036916351,-0.603793166938364
MOLM-13,374536,0.9670025892080272,0.6452791475048802
NCI-H2452,168313047,2.588327036215806,2.346360926157347
Granta-519,4917,3.021022166883331,2.7916249963933133
ML-1 [Human thyroid carcinoma],JQ-1-UNC0638 (2-1 mol-mol),2.6444298637243167,2.024161331993847
MOLM-13,selumetinib-GDC-0941 (4-1 mol-mol),-1.09695682780189,-0.08787156306227993
BICR 31,262093,3.397835562493394,3.0724353525828096
LS411N,12003241,-0.0946051023392001,-0.7224176777957577
HCC1500,5282054,2.2651950194203323,3.5864646794366912
HCC15,322968,4.854333863324092,3.937398581363855
RCC10RGB,9936388,2.3235560801623465,-0.22640277726284583
NCI-H2452,46199207,3.026577128215497,3.112252819509938
Granta-519,9444,3.3091580955395146,3.207151463636147
IGROV-1,53392493,2.352084848618059,2.4268433311077287
COR-L95,151289,3.0372683791028705,0.8196184573906408
NCI-H1568,216468,4.700562763036761,3.3884154816496137
WM115,25195348,4.859937697346287,3.3002801286242844
SaOS-2,2858523,3.094677154220442,3.10698319515433
SW1271,421610,4.471416490511734,3.223765906943464
BICR 31,637858,2.611871003184785,2.023418101219926
SW948,11175137,1.686043515242534,2.3094349211240788
MDST8,11625818,2.7981930885976705,4.69082536212004
Panc 02.03,11609586,3.3931905350155915,2.9822705847960047
Granta-519,selumetinib-UNC0638 (4-1 mol-mol),2.20466638812085,2.1487415974819997
PaTu 8902,9825149,2.767587999144615,2.3031660751532903
HCC1500,6918837,-4.362896894201754,-3.1321805359322825
BFTC-909,navitoclax-PLX-4032 (1-1 mol-mol),3.5024450661652153,2.1826959310351297
SaOS-2,5282054,3.07206551989859,3.6083965205730704
SK-OV-3,navitoclax-birinapant (1-1 mol-mol),-5.0727238052406705,1.5053142522295593
SK-CO-1,72376,-3.2194985981528808,-1.5534674756263478
Panc 02.03,carboplatin-UNC0638 (2-1 mol-mol),5.105759320304772,3.227213335270044
WM115,10302451,3.6553280898048905,3.278543015856206
Granta-519,613000,2.2510291651452143,1.9998078632255027
SaOS-2,11222830,1.0878926350484104,1.4740300612501391
IA-LM,54678924,1.6007306497128662,1.404499399126041
HEL,119607,4.922739390517752,4.4853325921686205
HCC1500,6918328,-0.2689126411143879,-0.48359152990621856
HuP-T3,crizotinib-PLX-4032 (2-1 mol-mol),2.5650363225974315,2.0121214660835616
LS180,3062316,2.327440880417239,0.8614474372333761
LCLC-97TM1,11317348,1.7152030009838672,2.609577877124204
SaOS-2,6918736,-1.8799034133096575,-1.7801962146234482
SaOS-2,12003241,-0.699813042979073,-1.395021302968815
LS180,10113978,3.7861477365363383,3.3047375531625223
SW48,54618359,4.4319552735559,2.1886384551555262
PaTu 8902,ISOX-bortezomib (250-1 mol-mol),1.241492124971151,0.7260829471967831
HEL,387447,-4.961191552031455,-5.141431499015248
RKN,6610216,4.220445612403551,4.145929720237765
P31/FUJ,656346,-0.3707458386499477,0.060261561580641575
Granta-519,selumetinib-JQ-1 (4-1 mol-mol),0.6993639444129659,0.0010495854117584268
PaTu 8902,navitoclax-gemcitabine (1-1 mol-mol),4.2969329187245,-0.71348783420741
MOLP-8,9952709,2.638563783306324,2.3883385722692823
SaOS-2,11455910,0.8777485884783317,1.2765490182854426
K-562,10184653,1.719293175029272,0.9205450870088088
Granta-519,4259181,-0.7648884727300508,-0.22929327076165054
BICR 22,4521392,3.4098909359208625,4.198024680241247
HCC15,2874250,4.519421691404506,4.545802287683093
SaOS-2,6918638,1.2055090485954645,0.39067773495808195
MOLM-13,9868037,0.9756233042827712,1.888149337794955
HCC15,navitoclax-sorafenib (1-1 mol-mol),0.4047669070332462,1.9113290062871662
MOLP-8,16659841,2.203571056365997,2.577674253884369
LS411N,656346,4.206497662771029,0.6299244632919133
RKO,5460769,5.660789679983863,1.916858604843341
BICR 31,6610355,4.797647038745592,4.684808423830803
ML-1 [Human thyroid carcinoma],17755052,4.154119256233629,1.9995028015149625
RKO,11964036,1.8153618806471208,0.36322843942667565
NCI-H2452,7326481,3.286880233884326,3.043912179276599
RCC10RGB,44491742,5.1484686760969645,4.294097492811733
IGROV-1,50905018,6.092412272559071,4.238941343506149
BICR 31,9884685,0.303781088019613,0.8824833836718148
Panc 02.03,3081361,3.1546648300373357,2.3721368405809997
BFTC-909,25126798,3.8219929141120166,3.9137304821601147
MOLM-13,66890843,1.9738756301734208,1.2826530669290364
HCC1500,24180125,3.164669305988548,3.0209386932659292
SK-HEP-1,53392493,3.66906541895257,2.7799983462001436
RERF-LC-MS,2945648,2.437954541344266,3.0858093116888234
HEL,25150857,2.447529551071105,1.6856496142539814
BICR 22,65064,5.333446499438452,5.0346692210929636
PaTu 8988t,carboplatin-UNC0638 (2-1 mol-mol),3.665220724432894,3.4298106876278562
P31/FUJ,123631,2.0303759233077017,2.031167369811679
HCC1500,tanespimycin-gemcitabine (1-1 mol-mol),2.493780816473477,-0.7625226419949531
IGROV-1,11175137,1.8411496230681277,2.5268369427054735
KU-19-19,44241473,5.030815161961597,4.79083671730303
SW48,72193861,-0.4534629909928462,1.5659126914807766
NCI-H2452,selumetinib-vorinostat (8-1 mol-mol),3.054936641040398,2.799026846589037
MOLM-13,5311281,1.6146001182421037,1.7737581003532188
HCC1500,9915743,1.9340540182592263,0.9352997234701569
SW1271,tanespimycin-bortezomib (250-1 mol-mol),1.119789259321392,-0.49804728106871854
SW1271,crizotinib-PLX-4032 (2-1 mol-mol),1.7792866548085249,1.8242376850783557
LS180,4096211,2.1975503712063604,2.0289472116768974
NCI-H2452,66577038,3.355972963473848,3.090218789713995
WM115,JQ-1-UNC0638 (2-1 mol-mol),1.9415560976310364,1.6800393057242278
HCC15,11175137,3.485795641541794,2.845823460868682
K-562,navitoclax-pluripotin (1-1 mol-mol),-4.5842278555306395,-1.8228632636548006
HuP-T3,2945648,2.5475895191101197,2.8974397705200214
Panc 02.03,6450551,4.166761052507323,3.094424715896533
K-562,2708,5.362475494708341,3.6583109164085204
RKN,219104,3.4277527780329096,3.8965259416480573
RKO,16722836,2.0172870973895085,1.1460323965472574
UACC-812,439501,-1.4243957864326813,-2.258245628922448
MOLP-8,11222830,0.9410853080031706,1.2098922592888457
WM115,1239801,4.563824386797348,3.897174643389523
Daudi,11717001,4.763561920962392,4.084131679524362
HARA [Human squamous cell lung carcinoma],24785538,-0.0579889747329333,1.6843139556498088
COR-L95,16736978,-0.5228132160938015,1.6176652813962504
IGROV-1,11213558,0.52356811652227,1.7705709812368327
MDST8,44202524,1.4033794041893788,2.3093849974974408
SU-DHL-6,10113978,2.1190356124222194,2.2789614036987538
SK-HEP-1,4917,3.764636353681369,3.030018713268633
HCC15,452548,-2.1001752731425727,0.27514680364801775
SW48,46191454,-0.9829938197758128,1.580147831738937
MOLM-13,4521392,4.5803067712490115,3.607858177412146
HuP-T3,25062766,2.4453672011464023,2.131583487212996
COR-L105,107985,-4.244896937866387,-3.4143269031389565
SU-DHL-1,89928392,0.4021872915525221,1.466063240750511
BICR 22,55508,4.44611517999926,3.2939260815973785
ML-1 [Human thyroid carcinoma],135659046,3.731165476589243,3.815615629114029
MOLM-13,675434,3.665195693175508,3.942238254958013
SK-HEP-1,6610216,4.694225049802747,4.245624316470223
IGROV-1,navitoclax-piperlongumine (1-1 mol-mol),2.320051681006032,1.7240122877099449
SU-DHL-1,49766530,-4.824875359994143,-0.5566159560162375
HEL,12001922,1.658840092002429,1.6444197899543758
HCC15,46398810,2.6134237903958093,2.7388331291395502
NCI-H1568,3136844,4.658915015928919,4.336544506969402
NCI-H2452,24821094,3.1123469452418537,3.2489962576457425
LS180,3543504,4.376890558116308,4.394753422947903
ALL-SIL,9927531,4.600523700119875,4.003069142169627
BICR 31,11167602,4.451308398956488,2.824423537646373
SW1271,16219061,4.25548468975063,3.2387045219134483
PaTu 8988t,448949,1.751499890417066,2.119643222724421
WM115,2858523,2.9957579985597467,3.0668360276368536
RCC10RGB,11364421,1.2845393833467151,-0.7457807686484412
SK-CO-1,984333,1.8899562330111348,0.7657678256210277
COR-L105,72376,-1.002534224494363,-1.4217060871289522
NCI-H1568,168312962,2.190321562510239,1.8205428289762886
SaOS-2,2746,3.4161371679978436,3.466847271290876
Panc 02.03,51039095,3.661030142872421,2.929990226947479
SK-CO-1,65628,3.554197618459022,4.2411509419661355
COR-L105,16725315,5.297524124299076,4.489513549438808
LCLC-97TM1,JQ-1-carboplatin (1-1 mol-mol),1.024195349701644,1.4416541705450143
RCC10RGB,46224516,2.231293839634299,2.9627768022672494
RKN,9956119,4.4432647969313,3.578542818414531
RKN,16065773,2.958619348149216,2.6407147027617195
WM115,17755052,0.4002517605741686,1.5356938496020363
WM115,168313200,2.1363369230808593,2.7754425248918775
BICR 31,ISOX-bortezomib (250-1 mol-mol),1.0654896454992784,0.9800497120473254
WM115,navitoclax-MST-312 (1-1 mol-mol),0.1056862983661574,0.9074637856833845
LCLC-97TM1,9903786,1.8016114643921617,2.6052997080036704
SaOS-2,49867926,4.146129188416838,4.416882359140579
RKO,25126798,4.002843113400742,3.4233403005258833
ALL-SIL,219104,1.1543769867483644,2.310043466956076
Granta-519,tretinoin-navitoclax (4-1 mol-mol),0.0394078475475117,-0.05939130013871351
SK-OV-3,3062316,0.5292744016150154,0.9756006271047881
SK-OV-3,11178236,-2.424602318267421,-3.1743373323715662
LS180,9887053,3.1718141126704618,4.119673771330289
BFTC-909,25183872,0.7872065650622051,-0.8168551149196703
NCI-H1568,2945648,2.136721092573253,2.8348266648663416
RKO,1716436,3.795795915163565,2.6083215425002675
SW948,65064,5.291153994733523,4.595950446920152
PaTu 8988t,salermide-PLX-4032 (12-1 mol-mol),5.538923116384137,4.761124485243351
SK-CO-1,16115403,-4.417233339728943,-3.6463909540268906
SaOS-2,400769,-0.6660591873157414,-0.5550689666866917
SW1271,2733526,3.2893803459487594,3.354849056918104
BICR 31,4521392,4.267019749412992,4.3790846597039526
P31/FUJ,25154868,4.728907139536709,4.144043319899591
HEL,676352,2.4086189638079643,1.8077171611355916
PaTu 8902,BRD-K27188169,4.434214541500356,4.065810012893748
KU-19-19,44607531,3.044914521934579,1.5350394041413082
RKO,selumetinib-tretinoin (2-1 mol-mol),2.520120690265609,2.4654186928874777
SK-CO-1,72193861,-0.1340038294528125,1.990548768680717
HCC15,selumetinib-UNC0638 (4-1 mol-mol),3.167456472626372,3.2507891818690045
WM115,135423438,3.926483426744841,2.597668035382351
RERF-LC-MS,135875424,2.839581382146162,4.101609319342914
PaTu 8988t,46926350,-4.145321949318386,-4.098560180692083
Daudi,23582824,-0.638376916275564,0.5427957611056438
Panc 02.03,168313200,4.226618217059218,3.0829226392238964
NCI-H1568,11175137,2.3278621292073067,2.687079970237822
COR-L105,11152667,-0.3968124554752262,-0.06615981353312081
IA-LM,5281672,4.428935042775787,4.574096052733003
IGROV-1,3062316,-2.2361832227909075,0.9176604980527842
SU-DHL-1,5281672,4.30860315799997,4.451075663141744
HuP-T3,tretinoin-carboplatin (2-1 mol-mol),5.021357813866161,4.92100642889064
BICR 31,11625818,3.9395546041344858,4.4110198134475045
ML-1 [Human thyroid carcinoma],5311281,2.103239185945236,2.462224718110343
NCI-H1568,445643,3.6093957886383814,4.060606505435136
NCI-H1568,4477,0.3996701755478256,0.33161546149854493
RKO,36314,-4.63858923378885,-2.079542535024369
Daudi,675434,3.694219652985114,3.9592696666687317
MDST8,60750,-4.217127024403589,-1.2587259779862252
WM115,9903786,3.894434750277636,3.031966996310846
RCC10RGB,5282054,3.6705963985990993,3.9654644415037206
HCC1500,262093,2.85046563878574,2.9870981837594632
BFTC-909,4259181,-0.0277162117211437,0.17325445168351425
COR-L95,252682,6.347695054422412,6.403314748889582
LS180,9911463,3.681535048080384,3.7031611597734404
SK-HEP-1,1566236,1.7725788045776691,2.4480387778263433
LCLC-97TM1,6918736,-2.1743152466595626,-1.479234523489693
SW948,10231331,-0.4116197219649379,1.095892835975529
COR-L105,selumetinib-vorinostat (8-1 mol-mol),2.277448874031188,2.382823890674769
KU-19-19,52912189,3.155674258646967,2.904547049510806
PaTu 8988t,44185566,3.1955818251601493,2.560844419269902
ALL-SIL,31703,-2.84181702758724,-2.803170036602917
MOLP-8,67156097,-2.505693621695456,-2.2402170376489017
P31/FUJ,12003241,-0.93015536828776,-2.071815036721111
HARA [Human squamous cell lung carcinoma],44607531,1.5873617953354324,1.6532656877320602
HuP-T3,72376,-1.771653200109272,-1.8063670369032707
COR-L95,vorinostat-carboplatin (1-1 mol-mol),3.640391778924097,2.529258129880529
ML-1 [Human thyroid carcinoma],3062316,-4.511354956700351,1.0847930256081566
SK-CO-1,54649381,3.727346200170898,3.7436773465829187
BICR 31,4578,4.306546690441069,4.424821868393188
HEL,24856436,0.2549549224561803,-0.32267256228568714
K-562,selumetinib-vorinostat (8-1 mol-mol),2.188537608414777,1.7601803481470992
Granta-519,selumetinib-vorinostat (8-1 mol-mol),1.614961732306094,1.8161878704867502
NCI-H1568,568763,0.1547040002068053,0.5247750030340869
SaOS-2,10184653,1.5674189620168135,1.5511051496832007
BICR 22,carboplatin-etoposide (40-17 mol-mol),1.4257688352427802,2.770232505268063
SK-CO-1,10127622,-1.7782095442547816,2.988888895840899
RKO,6450551,2.9764230599456782,1.6552997865520387
RCC10RGB,11222830,2.1708629162803654,1.8173655391694772
MOLM-13,439501,-2.531564352317227,-2.324825130328075
KU-19-19,5328940,2.592216165266187,1.7178154963945516
SK-CO-1,BRD-A02303741-navitoclax (2-1 mol-mol),1.7439599678595026,2.195768044431955
KU-19-19,navitoclax-pluripotin (1-1 mol-mol),-0.1990402991745543,-0.7042414770990842
LS411N,46224516,2.772468105753273,2.679496071057746
COR-L95,3465537,1.5360689669151406,2.189771992932698
NCI-H2452,650361,3.725817753027947,3.713655047738845
MOLP-8,135423438,1.7176055832456645,1.2383662630937287
Daudi,15953870,2.3174310256528017,3.0498892358330956
HEL,25062766,1.0860006913119025,1.5185847858156851
LS411N,9866186,0.9541786681011424,0.4835039355080754
NCI-H2452,72193861,1.1802568558602904,1.856901399361951
SW1573,104842,-2.57352069349058,-2.7936490003910306
SW48,1750826,1.3136286655933227,-0.6242427932336481
HCC15,25262965,-1.0400697166295236,-1.4670091295777343
SW948,156414,1.6424995325300082,1.15293521439619
HEL,49793307,-3.822273429090704,-4.239308304495414
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,2.0401979141395157
KU-19-19,15983966,3.017543110767297,-0.49534577212102904
Granta-519,445643,4.101892829369416,3.59180517256397
WM115,44462760,-6.607584862322745,3.2354479297507543
COR-L95,16722836,1.6737270586986386,1.6365627787326977
HuP-T3,19582717,-4.617931701404403,4.433317348558171
MOLP-8,135984461,3.690365922940533,2.861918577414341
WM115,25105715,3.143290836206988,3.2555221560389866
SU-DHL-1,6610355,4.337111630655639,4.296927328317489
P31/FUJ,107970,2.0437014771117425,2.1178064758937265
BICR 31,9903786,2.10396775229317,2.733603692779658
HCC15,119607,5.6213928119464285,5.327958576672023
K-562,53392493,1.9280012389180945,1.6797658510665345
Granta-519,erlotinib-PLX-4032 (2-1 mol-mol),4.2552857521313925,2.793565314481711
ML-1 [Human thyroid carcinoma],4788,6.371899932480547,5.6458346028963176
SaOS-2,6184667,2.75971928345779,2.916050450048732
HCC1500,49867930,4.391361036771465,4.851627972598406
HCC1500,156422,3.756088196252004,3.9895188359603484
LS180,2729026,2.858515315971793,2.8589765190999743
UACC-812,9926054,1.7122964049751828,1.9953685824762255
BFTC-909,2945648,3.347829093032643,2.9181795224102696
RCC10RGB,piperlongumine-MST-312 (1-1 mol-mol),2.4761046612469944,2.1278809995654298
COR-L95,10427712,3.3507411292398315,4.091005440501848
HCC1500,73707371,6.057238887548947,4.609945591516494
SU-DHL-1,5566,2.363543718324467,2.9392124389932097
RCC10RGB,navitoclax-pluripotin (1-1 mol-mol),0.1501865832808995,-0.5873668116523048
SW1271,44137675,2.993655891868926,3.776870164729861
PaTu 8988t,10385095,1.1295524511895831,1.2761258283639318
IGROV-1,107970,2.287061680908213,2.355101928482323
LCLC-97TM1,3081361,3.200154540210029,2.263776769482501
MDST8,24797083,1.659668465713326,1.270430703509067
MOLM-13,100016,3.967621300341963,4.758326398645518
SW48,6914657,-5.582748420606011,-3.864708416671192
RKN,54454,2.1815674244706407,2.6675339819428876
SW1271,54686904,4.077781574312711,3.7934797737770705
MDST8,tanespimycin-gemcitabine (1-1 mol-mol),1.2757210463641129,-0.43825154154504475
LCLC-97TM1,11152667,-1.9849905525936635,-0.36727227394381623
RKO,6610355,5.147293026177706,4.050224817736283
HuP-T3,11234052,4.425621489915021,4.180798344528308
BICR 31,11485656,2.9684140094972387,2.4943269623010047
HCC15,445643,3.643779771767104,3.947131745773232
BFTC-909,alisertib-navitoclax (2-1 mol-mol),3.1464879320843635,0.7517021109398339
Granta-519,6918878,0.9437787040623058,0.26373962471305085
SU-DHL-1,16720766,-1.7997333167058054,0.28909347045090333
COR-L95,navitoclax-MST-312 (1-1 mol-mol),0.0334777259745642,0.27645621339003734
RKO,11626560,1.596896929931414,1.076224826587181
IGROV-1,44589607,3.0909001492794377,2.9421627515264985
HEL,168313047,1.7739787927154282,2.035820447662905
IGROV-1,11964036,-0.1609353030421705,1.5217863950163235
SK-HEP-1,969516,2.3030983588134917,2.9242421751118814
LS411N,68056272,3.648680202626129,3.178023641551858
WM115,navitoclax-piperlongumine (1-1 mol-mol),2.2126166903364037,1.4902193557647678
HEL,2749,1.5352641298417238,0.902216815334568
MOLM-13,135398516,0.1807695197937267,0.988885133643767
Daudi,176870,1.9898427065198672,2.547080791238643
HEL,10427712,4.076538081897971,3.8821271409929734
SW948,24772860,-2.2115718578693495,-2.4311592467977574
Granta-519,2729026,1.8472912754822493,2.1445879635948377
COR-L95,5394,4.313147278509764,3.549203982864585
LS411N,46907787,0.8939335106347707,0.16726384386211934
ML-1 [Human thyroid carcinoma],2841722,5.015074505803474,4.364435399722216
KU-19-19,11485656,2.7576201496249264,2.5858045634579616
IGROV-1,2858523,3.196384505087132,3.058384562943074
SW948,702558,5.163408425848839,4.535421916120872
RERF-LC-MS,72734382,4.885789692793362,4.907494999145728
NCI-H1568,JQ-1-navitoclax (2-1 mol-mol),1.9826778797664537,1.0616718205034996
RERF-LC-MS,11964036,1.6707185338079893,1.61892387302222
ML-1 [Human thyroid carcinoma],25154868,4.839556149748317,4.666536712815768
SW48,3038522,2.575519148977434,3.1381601058178585
IGROV-1,11364421,-2.1205062036040982,-2.189977442033261
Daudi,24753719,1.7041863717102288,3.334234097174401
MOLM-13,selumetinib-BRD-A02303741 (4-1 mol-mol),2.2135360458532216,2.7071820261293227
SW1271,73707438,3.2742940196229022,3.967057483872854
MOLM-13,44487061,4.373293273870424,2.8442156718937253
SaOS-2,568763,0.7449819257203903,0.5468897550935405
SaOS-2,168313200,1.7182390433527042,2.9560753193654072
K-562,15547703,3.09098547046412,2.646576039561217
BICR 22,24785538,-0.3286106781648999,1.724051961813405
IGROV-1,9936388,2.10108466287406,-0.898030388046389
BICR 22,4477,1.559722374810713,0.4196792667992694
LCLC-97TM1,navitoclax-birinapant (1-1 mol-mol),-0.5917483578052505,1.4742434235411077
BICR 22,16038120,1.2563245393113998,1.2672837027531874
PaTu 8988t,56649450,4.324867884259214,3.41602455217639
PaTu 8988t,135411,1.3050507330755643,0.7509094435740379
NCI-H2452,12001922,2.2907278374018296,2.0504415113791925
RKO,44185566,2.4837284923488063,1.7766214000834128
K-562,9826308,0.1842141800186153,-0.19816778465535742
RCC10RGB,5311281,4.058856975975892,2.3277955176527176
WM115,5460769,2.9023963298546507,2.8134999206838414
HCC15,119182,0.1055567812373319,-0.5402066198073432
BICR 22,44607531,1.5270609291983028,1.3405824939018784
HARA [Human squamous cell lung carcinoma],26596,-2.1080424946580245,-1.1689054939634411
NCI-H1568,25262965,-4.225307409424958,-1.0751803358634167
SW948,5328940,1.2304763256018572,1.3912306795678935
IA-LM,10296883,4.25848729020474,3.3110635167752003
LCLC-97TM1,11964036,0.9095700511944136,1.2618621307726205
SK-OV-3,10074640,3.759507235638381,2.972873372817548
BFTC-909,25062766,1.7422044094415416,1.9177687681262008
MOLM-13,44202524,0.8413416322030352,1.4263750595837865
P31/FUJ,44137675,3.225768708166513,2.825876561332684
PaTu 8902,42642645,2.254917267204718,0.8057527601928172
RKO,53232,4.485666667988006,2.743329843148398
MDST8,51039095,3.753808380930837,2.7313308357801365
ALL-SIL,25150857,1.7729123360103365,1.6476231739531881
KU-19-19,136227924,3.1447471190609217,2.9955521318907508
BICR 22,9911830,2.5765146499323497,2.743671406048957
SW48,26596,-2.356334812614481,-0.8546138568220187
WM115,8515,4.149615392892544,4.087782050356207
SaOS-2,3025986,-1.3703894596366477,-0.6052013104326245
LS411N,6623618,2.410312404439064,2.2108703838057915
RKO,2749,1.3580925102381314,1.2737953297886082
SW1271,9915743,1.6128868969613257,1.1052088309360821
SaOS-2,44589607,3.1014372869468736,2.9261269620871313
BICR 31,9908783,4.390198834476992,5.160049047376583
RERF-LC-MS,1641662,3.403538628142178,3.519597213114497
SW948,168313200,2.3052543991742933,3.0732386986191234
BFTC-909,16720766,-0.0189955240044846,0.7179589358887379
HCC1500,46843906,3.5664723036358703,3.263147784341417
BFTC-909,5291,3.495280995080932,3.802002698584169
PaTu 8902,5287620,-1.817962379422155,-1.9816192681891227
Granta-519,24772860,-2.616849709254195,-2.833011301335048
SW48,selumetinib-decitabine (4-1 mol-mol),-2.392622848847121,3.4121439969956584
MOLM-13,2858523,2.990787770243497,2.4906605653353076
MOLP-8,73707398,-1.5200522985211378,0.4759052500162026
WM115,4788,5.364989483250021,5.7221831204442966
KU-19-19,11717001,1.9129980214779312,4.137882090401439
PaTu 8988t,3854666,2.839522644305469,2.27891945097538
MOLM-13,vorinostat-navitoclax (4-1 mol-mol),-0.987195893966014,0.061079308441094285
RKN,11222830,1.5707482267531538,1.5728125219170328
SK-HEP-1,5978,1.689065603838291,-1.6910558427765674
LS180,374536,-1.6764778169414856,2.350460396975435
HuP-T3,sirolimus-bortezomib (250-1 mol-mol),0.6074306873304286,0.8483973805783145
RCC10RGB,46199207,3.760684270246491,3.346378930255784
SW1271,49836020,-1.4027167140646708,2.0718745669936145
BFTC-909,2130404,3.366307483642889,3.393116099023362
SW1271,3384730,3.1846503121443144,2.8445844285332784
HARA [Human squamous cell lung carcinoma],selumetinib-MK-2206 (8-1 mol-mol),2.6906074312139676,2.202761897023019
SW1573,selumetinib-PLX-4032 (8-1 mol-mol),4.4065207246272005,3.402933014881372
SaOS-2,285033,-3.099559966451384,-1.998298174879147
LS180,71466578,4.68838045718991,4.509527833874341
LCLC-97TM1,2126,5.523539990092585,4.438669451093349
NCI-H1568,9936388,-8.53108348301746,-1.120576117054685
Panc 02.03,6505803,-1.93196111296706,-0.8321002805144881
BICR 22,9926054,1.8271931211135617,2.1751381549156146
SW1573,54618164,4.339091959582753,4.155877257467659
COR-L95,9907093,4.309721999642839,4.057886794007919
LCLC-97TM1,9911830,3.2250615193472085,2.336623688002952
K-562,151289,0.3703020531314545,0.7587090160703747
HCC1500,24821094,2.4557115965701257,2.5502084651077785
ALL-SIL,11222830,0.8263932665864424,1.1063676729898222
ALL-SIL,44490293,5.541636788423512,1.6841865937305545
BFTC-909,15547703,3.647732910564925,3.2457782333648337
PaTu 8988t,11175137,3.61207596874577,2.6797659181618423
COR-L95,44566777,1.612039010223373,0.6106520101623457
RKO,navitoclax-PLX-4032 (1-1 mol-mol),2.3429049321543083,1.6839019906372246
SW48,9444,3.3118033011757806,4.183856285661664
COR-L105,52947716,1.1539739817838972,0.07753206904659907
HARA [Human squamous cell lung carcinoma],11228183,1.9492387662676105,2.5590868124139976
SW1573,16013152,3.6979705228045354,4.069326872624831
SW1573,17759555,4.342323370433329,3.884629920770879
SW1271,11609586,3.768986685585146,2.779475845853404
K-562,3552672,6.190745251508109,2.0268241049958844
ML-1 [Human thyroid carcinoma],151289,2.136095657957592,1.1128867163545444
SW48,vorinostat-carboplatin (1-1 mol-mol),1.7573438485405597,3.312644918472397
COR-L95,selumetinib-BRD-A02303741 (4-1 mol-mol),6.0949369940274645,3.4132288345130153
IGROV-1,57519531,2.639098862164858,2.6229789227825044
IGROV-1,1716436,3.2816872421007375,3.077887055489849
ML-1 [Human thyroid carcinoma],11222830,1.0897337620982457,1.8200066435401347
SW1573,tanespimycin-bortezomib (250-1 mol-mol),0.6931535757645308,-0.5286909849388874
IGROV-1,2828334,6.070696247039626,6.122412260371473
SW1271,53495165,2.774319130141937,0.2620116055825696
SW948,67291369,3.8063591597957593,1.636959461386162
Daudi,11507802,0.3815953316544085,0.6946978070856155
RERF-LC-MS,2708,5.106155932743474,4.895828179326682
SW1573,52912189,3.9296893768173065,2.367701705528722
SU-DHL-1,25154868,3.5324679540942165,4.113267650648318
BICR 31,24772860,-2.497965982707089,-1.9461983239024352
K-562,11719255,4.077642177046201,2.3991196386678686
WM115,5470400,-1.5377493662522326,0.3456021593967635
KU-19-19,44589607,3.6813877406069246,3.0711583536544333
LS180,11626560,1.7567799331145733,1.7900831530563053
Daudi,11427553,0.4642664556868584,1.2873400817314817
HCC1500,44607531,1.3781074542184104,1.101315327239844
COR-L95,sirolimus-bortezomib (250-1 mol-mol),0.1452212598896528,0.33823368245665236
PaTu 8902,4259181,0.9791956381618654,0.10459841797302377
SaOS-2,216345,4.363902597199754,3.77661626415599
BFTC-909,100016,5.8134150302243865,6.0634508785179415
BICR 22,56963564,0.2615280103832354,0.6328226225800299
COR-L95,selumetinib-MK-2206 (8-1 mol-mol),3.988992383923742,2.3385134352565244
LS180,613753,3.1711720082363337,3.296034950959699
BICR 22,3825829,4.259881935728516,4.080280385596065
P31/FUJ,25262965,-1.897985536240049,-1.7839317896551874
RKO,15953870,3.3462063589818034,3.3184422295115117
ALL-SIL,26596,-3.0181503922951674,-2.4714108943023234
SW1271,4788,5.888244914590778,5.614108083539531
COR-L105,25150857,2.68968810352953,2.5384942576832206
RKO,24753719,3.882573791668401,3.3729701977039115
ML-1 [Human thyroid carcinoma],11719255,2.5461185366109453,3.7199245500777285
Granta-519,selumetinib-PLX-4032 (8-1 mol-mol),6.800610624755647,2.8513499782801865
P31/FUJ,selumetinib-PLX-4032 (8-1 mol-mol),0.7192847011043231,3.255614140022356
PaTu 8902,613753,4.768885644214674,3.067230179577823
PaTu 8902,44589607,3.762990171329796,2.895907352764533
MOLP-8,176870,4.692998654081846,2.5106282489097187
MOLP-8,216468,0.300035377459394,0.7019305669135028
NCI-H1568,1641662,3.419317894706959,3.5538364315043385
HCC1500,11626560,1.5792444837322512,1.9776027337599238
HCC1500,3689413,-1.6712109221216571,-0.1680008465016404
RKN,984333,1.094463938199557,0.7394139839882071
HARA [Human squamous cell lung carcinoma],9911463,4.1556235611039405,3.8860415516703197
COR-L105,4788,5.897633886873905,5.68828179050016
HuP-T3,carboplatin-etoposide (40-17 mol-mol),4.278227331004969,2.9006257342697745
PaTu 8988t,136227924,2.49705731140334,3.1800461514334426
LCLC-97TM1,3634881,2.947438100526324,3.111460008473539
RCC10RGB,53392493,3.4706572822964072,2.806106108633543
Panc 02.03,10385095,1.3097039910351371,1.3586970383888926
RERF-LC-MS,445455,4.41080153827665,4.844754445761407
PaTu 8988t,6918638,2.256433939948275,0.915166149227025
KU-19-19,24951314,1.2793314486163916,1.4437581465702234
MDST8,25183872,-0.5549651899708961,-0.5188955754355524
COR-L95,JQ-1-MK-0752 (1-1 mol-mol),5.448110634286577,1.5303129630222114
WM115,navitoclax-sorafenib (1-1 mol-mol),1.4633730841087864,1.8370461640757458
COR-L95,9908783,4.358103020890871,4.6808045659862065
COR-L105,3552672,2.0991572824292435,2.5520422435782977
SK-CO-1,5566,2.706069596509063,2.8822440708336425
RERF-LC-MS,969516,2.2498421794663095,2.9350565924991114
HCC15,JQ-1-UNC0638 (2-1 mol-mol),2.9546017932515256,1.6535978479958704
HARA [Human squamous cell lung carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.8572824243778725,2.1049426363533335
NCI-H2452,452548,0.0358025934468,0.4677900252840017
Daudi,409805,3.686040208403983,3.709112938793609
BFTC-909,5287620,-2.871557478653834,-1.928571486523839
UACC-812,25183872,-0.2383295665292847,-0.6749370484341466
SW48,36462,-1.5563073788110886,2.2064290586731343
SK-CO-1,327653,3.1822308576162692,3.1892834454518995
MOLP-8,11507802,0.9747707839930404,0.6721532382206215
SW48,55508,1.9258231187784565,3.0687077716607134
ML-1 [Human thyroid carcinoma],5329102,1.4103281602713895,2.2557702695359736
COR-L105,16065773,2.993283969068687,2.539915479608657
ML-1 [Human thyroid carcinoma],53495165,2.320007555236624,0.7419751689755415
LS180,451668,4.827094473942733,4.145854896599611
IGROV-1,36462,2.313632721410001,2.033645922443321
RCC10RGB,selumetinib-piperlongumine (8-1 mol-mol),4.460336891472633,3.3991924366224016
COR-L95,navitoclax-piperlongumine (1-1 mol-mol),-0.3992176902442844,0.3305584963097393
MDST8,11719255,3.580824685094748,3.1955418704736083
BICR 22,135984461,4.376718251500639,3.7637509586224924
BFTC-909,selumetinib-MK-2206 (8-1 mol-mol),3.672772019831091,2.360975234618879
Granta-519,2871966,-2.0442685638601947,-0.27625479862558355
Panc 02.03,136227924,3.0839082623333387,3.211113595721975
IA-LM,10074640,3.892343788144062,3.1138487891369873
HuP-T3,navitoclax-piperlongumine (1-1 mol-mol),2.1493116178026157,1.726608569007511
BICR 22,10231331,2.1949493731732095,2.122348029516262
PaTu 8902,carboplatin-UNC0638 (2-1 mol-mol),3.7190209158995273,3.4349722648372536
NCI-H2452,10127622,4.466077980380041,4.307400586016907
PaTu 8902,11178236,-2.9840755573739943,-3.1156194690855354
MDST8,6918837,-2.3764765121755,-2.36104895633338
HCC15,1716436,2.8917896521916537,3.1010527626820767
Daudi,5351362,0.314899635949887,0.9941665697672798
IGROV-1,1750826,-3.124548162001242,-1.226653287379397
SW1271,24779724,6.290779023739936,4.247656026116732
SW948,216468,0.513065020542466,1.8426840561952846
HCC15,5738263,4.375256926251463,3.4872048163544203
Granta-519,25183872,-2.24080905771406,-2.128066980088549
MOLM-13,selumetinib-navitoclax (8-1 mol-mol),-1.2398703731830696,0.25148494406393135
SaOS-2,46926350,-4.2820912559124995,-4.150578331916218
COR-L105,49766530,-0.5480688242609842,-0.18151129242923883
HEL,2874250,-2.245656223692803,3.8737298610560225
K-562,45279963,2.402740503794971,2.7842567902034276
SW1271,441298,2.7117876410913073,2.3715883927075385
Daudi,46215462,1.1016280052611975,1.4271213041082464
BFTC-909,9915743,2.0959000942543025,1.0729144921512697
Granta-519,55508,1.5366901224911111,2.951107822582269
ML-1 [Human thyroid carcinoma],11507802,1.1504003941708354,2.025551206648807
SU-DHL-1,445455,4.339452591135178,4.393755637701308
Granta-519,11222830,0.944926764715042,1.1979453859016602
SK-HEP-1,135421197,3.339831791709741,2.077710104175124
COR-L105,11719255,5.177770829400177,3.6191670926787736
SaOS-2,49793307,-3.0698778362667807,-2.4810746983640994
SU-DHL-1,54618771,0.3433661921186922,0.36040537764170766
SaOS-2,navitoclax-PLX-4032 (1-1 mol-mol),2.865443862493463,1.8177668677734098
IGROV-1,54618164,4.2184521751950115,4.158250972031609
ML-1 [Human thyroid carcinoma],44507138,2.4759759240399206,2.74176599173218
HCC15,4259181,-0.5021574884501439,0.16428836529314408
PaTu 8902,5311,1.4468060231693458,1.5027533993583393
SaOS-2,11609586,3.464015551213678,3.1341674619672455
BFTC-909,26596,-1.7437210940555867,-1.3077914979696794
RKO,3385,4.410917651107157,2.741968379155766
SW48,5282054,3.4229655251352984,3.553641897671637
HEL,3025986,1.4059985389197358,-1.4819869147780083
HCC15,2749,2.6993987110059456,2.071659443469899
RCC10RGB,serdemetan-SCH-529074 (1-1 mol-mol),2.3426493996230424,2.2593406093296666
MOLM-13,2733526,3.3430267495988693,3.340104096182501
HCC1500,71466380,5.203984730888507,4.572910133865218
SK-HEP-1,104842,-1.0887000355540395,-2.4203791367139056
SW948,5566,3.1149649258053107,2.9518837276745544
Daudi,11234052,2.508646185471885,2.845324545325858
WM115,tanespimycin-gemcitabine (1-1 mol-mol),-2.08510571323105,-0.6525385373096999
SW48,208908,0.7661322887377208,1.7478474020716468
SW48,24978538,0.0148337391131729,1.290694128035551
P31/FUJ,9926054,1.2698752833949425,1.7334428391079664
Daudi,5287620,-2.5355659158885167,-2.1121134597823485
BICR 31,53325874,4.467091056736401,4.548916090532236
LS411N,400769,-0.3072623933562745,-0.5988872762482562
HCC15,7326481,6.13295321500094,3.0597838718891155
LS180,6610216,4.524725364990245,4.2998578105047045
BICR 31,11609586,2.804864928293696,3.096631769310022
NCI-H1568,5351362,0.9370615420718584,1.7836670563527885
NCI-H1568,selumetinib-PLX-4032 (8-1 mol-mol),3.6289743773432463,3.830182418444607
HCC1500,26596,-0.8174609850015592,-1.0822891052598558
Daudi,JQ-1-UNC0638 (2-1 mol-mol),-1.821496210426365,0.4378289747640666
Granta-519,salermide-PLX-4032 (12-1 mol-mol),5.521121579042541,4.389715748048953
BICR 31,5311281,1.899563489561116,2.3277172214929727
HuP-T3,11964036,1.9148977928601396,1.399531299945595
HuP-T3,6918328,0.6989696425214073,0.2301027976723467
IA-LM,56963564,0.8197284064300991,-0.17294507553246288
K-562,25227462,-1.535473545694956,-1.0228142579069506
HARA [Human squamous cell lung carcinoma],68056272,4.667757023830857,3.6680405581476294
P31/FUJ,6438330,0.60015264799364,1.215102400551397
NCI-H1568,54143018,1.7330311939537375,0.6964673536549967
MOLM-13,10184653,-1.0304513474260102,0.9762932262806281
COR-L105,3081361,0.7591954413754667,2.3677491575416196
SW48,3465537,3.829258919586145,2.2589278904248844
SK-CO-1,135398516,1.0451560562277196,2.1769255705038737
RKO,selumetinib-vorinostat (8-1 mol-mol),2.2625933360113826,1.8832680184845352
BICR 31,11222830,2.7999268343872603,1.699855256503213
P31/FUJ,1750826,-3.787471607079622,-2.7300643611245476
MOLM-13,124202324,0.9453642044256088,1.038601572273082
LS180,445091,4.461419397707798,4.276824076004758
K-562,4578,4.401657334703153,4.010844305321511
BFTC-909,31703,-0.9928331583982526,-0.8662784962804
Daudi,54618164,3.154466747848232,3.715175765045107
HCC1500,375860,0.1348683063529126,0.14770357313283425
MOLM-13,3385,-0.0516453787728095,2.3868034786467254
Daudi,123631,1.6174763425926726,1.9851704362117588
SW1573,6610355,4.129027118562099,4.662368850982902
K-562,44589607,2.662527895237601,1.9927233218442897
SW948,24964624,1.7910099631647045,1.7528840767053577
LS180,387447,-4.2321913932512185,-4.346273046451852
SW1271,445091,4.3767610709371025,4.3959483860826545
LS411N,5328940,2.1913370268343324,1.0683311568905458
ALL-SIL,46199207,2.4207183231317826,2.552792984127627
BFTC-909,644241,3.062866082016443,2.2989656721100213
SK-CO-1,5738263,3.1381077819263954,3.4229286761190627
HCC1500,selumetinib-BRD-A02303741 (4-1 mol-mol),5.277663522211575,3.2913518519685145
PaTu 8902,3385,6.504553614083827,3.8593477182796163
SW1271,5328940,1.739297434861375,1.6046071301874383
Daudi,444795,4.05018196872557,3.033120762101015
SaOS-2,9887053,4.468769125876902,3.881198952931071
ML-1 [Human thyroid carcinoma],6610355,5.061552725322464,4.830353330663479
MOLP-8,9936388,3.4211096692910052,-4.955376102319863
SaOS-2,5746,3.648398890023908,1.1164864703829687
PaTu 8988t,135875424,4.8815767191826325,3.9455808718381387
SaOS-2,25195348,4.111342507306749,3.307006619388696
NCI-H1568,135398738,4.732110826035958,4.492637066676166
RKO,5329102,2.192208184281935,1.2887465608274915
ML-1 [Human thyroid carcinoma],122327,4.584045367066115,4.780033753925979
WM115,11612883,3.668907379861532,2.8857263246827984
HCC1500,24785538,2.8337652504333817,1.5973206266402569
ALL-SIL,3854666,-1.067048731148745,0.6622563594648564
WM115,11494412,2.975341542339242,1.9287194462063368
Granta-519,9884685,-0.5481626961732873,-0.3751605450705147
LS411N,selumetinib-vorinostat (8-1 mol-mol),0.590504538579532,1.6039984041082018
KU-19-19,5287620,-2.913600334543538,-1.7368257143269572
HCC1500,25227462,-1.134185511373382,0.741114393077754
SK-OV-3,9936388,2.038842599711319,-0.2518289218354553
HARA [Human squamous cell lung carcinoma],5113032,5.077717215414557,4.922382821656699
HARA [Human squamous cell lung carcinoma],46191454,0.0255281814012309,1.7410916628224242
COR-L95,9840324,5.902997789616562,5.719496625757735
SK-OV-3,159324,5.082712026660022,3.314319394639237
COR-L105,5426,4.419968019169297,3.4340406700193684
HARA [Human squamous cell lung carcinoma],carboplatin-UNC0638 (2-1 mol-mol),4.127490867447662,3.3633076307839787
HuP-T3,44491742,4.372770131484514,4.357815913584622
HEL,navitoclax-gemcitabine (1-1 mol-mol),-3.418603962504733,-2.001592155528945
MOLM-13,5978,-4.923441638627742,-3.296216147363859
KU-19-19,9911463,4.338553857034003,3.8633444459365687
LS411N,SNX-2112-bortezomib (250-1 mol-mol),-2.160208901072175,-1.2818323818023223
MDST8,9956119,3.20428794924567,3.753889210341369
IGROV-1,44137675,1.8406125640672395,3.695739047839833
NCI-H1568,24771867,2.7621066837370156,2.6700212805195687
SW1573,3503,1.662872296112478,2.394545258242217
ALL-SIL,54143018,-1.6646130342073118,-0.6540918744567548
KU-19-19,9903786,4.470072542277405,3.076460898953489
Granta-519,67291369,2.669151289874282,0.8795473518296356
HuP-T3,126941,-4.07371973001698,-2.285390755713274
IGROV-1,11175137,1.8411496230681277,2.5268369427054735
LCLC-97TM1,3543504,4.4040963352609825,4.128639949938746
PaTu 8988t,10184653,1.9115764380070437,1.5874573917817754
BICR 31,10184653,-1.3652350776002238,0.850387467049469
PaTu 8988t,4917,3.9515789700022728,3.0331895685699277
LS411N,9967941,4.95978669187673,3.308704541980134
SW948,6918837,-5.2716912634433815,-3.3790378459813257
Granta-519,19582717,3.2223711893143796,2.958095964602023
HuP-T3,753704,5.56041062328625,5.090916013249994
SW948,BRD-A02303741-navitoclax (2-1 mol-mol),3.1746461495638867,1.6181736297022105
HuP-T3,44819697,0.7007171788005963,-0.2742490014227114
Daudi,49766530,-5.535187194073846,-1.9685684777547987
RKO,168313047,1.9322709085928884,2.139889088543546
HEL,451668,-1.9900462993769088,-0.4490356921921071
BICR 22,selumetinib-tretinoin (2-1 mol-mol),2.504585066651982,2.6396843733541355
ALL-SIL,637858,0.2842777242368783,0.9849695174194776
SW48,375860,-0.9823609780883206,-0.08260501097342716
Granta-519,426756,3.1337304970475865,3.697769576956142
LS411N,3038522,4.360410119835835,3.217611870564445
BICR 22,SNX-2112-bortezomib (250-1 mol-mol),-1.3459249311621435,-1.1804707442846771
NCI-H2452,11626560,1.8431584922948163,2.0992486676229016
SW48,135398516,1.3232406127849534,2.4026662403304626
SW48,5329102,0.4162536894409948,1.9515316877333666
ML-1 [Human thyroid carcinoma],322968,3.685498672876688,3.9753964807116438
BICR 22,11427553,3.133254296040306,2.911628206772676
NCI-H2452,72376,-3.519434001557919,-1.35009891753523
ML-1 [Human thyroid carcinoma],11238147,1.6119243998814434,3.198902237459975
K-562,135984461,3.2548026411837787,2.942699286951612
SaOS-2,BRD-A02303741-navitoclax (2-1 mol-mol),3.697295369553163,2.1429549948864515
Daudi,73707398,-0.7942959168982594,0.4687123320156428
NCI-H2452,46398810,2.3683678826725387,2.6222729011015673
PaTu 8902,5738263,4.741832860910815,3.3947123547612783
MOLP-8,10322450,4.082153801594249,3.1830398335431935
HARA [Human squamous cell lung carcinoma],54618164,4.558968644978708,4.1585364374620815
SW48,5287620,-2.9796019172473747,-1.8937162251837478
COR-L95,navitoclax-birinapant (1-1 mol-mol),-1.5627413747354164,0.382491342934112
MOLP-8,56963564,0.2564931281605764,-0.16399493871319973
Granta-519,375860,-0.9367901929922506,-0.35374882751555303
SK-CO-1,656346,-0.6691405855346803,1.2028802316987837
RCC10RGB,44607531,1.912198544747903,1.4521164410975986
RKO,9823820,5.913042612438718,2.3714988013359353
SW1271,25262965,-0.6695626057691765,-0.9362777702079187
SaOS-2,2742550,4.001711578380083,4.099749385836799
SW948,44491742,3.910317363967626,4.176105495415484
K-562,25105715,3.3934107563871088,3.0416909441779554
K-562,3689413,1.0071697658281389,-1.1772195866073976
NCI-H1568,9911830,1.3917537385715242,2.591031148215224
IGROV-1,42642645,0.3750175292659389,0.9552733376567114
MOLP-8,53392493,1.8438027475223988,1.6440875851471162
BICR 22,4788,5.9489186959823845,5.707159222235099
IGROV-1,5287620,-1.5394168430569777,-1.9693459199999703
IGROV-1,446155,3.750396425244744,2.783767196769109
LS180,15983966,-3.417830365026362,-1.4569082688352217
MDST8,5566,3.234550965497495,2.8857824225884277
K-562,644241,-4.86229706466587,1.1783506865702729
SU-DHL-1,135421197,1.1384736779813156,1.9152304433822998
KU-19-19,44507138,1.5611189443326865,2.523129171112738
Panc 02.03,5281321,1.7682996743542674,-0.8271656306051011
SW948,44607531,1.464462944366021,1.5495749581086355
KU-19-19,54649381,3.8760376098429616,3.8646614795596204
Daudi,25062766,1.1734245449662122,1.7002768873768381
IGROV-1,56946209,-4.416985130578084,-4.008431886169497
ML-1 [Human thyroid carcinoma],49766530,-1.1158595986885904,-0.3299530454493973
NCI-H2452,11238147,5.37150149846425,3.10966391393924
HARA [Human squamous cell lung carcinoma],vorinostat-navitoclax (4-1 mol-mol),1.9090977342000552,1.0998086517809351
HEL,3689413,-2.191477482826257,-1.3515138411825598
WM115,285033,-0.1832916587196474,-1.888584639001012
SaOS-2,piperlongumine-MST-312 (1-1 mol-mol),1.0729634254150997,1.8552685803749582
SU-DHL-1,426756,3.3694285311129777,4.103340018778009
WM115,135999136,1.8466122948256136,4.081698113723588
IA-LM,45279963,4.638115534107364,3.1741446222631837
MDST8,JQ-1-UNC0638 (2-1 mol-mol),2.369730621007783,1.6565522003538538
SW948,4917,3.7157271581620166,2.8640731546222638
Granta-519,119182,-4.107570420442856,-2.55005818051502
MDST8,56946209,-2.145438357732055,-3.4899196553528253
HuP-T3,9927531,4.952379772704904,4.832070620266232
RCC10RGB,72967,3.7162805539485775,3.4264480656470964
P31/FUJ,vorinostat-carboplatin (1-1 mol-mol),1.4493920018144175,1.8712570323525841
COR-L105,25126798,3.974391104898093,3.9058264494446835
IGROV-1,676352,2.310492141650647,2.2718784709397224
MOLM-13,11640390,3.605079146985929,2.2666741204702965
SW1271,10302451,1.5832525718610488,3.1851229566096926
HEL,123631,2.2046071754004553,2.0634926482121236
Daudi,9887053,0.4273795924431001,2.3681494129888465
HCC15,53232,1.2438342439906054,2.724323494718919
KU-19-19,crizotinib-PLX-4032 (2-1 mol-mol),2.7637212964945745,1.9078787856984878
MOLP-8,107970,1.7976582890286323,2.127588484136274
COR-L105,12003241,-1.8759508779616432,-0.6675220581978175
SW948,11222830,1.2602033369542562,1.314378781789127
LS411N,60750,3.4958773713368725,-2.131876627391494
SK-HEP-1,selumetinib-decitabine (4-1 mol-mol),7.187577119098816,3.6573384970657474
COR-L95,11152667,-1.0192155235937173,-0.45324968618832684
RCC10RGB,136227924,3.611686331312014,3.2688128399836445
Granta-519,46398810,1.929291860170987,1.6389423133518548
SW1271,135999136,4.614562085611917,3.5079706091575322
IGROV-1,53232,2.4872106086763393,2.9035127762396105
SW1271,5329102,1.7502689549650896,1.9647064292799377
Granta-519,136227924,1.3333863896282263,2.40368291811078
HCC15,11213558,1.313690011959325,1.7292966631693885
BICR 22,54619267,3.924840101579574,4.138866693691226
MDST8,9907093,2.778674083883115,4.075136798720037
P31/FUJ,11175137,-0.7372235608093404,1.6129842154680043
MDST8,36314,1.6029219233562175,-0.7079520640186908
PaTu 8902,2746,3.932313359375791,3.383320103392588
P31/FUJ,3543504,4.167476980253382,3.7331746316534304
MOLM-13,selumetinib-decitabine (4-1 mol-mol),-2.0497039310535548,0.20079170676394575
HCC1500,2749,1.6972528944159595,2.0552925615079984
HCC1500,2858523,2.9580940168196372,2.956058367927495
P31/FUJ,241158,2.9181679480161997,2.6348454870753097
IGROV-1,44202524,1.8303703172382677,2.2771775207558638
COR-L95,24856436,0.3013384579313291,0.22998953263994598
Daudi,15983966,-4.480185591931726,-3.4585877018996545
MDST8,9903786,2.958137426904596,3.143769738467388
SU-DHL-1,57519531,0.9649766396601452,2.26909567270358
IGROV-1,25262965,-3.18785020602057,-1.3673594181451358
MOLM-13,135411,-0.7080955458923358,-0.4033343153974961
HCC15,24901704,2.315976175325417,3.492498120085411
SW1573,656346,0.5263129478884733,1.1194208006966873
SW1573,11238147,3.4967804964098517,2.9146071191802827
MOLM-13,6918837,-5.322581124261525,-4.522487297785813
MOLM-13,444795,-0.8871401586886155,2.6330681264113394
HARA [Human squamous cell lung carcinoma],2733526,3.2699742840947414,3.702103030338479
SW948,44486219,4.202726475674803,4.20162043319743
ML-1 [Human thyroid carcinoma],10302451,5.152653454280482,3.1184107614738963
SK-HEP-1,4259181,0.3926762831937545,0.3102332944179599
MOLM-13,11152667,-8.249378694414048,-1.8017872465526283
HCC15,46199207,3.454904957256138,3.360318764543049
COR-L95,BRD-K55473186,4.076833088818027,3.761338928524512
SK-HEP-1,11612883,3.763210558313423,2.7041078868468005
SW48,54619267,2.8192087316830587,3.7578740894060023
COR-L95,448949,2.666065821382702,1.7595945975640301
SW1271,31703,-2.541706035799043,-0.6390260038364052
SW48,374536,2.9137455711630365,2.1518086632177913
HuP-T3,25183872,-1.5149537087973208,-0.5085062582394291
BICR 31,71466578,6.11729815776394,4.66617926682012
PaTu 8902,JQ-1-UNC0638 (2-1 mol-mol),3.325968686418886,1.3496276063231436
SW48,135440466,-0.9616456131279733,2.139297531206723
Granta-519,322968,2.3569390760499234,2.1738399250889966
RCC10RGB,25227462,3.0929907596871646,0.7486073372622883
P31/FUJ,6917907,-6.201167718101803,-5.546347668052168
PaTu 8988t,49793307,-2.0749757720441164,-2.253349176051306
HARA [Human squamous cell lung carcinoma],9884685,2.402658407469787,0.6376863180310134
Granta-519,12001922,1.093482575381039,1.6481046939412736
SaOS-2,54649381,4.670802712896813,3.9868938060704675
BICR 31,11213558,1.307666782243681,1.9155506479085356
NCI-H1568,crizotinib-PLX-4032 (2-1 mol-mol),1.1920351291695386,2.2367117521180817
RKO,selumetinib-UNC0638 (4-1 mol-mol),2.378322605916553,2.7860879049561316
P31/FUJ,tanespimycin-bortezomib (250-1 mol-mol),0.0118872693017982,-0.9257902363297013
SW1573,216468,2.7570678542174294,3.581208940509548
WM115,selumetinib-UNC0638 (4-1 mol-mol),-1.6649688708670054,2.5932608740703107
LCLC-97TM1,441298,2.906797889353979,2.3282281037608588
LS180,24753719,4.21554861148433,4.220673263422359
ALL-SIL,65064,2.797289094590348,3.809716780768805
BICR 22,67291369,2.228219380635809,2.436957974225554
RERF-LC-MS,168313200,3.896073258981905,2.915359994926177
SK-HEP-1,9444,4.343802313850578,4.194451896860699
PaTu 8988t,5328940,1.37213408852796,1.7123239152043646
BICR 22,5311,1.9321946929787237,1.7495149567648816
BICR 31,219104,4.339385963743166,3.960909816932599
IA-LM,navitoclax-birinapant (1-1 mol-mol),0.9661669112911666,1.400257995342997
ALL-SIL,4477,0.1906678465210559,0.30486169845236594
K-562,25154868,2.7747166739598264,4.099629324393084
SK-HEP-1,16065773,3.000790971898234,2.640729794335905
PaTu 8902,11364421,1.1100050491651887,-1.2808419056721458
NCI-H1568,3081361,2.134244125445247,2.3379424838074727
HCC1500,11640390,3.4842141291887234,3.3677615716766627
BFTC-909,11626560,2.2197507332783735,2.0458888264050326
SW948,107970,1.650733689507072,2.1470693652019928
RKN,15983966,-2.847635435689191,-0.8579875670024433
P31/FUJ,11455910,0.7543092217738059,0.3294426613025198
MDST8,71466380,4.4925072325945825,4.434161061023854
HuP-T3,44185566,3.047929926499308,2.539002477873804
WM115,24772860,-3.130789858430774,-1.704303857839189
COR-L95,327653,2.664763845896721,3.206402153784872
BICR 31,46398810,2.284799792972812,2.7394098922391468
MDST8,46199207,3.2831338438462545,3.260086936786047
P31/FUJ,54143018,-1.089453758548118,-0.6176167890665325
RKN,119607,5.106543735080002,5.323909678302296
COR-L105,5746,2.3338049438674933,1.4620008947467331
ALL-SIL,alisertib-navitoclax (2-1 mol-mol),-3.0899588817168286,-2.1166788775367813
MOLM-13,5738263,2.9100103684660237,2.6388956653071176
RERF-LC-MS,216345,4.25766275770173,4.1903657451400855
P31/FUJ,10322450,3.023071845081992,3.0113592664834528
BICR 22,16065773,3.2562595111068933,2.38394777995393
HARA [Human squamous cell lung carcinoma],3136844,4.042885024123848,4.370482159741625
RCC10RGB,2858523,3.1824977664847833,3.066529848277867
HEL,3634881,2.3660153954756,2.4440558556115684
BICR 31,4705,2.7587837218207194,3.224980966107592
Daudi,16736978,-0.1290294552432643,0.8516166052157437
HCC1500,409805,3.5957056987066407,4.720328704238515
COR-L95,11497983,3.7904455836505977,2.1975938960228167
NCI-H1568,erlotinib-PLX-4032 (2-1 mol-mol),1.5802949352112503,3.1656629805646155
HuP-T3,123631,3.4682236131630213,2.5015618628688983
MOLM-13,6918736,-1.7098661921605196,-2.195000182698877
MOLM-13,46943432,-0.154947866345158,0.5586467389594432
HCC1500,219104,2.0821347677363473,3.75842055753225
WM115,salermide-PLX-4032 (12-1 mol-mol),1.9364726172790967,4.413359952497275
NCI-H1568,65064,3.2204713254113373,4.861525471876191
SW1271,16720766,0.8044088826386648,0.33885397557381247
Daudi,119607,3.8512151262400978,4.330974407687526
HCC1500,72193861,2.243893882523798,1.935225449363002
K-562,5328940,0.7651330448756731,1.1171829796333388
SaOS-2,644241,2.5011234622868415,2.394962740803949
HEL,60700,-1.2821695146150829,-1.9487818733165043
RERF-LC-MS,25227462,0.8140348385016122,0.9216732123690234
COR-L95,4521392,4.944619543772989,4.031542634066981
KU-19-19,16720766,1.6427063989874335,0.9642277204395032
SK-OV-3,3025944,4.375754256809385,4.444083162039841
P31/FUJ,36314,-5.221113398603202,-1.9543699656116635
Panc 02.03,568763,0.7660787595735656,0.6328359699147056
PaTu 8988t,60700,1.4149082605005396,-0.510928471120851
BFTC-909,421610,2.763760389372973,3.491327038549843
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,3.2838150134827115
RERF-LC-MS,123631,2.7610356359897104,2.5323245579683626
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,3.679315303017417
RKN,10385095,1.0188882527918253,1.2945865574812152
K-562,carboplatin-etoposide (40-17 mol-mol),2.706166377048538,1.4799409769284475
SW1271,selumetinib-vorinostat (8-1 mol-mol),1.620526536353516,2.0976308938973656
Daudi,44486219,3.679556481815833,3.836057910638674
SK-CO-1,JQ-1-carboplatin (1-1 mol-mol),4.771818519750647,2.1510429207178996
P31/FUJ,159324,1.227532336429348,1.0715595826395188
SK-CO-1,6252,-1.3434891204218062,1.2111171022383511
LCLC-97TM1,656346,0.6605690440583806,0.7510472468700781
Panc 02.03,SNX-2112-bortezomib (250-1 mol-mol),-0.27502478347835,-1.3928654130686757
RERF-LC-MS,675434,4.646232548137413,4.643761025047557
KU-19-19,123631,3.236221278135049,2.400369357924864
MOLM-13,15983966,-4.417403089755366,-4.005916033881745
HuP-T3,4917,3.663340719397695,3.15138732542169
LS180,44185566,1.7571027497277631,2.316252419395602
P31/FUJ,11228183,-0.9086595542209992,0.35308662163485793
WM115,9933475,1.7795579913266513,1.9280374002497012
RCC10RGB,445643,3.986839371383198,4.168151458334422
LS180,11238147,1.5426585727528574,2.9940427490663586
SK-OV-3,6918328,0.3966751205296329,0.13580359181980214
SU-DHL-1,71466578,4.395132834723917,3.089669467284157
ALL-SIL,135421197,0.8278001934093618,1.3289363019071203
BICR 31,2858523,3.440938149330432,3.0429371809380688
NCI-H1568,72734382,4.159676082420196,4.710629094902693
BICR 31,10427712,4.26091650049326,4.352007745232682
K-562,5351362,1.2059406782397044,1.046657660178681
HEL,44589607,2.8579344181758164,1.928834453191317
RERF-LC-MS,89928392,3.2509495975064193,1.7844322584190786
K-562,4705,3.481256778033869,3.1684023576779636
SW948,400769,-0.4902020150535968,-0.6288664589366301
RKO,46199207,3.448070090368443,2.8365461392808644
HuP-T3,10410894,4.484643398072658,3.1873022921481886
BICR 31,969516,3.644181632779252,2.877095455296756
WM115,54618771,0.9043395114740442,1.3399230777912123
MDST8,2749,2.5181508528519365,2.087460968975928
SW1271,4378219,1.9495591217614856,2.256645870425021
RERF-LC-MS,12003241,-0.3897829713203344,-1.2535316854722407
ML-1 [Human thyroid carcinoma],11683005,4.957719989216769,3.0886761612486424
PaTu 8902,44620216,3.796821774118314,3.8249335981008388
MOLP-8,4378219,3.751203523477959,1.9444688823617065
PaTu 8988t,11152667,-0.7220641758089987,0.07057108913740642
SK-OV-3,navitoclax-gemcitabine (1-1 mol-mol),0.2321972175274424,-1.0399809965401943
SK-OV-3,60700,0.4435128165358443,-0.06568988029424758
LS180,168313047,2.515878081381246,2.4251389222598827
K-562,400769,-0.7978860959413716,-1.046341697033732
Panc 02.03,126941,-0.7071805078882285,-2.2516699950501375
NCI-H1568,3634881,3.2529386900783024,3.383823430014569
LCLC-97TM1,24821094,3.5658031163211996,3.03619900944893
LS411N,11485656,1.6093796612349578,2.010445679732816
HCC15,16736978,2.153897232237977,1.6927123486450262
LCLC-97TM1,6610355,3.6494140877324273,4.3723629708634695
IA-LM,serdemetan-SCH-529074 (1-1 mol-mol),2.9054360397422387,1.770599208364353
IGROV-1,9911830,1.9130562323799436,2.5339590877972444
LS411N,159324,3.2133975478450005,1.5372982387442247
COR-L105,selumetinib-PLX-4032 (8-1 mol-mol),2.5098576733785705,3.774227729808905
SaOS-2,322968,3.970591848140582,3.603730812396295
BICR 31,216345,4.54975912567895,4.09751748277142
HEL,3825829,3.033394475732853,3.2054066088509137
COR-L105,46191454,3.4168297701439223,1.9675112825046726
K-562,5113032,4.649240406472478,4.481161365965971
BICR 22,156414,1.4774483319728589,0.6289299166137415
SW1573,135875424,1.8143158468632437,3.7641517167177643
WM115,12003241,-3.303596686294694,-1.2704357660584673
RKN,11640390,3.613472996393559,3.6907514278631237
HEL,23725625,2.914554844202699,3.715160849988091
COR-L95,36462,-0.8944975018350346,0.9784022926558111
HARA [Human squamous cell lung carcinoma],53232,3.05929528970331,2.739536984067755
HuP-T3,11977753,3.281021154274905,-1.137797184969602
SK-HEP-1,400769,0.2777482831309371,-0.5392542319702327
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,3.2752963218881535
SU-DHL-1,246676,5.693727803678488,4.054738789304071
HARA [Human squamous cell lung carcinoma],11626560,1.1307601374566012,2.2647526824833406
PaTu 8902,selumetinib-JQ-1 (4-1 mol-mol),5.2969208566894075,1.4321340422773474
RCC10RGB,44507138,4.147954700367582,2.785266065175621
LS411N,123631,3.048490743589503,1.9213516884140234
MOLM-13,11213558,-2.3442824820578347,0.729382372629903
MOLP-8,selumetinib-tretinoin (2-1 mol-mol),3.5259628447658495,2.354699829964344
SW48,tanespimycin-bortezomib (250-1 mol-mol),-3.595985811968766,-0.5408852077345236
PaTu 8988t,444795,4.288290341819835,4.690953723299827
SK-CO-1,66577038,1.9378658470267984,3.062603560215865
SW48,24771867,-3.897611921368264,2.5048065532011794
NCI-H2452,9907093,3.826391051371518,4.326612773812815
SW1271,171352865,2.2565348875691624,2.7516574355003973
SU-DHL-1,11152667,-1.9410189761528236,-0.6345481386895679
SK-HEP-1,148124,3.734435411699081,-1.4107659342749284
RERF-LC-MS,107985,-3.0933260647006215,-3.1359326550318305
HARA [Human squamous cell lung carcinoma],44589607,3.368220225067554,3.1696238816491666
ML-1 [Human thyroid carcinoma],36314,-4.393977809452653,-0.8236396851855367
RCC10RGB,10184653,2.2305820416370965,1.3375284731056556
LS411N,17755052,2.4732315703899226,1.1323619222574057
Granta-519,decitabine-navitoclax (2-1 mol-mol),-1.3661382782873654,-1.9311392455510805
KU-19-19,24753719,4.40371401160258,4.303642925733981
PaTu 8902,72376,-1.694582331183855,-1.5676075509378051
HEL,72376,-3.0304513894944933,-3.4330347951566136
ML-1 [Human thyroid carcinoma],25150857,2.4072078224567486,2.4799961207496173
SW948,9884685,3.1398548031465525,0.004947460067606422
Daudi,24748573,1.578133478161721,1.3954460649398093
COR-L95,4917,3.3160135329409406,2.7588193359162205
SK-CO-1,2708,2.7526164010571152,5.104082286935067
Daudi,5479543,1.606221989903471,2.6840572870991424
PaTu 8902,vorinostat-navitoclax (4-1 mol-mol),1.8599454099065449,1.2845465725846248
MOLP-8,44632017,0.8356757219547752,0.7677237962772132
SW1271,9868037,2.9396003878324857,3.1641890698817825
COR-L95,11455910,1.0154509596480157,0.9405762057031777
IGROV-1,445091,5.8777802446160825,4.314762796524292
IA-LM,107970,1.9308025720075177,2.152670889880131
BICR 31,15953870,5.115358479555731,3.647135380625069
HEL,135984461,1.7610482730169696,2.83376755780578
HCC15,vorinostat-carboplatin (1-1 mol-mol),2.4228610420151853,3.2960287709502394
PaTu 8988t,5311,3.6038975682992422,1.5734658285476721
MOLP-8,navitoclax-pluripotin (1-1 mol-mol),-0.3360266341011599,-1.5773611482743823
RCC10RGB,BRD-A02303741-navitoclax (2-1 mol-mol),1.3031528560505037,2.2159632475155053
SK-CO-1,11228183,0.9546983133897222,2.565266448173367
IGROV-1,JQ-1-MK-0752 (1-1 mol-mol),1.6911705649982345,2.0401979141395157
NCI-H1568,selumetinib-vorinostat (8-1 mol-mol),2.593817270705759,2.677883118724582
ML-1 [Human thyroid carcinoma],441298,2.939924630100921,2.5921490753407936
BICR 22,42642645,1.569820729256039,1.2914081498887138
RERF-LC-MS,387447,-4.351660250848144,-3.6691212978842747
SU-DHL-1,carboplatin-etoposide (40-17 mol-mol),-0.8202872264800385,1.3493211759362183
RKO,676352,2.3070338313311547,1.879325353409994
HEL,66577038,3.4935326109734217,2.6190291138751185
RERF-LC-MS,25062766,1.7296886540377192,2.0876333024054867
RKN,52947716,-5.912196482956353,0.12492952159785764
SW48,56973724,0.919295357428288,3.0617501181899485
LS180,66577038,2.8527700320727725,2.9699419893995973
K-562,7251185,2.894408284149289,1.6698834309126418
ALL-SIL,sirolimus-bortezomib (250-1 mol-mol),0.3093926374933456,-1.8327561344522554
ML-1 [Human thyroid carcinoma],3025986,-0.9166044093803444,-0.2232151048875384
MOLM-13,6918878,-0.6248914400619264,0.12046802088135239
IGROV-1,135421197,1.96820638017286,2.0761162754660805
RKN,11404337,0.6786980557761386,-0.23626262638713336
SU-DHL-1,6918878,1.5556600104975795,1.7612608959750227
MOLM-13,176870,1.4073018577806429,2.357068915745119
SaOS-2,44566777,0.9896093397626105,0.7364115339123614
COR-L105,5470400,0.2171168006478052,0.07153304140103108
LS180,44632017,0.4358481157568056,1.2029173882440154
RCC10RGB,16065773,4.176477311044804,2.6977301749630818
BICR 31,156414,0.5699919561712937,1.004256273562646
SW1271,tanespimycin-gemcitabine (1-1 mol-mol),1.3087817847802907,-0.3447248847581712
HCC15,JQ-1-navitoclax (2-1 mol-mol),-0.7343032708143507,1.1835910674302226
Daudi,54596490,4.948926549609605,4.122427998540133
NCI-H2452,11317348,1.7824301660124695,3.511765556628341
IGROV-1,60700,0.4424479122017752,-0.233078070269375
IA-LM,135421197,2.370501142960713,1.5559107922568234
NCI-H2452,135423438,1.816833708086427,2.558039054996883
NCI-H2452,6918837,-2.3246752526945413,-2.3386090795579073
HuP-T3,409805,5.703463345532586,5.082161157041077
Daudi,UNC0638-navitoclax (1-1 mol-mol),1.2047563677281543,0.4551499705176414
WM115,3025944,4.015069634557516,3.945138967146886
BICR 22,10127622,2.812639951672956,3.526780256402751
RCC10RGB,16741245,4.755009504271123,3.8127992336667496
MOLM-13,selumetinib-JQ-1 (4-1 mol-mol),-6.008931443997215,-0.8545602687716007
BFTC-909,1641662,3.805506520632872,3.5030618420460784
SK-HEP-1,3136844,5.506062707172487,4.390346608061598
MOLM-13,5335621,3.915836728943439,4.097853578033745
ALL-SIL,6918736,-2.784980550106597,-2.447343599128561
NCI-H2452,selumetinib-navitoclax (8-1 mol-mol),2.20402438215903,2.1269018300018296
SK-OV-3,5311,1.582209129738937,1.6598612629317333
NCI-H1568,4378219,1.8995328874154,2.7308575431272613
PaTu 8988t,135440466,2.5529183901912456,2.3686130919843884
P31/FUJ,208908,3.0114989034455415,1.9689064165337768
MOLM-13,55508,1.530825081139479,2.5027210011891756
ALL-SIL,15983966,-4.919474478826657,-3.4846145248366382
ALL-SIL,72193861,-0.8088702984298154,0.07153070629160387
Granta-519,135875424,2.983761714085865,3.0325576739863935
Panc 02.03,25062766,3.7424097220448207,2.1160999994191068
LS411N,5282054,4.11513360382112,2.8717027297990696
WM115,9956119,3.8110537513046423,3.601151495839143
Daudi,10077130,1.7104594990439606,2.652018638319723
PaTu 8902,54618771,-1.3103145579416535,1.345494838303576
LS411N,6610355,5.174673905344729,4.305965879436637
HARA [Human squamous cell lung carcinoma],446155,2.5576922800664006,2.6659501204135516
Daudi,11364421,-5.814557541528941,-4.769966046457652
SW48,10090485,5.377611493091081,3.669659636146392
RERF-LC-MS,252682,6.464777279315186,6.4355161920851875
RERF-LC-MS,25195348,2.310586589861769,3.055948285423347
LS411N,57330099,4.386912904802011,3.7287926893318235
RERF-LC-MS,5351362,3.2669953777859493,1.7067960826486714
SaOS-2,5281321,-2.1045144226453134,-1.1190216139800497
SW948,navitoclax-gemcitabine (1-1 mol-mol),0.2837649103664914,-0.795453845181151
HCC1500,15953870,3.698430879415157,3.279655048951178
BICR 31,107985,-2.559614665868775,-3.2615392644256813
SU-DHL-1,5978,-4.006589870739168,-2.691707318885877
SK-HEP-1,387447,-3.995016034956776,-3.890050461136836
HARA [Human squamous cell lung carcinoma],11609586,3.326388879496588,3.0329195142850858
BICR 22,44491742,3.912327775797625,4.42260687371668
NCI-H2452,10113978,2.1292579793865167,3.5917801865447574
SW1271,selumetinib-MK-2206 (8-1 mol-mol),0.1264422257766406,2.0429992903988743
HCC1500,JQ-1-vorinostat (2-1 mol-mol),1.1801971963023554,1.0341134321071452
MDST8,JQ-1-vorinostat (2-1 mol-mol),0.5745237647612197,1.1490011731460508
PaTu 8988t,10074640,3.912219918984309,3.251809253808342
RKO,25102847,3.0524897378806033,1.7761134079580896
K-562,446155,2.553560117982406,2.540036857065882
HuP-T3,3062316,-3.5835263694309862,1.1689312267394076
BICR 31,selumetinib-piperlongumine (8-1 mol-mol),5.193629730371027,3.343704778015704
HCC15,selumetinib-MK-2206 (8-1 mol-mol),0.2516850341197869,1.9807669693108938
COR-L105,9915743,-1.8659407955600968,1.0854537576156713
SU-DHL-1,676352,1.6127382742380425,1.8699429806081898
SK-CO-1,15983966,-2.8914318783251733,0.02818424772820566
BFTC-909,6450551,3.0302116860685886,2.739843750082733
HEL,salermide-PLX-4032 (12-1 mol-mol),3.70170985200322,4.474925911903245
LCLC-97TM1,6852167,1.822160840349085,2.6783866714774645
K-562,1716436,3.607306146681396,2.6802708732649734
ALL-SIL,6917907,-6.413711962559719,-5.473704398518254
SW48,44505237,4.455085659285412,2.7433982265366184
MOLP-8,4788,5.509648062033256,5.027868475994969
KU-19-19,49793307,-2.3409308252506777,-2.1601506267863484
IGROV-1,46843906,3.392503571349757,2.978205429298456
LS411N,selumetinib-navitoclax (8-1 mol-mol),0.3933540744124401,1.657084671978542
NCI-H1568,23582824,0.2708211860244319,0.8966565516591217
P31/FUJ,156414,0.8249508749632878,0.6305841490176655
HCC1500,vorinostat-carboplatin (1-1 mol-mol),3.9041081325977616,2.992038416230305
Panc 02.03,24951314,2.3006835537528585,1.6082996433309864
RERF-LC-MS,46199207,3.61094494328213,3.297405858156661
MOLM-13,docetaxel-tanespimycin (2-1 mol-mol),-6.839014739935568,-5.121432580262409
IGROV-1,25102847,1.7007012555618253,2.365418984926029
COR-L95,9884685,1.274087436172542,0.3281107830203595
RKO,5738263,3.4166283525852523,2.6377346812883036
BICR 31,446155,3.004688823756655,2.576100316061473
MOLP-8,3081361,3.002632255231731,1.9979780336236344
KU-19-19,124202324,2.2262797687523266,2.6488177757224762
COR-L95,241158,4.468160037389037,3.4640056451525276
PaTu 8902,selumetinib-UNC0638 (4-1 mol-mol),4.723826632745484,2.7997944103731323
SK-OV-3,9926054,2.1800400954819716,1.8875968522281616
NCI-H2452,285033,-1.1649166052412432,-1.7632191274115743
MDST8,SNX-2112-bortezomib (250-1 mol-mol),-1.5360671270430672,-1.0122956723465524
SaOS-2,3136844,3.967600163436525,4.4236519272622195
Granta-519,36462,-1.2340392932323463,-0.25763802594926494
Granta-519,24785538,0.1958729752370936,0.3376332746650984
WM115,5566,2.8846390038255127,2.867962923145855
IGROV-1,31703,-1.792518264692263,-1.0523269625166072
HCC1500,3025986,-0.5847488606379614,-0.9289617943878025
K-562,2828334,5.968313970587813,5.674611694681067
HCC15,navitoclax-gemcitabine (1-1 mol-mol),-0.4507382221714274,-1.5554702983264277
LS411N,72193861,2.8187845663214848,0.2932848931071602
SU-DHL-6,11964036,-0.1529025297927845,0.29662899323401043
LS180,6918837,-2.789669873343886,-3.1959586610831723
Granta-519,445455,5.050402748491994,3.868214145149358
LS411N,9926054,1.9376785020428349,1.8063922524199354
MOLM-13,135398738,2.371405234005272,1.9443819157729658
BICR 22,53392493,3.288173891171126,2.612218167811712
SU-DHL-1,crizotinib-PLX-4032 (2-1 mol-mol),-1.5954357785960134,1.5617633793762051
HARA [Human squamous cell lung carcinoma],2126,5.112984415511083,4.62979992383807
MOLP-8,9823820,3.862667538801475,2.528600700432848
SW948,219104,3.4463785749905886,2.7716356030265077
Daudi,56649450,2.7731175257265757,2.261649138361277
RKO,446155,4.170579555483674,2.832511445242692
COR-L95,2708,4.088828930735336,4.504052808756537
HARA [Human squamous cell lung carcinoma],11427553,0.5044011516017802,2.9579088987586517
SW948,6610216,4.184431800680971,4.05175284804616
SU-DHL-1,vorinostat-navitoclax (4-1 mol-mol),1.2163104495485748,0.9740116832379198
MDST8,24978538,-1.5034064763640302,1.1953539751334805
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.7048812993923622
Granta-519,vorinostat-navitoclax (4-1 mol-mol),-1.0034104350750142,-0.4658307860362014
RERF-LC-MS,44607531,1.5104561529736475,1.605922031897765
MDST8,16065773,2.461320056751215,2.463406464935858
Daudi,11955716,-2.451420398730992,-2.1403397623580007
Daudi,44566777,-1.3909109996970672,-0.2877220982648642
WM115,53495165,2.3633352174150155,0.6777677909413685
MOLM-13,10077130,2.656845569256352,2.551066063927593
LCLC-97TM1,11364421,-5.841421445385269,-2.2689282718919066
MOLM-13,9887053,0.5396890830211841,2.429221316523909
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,2.064810704161391
IGROV-1,46191454,1.3777495915525844,1.7199957899440679
Granta-519,5328940,0.7430401080732436,0.9341067908834846
SW1271,54618305,4.440463475812739,4.558884452249715
COR-L95,23725625,3.551891881441416,4.338354065131302
RCC10RGB,46843906,4.246883034106686,3.394827927994582
Granta-519,2945648,2.528276278220214,2.2054967469328814
Granta-519,11977753,-6.302388202708452,-2.4616187168899857
SU-DHL-6,15953870,2.4587311871536315,3.1078662354996704
MOLM-13,10322450,2.9930800125873045,3.0318860074110865
LCLC-97TM1,6505803,0.2281876141434561,-1.1499242620013301
WM115,9967941,2.88500943866673,3.918613243003865
K-562,44202524,1.302888790519651,1.8739949785793493
K-562,252682,6.220409267483573,6.503069219548466
HCC15,49867926,4.259454552862098,4.2637064281292
BICR 22,25183872,-0.1596442578279089,-0.5721056982324693
RKO,17755052,3.988455753476612,1.267202642713653
IA-LM,selumetinib-piperlongumine (8-1 mol-mol),4.519292467442182,2.2949676082030632
PaTu 8988t,5566,2.9380975134161553,2.9264763042260933
K-562,219104,3.3686951285077273,2.451423314868356
UACC-812,BRD-A02303741-carboplatin (1-1 mol-mol),6.034191295751065,4.003636143496147
WM115,100016,7.477930972064711,6.241532405655068
BICR 22,serdemetan-SCH-529074 (1-1 mol-mol),1.6325628481893268,1.9695148534537896
SU-DHL-6,46191454,-0.3846699961999978,0.1530912985157336
LS180,124202324,2.088899784140079,2.401034715229106
KU-19-19,navitoclax-MST-312 (1-1 mol-mol),0.8014531944430209,0.7979042707066794
K-562,4261,1.1039684536741017,1.1023940338637777
NCI-H2452,5282054,2.993265650723398,3.99533457410638
MOLP-8,168312962,1.5743557083321402,0.684940584656887
Granta-519,969516,1.9567849087702365,2.252072525972721
NCI-H1568,25062766,1.9660972036535989,2.4641971608693614
MOLM-13,448949,-0.3738099635599754,1.2281878271043591
SW48,11647372,-0.0986138935854908,1.0536116418621313
MOLP-8,selumetinib-piperlongumine (8-1 mol-mol),0.460809914604767,2.0815444116888147
SW1573,selumetinib-vorinostat (8-1 mol-mol),4.856763743237327,2.4060089859718916
RERF-LC-MS,11977753,-0.575574044510787,-1.4119883890675158
LS180,49793307,-3.6014942577594415,-3.1225571682921474
SW948,3854666,3.050289300885683,1.583744627734392
HARA [Human squamous cell lung carcinoma],4917,3.022180747101803,3.127228657161479
SW1271,navitoclax-PLX-4032 (1-1 mol-mol),5.386120495356167,1.8621452877429985
WM115,5278396,3.4301399168519153,3.751727728865445
HCC1500,JQ-1-carboplatin (1-1 mol-mol),3.891416287519206,2.4626927949267925
HCC1500,11485656,2.6610961572019103,2.3352188596869783
RKO,sirolimus-bortezomib (250-1 mol-mol),1.0887451358800992,-0.2241068651767376
Daudi,2945648,2.1407869976239087,2.2487268278750823
MOLM-13,3689413,-2.8005667715254017,-1.6248904185081303
RKN,3543504,4.234888347098623,4.574773467874164
IGROV-1,24964624,0.5052308994941754,2.4224170459650525
PaTu 8988t,676352,1.787056590779638,2.1328150796016545
RERF-LC-MS,10385095,0.7812016081678173,1.335760557871811
WM115,4259181,1.0090630393378868,0.45564006385370476
MOLP-8,navitoclax-gemcitabine (1-1 mol-mol),-4.985488409488958,-1.8026045782240436
SaOS-2,1239801,5.3522865443092575,4.126032554040504
Granta-519,44137675,2.975150065736677,2.762390891221679
Daudi,11455910,-1.173613913103254,0.5943194840973246
UACC-812,11152667,2.562952126743398,0.27768396797694384
SaOS-2,16219061,3.147835700454569,3.0757469203664836
P31/FUJ,erlotinib-PLX-4032 (2-1 mol-mol),2.316286260335057,2.7688165046756814
SaOS-2,71304818,3.198114510015862,2.4662393919537795
IGROV-1,57330099,4.391385744785918,4.1882070822513615
LCLC-97TM1,2729026,2.4668071198749555,2.576333579382754
HCC1500,5281672,4.190998095776345,4.5245342293755035
NCI-H1568,9884685,-0.6579514975056241,0.5549922499334047
ML-1 [Human thyroid carcinoma],53392493,2.260380394132801,2.6961381234910804
LS411N,107985,-2.091782559178726,-3.2674701623200497
COR-L95,42642645,0.7279572059378924,0.688376708323811
LS180,5566,2.7460265721966897,2.877379155792894
COR-L95,104842,-6.859012992539376,-3.035396005237115
K-562,702558,5.364922414830515,4.089698930359504
NCI-H2452,vorinostat-navitoclax (4-1 mol-mol),0.733087868835974,1.4195219125662004
LCLC-97TM1,9929138,5.774162864206733,5.392179337817119
LS411N,31703,0.7183186901084707,-0.9928922568975679
WM115,23725625,4.964211357698685,4.9792555033547305
HEL,piperlongumine-MST-312 (1-1 mol-mol),1.46077164854103,1.1439132354866985
SaOS-2,24978538,2.44958290959275,1.0431307265955865
HCC15,UNC0638-navitoclax (1-1 mol-mol),-0.269925552433359,1.5777072088968387
PaTu 8902,2858523,3.3217981805434196,3.082368420599552
HARA [Human squamous cell lung carcinoma],135398516,1.8495805389969304,2.450176147719157
SW48,65628,3.988389614478155,4.227972693239549
Granta-519,9903786,1.2937892753152922,1.8397485997958887
IGROV-1,71304818,2.4878074097553378,2.4835682188186397
COR-L95,25105715,3.673741872436949,3.2371434821667258
HuP-T3,6918837,-1.8626358392084263,-2.4327135012133536
PaTu 8988t,72376,-1.956580109455481,-1.3960603363135027
NCI-H2452,46907787,3.091101876271566,2.273428013939622
SW948,23725625,5.544404993552476,3.898834076703847
K-562,25062766,2.5223735702376753,1.7220563407816072
SaOS-2,753704,5.53840358060444,4.93885970647397
NCI-H2452,56973724,2.8465784993073564,3.305049131963324
Granta-519,71466578,4.383489061930637,2.3333258096937595
SW948,11609586,2.9863433458317714,2.204080864310858
HEL,71466445,1.5745300131733593,2.44465864759634
Daudi,5329102,1.2784768117884069,1.369284742912148
HCC15,409805,6.461768980239098,5.085913652704645
Daudi,2871966,-2.2343916463272873,-0.4040592329793956
HCC15,selumetinib-piperlongumine (8-1 mol-mol),4.822467978355287,3.4655285884818725
RERF-LC-MS,135421197,1.554065103888189,2.033851209855983
SW1271,selumetinib-tretinoin (2-1 mol-mol),2.7817516989696855,2.7866982002229315
RKN,serdemetan-SCH-529074 (1-1 mol-mol),2.47980812948558,2.0968670508311535
PaTu 8988t,25150857,2.5954794764360343,2.567781088528897
P31/FUJ,11152667,-2.5755274762926095,-1.764116260658672
BFTC-909,ISOX-bortezomib (250-1 mol-mol),1.0929987126714282,0.6818608809034531
BICR 31,2828334,6.263113325647995,6.227647932065274
MDST8,selumetinib-GDC-0941 (4-1 mol-mol),0.8218915121525238,1.5227264396525895
IGROV-1,11507802,1.5049911819213722,1.6132953549846087
Daudi,11485656,1.7254760898020216,1.6747398919606593
Granta-519,11152667,-3.975154363660797,-2.0115069278195254
SW48,11640390,-0.422464249163724,3.433717989403897
IA-LM,2828334,6.3387056990337705,5.788682469874832
HEL,36462,0.8349109175120154,0.5074261594388138
LS411N,4477,1.0450277541726452,0.5851777373559877
NCI-H2452,16219061,3.733701707144141,3.420851252928309
RKO,16741245,1.399079485469943,3.615966295979917
NCI-H1568,445455,4.330931204553833,4.705568907847605
K-562,15983966,-4.450185495623787,-4.256417681119847
HCC1500,4096211,2.7054358198440345,2.362779290097968
SU-DHL-1,46191454,-0.3713761809994262,0.7393241078355137
IGROV-1,387447,-3.9508602289798658,-4.352667549424805
NCI-H1568,71751553,3.6437596116554887,4.6109284834891024
HARA [Human squamous cell lung carcinoma],selumetinib-vorinostat (8-1 mol-mol),4.369788913914824,2.5100777454136383
WM115,46199207,3.650123600055899,3.162236183293643
SaOS-2,71680916,4.865393442781168,4.829656141957219
COR-L95,9823820,4.611798945344124,3.606377462776126
HuP-T3,44589607,2.433680498088492,2.9518892574364624
SK-HEP-1,vorinostat-navitoclax (4-1 mol-mol),1.9601053638256545,1.1508915998426883
IGROV-1,3634881,2.769147818550815,3.3661517976347306
COR-L105,54626689,5.0742986339862926,4.683756631884869
HEL,176870,2.3693727744318887,2.6135948775946876
LCLC-97TM1,9549297,2.332709006301325,2.8696281882386154
COR-L105,24180125,3.5925931777332676,3.0641796785641136
MOLP-8,89928392,0.1045876418070581,0.43467763616078187
BICR 22,3025986,-2.8899356497226756,-0.7596660288130724
ALL-SIL,400769,-0.758162988868875,-1.4769488248201412
BFTC-909,71466380,5.267829049221599,4.487149557920947
MOLM-13,24951314,-0.2336633009541456,-0.09648591943224134
MOLP-8,3038522,2.029025514425164,2.617371420852956
RKN,16741245,1.555254881894904,3.5067957236726977
COR-L105,71751553,4.255827287979035,4.525137554125642
MOLP-8,60750,-8.573260651984995,-2.951015397135466
HCC15,navitoclax-birinapant (1-1 mol-mol),-0.4439511388855052,1.59182230168884
BICR 22,24772860,-1.3590035600374548,-1.5541681414769741
LCLC-97TM1,5470400,0.2889153362640624,-0.49216408649638305
BICR 31,53232,3.653430995715962,2.7419043874615374
BICR 31,8515,4.104799625743522,4.03761159927433
COR-L105,10127622,2.236200578684094,3.907270079939278
NCI-H1568,5328940,0.3466597705312412,1.667935319789165
MOLP-8,135421197,1.7506124789909805,1.4618610453655023
SW1573,54454,1.176648172779268,2.594928859442896
NCI-H2452,11964036,2.1879069513719087,1.7049545245281132
MOLM-13,44493528,3.9608078939228175,4.051678407051996
SK-HEP-1,11396600,5.84824704867975,3.7271945184350694
WM115,46215462,1.6800224060395437,2.1638527577832236
Granta-519,23939,5.101725753715152,3.3056284931998947
BICR 22,46907787,3.4905986586009843,2.1898681081516607
HEL,10184653,1.0835446596032057,0.8262027215671912
LS411N,9903786,3.6806866285220017,2.536679338853457
SW48,9840324,6.311735261945371,5.759015748378111
HCC15,24753719,5.171121417544096,4.30268793776274
SW948,11507802,1.163064588903486,1.2948156273976599
COR-L105,2733487,7.427108299628283,6.220658289558905
SaOS-2,439501,-2.8243657156627724,-2.124528100947975
UACC-812,5287969,-2.4803922230812527,-1.6950157228110188
Granta-519,66577038,2.6663435544296346,2.679431529916717
RERF-LC-MS,6918837,-3.051376318733669,-2.9219141327483844
NCI-H1568,11152667,-1.392140833696634,-0.24794173687141036
KU-19-19,49850262,4.263742487880845,3.826519446897226
BICR 31,selumetinib-navitoclax (8-1 mol-mol),2.9853512378124023,2.4613194020180007
SaOS-2,156414,1.509432711545826,1.4340139371442064
KU-19-19,navitoclax-gemcitabine (1-1 mol-mol),-0.4466146105667509,-1.322486327453527
Granta-519,216468,0.2159572219264565,0.9881662978837307
P31/FUJ,3136844,4.357504973194935,3.604197183843003
MOLP-8,6918638,-1.572747132532541,-0.6105111381939206
LS411N,445643,4.311506480272609,3.933491255746233
MOLM-13,25126798,1.909946064109967,3.233157513275007
BICR 22,9927531,5.395078942533075,4.817034020266481
SU-DHL-6,3385,2.96945431954736,2.569779526106282
SW948,49766530,-0.6875988061214425,-1.5231463816909059
MOLP-8,5287620,-5.023262566828496,-2.367772003943777
SW48,selumetinib-JQ-1 (4-1 mol-mol),-4.010422232345994,1.3430149113110423
SW1271,5746,1.8306286254207629,1.2402326509275452
SU-DHL-1,4788,5.095368657375766,5.123500177584182
UACC-812,44607531,-0.3950460021726514,1.3856299901461064
SK-CO-1,10074640,3.0297361304753143,3.0573986238685404
IGROV-1,65064,4.920352624378345,4.924549691286046
P31/FUJ,9444,3.558733501871851,3.426190777034171
MOLP-8,16722836,0.6223558214261112,0.9232587929371446
LCLC-97TM1,11647372,-0.3650454903758569,0.7889390933404584
COR-L95,9911463,4.18924595414168,3.5580012655012077
MOLM-13,3634881,2.324290549736021,2.4423227704305788
IGROV-1,1242560,3.902441161940491,3.4067179832826615
LS411N,702558,5.325144902608101,4.209790763598283
MOLM-13,969516,1.839627080728713,2.1710597663894937
IGROV-1,50905018,6.092412272559071,4.238941343506149
SaOS-2,5311,1.6246857228566176,1.3566944231766862
ML-1 [Human thyroid carcinoma],5287620,-1.9113881956575816,-1.9860249339888663
BICR 31,11178236,-3.7191700347439176,-2.916945078247525
IGROV-1,16736978,0.1982875499977011,1.798022380124802
HEL,54613361,-1.063581606127445,-1.0199275434312332
LS411N,409805,5.900990799691521,4.029111003666596
RKN,44819697,0.8547407464301948,-0.13164107426712127
SaOS-2,7326481,3.920515261577408,2.828282963395207
HCC15,135411,0.5020362424433897,0.6416532154601261
SW1271,135875424,3.8663800475620542,3.720483771929258
SW948,5281321,-2.986965028390854,-1.6576558359189286
ML-1 [Human thyroid carcinoma],52947716,-0.2471601623530622,0.296536485828601
ALL-SIL,16722836,0.4684239096852854,0.7695510708772766
BICR 22,3384730,2.588423009806214,2.9310886007146975
SU-DHL-1,5282054,2.781862093779865,3.5014482042565045
COR-L105,10385095,2.1444085139831643,1.5582873741719216
Panc 02.03,409805,5.9877775932277615,4.971143089445684
RERF-LC-MS,11707110,3.327368501952155,0.29009184872394983
Daudi,46199207,1.9328464692742409,2.632210949522935
SK-HEP-1,9907093,4.5474965014619455,4.267341500360022
NCI-H2452,6918736,-2.096990091914002,-1.4200580338505384
SW948,25062766,2.473025838261029,1.947024769512222
SW1573,73707398,2.4757839790774123,1.4500312389002832
WM115,19582717,5.070140237856123,4.228986732122928
LCLC-97TM1,9926054,1.7367616025320842,2.006236176728163
Granta-519,46907787,0.1510211143130647,-0.41213533410082137
HCC1500,JQ-1-MK-0752 (1-1 mol-mol),3.680434993229653,1.5174664357953835
Daudi,9866186,0.2429325896096028,-0.0646829893426471
HCC15,19582717,3.4575202036464665,4.261491980093299
BICR 22,3136844,4.306912771504561,4.197863286409387
PaTu 8988t,15983966,3.5024124287376477,-1.4934298359926939
WM115,24964624,1.5810045411950775,2.4258139969903083
Daudi,5335621,3.7832010435602568,3.958940177021386
KU-19-19,selumetinib-PLX-4032 (8-1 mol-mol),2.356754737959246,3.6102845676990847
HCC1500,67156097,1.177976655162538,-0.13854770898392238
LS180,6918878,3.4964027843545775,2.938894788919927
MOLP-8,4096211,1.580191863417666,1.1234606187844016
P31/FUJ,6252,0.489412050489878,-1.2527702678110253
RERF-LC-MS,6505803,-0.6931241555509828,-0.10609165581818727
IGROV-1,24821094,1.720998716331183,2.941359199998162
BICR 31,5311,2.2783252682939876,1.7864682228877362
K-562,6438330,2.2742899368871123,1.4958586907266074
HCC15,71466578,3.4480874510133708,4.553502510842759
RKO,5566,3.2270609816668308,2.9219531861332033
MOLM-13,BRD-A02303741-navitoclax (2-1 mol-mol),-0.0183785057987459,0.5959651799499239
Panc 02.03,24785538,2.724480470289088,1.7820734853069766
Granta-519,3025986,-4.58955813375105,-1.5491204718211489
BICR 22,6918837,-3.531862368916405,-2.3121669491336907
MDST8,25262965,-2.668035259531665,-0.8421904696259175
IA-LM,5329102,2.7310604185474654,1.6208641287778902
SK-HEP-1,3385,5.476337571299632,4.279944180212036
LS180,16722836,2.063998190370722,1.6129787722686562
HuP-T3,tanespimycin-gemcitabine (1-1 mol-mol),2.6296169541858694,-0.5484098846529097
LS180,2749,2.025296960861402,2.1108205491490617
WM115,25262965,-0.2525217612691299,-0.8136299312798961
PaTu 8988t,5287620,-2.232870102756846,-1.771963164454279
BICR 22,1641662,3.554805763515046,3.5140804242811243
HEL,11152667,-1.5416892011653274,-1.6339936003978255
COR-L105,doxorubicin-navitoclax (2-1 mol-mol),-0.4088475134066937,-0.518699180437906
ML-1 [Human thyroid carcinoma],219104,3.7281299088831386,4.00134490692431
Granta-519,9907093,4.568904425758597,3.0527795256695107
HuP-T3,56946209,-4.563482636842077,-3.958560570464591
COR-L95,2126,5.99033959567007,4.251406782172534
WM115,216239,1.6966934324307903,2.685206498450075
HARA [Human squamous cell lung carcinoma],136227924,3.047223136335837,3.1865094577567175
BICR 31,6918837,-2.993188010662521,-2.5895441229444667
WM115,3676137,5.1484929308777225,4.516356143452984
COR-L105,5113032,4.587192003158758,4.870931518919655
NCI-H2452,23635314,-2.1133256000938596,-1.505479745597065
RKN,9887053,4.324470541002337,4.172241850668704
RCC10RGB,11427553,3.4421917630858387,3.040687641475088
SK-HEP-1,3025944,4.243935374614092,4.3180398392904
HEL,613753,3.431831043675297,2.851294063624235
LS180,navitoclax-birinapant (1-1 mol-mol),0.3756173230443141,1.7773118905835241
ML-1 [Human thyroid carcinoma],135411,-0.343606028350642,1.0520972163677758
WM115,6450551,3.3231751041078086,3.1352462135236316
LS180,11178236,-2.7486494175863703,-2.9603385936699738
SU-DHL-1,53232,0.8595699071174782,2.441357992269998
LCLC-97TM1,2742550,3.525188493197443,3.5650718652750015
Daudi,1716436,1.8661291896859675,2.4402790527313267
SK-OV-3,11964036,1.753508425012185,1.3924407896894653
LS411N,10385095,1.4098978051841675,1.1267203053953845
P31/FUJ,54613361,-1.6350280742113157,-0.9986027956202321
SU-DHL-1,638278,2.888532213305057,3.022514945170619
SW48,11228183,0.7765992306729816,2.4012190088017604
Daudi,54596558,3.73872893191344,4.044479768374478
IGROV-1,44543605,3.88270235241076,4.033192162507925
SK-OV-3,16722836,0.9083609759186712,1.6374999580497342
HARA [Human squamous cell lung carcinoma],tretinoin-navitoclax (4-1 mol-mol),0.6020182307201102,3.185493856561322
P31/FUJ,168313047,1.7496121138347704,1.9675628966926277
RCC10RGB,969516,5.025939213907113,3.1116880532474713
COR-L95,tanespimycin-gemcitabine (1-1 mol-mol),-2.183473735098961,-1.5349088324973241
Daudi,selumetinib-MK-2206 (8-1 mol-mol),2.382051987434729,1.6729808710607654
HCC1500,crizotinib-PLX-4032 (2-1 mol-mol),2.666541156679824,1.9066795053537706
LS180,11507802,1.428529607587261,1.4244090183833304
SW1271,2746,3.8382249001906814,3.194642443557089
RERF-LC-MS,navitoclax-pluripotin (1-1 mol-mol),0.4193939180883417,-0.6512161395110969
SW48,6918328,-0.3603149144304291,0.26595801213020576
RKN,11214940,-1.342915177510304,1.7800004703561023
NCI-H1568,24180719,2.911739165396745,3.6420012482467246
BICR 22,selumetinib-JQ-1 (4-1 mol-mol),1.538481754600391,1.0378821750505025
K-562,11234052,2.2960989815513013,3.156866936749557
SU-DHL-1,107970,1.234326472603969,2.197136095158319
RERF-LC-MS,5280436,-0.2566098032119844,3.5651415285443697
HARA [Human squamous cell lung carcinoma],10074640,3.2082861236873814,3.107144458417249
RERF-LC-MS,selumetinib-GDC-0941 (4-1 mol-mol),0.28876788592482,1.619827796438996
WM115,6184667,1.9705044508079528,3.122424488146207
P31/FUJ,26596,-2.2448149587984836,-2.524404871696743
RCC10RGB,216345,4.504390062805713,3.79938828610713
WM115,3634881,2.5774509186458183,3.220110098866891
COR-L105,5328940,1.3778120925573558,1.7866807282885135
NCI-H2452,135440466,3.051805385291023,2.381529695239589
P31/FUJ,51039095,1.7212337572708742,2.1711686727998325
Daudi,135398738,3.444692827115736,2.275761911966332
MDST8,753704,4.923832713886697,5.160463537562881
Granta-519,23725625,1.8582588361990624,3.1968980968452088
IGROV-1,6438330,2.7487580937365683,2.4229052215791764
BFTC-909,51037431,4.63288955594681,3.2421767856111274
LS411N,262093,3.2594677855419456,2.261907139920973
Daudi,12001922,0.8334324910861088,1.5286942402110126
LS411N,10074640,3.3220574057236876,3.0321834797936593
COR-L105,6438330,3.2365890454650867,2.3998644358773458
LS180,3689413,1.3392854552239355,0.41924634102081265
IGROV-1,53495165,1.3981720287668329,0.4043244085774363
RKO,10296883,4.075814636405189,3.0238321721899757
MOLP-8,24951314,0.5243645664323562,0.22425604767763727
IGROV-1,25126798,3.9275606774720817,3.8439692539812644
BFTC-909,5281321,-1.6266730162675118,-1.2001234708837374
MOLP-8,123631,3.0356710048833446,2.085425040984769
LCLC-97TM1,selumetinib-MK-2206 (8-1 mol-mol),2.0492378318223508,2.1909719696545498
PaTu 8988t,72193861,1.5880501840541692,1.689035483938239
COR-L105,JQ-1-MK-0752 (1-1 mol-mol),0.9583306241234884,1.8611683385063384
MOLP-8,2742550,3.824247044326815,3.390153226089078
BICR 31,10074640,3.67367044204876,3.2555243514306174
UACC-812,1750826,-1.5614417963348088,-1.125054455163673
LS180,9907093,4.718701288752834,4.136483791941216
BICR 22,25062766,1.615874512669176,1.8340996093333126
NCI-H2452,6852167,1.5258165813873172,3.195610469242271
ML-1 [Human thyroid carcinoma],5328940,1.048806619411155,1.8105667258050233
PaTu 8988t,52912189,2.515835026596807,2.6523385071395063
KU-19-19,9935249,4.318045076797651,3.311553935460538
KU-19-19,57330099,3.159149106170822,4.243662406372911
SK-OV-3,17755052,2.097752569372091,1.8176458913071967
SK-OV-3,73707386,3.7899266428434233,2.8733453330161125
HEL,navitoclax-PLX-4032 (1-1 mol-mol),-1.2293549578890797,0.18882291554487513
SK-HEP-1,216239,1.5998975447874937,2.4289416310280285
ML-1 [Human thyroid carcinoma],387447,-2.817858817217488,-3.734858825707816
RKO,3689413,3.093382349703003,-1.252027837037204
HARA [Human squamous cell lung carcinoma],11647372,1.8404588933860024,0.7991301823649337
K-562,44819697,-0.9868024060185686,-1.408788557907677
LS411N,322968,4.732979049951269,2.7154371818184
RCC10RGB,3689413,-2.0864832427963336,-0.08510479630469081
MOLM-13,BRD-A02303741-carboplatin (1-1 mol-mol),3.787495781999856,3.703356843287449
COR-L105,409805,5.8843358134901775,5.2115112414330955
ALL-SIL,11404337,-1.8413362349398936,-1.2015537622235803
Granta-519,135398738,2.4818536310203587,1.9954283389517757
IGROV-1,10385095,1.0670946713416192,1.239351522181285
KU-19-19,5311,0.9327005340349652,1.5471443788705241
MOLP-8,6438330,1.5207659246126146,1.4881765450643762
SW948,5351362,1.282672018702937,1.246685204686889
HuP-T3,54626689,4.821166418142214,4.609168146585948
HuP-T3,16013152,4.473149012747972,4.228433203808132
Panc 02.03,sirolimus-bortezomib (250-1 mol-mol),1.3966258084955054,0.9530449687501447
RKN,67156097,-0.5718675734992968,-0.783613816620816
IA-LM,241158,3.7495123409873528,3.0044391242190107
LCLC-97TM1,644241,3.02487415997038,2.106215292394036
NCI-H2452,9823820,3.552631474664052,4.0759740686126005
BFTC-909,2749,2.0212973698927184,1.9435783945341394
Daudi,9956119,3.1347708383856827,2.415117296863018
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.2519824935727627
ALL-SIL,136227924,2.439460537978413,2.3652453736269163
HEL,44507138,3.4784823626806296,1.709212772522647
Panc 02.03,3634881,5.203302993958793,3.3923887904895986
HCC15,3038522,3.407637609998807,3.0996241106980342
RERF-LC-MS,JQ-1-vorinostat (2-1 mol-mol),1.4753675236489834,1.2949621506460576
SU-DHL-1,5311,0.6388765020007606,1.2420113051244517
RKN,16038120,2.2721636156695357,1.2144368864032093
Daudi,6917907,-7.619939635694887,-5.561845606969906
MOLP-8,3385,2.1758430637220334,2.8085990302640944
COR-L95,2749,1.0184502693195283,1.4103417473076618
BICR 22,56946209,-6.158851096198738,-3.8383047518389817
SU-DHL-6,72193861,0.720057034069739,0.27984387550343953
RCC10RGB,122327,5.581829763733156,4.665496209681217
Daudi,5284329,2.65655795986699,2.4871715746434835
WM115,72376,-0.2019485443349478,-1.5614885507251244
HCC1500,4378219,1.8377088226049565,2.6616269019997914
SK-CO-1,246676,3.87632071272349,4.100925905843974
SK-HEP-1,docetaxel-tanespimycin (2-1 mol-mol),1.7150600920964667,-3.0870914828702674
IGROV-1,57519531,2.639098862164858,2.6229789227825044
P31/FUJ,serdemetan-SCH-529074 (1-1 mol-mol),2.3029277371957884,1.2972799703732114
MOLM-13,1714884,4.557672503718371,2.3672523324236385
MOLM-13,JQ-1-vorinostat (2-1 mol-mol),-0.8524574918693427,-0.9180998427344327
Granta-519,72193861,-0.9369484536210768,0.3439181829099079
RKO,5311,2.326095881991792,0.8951850287845998
SK-HEP-1,4521392,4.36382839215776,4.311603665520616
COR-L105,3062316,-0.8702764318143076,0.9126413028977405
COR-L95,387447,-4.370301659619954,-4.7003139542158445
COR-L105,10231331,1.4114577114599935,1.9888557982846087
SK-CO-1,637858,1.8597515079418403,2.147786371111997
SW1573,5282054,2.2636648441362417,3.7308937213309172
K-562,66577038,2.461713560075674,2.5191645480953015
Panc 02.03,984333,0.8671961837803726,0.9231448674370734
HCC1500,9967941,2.192170342398577,3.3908834929743468
NCI-H1568,5281672,4.0091617833462125,4.5749980607961565
K-562,11640390,3.4084234644631244,2.8110501200923244
SW1271,60750,-2.442139934484719,-2.2581229327611942
HARA [Human squamous cell lung carcinoma],5280436,4.238746998760762,3.449790569822741
MOLM-13,24889392,-6.717782140097413,3.557085491270504
Granta-519,11364421,-8.40665244505035,-4.267648059740199
LCLC-97TM1,11612883,2.215690343731866,2.553886183453759
ALL-SIL,serdemetan-SCH-529074 (1-1 mol-mol),2.0214253699045392,1.5017461718213239
PaTu 8902,1566236,3.6887913704860535,2.194639720784666
MOLM-13,16741245,4.189200129622084,3.5164669760273153
SW48,6184667,4.015043076320991,3.062194483658772
RERF-LC-MS,66577038,3.051572744120707,3.049532816864147
K-562,71304818,1.450074212827562,2.0810521668693123
RCC10RGB,44489675,4.041451654117508,4.02273875776368
LS411N,navitoclax-birinapant (1-1 mol-mol),3.012697957688565,1.5676192084921536
SW1271,10074640,2.938380325815859,3.167226631156444
RERF-LC-MS,11626560,1.1998891680987491,2.0054928598530055
PaTu 8988t,81146,4.470184859000855,4.615001533784505
HCC15,11178236,-3.9629964965138584,-3.3456124338787885
SW48,navitoclax-pluripotin (1-1 mol-mol),-1.096538281516441,-0.7792997151007508
HCC15,11317348,1.1767586352696475,3.307798309305193
P31/FUJ,9903786,1.0734919883099745,2.009287308072219
IGROV-1,23582824,0.3287266354391525,0.7458374205743113
Granta-519,3465537,1.1430845598370274,1.8528376918181195
PaTu 8988t,984333,0.9294993195358888,0.8038639829620076
HCC1500,11396600,2.707080690171913,3.7250660586588396
NCI-H1568,6252,-1.964470857288188,1.3396971823098864
NCI-H1568,7251185,1.379011815458227,2.6451796694064926
BFTC-909,UNC0638-navitoclax (1-1 mol-mol),2.418146384904106,1.8485301334410307
LCLC-97TM1,55508,4.820744956173848,3.314444109629247
PaTu 8902,9903786,4.041497343746548,2.739237608399408
SW1271,12001922,2.1604198968714754,1.9400214116080081
HEL,6505803,1.212867497705534,-0.9882554281645757
SK-HEP-1,216345,4.108495190728752,4.001118457857205
WM115,4705,2.3860154683324897,3.3356263335049845
NCI-H1568,JQ-1-vorinostat (2-1 mol-mol),1.325801474857881,1.0799534821768833
COR-L105,126941,-1.5036718028706904,-2.1298802530143943
PaTu 8988t,9926054,1.9241127892750265,1.9265052990373461
SW48,tretinoin-carboplatin (2-1 mol-mol),4.556026920056554,5.150589741967703
NCI-H2452,navitoclax-MST-312 (1-1 mol-mol),2.3760907472780137,0.8692494908477367
SK-HEP-1,374536,4.396616434658188,2.519220070748936
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.4796146082385224
NCI-H2452,208908,2.397298909776284,1.919886782817529
SW948,24821094,3.757524617053942,2.5384221232688136
K-562,44491742,3.373435641850853,3.9936886154065068
RKO,24180719,5.308193040989237,3.4167915077631714
MOLM-13,56946209,-5.150374128805616,-4.963423268906906
MDST8,54454,0.3151053774213321,2.5765549271458705
Daudi,969516,2.18084937908482,2.190244952849148
COR-L105,44607531,0.2442604090297878,1.6173579796260094
SaOS-2,54619267,4.116373312960232,4.058851407786909
MOLP-8,44607531,1.2227606502433142,1.2501778308341713
ALL-SIL,11427553,-0.6859128537837271,0.9051459977686
NCI-H1568,11427553,2.9296384487881166,3.000097612600421
SK-HEP-1,6918638,1.490993863020431,0.701577682986878
K-562,11175137,2.6421325977097663,1.933264840041491
MOLP-8,25126798,3.554030345273679,3.3929991538114486
MOLP-8,10427712,3.937375048887725,3.77242606271721
BFTC-909,11404337,0.4468911705694049,-0.27376930164033425
Daudi,19582717,2.1579117268337975,2.882206981088611
SW1573,9936388,3.0507391751654698,-0.2661090782890476
SW1271,156414,2.097129180606755,1.6955129637366946
Daudi,11213558,0.7122197709980888,1.4224133030845827
MOLM-13,135875424,3.721528356214304,2.9563647716537447
LS411N,3062316,3.313525141236135,0.9573759991527092
Panc 02.03,6438330,3.381062774421129,2.3401567350766155
MOLP-8,4705,2.7848528520877727,2.9032055114409725
SW48,675434,5.164587034175743,4.34774832469312
NCI-H1568,46215462,1.5662565779678703,2.1339397783375973
BICR 22,23635314,-3.9149935419765423,-0.8173210874137631
NCI-H1568,44607530,0.8979533446197012,1.7478596053917206
BFTC-909,89928392,2.1120581393996116,1.6703849409961895
NCI-H2452,8515,2.9816658051225344,4.047293385695299
WM115,252682,5.883677253194902,6.516457779107144
SaOS-2,11507802,0.9759404440699744,1.551100822317753
NCI-H1568,9935249,0.3822057580098375,3.266025112246733
SU-DHL-1,selumetinib-vorinostat (8-1 mol-mol),1.570079304001321,1.601414259916187
SW1271,65628,4.408026608161547,4.231276697973348
MOLM-13,2742550,3.0943449980031845,3.216365666192604
HuP-T3,56973724,4.820716068374067,3.4112557400560077
P31/FUJ,5328940,0.1000739186855886,1.0886814626657013
SW1573,sirolimus-bortezomib (250-1 mol-mol),1.011264687291747,0.48472044225294036
KU-19-19,9967941,2.4242338826427794,3.782197998296204
COR-L95,selumetinib-decitabine (4-1 mol-mol),6.271791154986272,2.4425996095799185
SK-CO-1,5328940,2.280320557186381,1.7687353394885057
HARA [Human squamous cell lung carcinoma],6184667,2.5882672266365128,3.016452888362198
COR-L95,1716436,2.176954941746147,2.5342468869753456
MDST8,46398810,3.011862004714757,2.374853708904563
SK-OV-3,654092,-0.1739817534251795,-0.0755909168097927
SW948,54613361,-2.2535675944820084,-0.24332057381544736
HuP-T3,25154868,5.141210696949765,4.521656606991602
SK-CO-1,selumetinib-PLX-4032 (8-1 mol-mol),0.4034815942312452,3.007861240624374
RKO,124202324,3.4391315101947386,1.0381204867630949
RCC10RGB,9444,4.509247284467684,4.369218244561271
P31/FUJ,135421197,1.0144502005310674,1.1373798239594626
MOLP-8,44487872,4.385798937588512,4.2653834982424765
PaTu 8902,448949,2.6032868845304606,2.0045018310127736
MOLM-13,11427553,-2.505370137631637,0.7428811863675996
IA-LM,60750,4.549488262081028,-2.1796815067058692
MDST8,3825829,4.752817875520721,4.069403018528916
SW1573,JQ-1-navitoclax (2-1 mol-mol),0.4708104580132937,0.8798178133692705
BICR 22,navitoclax-MST-312 (1-1 mol-mol),0.8152867092510746,1.0736988160245067
COR-L105,51037431,3.876010066295024,3.2819444312452277
RKO,31703,-1.8438289452025527,-1.3394159827569427
HEL,5978,-0.5240559956879017,-3.1683865549139756
SW948,168312962,3.6749765666335903,1.2719076129607714
IGROV-1,72734382,4.633226130326536,4.619740043142407
SW48,216468,-0.1130169029097753,2.8713749400989523
HuP-T3,216345,4.480282764347718,4.126771899727668
HCC15,439501,0.3030845703669018,-1.7578116947888212
P31/FUJ,638278,2.9129004591727057,2.867436090398738
BFTC-909,676352,2.5282943369079818,2.1433104009530513
SK-HEP-1,60750,5.759979022694095,-2.094771368635395
PaTu 8988t,4788,6.262210396704686,5.648458501213364
Panc 02.03,JQ-1-navitoclax (2-1 mol-mol),1.014156743517759,1.240734012256941
NCI-H2452,doxorubicin-navitoclax (2-1 mol-mol),-1.0690798948484177,-0.6365328645503773
HEL,24951314,0.022330385445513,0.25115001695856376
MOLM-13,46907787,-1.536709398859376,-0.8317835949830912
SaOS-2,54626689,4.533352391847383,4.451168042310994
RERF-LC-MS,10410894,3.034247655874134,3.2752045980952262
RERF-LC-MS,9903786,2.6182355767545213,2.842729739123411
IGROV-1,107985,-2.8971910842184516,-3.4393126126977682
WM115,10231331,-3.458943295987183,1.7976033093805068
Daudi,71466578,1.924283792281082,2.503587482668831
KU-19-19,6610216,4.876021689690227,4.36843187719241
COR-L95,6918736,-0.04136223528326,-1.901128231221291
MOLM-13,11625818,3.232701320691832,3.2725820825868066
Granta-519,16038120,-0.1772437220791911,-0.13848679138887252
BICR 31,46907787,2.190433361645711,2.2858828455304825
Daudi,702558,3.2750017094913657,3.836703486519961
MOLP-8,24856436,-0.8263886484359759,-0.4416568479310337
MOLP-8,135440466,1.6989907480456066,1.5179889755000389
SK-HEP-1,46843906,3.844316747572769,3.201140654588775
RKO,54626689,4.750442055573677,4.310711494977578
HARA [Human squamous cell lung carcinoma],navitoclax-gemcitabine (1-1 mol-mol),-0.596107332987684,-0.7114999260935
IGROV-1,11717001,4.394306548697183,4.1731764480174744
Granta-519,5291,3.886616753428741,2.7153511995736452
HuP-T3,vorinostat-carboplatin (1-1 mol-mol),4.326832101925159,3.2010617090238522
SW1271,262093,2.7991981503454495,2.8258382968921523
Granta-519,1566236,1.1036082649410253,1.3354650640337815
BICR 22,24753719,4.1427183131543615,4.195552108827309
Panc 02.03,9926054,1.881153725115377,1.9536165917556776
HEL,selumetinib-UNC0638 (4-1 mol-mol),4.439373718009897,2.0827542782254405
HARA [Human squamous cell lung carcinoma],6918289,2.581505632245523,2.842917057024402
LS180,54619267,4.074522434074431,3.913484024313527
SK-OV-3,5281321,-0.7098099698865428,-1.1511431978945903
BICR 22,selumetinib-MK-2206 (8-1 mol-mol),1.8488971729777937,1.8203371662623178
SK-CO-1,2729026,2.8886798476744246,2.7010156648120467
Granta-519,23582824,0.9303240666722092,0.7160810013006476
HuP-T3,JQ-1-navitoclax (2-1 mol-mol),2.3872748820971217,0.8546197731948629
WM115,24978538,1.155471911978994,1.4708292408893524
BFTC-909,navitoclax-gemcitabine (1-1 mol-mol),0.1512584221412147,-1.2993310513049179
NCI-H1568,11238147,2.925799577076833,2.9624167483031774
ALL-SIL,135398516,1.5622324093538014,1.1506524090261145
COR-L95,135659046,3.614564650544248,3.6348433520720413
SW1271,1285940,4.280510054640018,3.6832643718541256
SW1271,6505803,0.8186340021888412,-0.24575729044469452
SK-OV-3,SNX-2112-bortezomib (250-1 mol-mol),0.4595025269763413,-1.1470075244989304
RCC10RGB,UNC0638-navitoclax (1-1 mol-mol),1.9805139183388023,1.5925902307931752
IGROV-1,11626560,1.7276653519578558,2.107565080695102
ML-1 [Human thyroid carcinoma],24748573,2.352453339172467,2.058027978393852
P31/FUJ,3552672,1.950832295752278,1.9665584972807029
P31/FUJ,67291369,0.7371006748241407,0.9794599313959148
LCLC-97TM1,107970,2.3018486004849907,2.2519201419110995
SK-OV-3,44607531,1.947967745365508,1.569072445586919
BFTC-909,9936388,1.702123766125507,-0.9974927430973817
ALL-SIL,8515,1.9161675301812888,3.2888131678329837
LCLC-97TM1,25262965,-1.937189863749451,-1.2958713428014317
HuP-T3,ISOX-bortezomib (250-1 mol-mol),0.144245152578182,0.762014020586475
MDST8,6914657,-1.2463021469195388,-3.3016423865984996
RKO,SNX-2112-bortezomib (250-1 mol-mol),-2.626179791835481,-1.6620526971275928
HCC1500,53392493,1.8683885031226253,2.6163865551252274
MDST8,135411,0.5541309628089411,0.8355380575845776
RERF-LC-MS,1750826,-0.5689233588179538,-1.0998259474587015
LCLC-97TM1,5328940,1.525932870405189,1.716160875327901
NCI-H2452,25195348,3.541594611208225,3.5031073550489724
ML-1 [Human thyroid carcinoma],71304818,3.0426605111728517,2.529856736123482
RKO,crizotinib-PLX-4032 (2-1 mol-mol),0.8147825419497507,1.0829100988315226
SaOS-2,53495165,-0.9847313398251484,0.31161841963519854
SW948,11626560,1.2721393744446543,1.4550403341596931
LCLC-97TM1,tanespimycin-gemcitabine (1-1 mol-mol),-1.2417811136372243,-0.9666929937117618
HEL,25183872,-2.1054192111007657,-1.8129018960828385
RCC10RGB,89928392,1.8749323034057075,1.9959265741870698
Panc 02.03,10074640,3.562403354758929,3.210814612764054
PaTu 8988t,57519531,4.351537289113079,2.663143688164085
SK-CO-1,5281321,-2.128194299198524,-0.49589313643278826
RERF-LC-MS,5311,1.7201713868016182,1.5547058519421801
HuP-T3,11427553,3.1840600229712037,3.0464520918617484
ALL-SIL,4259181,-1.3200126273341632,-0.46498580739451134
HCC1500,11214940,3.550811671890936,1.9461768844615142
NCI-H2452,navitoclax-PLX-4032 (1-1 mol-mol),2.336639386671478,2.439062037037743
HCC1500,25195348,3.452030504957034,3.108674982266556
SW1271,52912189,0.6284206808713965,2.5191854868118195
MOLP-8,984333,1.0413549547234568,0.09567308694489235
SW948,72734382,3.6940713099503473,3.906706265888993
IGROV-1,46943432,4.105714883822214,2.3538219799527678
BICR 31,25227462,0.4256700478941367,0.735626606520138
SaOS-2,2126,4.6809882623674905,4.603441502772812
SaOS-2,11427553,2.020035940690151,2.6730545527565903
MOLM-13,6914657,-6.22505002098335,-4.812594817064574
NCI-H1568,24964624,2.125017418877952,2.454724036759732
HCC1500,11497983,4.502799578122533,4.136307039583045
K-562,23725625,5.2530061405843975,3.6124845552216067
SaOS-2,salermide-PLX-4032 (12-1 mol-mol),4.26549663284579,4.748844748868848
RKO,136227924,3.256787131627037,2.388586442896599
IGROV-1,31703,-1.792518264692263,-1.0523269625166072
HEL,6438330,1.7062913765539824,1.457915625219214
RERF-LC-MS,25126798,3.475546322259903,3.8987440194965575
LCLC-97TM1,409805,4.11204743963536,4.548203555039895
Daudi,2708,2.1654486353587266,3.257287529344635
SK-HEP-1,6914657,-2.911576812343612,-3.4420231670939954
MOLM-13,36462,-3.0478349617512466,0.06748400931328798
COR-L105,208908,1.1794902635628597,2.033156267391706
MOLP-8,44491742,4.067907034019371,3.8530524795404784
Panc 02.03,89183176,4.957506748320777,4.641859886901611
Daudi,3025986,-1.684737909075286,-1.3914073773305176
PaTu 8902,10302451,3.9687769441396608,2.8608022076277786
PaTu 8988t,9933475,2.2874108911255693,1.9681613368225672
SW1573,5281321,-2.072955292880288,-1.0723068254689674
IA-LM,2733526,5.6911514373146135,3.6672253649137705
Panc 02.03,6918837,-1.2317043962492993,-2.529724787308597
NCI-H1568,19582717,3.4209569673427342,4.178180234215547
WM115,55508,6.132181701054794,3.4928198027091777
MOLP-8,2871966,-0.632569947519592,-0.2857327733870349
ML-1 [Human thyroid carcinoma],decitabine-navitoclax (2-1 mol-mol),2.5515685650410216,2.104713102093917
MOLP-8,decitabine-navitoclax (2-1 mol-mol),0.2255247501063145,-0.041125956877917105
HEL,6918837,-4.248380638359999,-4.507476128811003
RKN,alisertib-navitoclax (2-1 mol-mol),1.493636711316015,0.30705825408787696
BICR 22,136227924,2.105383482893856,2.9196085222561035
SW48,135875424,3.469184081134181,3.6458793878764992
COR-L95,10127622,5.649647064343883,3.596000703347761
SU-DHL-1,60750,-4.603947913298721,-2.07881771294863
ML-1 [Human thyroid carcinoma],16065773,2.2629168527060117,2.7130339067016225
SaOS-2,446155,1.978878402700164,2.2820279975210958
Granta-519,tretinoin-carboplatin (2-1 mol-mol),6.438903911502162,3.0157182457504788
SK-CO-1,11625818,4.187860927408271,4.2379468106470695
COR-L95,676352,2.06388279354012,1.9096164126555033
RKO,11719255,3.406006587740275,2.6070577642658224
NCI-H1568,135875424,3.0063280878885967,3.938487216452223
IGROV-1,25195348,3.0698662305180275,3.4660747214903127
RERF-LC-MS,16659841,3.453543705685564,3.8714907205697853
SW948,1641662,3.2658822910658905,3.2900030528777484
BFTC-909,5351362,0.3148685714677321,1.6706691092744157
COR-L95,24771867,5.320672645408192,1.1035942839154074
NCI-H2452,16725315,3.1677771909290184,4.353915288589362
WM115,9926054,3.0880179510914454,2.0691668553542972
IGROV-1,135875424,3.3275053166921347,3.5602946310038495
LS411N,4259181,-1.386635238211632,-0.3653353306727281
SK-HEP-1,24821094,3.809459846332286,3.368103946547696
P31/FUJ,tanespimycin-gemcitabine (1-1 mol-mol),-1.9905845316732809,-2.2359361386826277
ML-1 [Human thyroid carcinoma],17759555,4.838019485799326,3.77174053933681
HCC1500,11364421,1.8102576985092016,-0.7440485826874591
WM115,11647372,-0.748702419415335,1.3773759319899364
IGROV-1,374536,0.7022324251593053,2.551184903752136
K-562,5311,0.9288629076778604,0.7209109716140086
LS180,navitoclax-piperlongumine (1-1 mol-mol),3.251687407924036,1.643981661860694
HARA [Human squamous cell lung carcinoma],375860,-0.967052520231088,-0.009658228371643979
Daudi,44607531,0.7322116783883826,1.064648387739187
HARA [Human squamous cell lung carcinoma],9840324,5.741888919857564,5.726228139791828
SW1271,448949,2.9810988383972084,2.0094583914741917
SU-DHL-1,42642645,0.6641769458510169,0.8168050858392406
ML-1 [Human thyroid carcinoma],168312962,4.623396193395582,2.4531898968301253
SW48,53232,2.98078944705874,2.9933268708889766
K-562,4096211,1.5585244853649294,1.082223309805382
LS180,89183176,4.9114720653238315,4.5136722701847525
SW1271,10427712,4.007366682408904,4.4749112845298535
BICR 31,JQ-1-UNC0638 (2-1 mol-mol),1.590211689658008,1.7217930003361313
SK-OV-3,72193861,3.227068856168802,1.7450690649718232
K-562,148198,-4.073315546446919,-4.031810148196838
ML-1 [Human thyroid carcinoma],25262965,-1.8922435286727564,-0.5434423112295045
K-562,tanespimycin-bortezomib (250-1 mol-mol),-0.7275623889359331,-0.8560861307404904
SW948,2729026,3.020599067804879,2.2897678788025333
SaOS-2,3552672,2.445112397338648,2.81561595015385
K-562,6918638,0.0740833242167517,-0.025859098938182248
HCC15,67291369,1.6613409933263477,2.9131514260790787
LCLC-97TM1,11396600,3.6456493290211425,3.5824276183185253
HCC15,6438330,2.907250953014235,2.3109680107965347
SW48,123631,-2.3971553119638553,2.2140702819797795
RERF-LC-MS,6918638,0.4520678244574614,0.6508672821406596
HCC15,54619238,5.509074276782743,4.888399540699542
HARA [Human squamous cell lung carcinoma],selumetinib-UNC0638 (4-1 mol-mol),6.072288250407716,2.9901268348485477
Granta-519,5351362,0.2173676915670352,1.019898731522154
SW1271,219104,3.9142621703193625,3.8577248023873234
WM115,selumetinib-JQ-1 (4-1 mol-mol),-1.8046253833707984,1.5804688680597934
SW948,11497983,1.2110688984787443,0.7110220976023126
Panc 02.03,11404337,1.528571500956484,-0.2014916146403811
SK-OV-3,107985,-2.353051363092625,-3.349608914947303
PaTu 8988t,selumetinib-GDC-0941 (4-1 mol-mol),1.0326932423441333,1.4195591188515184
HCC1500,56649450,4.199956636233384,3.178734638195293
MDST8,54649381,4.2434412709491385,3.8837917432922517
SK-CO-1,24772860,-2.764468608226056,-1.3454000424330752
SW1271,2708,3.697662973501111,4.756834138088326
COR-L105,25062766,2.3512127388642865,1.9610147517364112
BICR 22,9826308,0.9832071992526458,0.8627969142598387
SW48,navitoclax-piperlongumine (1-1 mol-mol),1.2226780800612655,1.5558356133921092
KU-19-19,11404337,0.0275069311149896,-0.4422601047629381
LS411N,decitabine-navitoclax (2-1 mol-mol),1.6875581183367745,1.2512014293762252
LS411N,452548,1.178688753001054,-0.9925340175202314
COR-L105,3025986,2.299444367217184,-0.5238374438364021
IGROV-1,25102847,1.7007012555618253,2.365418984926029
PaTu 8988t,24797083,1.3448554408655904,1.3635307505119891
IGROV-1,46398810,2.003787621940583,2.51984247651454
SaOS-2,2749,2.484303950908632,1.8867569057327171
WM115,7251185,2.999080033015298,2.6279437371736662
IA-LM,151289,3.753931026261757,0.6963216790620403
SW48,60168763,3.2354609354554924,2.868838374126035
IGROV-1,168313016,4.807199318661473,4.801964894630185
MDST8,5351362,2.4401541198795726,1.6650607199138958
RKO,5291,3.391339544898264,3.3455967704036755
LCLC-97TM1,23582824,0.7435680585464137,0.8946498549917804
BICR 22,16725315,5.207801943730372,4.217657421377362
HCC1500,44632017,4.723480031494906,1.4679419534024944
MOLM-13,219104,1.3929442819191806,2.2581879262480014
SaOS-2,44202524,1.4210473732360835,2.109189516841709
COR-L105,753704,5.105702577689745,5.180061129034414
BICR 22,216468,1.2752332856392885,2.9979877090819507
RERF-LC-MS,445643,4.345437949323675,4.0017621474140945
BICR 22,selumetinib-UNC0638 (4-1 mol-mol),2.123491609761504,2.859644685016418
HuP-T3,44607531,1.7591062122540748,1.2819816484260105
NCI-H1568,9915743,-0.8427224057935273,1.118674006049221
ALL-SIL,126941,-2.455728969669062,-3.0409321683163784
IGROV-1,168313047,1.93821625738322,2.425602405693409
LS180,100016,6.005443229591697,6.12228575656278
SaOS-2,60700,-2.625519230364934,-0.18392900606338863
KU-19-19,9907093,4.38040739031281,4.329219090453145
SaOS-2,9935249,3.097116977919543,3.5356681086375192
COR-L95,24821094,3.5692160345671335,2.798908480173681
Daudi,327653,2.694862581871668,2.3701269077520433
SaOS-2,65628,4.208345318362158,4.400878972908687
SW1271,navitoclax-piperlongumine (1-1 mol-mol),2.304332277449707,1.547258445274207
ML-1 [Human thyroid carcinoma],119182,-2.1546594526399647,-0.025824452060764922
LS411N,24772860,-2.6286287692739587,-2.368322355591515
HCC1500,15983966,1.4595203856942676,-0.6647521474993429
COR-L95,46907787,3.807595772412777,1.48953809943809
BICR 22,24821094,3.82687279949815,2.3477766772749886
RERF-LC-MS,56946209,-3.4945734927118552,-3.5903013713469183
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,0.8773888157506504
MDST8,49793307,-1.5088082080905487,-1.9778689789754111
RERF-LC-MS,tanespimycin-gemcitabine (1-1 mol-mol),-1.5952645398326415,-0.04481169809561523
SW1271,159324,2.241950485620868,2.96285748622768
LS180,doxorubicin-navitoclax (2-1 mol-mol),-2.003067068648065,-0.9551829807570468
HCC1500,135398516,0.4161092034804287,1.9348964854222894
Granta-519,46901937,3.6488183223471022,2.3563727712969724
RERF-LC-MS,5328940,2.240356815676024,1.6350461971496686
BFTC-909,navitoclax-sorafenib (1-1 mol-mol),2.944260401271062,1.951969690018783
Granta-519,400769,-1.7592122365530554,-1.5055810157930762
BICR 22,135421197,2.0438055763788556,2.134005480153033
BICR 31,9967941,4.3746614656618865,3.942005017635826
Daudi,89928392,0.010222000273875,0.2652122810573843
MOLM-13,151289,-0.2275053531847663,0.4748003298377988
IGROV-1,2874250,4.893662837169153,4.642438063694534
MOLM-13,4261,-0.2853779042398361,0.45723385150078266
MOLP-8,5280436,2.785612173209183,2.791039101576839
RKN,11427553,3.6372919842764424,2.542481151291934
LCLC-97TM1,2828334,6.057082646440782,6.037333635125657
Daudi,11640390,2.7767455060282873,2.680325791587384
SW48,selumetinib-MK-2206 (8-1 mol-mol),-2.489387055809161,1.954726039447816
RKN,51039095,3.7797830340785694,2.5901281172785633
HuP-T3,46398810,2.968900053185397,2.7181540208891364
SW948,60700,1.1260701186231294,-0.6378197852870262
LCLC-97TM1,168313047,1.50715487575417,2.1968484593772546
Panc 02.03,46174525,6.272327915554807,4.52544741147511
SW948,72193861,0.8788999866892542,0.5928934989375978
HCC1500,6918638,0.5709126385335386,0.19075830395896923
RERF-LC-MS,42642645,-0.4358765804877467,1.1180075223204542
LCLC-97TM1,selumetinib-vorinostat (8-1 mol-mol),2.6249327644586153,2.015597137699986
ALL-SIL,12001922,1.676377280214729,1.523268291507172
NCI-H2452,441298,2.247705741320954,2.494878882257155
BICR 22,46191454,1.6809351488377804,1.6383454970762952
COR-L95,16013152,4.05038947229277,3.7144641514240817
BFTC-909,72376,-1.4314875177558029,-1.5613685929924261
SU-DHL-6,15983966,-6.405792257227171,-3.8913480591521177
K-562,11497983,3.839483588328175,-0.03748050496303297
ML-1 [Human thyroid carcinoma],10184653,1.3933805894109417,1.6436012707295928
IGROV-1,4477,1.1767656777594142,0.39078778011898635
SK-CO-1,9444,4.465837668270579,4.146778724827973
SU-DHL-1,135999136,4.730243036337901,3.292389210510223
IGROV-1,54619267,3.9701367924453455,4.110513906289304
HARA [Human squamous cell lung carcinoma],6852167,2.790696024551457,2.971754794929436
SW948,31703,0.6983000463207195,-0.722013351738277
HEL,sirolimus-bortezomib (250-1 mol-mol),0.9395189968578028,-1.3222572255591567
SU-DHL-1,BRD-K03911514,2.3803066372148742,3.789299274014843
HCC1500,46398810,2.5427546617930905,2.4555378817330125
LS180,tanespimycin-gemcitabine (1-1 mol-mol),-3.220136839114834,-1.260302287652722
WM115,51039095,2.786212621210589,2.6978878944738436
Granta-519,JQ-1-carboplatin (1-1 mol-mol),-0.0687085528306087,-0.2746348337951664
HCC1500,24772860,0.2838196702204312,-1.6715903241222554
SU-DHL-1,71304818,1.6958772786188914,2.238381966639587
WM115,16736978,2.885535594388376,1.696096739746531
NCI-H1568,54618305,4.1006341963066255,4.4559676709982154
RCC10RGB,11404337,1.763382313076518,0.055480791775791086
BICR 31,navitoclax-MST-312 (1-1 mol-mol),1.028775915948256,1.2094585414554804
HCC15,17755052,4.876160174226561,1.9360321744235645
COR-L95,6610216,4.601423414679649,3.9986940392799157
LCLC-97TM1,10296883,3.762301074740285,3.6741233386980547
Granta-519,753704,4.381381177541046,4.0447490306214045
COR-L95,3825829,4.2210058836960265,3.6954018614077158
HCC15,51039095,2.370618956781999,2.8592869027613044
IGROV-1,erlotinib-PLX-4032 (2-1 mol-mol),3.0086678924768404,3.0941272405417704
SK-OV-3,crizotinib-PLX-4032 (2-1 mol-mol),2.8845128579100456,2.0030715361044837
K-562,9915743,1.457381054045144,0.8793918271128908
Daudi,644241,1.4114598324864769,0.9555767984962378
COR-L105,6610355,4.615259996363044,4.76169679320461
NCI-H1568,400769,-0.2296701698466811,-0.5737757576184485
PaTu 8902,4096211,3.3878786245174917,2.032953873390886
IGROV-1,6610355,3.969940996770339,4.321252789305607
NCI-H1568,15547703,3.0519937502167744,3.246180896074983
BICR 22,11609586,1.2076158919216122,2.894175014663153
NCI-H1568,6918736,-3.5744965026463893,-1.3199313348704234
Panc 02.03,2729026,3.1511226959620715,2.802959994152661
RCC10RGB,73707438,4.14323951901879,4.129586639591126
SK-HEP-1,11609586,4.257559552037769,3.118235263952171
KU-19-19,piperlongumine-MST-312 (1-1 mol-mol),2.2377116602988187,2.1369877102658426
WM115,9935249,2.3950107716018465,3.117904033185632
ALL-SIL,9929138,4.286241964174987,5.095472929441423
SU-DHL-1,452548,-2.7499107831448257,0.21658421743556008
ALL-SIL,JQ-1-MK-0752 (1-1 mol-mol),0.2899712696196563,-0.17033074063804754
COR-L95,262093,1.2094317801688714,2.406983956349475
LCLC-97TM1,4788,5.877974617736734,5.610356053428234
LCLC-97TM1,11455910,0.6647050862050086,1.107533642501704
HARA [Human squamous cell lung carcinoma],5978,-4.046402058806829,-2.0922880213219788
IGROV-1,3025944,3.9702787396819503,4.264316707727756
COR-L105,44486219,4.2268301570583,4.429800948754315
HEL,6852167,2.7971477189216207,1.6517720386267642
HARA [Human squamous cell lung carcinoma],6918837,-1.4537868658939308,-2.468099654886852
BFTC-909,SNX-2112-bortezomib (250-1 mol-mol),0.3698834200349636,-0.8089020677096563
MOLP-8,24753719,3.861578571306771,3.721173194611509
RKN,54649381,4.194319964969153,3.88404188003746
NCI-H2452,5738263,2.391583749104638,3.4408146318289687
RERF-LC-MS,11612883,2.474683430971872,2.907364056172572
LS180,67156097,-0.3004464994297747,-0.6443218576776841
ALL-SIL,638278,2.4844738615144797,2.8491082041951286
NCI-H2452,navitoclax-sorafenib (1-1 mol-mol),1.6826538344111892,2.112347337201333
WM115,89928392,1.4475546317176564,1.7361719759848686
NCI-H1568,4917,1.9457015565482707,3.101153344479232
Daudi,2746,0.9195319579001202,1.8778119119953587
RERF-LC-MS,136227924,4.560045704487339,2.9541809876851706
SK-OV-3,400769,-0.3757443057400228,-0.5640581638953115
Daudi,2742550,2.6022450411597764,3.455451491543636
SU-DHL-1,1242560,3.2887270842989285,3.328490097079314
IGROV-1,1750826,-3.124548162001242,-1.226653287379397
IGROV-1,3025986,-1.046010021597061,-0.6663773926720188
SK-CO-1,serdemetan-SCH-529074 (1-1 mol-mol),2.3873903217982155,2.084367944054237
COR-L95,11178236,-1.511835887926392,-3.354679629370949
MDST8,15953870,3.886262261351445,3.7145505759087865
P31/FUJ,71466578,3.434376258750051,2.4655483987765616
SK-OV-3,navitoclax-pluripotin (1-1 mol-mol),-0.7992901012574275,-0.6266068093482499
HCC15,16038120,-0.3287102193479797,1.1550011852764106
SU-DHL-1,selumetinib-JQ-1 (4-1 mol-mol),2.388331941434094,1.3719456890938908
WM115,44607531,1.8052962391610108,1.5395486129296296
SK-CO-1,322968,3.708989182542924,3.7695153684420872
IGROV-1,1716436,3.2816872421007375,3.077887055489849
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,3.98415301918012
SK-HEP-1,15953870,5.227718988850451,3.710797298766813
SW1271,10231331,-0.1974856956768426,1.5822158540563376
HuP-T3,168312962,3.781886601468438,2.215119059386761
Granta-519,11238147,3.49055902156802,1.8675979403959808
SW1271,54678924,4.1367056407476595,2.154600183244794
Panc 02.03,89928392,1.630028817710481,1.6687984962308773
BICR 31,148198,-3.2373882564770513,-3.021415876865778
IGROV-1,104842,-1.6690343627553987,-2.86379947122396
K-562,erlotinib-PLX-4032 (2-1 mol-mol),2.919036789421011,3.0710209859484427
HCC1500,10184653,1.0749855490236058,0.7493152803752321
HCC15,44202524,2.021204517823952,2.16835673943943
COR-L105,9866186,1.0648092573013754,1.1399402374108798
COR-L95,285033,-2.430535969260308,-2.5668759025019035
COR-L95,23635314,-1.8010937940640896,-1.8499046416340514
SaOS-2,11364421,-5.8107581348158,-2.565737891035729
BFTC-909,122327,4.590877432942681,4.425154061573553
IGROV-1,54618771,1.2456991772210466,1.1404879821031575
P31/FUJ,675434,4.075878142833804,4.10941764332468
HEL,tretinoin-navitoclax (4-1 mol-mol),-0.5211961958831923,0.3415777710787923
NCI-H2452,5328940,1.966899609603824,1.8017094843934394
RCC10RGB,72376,3.207429090732714,-1.0020445010307113
LS411N,selumetinib-tretinoin (2-1 mol-mol),1.6361357934026397,2.1905437291226173
NCI-H2452,4917,2.7944300449003907,3.2050330252548145
BICR 31,1716436,3.7157300626912617,3.071750101202653
MOLM-13,1239801,3.478439984806631,3.2571611852523006
HuP-T3,10296883,4.266239948990751,3.937134403246515
PaTu 8988t,107970,2.530920724052233,2.2520715401344296
ALL-SIL,675434,4.0400251875066715,4.114684857530218
PaTu 8988t,16736978,1.6582336139520693,1.7760000209937
LS180,5460769,0.3293841533128088,2.340063875611094
MDST8,11612883,2.4942536836786635,2.593279215733105
COR-L95,46191454,2.009346014708409,1.0428075694715424
MOLM-13,451668,-3.798095624109847,-0.927378635363648
Daudi,168313016,3.9002026806644734,3.666576224528546
ALL-SIL,135411,-0.5620485907345016,-0.27385357575528435
RCC10RGB,46215462,3.684591481140594,2.2513829067581645
KU-19-19,4917,3.607977283390518,3.137153814441421
Panc 02.03,71751553,4.925944110140211,4.5722222877132905
HCC1500,5281321,-4.561246998431513,-0.7064358865481657
LS411N,44202524,4.412838675121289,1.9885703892699462
LS411N,637858,2.7012095970179635,1.3767059918812368
ML-1 [Human thyroid carcinoma],46191454,1.5014607148772898,1.9074367274879744
SK-HEP-1,24797083,1.0035545042427043,1.2822431870883286
ALL-SIL,navitoclax-gemcitabine (1-1 mol-mol),-4.146952784268296,-2.677831006249039
HARA [Human squamous cell lung carcinoma],24951314,2.561199492034659,1.4619371510171748
BICR 31,387447,-3.4745770631768553,-4.154077920381641
SK-CO-1,452548,-1.5551413224098238,0.6789161968017061
SW948,6914657,-4.288216532991124,-3.9513597915695353
SK-HEP-1,216468,4.223762462623231,3.5712547173988036
ALL-SIL,71466380,3.7861137397034255,3.864386069232478
ALL-SIL,66577038,2.592918053791083,2.5317879405025963
K-562,46174525,4.631327159993839,3.1899397982487456
SK-HEP-1,11404337,1.0852289139958715,-0.12246004144557596
SW948,tanespimycin-gemcitabine (1-1 mol-mol),0.3148339676626304,-0.8117326969307629
COR-L105,156414,4.037454349539868,1.727060997055434
P31/FUJ,5351362,0.932451869978648,0.9057463325151319
BICR 22,57519531,2.122776388957543,2.7959321045884082
HARA [Human squamous cell lung carcinoma],crizotinib-PLX-4032 (2-1 mol-mol),1.0458249521104828,2.15454203125759
SW48,156414,-3.5613148313114293,1.2465515917570702
BICR 31,24180719,3.9564262696237096,3.6460203411509777
KU-19-19,11222830,1.7129831318158657,1.713207598834726
HuP-T3,9911463,3.677427040789425,3.9017394478467122
Granta-519,56649450,2.820913380280981,2.311418066879606
BICR 31,5328940,1.2878315189706533,1.6058582774103403
HARA [Human squamous cell lung carcinoma],navitoclax-birinapant (1-1 mol-mol),1.3986072497708624,1.7085782144478412
IGROV-1,19582717,6.764352444432722,4.229349084914892
IGROV-1,24951314,0.9075718706849548,1.5015284915516596
Granta-519,9911830,2.3469616146388033,1.780295741830186
RKO,3038522,3.342495330103654,2.7826179335049077
P31/FUJ,135440466,3.423250795887436,1.8092751923058075
IGROV-1,6918878,1.6706182189896102,2.8915080132850473
NCI-H2452,tanespimycin-bortezomib (250-1 mol-mol),1.699086924939448,-0.2680375620539243
SW1271,136227924,3.2074421772411372,3.1635060323148485
IGROV-1,16722836,0.856484234547582,1.5172717269028286
WM115,piperlongumine-MST-312 (1-1 mol-mol),1.2080674757764085,2.005375693588633
HARA [Human squamous cell lung carcinoma],3025986,-0.8541128463962537,-0.7565979534932685
IGROV-1,168313016,4.807199318661473,4.801964894630185
Panc 02.03,9935249,3.920507280118285,3.276411815813361
UACC-812,19582717,5.3439559865445245,3.9890636500693426
SK-CO-1,54619267,3.100073010472608,4.051843477557836
LCLC-97TM1,56973724,2.3842885859021985,2.8969414303063155
P31/FUJ,44185566,1.65624467652309,1.7411597225404294
BICR 22,erlotinib-PLX-4032 (2-1 mol-mol),2.8586424250405784,2.0338538284740673
LS180,568763,0.2796957344404436,0.6978906899761326
HEL,5281321,0.1504430999261452,-2.4431967196613216
COR-L95,168313200,1.9910859109269063,2.835065712989873
NCI-H2452,100016,6.6405878618594985,6.3296044836731475
SK-OV-3,vorinostat-navitoclax (4-1 mol-mol),1.2421133926861518,1.167292527689643
SK-HEP-1,71751553,4.559763777433237,4.456624720556306
COR-L105,6450551,3.13458936271996,2.968999583651432
MOLP-8,227681,1.7901539797099055,2.696481984432248
LCLC-97TM1,24951314,1.6929873886763296,1.1434596350408686
LCLC-97TM1,20959075,-3.5903877814282836,-2.676702656684772
Panc 02.03,11964036,1.263021853424522,1.4581630800805083
Granta-519,54596558,4.099782953798094,4.221946712995058
IA-LM,navitoclax-PLX-4032 (1-1 mol-mol),1.0143857311372344,1.5777730496895388
P31/FUJ,navitoclax-gemcitabine (1-1 mol-mol),-2.2174176001996626,-2.381371442719514
IGROV-1,246676,4.485924799339535,4.155398797077951
HCC15,25126798,3.760529318413009,3.8960951804408586
P31/FUJ,67156097,-2.27730723064269,-2.3063706740325056
KU-19-19,4788,5.856744699338042,5.678103246042318
MOLM-13,44507138,0.4726740823031857,1.4185619440243635
COR-L95,5281672,3.930459616892441,4.206301936973684
HEL,46191454,2.0114602406157487,0.42734677316499226
SaOS-2,25227462,1.0053365829052552,0.339473249046055
NCI-H1568,327653,2.9538763640308403,3.394784405571856
MOLM-13,126941,-4.1996343959718665,-3.5582435696329697
SW1573,23582824,0.5044187481506299,0.6485453968943589
SW1271,selumetinib-UNC0638 (4-1 mol-mol),0.1676161732677231,3.2619997448499487
RKN,46199207,3.372714950884571,3.229300353496291
MOLP-8,2113511,4.489524818659998,4.429407099456616
K-562,selumetinib-decitabine (4-1 mol-mol),3.3977333997002215,0.9836953547967692
MOLM-13,9907093,2.467705892800055,3.2474183853349525
BICR 31,135398516,1.997761003126595,2.3110832172629014
SW1271,216345,3.992520329028928,3.9225189921810317
SW1271,49766530,-1.8216621121390524,-0.6030530523128781
BFTC-909,44819697,-0.8003395289407239,-0.24064893175476026
COR-L105,tretinoin-navitoclax (4-1 mol-mol),2.190606174961121,2.7448472941833857
COR-L95,24951314,1.2848618182948477,1.0794098140691861
Panc 02.03,11427553,3.85172253134883,3.2440681187776503
RERF-LC-MS,11955716,-2.426679724944883,-1.5401510461744075
LCLC-97TM1,168312962,4.14705930417905,1.563168001075463
LCLC-97TM1,984333,1.7706091320352773,0.6715528933281173
RERF-LC-MS,3689413,0.4263782886644774,0.04635416627367106
HARA [Human squamous cell lung carcinoma],613753,4.606319217012033,3.205741240155797
HEL,72734382,4.138558929268269,3.5279494003673726
Daudi,5281672,3.0556000328651267,3.7268702447894024
Granta-519,73707438,4.294812737502366,3.8258453264997794
HARA [Human squamous cell lung carcinoma],23635314,-1.642514653884031,-1.9882712632639292
BFTC-909,3465537,1.8561429441463555,2.709162346302686
MDST8,53232,0.2243602329572143,2.667574582385771
PaTu 8988t,54618164,4.622822732421989,4.243214396782847
ALL-SIL,decitabine-navitoclax (2-1 mol-mol),-2.660613413513553,-1.3900386841203471
BICR 22,241158,4.423333712203234,3.815805208616242
IGROV-1,25150857,3.031865110078871,2.5292670606946244
MDST8,2729026,2.783400494590182,2.6421985589977517
IA-LM,56649450,5.159895082661475,2.74277713442505
RERF-LC-MS,44137675,3.373454428855253,3.7678105914250013
HCC1500,11612883,3.8728122953700113,2.7715043512025206
COR-L105,44491742,4.003695029376484,4.274793709755368
SU-DHL-1,17759555,3.5507610454949177,3.2848188170927024
PaTu 8988t,2828334,6.317024230854033,6.0962636266673735
PaTu 8988t,168312962,3.961414669504744,1.2978597250910537
NCI-H2452,15953870,1.9726746369071917,3.6607756916905623
LCLC-97TM1,54626689,4.751501808909531,4.20386332966435
PaTu 8902,136227331,5.567107594748722,3.996310282728265
HARA [Human squamous cell lung carcinoma],445643,3.755641736641804,4.074631960541697
COR-L105,ISOX-bortezomib (250-1 mol-mol),0.2804376845822182,0.917627368117803
ML-1 [Human thyroid carcinoma],selumetinib-UNC0638 (4-1 mol-mol),-2.912510210684258,3.2500465367787523
Daudi,11317348,0.8828508555827204,1.3856878981596454
IGROV-1,26596,2.910298792762654,-0.8302108578930314
K-562,2742550,1.8061055262772656,3.455203753790096
IGROV-1,25062766,2.144848161581278,2.1619997705352203
ML-1 [Human thyroid carcinoma],439501,-1.5032891627146094,-2.0767750044482343
IA-LM,navitoclax-MST-312 (1-1 mol-mol),0.5208691605540192,1.0784221753762995
SW948,123631,3.5700289871060327,2.1615735781446808
COR-L95,168312962,1.6965693753889812,1.3764591717201669
IGROV-1,9956119,3.7231415872817024,3.8166016729226078
RKO,doxorubicin-navitoclax (2-1 mol-mol),-1.0579033502847706,-1.348166729609755
HCC15,23725625,4.984445415553906,4.944736911430416
KU-19-19,JQ-1-vorinostat (2-1 mol-mol),1.2174768050309406,1.3885710290157594
RKO,2708,5.0364138660049935,3.687690355046655
HARA [Human squamous cell lung carcinoma],navitoclax-piperlongumine (1-1 mol-mol),2.215632811452015,1.7262263210547903
IA-LM,148198,-11.384967135346804,-3.667948944744272
PaTu 8902,44202524,5.539571067533291,1.9412630465189649
SK-OV-3,10127622,6.3662035368843535,3.7344327867301614
PaTu 8988t,16038120,1.6913300198770496,1.1162489252816905
HCC1500,6610355,5.5539350619643395,4.54449064754614
RKO,9956119,3.3077949428120195,2.7235259038564066
MDST8,8515,5.547245054967808,3.7487007278576834
HCC1500,5978,-3.1049031694332183,-1.7037553622379615
WM115,navitoclax-gemcitabine (1-1 mol-mol),-1.739473947075712,-1.1390533287469427
BFTC-909,262093,3.5924629632259792,2.9681432788969255
RKO,23635314,-2.140231911981244,-2.7804844988081787
MDST8,11626560,2.2403804115384207,1.746923811152407
COR-L95,UNC0638-navitoclax (1-1 mol-mol),-0.3776689942774316,1.067876929811335
COR-L95,44819697,-0.3616253875757693,-1.043374587366703
BICR 22,5351362,1.2051272382141311,1.7933866689692843
K-562,9967941,4.015535149970178,3.0847546491266318
Panc 02.03,selumetinib-piperlongumine (8-1 mol-mol),3.9730948608994385,3.3537040280648363
HARA [Human squamous cell lung carcinoma],42642645,0.3266919515257925,0.7739939951433381
UACC-812,25102847,4.053875686762356,2.4708215623472256
SK-OV-3,6610355,6.222226160480143,4.770747959987203
IA-LM,11152667,1.0642318645878492,-0.8681406702439192
BFTC-909,6918289,3.427790661189136,2.9041052804527614
Granta-519,11167602,4.36712443545526,1.948918662098116
BICR 22,60700,-0.4008092990404712,-0.03641533232733125
LS180,BRD-A02303741-carboplatin (1-1 mol-mol),4.457802595485306,3.8787610622442763
RERF-LC-MS,241158,4.36087401910034,3.8735171751909885
K-562,JQ-1-UNC0638 (2-1 mol-mol),0.4182690397422658,0.3871039446937262
HCC1500,24951314,1.2674136228128516,1.2774880415859615
K-562,65064,5.606410384518605,4.1625670472279594
PaTu 8988t,6852167,4.186106645973286,3.1393129646258426
NCI-H1568,BRD-A02303741-navitoclax (2-1 mol-mol),5.689804602568574,2.556444626956856
RERF-LC-MS,25154868,3.293982375318642,4.529752778584003
Daudi,11719255,1.9605498566152704,2.622768754193128
LCLC-97TM1,selumetinib-piperlongumine (8-1 mol-mol),3.449521534433945,2.7486988930143674
P31/FUJ,9907093,4.323796399268767,3.282255815296529
SK-HEP-1,56649450,4.110961369423777,3.473353505722867
SW948,11238147,1.5812364597614252,2.203201026602388
MOLM-13,60700,-3.6931560077615337,-1.8148140722280461
SK-OV-3,54618164,4.236989567252486,4.146428278073814
WM115,53232,2.2909547616931243,2.915409086115483
Granta-519,11213558,2.214733921051264,1.0953428865694894
HCC1500,12001922,1.110118640671234,1.9490127013502265
MDST8,12003241,0.3559193403256231,-1.027823843674264
ML-1 [Human thyroid carcinoma],452548,-2.1962617612927375,0.3541665530421348
MOLP-8,44819697,-0.0313402586892576,-1.716663882283881
COR-L95,136227924,2.879022500990784,2.767514716563232
Granta-519,135421197,0.2234065586927925,1.4915142003843684
MOLP-8,SNX-2112-bortezomib (250-1 mol-mol),-3.1816176018347018,-2.389724021344196
SW48,6505803,-3.5264924347891897,-0.7045427206807858
IGROV-1,8515,2.1861539315976053,3.9210971556900036
ML-1 [Human thyroid carcinoma],10410894,4.287937298613586,3.595625321757103
RCC10RGB,doxorubicin-navitoclax (2-1 mol-mol),1.2475465934468772,-0.577931940659586
MOLM-13,25102847,-4.845176201807707,1.9772875258930458
SK-CO-1,selumetinib-JQ-1 (4-1 mol-mol),-1.696692082912101,1.353558745086263
SW1271,53481919,3.611390941951582,3.8528524517686953
RERF-LC-MS,24964624,3.0594292113466515,2.496927357693293
LCLC-97TM1,969516,2.175595213634207,2.629009237936954
WM115,JQ-1-carboplatin (1-1 mol-mol),1.8205622185822876,2.47292035137768
RKN,49793307,-1.2643121180608,-2.340197550596814
K-562,selumetinib-tretinoin (2-1 mol-mol),3.758766106216507,2.282284192153235
SU-DHL-1,15547703,1.7605543364675147,3.1157588823858835
COR-L95,11625818,4.182153411947424,3.6854903315787393
BICR 22,12003241,-0.4808187565312439,-1.1364866160015665
LCLC-97TM1,124202324,2.4863882679536133,2.204286470113978
BICR 22,24797083,1.5794716057353129,1.603888430966122
WM115,136227331,3.7917327546536983,4.214076239773089
MOLP-8,23725625,3.090240324780466,3.5684606106072674
NCI-H1568,3552672,1.826953477138791,3.0210937111439558
SU-DHL-1,selumetinib-navitoclax (8-1 mol-mol),2.4518113927127754,1.370312409681737
IA-LM,51039095,2.817946248906647,2.7180310649592623
K-562,11964036,1.6077176524784418,0.5750596526888431
HCC1500,5470400,-1.7385310235308598,-0.28901449200279766
SU-DHL-1,11396600,2.533401176626175,3.0472311304720923
BFTC-909,216345,4.226804426652683,3.9425909147269196
Panc 02.03,71304818,4.256945507775637,2.548811916849455
Panc 02.03,219104,4.2068478561753375,3.9907740861713283
SW948,23582824,0.2041553679799947,0.8301344519288781
NCI-H2452,5287620,-2.107035322199283,-2.0651160401629
SW1271,15953870,2.918493523161381,3.538174674387641
IGROV-1,119182,0.2112476135388779,-0.7593349575503742
SW1271,11656518,1.475105479065936,1.9728352553051487
Panc 02.03,49766530,0.9655059796360064,-0.5415762333062478
LS180,89928392,1.7442798189695845,1.5579810471181565
SW1573,53495165,2.229023421141798,0.338268960345834
WM115,16659841,5.127619480623103,3.9272412917175803
SW1271,3552672,3.981050843991283,2.6149542821568916
SW948,9926054,1.8406028662949705,1.9799663137673007
MOLP-8,JQ-1-MK-0752 (1-1 mol-mol),-1.2157281413611027,0.6136149146337695
RCC10RGB,71466445,4.397911896340776,4.288943837174241
WM115,7326481,2.374260909001927,2.9898014259268666
SW948,44202524,1.7116279237548724,1.8416619280319
RCC10RGB,46907787,5.224507823938942,2.42931821407582
LS411N,9936388,1.997277136132151,-4.216246418169703
SW1271,135423438,1.1699634662635283,2.6442721937017337
SK-OV-3,ISOX-bortezomib (250-1 mol-mol),1.1042689402938264,0.6544102840547672
COR-L105,123631,-0.3749766708664047,2.4833235915129825
MOLM-13,52947716,-3.8827491455655694,-3.3885238727727875
HEL,36314,-3.7348038354216593,-2.1278559913736474
KU-19-19,54454,2.6957608866389866,2.806666631348477
Granta-519,BRD-A02303741-navitoclax (2-1 mol-mol),-0.3585433064620935,0.051510129418409274
MOLM-13,71680916,4.890723285268907,3.8556311886685144
SW1573,65628,4.136448104244246,4.2912801556112505
HuP-T3,11178236,-4.0067645508863174,-3.294107628950261
WM115,11364421,-5.628114250516673,-1.4156368969667563
K-562,613753,3.252228295501032,2.857263439822638
IGROV-1,24771867,1.9944882740161016,2.8956964841606574
ALL-SIL,11152667,-2.075218964097288,-1.9959341217017552
BICR 31,3081361,0.7844567898788304,2.131001764109365
SK-HEP-1,piperlongumine-MST-312 (1-1 mol-mol),1.9419225552023804,1.9185216508039031
RCC10RGB,4788,6.17872638158586,5.752410522652804
Panc 02.03,11626560,2.1710424521283427,2.0036670808173755
IA-LM,11175137,3.357915620650256,2.0575975203055
RCC10RGB,11626560,2.6825909392900376,2.030785027648488
SW1573,168313200,1.7327341920391253,2.990618106608462
Granta-519,2828334,6.191507302277889,5.547960672835819
SK-CO-1,selumetinib-piperlongumine (8-1 mol-mol),0.2146036861774908,2.8510371309402767
MOLM-13,5460769,1.2989705913507943,1.7682393216786942
SU-DHL-1,216345,3.4378126257341406,2.882575283525231
WM115,vorinostat-navitoclax (4-1 mol-mol),2.428259860783612,1.2891434856406025
MDST8,9926054,1.8075400364112937,2.2083495361597074
WM115,676352,1.7628184284101875,2.2715084757096644
BFTC-909,55508,3.078625314561866,3.5056809210698874
RKO,100016,5.817852214634293,5.162398789040375
MDST8,46943432,3.6174081091701886,2.7231760448836506
SW48,5978,-4.7084088584036525,-1.7277123242831742
ALL-SIL,44491742,3.700418914769662,3.808815153636699
ALL-SIL,navitoclax-piperlongumine (1-1 mol-mol),-1.3160613464557556,-0.2453435415424538
SU-DHL-1,11178236,-5.1175240313736845,-3.2282082262571334
BICR 31,11955716,-3.162575487986667,-1.325676749546422
HARA [Human squamous cell lung carcinoma],11364421,-4.71423157944935,-1.7868469413621446
MOLP-8,374536,-0.3332412159105151,0.9594479107520373
BICR 31,66577038,3.1838871840280745,2.9997153542868285
MDST8,409805,3.941558883413243,4.6743185507308365
K-562,6918878,0.8571724386049573,0.6656310470967943
ML-1 [Human thyroid carcinoma],56973724,3.438642865372283,3.4573337159499453
COR-L95,crizotinib-PLX-4032 (2-1 mol-mol),1.858262555354691,1.5296190002454872
NCI-H1568,5281321,-2.717480517336961,-0.7898245289791862
LCLC-97TM1,374536,2.574075324433214,1.7222590240038307
HCC1500,docetaxel-tanespimycin (2-1 mol-mol),1.2750885769824285,-2.2185153402705144
HCC15,66577038,3.417660968254761,3.1427360267641546
IA-LM,9911463,2.6703246121465436,3.3964957248649568
SW1271,1566236,1.9677070098040983,2.0892796820267647
IGROV-1,11238147,2.1723642292765084,3.0742671027762407
SK-OV-3,11364421,-1.984047807336832,-1.8968971508507102
SU-DHL-1,54613361,-0.1121754666598921,-0.6833157640672246
COR-L105,119182,0.6226208228567816,-0.04128724388022117
WM115,3384730,6.229532895174781,3.161141536204011
COR-L105,9967941,2.071649254258539,3.845274578452524
RKO,72193861,0.7735395045157347,0.18994228069112842
COR-L95,753704,4.781559661696253,4.665517347529444
IGROV-1,49766530,-0.195540678413639,-0.5936143478334672
BFTC-909,8515,4.73152093133166,4.049507245156012
Granta-519,31703,-4.611611754102639,-2.5085451721232532
SW48,19582717,4.381046957550593,3.861448051670341
P31/FUJ,selumetinib-GDC-0941 (4-1 mol-mol),0.2780140376369148,0.39925339913112395
HCC15,15547703,3.515422457694346,3.164331643197313
HARA [Human squamous cell lung carcinoma],36314,-5.79294260923826,-0.7764130534566784
SU-DHL-1,BRD-K58730230,4.384837032763104,3.4106050145482247
HuP-T3,2858523,3.211348955084378,2.9820828787423586
LCLC-97TM1,24901704,3.846855123751057,3.098256913156394
NCI-H2452,44607530,1.9759156929339727,2.0797860255918446
HCC15,9936388,-3.3305479025951783,-0.8040495594327914
RKO,46191454,0.9841477576830012,1.297223553889443
SW1271,3081361,2.248142117307072,2.286823673001315
HEL,100016,4.260371486080393,5.084262405858949
Panc 02.03,327653,3.634511095206161,3.1974788837328454
NCI-H2452,25062766,2.439590704022921,2.0598373455724275
SaOS-2,44607530,1.05170222821091,1.7066061120672444
HEL,5335621,4.9483155198907225,3.938980634903167
BFTC-909,6852167,2.133526407129769,2.7540014130188712
MOLM-13,638278,1.880317910461832,2.7331461041759595
SW1573,selumetinib-GDC-0941 (4-1 mol-mol),3.5855850407433225,1.5338893740852706
SK-CO-1,387447,-5.86001644251988,-3.894994738643586
MOLP-8,10113978,2.697897563265303,2.304637401396552
MOLP-8,216239,2.6519870661660803,1.7275974479683518
NCI-H1568,46174525,4.305444868539079,4.575913520802717
HCC15,navitoclax-pluripotin (1-1 mol-mol),-1.3512127688258049,-0.6714922858645636
LCLC-97TM1,44607530,2.097748917507136,1.6055132614095027
SaOS-2,9911463,4.168030006572111,3.7806517222299822
Daudi,24889392,0.6157424479011876,3.337689811547922
PaTu 8902,51039095,3.3801139171258976,2.5522622977283036
Panc 02.03,navitoclax-piperlongumine (1-1 mol-mol),3.4917646743182216,2.250154253785483
COR-L95,JQ-1-UNC0638 (2-1 mol-mol),1.8178477009164715,1.0034200146587577
Daudi,387447,-5.635352264179238,-5.3226328888582035
IGROV-1,5702613,4.420745339537274,2.8418352495255594
LS180,375860,-0.0541765269880971,-0.22867176787926563
HuP-T3,tanespimycin-bortezomib (250-1 mol-mol),0.6963202387947334,-0.05274945203063875
MOLP-8,241158,1.846975252387852,2.545426880228934
SW948,44819697,-1.5719383449848416,-1.1071045967981568
NCI-H2452,5951923,4.988154330604512,4.683434700971836
MOLM-13,54613361,-1.833470941599732,-0.8067044533073277
SW948,148198,-4.802987893737634,-3.4871994569742735
BFTC-909,4261,3.835594401773327,1.7714507984196615
Daudi,45100481,4.914271492759253,2.409349110916255
MOLM-13,3384730,-1.9717967977442377,1.4943597425501374
IGROV-1,5566,3.174346862827938,3.0552492016577304
SU-DHL-1,10302451,2.2731723403274535,2.7429686375545383
NCI-H1568,SNX-2112-bortezomib (250-1 mol-mol),1.539717951588267,-1.0840563731189432
RKN,24797083,0.944322820476056,1.2718815876430711
SK-HEP-1,148198,-3.434194259121147,-3.3970411535786855
SW48,16736978,1.8227831775957584,1.430653539624173
HCC15,2708,6.122532058448304,5.009900158156911
SW48,5335621,4.0461877603353855,4.638307294858215
SW948,JQ-1-MK-0752 (1-1 mol-mol),3.431430026033012,1.345847701434471
NCI-H1568,71304818,2.2110745175145876,2.505531476529676
COR-L105,5311,1.9211659995219237,1.7607661127559266
SK-OV-3,5328940,3.4311724872159903,1.771092792018554
RCC10RGB,1716436,3.489109378341682,3.1021051767274965
MDST8,6918878,1.145593411739036,3.04893266351261
RKO,11364421,1.233720517884939,-3.702661116309886
P31/FUJ,65064,5.109694638799521,3.8411739546223846
HARA [Human squamous cell lung carcinoma],BRD-K27188169-navitoclax (2-1 mol-mol),2.401020533417727,2.2748239843083007
PaTu 8902,3025944,5.120505038776715,4.310092646638389
Panc 02.03,12001922,2.5444953584324193,2.0503921231216116
HARA [Human squamous cell lung carcinoma],135421197,2.918907943246249,1.8778661123006422
ALL-SIL,54454,2.130103786841792,2.122276677011631
Daudi,11238147,1.1945947480643642,2.054468466769668
WM115,148124,-1.9357807696466565,-1.5159828070653996
PaTu 8988t,25262965,-2.4539636298097376,-1.3012367688091675
IA-LM,49766530,-3.412847117105243,-1.3756260159486715
Granta-519,44185566,0.7632366174102183,1.693373772639741
MOLP-8,44607530,1.0628729381864028,1.4024668007963663
K-562,409805,3.7514940654800064,4.0886578191188265
BICR 31,89928392,2.942196417475874,1.7044533465501175
SW48,23725625,4.606874242451815,4.922958036967112
RCC10RGB,16038120,1.536821218292656,1.131017259157666
MDST8,UNC0638-navitoclax (1-1 mol-mol),0.0251885834350385,1.672963873729224
RKO,148198,-2.1467795088860875,-3.955432749490453
SK-CO-1,409805,5.790109243945559,5.039869613354204
HuP-T3,7251185,1.9415241444855404,2.6843405222982852
LS180,11612883,2.759028826688456,2.7595906271397523
WM115,11507802,3.278245549501506,2.090549643967527
IA-LM,168313016,4.257474229118996,3.881194316018455
ML-1 [Human thyroid carcinoma],5566,3.147714437598846,3.1184681867447144
MOLM-13,crizotinib-PLX-4032 (2-1 mol-mol),0.492576617206884,0.8029865401794019
SW48,10302451,2.1638159560649157,2.904019064582448
Daudi,65064,2.8809848507042095,3.5222629834784347
LS411N,11612883,3.0472980958623705,2.188187707279397
NCI-H2452,11214940,1.2392722713501154,1.9751258327511763
ALL-SIL,984333,-1.3370961884574026,-0.7670170654091002
P31/FUJ,1641662,2.802136916275355,2.8052138869185272
MOLM-13,25183872,-2.142456248879295,-2.1686675116948364
K-562,969516,2.7986550178028216,2.290239940917436
Granta-519,54143018,0.4327684951223574,-0.3302333654965053
SU-DHL-1,44819697,-0.3444138900100821,-0.46223269852786414
HEL,selumetinib-vorinostat (8-1 mol-mol),2.406012225394231,1.4995299787806449
Daudi,9933475,1.2993243126142855,1.539201358410174
SK-CO-1,10427712,4.208191107568486,4.235360129349921
IGROV-1,selumetinib-decitabine (4-1 mol-mol),3.5551285698551225,3.679315303017417
HEL,2841722,4.805306475973069,3.8764850905435164
COR-L105,9926054,1.7310748902984938,2.1199596939937284
RCC10RGB,15983966,2.263334704673794,-0.21617096123796511
COR-L105,JQ-1-carboplatin (1-1 mol-mol),-0.012244733852177,2.6101096934445445
IGROV-1,46174525,4.5083762186279595,4.645565790078964
BICR 31,11175137,2.7548462189262817,2.7130422950962223
COR-L105,11609586,4.426382611322312,3.121363677398433
COR-L105,tretinoin-carboplatin (2-1 mol-mol),4.8464312209914056,4.9778470309441305
IGROV-1,107985,-2.8971910842184516,-3.4393126126977682
SW48,selumetinib-tretinoin (2-1 mol-mol),-3.039219122646087,2.8650069620462215
IA-LM,71466380,4.547922152882383,4.161134034553487
Granta-519,navitoclax-sorafenib (1-1 mol-mol),-1.03945044820541,-0.28678077184351386
K-562,11612883,3.292128537791773,1.9857536316785411
HuP-T3,15953870,4.533958601099395,3.5587491657690062
NCI-H1568,219104,4.078417481216408,3.9284470306606654
RKO,65064,4.5178366082525,4.391432193547289
NCI-H1568,9911463,2.564901149372131,4.006976692339883
IGROV-1,tanespimycin-bortezomib (250-1 mol-mol),-0.1082561672623384,-0.41122118675425556
ALL-SIL,6852167,2.025737624061405,1.4522266233190881
Daudi,16065773,1.627011760718674,2.107073504851099
MOLP-8,10410894,2.1334782114390425,2.6036001640505737
RERF-LC-MS,73707371,5.9060077591992375,4.751709116569686
RKN,1566236,1.687441004968786,2.128585402063673
IGROV-1,439501,-2.1510551928674557,-2.2303054243174416
MOLM-13,57519531,1.2030375936335158,1.364891919371005
Granta-519,11625818,4.458439944218401,2.905958388120324
WM115,JQ-1-navitoclax (2-1 mol-mol),1.0904660510926631,0.8999899039663337
MOLP-8,3689413,-2.303477592076259,-1.7356789844320288
SK-HEP-1,54596558,4.485352352092043,4.506953427179833
SW1271,4705,3.86061099620112,3.1682287053046996
Granta-519,9927531,4.885085469625254,4.171563430460882
SU-DHL-1,11427553,0.3775832797434548,2.48089045020323
ALL-SIL,15953870,2.429039509996585,2.8594978851240858
COR-L105,4259181,2.2372065992854133,0.6885362932924012
HCC15,17759555,4.480266922784899,3.445629265680773
COR-L105,10184653,-3.6529884694455608,1.4811843307802564
RKO,72376,-2.4980018930037673,-3.0653288563339713
RKN,vorinostat-carboplatin (1-1 mol-mol),3.833796397117187,3.2031277837142182
RKO,613753,3.427719504210608,2.8021311883545734
LCLC-97TM1,10302451,3.3699574981481217,2.4915851253649888
PaTu 8988t,JQ-1-UNC0638 (2-1 mol-mol),3.720997870166264,1.7993717132781943
MOLP-8,3634881,2.730356562919761,2.603243126831454
SW948,11612883,1.2539645440532456,2.3029028141375614
HCC1500,carboplatin-etoposide (40-17 mol-mol),4.564857215457985,2.266347789499381
BFTC-909,10074640,3.0053798884123837,3.2286247057493607
LS411N,24901704,3.828527152917887,2.5263329607626672
SW1271,51039095,2.010271277744507,2.7368711203754748
K-562,9935249,0.8993678101188762,1.4796230163055641
COR-L105,462382,1.111643181026989,0.8079335430195078
Granta-519,10385095,0.7144131323279258,0.9557324988779794
COR-L105,5281321,-2.635307184860664,-0.7120170467633925
KU-19-19,selumetinib-piperlongumine (8-1 mol-mol),2.2054937321135775,3.6549636523377194
LS180,11234052,4.148077533652898,4.177202624311995
MOLM-13,sirolimus-bortezomib (250-1 mol-mol),0.2337551440217556,-1.2566939866849502
COR-L95,25154868,4.601001468087818,4.324003101440314
Daudi,3025944,3.5610963405625267,3.6632216750586064
SW48,24180125,2.6937498240420457,2.955196893167374
SW948,navitoclax-birinapant (1-1 mol-mol),2.127959258569347,1.4948726224503812
PaTu 8902,168312962,5.583922762984923,1.889784453811791
COR-L105,5280436,1.8180108392693488,3.5367662319932136
SU-DHL-1,44507138,1.5242294298964132,1.7974170908063583
MOLM-13,10302451,1.7245492330691454,2.492288950187782
HARA [Human squamous cell lung carcinoma],72376,-2.3262904878865083,-1.8777147200487934
SK-HEP-1,44607531,1.6636821475505756,1.6795740197635742
IA-LM,15983966,2.169762444969255,-2.6107447950539737
IGROV-1,56946209,-4.416985130578084,-4.008431886169497
P31/FUJ,25126798,3.55669651950966,3.435917850180587
LS180,piperlongumine-MST-312 (1-1 mol-mol),1.6478111921038412,1.8790207953737244
BICR 31,15983966,1.7355748159582445,-0.3940600480436064
ML-1 [Human thyroid carcinoma],carboplatin-UNC0638 (2-1 mol-mol),3.254418532258765,3.3387739371382663
NCI-H1568,135421197,1.29303587511011,2.2724887157184064
HEL,374536,0.3200488785786777,1.004895289687888
NCI-H1568,25161177,4.305259269080427,4.060000764956114
Granta-519,24951314,0.3336244464551668,0.1599737811825285
LS180,400769,-0.7559227838025858,-0.7777668211881938
MDST8,44607531,3.32682409463767,1.6331457476726008
WM115,46843906,3.7194943725295992,3.099756047531146
RKN,24771867,0.8860225124393014,2.64434133239304
HCC15,tanespimycin-gemcitabine (1-1 mol-mol),-1.7446538355575971,-0.9435523256736377
MDST8,72734382,4.130038178532864,4.880926549671327
SK-CO-1,1750826,-0.0283504159212216,-0.5921602000859592
MOLP-8,10184653,1.0374255182903005,0.9213177955934034
NCI-H1568,46398810,2.1853633940590966,2.593091310372456
PaTu 8902,6438330,3.32865710338655,2.260428697295114
K-562,60700,0.041873955903415,-1.4875934336501877
KU-19-19,23725625,4.865374475902274,5.078285132447652
BFTC-909,6438330,3.0201113942824436,2.1219856610125665
Panc 02.03,JQ-1-vorinostat (2-1 mol-mol),1.3831414404100788,1.094292213213557
HCC15,65064,4.883028365063005,4.963655066715915
HCC1500,285033,-0.4229420433590342,-2.2131822365147626
LCLC-97TM1,navitoclax-pluripotin (1-1 mol-mol),-0.4086079898924854,-0.7118600108793026
LCLC-97TM1,5479543,3.538440111241957,3.4888491727771958
PaTu 8988t,613753,3.3970334474933495,3.185692324075965
SU-DHL-1,tanespimycin-bortezomib (250-1 mol-mol),-0.8883081844697346,-0.6500124001489717
SW1271,2949965,2.7362256869687895,2.6665667730717475
SaOS-2,4705,3.668938036329027,3.312195813665022
KU-19-19,11364421,2.01242470272022,-1.1122175573657829
SW1271,676352,2.2943086949623885,2.2677217414557957
RKN,24856436,1.2279395925477072,0.15172475836214525
SW48,159324,-1.9628962598081805,2.6438734375765645
ALL-SIL,568763,-1.7129740739789223,-0.43001448947499915
ML-1 [Human thyroid carcinoma],73707398,0.9772448893034968,1.5265958090077785
WM115,9907093,3.0763750955907883,4.3257187785592714
SW948,637858,1.5262532123254355,1.4802103406803504
PaTu 8988t,24901704,4.232615528659116,3.43119504495437
SU-DHL-1,11238147,0.4308170484254632,2.3444634039056496
BICR 22,alisertib-navitoclax (2-1 mol-mol),0.0230518675395602,0.5485947505108757
COR-L105,3634881,3.59150153069964,3.310051126416117
BICR 31,49766530,2.6564815829329236,-0.6103699998501037
SU-DHL-6,439501,-2.4303946334698057,-2.4497314477272827
SK-CO-1,6438330,2.884853035173295,2.463787587668394
RERF-LC-MS,tanespimycin-bortezomib (250-1 mol-mol),-0.8960063928147526,-0.4925562656459876
SW948,23635314,-3.685869994463448,-2.4292620635482334
ML-1 [Human thyroid carcinoma],24951314,0.9772476096511332,1.6237878659620357
RCC10RGB,24753719,5.18895385781671,4.422182181414081
RKN,tanespimycin-gemcitabine (1-1 mol-mol),2.340236610046533,-0.4970408034797934
HCC15,53481919,4.945944641956239,4.031664024940108
HARA [Human squamous cell lung carcinoma],52947716,4.13690029570622,-0.4376440362100411
BICR 31,11612883,2.9886930364048387,2.9690468158958856
HEL,20959075,-3.3486318540939535,-3.0566219850937695
SU-DHL-1,24964624,1.891650824203322,2.0007304335893337
K-562,11609586,2.0906528510972775,1.921054400635997
KU-19-19,89183176,4.239044338938638,4.633880166222349
MOLM-13,9927531,3.44947203831576,4.1883112145244965
COR-L95,10302451,3.773437494355592,3.161615556050634
SW1271,10385095,1.244878723840673,1.2640533606201618
SK-HEP-1,navitoclax-MST-312 (1-1 mol-mol),0.5798914619314417,0.8855276139651962
IGROV-1,17755052,-1.0246415273055465,1.7534076082839298
Daudi,3634881,1.264969339465191,2.478995070509509
MDST8,46224516,2.508010817025431,2.7030038695793497
SK-OV-3,65064,5.055886881526936,4.9918316521063
IA-LM,11364421,2.389092199855664,-3.638763509265237
P31/FUJ,6918878,-0.2487475841908946,0.3629069099912941
SaOS-2,426756,5.396474834861055,4.243656993546528
MOLP-8,25150857,0.9011737742745826,1.5863671065514127
BFTC-909,11167602,2.8757137848929006,2.5815350950859175
RKO,10302451,3.926970734642152,2.428279136227529
HCC15,6252,2.2097348223357396,1.1506149130866314
PaTu 8988t,135421197,1.788370067257354,1.8254580794603337
SW48,42642645,-1.378549292450493,0.9537266760021393
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-2.6549725244589126
COR-L105,73707398,2.56355231698926,1.5392444258323377
Panc 02.03,3854666,5.373190444337423,2.6058692978359064
WM115,11404337,-2.7813606850874595,-0.33038534843094325
MDST8,selumetinib-BRD-A02303741 (4-1 mol-mol),1.9743607330604616,2.955080777850532
K-562,9803433,4.389269041756261,4.483709752909774
LCLC-97TM1,JQ-1-vorinostat (2-1 mol-mol),0.588169137305971,0.6717111295757037
SW48,11152667,-1.5089069748808788,-0.23938401440117402
MOLP-8,BRD-K55473186,4.200306440270822,3.773804517734376
MOLP-8,3854666,0.8063321236158104,0.8592521958004536
WM115,156422,4.742483160763306,4.020683894560799
BICR 22,10302451,3.218470138701286,2.4160768562126775
P31/FUJ,3815108,3.712799909664185,2.17995308844117
SK-CO-1,5280436,3.963354946284049,3.3529362358168338
SaOS-2,11625818,4.3669462586555055,4.5089614747654165
SaOS-2,serdemetan-SCH-529074 (1-1 mol-mol),2.337619260674083,1.9214096854191498
NCI-H1568,24856436,-0.7402646666066086,0.6703962793512368
MOLM-13,19582717,1.836192229041244,2.6871565839739238
SaOS-2,selumetinib-vorinostat (8-1 mol-mol),3.065255136374356,2.715830142627589
LS411N,65064,5.143309491248943,4.807567008811283
HCC15,selumetinib-PLX-4032 (8-1 mol-mol),2.5653564815538075,3.4856983881776484
SW948,1716436,3.337695569228523,2.7179284278216174
HEL,60750,-4.342121097179363,-2.9271488674860975
SW48,5738263,2.8832489904283207,3.3666062953069114
HARA [Human squamous cell lung carcinoma],216468,1.0737616041415703,3.187300084006121
LS180,135984461,4.839780886141452,3.9044128336969215
ML-1 [Human thyroid carcinoma],123631,2.4078761561490025,2.4820059315135463
SW48,3634881,4.093042888484318,3.0924767043718977
WM115,82146,3.7974591517158,3.983909042477669
MOLP-8,24901704,2.731912612856625,2.1632147160469817
SU-DHL-1,9826308,0.1808938529022712,0.7082880032269447
SK-HEP-1,60700,1.3088528574816594,-0.07117082147286867
SW948,49793307,-5.1176222473357775,-3.205532499350525
BICR 31,selumetinib-decitabine (4-1 mol-mol),4.509241156469813,3.598855897144763
P31/FUJ,15953870,2.7000087530897776,3.034025886226911
SK-CO-1,24901704,3.265743022928408,3.1678968489407824
K-562,selumetinib-UNC0638 (4-1 mol-mol),3.2530488329097698,2.571634475596739
Panc 02.03,100016,6.582809568040202,6.184245372829776
RKO,168312962,-2.5117583451491012,1.0657121126184104
RCC10RGB,25126798,4.759098567819552,3.853423025008459
SW1271,24964624,2.7126751219569147,2.3908245140373263
ALL-SIL,9444,2.1167841583667277,3.3961435528533963
SW1271,1641662,3.842487885295187,3.515675365726405
BICR 22,676352,2.452861704781308,2.1088979019718566
K-562,54596558,4.166105900128149,4.182690750128332
Panc 02.03,9933475,2.3025810529048205,2.0762355760684845
NCI-H2452,374536,-3.751500666928139,2.8488690533815566
SW48,9825149,0.0451584979105152,2.036752248602843
MDST8,3634881,2.8722303311625006,3.2182163300404043
SW1573,24180125,4.83914798243841,2.9491812515566256
WM115,42642645,1.5932691238490415,0.8591761266136241
SaOS-2,24753719,4.762341084721446,4.338848060931467
SK-CO-1,25062766,1.7088187930933407,2.194773060095628
Daudi,71466445,1.7957550148901065,2.2744080745647337
K-562,9903786,3.6050720376028105,2.4809744362826316
MDST8,5281321,-0.743993786053836,-1.1214796550895885
WM115,216345,2.152490626678771,3.6169139365327125
RKO,salermide-PLX-4032 (12-1 mol-mol),6.251314610722333,4.566627772278784
Panc 02.03,44566777,1.8066319547984584,0.6399615336932643
Daudi,carboplatin-etoposide (40-17 mol-mol),-0.43265013296543,0.6053206874239573
SW48,1716436,3.2732206570492512,2.9508004686642018
KU-19-19,serdemetan-SCH-529074 (1-1 mol-mol),2.9806718783116337,2.3211823978029504
COR-L95,5281321,-5.086788267908354,-1.8355251740388625
ML-1 [Human thyroid carcinoma],2126,5.801287401499987,4.721904549516512
LS180,5287620,-2.159393408078438,-2.132724374969671
HCC15,24856436,0.7194572205096856,0.7769634692464596
HCC1500,JQ-1-UNC0638 (2-1 mol-mol),1.6511332544763542,1.1326455898297596
RKO,BRD-A02303741-carboplatin (1-1 mol-mol),3.1646455891745084,3.861094699081834
K-562,54613361,-1.429503199294265,-0.5458400541201661
PaTu 8988t,5311281,3.776140248734943,2.2266620195670526
HCC15,10090485,4.457627969814505,3.8763515754211375
LS411N,1242560,3.5784744482633526,2.9894234114382976
P31/FUJ,JQ-1-carboplatin (1-1 mol-mol),-0.13727273351174,-0.3378135185674979
MDST8,3854666,1.4298592595361392,2.2688557414536756
HEL,carboplatin-etoposide (40-17 mol-mol),1.8930260059492108,0.8998587001319472
BICR 22,doxorubicin-navitoclax (2-1 mol-mol),-2.5908889748637467,-0.7286225161474443
SaOS-2,448949,2.4147534872316916,2.231930303293205
K-562,44607531,1.5533391017282614,1.1638963158243165
RKO,656346,1.2468664563159324,0.5379456527412786
SW1271,54619267,4.215254166837184,4.1117130714522325
PaTu 8988t,107985,-3.7439330143768106,-3.735624832116193
Daudi,107985,-4.311158471957254,-3.9827518401036524
K-562,89928392,1.1726799483120014,0.6186285901219226
BICR 22,2828334,6.182973514514405,6.182298436603652
PaTu 8988t,462382,0.0850922030405946,0.6302624494813981
COR-L95,54619267,4.025082196689936,3.8906199454152794
SW48,44486219,4.521255071137468,4.05275314697764
MOLP-8,136227924,1.5113872866650588,2.5935570042179408
SU-DHL-1,vorinostat-carboplatin (1-1 mol-mol),1.1997073903631768,2.882380375854503
LS180,176870,3.0513508415646644,3.146100351914654
ML-1 [Human thyroid carcinoma],409805,4.766723032315811,5.156617657760548
NCI-H2452,60700,-2.076184021255351,-0.08761905343081423
ML-1 [Human thyroid carcinoma],3465537,2.728802739434878,2.5684470676042945
Daudi,2749,-0.7661278600765006,0.7342436357126395
SW1573,SNX-2112-bortezomib (250-1 mol-mol),0.5082376174745985,-1.1734056079400792
HCC15,11364421,-3.377820549130246,-1.55338208360946
ALL-SIL,135984461,1.7193250250744925,2.684762672192558
HCC1500,1750826,-2.1124887265082255,-1.0660104389400857
RKN,53392493,3.005817826052642,2.755963839071418
P31/FUJ,JQ-1-UNC0638 (2-1 mol-mol),-0.0749230690326744,-0.021362392709899335
BICR 22,5287969,-2.619429839358568,-1.7211540468614441
BFTC-909,24978538,2.589526114093726,1.4627102138012535
SK-HEP-1,2828334,6.264472809398218,6.107630459574555
Daudi,4705,2.565440722309658,2.797621308785855
HEL,11485656,1.96241131365886,1.2496403712931805
BICR 22,23582824,1.0399288647056628,0.8603771578457156
Daudi,doxorubicin-navitoclax (2-1 mol-mol),-4.527956590288398,-2.3092532972446618
HCC1500,navitoclax-gemcitabine (1-1 mol-mol),-1.5596806456791137,-1.2148368804818768
MOLP-8,11364421,-5.744944118703229,-4.175664408665883
COR-L105,374536,-3.312479831607182,2.6335847316701884
SK-CO-1,56973724,0.9140094173628892,3.2787604728533277
HCC1500,135440466,3.12374064827048,2.2963694907873426
COR-L105,24978538,1.189273057385404,1.4580569862839343
SK-HEP-1,45279963,4.052806603396004,3.8483002442388754
K-562,11317348,0.8853213314815674,1.6204722434458168
RKN,6918837,-0.6134153399361431,-2.4153189362029694
LCLC-97TM1,285033,-3.3608842191269104,-1.694614817897572
HCC15,11455910,-0.3399110905288865,1.286167914842698
SK-HEP-1,176870,5.630942733934813,3.5926037766422207
RKN,23635314,-1.997093039658799,-1.6501458678070458
HuP-T3,selumetinib-BRD-A02303741 (4-1 mol-mol),4.443167910893738,3.832583453182017
IGROV-1,serdemetan-SCH-529074 (1-1 mol-mol),2.258983073493191,2.064810704161391
SW948,969516,2.384481795832599,2.5551062716665283
WM115,24180125,3.7433275341391057,3.0991072517404654
SK-HEP-1,135440466,3.4774178685499324,2.4303620053052537
KU-19-19,11626560,2.7733848967135017,1.8803229574206863
ML-1 [Human thyroid carcinoma],675434,4.374805668496918,4.671338381470678
LCLC-97TM1,44507138,1.7278080476353117,2.4001700009665443
SK-OV-3,25150857,2.8200349544845045,2.6272941826178093
HCC15,44491742,4.47716804785037,4.259990217736624
NCI-H2452,carboplatin-etoposide (40-17 mol-mol),4.403260682335101,2.940396890338172
LCLC-97TM1,25150857,2.1625900659079296,2.337387290828452
P31/FUJ,124202324,0.9428129005296164,1.0606401328240653
IA-LM,BRD-A02303741-navitoclax (2-1 mol-mol),1.2493454608743932,2.085563642385087
COR-L95,6505803,0.0712785503404296,-0.7976231418643251
HCC15,24964624,3.0755429715166063,2.4647923888269307
MOLP-8,11647372,0.2904161448795228,0.07076248453426631
BICR 31,11977753,-1.0341786941527915,-1.1445012112936714
HARA [Human squamous cell lung carcinoma],216345,4.215325728716343,4.148639615259704
HuP-T3,5282054,2.779269170716028,3.9760106479239914
SW948,54618771,1.4567685239775812,1.2206845519164216
Granta-519,24797083,0.9051026865971544,0.6689485626750716
SW48,73707398,0.6331221198690845,1.2802603453414927
BFTC-909,135411,0.8518885281649031,0.8823608265789101
HCC1500,675434,3.977739266447536,4.564044377314765
SK-HEP-1,6918328,0.8938731782790444,0.2931552158771511
ML-1 [Human thyroid carcinoma],2113511,5.6174346670931286,5.668471293714394
LS180,159324,3.258862193159196,2.8704572941286632
HEL,168312962,0.5016152377841688,0.4576117781586963
SaOS-2,44607531,1.4975746891341548,1.590707994049638
IA-LM,vorinostat-navitoclax (4-1 mol-mol),2.163605213189375,0.9669683314779565
MOLP-8,6610216,4.187822370904977,3.8456754989627524
HCC1500,5278396,3.6802956879537856,3.517597862688065
K-562,445643,4.07029800941494,3.61963745254317
HARA [Human squamous cell lung carcinoma],11178236,-2.833191042701781,-3.454028364903788
Panc 02.03,5351362,2.6810485074832,1.7559124597954459
BFTC-909,23725625,7.000464253417552,5.169151541204875
SK-OV-3,8515,5.143916520422132,4.187415116165968
RKO,24779724,5.847036108864024,3.555297803902349
MOLM-13,65064,3.286890258414819,4.137940644552916
P31/FUJ,9868037,1.2869642230829814,1.8257070603903347
MOLP-8,52912189,-0.8757353744499203,0.12136398852086874
HCC15,2113511,6.327015395869061,5.622625108006279
IGROV-1,25183872,-0.4560099928976716,-0.8563793594808784
MOLM-13,44259,-1.8425758706378912,0.7967870148285704
P31/FUJ,9911830,2.020541196825024,1.6575183268888503
NCI-H1568,11455910,-0.0792581795853734,1.3099247386756272
Granta-519,409805,2.9966967612339417,3.811909534964427
IA-LM,7251185,3.003277248553597,1.8326216048864978
LCLC-97TM1,24771867,-3.13973757551719,1.3114130724395054
SaOS-2,387447,-3.480142635313653,-3.9427091550993265
SW1573,JQ-1-carboplatin (1-1 mol-mol),2.7673375122522,2.2636476334626625
HCC15,71466380,4.492977556176778,4.558381275703956
KU-19-19,11178236,-2.578122805273377,-3.1349974402585996
SK-HEP-1,107970,2.7276242080982405,2.366906433139016
SW948,3503,2.019264798250741,2.305341920710489
MOLM-13,11455910,-0.3133362084586128,0.3032714273622233
COR-L95,216239,1.9606601522489808,2.1485629327381317
MOLM-13,20959075,-3.627453597088981,-3.283890600007422
SW1573,3543504,3.864321270652805,4.6457626198417294
NCI-H2452,16722836,1.367876124233394,1.8233747885738938
LCLC-97TM1,2949965,2.4577774402858203,2.523464457944794
HARA [Human squamous cell lung carcinoma],5479543,3.520150804916199,3.851226339461693
SK-HEP-1,9911463,4.3683168964450125,3.8436098949248105
P31/FUJ,11404337,-0.879305702132212,-1.086436583841495
RERF-LC-MS,23725625,5.011639185934848,5.375211097124005
LS411N,alisertib-navitoclax (2-1 mol-mol),1.9281713469171404,0.3112711173974931
SW48,126941,-4.535727103151088,-2.7131569902950763
BFTC-909,6184667,3.207156937684644,3.025320072985924
KU-19-19,2945648,2.475372674219151,3.1286523306248957
HuP-T3,387447,-4.787053098216054,-3.9658253498579814
Panc 02.03,44493528,4.298055948100647,4.322206210696659
Daudi,4788,4.597613323137637,4.88324043767676
K-562,46907787,1.0881737362577,-0.0777991681464158
HCC15,6505803,-2.813846830430111,-0.6298813895455505
MOLM-13,3503,1.2246558483585983,1.735624350103873
NCI-H1568,136227924,3.032081072579533,3.1608201775688745
RKO,9444,4.448790979485227,3.707783891700003
Daudi,107970,1.216737596928884,1.90459581548448
Daudi,5311037,3.4563783042396015,2.7216432009120255
SW948,10184653,-0.1197105127119604,0.8107670007895389
HEL,89928392,0.5480178499310975,0.2964534618774697
SK-HEP-1,5566,3.210365271342881,2.9684107512233617
NCI-H2452,44493528,4.324080951064212,4.498075677352126
SW948,24753719,4.222068008445673,3.48491484848117
K-562,11717001,4.3318290739670555,3.94130319422411
HCC15,11647372,2.6612404016221824,1.2757582560808407
COR-L95,11214940,4.129361910595318,2.0956388801245005
P31/FUJ,57330099,4.216278217816623,3.7037792303652948
COR-L95,24889392,4.336996294263524,4.056352803185794
ALL-SIL,16725315,3.2612856597636064,3.21627615324317
SU-DHL-1,2749,0.1348057545057474,1.924747166310367
IGROV-1,6918736,-0.950858733923241,-1.377845060197082
HEL,46398810,0.908204113249262,1.7618822879350833
COR-L105,969516,2.680370673187369,2.7888953675233683
MOLP-8,613000,0.7667530859484226,2.11952223291546
HARA [Human squamous cell lung carcinoma],6252,0.9917938801151434,1.2867704868058345
SW948,375860,-0.5776308885037049,0.03334160119413056
Granta-519,6438330,1.446800550416973,1.13288505552874
SaOS-2,3384730,0.9471099210722488,2.833952620798162
COR-L105,navitoclax-pluripotin (1-1 mol-mol),-0.739242899323645,-0.6509143087404158
SW948,10127622,1.0689347689119728,3.15292415037146
SK-OV-3,104842,-0.359869843998673,-2.445193366291821
HCC15,2733526,3.237047771361035,3.8458873274361194
ALL-SIL,9884685,1.523019065964201,-0.5150172481665263
HCC1500,31703,-0.1591983874970776,-1.14038962132
MOLP-8,24785538,-1.5077289265748457,0.4517627695734436
COR-L95,6918328,0.296514622397876,-0.4190276897958084
LS180,24964624,2.8898766327054153,2.4311225804711323
PaTu 8902,2945648,2.947030382730425,2.9875499026844055
IA-LM,16038120,1.0865848932778794,0.6307239231083
Daudi,54619267,3.035333918034676,3.6936966344565105
Daudi,5284373,1.725683673378691,2.322780721648728
SW948,56946209,-4.45606402023299,-4.005607184126405
SU-DHL-1,9956119,2.7884192993685666,3.521094955686952
PaTu 8988t,3689413,2.4784022576221836,-0.14314521167206767
WM115,44241473,4.443917717257507,4.866426035593788
HEL,11507802,0.749942791895586,0.681435339064465
LS180,25150857,2.6595729662678846,2.3998557340427826
ALL-SIL,11964036,0.9057184864624424,0.3472354482704918
SW1271,5351362,2.529410314371741,1.5108821944421909
KU-19-19,151289,4.45756440863607,1.169975203455221
MDST8,24785538,2.8042557252914597,2.011415407635025
LCLC-97TM1,11228183,2.6499520646531254,1.6993174589417768
NCI-H1568,10127622,5.078058454742808,4.388947579769857
RKN,676352,2.5860960344205175,2.1716626195067796
WM115,6505803,-4.475953396274594,-0.3267963227507162
MOLM-13,5278396,2.870927952465231,3.0467384476620856
SW48,1641662,2.4016053281737544,3.518092204703245
Panc 02.03,5329102,3.1751218779490404,2.3260616545045054
P31/FUJ,136227924,2.3905530687579497,2.372196234143972
LCLC-97TM1,5281321,-1.0764177966981967,-1.410027764875039
SU-DHL-1,23635314,-2.2508595154996844,-1.2641326194797973
SK-HEP-1,navitoclax-pluripotin (1-1 mol-mol),-0.7942291093316414,-0.7701839389019556
MOLM-13,44494015,-5.247330257185634,2.722984614667683
SK-OV-3,carboplatin-UNC0638 (2-1 mol-mol),3.7911977444327034,3.3242508659115555
HCC1500,46199207,3.053954841618667,3.0008200014648363
NCI-H1568,6610355,3.436001375430949,4.607795698551479
HCC15,54618164,4.329878027642837,4.104968012939669
RKN,969516,2.6409066030454804,2.881730546828123
COR-L105,71680916,4.738410817171978,4.893428982880477
SU-DHL-6,3634881,2.3700422517918653,2.60555436234401
Daudi,374536,1.069903440531545,1.0982883511937402
K-562,322968,4.0833948777840225,2.7037991312252014
HCC15,tretinoin-navitoclax (4-1 mol-mol),0.5454082454604786,2.737878097803593
K-562,136227924,2.737847329779252,2.4727351481075504
HCC15,15953870,3.1000423449826275,3.5514693185783917
BICR 22,6505803,-0.8504421983690468,-0.6429485346583189
BICR 31,409805,3.7719372874267982,4.926605150515522
MOLM-13,navitoclax-pluripotin (1-1 mol-mol),-3.59227040291678,-1.6548075206476591
KU-19-19,71304818,1.8280747292346609,2.6499481317644906
SW1271,6917907,-6.616351101315701,-4.654342331391559
SW48,44589607,2.4172125993075335,3.0082278701854324
KU-19-19,3854666,3.1161318305167995,2.228374810028798
MOLP-8,11404337,-0.9705317414577028,-1.234535501088272
SK-OV-3,11152667,-0.6824217491873509,-0.08220271889500054
LCLC-97TM1,72199292,1.0139745528188595,0.6662751944202305
SK-OV-3,5566,3.179406871626594,3.14945278090908
SU-DHL-1,11683005,2.624367478757415,2.607512445856232
PaTu 8902,71466380,4.078142681912824,4.611832233046969
Daudi,56963564,0.012925039709307,-0.4613500356764246
HARA [Human squamous cell lung carcinoma],656346,-0.3153592740671193,0.7483983129235425
SU-DHL-1,25195348,1.1859308431356896,2.5346081067076907
RERF-LC-MS,11494412,1.0302757077826894,1.875740173907849
IGROV-1,3634881,2.769147818550815,3.3661517976347306
SW48,445643,3.7110082204631545,3.9104107074266494
IGROV-1,3854666,2.3355254440561137,2.211039523851018
BICR 31,tanespimycin-gemcitabine (1-1 mol-mol),0.6260798256664765,-0.47113821662157696
HARA [Human squamous cell lung carcinoma],49867926,4.231294833351195,4.342022943952374
PaTu 8902,387447,-3.44390255134181,-3.7777693395033514
BICR 22,25150857,2.1797682691439233,2.439755755525568
SK-HEP-1,54618164,4.274964046269975,4.207579777720327
BICR 22,44493528,4.288893884195869,4.3858655937047155
NCI-H1568,969516,2.3539842482072353,2.7794855236560676
HEL,52912189,-0.3930066433927971,0.21758392547764402
BICR 31,53392493,3.0187901836288824,2.6574334245497004
Panc 02.03,6610216,4.56797737488032,4.214563173691397
PaTu 8988t,selumetinib-UNC0638 (4-1 mol-mol),4.596522805557342,3.2415341334280985
SaOS-2,445643,3.906030165734591,3.7777935077498954
SU-DHL-1,9967941,3.123701665105139,3.2772024321471043
P31/FUJ,10113978,2.718593007254544,2.169778710774752
K-562,54618771,1.1969173800987956,0.4995897955173224
SW1271,445643,4.255849699563793,3.934192913962658
SU-DHL-1,16741245,1.9818901112506189,3.5905994243663084
Granta-519,selumetinib-GDC-0941 (4-1 mol-mol),1.138104902542422,0.12659051078322758
SU-DHL-1,9935249,2.376788737359572,2.364815303344527
HCC1500,doxorubicin-navitoclax (2-1 mol-mol),-1.8241267045237697,-1.0189562209167746
Daudi,11625818,2.088957631704298,3.1617897183727264
IGROV-1,11213558,0.52356811652227,1.7705709812368327
HCC1500,selumetinib-MK-2206 (8-1 mol-mol),4.693148185456232,2.2308957414261195
SaOS-2,9907093,3.731287417721421,4.2489070749453095
COR-L105,54618771,2.0419110046350135,1.5748457949364876
RKO,9935249,5.020114551473781,1.4251830231645746
RCC10RGB,54649381,5.891551456540707,4.057903436965579
RCC10RGB,11228183,3.0224846047699288,2.66118730517775
BFTC-909,selumetinib-navitoclax (8-1 mol-mol),4.610305702630868,2.348360328221096
ALL-SIL,11683005,2.0727325774258794,3.1966480858914355
RKN,9935249,4.428036529076262,3.26556635623187
SK-HEP-1,6918837,-2.2229066751457345,-2.2206373801577755
Panc 02.03,36462,3.4500230117265933,2.298856718740818
SU-DHL-1,9866186,-0.7631869517914462,1.1160970225998503
LCLC-97TM1,448949,2.0046135576158637,1.8791029180923708
SW1271,2858523,3.03244629786768,3.06470051393096
SaOS-2,46398810,2.449640817433895,2.685756224068285
ML-1 [Human thyroid carcinoma],navitoclax-piperlongumine (1-1 mol-mol),1.771267146894677,1.8552144011182135
COR-L105,16013152,4.074366111138725,4.141996644150018
SW1271,10127622,0.8769341404821704,3.1521267044025985
PaTu 8902,24951314,1.6215809376037376,1.4319068207481147
P31/FUJ,navitoclax-birinapant (1-1 mol-mol),-0.4716815446348188,-0.0731092060368884
NCI-H2452,sirolimus-bortezomib (250-1 mol-mol),-3.2659140212788733,1.071073728541001
Daudi,72199292,0.1565760694605324,0.4558838989485507
PaTu 8902,409805,5.142449436796194,4.71962084845017
BFTC-909,16115403,-3.993091010962378,-3.93887726547577
LS411N,serdemetan-SCH-529074 (1-1 mol-mol),2.4339981987212256,1.7014973408194027
NCI-H2452,6505803,0.3706171048891257,-0.16114098052274206
K-562,123631,1.7867714727142892,2.2050307092777643
SW948,selumetinib-vorinostat (8-1 mol-mol),-0.2109654118959779,1.8889505120245211
SW948,56963564,0.1376223024943695,0.19664043192918526
P31/FUJ,doxorubicin-navitoclax (2-1 mol-mol),-2.963925883799113,-2.302784042621947
KU-19-19,25183872,1.353604037781074,-0.6275291851538609
K-562,462382,0.6666012292356907,0.5334765616601714
BICR 22,216239,3.622359576149126,2.393814580953468
SW948,72376,-2.235310823117723,-2.870857614162465
SK-HEP-1,16736978,1.840110323821058,1.8378880694676647
LS411N,135440466,2.8415058675889,2.1391651809731838
BICR 31,2871966,0.8542621552894032,0.8918096907014973
NCI-H2452,5311281,2.597680352332147,1.9886708043483439
HEL,25195348,3.2451646073619416,2.3868414987272355
MOLP-8,navitoclax-MST-312 (1-1 mol-mol),1.0636024254561756,0.4283780347604912
SW48,24856436,-0.3608375787119608,0.26525998393471933
COR-L95,23582824,1.713723586402061,0.5743271460541323
NCI-H2452,400769,-0.2625889565980605,-0.492384591766406
Granta-519,6610355,5.056177796240837,3.898073502816106
RKN,135984461,0.6080422026652917,3.8530919365990646
IGROV-1,9956119,3.7231415872817024,3.8166016729226078
SU-DHL-1,24856436,-0.2626900450765423,-0.5382028132603116
BICR 31,9911463,4.617619725588035,3.900303554802175
BICR 31,2742550,4.742856926113666,3.7900449418946085
Daudi,6450551,1.0042642679666238,1.4348398025339513
HEL,57519531,1.593967479342305,1.7112467814005063
SW948,sirolimus-bortezomib (250-1 mol-mol),0.0443839489335638,0.5779019486684749
RKN,216345,4.602972623005823,3.97948020557995
SW48,46224516,2.362473255058207,2.3695520817549856
RKN,10184653,1.939164173873933,1.4899867719211477
MOLP-8,31703,-3.4249459011432912,-2.476120421922062
HCC15,9911830,1.9028880277746671,2.4466296461631303
P31/FUJ,24180125,3.650250525491935,2.1914170043500385
HCC1500,11427553,3.400784702269924,2.840648316265371
WM115,4378219,1.986798403927216,2.459955026384969
MOLM-13,445643,3.334033231716822,3.5396995541379526
HuP-T3,135440466,1.565116417651368,2.1493440945743476
ML-1 [Human thyroid carcinoma],44491742,4.3341380025681175,4.2896711811318085
SaOS-2,5284616,3.138246393599145,2.6212207151307125
LCLC-97TM1,156422,4.251965697410575,3.5718324283288827
Granta-519,71680916,3.9040498639791226,3.799859046900591
SU-DHL-1,16725315,3.3729799888412257,3.9050431507715397
P31/FUJ,20959075,-3.3972839651855207,-3.0919530678729052
K-562,16720766,1.059873963232806,-0.2735983269434
WM115,9915743,2.6223908273409515,1.075713191157019
COR-L105,11238147,3.8255779395664065,3.1971607247077443
HCC15,6918878,1.2461206152093485,2.9214260804313743
SK-OV-3,11427553,3.3243369937323877,2.9097343874321733
RKN,6918736,-2.1202784612128416,-1.694396548465582
NCI-H1568,10385095,0.5241849666466598,1.3189544834541258
LS180,6623618,2.712323731600185,2.4266059958300072
COR-L105,BRD-A02303741-navitoclax (2-1 mol-mol),1.6973601808682428,2.8010884713063224
COR-L95,5287620,-3.7742892062529183,-1.8084850993727901
Daudi,11977753,-5.803293235753203,-2.6334964407405494
NCI-H1568,375860,-0.3746562160702436,-0.12738737298518008
Daudi,1242560,2.7879344365615633,2.9662209395980415
RKN,2729026,3.0549768432694377,2.772284308881244
SU-DHL-1,56963564,-1.155496663147979,0.28822842011694966
SK-HEP-1,42642645,1.5394057036271682,1.334233463564903
COR-L105,9935249,3.5389604716579175,3.313647266019183
SK-CO-1,107970,2.4721550322855843,2.4223231457585173
RKO,5113032,5.90165838842917,4.447546772336742
SW1573,135411,2.599466343128946,0.7900279785604342
WM115,selumetinib-GDC-0941 (4-1 mol-mol),-1.581349987351192,1.123827148513137
RCC10RGB,6610355,5.214940260192328,4.892729631273131
BICR 31,5287620,-1.513974949921974,-1.6327466636591559
HARA [Human squamous cell lung carcinoma],10427712,4.036967432982734,4.3429593257933945
RERF-LC-MS,72376,-2.3536044208150644,-1.5448772345364596
UACC-812,7326481,2.606201441290427,2.979262070844543
MOLP-8,11717001,3.6554432811683824,4.0670254126736385
P31/FUJ,1317464,4.709019850634407,2.9133267589593226
HARA [Human squamous cell lung carcinoma],9956119,4.138225192842101,3.6484794112116568
HARA [Human squamous cell lung carcinoma],5328940,0.878974684606101,1.6501667243177218
SaOS-2,44507138,2.054017263478066,2.26496021544075
IGROV-1,445091,5.8777802446160825,4.314762796524292
RERF-LC-MS,54613361,-1.445874788963763,0.04181574128255387
RERF-LC-MS,72193861,1.0218744083195843,1.863621747110325
RKN,vorinostat-navitoclax (4-1 mol-mol),2.458310168873828,1.239520417041723
HEL,56963564,-0.4081404928481738,-0.13963914280033202
PaTu 8902,136227924,3.2072125986231117,3.3629512851928896
SW1271,25183872,-0.9123448839798644,-0.5750777341510864
LS411N,navitoclax-MST-312 (1-1 mol-mol),1.1524396159944978,1.0118346114362073
IGROV-1,25154868,4.833387840688245,4.297897468592701
LS180,107970,2.4480125060803077,2.2960523203013277
RERF-LC-MS,9840324,5.508232790936476,5.703185906091411
HARA [Human squamous cell lung carcinoma],55508,3.1590088041564752,3.4074242279152505
ML-1 [Human thyroid carcinoma],6918736,-3.4697519345619843,-1.6090881306223608
COR-L95,60700,-2.695152938475503,-1.1272052992882513
HCC15,24785538,0.0662714662573936,1.6216404528309658
IGROV-1,selumetinib-UNC0638 (4-1 mol-mol),2.5141275878807563,3.0941744319636317
ALL-SIL,73707398,-0.324762560862376,0.4683408116750336
HuP-T3,23725625,5.187021863055133,5.218659520326403
IGROV-1,selumetinib-piperlongumine (8-1 mol-mol),2.9206278268520163,3.2838150134827115
ML-1 [Human thyroid carcinoma],53481919,4.335778865313171,3.9462667838156307
MDST8,6505803,-0.0816923181525763,-0.29986639299001283
SK-OV-3,5351362,2.7626479495985765,1.5412259506146018
IGROV-1,36462,2.313632721410001,2.033645922443321
BICR 22,54618305,4.315554591509874,4.203085152029136
MDST8,5311281,0.3396864368094036,2.3955074093232205
MDST8,9866186,0.4787443726889831,0.9966971236847952
COR-L105,9840324,5.89386509883338,5.758018410555045
SU-DHL-6,9887053,3.723065049771557,2.6236833678447993
SU-DHL-1,10113978,2.4232665022526154,3.1333146633197257
K-562,6610216,3.734328570580528,3.873337317197939
MOLM-13,9936388,-7.059788369591511,-5.405334504947506
Panc 02.03,vorinostat-navitoclax (4-1 mol-mol),1.4480782846728824,1.4787197286627007
WM115,135659046,3.4373276092449667,3.647824398038215
HARA [Human squamous cell lung carcinoma],16736978,1.7495486591528322,1.6363339722249675
RCC10RGB,2708,5.228545547030361,5.010807233783795
MOLM-13,JQ-1-navitoclax (2-1 mol-mol),-1.828604943394028,-0.383095582456994
HuP-T3,969516,2.913535439683091,2.9266671175129573
P31/FUJ,135398744,5.7727848933678,4.717149245225151
SaOS-2,168312962,3.518591614256865,1.533445743723241
BICR 31,docetaxel-tanespimycin (2-1 mol-mol),0.9040464385667872,-2.7097065955443598
Panc 02.03,11364421,0.2085573081853932,-0.5796672302727117
SU-DHL-1,3385,0.1709309619587451,3.4167773958009473
COR-L105,3854666,3.5309487733662923,2.499627565290715
K-562,3025986,-1.372296763308674,-1.2307692246242534
PaTu 8902,25183872,-0.4459453921876214,-0.4674611745004209
BICR 22,25022340,5.75714905141274,2.726931401595948
SK-CO-1,71466445,5.862416915369376,3.8528435418420575
HEL,159324,1.7687894675630291,1.426672634121215
P31/FUJ,135411,-0.6620772647112111,-0.21475245791647654
K-562,11455910,-0.068399521398108,0.2376598318627346
BICR 31,doxorubicin-navitoclax (2-1 mol-mol),-0.8834140125072127,-0.7271147049864294
SaOS-2,135421197,3.6760992974277817,2.1430264070100216
RKO,54678924,1.753529637740366,1.6321699053679983
LS180,9926054,2.059729849775666,1.8718391671663255
PaTu 8902,3081361,4.091517551590367,2.2212143996916893
HCC15,54618305,4.644823264977023,4.621184619126964
SK-CO-1,135421197,1.070123520764916,1.8649410536986175
MOLP-8,5282054,2.3704039128819603,2.7120489919630835
Granta-519,2874250,5.483813332492178,3.953004169930168
SW948,15547703,2.460178853059974,2.8772391786502247
RKN,11175137,3.1657803092866224,2.6765575028760322
HCC1500,15547703,2.6330912213710693,2.984221533479091
PaTu 8988t,3503,2.8268609009838706,2.17806032544736
P31/FUJ,JQ-1-navitoclax (2-1 mol-mol),-0.8945725612384452,-0.7608456196137675
NCI-H2452,409805,5.262030999116563,5.052596709254007
ML-1 [Human thyroid carcinoma],9927531,5.643924198323062,4.844748468751558
K-562,107985,-3.1543528536618175,-3.688137475000433
RCC10RGB,6918837,-1.099435459858538,-2.1286696991585163
HuP-T3,2746,4.662800576379415,3.44419334853509
Granta-519,135928012,3.1328015926823065,3.968429634096762
HEL,2733487,3.1527152778808794,5.473381956745985
RCC10RGB,11175137,3.603105896683611,2.6999374109727716
RKO,51039095,3.7257826703811014,2.3632499916247975
WM115,3689413,-0.1044392328624619,0.09944932710359441
SaOS-2,25154868,5.397428200613107,4.277854278327147
RKO,25195348,3.4491832635970585,2.724339188658133
BFTC-909,49850262,4.237463012213885,3.4689725402103777
SW48,168313047,2.500888470511616,2.137760853074679
WM115,444795,4.375682835505768,4.744139015501044
IGROV-1,5738263,4.037832478240785,3.483939102133446
MOLM-13,24748573,1.5626639761830592,1.4022193198102832
UACC-812,6917907,-5.293133909322777,-4.211873957577046
IGROV-1,168313200,3.9938362637732983,3.0829760188618707
PaTu 8988t,262093,3.2462588578894587,3.057061764150411
KU-19-19,selumetinib-navitoclax (8-1 mol-mol),1.098074451823129,2.093694646448095
WM115,3543504,4.159835009416132,4.473511306108772
Panc 02.03,selumetinib-MK-2206 (8-1 mol-mol),1.9117134680972272,2.38360839448649
SU-DHL-1,9903786,2.5464454731205777,2.501823206369295
ALL-SIL,6438330,0.5772640537372373,1.1203782186497107
SK-HEP-1,322968,4.726859452680793,4.032470197296141
ML-1 [Human thyroid carcinoma],1716436,2.512454049061402,3.071082986081084
WM115,2874250,4.6839306454467975,4.184795456214689
HEL,327653,2.969363674974165,2.4797867496595227
SU-DHL-1,11625818,3.655247454502854,3.6674563461199803
UACC-812,49766530,0.2629782697340875,-0.5273552435137417
SU-DHL-1,3815108,2.229733806447586,2.3816325042777446
IA-LM,71466445,4.189377103287156,2.895815927646524
HuP-T3,1716436,3.1901993610711092,3.1505479345393788
SW948,44566777,0.0218128389697893,0.7009220821643227
SaOS-2,24821094,3.1556587771151117,2.711517642583482
Panc 02.03,135875424,4.996461687769912,3.829377765212436
COR-L95,3136844,6.4544258549997675,4.027590477035455
ML-1 [Human thyroid carcinoma],72193861,1.5092085092070135,2.002547013212776
LCLC-97TM1,3385,2.7516430893834696,3.824936009368378
K-562,135875424,2.7247406179323055,3.1696881812665674
LS411N,5329102,2.797825403975713,1.6413124237004977
MDST8,24964624,1.7196440159479949,2.5165341152264946
KU-19-19,10090485,5.355458016675434,3.815170415615997
HuP-T3,vorinostat-navitoclax (4-1 mol-mol),1.7749149652569187,0.9596869145673853
RKO,89183176,-5.254565057669901,3.7475574273630543
WM115,decitabine-navitoclax (2-1 mol-mol),3.441832187102982,2.015988695310994
Daudi,24775005,2.5651956502981093,3.367768148975496
SW948,46215462,1.7533079238953375,1.239337855712723
BICR 31,6610216,4.499990209090508,4.117231781354833
ALL-SIL,89928392,-0.8842785165403505,0.17483465570863216
MOLP-8,carboplatin-UNC0638 (2-1 mol-mol),1.5821453597747015,2.9026952960926193
SaOS-2,9933475,1.7767718055197024,2.0209408069781225
LCLC-97TM1,16722836,1.3652485758433368,1.3371549742395492
LCLC-97TM1,49793307,-2.6941720612695814,-2.7261531186802506
SW48,10127622,-3.686333454689576,3.3089334536419903
Daudi,451668,-1.5751627659840317,-0.5934773003395828
NCI-H1568,135398516,0.1447365774963497,2.3038526457525097
MOLP-8,11178236,-5.22072808334844,-3.4016615891915545
NCI-H1568,46907787,2.5747387573296425,2.353744320836064
PaTu 8988t,6914657,-5.535111189097384,-3.4997612754035554
Daudi,vorinostat-navitoclax (4-1 mol-mol),0.7138664459313301,0.366907298018921
SW948,3025986,-0.0730103520402185,-0.583417072912768
IGROV-1,11612883,1.8715405446213529,2.74841496039256
RCC10RGB,3081361,3.5981013353753464,2.330216070167878
MOLM-13,73707398,-1.293008226929777,0.27945941145856934
RCC10RGB,9915743,0.9759946846108524,0.8991254239908038
HCC1500,24771867,4.066345817331682,2.434415932276165
K-562,44137675,5.346911467461658,3.029012784262558
BICR 22,89183176,4.4276408454646,4.107497322748245
MOLP-8,tanespimycin-bortezomib (250-1 mol-mol),0.0565968388812305,-0.647984658910022
BFTC-909,54619267,3.991913685478571,4.183690420054432
RKO,71304818,0.9175289508752972,2.0203608445303844
SW1271,selumetinib-navitoclax (8-1 mol-mol),0.9104447168636678,2.098553989519076
BICR 31,25161177,4.144120396566418,4.024946929829415
SK-CO-1,6918328,0.4731277879927994,0.19132800143605588
RERF-LC-MS,6914657,-3.1593675222943896,-3.2778651706957422
NCI-H1568,44185566,2.743919877007031,2.5566305249572707
BICR 22,navitoclax-pluripotin (1-1 mol-mol),0.259222956634469,-0.8471418499420238
COR-L95,6852167,3.112371536345172,2.650955388016908
P31/FUJ,5113032,4.875284905433655,4.143462525111564
BFTC-909,24180125,2.699370118217823,3.109057391781462
SU-DHL-1,6252,0.3334498529847555,0.692441068488068
K-562,tanespimycin-gemcitabine (1-1 mol-mol),-1.5492083628260829,-1.9192421268187945
LCLC-97TM1,322968,2.924684365208183,3.281296752710665
Daudi,60750,-4.624244800464318,-3.464081833831858
NCI-H1568,3385,5.30334090203815,4.153561656110128
COR-L95,5978,-2.5997235685562026,-2.369899324710433
Daudi,24856436,-0.3602858360333429,-0.5349524342111122
HARA [Human squamous cell lung carcinoma],54618771,1.4449475826214635,1.1551344785621007
MOLM-13,445455,3.1473640199222386,3.6470051669966206
SW1573,135421197,1.3915330004591782,2.1033501330583273
HCC1500,16065773,1.504426355167742,2.168694955484731
HARA [Human squamous cell lung carcinoma],54454,2.560964814308564,2.6786834154066
K-562,piperlongumine-MST-312 (1-1 mol-mol),1.115742811823549,1.1757282385241459
Daudi,9826308,0.3207715704810925,-0.11033977550540662
RKN,17759555,4.047966260499275,3.6483763294471783
RKO,navitoclax-piperlongumine (1-1 mol-mol),3.004924162452904,1.2114005558592618
PaTu 8902,9911463,4.390925153080421,3.87730823366679
LS180,54613361,-0.777399447336216,-0.49768815967943647
COR-L95,11396600,3.695258257335492,3.5752599580195623
SU-DHL-1,9911463,3.067527187401269,3.3710087344137274
COR-L95,4477,0.8356196347588036,0.2789199152601476
SK-CO-1,BRD-A02303741-carboplatin (1-1 mol-mol),4.065917743830426,3.7282262448682517
COR-L105,12001922,2.476912212032941,2.115748158338991
NCI-H1568,25154868,2.392234118098981,4.462858724047267
P31/FUJ,24964624,0.604485461730223,1.0886447323130728
RKN,11507802,1.1392194525963166,1.690061332162556
Granta-519,2746,3.996696473436098,1.6553738231637631
BICR 22,6918736,-3.590209831667407,-1.1323061739724836
IGROV-1,135423438,0.764137689665023,2.510268332774208
SaOS-2,5460769,2.263492155098724,2.4305806262150416
MDST8,3025944,3.984610722170807,4.354316463338194
HuP-T3,9935249,3.692881062494191,3.235530702489724
BICR 31,54618164,5.999146696375086,4.17146850793489
MOLM-13,3552672,1.8354180523958712,2.2359457784155783
ALL-SIL,24889392,1.2675997647257198,3.0234399481124563
P31/FUJ,5470400,3.6840145170482383,0.08056929041392376
RCC10RGB,68056272,3.770230744947895,3.621129241604167
K-562,135440466,2.878154323162211,1.8480452288040974
KU-19-19,16038120,2.2784541929956563,1.3289536359000034
IGROV-1,969516,2.460805405371151,2.7630238830920075
RCC10RGB,54596490,4.957303932772775,4.657659575989251
SW48,54618771,0.2213541125267267,1.183389699079259
SK-CO-1,56963564,-1.3743653333208103,0.9153704753555929
HARA [Human squamous cell lung carcinoma],7326481,3.3732570103291657,3.014058902605086
SaOS-2,4096211,1.593922478920674,2.2288119082010387
WM115,11317348,4.689716075377342,3.51073223398293
LCLC-97TM1,ISOX-bortezomib (250-1 mol-mol),0.9661454802906008,0.6873671595454942
LS411N,387447,-3.952629374311597,-4.322178443817485
SK-CO-1,11396600,4.255124433433546,3.7538033313870245
RKO,2828334,5.934464187728916,5.648156326616281
NCI-H2452,6184667,2.981030320075281,3.2610131721747733
MDST8,119182,-3.087899770061731,-0.5851328059628397
NCI-H1568,5282054,2.3545727551586744,3.883820188347825
SK-OV-3,selumetinib-UNC0638 (4-1 mol-mol),4.410799167981822,3.4211682718334604
HuP-T3,navitoclax-sorafenib (1-1 mol-mol),3.5500030348393667,1.7202857515798087
HARA [Human squamous cell lung carcinoma],56963564,-0.1933628562955875,0.41705006556721425
MOLM-13,5311,-0.2452037316548625,0.27363619976384734
Panc 02.03,119607,6.223236877281167,5.380686972670713
P31/FUJ,5566,2.621678413077409,2.702559549590282
RKN,5311281,3.300248210659573,2.381172121940493
HARA [Human squamous cell lung carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),2.096379077317258,2.585148710815961
K-562,11152667,-1.0937594737206502,-1.5555146159092306
WM115,241158,3.4880777915567496,4.021877327840682
HARA [Human squamous cell lung carcinoma],176870,3.342277724847585,3.113284148767201
SW948,11707110,-5.12001559624384,1.6862993115406295
ML-1 [Human thyroid carcinoma],tanespimycin-bortezomib (250-1 mol-mol),-0.335060121238308,-0.36528063853549997
RKO,3503,2.683687073265507,2.0924357825854245
SW48,tretinoin-navitoclax (4-1 mol-mol),1.442618908951043,2.5671735713317947
HCC15,3081361,2.87617011057776,2.4786482295884538
SW1573,25102847,2.4268351657646874,2.513742438573788
SW48,24785538,-2.175303706573729,1.4611396543729789
NCI-H2452,5329102,1.9284891088724192,2.17737560096767
NCI-H1568,56946209,-4.312547212322036,-3.416260842204485
SU-DHL-1,23939,4.934189555353841,2.9506098541784795
IGROV-1,2708,4.438419625543199,4.994682683465743
COR-L105,JQ-1-UNC0638 (2-1 mol-mol),-0.3865258904960421,1.884674227017812
K-562,44489675,3.6585617881709585,3.856535540835592
SaOS-2,23582824,0.6839328831098858,0.5985802595760864
WM115,1242560,3.734530534800184,3.5334097890574396
BICR 22,89928392,1.801349914013067,1.7098721092128975
MDST8,375860,-0.0509298762434446,-0.15944169438737543
WM115,387447,-5.543981096917634,-3.995852672501562
PaTu 8988t,46215462,1.6929329300119484,2.0570677299733413
SK-CO-1,25150857,2.4521914239487965,2.4674719048268243
RKO,46843906,3.289277038806309,1.7132235311808068
SW48,sirolimus-bortezomib (250-1 mol-mol),0.5064948335670021,0.8233477276304245
SU-DHL-1,3062316,2.138301047480956,0.4972862137490005
LS180,31703,-0.5385699496513472,-0.8951167284751052
NCI-H1568,54619267,3.44714412714971,4.214839581941387
NCI-H2452,BRD-A02303741-navitoclax (2-1 mol-mol),3.2540850576086644,2.955054766846914
SK-HEP-1,5351362,3.433378240202124,1.7090311516111338
Granta-519,119607,5.75770191278477,4.354294874317917
HCC15,2729026,2.745990777117554,2.7682363637932585
ML-1 [Human thyroid carcinoma],5746,-1.0436745341015816,1.4641602647802323
MOLP-8,24797083,1.4809895165463562,0.8533213406374043
MDST8,446155,3.7715450651151854,2.5613754298439204
SaOS-2,11317348,2.7618337203443377,3.4967220242120516
SW948,67156097,-1.6378764151549952,-1.6101321064722112
ALL-SIL,448949,0.3821166271144734,1.1760390234466906
SW948,5287620,-5.231918659547503,-2.0008139786104633
HCC1500,selumetinib-decitabine (4-1 mol-mol),6.513754829735322,3.4987850361797372
RKN,159324,4.081844329649501,3.26556635623187
SU-DHL-1,6917907,-5.829381256855267,-5.2510380046536
BFTC-909,3825829,4.25128930140834,3.8806560845347207
SK-CO-1,119607,5.49560679798916,5.109340560753764
LCLC-97TM1,6450551,2.230680139016655,2.251500151792672
IGROV-1,sirolimus-bortezomib (250-1 mol-mol),0.9316067440920404,0.682467064015046
HARA [Human squamous cell lung carcinoma],644241,2.250939574369427,2.4509194086386934
HCC1500,54626689,4.657243866783195,4.674939850646223
IGROV-1,selumetinib-PLX-4032 (8-1 mol-mol),2.802309242721903,3.7193984896208905
IGROV-1,9866186,0.4571266497661056,0.9336821416967145
K-562,24772860,-2.920105669473321,-2.6880615784197035
SW1573,9956119,4.0915863238100645,3.8111944810038225
BFTC-909,5280436,4.2143472852581025,3.3715683840775794
SK-OV-3,5282054,5.04615494272688,3.778806102548699
SW1271,24180125,2.511417012575286,3.171405412832621
MDST8,doxorubicin-navitoclax (2-1 mol-mol),-1.1540260466133785,-0.9270852037320145
LS180,46398810,2.878388522539818,2.5603193693511095
P31/FUJ,2749,0.384854271149864,0.9787598772949676
NCI-H2452,5281321,-2.0767365956379944,-1.1417539155067642
SaOS-2,9927531,5.410264314347966,4.631690685579835
WM115,156414,1.595819692541897,1.3355575339938406
COR-L95,15983966,3.7167583960216897,-1.585724270474537
SU-DHL-1,10322450,2.9485372728674473,3.523606602399756
HuP-T3,66577038,3.287519898796673,2.936209648052544
Daudi,6505803,0.7229387165377155,-0.5589096369978122
COR-L105,46926350,-4.1614749205792565,-3.8340840572357306
HARA [Human squamous cell lung carcinoma],36462,1.692464431977034,2.2870324881006763
MOLM-13,tretinoin-carboplatin (2-1 mol-mol),-0.195663512171335,3.10260019266193
MDST8,24901704,2.355370692316459,3.315071342479641
IA-LM,navitoclax-piperlongumine (1-1 mol-mol),0.8087427714288938,1.3482357672260168
NCI-H2452,25126798,3.2665335299764298,3.9560225124983672
ALL-SIL,107985,-3.6188373708521495,-3.8126298652931756
P31/FUJ,5738263,2.6277017246063252,2.45480445716206
HCC1500,2742550,3.2494473825713026,4.143308559998461
LCLC-97TM1,54618771,0.7707104681824843,1.0649853944759797
MDST8,3062316,2.63216781392049,1.1086581012250836
K-562,100016,4.034095210213227,5.163988748828658
NCI-H2452,136227924,3.4253193575490695,3.1072979871824815
IGROV-1,3025986,-1.046010021597061,-0.6663773926720188
IGROV-1,135875424,3.3275053166921347,3.5602946310038495
RCC10RGB,400769,0.8506758933165035,-0.26681057248187157
HCC15,44241473,5.510013950441446,4.839209821821128
SK-CO-1,26596,-2.200264316257102,-0.9714563472274276
HCC15,613000,1.6197134073445976,2.6424159170847457
Granta-519,10427712,3.8202730219655496,3.595825915568545
HCC15,5479543,3.813478020040636,3.8378625815442184
PaTu 8902,135423438,1.708930423466824,2.5536533485135178
Panc 02.03,24964624,3.328827283539013,2.861242269206856
LCLC-97TM1,25154868,4.98783448400422,4.3067848743258415
RERF-LC-MS,5113032,4.48589538963195,5.145371820076309
SK-CO-1,168313016,6.229837204453753,4.829850696449767
SW1573,9926054,3.1618263718643513,2.0768057417337498
MOLP-8,451668,-1.0880279758209197,-0.08758280680521108
Granta-519,doxorubicin-navitoclax (2-1 mol-mol),-4.791758111451553,-2.4084215683421353
SW1271,46191454,0.8015154670027128,1.7544497750512493
IGROV-1,156414,1.4212019235656712,1.5898150563786748
IA-LM,vorinostat-carboplatin (1-1 mol-mol),4.059193114117947,2.356188836190398
NCI-H1568,11647372,0.9090690740398496,1.26609034341597
ALL-SIL,JQ-1-carboplatin (1-1 mol-mol),0.1765424524035188,-0.11912435395531693
HEL,5394,4.33544579006292,3.4900810801102953
Daudi,23635314,-4.750280690911186,-3.0157578479452707
SK-OV-3,3543504,4.529917197725731,4.591966975978938
NCI-H1568,51037431,4.33384460889792,3.6116748326731583
SU-DHL-1,2708,2.612747958759665,4.332398642004529
SW48,151289,-0.0884278513227002,1.2176018485098876
SW1271,24772860,-2.1080107772753607,-1.7363632826592335
SW1271,675434,4.352597318848774,4.632340667136332
Granta-519,44632017,0.2326960109936577,0.9728011119695854
SaOS-2,11955716,-1.373693500458253,-1.275580168641183
KU-19-19,159324,4.255883770522122,3.311553935460538
SU-DHL-1,4261,-0.6665613942828803,1.008754336689603
COR-L105,10302451,1.2881684147693646,3.23436457656498
IGROV-1,navitoclax-MST-312 (1-1 mol-mol),1.1838863893343448,0.8773888157506504
ALL-SIL,4096211,-0.2650943934034739,0.826320793501481
IGROV-1,216468,0.5330864756407336,3.1673782688456855
Daudi,46907787,-0.707382985228944,-0.6068341892592397
ALL-SIL,11175137,2.2895463411974597,1.787848749444004
HuP-T3,7326481,3.4338903427833674,2.692039338046895
SK-OV-3,11626560,2.736987670099794,1.906288426454259
NCI-H1568,5978,-3.194054905017319,-1.2287468996142907
P31/FUJ,25062766,0.5108470478058419,1.5276352726759401
LS180,4261,0.8191216854939201,1.5806051273909958
HEL,71304818,2.1837189642761645,1.9849931351467824
NCI-H1568,71466445,4.632148673172368,4.1842932365924606
PaTu 8988t,5282054,4.412677005920707,3.734005140096624
SW1573,54686904,4.039437320121271,3.760938868146925
RKO,53392493,2.7606647137416616,1.6293871713062011
PaTu 8902,156422,4.606541116596145,4.016475310962034
COR-L105,54454,1.772071227552003,2.675669388572297
KU-19-19,9926054,2.3371072555508445,1.986946673812086
IA-LM,3136844,4.47285753340146,3.8409944155491385
Daudi,3854666,0.3283534306514684,0.7896773310199814
MDST8,tanespimycin-bortezomib (250-1 mol-mol),-0.1010970299548422,-0.13808995819861458
SU-DHL-1,72193861,-0.6645199564816581,1.6072545098442952
SW1573,navitoclax-gemcitabine (1-1 mol-mol),-2.643981149214972,-0.9083672373920169
SK-CO-1,44202524,0.5946445627983161,2.5409495336079315
K-562,1750826,1.7671131923879069,-2.5900335897462434
LCLC-97TM1,3854666,0.8191923722369518,1.862033789722134
SK-HEP-1,4477,0.3599343153867445,0.42012835100603974
BICR 31,5282054,4.622453961920413,3.8708330411040794
ALL-SIL,3025986,-1.187507928097146,-1.4365816953028243
BFTC-909,3062316,2.03384364484094,0.866237577842844
ML-1 [Human thyroid carcinoma],135875424,5.514442636506433,4.301805236975473
Granta-519,444795,4.599812836973149,2.885863014476934
UACC-812,piperlongumine-MST-312 (1-1 mol-mol),1.224354228260847,1.940683047825316
COR-L95,selumetinib-JQ-1 (4-1 mol-mol),4.793493423716469,0.7572158888045822
RKO,1566236,3.4833841973625725,1.839160903491329
BICR 31,navitoclax-piperlongumine (1-1 mol-mol),2.358684882853314,1.579272543076383
LS411N,carboplatin-UNC0638 (2-1 mol-mol),3.912215714956053,3.404979579956154
ML-1 [Human thyroid carcinoma],JQ-1-carboplatin (1-1 mol-mol),0.7562453345428342,2.4132355963548413
NCI-H1568,8515,2.0721444777555327,4.16044878662933
MOLM-13,24978538,-1.2743594434772367,-0.13843488211459357
SW1573,23725625,4.357604161446221,4.832022384072343
HEL,15953870,2.2428109686656295,2.9214079332016936
Daudi,52947716,0.9938257746380776,-3.5203683304654287
BFTC-909,44259,1.3269924163099676,0.8522900798109287
MDST8,selumetinib-UNC0638 (4-1 mol-mol),2.2725517612456416,3.150353863174485
SaOS-2,6918328,0.1895131607356872,-0.23450390559119513
HARA [Human squamous cell lung carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),5.192132134204876,3.555053663013833
NCI-H1568,3503,1.1278876480867208,2.3158669367182267
IGROV-1,72376,-2.111352545322758,-1.665119875909995
SaOS-2,selumetinib-piperlongumine (8-1 mol-mol),3.928507120342424,3.1896838022509453
SK-CO-1,654092,0.6285789884023978,0.04272337384814012
SU-DHL-1,44589607,1.246014317818898,2.5239308371153344
PaTu 8988t,3552672,2.097731757890035,2.6908869454810156
HCC15,5282054,3.6050373222028815,3.8893886668072395
HARA [Human squamous cell lung carcinoma],1641662,3.0207416829742058,3.497794532858003
WM115,16013152,3.8161355323039,4.008309354485403
ALL-SIL,54618305,4.365324809283883,3.253832412725407
SK-CO-1,25195348,3.743308569883415,3.559207042670682
BFTC-909,123631,2.8792987518934403,2.2988080091429306
NCI-H2452,25022340,5.0430378131248785,2.6870382016816428
BICR 31,11719255,5.311316415457661,3.5270740940199636
BICR 22,JQ-1-vorinostat (2-1 mol-mol),0.486661425618767,1.1364808362845844
HuP-T3,568763,0.3762081962980199,0.5668234375216966
Panc 02.03,71680916,5.6819891784443595,4.797503461290834
SK-CO-1,44484440,3.788843022204708,3.0854289197420584
HCC1500,60750,4.75355506285403,-1.4439552614136724
SK-CO-1,44607531,1.475264767684201,1.44326185409982
MOLP-8,1317464,4.425962710369034,3.053653812563857
BFTC-909,107985,-3.700699007813787,-3.268123919611747
SK-CO-1,3025986,-0.6416687634539443,-0.6737309113495925
BFTC-909,44493528,4.370300807083883,4.437929366104431
SW48,49850262,3.202043440642355,3.700223603739722
HCC15,sirolimus-bortezomib (250-1 mol-mol),2.085701918672026,1.0224189068568008
MOLM-13,5746,-2.6320399073484633,-0.393612450753901
NCI-H1568,36462,0.6787379731584755,2.389954577472614
SW48,vorinostat-navitoclax (4-1 mol-mol),1.1280429303528072,1.111078335853846
LCLC-97TM1,31703,-1.7062756219896058,-0.9140420671832458
BFTC-909,54454,2.6967031082973527,2.4883102593258544
BICR 31,5351362,2.0722735669158876,1.7258081419865616
ML-1 [Human thyroid carcinoma],20959075,-2.269435131540743,-2.5673262785966604
HEL,3543504,3.6690825601144064,3.7351209256876126
IGROV-1,11178236,-2.8618715106425725,-3.006036807187512
SW48,176870,1.305545107688616,3.042957352649683
LCLC-97TM1,3062316,0.5973926668956511,0.6749662389239096
HCC1500,6852167,3.541859976914812,2.7752270382612396
MOLM-13,54626689,4.673711949381485,4.1482815976075695
RKO,11175137,2.9264569639519906,2.105666537870124
SK-OV-3,carboplatin-etoposide (40-17 mol-mol),4.59219202218907,2.867561359513918
BFTC-909,73707398,1.325657316242966,1.2290047592382642
SK-HEP-1,11485656,3.3898088020096324,2.3952100024170924
SW1271,637858,1.8302889918552376,1.9534103897782729
P31/FUJ,151289,0.3376751835645198,0.6122455213334077
MOLM-13,6918289,0.5846893448973186,-0.5487368568730667
RKO,4096211,2.0568907070726397,1.1731623316200226
HCC15,42611257,3.545791426903468,3.339863353669927
RKO,51037431,1.443783779144223,2.8444614567885265
RKN,1716436,3.648262431092988,3.034330092869275
RKO,216345,4.0768365061219525,3.226726723421733
MOLP-8,54454,2.3030156333842533,2.166080150040677
HuP-T3,JQ-1-carboplatin (1-1 mol-mol),1.982980925186552,2.0057817049169064
SW1271,11719255,2.0964009449704335,3.299975212407741
SK-HEP-1,5328940,3.1706915881362097,1.8109944424375477
HEL,6914657,-6.908409772348001,-5.042675297780406
LCLC-97TM1,6918878,3.384977217975284,1.9195701338762554
HuP-T3,46943432,3.2592232125577665,2.5413056285817985
KU-19-19,11152667,0.8748891502312,-0.49261578263544514
MOLP-8,5278396,3.6007551773478093,3.184650249532443
MOLP-8,71304818,1.8062780808091792,1.9884369183497848
BICR 22,selumetinib-navitoclax (8-1 mol-mol),1.8614529515345275,1.896339013057811
SaOS-2,5280436,3.62212536353362,3.1778765055339186
IA-LM,71751553,4.579394980470846,4.106498351639084
COR-L95,374536,2.031472802797221,1.7719490745954447
HCC1500,1716436,1.6304357372897462,2.9581040548699065
HARA [Human squamous cell lung carcinoma],10385095,1.0837341672046903,1.208888338882349
SW1271,9967941,4.951865473173475,3.6367457280848328
KU-19-19,6918837,-3.3861016705907203,-2.308451941391982
LCLC-97TM1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.91566117969414,3.8578222737800814
RCC10RGB,54626689,5.11978438920743,4.750900799406633
COR-L105,24964624,2.7213287093015848,2.7418112632669307
RERF-LC-MS,10184653,1.661334722418144,1.8191731934469955
COR-L105,9907093,4.049740181744662,4.291000227594411
WM115,4917,1.7802954819592542,2.8760103390286047
Daudi,25262965,-3.918146889356354,-2.1155836098587737
RKN,9926054,2.8101544562472056,1.983494333081692
COR-L95,969516,2.641832541585458,2.544366022363139
ML-1 [Human thyroid carcinoma],9868037,3.639883526106939,3.6468155857892155
LS180,60700,-0.831384616867798,-0.4881966248929613
HCC1500,25062766,2.7449885477672136,2.413574823946691
COR-L95,11640390,2.478695805138082,2.92630875606558
HuP-T3,54618164,3.3933985234085755,4.1097365770887055
SaOS-2,25105715,3.6317688538247968,3.3596864692823956
SW1271,5335621,2.365445027841909,4.792182450776984
NCI-H1568,72193861,1.9818580959671683,1.6611823167692945
HuP-T3,JQ-1-UNC0638 (2-1 mol-mol),1.1921000919454006,1.756169303405783
SW1573,10385095,0.5068001344623563,1.4024430347925025
ALL-SIL,2841722,3.706104916487932,3.814147159785136
P31/FUJ,71466445,3.0287439983851225,2.4160199620628515
IA-LM,JQ-1-UNC0638 (2-1 mol-mol),3.2694867389724744,1.479105377750389
COR-L105,4917,3.658916006838,3.135744764221098
RCC10RGB,9903786,5.708919982977709,3.1026110002310645
HuP-T3,25161177,3.646148401953212,4.144427223147867
K-562,71466445,2.3693775657442373,2.6081409610076776
K-562,11977753,-1.2336845020581693,-2.240580118228082
LS180,16725315,4.563180557999628,4.237835607231293
NCI-H1568,66577038,1.9593359628641709,3.078419993063378
SaOS-2,3465537,1.5281169625539155,2.263899933979778
ML-1 [Human thyroid carcinoma],11640390,3.608850000621235,3.617714058577464
MOLM-13,17755052,0.2343645648969551,0.38694279283413346
RERF-LC-MS,67156097,-1.006688958645714,-0.5452641948175042
SW948,5470400,-3.941225454290086,-0.493923445829377
HEL,44185566,1.408371464536178,1.7499582831648177
RCC10RGB,3503,3.522457107356278,2.3068055743709124
BICR 22,9866186,0.6641273098552615,0.8952857595683524
K-562,52947716,-5.609155633475852,-1.5669184819772688
SaOS-2,1641662,3.0320316508312883,3.4856729564509874
SW48,5460769,-0.8804369809799648,2.3120527599187004
MOLP-8,11625818,3.354870459420626,3.31539493069954
KU-19-19,3025986,-0.2897675094370045,-0.7033805162345128
K-562,9444,4.095192274458736,3.8054548689466894
IGROV-1,5329102,1.2794664511054334,2.0783120287897403
LS411N,11427553,2.839596649209722,1.67085029871602
SU-DHL-1,10385095,0.4695713178913991,1.2014201992881963
SW1573,124202324,3.209850220678193,2.50075289603144
BFTC-909,2949965,3.0294119536880197,2.992157981754182
Panc 02.03,44589607,4.606435993835204,3.1973447147296543
LS411N,25126798,4.124739072985443,3.4126724582371923
RKN,24785538,4.869460471506453,2.0905204364303946
SU-DHL-1,31703,-2.5255735182995203,-2.054062672462163
KU-19-19,6505803,0.0199416611110358,-0.036071432741840576
MDST8,5281672,5.754114909876849,4.691676349880111
PaTu 8988t,9903786,4.140175125497243,2.918902451190347
SK-CO-1,11717001,2.027201802005241,3.7828731228144195
K-562,navitoclax-sorafenib (1-1 mol-mol),1.3368563864105187,0.7972596439859229
HuP-T3,54454,3.567661200928428,2.8901978607406202
MOLP-8,262093,0.615798330418347,1.4611093903505887
SW1573,6918328,0.8267852089643692,0.16355233375129022
LCLC-97TM1,73707398,0.638027637531153,1.1083647103835983
SaOS-2,11719255,3.097989779485228,3.4439134525865915
SU-DHL-1,73707386,2.8817783064824773,2.168063966784108
HARA [Human squamous cell lung carcinoma],2841722,4.596341456340547,4.503944101518559
LS180,9915743,2.834892961755663,0.4609524759142103
ML-1 [Human thyroid carcinoma],54143018,-0.4485048931823356,0.6842091516881459
BICR 22,4578,4.285603675470092,4.074498079367916
SaOS-2,24951314,1.4499530102948022,1.386578827690963
RKN,6918328,0.5495182279950256,-0.19176324009452814
IGROV-1,66577038,3.2148239132520455,3.0754171552598772
COR-L105,15547703,4.316721747481802,3.1256590671491478
HCC1500,753704,5.032412058463686,5.044598255933968
RKO,44819697,-0.2126149769206573,-1.5856498566831083
HCC1500,16013152,3.952751911590144,3.8633746422456867
SW948,89183176,3.757757719513151,3.607677429882878
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,0.8903437817407316
ML-1 [Human thyroid carcinoma],BRD-A02303741-navitoclax (2-1 mol-mol),3.3397252964004593,2.926904016900317
ML-1 [Human thyroid carcinoma],11427553,2.643507576643823,2.869909207603447
IA-LM,44819697,3.529669119404179,-1.4137532465854374
PaTu 8988t,148198,-4.283282973565046,-3.71660855189141
HCC1500,5287969,-0.1960949732639439,-1.6670409665037431
RERF-LC-MS,5460769,5.094680634820597,2.4152444275647262
BICR 22,10113978,3.5652875556244923,3.3232709378241996
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.4465586153497951
LCLC-97TM1,6184667,3.4160200622822736,2.9168913754657724
SK-OV-3,44507138,1.930427516054787,2.6849160153548155
SW1271,54626689,4.884226988721356,4.687089094848737
COR-L105,25195348,2.918205578273492,3.6950292848670823
MOLM-13,49850262,2.0503909100702873,2.6612368689638446
LS180,104842,-3.608354535822108,-2.7088481719952298
Granta-519,6184667,3.6411271735359207,2.2393027220500805
IGROV-1,49836020,5.658436828096057,2.5484006334699942
HuP-T3,54619267,3.893027602521098,4.150122603423751
SW1271,409805,4.993473873943069,4.782821432437529
NCI-H2452,2749,1.5209092727807076,1.9841246990954984
MOLP-8,JQ-1-carboplatin (1-1 mol-mol),-0.7588683882378918,-0.5840873710579543
SK-OV-3,119607,5.6958068077620405,5.323489014257429
Granta-519,JQ-1-navitoclax (2-1 mol-mol),-0.9470910727061151,-0.8794476351036731
SU-DHL-1,6184667,2.253300303827536,2.8141532317125906
WM115,2871966,2.231269661110087,1.0864723113381718
SK-HEP-1,219104,4.349330089087446,3.8915485828908856
SW948,selumetinib-piperlongumine (8-1 mol-mol),0.6665506156446188,2.2463262610109553
SW48,8515,2.6507036204950256,3.8366964652524116
MOLM-13,241158,1.7093626682651633,2.5482935578186727
RCC10RGB,71576739,5.1028364410536735,3.971715933257046
LS411N,54619267,4.196494516067777,3.94570197330458
Panc 02.03,637858,2.766769284687194,2.03229171717928
P31/FUJ,25150857,2.053516150415863,1.3627773934751966
P31/FUJ,24951314,0.294555023880993,0.20805189349369058
SU-DHL-6,16736978,-0.092754907722646,0.7836514818831654
RKO,151289,1.190219151105647,0.6861891734597879
NCI-H1568,1716436,2.664872339798973,3.0527046096010206
SK-CO-1,doxorubicin-navitoclax (2-1 mol-mol),-2.167378618505947,-0.45786247179568124
LCLC-97TM1,49836020,1.9924259842665932,2.7001793569640906
HARA [Human squamous cell lung carcinoma],navitoclax-PLX-4032 (1-1 mol-mol),1.441529788664552,2.010800344765424
HARA [Human squamous cell lung carcinoma],44137675,4.310894105428011,3.627679030274759
SW948,11647372,1.3621251009964823,0.40061001737354074
LCLC-97TM1,selumetinib-UNC0638 (4-1 mol-mol),3.547341579124928,2.699354149958304
LCLC-97TM1,56963564,-0.6229750501206363,0.15636185486771198
IGROV-1,11427553,2.926316692603687,2.734293662357305
HARA [Human squamous cell lung carcinoma],54618305,5.079823174852019,4.427732272507046
SW48,24951314,0.6660870475429757,1.4285130842746974
RCC10RGB,46398810,2.467266718263722,2.548024950887268
NCI-H1568,16720766,0.7309820541773976,0.8139402346438771
K-562,decitabine-carboplatin (1-1 mol-mol),4.43725246072026,0.7108434735629189
HCC1500,6918878,3.8452122267855544,2.4721926384153745
MDST8,JQ-1-navitoclax (2-1 mol-mol),0.0958031568177067,0.7003795617669608
BFTC-909,BRD-K27188169-navitoclax (2-1 mol-mol),3.3946327784578245,2.2835617796493266
NCI-H1568,9840324,5.648333485386012,5.574180251514362
SaOS-2,24772860,-2.2454069761524416,-1.7881405266931945
NCI-H1568,12003241,-1.4870303892505918,-0.8797688595861562
IGROV-1,135411,0.626702113064729,0.7093943689116428
SU-DHL-1,123631,2.2104669936854817,2.4261922000672236
BICR 31,676352,2.5344425849235472,2.2245863340452887
WM115,2828334,5.840169576442124,6.179536479628075
BICR 31,16722836,0.993439631718574,1.8358810263863738
LS180,71304818,2.5144465721497573,2.4004746099110608
HCC15,176870,4.3801450304989835,3.340211256819148
SaOS-2,44137675,2.8908105588075537,3.549014778355341
SW48,57519531,1.1891467216952898,2.514337863731725
LCLC-97TM1,46943432,0.977611384475134,1.627569193292534
LCLC-97TM1,selumetinib-tretinoin (2-1 mol-mol),4.0009002077883755,3.347072765802184
MOLM-13,alisertib-navitoclax (2-1 mol-mol),-6.0299100304654365,-1.2614573032486733
UACC-812,52912189,-0.0403441295384107,2.4563745677781594
HEL,638278,3.1804055556137394,2.7688710013999094
ML-1 [Human thyroid carcinoma],135440466,2.0685655954708824,2.251487572114458
UACC-812,45279963,4.1756281682233185,3.218993328155837
MDST8,12001922,2.1068751805520423,1.8663823383926554
HuP-T3,11626560,2.4663043755994094,1.9426415499531484
HCC15,9884685,1.2743229964902805,0.8891530464819833
Daudi,82146,3.751797413920901,2.7447099114233215
IGROV-1,vorinostat-carboplatin (1-1 mol-mol),2.9918987847321645,3.2752963218881535
BICR 22,969516,2.807563254821311,2.9151299738808047
RKO,6917907,-7.36544436443182,-5.127101083644771
LCLC-97TM1,BRD-A02303741-carboplatin (1-1 mol-mol),3.5226633114065407,4.010367206381672
P31/FUJ,54649381,3.661627004097492,3.285929230388666
P31/FUJ,15983966,-4.570279214878008,-3.941302999021767
COR-L105,49793307,-0.7736136433109717,-1.7540966703194893
HARA [Human squamous cell lung carcinoma],107970,2.425047737070786,2.456568865674704
SK-CO-1,57330099,5.774767561552264,4.234139373798761
SW48,navitoclax-gemcitabine (1-1 mol-mol),-2.8390563906078543,-1.2299620055185934
Daudi,36462,-1.782907247885185,0.3330981924470664
SW1271,10077130,5.262255440725952,2.816251290132742
PaTu 8902,124202324,2.5191853508509823,2.456582622678154
SW1271,4261,2.1417567232825157,1.767428301969008
SW1271,568763,-0.4148311333850545,0.3601311257192375
IGROV-1,44185566,2.2104732991243248,2.6023348867449156
PaTu 8988t,piperlongumine-MST-312 (1-1 mol-mol),1.7723365960000816,1.804893264976889
RERF-LC-MS,54678924,1.4734481784853186,2.36943549469082
SW1271,17759555,2.4829827438054104,3.6572183898492114
HCC1500,2871966,-1.8945265193529464,0.6308916678110452
RCC10RGB,119607,6.074674808773517,5.411733506670161
MOLP-8,5566,2.8349074996791295,2.885458141062307
K-562,24901704,1.0460453676907424,2.562234708639686
SK-OV-3,44607530,2.4027946355264507,1.9118292932666408
IGROV-1,44589607,3.0909001492794377,2.9421627515264985
SU-DHL-1,44185566,1.07324922266726,2.057361992828583
MOLM-13,navitoclax-gemcitabine (1-1 mol-mol),-4.310291489660192,-1.994824807971485
SaOS-2,42642645,-0.01972406793895,0.6052791986594119
SaOS-2,327653,4.165382989627235,3.2273682961746473
RERF-LC-MS,44491742,4.380479941679622,4.387780565346903
Granta-519,navitoclax-gemcitabine (1-1 mol-mol),-5.4729921992931665,-2.7917325129278567
K-562,3038522,1.918387146447148,2.5766493397207237
HuP-T3,702558,5.633624519144866,5.419874568311229
ALL-SIL,2858523,2.9846374491002376,2.6590291155887114
WM115,44589607,3.0632481185375933,2.9379618777929064
LCLC-97TM1,11977753,-2.2409153175434953,-1.536884165333803
Granta-519,7251185,1.138949301849667,1.5925144083181408
MOLM-13,446155,1.5984418257641329,2.1218129191392094
SW1271,11455910,0.4702460968788743,1.1215209370520154
WM115,10184653,1.7306018843706388,1.4481801997654526
SW1271,12003241,-1.4062779923685875,-1.2991869978568689
SU-DHL-1,3038522,3.3518104703058467,2.5269578632163636
RERF-LC-MS,44819697,-0.3406635094896507,-0.007456420164334676
SW948,tretinoin-navitoclax (4-1 mol-mol),4.012168549649723,1.7936072295982897
SK-OV-3,piperlongumine-MST-312 (1-1 mol-mol),2.5779047815349627,1.9751497185671578
RERF-LC-MS,3825829,3.876424055067748,4.2581164082636676
SU-DHL-1,208908,2.168834483257838,1.832576056892024
COR-L105,4378219,1.9356703916494296,2.775033842715646
SU-DHL-1,44489675,4.002710700308593,3.8082152740805837
BICR 31,5329102,1.5123342757929257,2.03263503909642
BICR 22,72193861,1.1787223619968317,1.7435380571173298
SK-CO-1,4259181,-0.2853622975740302,0.46248937976307714
RKN,5278396,4.050807510430523,3.635063937253277
LS411N,3543504,6.407278726964401,3.635311671202789
Granta-519,2749,-0.6711865738648753,0.936556402037239
LCLC-97TM1,11222830,0.9756157307321038,1.4731471089067123
HCC1500,49766530,0.4188049276678212,0.265389718726995
BICR 31,24821094,2.272776200428542,2.8814152841087433
LS411N,15953870,3.79326986504028,3.3747924482921885
KU-19-19,15547703,3.5460273004695364,2.9675750989530654
IGROV-1,10410894,3.2660402181528263,3.325012124443796
SK-HEP-1,9936388,2.725726666175631,0.24024777880319245
SU-DHL-1,68056272,2.8441937668208297,3.1521742486817472
BICR 31,107970,2.625018410874988,2.392738252469817
RCC10RGB,24978538,2.2083570886635258,1.0633297022055164
MOLP-8,42642645,0.4027543307161444,0.2024802131054475
IA-LM,6438330,0.5920782597943414,2.193525509616132
HCC1500,25102847,3.871994319987046,2.3720988144638455
SK-CO-1,9903786,1.8148473241522671,2.724083500257111
SK-HEP-1,51037431,1.9503987957256583,3.295768714137657
SU-DHL-6,15547703,1.663295720719241,2.6284600348500238
PaTu 8988t,42642645,1.5127014290808742,0.9326649387940784
Daudi,4578,4.14840859618435,3.8741864547305873
HEL,73707398,1.0006953763352662,0.518408803529213
RERF-LC-MS,3634881,4.923247717838372,3.1224845458182524
HCC15,9907093,4.55737056946543,4.283027917362035
IGROV-1,16725315,4.890680859998698,4.25019687846544
COR-L105,navitoclax-PLX-4032 (1-1 mol-mol),0.9673135251369994,2.1592544041319455
COR-L105,107970,2.936160881286492,2.3445059357983578
PaTu 8902,11485656,3.4031855994132663,2.379193256599545
BICR 31,5287969,-2.0848564793948423,-1.922576628872997
SU-DHL-1,3503,1.2104794697541517,2.0333892651606194
WM115,selumetinib-MK-2206 (8-1 mol-mol),-1.676879875544035,2.171260993368935
RCC10RGB,107970,3.009214725762471,2.4075229968398677
KU-19-19,51039095,3.4730458815699743,2.877372822144378
KU-19-19,selumetinib-MK-2206 (8-1 mol-mol),2.230752575212941,2.2352627522150104
IGROV-1,16038120,0.2864038103759729,1.2847241613095646
P31/FUJ,selumetinib-UNC0638 (4-1 mol-mol),1.8703414483738705,2.1392579581094058
SK-OV-3,1323703,3.751791158325908,1.0020014864404123
K-562,JQ-1-MK-0752 (1-1 mol-mol),2.296423482837328,0.8543102105297344
LS180,56946209,-4.291807545115399,-4.165529078567001
BICR 22,16741245,4.124711805224883,3.749217963165214
Granta-519,11396600,3.399615682634249,2.2837625559994974
LCLC-97TM1,4378219,2.0431586025336332,2.413924660657577
COR-L95,piperlongumine-MST-312 (1-1 mol-mol),1.3307800151979865,1.6207093081479838
PaTu 8902,3062316,3.1999770976977966,0.7596130213061005
MOLM-13,9825149,-0.4975121245832732,1.777303276566134
PaTu 8988t,36462,2.8739750906545263,2.456885549040107
WM115,4261,1.0617223830766982,1.4621726821348935
BICR 31,54618771,0.3365869204450262,1.2305877011023854
IGROV-1,6918837,-2.9804518885508635,-2.8213036805172034
SK-CO-1,49850262,4.729060483840123,3.5338936282924838
NCI-H1568,selumetinib-MK-2206 (8-1 mol-mol),2.137801357231392,2.310884877227952
SK-CO-1,49793307,-2.625714785229563,-2.7401262065792538
ALL-SIL,159324,0.7144692186053382,0.9806068048668339
BICR 22,tanespimycin-bortezomib (250-1 mol-mol),-0.7202446559484896,-0.3679015436230134
RERF-LC-MS,24821094,3.899392046553833,3.0858739629365726
NCI-H1568,selumetinib-decitabine (4-1 mol-mol),4.70224066359239,4.129066279353154
ALL-SIL,54613361,-1.2150310590443698,-1.0404333057427662
MDST8,54618771,1.2096098448968695,1.2113638941592204
MOLP-8,26596,-2.4791577040777812,-2.5540703145648993
RKO,4788,5.372325515812119,5.373329283449571
P31/FUJ,44589607,2.3901798108348533,1.6933565708655822
SK-OV-3,613753,3.56222269809742,3.2103096685426267
SW1271,navitoclax-sorafenib (1-1 mol-mol),2.5597569107989457,1.7027396787057163
SW1573,2858523,3.1892649395611556,3.1964292083188957
LS180,72193861,-0.0461725132802377,1.4463493282218687
RKN,25126798,3.956068538327861,3.730663725105004
MOLM-13,6917907,-6.412365954060792,-5.427181300723529
WM115,50905018,4.954075896774319,4.29650282236133
HCC1500,54619267,3.954111090910006,4.207777591076595
IGROV-1,6252,1.1284141516966473,1.0827273080629138
Granta-519,49766530,-2.591856607816134,-1.9816650013641774
RKO,400769,-0.364727826621167,-0.6677871535116641
SaOS-2,5113032,4.015669070835574,4.9402917723230715
MOLM-13,JQ-1-carboplatin (1-1 mol-mol),-1.1937671788026978,-0.4543662294465537
BICR 31,400769,0.3553213589698107,-0.3743800457212948
HARA [Human squamous cell lung carcinoma],16720766,-0.0810608938508249,0.8009253808535972
MOLP-8,JQ-1-navitoclax (2-1 mol-mol),-1.8736660374722776,-0.16246746394128894
RKO,24901704,3.90150667551114,2.2484635498421075
K-562,675434,4.134192231732703,4.174817575705745
PaTu 8902,vorinostat-carboplatin (1-1 mol-mol),3.3056109148195936,3.122654777345169
IGROV-1,60700,0.4424479122017752,-0.233078070269375
RERF-LC-MS,439501,-1.3704502050640626,-1.9123556304114726
PaTu 8988t,3081361,3.3861147832051004,2.422780854492666
PaTu 8988t,11507802,1.1782523393568187,1.6714871425704985
RKN,25154868,3.091821445991922,4.509349296358339
SK-HEP-1,3384730,4.617019540739567,3.1118104672933176
IGROV-1,135411,0.626702113064729,0.7093943689116428
RKN,44202524,1.6880658914716755,2.090486345500554
MDST8,10127622,1.4568360900186117,2.9902572388869793
ALL-SIL,5978,-4.2912860791141725,-3.439730752143708
LCLC-97TM1,25195348,3.14182472834864,3.0206627940981803
MDST8,navitoclax-piperlongumine (1-1 mol-mol),-0.5700737020348542,1.686098610883108
MOLP-8,2949965,2.304667717892232,2.357191593094572
IGROV-1,alisertib-navitoclax (2-1 mol-mol),1.5599487267475047,0.2519824935727627
NCI-H2452,11485656,2.991875358712002,2.521622009600705
Panc 02.03,2708,5.654354843286421,5.060796923289411
SaOS-2,15953870,3.7774839542606617,3.7722418975971017
LS411N,11238147,4.220683195687341,2.2774280958672786
WM115,selumetinib-vorinostat (8-1 mol-mol),-1.5219389321344234,1.9800211683152815
COR-L105,11404337,0.9270352493146456,-0.2561496703898137
RKO,20959075,-2.9107192765247536,-2.923957963269267
IGROV-1,452548,0.0422661560146271,0.5073440220821008
SW1271,25062766,1.8071163488926476,1.8340055252153642
SK-OV-3,24180719,3.148638094054939,3.6504703610727
IA-LM,doxorubicin-navitoclax (2-1 mol-mol),-0.2967430289420483,-0.9748022988940004
MDST8,sirolimus-bortezomib (250-1 mol-mol),1.3453299631576727,0.7185897974208305
Daudi,selumetinib-PLX-4032 (8-1 mol-mol),4.542051250808824,3.5421564184866416
NCI-H2452,25150857,3.315566378385427,2.5956598177944725
P31/FUJ,carboplatin-UNC0638 (2-1 mol-mol),3.2617545834686155,2.6817501251669142
LS411N,216239,2.6090534487015953,2.0245824843830937
SW948,2828334,6.27053385486612,5.808764954878497
HEL,25262965,-1.9607005706581808,-1.7035288011402605
SK-HEP-1,46398810,3.2056962377986333,2.522850219841428
P31/FUJ,46191454,0.7861082656977861,0.01574879414219413
SaOS-2,11404337,-0.7935370479535776,-0.3651366182315078
LS411N,6918878,3.507421995092854,1.1518078276434334
COR-L95,5566,3.0030322186541754,2.7827775111248707
NCI-H1568,2729026,2.4592472427928795,2.585714525810632
Granta-519,5566,3.1418180472473023,2.858323319439977
SW948,15953870,3.980690301912255,3.3556131799514817
IA-LM,selumetinib-navitoclax (8-1 mol-mol),1.3709865001695822,2.141715478618232
SaOS-2,tanespimycin-gemcitabine (1-1 mol-mol),-1.7775872222613356,-0.7871895407505545
COR-L105,decitabine-navitoclax (2-1 mol-mol),1.4499610580472069,2.247496475788948
PaTu 8988t,4096211,4.042256121680771,2.4157341578939957
HCC15,638278,3.5096393014384346,2.962438147982722
LS411N,44185566,2.59688005994845,1.72078683268483
WM115,15547703,2.53174585982074,3.2373723670327945
RERF-LC-MS,46907787,3.883745984979501,2.4916796775100254
RERF-LC-MS,49793307,-1.4864117200972382,-2.699748841295063
LS411N,6918837,-3.511331359252859,-3.217736874132319
HEL,2729026,2.9938268289747394,2.3441874809162666
SU-DHL-1,9911830,2.4926956672938543,2.1415662462907425
RKO,6505803,-0.9276151073099124,-0.4993901424450479
HEL,5351362,1.012542471793317,1.063356260753866
SW48,448949,2.118847083295334,2.1098695065792334
LS411N,3854666,3.592971008902542,1.6162419145045772
Daudi,55283,2.1333092426313143,1.9861543148251628
WM115,568763,0.4176363376103466,0.5212055916384917
ALL-SIL,JQ-1-navitoclax (2-1 mol-mol),-1.241318632460125,-0.7779830689141746
K-562,54143018,0.8143265967368298,-0.30345184103536066
WM115,6914657,-1.139050920215431,-3.4240766637871998
BICR 31,JQ-1-navitoclax (2-1 mol-mol),1.1041257622460865,0.8032204042510783
ML-1 [Human thyroid carcinoma],24821094,3.2142530929148982,3.1103215607423964
Daudi,57519531,1.0816397392331083,1.3695135318596992
MDST8,9840324,7.1320098113776185,5.8009112641823775
ML-1 [Human thyroid carcinoma],selumetinib-navitoclax (8-1 mol-mol),2.127776457092234,2.3240630730831513
NCI-H2452,67156097,-0.4931697978204585,-1.0040226865066806
ALL-SIL,11507802,-0.6218585688390301,0.44919839202045636
MOLM-13,9926054,0.378361077880871,1.6130796332986992
LCLC-97TM1,676352,2.332754642745106,2.3211733334822564
SW48,6450551,-0.0066484474606689,2.6230013972797845
LS411N,tanespimycin-bortezomib (250-1 mol-mol),-0.7094268710043169,-0.5708795969875128
MDST8,vorinostat-carboplatin (1-1 mol-mol),3.0562610561977004,3.1192216259935077
ML-1 [Human thyroid carcinoma],53232,3.218931075380609,2.903922611794885
KU-19-19,46191454,1.4474607873871597,1.7345580356301713
BICR 31,135440466,1.3506373291640237,2.0715304387941553
SW948,44632017,0.8619787858061628,1.4196240952063903
NCI-H2452,159324,4.677055932941875,3.447616745671337
WM115,60700,0.0008203329731028,-0.0873661607613915
HuP-T3,selumetinib-navitoclax (8-1 mol-mol),3.027921751084016,1.7729349808894133
RKN,9936388,2.306220468641662,-0.7342231871499181
MOLM-13,2945648,3.0282797197343374,2.1499027544864875
P31/FUJ,135875424,3.622681212031297,3.0700805322984412
LS180,navitoclax-gemcitabine (1-1 mol-mol),-2.7206195218400007,-0.6411870838973257
BFTC-909,24964624,2.4776408698208003,2.533925369064309
HCC1500,3825829,4.205963950909598,3.890665053080117
P31/FUJ,selumetinib-MK-2206 (8-1 mol-mol),-0.6510792771612892,1.4065389046163628
SU-DHL-1,135984461,1.9491307161872016,3.501984383799652
NCI-H1568,409805,3.8387714265583592,5.004687733713217
COR-L95,2945648,2.3261820103406183,2.9178356807177925
LS180,selumetinib-tretinoin (2-1 mol-mol),1.4682365811163622,2.7773912324059413
IGROV-1,5746,1.9055212643377857,1.038827917962998
BICR 22,selumetinib-decitabine (4-1 mol-mol),2.485402962452582,3.3993229353536805
HCC1500,104842,-2.1208898309536073,-2.295272705827386
IGROV-1,148198,-2.659972993252853,-3.430739470097038
ML-1 [Human thyroid carcinoma],4259181,0.3770562232502641,0.2871941650042957
K-562,crizotinib-PLX-4032 (2-1 mol-mol),0.2702262717922032,1.2664788966717455
IA-LM,5746,4.310443233142937,1.321087030613024
WM115,10427712,3.357641117907952,4.473247785268948
WM115,31703,-1.493876478932265,-1.110125236497809
K-562,10296883,3.719487542859837,3.047312332499954
UACC-812,JQ-1-navitoclax (2-1 mol-mol),2.277260275544626,0.9936807274220518
SW1271,selumetinib-BRD-A02303741 (4-1 mol-mol),1.6288124556214316,3.4346908029835537
IGROV-1,10184653,0.79276129336756,1.5507904459485082
K-562,5287969,-0.8630520858269013,-2.0266236848137047
MOLP-8,148198,-4.437033387624053,-4.1642400672616215
BICR 22,navitoclax-gemcitabine (1-1 mol-mol),-3.257857035264034,-0.7240395490533175
BICR 31,24951314,2.26082148142024,1.6446556381874675
COR-L95,9887053,2.0711365362831193,3.265109542158763
SK-CO-1,2841722,4.495379043063509,4.174048816968971
COR-L95,54618164,3.8157010413732406,3.8751718086773947
ML-1 [Human thyroid carcinoma],107970,2.5074769228196025,2.415805704948592
SaOS-2,25262965,1.6840235781335875,-1.3436549148427241
MDST8,25150857,2.921484336528134,2.332277402759105
SK-HEP-1,984333,0.8474815446030621,1.0344524684929153
COR-L105,5311037,4.270584574919318,3.730545025388831
P31/FUJ,selumetinib-navitoclax (8-1 mol-mol),-1.1281624183387444,0.46378381835477483
LCLC-97TM1,3825829,3.858617243526108,3.9336770018939666
SK-OV-3,24951314,1.413681041410239,1.466271737623127
NCI-H2452,9903786,2.1501841215173396,2.8069858443443167
PaTu 8902,56963564,4.5637436248697565,0.29561168868928567
SaOS-2,262093,2.7398792490382244,2.8464006092499954
HARA [Human squamous cell lung carcinoma],4788,5.847017929418924,5.63709377116652
BICR 31,3854666,2.26793763186435,2.4169943557421587
SK-OV-3,15953870,4.452396287203901,3.6158592242597716
HuP-T3,serdemetan-SCH-529074 (1-1 mol-mol),2.447475280373413,2.1183923577705897
BICR 31,24785538,2.8976650742045127,1.795267882511032
HuP-T3,9903786,4.0743016574038915,3.0840874205641273
Granta-519,11175137,2.0306520437568767,1.8181213354484933
Granta-519,25105715,3.663648488967505,3.000955266555697
NCI-H1568,49867930,4.553956635433513,4.684601621631104
HCC1500,16038120,1.5738549040879308,0.9821818737511504
LCLC-97TM1,227681,3.759896348853487,3.4027580570622598
BFTC-909,49867926,6.076136735210805,4.123025517229669
ALL-SIL,5278396,3.0589186731365814,3.010737446367463
HCC15,2742550,3.2685764522673972,4.046603701020987
RERF-LC-MS,44486219,4.018485879154908,4.353181478552108
RERF-LC-MS,462382,0.9319597157341816,0.42149188847849745
SK-CO-1,selumetinib-UNC0638 (4-1 mol-mol),-0.0758878647184332,2.7541737313940073
SW1573,3854666,2.927116287337192,2.3272948174065475
Daudi,9935249,-0.0031627785077317,0.8226417560007441
MOLM-13,10231331,1.9024628033326092,0.12234075195833304
SaOS-2,6918837,-2.9214939411920593,-2.639642281758082
HCC1500,11507802,0.960722132601806,1.6406660162638838
WM115,doxorubicin-navitoclax (2-1 mol-mol),-1.5072575260972283,-1.2883575520051844
BFTC-909,navitoclax-birinapant (1-1 mol-mol),3.573845080821179,1.8028368370558294
LS180,9911830,2.83226076921101,2.4994906356864086
RERF-LC-MS,11222830,1.7620759794741472,1.769405898386713
MOLP-8,6252,-2.041702184925406,-1.2026302786248204
SW1271,5978,4.916909360273371,-1.8199612836715182
MOLM-13,5479543,2.5400848053862264,2.6552255854929325
NCI-H2452,11612883,2.7546488169018963,2.8658369182692995
NCI-H1568,44493528,4.1542795967274175,4.452986234778957
RKN,46398810,3.1612721401313792,2.5627277482947193
ML-1 [Human thyroid carcinoma],676352,2.608959843452948,2.2678003377775426
MOLM-13,ISOX-bortezomib (250-1 mol-mol),-0.222539624438373,0.03087119626338887
ML-1 [Human thyroid carcinoma],31703,-3.706133682115605,-0.7070862146782412
SW1573,31703,0.7694714266266048,-0.7909111481155563
BFTC-909,11238147,5.503103761619835,2.828215349073107
SK-HEP-1,637858,2.866868896175592,2.146395535472107
HARA [Human squamous cell lung carcinoma],12001922,1.8002757111950325,2.0317714242592215
KU-19-19,2828334,6.071698785304069,6.149290360862692
SW48,JQ-1-carboplatin (1-1 mol-mol),0.1401684728057108,2.2756460117599606
RERF-LC-MS,2828334,5.9123201087220325,6.231287140000125
SK-HEP-1,vorinostat-carboplatin (1-1 mol-mol),4.117273876837617,3.287678334967574
PaTu 8902,54649381,5.340946431274584,3.9404993546936704
RCC10RGB,11214940,1.429625683961422,2.1287718713564168
NCI-H1568,25195348,2.211268152441431,3.0952415343005466
COR-L95,10184653,1.5221413196357014,0.8942585662359965
BFTC-909,3634881,3.6308731463535704,3.29852593334696
IGROV-1,navitoclax-pluripotin (1-1 mol-mol),-0.9669423716100508,-0.7048812993923622
SaOS-2,24785538,-0.4134197784310965,1.8463233873437193
RERF-LC-MS,4705,3.292681011259135,3.390290096745346
MOLP-8,10127622,1.9499981558353492,2.893034939992957
Daudi,11626560,0.3779689739853294,0.8153477106793942
MDST8,168312962,1.677679532849221,1.722105902590831
IGROV-1,selumetinib-vorinostat (8-1 mol-mol),2.2605882474472057,2.5931618348670695
MOLM-13,10113978,0.7724135376915046,2.30215137238076
PaTu 8902,selumetinib-MK-2206 (8-1 mol-mol),3.282015538774474,1.7995291389590509
HCC1500,216239,1.4805608336728902,2.3314002927276114
RKN,5281321,-0.4803497212669658,-1.3122254943307292
PaTu 8902,11175137,3.538788964844938,2.7182360487323933
Daudi,10113978,1.6179427120332186,2.185405540317867
K-562,26596,-3.6076758496321832,-2.6666629181454766
UACC-812,tanespimycin-bortezomib (250-1 mol-mol),-2.245399368845158,-0.31043865239313206
Daudi,5291,1.8632614405000685,3.0310634208360954
NCI-H1568,2874250,4.364133169191667,4.216997362904298
LS411N,984333,1.2324204412799928,0.6714459396370092
PaTu 8902,11222830,2.39915227633331,1.6374455730580295
MOLP-8,54678924,1.6307832002497362,1.2065901730625777
COR-L95,49793307,-5.549400502924621,-3.5820544164896626
HCC1500,45279963,3.5713917460093434,3.3295955802245016
WM115,54765302,3.574934655958074,4.170820833899162
SaOS-2,136227924,4.496792726095474,3.0406532678272016
NCI-H2452,107970,2.3345640718356364,2.4076792459759013
LS411N,16720766,1.2713952174238143,0.0501206449245886
MOLM-13,navitoclax-PLX-4032 (1-1 mol-mol),-1.1656285238385289,0.46572881423865875
MOLM-13,216239,-5.069803023561943,1.275963950315897
RERF-LC-MS,44241473,4.536869636330491,4.994471277724326
LCLC-97TM1,10074640,3.2021543880531156,3.0909334435677245
Panc 02.03,10296883,4.297264305827386,3.8990075292392317
IA-LM,3689413,-4.432004355370191,-1.1269202716138915
RKO,375860,-0.2095842697906711,-0.24133886054011783
HuP-T3,676352,1.9029965224961456,2.0783002495022713
SW1271,5470400,4.349220092525355,-0.03180487370528903
NCI-H2452,656346,1.056906556032961,1.1236009307920418
BICR 31,56649450,1.7574149169243078,3.3575794252622604
RERF-LC-MS,24785538,0.8057743011820994,1.9212558188614768
SaOS-2,9825149,0.8893885919981879,1.8365016103805079
HARA [Human squamous cell lung carcinoma],51039095,3.2872110498619573,2.8308434062264087
PaTu 8988t,carboplatin-etoposide (40-17 mol-mol),3.874190963823487,2.913642168340199
SK-CO-1,638278,3.4780853527987854,2.9519642258360377
WM115,4096211,3.685037910266886,2.211547705544731
RKO,126941,-5.081226966265268,-2.957626859743534
RERF-LC-MS,54618771,0.9955970244631366,1.4580011042532814
Daudi,50905018,3.9297282000687312,3.440377771909377
WM115,11609586,3.058244435077658,2.9686231377701535
BICR 31,9926054,1.721382648019371,1.9378851838185163
RKO,24821094,3.7157598247146977,2.5257526431824484
IGROV-1,135440466,0.9791523710816318,2.302257172028229
NCI-H1568,44202524,1.0522971592210668,2.430721196041793
HuP-T3,9933475,3.0776536859408807,1.920076117916726
COR-L105,carboplatin-UNC0638 (2-1 mol-mol),4.035332544942737,3.442126698411002
BICR 22,11612883,2.729453217725868,2.796155566205601
MDST8,25154868,3.4078840547236333,4.5797832343383655
WM115,12001922,1.1273981641266086,1.9131990395231449
SW48,2742550,3.28553671385033,3.9305041650928176
WM115,445091,3.8598878691820886,4.2307453366984795
RKN,135875424,3.6230459419726526,4.004548400336211
BFTC-909,2708,5.254338200716292,5.053966606810334
SaOS-2,2871966,1.7918423486815835,0.4726134485666279
SW1271,serdemetan-SCH-529074 (1-1 mol-mol),2.3446355759055684,2.025703670770022
HCC15,44632017,0.3758817607479284,1.5220621217364418
COR-L95,2729026,2.664378744829576,2.5912632275273797
SaOS-2,1566236,1.7620742085681662,2.2964688440995062
BICR 22,11955716,-1.4294009955010087,-1.3797061237472326
BICR 31,2729026,2.966794528433677,2.80587636857731
COR-L95,119182,-1.6347192148686482,-0.786931618334515
LS180,5328940,1.742567210928755,1.710440528849108
Panc 02.03,46398810,3.420081587494409,2.8246568083331023
RCC10RGB,60700,3.171193268028763,0.2929571496741437
SU-DHL-6,451668,-1.4332734905345434,-0.18039831901655248
Granta-519,16219061,2.116318709414125,2.1441824252256736
ML-1 [Human thyroid carcinoma],42642645,0.1882919364816784,1.1448093816878429
HEL,53232,2.5038982548529747,2.6508913886762273
RKO,44507138,3.480554434186059,2.090075058583721
NCI-H2452,3081361,2.98247650375621,2.6003823280512073
RERF-LC-MS,44202524,1.2785968032229695,2.2266222325582903
RERF-LC-MS,16722836,2.4162442447682193,1.9546253750054334
HCC15,637858,3.032734575357801,2.1494053569629705
IGROV-1,11396600,3.99372654279783,3.748066213082582
BICR 22,44202524,1.658152527320416,2.2999359896116647
MOLP-8,54618771,0.2679151571300236,0.6542521208018575
NCI-H2452,navitoclax-gemcitabine (1-1 mol-mol),1.5021089136928458,-0.848430762037934
LCLC-97TM1,54678924,1.535359034662644,1.9263335389069056
BFTC-909,49793307,-2.946331542038894,-2.494207174496175
KU-19-19,5738263,3.812580710038467,3.44307975261024
PaTu 8988t,24821094,3.93253598055128,3.111280717345997
LS180,148198,-2.644013472885731,-3.3305161353480184
HEL,409805,5.92709656224454,3.8892681600977697
RKO,11612883,3.106052261550285,2.036995411794259
SW1271,122327,4.37632222345113,4.8455231673255925
MOLM-13,44241473,6.124350775268443,3.798018651186801
HuP-T3,2126,5.715410620657667,4.682847437028606
K-562,5291,-1.1872539047134878,1.8377572154859687
RKN,5282054,3.624299707956654,3.6765012824504053
BICR 22,613000,2.6534426018316277,2.5520189241863065
HCC15,49850262,3.6300454046422774,3.7941297800047407
SW948,613000,2.5939391420023212,2.502337813467227
COR-L95,135440466,3.0574476104836914,2.231864609571366
SK-HEP-1,262093,3.158620019748703,2.8489820336431997
UACC-812,sirolimus-bortezomib (250-1 mol-mol),-0.7676605385666967,0.8732977944286695
MOLM-13,123631,1.0914116119684203,1.875675537272687
BICR 31,4378219,2.049792351388142,2.552825055549727
LS411N,16722836,1.825979837410603,1.0302259848502118
SU-DHL-1,10074640,2.3568880289385654,2.535957545606361
ALL-SIL,6918328,-1.7903684912223865,-2.038623392093214
SU-DHL-6,3384730,1.0298608560692932,1.4704691841970687
SU-DHL-6,11485656,1.7981230616770194,1.401804302378348
ML-1 [Human thyroid carcinoma],24785538,0.9232201957937346,1.8169237368233673
NCI-H1568,176870,1.641159934282528,3.071379621624508
HEL,5280436,3.9989145330348896,2.781558380525918
BFTC-909,5328940,1.2290524134113243,1.7091731383685123
SK-CO-1,151289,0.7492352886663923,1.1177563334294285
RERF-LC-MS,104842,-3.024577047260716,-2.5579554194826644
PaTu 8988t,46843906,4.444995617536364,3.0147598824202397
BICR 22,24856436,-0.0251718817877118,0.6509664367221742
HARA [Human squamous cell lung carcinoma],208908,3.016531266929929,1.8274850931533175
IA-LM,67156097,4.3159050642226,-1.8043673825169901
HuP-T3,6438330,2.3942211080747837,2.4749371971752647
HCC1500,10296883,3.843895309810077,3.7571242741981354
HARA [Human squamous cell lung carcinoma],3062316,1.9438846554207736,1.194706881671597
SK-CO-1,56946209,-3.7989193199280016,-3.931332007500022
Granta-519,148198,-4.763660659469611,-4.299835625020615
HEL,4917,2.9031193377759603,2.7172193228333494
RCC10RGB,66577038,3.312011612499516,3.0590573280997417
Panc 02.03,3689413,0.2165954212360822,0.3683265925685443
ML-1 [Human thyroid carcinoma],89928392,0.0943028098974214,1.7065924892074
SW48,241158,3.5185545260205364,3.813975274974489
COR-L105,selumetinib-GDC-0941 (4-1 mol-mol),0.702191872416662,1.5370517357219853
HCC1500,navitoclax-birinapant (1-1 mol-mol),-3.387149505683513,1.2554929232013325
K-562,11167602,1.4540526159902811,1.877655276925511
HEL,9911830,3.2406370139452134,1.6050819197490203
SW948,25150857,2.687963392787196,1.9457446493441095
WM115,44137675,0.4260207876885596,3.6782933418047166
SaOS-2,4917,3.064827494863108,3.0823733537270352
SaOS-2,3503,1.987605483793098,2.070278383665841
LCLC-97TM1,9840324,5.858053248657865,5.708161081685247
RKN,11178236,-3.061903912386503,-3.248844523174654
COR-L95,46843906,2.16387123849571,2.603390824430669
K-562,46191454,1.7723208241237427,0.7915779118353414
LCLC-97TM1,5746,2.627938158922912,0.9875870500356734
RERF-LC-MS,613753,3.34976336152667,3.3542004031980066
HCC1500,9823820,4.617789125102065,4.083773481687281
PaTu 8902,49793307,-1.5016152541437175,-2.2279389534779863
LS411N,24964624,2.837560916730962,1.3568602080021708
Granta-519,42642645,-0.7384711962533689,0.037045960252844984
Daudi,156414,0.7854974484116999,0.5958937677173012
HCC1500,9840324,5.570797833564005,6.029549280212566
HuP-T3,6914657,-2.995276103152913,-3.5156511044116376
SW48,11178236,-2.976969958039468,-3.1117180770893302
Granta-519,11214940,1.149911870185247,0.830493762828012
Granta-519,72734382,4.317814968690637,3.436628327076988
SK-HEP-1,selumetinib-JQ-1 (4-1 mol-mol),3.7826975046986697,1.7036271024523915
SK-HEP-1,15983966,0.8278271069258164,-1.2552679956310069
BICR 22,6610355,3.5129220888937622,4.480978478140163
HCC1500,44489675,3.6836892776405854,3.898484489937727
IA-LM,3634881,3.385658224323674,2.626328021150574
SaOS-2,JQ-1-vorinostat (2-1 mol-mol),0.950161902916163,1.165319439515833
COR-L95,4788,5.892645370038274,5.324558078439069
NCI-H1568,11717001,4.19629869858104,4.069582262359226
RKO,46224516,2.430810450928805,2.211303826001059
LS411N,6505803,-0.6536233604701492,-0.8242187749218435
HARA [Human squamous cell lung carcinoma],135423438,3.0787654328489986,2.29721026939604
HCC1500,16725315,3.090868252599208,4.198926436635638
Panc 02.03,5287620,-2.132468814908427,-2.0394815097349484
ML-1 [Human thyroid carcinoma],5470400,0.2567315670041485,0.20608973550864865
LS411N,5351362,1.130738510814583,1.297276757568319
IA-LM,168312962,3.008218706470952,0.9264362037085894
SW48,9887053,1.6385742110161594,3.907792274188844
HCC15,2945648,3.8992008266513305,3.2656074785479263
WM115,10385095,0.3137764342063494,1.203317260946686
SW48,11213558,0.38171338020492,1.6882501687684879
IGROV-1,9911830,1.9130562323799436,2.5339590877972444
HARA [Human squamous cell lung carcinoma],6918736,-1.65788247009277,-1.4682914351364176
LCLC-97TM1,5284616,3.038958191933125,2.3066413763086984
SW948,5311,0.5245292911924586,0.9442454312755093
PaTu 8902,2949965,3.498586647815041,3.1752103182052154
PaTu 8988t,53232,5.050646647161413,3.096517418449256
ML-1 [Human thyroid carcinoma],navitoclax-pluripotin (1-1 mol-mol),-1.2739160400163367,-0.581167177516579
P31/FUJ,2729026,1.895106624580685,2.291135473525455
SW48,568763,-0.0201118962331156,0.6533735399424336
SW48,selumetinib-GDC-0941 (4-1 mol-mol),-3.255152499343646,1.2688195064973673
SK-CO-1,docetaxel-tanespimycin (2-1 mol-mol),-5.721099284006835,-2.293836137868596
SK-CO-1,54454,2.352526453014332,3.035979081124403
MOLP-8,tretinoin-navitoclax (4-1 mol-mol),4.347252260304068,1.4227020746896277
SW948,151289,0.9927868711009586,1.0675830579796288
RCC10RGB,676352,2.417271143726191,2.2233396484642713
LCLC-97TM1,15953870,3.316413299321368,3.4345513019973457
HCC1500,252682,6.335850466863892,6.3790200783106785
LS411N,doxorubicin-navitoclax (2-1 mol-mol),-0.6349980356208603,-1.0707821135652091
SW1271,702558,5.67814751001827,5.259605494139229
HEL,3503,1.2339935625044716,1.7844501324489266
SW948,6918328,0.2458443826474451,-0.23317181066313059
ALL-SIL,124202324,0.3755400921280209,0.862666527509
SW1573,2729026,2.4001203305493397,2.772659191072663
SW948,57330099,4.403961221202979,3.9553299181516826
UACC-812,42642645,2.375397400257474,1.225078901488824
LS411N,tanespimycin-gemcitabine (1-1 mol-mol),-0.1859317712708109,-1.1800440048372558
PaTu 8902,984333,1.3011106079808883,0.8549569116832905
P31/FUJ,135398516,1.7387657861081838,0.8653209895232233
WM115,46224516,3.0669076127990276,2.3747346090664068
SW1271,24771867,3.777194428597206,2.769074763466902
HEL,73707438,4.0836720937600175,4.049151176829917
MOLM-13,16038120,-1.7825288578452578,-0.18666744337766483
IGROV-1,10427712,3.944243047938238,4.156186571093977
LS180,3815108,3.93048377981505,2.835803040806924
HCC15,1750826,-0.4775912601104041,-1.0698188884757738
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,3.2399625664763825
P31/FUJ,42642645,-1.1469220315427042,-0.10731633268782943
HEL,1750826,-3.7677259179114047,-2.5829404323401395
NCI-H1568,25183872,-0.3156837582718859,-0.4283699334972698
SW48,54143018,-1.2192841502688678,0.7336299424137285
SaOS-2,441298,1.6833347099113902,2.424919306494993
SU-DHL-1,119607,3.7964753700545546,5.097457684432689
LS180,654092,0.275565618798522,0.007402937396419435
RKO,6918736,-1.762610939534952,-2.0308480751268756
ML-1 [Human thyroid carcinoma],6918837,-4.218663166819277,-2.070405856857799
SK-OV-3,168312962,4.003119281373622,2.2565981677399294
PaTu 8988t,3062316,1.6786738127042626,1.449966892301316
P31/FUJ,5746,-1.0128835373821496,-0.2402356680375366
ALL-SIL,46943432,1.7359798293614472,0.9982208136775357
IGROV-1,119607,5.004384040905396,5.307612200730618
LS180,135440466,2.758543039731734,2.1248916310577943
HEL,15983966,-4.130179752932702,-3.6661436545321995
SW948,11228183,2.319596035574442,0.4254848406394938
SK-CO-1,navitoclax-birinapant (1-1 mol-mol),0.739134837908099,1.3414699159424768
NCI-H2452,219104,4.089454197150707,3.947270376736198
LCLC-97TM1,24856436,-0.9719468010392746,0.48899720365155247
WM115,1716436,2.084402062067542,3.00172689334005
WM115,54596558,3.929397107249587,4.471571911024394
HCC15,selumetinib-GDC-0941 (4-1 mol-mol),-0.1827234466059498,1.5029888258687796
SW48,2828334,6.103861625006206,6.098371728356987
Granta-519,5335621,4.386788840750005,4.125548035458632
NCI-H2452,25105715,3.487348959516136,3.536169007567418
LS411N,11152667,-0.1489697958567156,-0.8658154244629056
HCC1500,4259181,0.9827468065480526,0.20276374717284537
SW1271,1716436,3.164329770032204,2.9285796907568304
PaTu 8902,tanespimycin-bortezomib (250-1 mol-mol),1.9395223164568671,-0.5615029510415996
KU-19-19,637858,2.3404288739792314,2.1095662701591733
SK-OV-3,3081361,2.5908903164469317,2.3973194101296977
BICR 22,10322450,4.612637955736889,3.862782263517382
ALL-SIL,44819697,-2.9345943950607136,-1.9231951788822852
LS180,4259181,0.5796574720850999,0.33050599709176537
IGROV-1,6918328,-0.5330006254346346,0.022920153438830023
RERF-LC-MS,11178236,-5.98494163410248,-3.2746346462166787
SK-HEP-1,SNX-2112-bortezomib (250-1 mol-mol),0.9629137048911888,-1.1737023942396916
IGROV-1,11485656,1.900409616013456,2.4004944477385313
HARA [Human squamous cell lung carcinoma],5281321,-1.682952924947167,-0.647593188108411
BICR 31,16065773,3.973194001978765,2.68811825399469
IGROV-1,6252,1.1284141516966473,1.0827273080629138
SaOS-2,135398516,5.990406168261382,2.1626127006154716
RCC10RGB,11485656,3.364959979667133,2.685244342371233
NCI-H1568,46926350,-5.085925204635643,-3.797870406425139
LCLC-97TM1,123631,2.4246211789463445,2.0503227404762594
BFTC-909,44185566,2.75887016136311,2.6642227950804585
BFTC-909,124202324,2.9321657702899295,2.740741895356209
LS411N,4917,3.429074291339912,2.8056187601459306
BICR 22,135440466,2.8663984884678513,2.296254101846901
HCC1500,10127622,5.201205269222406,3.3877789080953216
WM115,24748573,1.2650334763374356,2.358361284224967
LS180,17755052,1.7669119525953814,1.5835496347382838
HEL,5278396,2.941082820113368,3.048048464514387
K-562,6917907,-5.621792844351372,-5.299316808183014
WM115,11175137,1.8074191527620995,2.577675287048271
ALL-SIL,6610216,3.679901693613009,3.853328525062042
IGROV-1,3815108,1.915722485757852,2.998682905051727
IGROV-1,44491742,4.406671418311328,4.1516122406261475
NCI-H2452,11647372,3.7610160121318055,1.4486469454141768
Granta-519,25262965,-5.6090339200635375,-2.413166171053658
HuP-T3,5287969,-2.0305885584054693,-1.9644985434726416
Panc 02.03,4578,4.394890119629889,4.319811289488863
PaTu 8902,46199207,3.581196343990194,3.141585585948149
MOLP-8,5329102,1.1360795478534944,1.4734539504924025
SW1573,24797083,0.9725439959134782,1.333696658366583
COR-L105,11507802,4.378208095645504,2.0383936256975597
SK-HEP-1,10385095,2.0924930980552148,1.5965307657335774
ML-1 [Human thyroid carcinoma],44185566,2.5450411112530475,2.564944671196583
MOLM-13,54618164,3.841266236609366,3.5002282944532173
SW1573,5287620,-0.7347028317725576,-1.8159378997382776
Panc 02.03,24821094,4.183998590604807,3.362950662912505
NCI-H2452,11977753,-3.0535753971711617,-1.8385374209200405
MDST8,selumetinib-tretinoin (2-1 mol-mol),2.2380074013059086,3.386695125495397
K-562,5278396,3.2143611477277325,3.018653496765875
MDST8,46907787,1.4338285439483007,2.2609739261425204
MOLM-13,16219061,2.363003680724254,2.2967872246927716
IGROV-1,3854666,2.3355254440561137,2.211039523851018
LS180,11175137,3.0855574956004506,2.577524834730972
PaTu 8902,24180125,3.5735575491444505,3.2124983776891
Granta-519,135440466,3.2501433765769097,1.7043531019493878
Granta-519,3634881,2.8250958488191533,2.5099514368777376
BFTC-909,24785538,3.0409365635840433,1.7720455869532128
Daudi,9903786,1.3988461789185107,2.0306835736548767
IGROV-1,126941,-2.246216453812328,-2.5834810706469953
HuP-T3,327653,2.4979616286385573,3.196609633578672
KU-19-19,24785538,4.6207321752497545,2.073446709050015
PaTu 8902,11238147,5.651020754323713,2.8999505519796624
P31/FUJ,24772860,-2.926152167827307,-2.8487210114906714
SW48,969516,2.6010409472277303,2.9415302759250808
NCI-H2452,11656518,-0.3763326461825258,2.2722666281696475
LS180,156422,4.137124258725139,3.907569984458988
K-562,16038120,0.8140588279430221,0.1094494619659245
HEL,9956119,2.2634866876643924,2.881652265877079
MOLP-8,16013152,3.9032026583920656,3.4339801701655124
SaOS-2,7251185,2.1177882155213488,2.4712296787298635
SW1271,16722836,1.1489272284540188,1.6366816894676872
SW1573,1750826,-4.895155026964416,-1.3857602703917544
COR-L105,6918878,5.053406021852451,3.2756266088998216
HuP-T3,44566777,1.596285673654969,0.7688005290328946
RCC10RGB,11167602,3.5267453541831695,2.5925445096894397
KU-19-19,3689413,0.155027117273248,0.04364585180735911
LS180,262093,3.1953995116592826,2.9113508535280914
HEL,168313016,4.358661125075543,4.163769051244937
LS411N,448949,2.5849168666236273,1.6922411349019533
RERF-LC-MS,11507802,1.168612691302407,1.8477883162022772
RKN,3025986,-0.1432368238740909,-0.6453511500825212
LS411N,5566,3.1552423609786153,2.7973156065826656
MOLM-13,168312962,1.173226591058953,0.5635438895716326
KU-19-19,16741245,1.8623441782077492,4.162129895957826
BICR 31,5746,2.9612823230829592,1.2880745161566336
RERF-LC-MS,448949,1.7883798522328354,2.1023409358893868
Panc 02.03,piperlongumine-MST-312 (1-1 mol-mol),2.606918356339114,2.167383999767019
K-562,135411,0.731253239019591,0.03539727792089754
WM115,3825829,3.803690072721518,4.1516749854764985
PaTu 8988t,1566236,2.792784501487116,2.4431463990445077
SK-HEP-1,25102847,3.375423501622406,2.6449589257805233
RCC10RGB,4378219,3.5112219508307017,2.6724148187600134
IGROV-1,46907787,2.182756719431072,2.0262298091970137
ML-1 [Human thyroid carcinoma],176870,3.163449715300446,3.677860249025995
COR-L105,9903786,2.948812050867326,3.1856114920081997
SK-HEP-1,5287969,-1.6185163943497696,-1.7956050023259968
LS411N,66577038,3.114674219164565,2.6831048225290055
LS180,11152667,-1.0678137233062412,-0.5291135924809841
SW1573,10322450,3.835483834832597,3.8672003512462787
ALL-SIL,4369359,5.632204520937589,1.8994303099180754
P31/FUJ,6918289,5.395091759648689,-0.4480221734222297
NCI-H1568,carboplatin-etoposide (40-17 mol-mol),1.7182211320205656,2.7498653462640466
BICR 22,54626689,4.975060177279609,4.72830343333744
RKO,11455910,0.1271196393609195,0.47507709665796277
NCI-H1568,2749,1.8950065449811435,2.018241733308738
SK-HEP-1,2858523,3.173409588420467,3.1388941984333503
HARA [Human squamous cell lung carcinoma],46907787,3.600628557962214,2.42048029542022
NCI-H1568,16736978,1.0202421307584555,1.6958650713922603
NCI-H1568,11640390,2.883529605834316,3.4683030429796946
SaOS-2,375860,-0.2844076074043694,-0.049499836891937765
Granta-519,9549297,1.4990763156673828,1.4639480598223868
ML-1 [Human thyroid carcinoma],24772860,0.5673209260643837,-1.6166798274652692
MDST8,9915743,3.1722151191536607,1.3147466063046231
HCC1500,7251185,1.592161448601532,2.455807555946917
PaTu 8902,654092,0.4014878659730266,-0.2549259302290679
HCC15,36462,0.276886424919507,2.298673256829356
HEL,11222830,1.7664464656365049,1.2036632248872114
LCLC-97TM1,6918328,0.5489211755624944,-0.0028031816300113973
SW1271,11427553,2.280233400826346,2.6658095432279323
MOLM-13,tanespimycin-bortezomib (250-1 mol-mol),-1.8317105130308673,-0.9756436421535807
SW1271,216239,2.3992651597700805,2.3051380229625513
LS411N,52912189,2.124177170278397,0.564605276297295
RKO,262093,2.7220373961576834,1.8731511432043364
RKO,selumetinib-piperlongumine (8-1 mol-mol),2.2390647410806306,1.8741860695884072
SU-DHL-1,24180125,2.3898229933344193,2.6867826391814846
P31/FUJ,10231331,0.360402840185862,0.6231338143444355
COR-L95,navitoclax-PLX-4032 (1-1 mol-mol),-1.058390181093963,0.8666907991986185
HCC1500,4705,3.1720127097688073,3.1533247337076666
ML-1 [Human thyroid carcinoma],16722836,0.1571893320134409,1.7993621281224461
ALL-SIL,49793307,-3.5976005593324607,-4.430915075976747
LS180,decitabine-carboplatin (1-1 mol-mol),4.499129095785504,4.275535932336296
BICR 31,selumetinib-PLX-4032 (8-1 mol-mol),3.623780948669338,3.740207920203551
HARA [Human squamous cell lung carcinoma],409805,4.942295126142001,4.943655336887779
ALL-SIL,44489675,3.868517697091687,3.592058664626594
COR-L95,9825149,1.4009706639997015,1.9505092597919345
SK-CO-1,25102847,2.4259034566713087,2.382884453406522
COR-L95,36314,-2.5383774872687743,-1.5247193671351895
IGROV-1,1641662,3.5854177848263675,3.663318950700323
BICR 31,16720766,0.8786813091838682,0.5778736382788656
BICR 22,51037431,2.6213243445689254,3.1934099781382566
BICR 22,2742550,3.9616050819266326,4.009711107223146
Panc 02.03,46843906,3.852893526574364,3.4367253643176268
NCI-H2452,2708,3.4614923437122704,4.9923185325435995
RCC10RGB,15547703,6.556615668020641,3.286007582094694
RCC10RGB,5311,2.218274000934613,1.7127736623386065
ALL-SIL,erlotinib-PLX-4032 (2-1 mol-mol),2.6221278423473446,2.795326176117769
LCLC-97TM1,24964624,2.5877637900313384,2.3681707206354896
KU-19-19,107985,-2.420790531142743,-3.3858894840763782
PaTu 8902,67156097,4.866613623772486,-0.41859081760399697
KU-19-19,676352,2.681008284282423,2.2659982602737823
NCI-H1568,67291369,4.628091486396258,2.875579228448652
BFTC-909,54143018,0.6300785047889099,0.7753765672632007
BICR 22,5329102,1.9183442886017033,2.051265665329482
LS180,JQ-1-carboplatin (1-1 mol-mol),1.5137098822728978,1.8928606161805819
SU-DHL-1,1641662,2.0867851207635044,3.1628940350893844
SU-DHL-1,54143018,-1.2287450259829942,0.6374370193610479
WM115,3552672,1.460151745141153,2.6896874743734305
Granta-519,6505803,0.3707466177802866,-0.7517734901579993
BFTC-909,2733526,3.41724914482818,3.5436591374281705
COR-L105,445643,5.447871607768224,4.061325540514435
SW1573,BRD-A02303741-navitoclax (2-1 mol-mol),1.994158389176884,2.3706293461671164
COR-L95,135421197,1.4504202802892363,1.553178137797138
BICR 22,4096211,1.2113689067872688,2.518394319488515
Daudi,241158,1.9180708700138325,2.6253090412456546
RKN,docetaxel-tanespimycin (2-1 mol-mol),1.659975764237714,-3.5055748627839494
COR-L105,44543605,3.798835657012519,3.863269566122916
NCI-H2452,1641662,5.47511848960003,3.674902151727543
IGROV-1,SNX-2112-bortezomib (250-1 mol-mol),-2.6574753619864233,-1.3420938634621882
HARA [Human squamous cell lung carcinoma],9826308,0.352829852370258,0.576995413366846
MOLM-13,44489367,5.70063080501961,4.484336017932889
MDST8,9936388,-2.5080849755955485,-0.06365770934187516
Panc 02.03,5311281,4.827416145020449,2.6394963512980225
MOLM-13,carboplatin-etoposide (40-17 mol-mol),-1.2909434999313618,0.46998340653809584
Panc 02.03,71466380,5.929652601038649,4.548797158105707
BICR 22,148198,-3.168643556299537,-2.9432982018069556
LS411N,salermide-PLX-4032 (12-1 mol-mol),5.97516001818146,4.422699543859497
SK-HEP-1,serdemetan-SCH-529074 (1-1 mol-mol),2.785522004432589,2.2480500641961765
MOLP-8,36462,-1.3356090090333852,1.0178218576821882
RKO,168313200,3.1169425006108455,2.704842961426736
SK-HEP-1,24951314,2.4991128927954063,1.5730837903141874
HARA [Human squamous cell lung carcinoma],654092,0.0602204093244996,0.030487925695291164
COR-L105,71304818,2.509036292239667,2.6125336052551758
LS180,11485656,2.0322073649322716,2.2089546066237546
SW1271,44185566,2.531281599529394,2.5891396933925255
P31/FUJ,49836020,4.674155414221834,2.732919669704442
UACC-812,carboplatin-etoposide (40-17 mol-mol),1.4623710182991412,1.9541847127038268
SW48,selumetinib-piperlongumine (8-1 mol-mol),-1.6389231751651676,3.2822672663976094
RERF-LC-MS,9933475,2.253072026550434,1.9430714117319612
SK-CO-1,24964624,3.1718881088721735,2.2334278368888487
Daudi,serdemetan-SCH-529074 (1-1 mol-mol),0.5315798853273473,1.4562404754239517
LCLC-97TM1,54619267,4.094508182091097,3.953853643289731
SW1271,53232,2.609582991635379,2.829802716371619
COR-L95,5282054,2.7623794331923293,3.121400775097421
LS180,navitoclax-MST-312 (1-1 mol-mol),2.264329466995316,1.204492043744242
ALL-SIL,2749,0.4174204822378836,0.7864239502268079
MOLP-8,11455910,0.4759456923848041,0.2839580177391634
SK-OV-3,5329102,2.1848030817162427,2.2003309395640063
IGROV-1,5978,-1.5618214380165825,-2.1082377770197516
BICR 22,135411,0.5903998872112299,1.045240192884672
NCI-H1568,6610216,3.52063980115584,4.301368789365573
SK-CO-1,176870,3.965368978694832,2.987115171153683
BICR 22,selumetinib-GDC-0941 (4-1 mol-mol),0.9236459983080146,1.0464805557637569
BFTC-909,doxorubicin-navitoclax (2-1 mol-mol),-1.537563048544383,-0.9452129582414295
IA-LM,9936388,2.150111055311291,-3.541721569651761
ALL-SIL,selumetinib-BRD-A02303741 (4-1 mol-mol),5.278969536899067,3.456996017362976
ML-1 [Human thyroid carcinoma],selumetinib-PLX-4032 (8-1 mol-mol),-0.2880991888537167,3.236052499713385
SW1573,navitoclax-MST-312 (1-1 mol-mol),-1.0459858342436132,0.9439940287704809
P31/FUJ,11214940,0.6332731592867608,1.2605682069603885
WM115,421610,3.513747492259629,3.3658312880557486
SaOS-2,227681,4.210698048028356,3.164145510369424
BICR 22,25102847,3.5270600092516444,2.5518443141867397
BFTC-909,46199207,3.2760821272908753,3.107430911443468
IA-LM,25154868,2.8804249714329537,4.5128796839951075
SaOS-2,5738263,2.656867973667437,3.3986015255594197
BICR 22,5738263,3.828959854789421,3.385302958581079
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.7349156816775826
SW48,SNX-2112-bortezomib (250-1 mol-mol),-3.704667477676808,-1.4136648092534176
Daudi,24771867,-1.2539165255857252,-1.5380593437887946
Daudi,446155,1.8075236258569949,2.2712488206679464
LCLC-97TM1,56946209,-4.83981355951691,-3.728300394012472
BFTC-909,702558,5.601571619782522,5.298255343021595
LCLC-97TM1,24797083,1.6672233423539589,1.2875759495093575
IA-LM,2945648,2.6647419367463794,2.5801508437816922
LS180,11717001,4.39666521822979,3.699791836040637
LS411N,42642645,1.4293896003043414,0.18988198376108978
SaOS-2,16038120,-0.4228492368909831,1.0233889896447526
HCC15,387447,-3.5284625014182556,-3.6990333200408627
K-562,24785538,3.0712560410264436,0.5857330018889882
PaTu 8902,6918289,3.1585202712855196,2.504987111080393
BICR 31,11404337,-0.6318210319309021,-0.15214053638724498
Daudi,navitoclax-PLX-4032 (1-1 mol-mol),2.817343533206949,0.30674829144534077
LCLC-97TM1,5460769,-2.8089441547625067,2.5855888167500565
IA-LM,25150857,2.846024040084871,1.963461601060055
HCC15,56973724,1.575466068691269,3.343383422882585
ALL-SIL,3384730,0.9130815120154347,1.1835720983143987
Daudi,426756,2.2442144831253383,3.6167620622262753
NCI-H2452,6918328,0.3371182351616307,0.34024579314411324
SW1271,11364421,-1.228057709924225,-2.275517702371107
HCC1500,9911830,2.253316240952314,2.564845341539046
COR-L95,60750,-4.239654973449372,-2.411464136376336
COR-L105,675434,4.897128449999278,4.66508316440327
RKN,5978,-1.5379865785523688,-2.115043256296697
BICR 31,1641662,4.3069637553272715,3.753132652388636
SW48,5281321,-2.141746406212142,-0.9191100895795818
SaOS-2,navitoclax-gemcitabine (1-1 mol-mol),-3.208051277471344,-1.1710251381413999
SW1271,vorinostat-navitoclax (4-1 mol-mol),2.219898250998274,1.1458901676112356
K-562,12003241,-5.632155645383806,-1.0359091326049936
IGROV-1,11455910,-0.2792640061206097,1.0193202880748053
COR-L95,10410894,3.9632969340699735,3.134250179203734
SW48,5351362,1.0988845715277948,1.4205205241336125
HuP-T3,9907093,4.467626530245781,4.287540478886291
IGROV-1,16065773,3.3717508464278585,2.474366898323353
Panc 02.03,439501,0.4668648826805023,-2.0410896594054204
COR-L105,11427553,3.315123926488956,3.004410832638399
IGROV-1,119607,5.004384040905396,5.307612200730618
BICR 31,151289,1.9519908762907336,1.1253431422263984
SK-CO-1,60700,-2.5556595153787915,-0.19017317667963968
ML-1 [Human thyroid carcinoma],2828334,6.601742138030732,6.213784712466337
BICR 31,3825829,4.543850483279072,4.071141535399978
SK-CO-1,65064,5.377201033407044,4.810857004755692
HuP-T3,613753,3.2946831222357233,3.3328058714653745
SK-HEP-1,89928392,1.6602086186634375,1.682467982203342
NCI-H2452,5291,3.747673065274588,3.804075872911607
NCI-H2452,24964624,2.8171716992687967,2.49803853728788
SU-DHL-1,654092,-1.6609972231677514,-0.17952922248372405
LCLC-97TM1,327653,3.202975625508304,3.1291281844181302
LCLC-97TM1,11507802,1.3666879232460134,1.3953826671184026
SK-HEP-1,sirolimus-bortezomib (250-1 mol-mol),1.4424973508492578,1.0344585154213775
BICR 31,selumetinib-UNC0638 (4-1 mol-mol),2.7430116861345977,3.0210645235570297
SK-CO-1,11222830,1.7982943188317977,1.7049019183526293
WM115,24951314,1.781657055553587,1.5136806335695807
WM115,135421197,2.9135607351561883,2.1149859101614585
LCLC-97TM1,136227331,4.3740550996774745,3.9748116819013557
BICR 22,24951314,1.8959621159637303,1.7301311049524335
HCC15,15983966,-4.250826265389746,-1.5577441862909074
Daudi,24964624,0.5895170730703193,1.0451368989691703
SaOS-2,11257553,0.2323229130258903,1.1297470781812158
RKN,doxorubicin-navitoclax (2-1 mol-mol),-0.6554911641899885,-1.1362358341414633
RKN,46191454,2.1430961760764897,1.5694941347544207
ALL-SIL,navitoclax-sorafenib (1-1 mol-mol),-0.9804805399961952,-0.23736223563616426
HARA [Human squamous cell lung carcinoma],24180125,3.640570848683534,3.2499470449500065
BICR 22,10410894,2.962619033825151,3.1820823794099384
NCI-H2452,168312962,2.634597095527088,2.1945527033082963
MOLM-13,452548,-4.1979459883625045,-2.5124787370458463
HARA [Human squamous cell lung carcinoma],doxorubicin-navitoclax (2-1 mol-mol),-1.5170547368842298,-0.9664843186220289
SW1573,44185566,2.872643000979188,2.719292723891984
SK-CO-1,5470400,-5.490738264790885,-0.7342858267850088
BICR 22,9933475,1.970614134756263,1.8350421453230206
BICR 31,24753719,4.233476426959058,4.314770396772426
HuP-T3,4261,3.8165819220848767,1.5179340678151343
COR-L105,7251185,3.034502689275401,2.702222836864432
ALL-SIL,selumetinib-MK-2206 (8-1 mol-mol),1.6757681784854677,1.4264982367601875
SW948,crizotinib-PLX-4032 (2-1 mol-mol),1.0252435682890393,1.512217201684987
SK-OV-3,49793307,0.1269396758315965,-2.1882252054022775
ML-1 [Human thyroid carcinoma],11647372,1.3935699525801049,1.2694833440506912
KU-19-19,216345,3.688803948438149,3.9454157471634113
LS411N,638278,3.5631537252490917,2.9998183012935193
SK-CO-1,374536,2.850215581982446,1.8777635145073814
ML-1 [Human thyroid carcinoma],25126798,4.037868296097697,3.8869139670651442
P31/FUJ,11178236,-2.454576103037029,-3.8913042540856035
SW948,439501,-2.1692174321648174,-2.0454005645712012
NCI-H2452,9911830,3.1691750432917645,2.6932377623570494
IGROV-1,9911463,4.195269991960018,3.7542831509119474
PaTu 8988t,JQ-1-vorinostat (2-1 mol-mol),2.250446694675845,1.3741287814090573
KU-19-19,46199207,3.5920417522591723,3.2856084946930353
IA-LM,25102847,3.5065737869109017,2.274790720865762
SaOS-2,10385095,0.9171223668306429,1.2610487794568872
SK-HEP-1,285033,-0.6546577384402199,-1.5345808208371705
WM115,1566236,3.8332358430398847,2.4881712303447543
LS180,3025986,-0.3657173630682503,-0.9708951418288305
HCC1500,11625818,4.269459310239442,4.182069402520185
HCC15,44259,1.006506996100477,0.8568794193006636
RERF-LC-MS,285033,-2.0574538896256587,-1.528166850487875
IGROV-1,241158,3.288496474515495,3.870161242745774
BFTC-909,6917907,-4.2174557642594035,-4.468451294925418
BICR 22,375860,-0.6251605141105395,-0.06520073124732546
BICR 22,119607,5.438520616053313,5.170315867623381
RERF-LC-MS,676352,1.6328584527608256,2.2444370652896937
HCC15,6918289,2.816502870816243,2.8753459677230833
RKN,241158,3.8611150596916577,3.9893149792091265
COR-L95,3634881,3.005165393659793,2.9293102422312507
IGROV-1,11626560,1.7276653519578558,2.107565080695102
LS180,3385,1.8718372753364907,3.7279963720937523
SU-DHL-1,56946209,-5.3778659012875325,-4.605612599847803
Panc 02.03,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1370964450490924,2.9851481015430927
NCI-H2452,448949,2.771204919609998,2.1409595520183697
SW1573,5113032,6.532830278238065,4.992306613050283
SK-OV-3,11485656,3.3782074628341894,2.397818942089834
BICR 22,81146,6.036644504914818,4.602143822543722
P31/FUJ,76446078,4.256026108364254,2.8779794364659725
Daudi,2113511,3.606563716227827,4.410185592291459
HuP-T3,5328940,2.3682781464336147,1.7410207844775392
RKO,6852167,3.601912647929868,1.9043092740329515
SK-HEP-1,1750826,-4.478019715406424,-1.4279285466952953
SU-DHL-1,25102847,1.7846654255237482,2.1061197899299144
KU-19-19,2749,1.0704171129437314,2.133800229133046
COR-L105,136227924,2.729950058152846,3.034254034972447
RERF-LC-MS,crizotinib-PLX-4032 (2-1 mol-mol),1.247076899545937,2.103909073285725
RKO,25154868,3.654559992823761,4.14367921814165
HCC15,5113032,5.023051877119823,4.94485828179749
LCLC-97TM1,3815108,3.2576294300862867,2.6352433889943767
SU-DHL-1,6610216,4.061950863639378,4.069529714730044
LS411N,136227924,3.1900427132689724,2.379216421694861
BFTC-909,selumetinib-piperlongumine (8-1 mol-mol),4.839600666891057,3.410768621869627
KU-19-19,51037431,1.6044173216619535,3.388340057727787
MOLM-13,637858,0.5048034575879493,0.8412739845554814
SW948,5329102,1.476566645762777,1.7596266413928296
NCI-H1568,tretinoin-carboplatin (2-1 mol-mol),4.637834792559274,4.786926880777522
K-562,serdemetan-SCH-529074 (1-1 mol-mol),0.9314801413999184,1.6612252075775111
SW1573,1566236,3.3872191513469025,2.4525063858601137
IGROV-1,46174525,4.5083762186279595,4.645565790078964
SW948,9956119,4.230492181635778,2.9646949241952614
SaOS-2,100016,6.565789067704999,6.391268278386733
WM115,11152667,0.9737214532192616,-0.5043455668469845
HCC1500,439501,-1.4156205398968564,-1.748163360084636
SU-DHL-1,selumetinib-UNC0638 (4-1 mol-mol),2.6727434521528894,2.4042539916678853
NCI-H2452,49793307,-1.217787389832333,-2.1748537860735357
BICR 22,208908,1.938925459708866,1.7385461007280751
KU-19-19,675434,4.307992798559183,4.434041553528362
SU-DHL-6,168312962,-0.817402334599034,0.6536262881395243
RKO,4705,3.750134101835121,2.636352080707145
MOLM-13,72193861,-0.3301410770598842,0.11314949676998295
SU-DHL-6,11497983,-4.838706392617486,-0.47604203310420634
IA-LM,6610355,7.432350505906943,4.360423240839191
SU-DHL-1,100016,4.0163007651424945,5.946704144965305
SW48,tanespimycin-gemcitabine (1-1 mol-mol),-4.429955017650206,-0.8965075563063063
BICR 31,11717001,4.942461846011657,4.120958659099997
MDST8,452548,1.517979290481689,0.6032201711998111
SaOS-2,vorinostat-carboplatin (1-1 mol-mol),3.1714498028608573,3.2301315628630505
ML-1 [Human thyroid carcinoma],tretinoin-navitoclax (4-1 mol-mol),3.335416129341979,2.967886504653835
HCC15,216239,2.699139377969599,2.1849000421441342
SW948,54143018,1.1269042701713536,0.04257845922454934
PaTu 8988t,2871966,0.7913795837456433,0.7656709052568681
HARA [Human squamous cell lung carcinoma],24889392,3.022552356394008,4.197829834411365
MOLP-8,702558,5.64086941386953,3.9194389280676827
SK-CO-1,9926054,2.0008566323964576,1.9010734160981406
NCI-H1568,208908,1.6425276108518176,2.056653586137157
BICR 31,11364421,0.6668909809197356,-0.5616568326211512
RKO,6438330,2.4839059464581785,1.6093977454495856
HCC1500,11717001,5.16685929391629,3.811446310402798
NCI-H2452,5335621,2.361346054519045,4.741055612591295
SK-HEP-1,168313200,3.8713243832650335,3.2039718165607587
MOLP-8,5281321,-3.090542457479921,-2.742163015485173
LS411N,5287620,-2.7795044954925423,-2.043927799159426
BFTC-909,42611257,4.384387627976705,3.259420504563634
MDST8,135421197,2.23565927197073,2.3688531400285244
LCLC-97TM1,navitoclax-MST-312 (1-1 mol-mol),1.32635815912294,0.9836167688887456
ML-1 [Human thyroid carcinoma],4261,2.09291450929782,1.9287507728519493
SU-DHL-1,136227924,2.1802521862386395,2.7968542692314395
HEL,9929138,6.278460484472286,4.919052598362891
BICR 22,100016,6.157225392196351,6.12165581961198
BFTC-909,6610216,4.898578232775107,4.398329367258986
ML-1 [Human thyroid carcinoma],327653,3.144384021244803,3.276847569158237
P31/FUJ,2708,3.1798246734444535,3.0974262152166476
SK-HEP-1,11222830,2.864448489509693,1.7551433036116375
SW948,6450551,1.190778779915613,1.8404775551387944
P31/FUJ,3503,1.1912257572322915,1.7065696309746738
SU-DHL-6,11214940,-0.480666123434414,0.9586308660743922
Granta-519,3101542,4.848909880356854,1.2274034847844337
COR-L105,JQ-1-vorinostat (2-1 mol-mol),0.2989866544918393,1.4163928937491361
SK-OV-3,54613361,2.1799599530092597,-0.05635794608982918
SaOS-2,navitoclax-MST-312 (1-1 mol-mol),0.5918912917357866,0.6763136941645856
PaTu 8902,9866186,4.760639543290191,0.6661738857695378
BFTC-909,selumetinib-UNC0638 (4-1 mol-mol),3.893293421232559,3.2638503328128348
MOLP-8,445455,4.348825488954634,3.9877570203687993
LS180,327653,3.1909584751660973,3.070564888036418
LS180,selumetinib-JQ-1 (4-1 mol-mol),-1.4901017430136672,1.1155118727454818
WM115,24889392,3.868386170167097,4.241977257541818
SK-CO-1,54618771,-0.118181134306818,1.1071055488531636
SaOS-2,9868037,3.691858985861763,3.376938409516368
Granta-519,navitoclax-PLX-4032 (1-1 mol-mol),-1.627997667174391,-0.5173200966793494
HCC15,10385095,2.335943691067567,1.2461215318215513
MOLP-8,2874250,4.289349020932475,4.138693231164791
IA-LM,selumetinib-PLX-4032 (8-1 mol-mol),3.550842721167267,2.9682493986539225
SU-DHL-1,44137675,2.905771721153928,3.423517107916345
SW948,16038120,-0.173493225813213,0.33247174767458376
SW1271,387447,-4.431171658059158,-4.102542565654952
HCC15,71304818,2.608087345638841,2.6907392091852738
HuP-T3,navitoclax-pluripotin (1-1 mol-mol),0.368847097693027,-0.5990125173779556
SW48,44259,-0.1330653223053438,0.521975280640745
SK-CO-1,selumetinib-tretinoin (2-1 mol-mol),0.0609322450258742,2.3943101972994314
BFTC-909,216239,2.6603594422751136,2.3523857690181798
MDST8,9825149,2.535214047656483,2.616981556770187
BICR 22,11625818,4.758067302616356,4.178311588909756
LS411N,6852167,3.3651093558735035,2.106580348677686
BICR 31,7251185,3.1852875333924415,2.7387870144066584
ALL-SIL,25195348,0.8279476297727174,2.5003692918212086
SaOS-2,73707438,3.8840228628110336,4.186186202843611
Granta-519,selumetinib-MK-2206 (8-1 mol-mol),2.927373885066516,1.8169846057106782
BFTC-909,17755052,1.7621152527207813,1.7803928205834065
MOLP-8,vorinostat-carboplatin (1-1 mol-mol),1.858459936032215,2.0041484547460393
SK-CO-1,3815108,2.810447278858876,2.919620806764864
COR-L95,3025944,4.2211844332657344,4.114325010787034
RERF-LC-MS,9825149,2.3136516136403595,2.2530573337186413
KU-19-19,72376,-1.7461965003174784,-1.3066883226291586
K-562,568763,0.3044566284292496,0.06143464073106241
ML-1 [Human thyroid carcinoma],4521392,4.335063435629941,4.31460226158839
Granta-519,6917907,-6.07944377191165,-5.415982688334729
SK-OV-3,4788,6.178998906779571,5.65517085356486
HARA [Human squamous cell lung carcinoma],3081361,3.3764732224556533,2.1167813485758034
RERF-LC-MS,6852167,1.8897499878184068,3.143209097570201
RCC10RGB,2746,4.042085650474663,3.5737931420635443
SaOS-2,54143018,-0.9786223984268784,0.5773382295381221
HCC15,451668,4.7728580097586635,4.48203452251543
RKN,135999136,4.319110081529012,3.3470574893696696
ALL-SIL,11228183,-1.4217334963731665,0.17512832626440222
RKO,568763,0.6942409100068829,-0.05420462904077592
SK-CO-1,71304818,2.179260281615582,2.4540819723319514
SaOS-2,151289,0.9278405880660672,0.8073290624022416
BICR 22,tanespimycin-gemcitabine (1-1 mol-mol),-1.0672550933922087,-0.7372595804897563
MDST8,241158,1.799926141571129,3.9962837924601673
BICR 22,11214940,1.8032425349242045,2.182740903671469
BICR 22,navitoclax-birinapant (1-1 mol-mol),0.9663061977057198,1.42469006086839
LS411N,9825149,1.7370452341191267,2.173047940531344
K-562,72193861,0.1570904811456113,0.1308518374677291
RKN,89928392,1.2442310560485252,1.7607779080505122
HARA [Human squamous cell lung carcinoma],25150857,2.860855820493058,2.495100644050346
RERF-LC-MS,44493528,4.358183394704722,4.3305086725715185
COR-L105,5738263,4.054674337055045,3.527825919075371
P31/FUJ,5280436,3.1830796623136832,2.6237628821104004
Daudi,JQ-1-navitoclax (2-1 mol-mol),-0.7335137922261505,-0.38773125958681376
LCLC-97TM1,135398516,2.1563049020997593,2.109814195907626
COR-L95,25102847,2.826830714185171,2.4503097296531875
BICR 31,11427553,1.8414471938085448,2.837129857109052
P31/FUJ,navitoclax-MST-312 (1-1 mol-mol),-0.1859808943498902,-0.4074023040233363
IGROV-1,15547703,3.339928221860449,3.1793070164907213
LS411N,navitoclax-PLX-4032 (1-1 mol-mol),1.1305163231038025,1.4919932266446743
LS411N,6918328,-0.170211770014818,-0.12199413121412933
Daudi,3136844,3.4483363469146098,3.638668133708791
MOLP-8,10302451,3.559537910744256,2.743685640575792
LCLC-97TM1,24772860,-2.203105978452304,-1.9227914290313908
SK-OV-3,selumetinib-GDC-0941 (4-1 mol-mol),2.556628673081414,1.771310928510417
ML-1 [Human thyroid carcinoma],637858,1.1825057393141218,2.045530787217219
SW1271,119182,-0.4023310904747799,-0.5041911587338713
RERF-LC-MS,135398516,2.452363199699896,2.3880378168980823
SK-CO-1,44495899,4.504236306700641,3.188623281694739
IGROV-1,10127622,3.2581804056600165,3.5214634094024335
SK-CO-1,44491742,5.1736211152382285,4.265950946006473
MOLM-13,4477,0.1750371811238646,0.7506086324409738
WM115,25183872,-1.8696572442850008,-0.829902002723322
BFTC-909,JQ-1-navitoclax (2-1 mol-mol),1.710597904541152,0.7681739456239489
LS180,JQ-1-MK-0752 (1-1 mol-mol),0.6783898145505391,1.3901049533189096
HCC1500,5335621,4.362965892261437,4.443611110923304
P31/FUJ,1716436,3.053886593694114,2.4978111622159225
Daudi,9915743,0.3665260221427978,0.2062175273690606
UACC-812,selumetinib-MK-2206 (8-1 mol-mol),1.487616505543695,1.7908373146431247
SK-CO-1,5311281,1.7217135985324663,2.354588273985765
IGROV-1,3503,2.453392942972796,2.142733557141935
SW948,17755052,0.6738246482480579,1.212011461652456
Granta-519,5329102,1.3717145166802862,1.2539034043117696
HCC15,25183872,1.7330298559310635,-0.5570562181979415
IGROV-1,23635314,-0.611739968448912,-1.2338186259278645
HuP-T3,46174525,5.4457837824532245,4.5903211493126
IGROV-1,46199207,3.293579955374855,3.2915593550911275
NCI-H1568,11656518,0.902462789439692,1.710416506301525
SW1573,12001922,2.294011710402099,2.064284418184622
HCC1500,navitoclax-sorafenib (1-1 mol-mol),-0.1825981932609776,1.4576654571446475
ML-1 [Human thyroid carcinoma],6918289,2.565001109569917,2.8499866889775785
SW948,2871966,1.833559506117821,0.007072364844284127
RKO,42642645,1.3055497818976145,-0.053783531658365656
NCI-H2452,6450551,2.947106204512916,3.1286799240181766
P31/FUJ,10302451,4.186780329312711,2.597514176279098
P31/FUJ,6918837,-4.676526715032863,-4.582132490930016
HuP-T3,3552672,1.4793505278318,2.882638329746946
BFTC-909,25105715,3.3944682152224455,3.4242366422952393
HEL,44197249,3.8651368484410056,2.267820790311292
HCC15,JQ-1-MK-0752 (1-1 mol-mol),3.1823820949476564,1.652007603932287
BICR 31,46215462,1.6669957894505008,2.084031255624027
HuP-T3,9866186,1.729562359157257,0.9682725639419049
HuP-T3,11717001,4.25253085122872,4.144186708898531
NCI-H1568,54618164,3.652866089784218,4.18981834360753
WM115,441298,3.225500618866892,2.4256844542989766
LS411N,71304818,3.0616651991102697,2.2085265849813145
NCI-H1568,navitoclax-sorafenib (1-1 mol-mol),1.4784994486098395,1.7095915098970584
SK-HEP-1,10184653,3.249474772070569,1.5040048871157985
BICR 31,12003241,-1.4237270953299652,-0.9163848904408421
RERF-LC-MS,25150857,3.1332692975488934,2.5802567977667343
COR-L95,24964624,2.1587115359420994,1.906847579789253
SU-DHL-1,44241473,4.633491620971472,4.373695588386924
HARA [Human squamous cell lung carcinoma],72193861,-0.0489023079435419,1.760834511635373
ML-1 [Human thyroid carcinoma],11152667,-4.726499990059393,0.03575709928259617
MOLP-8,6918878,0.495059053850733,0.5923515542525756
RCC10RGB,448949,3.406339167429426,2.0732483297271864
HCC1500,148124,1.3380754252474834,-1.2279742864882925
HCC1500,5280436,1.8565158203383687,3.39352582239435
IGROV-1,10302451,0.4135234554742116,3.035197704696989
Granta-519,285033,-4.09305161448312,-3.606193828560894
HEL,JQ-1-navitoclax (2-1 mol-mol),-0.660921199279695,-0.28296767234665277
Granta-519,71304818,1.7993370678919798,1.7700980479981532
NCI-H2452,3689413,1.184555113675537,-0.2347558058247297
IGROV-1,2708,4.438419625543199,4.994682683465743
SW1271,49850262,4.063818012025616,3.924008087986388
LS180,6918736,-2.1262365465987907,-1.5597246056649274
PaTu 8902,10127622,6.3250626499292295,3.8858067431698387
SW1271,57519531,1.4534695216386555,2.52243468873053
HCC15,57519531,1.9577451103636032,2.611467773707406
SK-HEP-1,navitoclax-PLX-4032 (1-1 mol-mol),2.657614017988428,2.275558912885566
SW48,44185566,0.7812235367324193,2.583444873264474
Granta-519,navitoclax-birinapant (1-1 mol-mol),-1.2889388818955343,-0.2362853888623389
KU-19-19,241158,4.34083218708613,4.164556348146686
NCI-H1568,11404337,-0.63897934294681,-0.1881952690832511
Granta-519,219104,2.15431657191886,2.1810423710056814
SK-CO-1,5746,-2.8271360432483035,1.29260593182663
WM115,6918837,-2.450050091846588,-2.4329345122834733
SK-CO-1,11152667,-1.1935109806009474,-0.35652096877228723
SW1271,9825149,2.2012182796133084,2.4676757698303438
SaOS-2,208908,2.5337103611164893,2.1104378237501864
SW48,5470400,-1.7303817372543355,-0.18193976719005606
NCI-H1568,JQ-1-UNC0638 (2-1 mol-mol),1.923479920407172,1.8202646652088752
SW48,15547703,3.0370188863847414,3.2429054619944733
SW948,46907787,2.3709287142369555,0.5760580523418967
Daudi,5113032,4.739966647777949,4.4915856111493495
SaOS-2,135984461,4.8186429168984475,3.8247276508670973
MDST8,168313047,3.800021027786958,2.315309221793275
RCC10RGB,11964036,2.4986740771219673,1.4858107152310254
SW1271,24785538,1.505278847517323,1.6892817131730187
BFTC-909,3676137,5.055523871435828,4.588309568551826
SW48,9868037,2.459515994210572,3.1729572654463913
KU-19-19,10231331,0.2937024112037242,1.764778844554712
ALL-SIL,54619267,3.6744484896003713,3.4598925423415245
BICR 22,selumetinib-BRD-A02303741 (4-1 mol-mol),2.600469012399248,3.273123496311138
RCC10RGB,24951314,2.138755705452886,1.6152084819750772
SU-DHL-6,26596,-1.882707371112463,-2.5540256245730957
COR-L105,46843906,1.9821208299636863,3.207439588651231
RERF-LC-MS,4477,-0.1141702320643991,0.6538157416402913
MOLM-13,49766530,-2.4914272268054107,-1.8388068302062115
SK-CO-1,4917,2.9299888563447163,3.0466330672035578
Daudi,72734382,3.17690285998388,3.3676233007256378
LCLC-97TM1,11625818,5.063433550011292,4.069555453350526
LS411N,vorinostat-navitoclax (4-1 mol-mol),1.2590657469614004,1.1223923590147447
ALL-SIL,451668,-1.1904263441284522,-0.7112382754973173
SK-CO-1,219104,3.537047767593632,3.9952004349028503
NCI-H2452,65064,5.258935158123576,5.079718379251563
BICR 31,25062766,2.0025728701089904,2.101628793860042
LCLC-97TM1,4261,1.8883571230172835,1.5081854960017282
BFTC-909,54618164,4.281231487810877,4.2155722394990285
NCI-H2452,16736978,0.9447398024439234,1.7333983769189254
NCI-H2452,selumetinib-BRD-A02303741 (4-1 mol-mol),6.449127799684226,3.972025078257842
ML-1 [Human thyroid carcinoma],selumetinib-decitabine (4-1 mol-mol),4.367801531941202,3.9360024923374706
WM115,6917907,-5.049795628811172,-5.126183184981503
HuP-T3,5746,1.6464242063318688,1.183570557793609
MOLP-8,327653,2.384727852533787,2.5767558402066255
SW48,72376,-3.1415011638088144,-2.0203281820786314
SK-HEP-1,23582824,1.0257570544783106,0.8794513035485876
K-562,12001922,1.1213264373636214,1.6225036302273728
WM115,10410894,3.2188686198907743,3.4800589665230293
IGROV-1,selumetinib-GDC-0941 (4-1 mol-mol),0.4544090747009681,1.4465586153497951
ML-1 [Human thyroid carcinoma],49850262,3.5297334075235245,3.957225533524686
KU-19-19,44819697,-2.543386759740491,-0.25299617826758664
LS180,46199207,2.9384583216685023,3.1368095402502933
LS411N,56946209,-3.80128700519076,-4.105485564139103
LCLC-97TM1,6918289,3.014261251605047,2.323390520792768
KU-19-19,107970,3.004209688555129,2.4454697912441516
MOLP-8,72376,-3.958595065171294,-3.351943395444412
IGROV-1,5291,3.6852809555447985,3.7789055069851853
Granta-519,46191454,0.5060764897707477,-0.15068632007938368
COR-L105,24901704,3.8942422617258714,3.342980484716191
NCI-H2452,24797083,2.030715286150645,1.4389360879851438
NCI-H2452,124202324,3.032884210730814,2.6313066471577122
LCLC-97TM1,4259181,-0.2611730486969081,-0.1039704280122805
KU-19-19,73707440,5.592820593626321,3.895737474121448
RKN,5460769,5.79272629497122,2.7930986577584203
RKO,10184653,1.6814092199651305,1.2623198520248193
PaTu 8988t,24180125,3.300808715406375,3.164621356514388
COR-L105,2858523,3.082532365215724,3.071814988336672
BICR 22,decitabine-navitoclax (2-1 mol-mol),1.4331437420597166,2.109415409847061
LCLC-97TM1,16065773,3.044024356255971,2.5377178140569225
MOLM-13,16115403,-5.622868208190141,-4.356837737849013
Daudi,104842,-7.567274671559235,-3.8220599059646507
PaTu 8988t,3825829,4.270364787448243,4.007300369716015
HuP-T3,227681,2.514870644267688,3.6007379850382195
ML-1 [Human thyroid carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.142388159439524,1.3370180343085947
COR-L105,11964036,1.2117851204645589,1.333413409871214
SW1271,135659046,3.922158232881772,3.7554034536281624
IGROV-1,4917,2.985904350427039,3.2258012285826676
HCC15,9826308,1.2579647962340863,0.5232777231126746
SK-OV-3,46199207,3.479599233509405,3.2184033560279204
KU-19-19,2729026,3.069520174525383,2.7430850496497987
COR-L105,25102847,1.810865395215699,2.580644293891006
SW1573,9935249,2.8664920450292852,3.1275222703262346
COR-L95,1714884,3.7968274989469992,3.0379641799614414
PaTu 8988t,7251185,3.286029674356028,2.6852049875402453
SK-CO-1,24856436,0.7128954142297991,0.5780247667016252
HCC1500,5738263,2.955373895930653,3.5060825537584956
SU-DHL-1,6914657,-4.020831804674196,-4.596394854479601
SW48,638278,3.16751315896482,3.1550013722194103
LCLC-97TM1,135421197,1.517750954289076,1.7640405790238853
ML-1 [Human thyroid carcinoma],11404337,0.3501599152959295,-0.4890984590215044
RERF-LC-MS,selumetinib-decitabine (4-1 mol-mol),3.240984973519631,3.817373641791999
NCI-H1568,6914657,-5.120590256929669,-3.9532982453604517
NCI-H2452,3676137,5.703513737309888,4.649590273859621
PaTu 8988t,11238147,3.9795465318298526,3.0513243182695367
RCC10RGB,5113032,2.807854627845623,5.229355892828623
IA-LM,44607531,1.5934898700442923,1.6661958148355651
MOLP-8,BRD-A02303741-carboplatin (1-1 mol-mol),5.885720002784475,4.033220089394346
SW1271,docetaxel-tanespimycin (2-1 mol-mol),1.954654024202385,-2.671863251341661
RKN,3815108,2.827407220517517,2.9665027018402967
IGROV-1,448949,2.098499309472767,2.0812100322419296
BICR 31,5426,4.483861121335425,3.459016619593346
SK-OV-3,322968,3.987773865251791,3.9014225958686852
BFTC-909,15953870,3.192835350037467,3.7466979570178243
BFTC-909,4378219,4.497242068417329,2.6406424172786105
COR-L95,54143018,1.379812266453913,0.27678506142866
SU-DHL-1,11612883,2.467580560997241,2.6203763662761888
COR-L105,alisertib-navitoclax (2-1 mol-mol),1.2187125492955395,1.0013388681507154
LS180,5978,-1.0800938866172374,-2.0214349877469115
NCI-H1568,44566777,1.438409258191859,0.8522932671676812
BICR 31,42642645,1.5553576315566706,1.3979639310174945
MOLM-13,654092,-2.113392174262404,-0.9290946323617659
LS411N,124202324,2.3656166654970137,1.449408725933569
SU-DHL-1,5329102,0.4187283879213827,1.8554170488463024
Daudi,51037431,1.7669670215364446,2.6542340643691547
RERF-LC-MS,45279963,3.7797867340420215,3.5937263529154966
IGROV-1,49850262,4.068828647042517,3.4771023029694934
BICR 31,12001922,2.662375748901725,2.024314049684279
IGROV-1,49793307,-2.5291790820063538,-2.552788761671288
PaTu 8902,2828334,6.440933390339598,6.1616026387348475
SU-DHL-1,24951314,0.6018835624310062,1.035333412615689
MDST8,676352,2.6149374435458643,2.1410277730395473
HARA [Human squamous cell lung carcinoma],3503,1.5305596721968624,2.228354518490298
MOLP-8,44185566,2.3020252385384747,1.579489475891809
RKN,44137675,5.459450119186335,3.616911047127806
SU-DHL-1,216239,2.4334915471860064,2.172396859972921
RCC10RGB,5328940,2.5920229504771264,1.8919963478464623
MOLP-8,5351362,0.578803181676615,0.8331298954133978
KU-19-19,4521392,6.281175440463305,4.358813063850463
HuP-T3,219104,4.090562015064086,4.009954882135975
BICR 22,16722836,2.37465920140225,1.6985141583143224
Granta-519,54678924,3.4908303220152512,1.2939503261227032
SW948,5738263,3.889172676108031,2.9212824354701583
SW1271,9549297,2.1335240165820606,2.753938060699815
MOLM-13,5280436,3.611781786093365,2.691584193576046
BICR 22,3062316,1.4778056821676904,0.28116691883486067
HCC1500,46191454,2.281809335685502,1.4265182431387202
HARA [Human squamous cell lung carcinoma],445455,6.075035505832661,4.682453651888872
SW48,9549297,0.4487326680785643,2.3511845533974665
SK-OV-3,46843906,3.785109660734252,3.141708415073795
NCI-H2452,5351362,1.571040634520482,1.5324725023466204
RKO,56946209,-3.445993729976747,-4.297434822817734
SaOS-2,56649450,2.657103116813459,3.364106622651861
KU-19-19,doxorubicin-navitoclax (2-1 mol-mol),-0.7241135755509572,-1.202201630094655
LS411N,23725625,5.218761480016774,3.6474558615612556
RERF-LC-MS,4578,4.625372786711685,4.430398733783486
MOLM-13,11507802,1.0337656748409854,0.6760558645514643
SW48,65064,5.106206142410259,4.820985443185481
HCC15,2828334,6.579413009448801,6.1336881686218705
SaOS-2,4378219,3.572923749570723,2.3410883207997264
BFTC-909,23939,4.493588141952023,3.9289534827828962
RCC10RGB,439501,-2.548266242367821,-1.9455028538052077
SW1271,3815108,3.2377532103389832,2.629883869897858
P31/FUJ,5287620,-2.889875327880449,-2.1700481769591233
HARA [Human squamous cell lung carcinoma],448949,2.536052822584039,2.151272021459888
LS411N,5281321,2.872375461605106,-2.0201727181465943
ML-1 [Human thyroid carcinoma],4917,3.4875612389510184,3.0623329351771287
MOLM-13,16736978,-0.7178102164081313,0.5924734872429179
HuP-T3,24964624,2.5347495437600753,2.4235837347063036
SW1271,3038522,2.6397404309625574,3.148161165425742
SK-OV-3,6852167,3.0870556066687076,2.9673082616347055
PaTu 8902,25262965,1.559985123462204,-1.328832409920618
PaTu 8988t,89928392,1.7442497788257625,1.5751962964113921
RCC10RGB,5494449,5.764110819730859,2.78886143865306
LS411N,JQ-1-carboplatin (1-1 mol-mol),1.929098606006951,0.34671636782345566
Daudi,5282054,2.334684985175564,2.609443275507427
SW1573,9866186,2.2605214925080035,1.04890626010036
SK-HEP-1,16013152,4.2454363352103925,4.258348190875353
IGROV-1,11647372,-0.6595372928368528,1.0746870496139285
RKO,60700,-0.2024014556335324,-0.9281410467247304
SaOS-2,66577038,3.461550546017496,2.962682864838756
BICR 22,6918638,0.0558003797401064,0.6082704614907866
NCI-H1568,6918878,3.5715267618547832,3.208294239403001
RKN,17755052,4.615024850417848,1.772807083469637
RKO,10385095,1.2981289243482117,1.0562748239851802
NCI-H1568,25227462,1.3523005990409367,0.4968675051889038
IGROV-1,168313200,3.9938362637732983,3.0829760188618707
LS180,52912189,2.5201251776162454,2.0541562522403716
SK-OV-3,446155,4.068831864004445,2.6947479602806834
SaOS-2,2729026,3.0079080963172573,2.8125670525325854
COR-L105,24785538,1.9787344511962284,1.902310541747066
WM115,9549297,1.875565618317202,2.6316080231343135
COR-L95,53392493,1.7864953470488698,2.3003338081668816
SaOS-2,219104,3.933074432676362,3.5394821258080476
WM115,3854666,2.6196721416111024,2.653066261180371
PaTu 8902,11626560,1.9806688551606229,2.043454238576169
P31/FUJ,24901704,1.8625310117446785,2.3011813835090087
IGROV-1,9911463,4.195269991960018,3.7542831509119474
LCLC-97TM1,216468,0.7418366776466117,2.492134667117093
MOLP-8,387447,-5.214034261316855,-4.683586347640159
RCC10RGB,16722836,2.017391543442539,1.8403746916339296
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,1.2044093007716576
SW48,5311281,1.5627745937535438,2.268150605833827
MOLM-13,11497983,-4.003769607545663,-1.0489173997424843
KU-19-19,2858523,2.990442019675252,3.075020341294269
COR-L95,11626560,1.5180153972734145,1.5305360749189303
WM115,123631,1.7981952102566006,2.378501618225262
RERF-LC-MS,2874250,4.628157945253743,4.925560926203049
MOLP-8,65064,3.020382379730844,4.0719356923693315
RERF-LC-MS,3854666,0.8294073497518095,2.2304456575514138
HCC15,3689413,0.3467742153458734,-0.21769857408618998
HCC15,25150857,2.8177810894811786,2.4181528453401064
LCLC-97TM1,46174525,4.403281113181967,4.293969798478895
SK-HEP-1,31703,0.3185055118054912,-0.917157584777575
BICR 22,123631,2.0553358195001383,1.6985547605387732
Panc 02.03,selumetinib-PLX-4032 (8-1 mol-mol),3.6013795626113163,3.096399321066518
ML-1 [Human thyroid carcinoma],JQ-1-vorinostat (2-1 mol-mol),1.0159563388217403,1.1449722062519854
COR-L105,11213558,1.6245415685033464,1.8810685065460309
COR-L105,3689413,-2.1605707630353708,-0.05204188969643374
MOLP-8,4917,1.932746630984224,2.833942654815548
HEL,11238147,1.9261110470981635,2.2235474973949625
HCC15,46907787,1.7788170946404287,2.2629955358928955
HCC1500,3062316,2.994925150114549,1.0699770356947327
MOLP-8,9935249,-5.983061984872936,1.1793324555610913
IA-LM,135398516,1.3190430503048431,1.6376193582142782
NCI-H1568,6917907,-6.013699668749745,-4.802316985821017
PaTu 8988t,25062766,2.121196656552597,1.8811369144234376
HARA [Human squamous cell lung carcinoma],49793307,-3.043253960744797,-2.481231372043798
BICR 22,JQ-1-carboplatin (1-1 mol-mol),2.1312623877062125,2.104022072641415
HCC15,3825829,3.261310602619802,4.184566638938429
SaOS-2,36314,-6.649536011740597,-1.7151876477137784
BFTC-909,54613361,0.5481358040879688,-0.01714914391376193
HCC1500,navitoclax-MST-312 (1-1 mol-mol),-1.0378024218006647,0.8838858542591597
KU-19-19,135999136,4.912207411852192,3.8235314965980622
HCC15,126941,-2.714458984381298,-2.424455801109802
K-562,387447,-4.172741798582805,-4.85669067715013
BFTC-909,400769,-0.3884900564724624,-0.5489584454194507
SW948,serdemetan-SCH-529074 (1-1 mol-mol),2.314613339768124,1.3668350773325406
K-562,19582717,3.29667086675107,3.125240840204134
LS180,676352,2.815097827506973,2.0481237743188965
SK-CO-1,5278396,2.886619996042885,3.5681034869884245
SW1271,654092,-0.6724961197062129,-0.2514884864548507
BICR 31,984333,1.688597902845401,0.9451394025690426
ML-1 [Human thyroid carcinoma],3854666,0.5957604923029644,2.5808026523268195
PaTu 8902,6918328,0.0837665640709721,0.02118309996223706
KU-19-19,25126798,3.8528221502524262,3.9318340108322802
SW48,BRD-K27188169-navitoclax (2-1 mol-mol),2.506636688150973,2.2310999507474927
K-562,984333,1.160515473081413,0.25242458515947663
BICR 22,4261,1.6582900308021409,1.4240980577943665
P31/FUJ,24753719,3.279397605233023,3.369771284748903
RKO,89928392,1.6264666324972337,0.5387130084518293
ML-1 [Human thyroid carcinoma],11364421,-5.159158552339723,-0.901413823676745
MOLP-8,2746,0.9128995235322724,1.7225886935267365
PaTu 8988t,44589607,3.069724280166482,2.976705078493199
Daudi,55508,3.074140286884227,2.632523866027893
IGROV-1,53232,2.4872106086763393,2.9035127762396105
HCC1500,11178236,-0.8618797474299623,-2.731523223806863
SW1573,11228183,1.3544411199442492,2.5318815382346465
ALL-SIL,docetaxel-tanespimycin (2-1 mol-mol),-8.351495985477111,-4.874953519278699
HCC15,151289,0.5818248951012718,1.4824019093093972
RKN,navitoclax-sorafenib (1-1 mol-mol),2.725354143371073,1.8104593206586828
LCLC-97TM1,9956119,3.701469228999412,3.478772800773125
LS180,65064,5.333283055182179,4.918523908895102
Panc 02.03,1566236,1.9322803720882225,2.3314546694477998
WM115,UNC0638-navitoclax (1-1 mol-mol),2.6292832027586783,1.6794518107352565
COR-L105,5311281,2.5909348271223833,2.5620749698129273
COR-L105,4261,1.037866526492344,1.824523876346101
MOLM-13,6505803,-3.0527041000310255,-1.169542321477809
SaOS-2,24797083,1.1743557883271736,1.26195571909302
NCI-H1568,selumetinib-GDC-0941 (4-1 mol-mol),1.6241640738587435,1.5565749537279399
PaTu 8988t,44819697,-1.4855632158782932,-0.45799799974153255
IGROV-1,JQ-1-vorinostat (2-1 mol-mol),0.7179438393808574,1.2044093007716576
MOLM-13,136227924,1.704251401840426,2.2090444019947486
K-562,11955716,-2.44804051648688,-1.8890958169342853
PaTu 8988t,119607,6.161307312166748,5.277074728232428
COR-L95,71466380,4.385390307812106,4.195983245269399
SW48,400769,-1.161678790289576,-0.49894840902150817
SK-HEP-1,54618771,0.9570801540222316,1.3873404660214357
Daudi,10410894,2.7348964142664096,2.7242943904593515
P31/FUJ,8515,2.4023085754769133,3.0679929613158894
MOLP-8,12001922,1.340541943266141,1.5538629451364354
SaOS-2,24180125,2.5037581025896896,3.042949387923763
LCLC-97TM1,11497983,-3.4928977535107872,2.641654908076861
KU-19-19,54618771,0.4920305765445359,1.2352693391783078
BFTC-909,9826308,0.9467806471528852,0.4756852992106582
HEL,6252,-2.3526628041976547,-1.4741256409816947
PaTu 8902,1750826,3.002378182351502,-1.1109864184352494
HEL,375860,-0.4243086466742362,-0.5700924037090264
SK-CO-1,erlotinib-PLX-4032 (2-1 mol-mol),3.6761827416716737,2.885471905621417
LCLC-97TM1,44137675,2.6535109564984403,3.521853540352487
BFTC-909,4096211,2.208598833058293,2.3681704056631454
SW948,piperlongumine-MST-312 (1-1 mol-mol),2.3670131047839496,1.5430976230965383
MDST8,serdemetan-SCH-529074 (1-1 mol-mol),2.3277787595180417,1.9194608363285945
ML-1 [Human thyroid carcinoma],46215462,1.6577528274030604,2.0256836740024924
SK-CO-1,10231331,-0.7210930575000714,1.6039747012552683
RERF-LC-MS,9908783,5.63449812951243,5.02596969118054
SW48,BRD-A02303741-navitoclax (2-1 mol-mol),2.3907101942881392,2.352994621540989
SaOS-2,navitoclax-birinapant (1-1 mol-mol),2.783475564423097,1.3208189053586767
SaOS-2,54618795,3.185724709117328,1.4237379355444264
PaTu 8988t,637858,2.5993481939897314,2.064921991090521
HEL,984333,-1.1600295079037413,-0.5619628633033651
HCC15,2841722,4.4106331963661285,4.488327545360281
SW948,676352,1.6772543111300298,2.063947280635982
BICR 31,24964624,2.1782924417506235,2.4958984830474216
MDST8,984333,1.6302493723588198,0.8932439981588419
SaOS-2,25102847,2.0054521503393956,2.6983253809466667
NCI-H1568,11396600,3.496587037401377,3.966780034233433
SU-DHL-1,25126798,1.813712960287442,3.583937794126621
MOLM-13,445091,4.269392983422825,3.4324554329651487
IA-LM,6918328,0.468629569752011,-0.03562233108005584
RKO,16038120,2.1201165412688385,0.13559281735203738
Daudi,3689413,-4.376822515219121,-1.5205055349441579
LS411N,1750826,2.0365622567800985,-1.76950267239819
SU-DHL-1,selumetinib-GDC-0941 (4-1 mol-mol),2.071258944893258,1.0256388949429398
LS411N,11640390,3.2208706785393972,2.5623648171742026
SK-OV-3,2729026,2.529477515357917,2.8187255250861507
BICR 22,1317464,3.72634745746102,2.8171638185440804
PaTu 8988t,6917907,-5.027469783550181,-4.073072182418595
BICR 22,168313200,4.032164885313491,2.9192532472866413
WM115,24180719,-0.1236916700903925,3.004134361987545
WM115,2708,4.839353437835411,5.104098793085864
Daudi,erlotinib-PLX-4032 (2-1 mol-mol),2.269531504347571,2.8082343006405437
SW948,135398516,1.5329637117305952,1.661302741392299
SK-HEP-1,15547703,3.182423809990023,3.2544723668209286
HARA [Human squamous cell lung carcinoma],17755052,1.9898088824831797,1.7161283640708647
SW1271,400769,-0.393739366900267,-0.19717583860192833
COR-L95,11657048,4.451680892653422,3.2745907098997957
KU-19-19,5470400,0.4514058362673593,0.04225716290793713
SU-DHL-1,46199207,2.2603615990150803,2.7461455279296967
LCLC-97TM1,452548,-0.620032222833134,-0.11308179534822038
COR-L105,216345,3.681753487249753,4.124065621498624
SK-CO-1,6918736,-2.135863333000623,-0.8080146595452026
SK-CO-1,5351362,1.1244803572081656,1.7787882879377248
Granta-519,451668,1.0102660805443675,-0.6862442984803461
RCC10RGB,71751553,5.18764953581067,4.65070828040859
SW948,44137675,3.8395253943289553,3.387596501253804
SaOS-2,JQ-1-navitoclax (2-1 mol-mol),0.6153479757572562,0.8329892480269959
LS411N,654092,0.6196619744838121,-0.8129085913275363
HCC15,11222830,1.5967166138936082,1.700252521988968
RERF-LC-MS,54143018,1.1379926617289184,0.7449520562246985
HuP-T3,107970,2.2315719384591133,2.3653050406506573
MOLP-8,462382,0.932516774133838,0.4635007523920812
ML-1 [Human thyroid carcinoma],24889392,3.5627585346619712,4.118413269807481
COR-L105,448949,1.923777772079977,2.0830451183077736
SU-DHL-6,5311,0.0847535344452709,0.555348151935336
COR-L105,65064,5.250674314711081,5.150505130384147
RKO,9908783,5.5436232623995805,4.414475302782594
BICR 22,1566236,3.7080344976190434,2.5371833011450273
SK-OV-3,2708,5.531711784720637,5.027572407477386
RERF-LC-MS,148198,-3.5927713028936834,-3.076407392928184
K-562,10127622,4.587499993681003,2.844960302962686
MDST8,3543504,4.366917593553272,4.599097731220683
NCI-H2452,675434,4.57874791360699,4.5574556822843855
BICR 22,vorinostat-carboplatin (1-1 mol-mol),3.8807496375646937,2.978778720739383
K-562,73707398,1.1020172598138147,0.6001646920316425
BICR 22,11178236,-2.3138277354389176,-2.889538773148506
KU-19-19,53232,3.650570649303299,2.878216841159032
COR-L105,2126,5.6436039579971045,4.75180038448116
MOLP-8,alisertib-navitoclax (2-1 mol-mol),-4.498852011390448,-0.8732261490808184
WM115,984333,1.7219326558446977,0.8402437257475781
Daudi,6918878,-0.3078198284611306,0.3193223409163386
HCC15,16725315,4.804384009366738,4.2933777962403505
Panc 02.03,tanespimycin-bortezomib (250-1 mol-mol),-0.3690940442428398,-0.5895751493668253
ALL-SIL,56946209,-4.755076906810128,-4.84591509333024
P31/FUJ,25195348,1.3039046822632598,2.5387326200527722
NCI-H1568,4261,1.7177455985107426,1.534334525374842
BICR 22,11238147,2.160553784520482,2.7082052421313225
SW48,decitabine-navitoclax (2-1 mol-mol),-0.1693110303669234,1.8083315742272605
LCLC-97TM1,25126798,4.007107372760091,3.771662183107655
PaTu 8988t,11612883,3.2937262662044424,2.8410973614333863
SW48,44507138,1.5733509414979852,2.1197248527728294
SU-DHL-1,66577038,2.452346655400699,2.890219446712315
ALL-SIL,60168763,4.204461937910143,2.359923648519988
Daudi,25227462,-5.495402710114509,-2.383835595504785
LCLC-97TM1,613000,2.0466318432711708,2.528530889924082
LS411N,2828334,6.327786282136184,5.733369318261639
IGROV-1,9866186,0.4571266497661056,0.9336821416967145
SU-DHL-6,72376,-4.568822946856545,-3.465268748461034
P31/FUJ,984333,-0.8646677641211812,-0.5156762390536109
COR-L95,123631,2.8240072692867915,2.349030491901302
IGROV-1,11497983,4.37450324471555,4.388835981305245
BFTC-909,5281672,4.401358042981416,4.501137751104634
PaTu 8902,44607530,2.9609228636650826,1.6894168895958068
HuP-T3,5566,3.0002994658008935,3.0275555881849527
NCI-H2452,JQ-1-UNC0638 (2-1 mol-mol),2.3308008637008837,1.7902521993965208
IGROV-1,2729026,2.3541792737160296,2.6182496402533895
COR-L95,11222830,1.53452681839189,1.3504431544227822
LCLC-97TM1,66577038,1.6013450181273698,2.691111534029243
IGROV-1,24772860,-3.2892316801587835,-1.651278373614719
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-1.0164784418249224
HCC1500,navitoclax-pluripotin (1-1 mol-mol),-1.6377620908642292,-0.5856416946287621
NCI-H1568,54678924,1.274078635657008,2.147038936430705
ML-1 [Human thyroid carcinoma],navitoclax-MST-312 (1-1 mol-mol),1.8932386957075495,0.9418069971486221
RCC10RGB,9908783,5.908182650801537,5.0734272731654455
IA-LM,66577038,3.3956332242260765,2.499062336955902
LCLC-97TM1,selumetinib-JQ-1 (4-1 mol-mol),1.553276046289172,1.3233790400316507
COR-L95,9935249,2.976260244275784,2.3003382258176788
SU-DHL-6,9868037,3.231553190440303,1.5910093428070573
RCC10RGB,11640390,5.2605770793622275,3.756468576962915
Daudi,285033,-6.062056136351362,-3.3839565303052628
BICR 22,11626560,2.057582050988773,1.7852392646884314
NCI-H1568,60750,-4.838669884752028,-1.6575123103960139
MOLM-13,2708,1.6215518677504634,3.327377880851705
LS411N,crizotinib-PLX-4032 (2-1 mol-mol),1.3060638395576354,1.4217884981786586
K-562,10385095,0.5975872383647969,1.0991750814207317
P31/FUJ,tretinoin-navitoclax (4-1 mol-mol),0.2737114955755992,-0.04875227219931741
ALL-SIL,9887053,2.3955838154567703,2.4558336234471603
RERF-LC-MS,151289,1.06337646711186,0.8766689247658289
LCLC-97TM1,71466445,2.7974721848465025,3.5685698847673626
RKO,15983966,1.976330033309676,-3.1194855734899893
SU-DHL-6,54143018,-0.9166021499884252,-0.5999710658524497
WM115,sirolimus-bortezomib (250-1 mol-mol),-0.1340053181182992,0.5760266428271146
MOLM-13,vorinostat-carboplatin (1-1 mol-mol),0.7090489644750352,1.9547852293987587
IGROV-1,49793307,-2.5291790820063538,-2.552788761671288
COR-L105,crizotinib-PLX-4032 (2-1 mol-mol),2.1629523176516248,1.9616902135914367
SW48,9866186,-0.0602537260044697,0.927713645617739
ALL-SIL,24753719,3.3195109491118635,3.1406831265738795
PaTu 8988t,409805,3.676693079768219,5.058817328573074
BICR 22,11175137,1.6412636442827269,2.6327981891002317
PaTu 8988t,vorinostat-navitoclax (4-1 mol-mol),3.0451026382172732,1.2570971536904638
MOLP-8,9887053,1.3364969406129874,2.6894170104819772
Daudi,81146,4.468898659357518,3.7507655206027666
NCI-H2452,6438330,4.066979701794873,2.2719233093779247
SU-DHL-6,73707438,4.161722925172636,3.7827757547840677
SU-DHL-1,9825149,2.3972801394012415,1.8516505452571397
LCLC-97TM1,1242560,3.1698209685240832,3.487321349581648
RKO,44632017,0.9673312213076444,1.1206310710502299
ALL-SIL,10184653,0.3156525087572682,0.43281306328302394
MOLM-13,15953870,2.45012914744678,2.933005477515086
WM115,docetaxel-tanespimycin (2-1 mol-mol),-3.9058848396527464,-3.229709184166471
HARA [Human squamous cell lung carcinoma],3038522,4.1452744027346045,3.241443439110827
Daudi,9908783,4.64363842559646,4.413273090740119
BICR 22,2746,3.5358057095338404,3.421968539987034
SK-OV-3,9903786,2.611217845094376,3.0365871224890855
Granta-519,446155,3.3236756015859266,2.357345767692793
HuP-T3,46843906,1.6260119885378777,3.337460581699882
RCC10RGB,25102847,4.4790627708666255,2.820683330681062
SW1573,119607,3.675967979424282,5.17339989461798
NCI-H2452,36462,2.3648017756260327,2.3628829799792386
RKO,9926054,1.883626680074333,1.9489203003114843
UACC-812,11396600,4.679415745859403,3.6829434607021017
LCLC-97TM1,67291369,2.1623476689900527,2.077484526949907
SaOS-2,9926054,1.5065280757428428,2.1402020217319584
SW1271,11485656,2.5257448561020053,2.215761527033942
SU-DHL-1,65628,3.0805404655500843,3.9235933909842187
RERF-LC-MS,24889392,5.73600211591012,4.267791232808488
IGROV-1,16720766,-0.0562020789376145,0.6697370776661269
SaOS-2,53392493,1.7453499080757628,2.645078128579852
BICR 31,JQ-1-MK-0752 (1-1 mol-mol),2.163474213011291,1.6121103643196024
LCLC-97TM1,71466578,4.4967812415195025,4.098460494628608
MOLM-13,135440466,-1.1165614244178856,1.5686449897590742
IA-LM,1566236,2.064855820915055,2.2247969535707126
SW948,3825829,4.076553662425885,3.6048035405661603
HARA [Human squamous cell lung carcinoma],44491742,4.175098575791361,4.251203602774275
WM115,322968,4.566671406107956,3.874867927945514
RKN,637858,2.0099352926359533,2.0322109416696454
COR-L105,135398516,1.4567379833558207,2.1312423835961685
LS411N,15547703,3.407600768992332,2.9437679555563454
SW948,6918878,-0.2941800388813576,1.1465225207380145
SK-OV-3,31703,-0.6007067740148971,-1.024866313102828
BICR 31,16038120,0.7865824758597759,1.0914923512825554
SW1271,46943432,0.8939870827443378,2.1737068460135127
Daudi,67291369,0.2775886597323658,0.6266387784601285
WM115,SNX-2112-bortezomib (250-1 mol-mol),-3.3081919953178507,-1.1937217630817119
BICR 31,11455910,2.0785566961581186,1.63097090184536
MOLM-13,25150857,2.0975264071969075,1.476113111437356
COR-L105,46174525,5.553907170062061,4.607566731360766
COR-L105,piperlongumine-MST-312 (1-1 mol-mol),2.3163882961547086,2.10971468363725
SW48,serdemetan-SCH-529074 (1-1 mol-mol),1.5320240627835209,1.9522918998061995
IGROV-1,135398516,1.9751898057484376,2.407258726324599
PaTu 8902,3689413,3.662647678116459,-0.1071733015571436
Daudi,31703,-5.42156315939604,-2.4413479753846157
IGROV-1,24785538,1.106246320450551,1.7895753786502815
Daudi,navitoclax-MST-312 (1-1 mol-mol),0.6762626360352524,0.027927078168785906
PaTu 8902,676352,2.5672836386659625,2.195772242784989
MOLM-13,426756,3.5583078181784504,3.6847158304870766
WM115,64971,1.594754361798162,2.684165108663238
SW1271,4521392,3.9428497415690713,3.9198268710991955
HCC1500,19582717,3.689290387765622,4.223142735767944
BICR 22,71680916,5.5411632888305755,4.677586597732379
IA-LM,462382,0.6444148679919928,0.5169230830560906
P31/FUJ,24856436,-2.072993507389728,-0.5300217455476719
LS180,135411,0.2951252953722391,0.6577347244375992
MOLM-13,72376,-3.7215877343251456,-3.5111537748104222
RKO,6610216,3.958403220086871,3.945848871511676
RKN,452548,0.7515073582009456,0.15265676391755595
P31/FUJ,navitoclax-sorafenib (1-1 mol-mol),0.3998417690889591,-0.33893426851591507
SaOS-2,3038522,3.0360203721983257,3.0323247288641597
SK-HEP-1,409805,5.808157500863876,4.959454661457443
BFTC-909,44137675,3.23817368119839,3.844378075158779
SW1573,25183872,-2.56928333929943,-0.5291539356326096
HCC1500,23582824,1.5666293035108128,0.5563209391906915
MOLM-13,11612883,-1.8374573083034769,1.478580031959157
MOLP-8,selumetinib-GDC-0941 (4-1 mol-mol),0.1535423507469189,1.1020738189280193
ML-1 [Human thyroid carcinoma],445643,4.241689590807037,3.9866038193161013
KU-19-19,135421197,1.2163789616721166,2.1598439356268333
SK-HEP-1,49766530,-2.8567737760804324,-0.6617565097526885
Daudi,46843906,1.1534141628569738,1.4522848277639602
HARA [Human squamous cell lung carcinoma],322968,4.828098936758316,3.8521580146228684
IA-LM,11494412,5.732457488131999,0.871821747603052
RKN,sirolimus-bortezomib (250-1 mol-mol),0.997863897964826,0.8460724104561324
Granta-519,selumetinib-piperlongumine (8-1 mol-mol),3.4654025033242712,1.982396396375965
Granta-519,46943432,2.0409318821812477,0.8011791190527998
MOLP-8,46174525,3.423634821116614,3.2596536687528306
RCC10RGB,19582717,5.580606305911862,4.351509746915479
NCI-H1568,71680916,4.3779497666633915,5.05828999662584
SW948,3689413,-2.2648112033429824,-1.227860285378896
RCC10RGB,252682,6.528801566934436,6.524529540652903
Daudi,135875424,2.734623655159311,3.1794593808549707
K-562,4788,4.09681667300412,5.162456328337219
BFTC-909,66577038,2.856590203747272,2.935314419808632
BICR 22,56649450,1.894872176339528,3.086780204866565
LCLC-97TM1,23635314,-2.2617116518456792,-1.515480926194963
SaOS-2,16013152,4.240825830990255,4.044711231207101
MOLP-8,5738263,2.3540234006064424,2.6467276688332095
IGROV-1,3552672,2.134472496867482,2.7370039775952177
BFTC-909,6505803,-2.7076869289136147,-0.38714968173509073
NCI-H2452,9952709,3.912471204941481,3.382808673230406
SW48,4477,0.2937974315698831,0.560043481199737
IGROV-1,10113978,2.874171865860951,3.63545771313453
Daudi,3465537,3.6729414318228697,2.050591016434905
HARA [Human squamous cell lung carcinoma],400769,-0.3643318812201842,-0.6482649401795009
WM115,60750,-0.3155979924811316,-1.9545487136618152
LCLC-97TM1,3552672,1.9872160910848609,2.31725084819474
P31/FUJ,16720766,-1.2973124396101832,-0.6431089335593879
PaTu 8988t,16722836,1.7927006401716397,1.7505450104792915
RCC10RGB,24785538,4.443576486987547,2.135172152874165
LCLC-97TM1,54454,2.264936650655555,2.600387555545276
BFTC-909,44202524,2.4582417316930916,2.084109298182191
NCI-H2452,9956119,4.089312834038711,3.710464397728048
LCLC-97TM1,44589607,2.470818031732135,2.7431879800850076
K-562,9911463,2.5078915917546336,3.1761279721513653
RKO,12003241,-0.2410566552434749,-0.8549747630688219
SK-CO-1,9887053,2.665990529661509,4.114935404899846
HEL,9444,3.6260707724362113,3.631168117732374
RERF-LC-MS,54618164,3.9158352593779377,4.195473725378399
SW1271,vorinostat-carboplatin (1-1 mol-mol),3.5487525185295774,3.0236860102176872
MOLM-13,400769,-1.4398892181534526,-1.4846239437753104
RKO,54454,4.6965621210229225,2.5430197129013767
HEL,3815108,1.7280464955300685,2.1735030128389328
HuP-T3,400769,-0.02490432142157,-0.5343832951196796
COR-L105,439501,-1.395093001857319,-1.9095267356444432
P31/FUJ,11717001,4.27266863837082,3.8240794691763758
WM115,44566777,1.1755609042254629,0.7199026254734621
Daudi,9823820,1.816535221490948,2.387375676037759
K-562,selumetinib-BRD-A02303741 (4-1 mol-mol),3.9452785747148233,3.688699629339356
SaOS-2,11178236,-4.192404287761835,-3.4507153257735386
RKO,107970,2.3673735748138265,1.8958757994612268
Granta-519,3384730,1.8851059301538475,1.3281758360405769
Daudi,3081361,1.2348545680767924,1.9410523859637845
COR-L105,11656518,2.8708923278875846,2.084035515057618
SK-HEP-1,4261,2.0689452694586596,1.8633288345954273
IA-LM,4261,0.3595729013120086,1.5384379304085078
SW1271,5282054,4.135247135343962,3.6878647004740537
NCI-H1568,44491742,3.692908194165655,4.353912287206329
K-562,10074640,1.329135681779355,1.768048870026987
IGROV-1,9908783,5.873270433212515,4.998055912604027
MDST8,24951314,1.0921901869172437,1.4016598945024514
ALL-SIL,3081361,0.1962192778787347,1.6545297361862332
SaOS-2,4578,4.61303870633514,4.414914850712596
HARA [Human squamous cell lung carcinoma],3689413,3.203435099189031,0.013839655058773968
SW1573,selumetinib-navitoclax (8-1 mol-mol),2.299465388888248,2.006070559500047
IA-LM,25227462,1.9658589227885097,0.20734777563243656
MOLP-8,71466578,1.6771539715617054,2.6019485024469784
HCC1500,11977753,-0.4307765862265268,-1.239568477726257
BICR 31,vorinostat-carboplatin (1-1 mol-mol),4.357832771492993,3.2614532252896296
BFTC-909,568763,0.745825262149274,0.49881367403954024
HARA [Human squamous cell lung carcinoma],16741245,4.4624437574750955,3.8405171341294873
RCC10RGB,613753,3.3201179844199498,3.1909894345219003
BICR 22,421610,1.881248812005912,3.1449276804834936
COR-L95,55508,1.7090560645840305,3.1987556907204278
SaOS-2,2945648,3.259308629519986,2.970430774049061
LCLC-97TM1,selumetinib-GDC-0941 (4-1 mol-mol),1.4589950943419845,0.8614034377675182
RKO,409805,3.580644131410829,3.8413709383347237
COR-L95,53495165,-2.3377393798516395,-0.7177683833569914
SK-HEP-1,25154868,3.1824362497542182,4.450921109923357
NCI-H2452,tanespimycin-gemcitabine (1-1 mol-mol),1.9681737644651764,-0.2411476459733895
SaOS-2,5978,-3.9287237947590494,-2.097872202885315
COR-L105,4096211,2.67395928769434,2.4154660828120442
LS180,15953870,3.325208983942858,3.426993072178227
Daudi,66577038,1.2731684674623205,2.4876091909869915
HARA [Human squamous cell lung carcinoma],carboplatin-etoposide (40-17 mol-mol),3.125998778003278,2.6715244426188463
RKO,6918328,0.803085247134139,-0.6363795035618998
SW48,4259181,-1.8199657809061969,0.35568738575978887
SK-CO-1,44185566,2.2410285456889176,2.5469368657054354
K-562,5978,-3.1400031562505393,-2.9046243936787506
SaOS-2,613000,1.0847199338514617,2.563502206844961
LCLC-97TM1,9826308,0.172966057550933,0.4412295636932857
Granta-519,5311,0.5114694341413046,0.3259915022291143
SaOS-2,carboplatin-etoposide (40-17 mol-mol),1.667562518729443,2.5041340676659907
SW1573,4788,4.2029613497215195,5.562865059473279
PaTu 8988t,vorinostat-carboplatin (1-1 mol-mol),4.263432325084182,3.2371197840319588
WM115,2729026,3.0250773642114175,2.629718554740945
IGROV-1,23725625,5.712368491237602,5.043773980853625
ML-1 [Human thyroid carcinoma],8515,2.907082200923046,4.090162475194673
SK-OV-3,24964624,2.562140083880341,2.6356816143150605
HCC15,navitoclax-PLX-4032 (1-1 mol-mol),0.321962590188161,2.2272815988147845
MDST8,5278396,3.853168516309647,3.4762895120171384
RKO,119607,4.75876667689532,4.47341992829794
MDST8,65064,4.754326425577863,4.909676385542841
MOLP-8,54596558,5.109397009340411,4.208121731519709
WM115,9911830,1.4636751787761997,2.481529534796366
SK-HEP-1,44486219,4.3977685724309215,4.334748764934699
BFTC-909,15983966,-4.834157449814871,-0.970593251932428
SU-DHL-1,24901704,2.0463171426909086,2.9538260385470023
NCI-H1568,3025944,3.938114410703908,4.2529155430455345
LS180,selumetinib-PLX-4032 (8-1 mol-mol),2.448756445045049,3.072093791888922
ML-1 [Human thyroid carcinoma],4477,0.6808915512553289,0.5436537684197501
RCC10RGB,16725315,5.2458056955252275,4.345780852180388
RKO,53495165,0.8925500623489324,-1.7036689084885028
HCC1500,71304818,1.489157695167493,2.403152596653038
COR-L95,135398738,4.3251787986630195,3.6537146596661048
HARA [Human squamous cell lung carcinoma],9903786,2.5216559880194263,2.625896593299717
SaOS-2,56949517,5.721423210410403,4.134928592699981
ALL-SIL,644241,-6.056766449232899,0.632574772809001
MOLM-13,42642645,-6.876168570605093,0.028858620832300837
RCC10RGB,51039095,3.636696049778912,2.8102626351154587
ALL-SIL,60700,-4.240130526526249,-2.4662308349318733
PaTu 8902,15547703,4.581249636071297,3.075017794611708
BFTC-909,11609586,2.9417391320909134,2.8697619443265716
SW48,11455910,-0.1633281652990052,1.1458254333462639
LS180,selumetinib-MK-2206 (8-1 mol-mol),1.4028786728536926,1.682871065785523
HARA [Human squamous cell lung carcinoma],JQ-1-navitoclax (2-1 mol-mol),2.200588179814963,1.0772619102955168
MDST8,11364421,1.2673702676732186,-0.4501602656811018
BFTC-909,navitoclax-piperlongumine (1-1 mol-mol),2.723586959528991,1.6804443573710304
IGROV-1,23939,4.412541857664819,3.8804120946264167
HCC15,11626560,0.3588759938830249,1.941848247941848
MOLP-8,1750826,-2.6273703880538166,-2.3396069116850966
RKN,crizotinib-PLX-4032 (2-1 mol-mol),3.0048201060690314,1.759588085871065
SaOS-2,3634881,3.4478485283346454,3.3600683976885346
KU-19-19,65064,5.4276979548790285,5.053925700624107
SK-OV-3,53392493,2.9853646548342767,2.7279404191263246
BFTC-909,44607531,1.7004331217528663,1.389728119339774
RKO,9915743,2.8851858618766957,0.6301643536284116
WM115,969516,2.5733075045080405,2.8481231081046507
MOLM-13,navitoclax-MST-312 (1-1 mol-mol),-0.7732876947237494,0.06146076006367041
HCC15,1641662,2.7903081608832743,3.584925449698578
PaTu 8988t,24856436,-1.0780184146975675,0.7834590601078646
BICR 22,151289,1.1052603945032196,1.489367276970473
RKN,10302451,3.971829298943927,3.225581444005474
Daudi,9840324,5.326423492349393,5.291452477472839
Granta-519,24978538,-1.4483375486726318,-0.7413771880661508
IA-LM,969516,4.593397144463051,2.445048165746655
LS411N,16741245,4.421981695824733,3.8477038829377896
SaOS-2,241158,3.6917409878316136,3.811403071284864
HCC1500,49846579,-4.075833194843517,0.7524591219313307
LS411N,11626560,1.8283516183370416,1.1350203981924338
NCI-H1568,2746,2.7741418395417163,3.291731694973813
PaTu 8988t,375860,0.0559535091713014,0.14754276632233462
BICR 22,613753,3.418897622092284,3.2101413041545226
ALL-SIL,52912189,0.8155728349845486,0.11953218141378391
BICR 31,erlotinib-PLX-4032 (2-1 mol-mol),1.9143994783784697,2.6416413170171102
BICR 22,3634881,3.8771660288779457,3.1538894766702135
RKO,3543504,4.836700902585943,3.762266586426595
Granta-519,6918837,-5.331886820340028,-4.7153045147908115
SW48,56963564,-0.9893979738252238,0.40140955013087676
Daudi,4259181,-0.0890599021012781,-0.2934296723976317
Granta-519,7326481,2.8185757173328927,2.611187119800353
SK-OV-3,4096211,3.632564776557465,2.3989914743073975
HARA [Human squamous cell lung carcinoma],11317348,1.2268055094863417,3.2513673917114057
SK-OV-3,24856436,1.946601057004947,0.8003111174887987
Daudi,613753,2.7401651571031618,2.711879617294926
ALL-SIL,navitoclax-pluripotin (1-1 mol-mol),-6.100095381264916,-2.4142417374537115
BFTC-909,452548,0.7682850038212578,0.17165185689788895
P31/FUJ,409805,3.653161003579303,3.835999092749221
IGROV-1,11404337,-0.7659238947812715,-0.16410051103982934
SU-DHL-1,24753719,3.670729792524347,4.2641324672329395
BICR 22,24901704,3.9299918475898408,3.3544381939770656
ML-1 [Human thyroid carcinoma],9911463,4.5829335325836436,4.02576929319596
NCI-H1568,135411,0.4069452326541798,0.8760884487329009
ML-1 [Human thyroid carcinoma],SNX-2112-bortezomib (250-1 mol-mol),0.4585620616557309,-1.216377973812303
K-562,126941,-4.461586339574126,-2.8520208708248957
Panc 02.03,2113511,6.868929428825361,5.639772181967411
NCI-H2452,44241473,5.273016525632626,4.764809895306225
RERF-LC-MS,135984461,4.284403636339015,4.0270535930315825
KU-19-19,5329102,2.6076401407195355,2.1918730503307784
SaOS-2,49867930,4.412008076102657,4.580449178796942
HARA [Human squamous cell lung carcinoma],9926054,1.843677597683555,1.868500441914454
IGROV-1,54618771,1.2456991772210466,1.1404879821031575
BICR 22,7251185,3.2802016727508105,2.635487952297879
WM115,11178236,-3.130587173648645,-3.0782305126581484
BICR 31,168312962,4.404506435623785,2.2161996522302276
BICR 31,135421197,2.236076370585341,2.1931385024809633
K-562,72734382,4.39493075447737,3.5295624115285564
Daudi,4521392,3.754955104648716,3.7886216869288303
NCI-H1568,9903786,2.4011050725962115,3.105748969694889
Panc 02.03,1242560,3.876690059869664,3.697757741774651
SaOS-2,24771867,1.911103494547597,2.3552599863882184
NCI-H1568,46224516,1.8217130718981496,2.7222654642839177
HuP-T3,637858,1.096014734488476,2.0950549575723625
HARA [Human squamous cell lung carcinoma],10184653,0.92256613856931,1.1759926089350408
HCC15,9825149,1.99442718669858,2.4774093223983815
ML-1 [Human thyroid carcinoma],1285940,4.2577484489413004,3.708974670366932
LS180,9967941,3.3265068520356227,3.548817659889358
BICR 22,15953870,4.283514914534557,3.7649223484518326
ML-1 [Human thyroid carcinoma],124202324,2.283804161098842,2.594574684978499
P31/FUJ,49766530,-2.577046245506879,-2.115379339171895
COR-L95,erlotinib-PLX-4032 (2-1 mol-mol),3.78665088959685,3.0643955320900953
IGROV-1,5470400,-0.2457809435208252,-0.497139583851838
K-562,3025944,3.938999685525622,3.9975234797279224
ML-1 [Human thyroid carcinoma],5282054,2.990899024296238,3.851624773423215
Panc 02.03,1641662,3.717230762709902,3.7239470243142234
UACC-812,selumetinib-JQ-1 (4-1 mol-mol),2.304813012505874,1.5036375485367872
WM115,tanespimycin-bortezomib (250-1 mol-mol),-3.082960536086858,-0.21888631984155738
SK-CO-1,613753,3.569116813952151,3.151454962522858
RKO,navitoclax-gemcitabine (1-1 mol-mol),-2.8709534482220196,-0.8249278476759921
LS411N,73707398,1.3643081745247092,0.72281124773955
RKN,60700,0.8209474049972991,-0.32227582913709363
P31/FUJ,52912189,-0.0654684439378525,0.04146090524756036
Granta-519,49793307,-5.0235824363471675,-4.563790248644731
LS180,439501,-1.9142457865624176,-2.111639369326537
BICR 22,19582717,3.5857042125142247,4.308249394853529
P31/FUJ,11612883,1.4537759753270971,1.736173899324968
RCC10RGB,135423438,4.4299924289236055,2.8721701826893287
HCC1500,piperlongumine-MST-312 (1-1 mol-mol),1.4293216638390454,1.9984709152098767
IGROV-1,24797083,1.5319862293819655,1.2853330235387879
WM115,11657048,4.298694485616108,3.8447931223212084
SaOS-2,5328940,1.8581375817896455,1.6959604836799127
K-562,11427553,0.716330793964625,1.6524410070341364
BFTC-909,60700,0.4554202898414442,-0.046312144729324094
HARA [Human squamous cell lung carcinoma],24964624,2.781169175627229,2.528653128976502
HARA [Human squamous cell lung carcinoma],44259,0.8184068416156438,0.7412989042832229
HEL,656346,0.4971755704716853,0.45426888479697214
ML-1 [Human thyroid carcinoma],3384730,3.994618489141425,3.1263800054620305
SK-HEP-1,25126798,3.9918710327668503,3.9302145670340964
HARA [Human squamous cell lung carcinoma],sirolimus-bortezomib (250-1 mol-mol),1.6380791342220933,0.7151658479254454
HCC1500,568763,-0.919346546730658,0.6149778812883647
SW948,selumetinib-tretinoin (2-1 mol-mol),-0.8554904901249896,1.9917284323629816
NCI-H2452,71466578,5.120149615089657,4.595523618819229
COR-L105,2871966,0.4959639880090196,0.8579013863500387
SW948,5746,1.511438037719251,1.076464414869389
WM115,10172275,3.759074377781229,3.532843803156883
PaTu 8988t,11964036,2.992263460840089,1.6879382849563118
SW948,16219061,3.499504842183279,2.6245873402171878
LCLC-97TM1,53495165,-0.6427926162361222,-0.40826300376222086
UACC-812,3081361,1.9829916627298712,2.2307752247212274
SaOS-2,5287969,-1.655987163162804,-1.8992750210154647
IGROV-1,25183872,-0.4560099928976716,-0.8563793594808784
IGROV-1,44607530,1.2936443589937894,1.710612125649879
BICR 31,salermide-PLX-4032 (12-1 mol-mol),5.564689341846323,4.96090752781764
SK-HEP-1,57519531,4.12625544642691,2.672257937183897
BICR 22,119182,-2.736639797021525,-0.16609406333042723
PaTu 8902,4521392,4.129468839379376,4.194581272984642
LCLC-97TM1,60700,-0.7670870439402468,-0.489467848765102
ALL-SIL,44607531,0.7892287314343482,0.9399906114646341
SW48,16720766,-1.213948450866439,0.6141320443388598
LCLC-97TM1,9911463,3.937478558519083,3.6975573900061307
SW1271,6918289,2.985913038733717,2.7224812288208744
SK-HEP-1,25183872,-0.6604608842788147,-0.7727826571453869
P31/FUJ,5311281,0.8046363155731003,1.6779124108140153
MOLM-13,107970,2.204740997332017,1.81745408927736
PaTu 8902,44607531,2.4953979740561136,1.5706773330630062
BFTC-909,5978,-2.385180460490498,-1.5057274082049068
IGROV-1,9926054,1.8111808945519428,2.0021356496637677
MOLM-13,JQ-1-UNC0638 (2-1 mol-mol),-0.7004023711482303,-0.04392869145941537
SaOS-2,44632017,0.980304929421305,1.4081410295808223
WM115,23582824,-1.5173797182891284,0.8627806906611908
RKO,5746,2.147448518007633,0.5418478637504429
SU-DHL-1,docetaxel-tanespimycin (2-1 mol-mol),-2.528242404368283,-4.205811959497199
COR-L95,11234052,4.796206825131301,3.797822403405442
HuP-T3,navitoclax-gemcitabine (1-1 mol-mol),2.4880623143443965,-0.7626458681626714
MOLM-13,46199207,1.8343479247638497,2.7876235102253126
SK-CO-1,216345,2.2578794962248403,3.6976464592034883
LS180,24951314,1.284825385865239,1.5440959115580546
SW1573,71680916,4.0865163925225385,4.770189604622561
LS180,11427553,3.214146965067504,2.8500369446934495
HuP-T3,17755052,3.4304742988115366,1.6703143487356706
IGROV-1,44607530,1.2936443589937894,1.710612125649879
HCC1500,11964036,2.769497384705972,1.3233918011144974
LS180,446155,1.950458971830876,2.6357263519120533
SK-OV-3,10385095,3.0219456492917485,1.223817783870189
BFTC-909,serdemetan-SCH-529074 (1-1 mol-mol),2.384231187993096,2.1620134710988435
LS180,23635314,-2.728761007932067,-1.7412855377382175
ALL-SIL,25262965,-0.0785584741633136,-1.9781468276043592
MOLM-13,9956119,3.465056755214706,2.6561809583869604
Panc 02.03,54619267,4.6873070757127335,4.190912314849913
MDST8,45100481,5.670163105184411,4.221791559734661
P31/FUJ,11427553,0.2126015278922564,0.9928305082622261
RKO,navitoclax-sorafenib (1-1 mol-mol),2.2009176263452983,1.5411851466502835
SW1271,123631,1.9601206845091983,2.673551657748632
HARA [Human squamous cell lung carcinoma],5738263,3.6004475982525825,3.46510254947808
SW1573,11626560,2.096503053081923,2.02095437846691
COR-L105,11717001,4.401406695561914,3.985238483877304
COR-L95,JQ-1-carboplatin (1-1 mol-mol),1.8062318254958765,1.3640783573463269
IGROV-1,135984461,4.285945029851472,3.995341846936626
HuP-T3,16725315,3.145396972494799,4.3869517313589075
SK-OV-3,5278396,4.0115131897954175,3.699453410255885
HARA [Human squamous cell lung carcinoma],9907093,5.03391680027973,4.268445744885181
RKN,piperlongumine-MST-312 (1-1 mol-mol),1.5374075036414252,2.024593048714597
HCC1500,7326481,2.1911838281348897,2.839473333429083
ML-1 [Human thyroid carcinoma],6918328,-0.1732040518011542,0.17106812928533596
RKO,11485656,2.16906736756012,1.6348000887999448
HCC1500,17755052,3.708779056995352,1.355806736981683
RKN,16720766,0.5941206863048918,0.5036029313305767
SK-OV-3,49766530,0.1985460846164677,-0.5016908319170889
NCI-H1568,11178236,-4.756412327662482,-3.1715793471714164
K-562,613000,2.5009117496842292,2.365292348639819
SK-HEP-1,doxorubicin-navitoclax (2-1 mol-mol),-0.2519782158989084,-0.8432987412013807
Daudi,49867930,3.141108082189553,3.7552179834269883
P31/FUJ,451668,0.4769801026955246,-0.6740040839647424
SU-DHL-6,2708,3.434249932793118,3.339499919537449
RKN,11497983,4.544575984994342,4.069775732295799
IGROV-1,23582824,0.3287266354391525,0.7458374205743113
HCC15,2858523,2.7763462118547833,3.151269571195893
RERF-LC-MS,3025986,-0.71270364092759,-0.38973854044817535
LS180,984333,1.4840791700280882,0.8983890752691781
COR-L95,24901704,3.9540534266274183,3.057193577168169
NCI-H2452,selumetinib-JQ-1 (4-1 mol-mol),2.500134928300083,1.8333617591063485
MOLM-13,piperlongumine-MST-312 (1-1 mol-mol),1.1119295359137316,1.0782409742293357
COR-L95,409805,3.71634228772174,4.3586354972805506
PaTu 8902,9823820,4.420414335239228,4.147915884161735
Granta-519,24821094,2.4908648032560183,2.343449944859746
SU-DHL-1,26596,-2.3613305357908625,-1.0806495164280523
RKN,285033,-0.0275118271199953,-2.06781965016918
BICR 22,sirolimus-bortezomib (250-1 mol-mol),4.6715609696805505,0.7013599417964683
WM115,ISOX-bortezomib (250-1 mol-mol),0.2831832229570691,0.571745525275721
NCI-H2452,9936388,2.1806204942966803,-0.21991806381475965
LS411N,54618771,1.0517408544895162,0.9295147342225546
RKN,72193861,2.3331130274465313,1.9014752438466938
MDST8,46843906,2.4704071908178844,3.0318508379528013
HCC15,11485656,2.480533785053976,2.2752577853892966
MDST8,11977753,-2.9914432786855305,-1.4875546943306284
PaTu 8902,168313047,2.1566405666580963,2.180702811821235
MOLP-8,135928012,3.056644501758044,3.9204565385949133
ML-1 [Human thyroid carcinoma],25062766,2.2645177949682775,2.0701165933653534
MOLP-8,10074640,3.1436066614625173,2.717744692106797
HCC15,12001922,1.9087360775911748,2.146044607370239
LCLC-97TM1,3025986,-2.553955076787079,-1.1075946414874707
BFTC-909,2842253,5.585220688564769,5.192324515162576
RKO,216239,1.9979551619375524,1.7063135381649102
HARA [Human squamous cell lung carcinoma],241158,4.240217877475157,3.852692674132845
RERF-LC-MS,JQ-1-carboplatin (1-1 mol-mol),4.276053499927872,2.3993454139322017
Granta-519,135398516,2.1425852334349575,0.9095440250690041
KU-19-19,10385095,1.1563887024661463,1.2748656486057046
LS411N,navitoclax-gemcitabine (1-1 mol-mol),0.4425335439188313,-0.4036919348529858
SU-DHL-1,9803433,4.734138876460479,4.562521260163043
HCC15,135999136,4.472611779685761,3.9487922562870783
SW48,11238147,3.1100916590750045,2.8393380447109333
HCC15,tanespimycin-bortezomib (250-1 mol-mol),-2.289156821264784,-0.5709411961896059
BICR 22,409805,3.8456212820768214,5.002536938604019
SW948,selumetinib-GDC-0941 (4-1 mol-mol),-3.896690328067956,1.000346902611136
P31/FUJ,24785538,-0.2737810661065927,0.3752005483528806
Panc 02.03,176870,4.923826321280428,3.4360572816417356
RCC10RGB,322968,3.1449149812629877,4.017389384800929
HCC15,107970,2.678547076190946,2.2863566440256164
SW1271,71304818,2.7682192858067385,2.4684998347950877
LS180,3634881,3.5372782333734696,3.3026938241806
COR-L105,11214940,1.6414587299435788,1.9174087139725078
SW1271,5287620,-1.7165830209074355,-1.8109327248063603
HCC1500,navitoclax-piperlongumine (1-1 mol-mol),-1.489158158277352,0.8197777780045693
COR-L95,49766530,-0.268325836176492,-0.9717121470189215
P31/FUJ,6450551,0.3392586382091512,1.1845690298972935
PaTu 8902,5566,3.0665407385312182,2.9638145505852695
SW1271,6610216,4.395476769861187,4.349701483976556
IA-LM,4477,0.1872236957364025,0.5136739625873239
BICR 31,6917907,-2.0849244140580683,-4.8302502559870195
Daudi,56949517,3.615784656128556,3.417956953854582
SW948,selumetinib-navitoclax (8-1 mol-mol),-0.0800083599001994,1.6657774790044386
Granta-519,156414,1.3767921664113123,0.5877683299145866
SW1573,60700,0.5293530759970745,-0.5137146539469274
PaTu 8902,11404337,0.5155229173062875,-0.442282893457344
BICR 22,52947716,-3.710960782083666,-0.41416930906564536
HARA [Human squamous cell lung carcinoma],5311,2.3146371221244184,1.4853775158383957
ML-1 [Human thyroid carcinoma],135398516,0.6909808613935852,2.395720415049469
SW48,216239,2.7420558854204105,2.0548369999635687
HCC15,136227924,3.0147456858017923,3.062168012909281
MDST8,400769,0.2052239388954162,-0.1973997160160904
IA-LM,navitoclax-sorafenib (1-1 mol-mol),0.7106711881893861,1.7137813304078924
RCC10RGB,4917,3.4531775579708044,3.1400713012225645
RERF-LC-MS,73707398,2.0319367406190483,1.6229402328503864
LS180,4917,2.9590600733191272,3.029695251969087
Granta-519,46926350,-4.5411361861126,-4.513520537239579
BICR 22,1716436,3.778329286476686,3.0011336573802656
LCLC-97TM1,55283,2.725406070596606,2.455571824501789
LS411N,BRD-K27188169-navitoclax (2-1 mol-mol),3.592750133273901,1.7275976272650224
RKN,168312962,-2.199105388969794,1.7997307224148391
MOLM-13,54619267,3.3881439662249657,3.449275070983741
Granta-519,sirolimus-bortezomib (250-1 mol-mol),-0.0602153873263711,-1.2669142076642244
COR-L95,1239801,5.40725658561935,3.660319244543603
IGROV-1,10184653,0.79276129336756,1.5507904459485082
HCC1500,16741245,3.4170657459529865,4.139861595217958
LS411N,44491742,5.693616041532359,4.064658193103561
HARA [Human squamous cell lung carcinoma],5282054,3.837128949835148,3.8459092339133805
Granta-519,24753719,3.151565571990212,3.3059771567101226
MDST8,decitabine-navitoclax (2-1 mol-mol),-0.200661322464638,1.8902180844873586
RKO,107985,-4.24085601271806,-3.645408533716093
HEL,322968,3.0393820993226535,2.289432627143493
Granta-519,46224516,0.9242838162777752,1.9554239319809688
LCLC-97TM1,9823820,4.2474508710721315,3.554147727514503
MOLP-8,23582824,0.4015956903029024,0.7083882036650927
NCI-H2452,60750,1.245026450810127,-1.7724968438616477
NCI-H2452,piperlongumine-MST-312 (1-1 mol-mol),2.5229701837483263,1.924102001218804
COR-L95,54596558,4.049100773357865,4.348159188050124
SW948,135398738,3.916695667859345,2.8788187497546875
SK-CO-1,9936388,-6.4137542305703015,-0.5004726358361906
Daudi,60700,-3.752408099295295,-1.689262376179811
COR-L105,11612883,3.356288934915157,3.0354724165190015
PaTu 8988t,10302451,4.044762571435361,3.07844749986025
SK-CO-1,44507138,1.8454813707467936,2.343116982113682
COR-L95,44486219,4.398500193784116,4.205181471285246
LS180,1242560,3.670855291471482,3.5881956510167203
PaTu 8988t,25102847,3.84691315859083,2.4985598652623944
SU-DHL-1,1750826,-3.9186889861650713,-1.1112260883981453
IGROV-1,4261,1.934016649932683,1.6818414062740488
IGROV-1,9903786,1.7387584479757865,2.975138443999421
IGROV-1,9935249,3.330117761231163,3.054280232946636
COR-L95,446155,4.383849487789403,2.7704285308752383
COR-L95,9967941,2.195306027237361,3.35879289407849
BICR 31,49793307,-0.900639036765476,-2.1769241805087445
Daudi,52912189,-0.5619081020202099,-0.052952142905915586
MOLP-8,9911463,4.2009596294807245,3.2266122080440214
LS180,44589607,3.154958497437342,2.8874894657185775
Daudi,24821094,0.7293316215174883,2.679350270207136
RKN,12003241,-0.3350096455718494,-1.3398151710533943
LS411N,148198,-2.2204558676981576,-3.5338375588543407
RERF-LC-MS,446155,1.000000375050646,2.821752822899364
MOLM-13,10127622,2.24693559354045,2.379822506871607
SU-DHL-1,decitabine-carboplatin (1-1 mol-mol),1.7663528844174463,3.8077029248606835
P31/FUJ,72734382,3.508076038929844,3.1369434164897303
SU-DHL-1,568763,-0.4525318049600722,0.5686413113085568
SaOS-2,11977753,-0.3684170228919589,-1.4227523046907686
SaOS-2,969516,2.4754458532868067,2.9132267169076957
SU-DHL-1,54619238,4.649416356939895,3.8718798209234166
SK-OV-3,6623618,3.404966669354166,2.3811276935262247
WM115,9952709,2.366340614566085,3.355338946580988
Panc 02.03,10184653,2.526680989613479,1.500668372921388
SW1271,3634881,2.897813479014186,3.0417382710565835
P31/FUJ,72376,-3.3088434861533704,-3.6283495821445424
P31/FUJ,46907787,-0.8407426122417735,-0.5590269907530228
IA-LM,5351362,3.020488284300014,1.1249844901637787
NCI-H2452,676352,2.443862996701222,2.1967709991494857
SU-DHL-1,56973724,1.0008411647005613,2.761194915390427
PaTu 8902,1716436,3.3992265902353425,2.8747882445755475
ML-1 [Human thyroid carcinoma],10074640,3.5607250325369812,3.258428269762663
MOLM-13,11717001,3.6418982852877457,3.393240345064763
MOLP-8,613753,2.6774354597179,2.7788157264933044
IGROV-1,44137675,1.8406125640672395,3.695739047839833
P31/FUJ,6914657,-6.361388893160888,-5.0164197277750855
LS180,60750,-4.478139976515186,-1.8599256798007144
SW1271,3062316,-1.9256219632112692,0.5975677232529337
RCC10RGB,219104,3.453227771477981,4.070878203405077
HuP-T3,6917907,-1.7519392074642692,-4.530799692687393
SU-DHL-1,11656518,1.4392799669460994,0.9614916986222296
MDST8,54626689,6.955475194588027,4.642896476451254
SW48,10410894,3.4061289364485794,3.0020849479111558
HEL,72193861,0.4910118925931417,-0.05510568436989027
Panc 02.03,65064,5.367712415574159,4.979976700664932
BFTC-909,984333,1.0937084793466407,0.7436505100115868
IGROV-1,426756,6.142776526139055,4.238726119138235
RKN,11152667,0.0617927102225113,-0.5729840574345986
BICR 22,3025944,4.210034761741456,4.295442442043376
SU-DHL-1,11640390,4.597120644825806,2.7679592110996225
RKO,44589607,3.597229089573096,1.7898387829471907
IGROV-1,56963564,1.8260986108097368,0.7341950430361617
Daudi,24180719,3.437659555986817,3.381415313673523
BICR 31,45279963,4.353781648061694,3.787786411540647
KU-19-19,445455,4.442962740031222,4.731834185377187
Panc 02.03,5281672,4.500820026656837,4.726578695204515
Granta-519,675434,3.9057117034292976,3.920555476241178
WM115,46398810,3.009678027858605,2.643710908626074
BICR 31,119607,5.814089022953436,5.367512153846209
IGROV-1,23635314,-0.611739968448912,-1.2338186259278645
HEL,44819697,-3.010940469478465,-1.8190525085833371
ALL-SIL,5282054,2.788902246408387,2.5301093063602833
WM115,5328940,2.031963430852867,1.7999734717820781
BICR 22,11455910,2.0554057071158303,1.3974480821194657
COR-L105,serdemetan-SCH-529074 (1-1 mol-mol),2.960742836944571,2.2591104858541384
P31/FUJ,4259181,-1.476581151251805,-0.2563656219990373
MOLP-8,54619267,3.766514987830834,3.590060381960793
P31/FUJ,44489367,5.126164790260484,4.435393529099417
RKN,11625818,5.974552631000589,4.4464579028343385
SK-CO-1,alisertib-navitoclax (2-1 mol-mol),-2.923852550533504,0.4407421381222798
BICR 31,5470400,2.045329114611378,-0.40840030880566125
LCLC-97TM1,5738263,3.894572665100205,3.268938528816942
SW48,2729026,2.3283979545053155,2.7480278519146655
HARA [Human squamous cell lung carcinoma],123631,2.9564926917309635,2.3257796100217054
COR-L105,11167602,4.878993593502554,2.494204197485788
HCC15,9549297,1.5760835884765407,2.6902350204085703
HuP-T3,448949,2.1685596620814565,2.155774826311924
Granta-519,9915743,0.9460784198503543,-0.027707644870639977
MOLP-8,51039095,1.4019996450160122,2.106518481128509
COR-L105,56649450,3.0558986692826595,3.548009640240852
WM115,16038120,1.6321211746217177,1.1737285855820963
K-562,31703,-1.219746708928784,-2.2624018701269635
ML-1 [Human thyroid carcinoma],serdemetan-SCH-529074 (1-1 mol-mol),1.7858982688933729,2.19493369952354
SU-DHL-1,11609586,1.5538406664396571,2.4524783355397797
BICR 31,3025944,4.108701914406302,4.385905748924437
SW48,66577038,3.1598846844687545,3.130507709858488
Daudi,24180125,1.1000611971852634,2.1731117065167247
SK-CO-1,6184667,4.676967004326267,2.988046208096054
Daudi,SNX-2112-bortezomib (250-1 mol-mol),-4.343389130323972,-2.5718268142359118
SU-DHL-1,67291369,2.039504043535649,2.0616805541818928
IGROV-1,3815108,1.915722485757852,2.998682905051727
ML-1 [Human thyroid carcinoma],2708,2.4589573831191633,5.0442854100193095
SW1271,selumetinib-GDC-0941 (4-1 mol-mol),0.8746912096343703,1.6141293924643645
LCLC-97TM1,68056272,3.7652459105524585,3.434162902548406
NCI-H1568,9926054,1.8156743035592564,1.9958570481278033
SU-DHL-1,2113511,3.6581551041454823,4.965253390906243
HCC15,3503,1.8764785687467953,2.3805843886330202
SaOS-2,3062316,2.2990980703822115,0.7602921734154107
K-562,16736978,2.075477087199636,1.2558331234255318
SU-DHL-1,selumetinib-decitabine (4-1 mol-mol),2.598187269312087,2.916886884182844
RKN,135440466,3.1815161125023033,2.258640181106056
SK-CO-1,89928392,1.2451759556756246,1.780361665957583
NCI-H1568,54596558,4.146513733670967,4.451614208617502
LCLC-97TM1,4477,1.1810793422928998,0.7998472585016533
LS180,16741245,4.152630132762677,3.8632037934073367
SK-CO-1,decitabine-navitoclax (2-1 mol-mol),-0.6610169057545121,1.5765140627412677
BFTC-909,159324,4.114702101808939,3.1205350483163414
PaTu 8988t,2113511,6.37119394515457,5.575925052495745
ML-1 [Human thyroid carcinoma],alisertib-navitoclax (2-1 mol-mol),-1.2100779480376045,0.5517124768877066
IGROV-1,5291,3.6852809555447985,3.7789055069851853
PaTu 8902,16038120,1.215016097060631,0.8212679506470459
ALL-SIL,10302451,-1.1728976190372558,2.631304569981203
UACC-812,tretinoin-navitoclax (4-1 mol-mol),2.4411364981876043,2.262749641622165
LS180,vorinostat-navitoclax (4-1 mol-mol),1.6395407762655403,1.442712624276672
IGROV-1,docetaxel-tanespimycin (2-1 mol-mol),-1.5830865659631668,-2.6549725244589126
P31/FUJ,vorinostat-navitoclax (4-1 mol-mol),-0.3847698718995038,-0.39339759941835467
ML-1 [Human thyroid carcinoma],7251185,4.28899372473645,2.672224180638166
SW948,7326481,3.486606738365962,3.077182141912409
HCC15,44507138,1.6295786006094204,2.5919490500549376
RERF-LC-MS,16725315,4.583339442818838,4.297185131635592
P31/FUJ,148198,-3.664233852608881,-3.966819437280122
HEL,49850262,3.2265871136708997,2.3521279201001892
HARA [Human squamous cell lung carcinoma],25126798,3.0348047735223935,3.7627797242776855
BFTC-909,60750,-1.7298046099952136,-2.179308831864903
SW48,doxorubicin-navitoclax (2-1 mol-mol),-4.619867397585904,-0.9968523722380803
NCI-H1568,675434,4.067969537829177,4.597511178853682
COR-L95,19582717,3.635233206850296,3.63953752212494
COR-L95,148198,-4.800055382400855,-3.855514445011573
BICR 22,44819697,0.2156040754176,0.11107353759420827
SK-OV-3,46224516,3.444215787907748,2.925083540187641
HCC15,5281672,5.6563329698974965,4.6218689972609965
HEL,6918328,-0.4966077251990671,-1.5614116355715137
NCI-H1568,24785538,0.5698046292147018,1.847712992878618
RKN,23582824,1.7370647325872666,0.7215071480216524
PaTu 8988t,navitoclax-gemcitabine (1-1 mol-mol),-0.4570432900108468,-0.9641330056384446
SU-DHL-1,322968,2.585334286015635,3.031967304152592
BICR 31,24797083,1.8361324304615187,1.4171528582516886
SK-HEP-1,3062316,3.432714145613195,1.2440772383032028
PaTu 8902,2729026,2.7803221257085884,2.741619483784882
SK-OV-3,11609586,4.251063762376387,3.1675875945499383
HARA [Human squamous cell lung carcinoma],3025944,5.227932597847333,4.309386088190033
ML-1 [Human thyroid carcinoma],156414,1.0547615836858202,1.6904919630629955
Granta-519,44607530,1.7224857333943702,1.070220695001918
NCI-H1568,15953870,3.42403550557497,3.719534088122906
RCC10RGB,carboplatin-UNC0638 (2-1 mol-mol),3.3801418218563337,3.3732188999265933
MOLM-13,erlotinib-PLX-4032 (2-1 mol-mol),1.7877509525982431,2.6438553195566685
MOLP-8,252682,6.161004481234046,6.114248229689182
SW1573,126941,-1.0305779796426808,-2.574679955650716
BICR 31,9927531,5.661036072082279,4.910168263242977
RCC10RGB,441298,3.7731685554529384,2.5297516638341806
MOLM-13,387447,-5.119095777855545,-4.938863759345232
Granta-519,216345,1.0997896286755158,2.571066823674551
LCLC-97TM1,107985,-4.222636663811031,-3.4506221931438734
LS180,3384730,2.894746509752001,2.9260865225750106
HARA [Human squamous cell lung carcinoma],9936388,-6.286258703982233,-1.63400672424885
ML-1 [Human thyroid carcinoma],2746,-1.478438692576885,3.5995137575000355
KU-19-19,44493528,4.383684457454455,4.194578444683595
LS411N,53232,4.5193815700089655,2.756692567794165
ML-1 [Human thyroid carcinoma],46907787,2.3673247902218804,2.4228092257397438
LS411N,6438330,3.3380693145982816,2.1689856090433968
HARA [Human squamous cell lung carcinoma],5284616,3.060508834181737,2.5978215343663837
NCI-H1568,JQ-1-carboplatin (1-1 mol-mol),3.4150339974619457,2.4974245505700905
BFTC-909,16725315,4.495652912061774,4.2589074627572225
RKN,124202324,3.704376342602573,2.612488348076827
LCLC-97TM1,10127622,3.458194652659875,3.731763836393854
SW948,vorinostat-carboplatin (1-1 mol-mol),1.7834644899516086,2.3889393758835396
SaOS-2,5494449,1.7356769079300427,2.804680507744767
HEL,702558,3.166026376934585,4.065303745891381
KU-19-19,11612883,2.975593545287462,2.8940923716454945
BICR 31,6914657,-2.1990076047646703,-3.723043973316237
PaTu 8988t,2858523,3.414247843041017,3.0256739440843132
SW48,9911830,1.5953282800372102,2.5894774627329626
Daudi,11178236,-7.583909031047052,-4.039199639497101
Granta-519,44819697,-1.094231558387569,-1.865199948014988
MDST8,2828334,6.077771510152207,6.281291607601004
RKN,9911463,4.114615883902867,3.9413278769446203
RCC10RGB,JQ-1-vorinostat (2-1 mol-mol),1.4034358595851535,1.2071152139866148
SaOS-2,9903786,2.3206358959344264,2.7159738222388325
RKO,44607530,2.6096687798301677,1.716974937787158
SK-CO-1,11455910,1.152685438196598,1.4223547517562631
SK-OV-3,25183872,-0.070614613180641,-0.6330856622235982
WM115,25227462,1.5125525407178182,0.15596313919425428
HCC15,2126,5.047391044285817,4.682936151244946
HARA [Human squamous cell lung carcinoma],9823820,4.297752192216693,3.9146634922525907
HuP-T3,11238147,3.6375005285241033,3.097688997673401
SU-DHL-1,168313047,2.0629090722275945,2.158891850308219
BICR 22,5335621,5.24838502551373,4.566773870985531
SK-OV-3,135398516,2.140261030425796,2.153746554837085
ML-1 [Human thyroid carcinoma],6852167,2.7131700239928316,3.0308958237860297
RKO,11214940,1.6564081526645635,1.555357168722939
SW948,9935249,-1.8483271913214137,1.8808507533806114
NCI-H1568,2871966,-1.5477941874243064,0.575337643675644
WM115,54626689,3.4845925362433,4.674342287518222
IGROV-1,46398810,2.003787621940583,2.51984247651454
NCI-H1568,alisertib-navitoclax (2-1 mol-mol),0.1984676648447771,0.6404796648718175
RCC10RGB,selumetinib-UNC0638 (4-1 mol-mol),4.208062457345683,3.218416524362295
SW1271,selumetinib-PLX-4032 (8-1 mol-mol),0.5021040652093107,3.392594204588254
BFTC-909,3025944,6.464154930724253,4.395129079192136
BFTC-909,10113978,3.8739618499623094,3.4871731495141574
LS180,docetaxel-tanespimycin (2-1 mol-mol),-5.0888233311005795,-2.7960723886293963
BFTC-909,24748573,2.672786285704278,2.309960717141926
MDST8,23582824,0.3553467044538872,0.9255556832306873
MDST8,navitoclax-MST-312 (1-1 mol-mol),0.0883996467230522,0.5207601368438913
SW948,53392493,1.921137473015096,1.8165611550994947
LCLC-97TM1,5287620,-2.537847801025228,-1.8280571768666822
HCC1500,3552672,1.623977684405255,2.684258292726485
SW1271,2113511,4.856200971437617,5.5673219033055235
RKO,11238147,3.3996395604326977,1.8416380575685654
MDST8,56963564,1.9609696235744132,0.7004169860728154
HEL,JQ-1-vorinostat (2-1 mol-mol),-0.5678151706430512,-0.5794954199995547
MDST8,73707398,0.930898424190815,1.3294070042798785
SaOS-2,selumetinib-GDC-0941 (4-1 mol-mol),1.0166144741288403,1.3481017897742626
COR-L95,serdemetan-SCH-529074 (1-1 mol-mol),-0.7704324455951623,1.8380319347100014
HCC1500,107970,1.6380228058856745,2.3338711669281995
HARA [Human squamous cell lung carcinoma],262093,3.694607099499911,2.9373944437706063
ML-1 [Human thyroid carcinoma],5335621,2.3456257872682933,4.839022929832136
MDST8,11222830,1.739834123793711,1.7273362602508908
MOLM-13,11364421,-4.614262921489179,-4.80455006606953
MDST8,89928392,1.3331112546959425,1.6888704526588734
SW1271,doxorubicin-navitoclax (2-1 mol-mol),-1.1619625703073235,-1.0055258982549335
RERF-LC-MS,148124,-5.592640359076286,-1.8109384269955737
PaTu 8988t,219104,4.30352428274638,3.8617388474134042
SaOS-2,16659841,3.6368059645085737,3.594027187534981
HuP-T3,selumetinib-vorinostat (8-1 mol-mol),2.242647534898157,2.3334854587070124
ALL-SIL,25183872,-1.1896517316661384,-2.2505234029907926
HuP-T3,3503,2.6961085729175465,2.4712542114279765
SaOS-2,148124,-5.379251304292956,-2.5985746738453055
SW48,25102847,1.5289459974072863,2.4699733240997452
PaTu 8902,6852167,4.282216220168943,2.6236733595302395
ALL-SIL,11396600,2.960335319566646,2.5649437984850643
LS411N,54649381,4.0879656113234315,3.265158744058044
LCLC-97TM1,56649450,1.9268896253969057,3.0895195745886586
Panc 02.03,42642645,1.4849485241267697,1.1855329234252616
PaTu 8902,5328940,2.100447742300893,1.6896346200875052
Daudi,10127622,5.05479511248997,2.99621834309922
SaOS-2,15983966,-4.612114381732812,-1.5041920180671047
SK-CO-1,selumetinib-decitabine (4-1 mol-mol),0.410871863589865,3.2175808193546622
MOLP-8,11214940,2.188017762346292,1.3620421598338346
SW48,44607531,-0.0703962424187993,1.4094613228315631
IA-LM,637858,2.795809218533269,1.3458971082193047
LS180,119182,-2.2864715680735603,-0.9558537241726062
SK-CO-1,135411,-1.9906675184189948,0.973889177623111
SW1271,15983966,-1.9627382742922743,-1.4943770653674526
LCLC-97TM1,11485656,2.4293249862604913,2.2458977394471487
Daudi,135984461,3.9990978127252728,2.5660990007778666
HARA [Human squamous cell lung carcinoma],11455910,0.2072973533181662,1.280667030655134
SW1271,24180719,4.447587763279296,3.2809878872921785
RERF-LC-MS,4917,3.617944790726347,3.145967200575557
HARA [Human squamous cell lung carcinoma],1242560,4.08747373250943,3.510547632990594
COR-L105,44185566,3.03526972595121,2.5989162016485805
MOLP-8,8515,3.727464051425151,3.2836405114876097
Daudi,11656518,1.0836561052202376,1.0802106967205223
MDST8,10302451,4.267643132743765,3.0970056163416917
Panc 02.03,tretinoin-navitoclax (4-1 mol-mol),6.083694650761559,2.904955252913656
MOLP-8,135398738,4.11621412508813,2.4909144129349228
RCC10RGB,568763,0.4218853975706897,0.7692382380700288
SW1271,285033,0.340737243750418,-1.9281306061408505
Granta-519,67156097,-3.3327998752636483,-2.2016948602534026
WM115,11964036,0.4423113132234746,1.3581552326719872
SK-CO-1,156414,0.1991331726980137,1.11012248104476
BICR 22,568763,1.1340411223212885,0.55358441288281
P31/FUJ,176870,1.9707243184949097,2.42860369494864
SW1271,24748573,2.5868513601661336,2.4328930927137806
MOLP-8,72199292,1.2541603744267094,0.3505933803194835
RKO,5282054,3.8735499096789856,2.7446647992440365
RKO,selumetinib-decitabine (4-1 mol-mol),2.541552473841643,1.0261609521956212
HCC1500,16722836,2.402902940836366,1.9034023083776597
Panc 02.03,46199207,3.8452319744534886,3.234448648529231
PaTu 8988t,71304818,2.8353343090304257,2.616782753651647
IGROV-1,241158,3.288496474515495,3.870161242745774
Daudi,71751553,3.830487233171358,3.817967257224191
COR-L95,46174525,3.763282126483136,4.060708316300358
NCI-H2452,2126,4.762499509878762,4.728766675855644
HCC15,11228183,0.6025691709173914,2.5196491257934066
HCC1500,11404337,-1.1638452247583002,-0.13662524004167792
PaTu 8988t,16725315,5.4103858057829095,4.18014864497119
MDST8,4378219,1.9480435949418269,2.462275347262969
IGROV-1,5351362,1.961059142684053,1.635212412740333
HuP-T3,44489675,3.6946366435409352,4.11232149849777
SW1271,4259181,0.7411137136724786,0.1682137048204773
RKO,5978,-3.7617282032773582,-2.9297106051296797
MOLM-13,11485656,-3.968420003132376,1.2662820538884716
K-562,24821094,1.908113699718487,2.658894469417257
SW1573,89183176,3.862510153781557,4.1883831556684905
K-562,24180719,3.2747438118023533,3.348742645662471
LS411N,4788,5.997281207159956,5.587974146936926
IGROV-1,66577038,3.2148239132520455,3.0754171552598772
SaOS-2,selumetinib-BRD-A02303741 (4-1 mol-mol),7.165298435960504,4.480328160689787
Daudi,9549297,1.403366421117492,1.682978996308439
UACC-812,11427553,3.574449796486334,3.0429847130381154
MOLM-13,52912189,-1.0667663091505395,-0.12857816676859254
HCC1500,selumetinib-JQ-1 (4-1 mol-mol),2.938993597127826,1.5180841179696072
SW948,erlotinib-PLX-4032 (2-1 mol-mol),3.457135081619971,2.7533846244682194
PaTu 8988t,selumetinib-JQ-1 (4-1 mol-mol),1.6621315506186802,1.7886565195588022
IGROV-1,24821094,1.720998716331183,2.941359199998162
Granta-519,11427553,-0.9723301484726812,1.2491855984256905
MOLM-13,208908,2.7636340376000317,2.0223726719965454
IGROV-1,9915743,-0.4757488934941289,0.9882468101910099
Panc 02.03,241158,4.402915180139186,4.167974427685496
IGROV-1,24748573,-1.0654275876710166,2.3294256412025534
COR-L105,5287969,-1.8496230723467,-1.7408162093576762
MOLP-8,10296883,2.725727750190508,3.1845562373302987
SW948,241158,4.5321951743877005,3.487440637590717
ML-1 [Human thyroid carcinoma],216239,2.965937740464059,2.352819611508394
MOLM-13,navitoclax-piperlongumine (1-1 mol-mol),-1.0908841522604569,0.11597923748433123
SU-DHL-6,10302451,3.370117636140473,2.89800443787697
IGROV-1,9936388,2.10108466287406,-0.898030388046389
HCC15,72376,-1.512462057486854,-1.4547248816383294
COR-L95,6450551,2.8920154707175776,2.2423787142002958
NCI-H1568,5738263,3.2402226460817323,3.5216720661165652
RKO,54619267,4.028311361432676,3.9721411004426495
RERF-LC-MS,4261,2.068565192175152,1.858533675924698
K-562,73707371,5.645446798773975,3.4986872804281446
SK-HEP-1,carboplatin-etoposide (40-17 mol-mol),5.6878657292744075,3.0211283092733425
P31/FUJ,ISOX-bortezomib (250-1 mol-mol),-0.0400156428773503,-0.17688200663880693
WM115,122327,3.780637240577924,4.608257995097583
WM115,25150857,2.4679229997528394,2.3933407675935117
SK-CO-1,11178236,-3.2010052407962215,-2.9134931738338667
RKN,753704,4.966407297087677,5.001310773729698
BFTC-909,selumetinib-PLX-4032 (8-1 mol-mol),5.555922755682714,3.5064284436901447
SW1271,227681,3.2917347097405725,3.46793947466594
MDST8,568763,0.1407924711645573,0.5656592427609051
BICR 31,5566,3.2898773587253096,2.93151511365635
HARA [Human squamous cell lung carcinoma],3385,4.962584280578164,4.210657468359377
RERF-LC-MS,6450551,1.967154760545028,2.9443060285707134
IGROV-1,2874250,4.893662837169153,4.642438063694534
ML-1 [Human thyroid carcinoma],ISOX-bortezomib (250-1 mol-mol),0.9716953544539896,0.8213420171041608
HCC15,56946209,-3.385198311974778,-3.7354610417509235
BFTC-909,136227924,2.3418993883842134,3.000589650209757
Granta-519,1750826,-3.7858867937492984,-3.263847924959186
P31/FUJ,11625818,3.2136174191857174,3.187521861688501
COR-L105,10322450,4.112392966182136,3.890861501330664
HCC1500,5566,2.905130044911903,2.8315875856152637
SW48,51039095,1.7096770563148074,2.8037742789794855
SW1271,8515,5.208985199998064,3.896913716440088
KU-19-19,73707398,1.7453733414385195,1.3519487612076906
K-562,11707110,1.6681367726124623,1.1672821674580784
COR-L95,16065773,1.8842547212847705,2.2965754139290824
LS411N,docetaxel-tanespimycin (2-1 mol-mol),0.1660438979420715,-3.642160460401872
IA-LM,11178236,-6.720771550362321,-3.4060582026956547
MOLP-8,54596490,4.413151323823571,4.320292607355449
ALL-SIL,44202524,-0.4119558263455749,1.1231322143084623
WM115,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.6716900719045018,2.8361494002484937
MDST8,6918328,-0.3527629143091293,-0.058462685396076866
BICR 31,104842,-0.0442586507462943,-2.6574409646207067
BICR 31,6852167,2.001013365002547,2.8233554498922655
MDST8,vorinostat-navitoclax (4-1 mol-mol),-0.0959848783200281,1.140355566716921
IA-LM,24821094,3.0699000024292293,2.582390352800589
IGROV-1,73707398,0.8848064516600974,1.3471493808954313
SaOS-2,46191454,1.8159544721998524,1.8457504165512526
NCI-H2452,selumetinib-GDC-0941 (4-1 mol-mol),2.2378905262634343,1.652359754208628
LS411N,25150857,2.959758413524705,1.7705972251139586
HuP-T3,11175137,3.603877049706456,2.690638749579144
LS411N,135984461,5.061110843141604,2.866684322257093
IGROV-1,4261,1.934016649932683,1.6818414062740488
SK-CO-1,BRD-K27188169-navitoclax (2-1 mol-mol),1.3228586557967312,2.126073298712661
HCC1500,9952709,2.298703589628035,2.934249225549079
SK-OV-3,176870,3.5610869734905255,3.2002897803157238
PaTu 8902,9952709,4.3707417693645745,3.0964205552739776
P31/FUJ,56973724,0.796880831995934,1.473725030922197
RKO,2729026,2.3662843020346753,2.459260973422955
RKO,387447,-4.452540898932811,-4.315090805797718
SK-CO-1,135398738,3.5773200936681584,4.371180134820916
BFTC-909,3552672,4.498195948808332,2.6848116297434497
Panc 02.03,7251185,3.0530850004567767,2.704784001232521
K-562,sirolimus-bortezomib (250-1 mol-mol),0.4974638580928024,-0.2188943732039388
RERF-LC-MS,serdemetan-SCH-529074 (1-1 mol-mol),2.886633168137992,2.2286360680717494
Panc 02.03,53392493,3.617637281515077,3.00500650289684
LCLC-97TM1,446155,3.780165105352184,2.5963897792374495
BICR 31,23725625,6.004496967521932,5.065589635874289
RCC10RGB,11612883,4.41570881394896,3.016942200907357
WM115,5280436,2.216411919293008,3.5865181086159232
RKO,selumetinib-JQ-1 (4-1 mol-mol),0.7539248953092096,0.3353321667599014
NCI-H1568,10184653,1.3826991243685076,1.4909453629128075
LS180,10427712,4.740953715848998,4.19133546378368
SU-DHL-1,JQ-1-carboplatin (1-1 mol-mol),3.662871226226577,2.0824576552789313
ML-1 [Human thyroid carcinoma],56963564,0.9868520726565888,0.8177008658032962
HuP-T3,12003241,-0.2833744856936582,-0.748880544388199
Daudi,9884685,-1.7998414591903729,-0.16948500895079305
SK-CO-1,44259,0.6005082969424771,0.8899982758497466
MDST8,10231331,0.2022855962524302,1.5491863328017466
SK-CO-1,4261,0.7789911540114764,1.4437649906312564
P31/FUJ,10074640,2.9862675466657764,2.6567862887770097
SK-CO-1,12001922,1.782153173177779,1.9643051330889925
SaOS-2,16720766,-1.9505026731708328,0.7174789044151482
RCC10RGB,216239,3.3222265979679375,2.4065166776346816
BICR 31,navitoclax-pluripotin (1-1 mol-mol),-0.5418229135264367,-0.8254728863310682
KU-19-19,sirolimus-bortezomib (250-1 mol-mol),2.2113915758762133,1.0995255160302921
COR-L105,72734382,5.425179503032161,4.92226703803758
LS180,11640390,3.36619781023128,3.2644375857495063
K-562,25262965,-1.232298297425116,-2.239740782911285
IA-LM,piperlongumine-MST-312 (1-1 mol-mol),2.1673101171047513,1.3841839315673088
LCLC-97TM1,135411,0.5874500365845237,0.3727948682355635
SU-DHL-1,46398810,1.696894130738712,2.144806512240529
P31/FUJ,6610216,4.336076332167018,3.7522225831873772
BICR 22,5291,3.723640910280853,3.5261455402263726
HEL,44632017,1.0842639602191189,0.8227809212835901
Granta-519,4261,1.1412453306659267,0.1813942922124851
Granta-519,56963564,-0.5609340564012296,-0.16748028757359712
MDST8,53392493,2.9375507482716334,2.530811832236125
LS411N,44819697,-0.923326266781905,-0.9850923625868042
NCI-H2452,selumetinib-decitabine (4-1 mol-mol),5.979248786857892,4.272678825500114
NCI-H1568,5291,3.770643134542437,3.796287284517768
BFTC-909,11612883,3.5324782187628827,2.6944451254149584
RCC10RGB,11955716,4.4260489213830425,-1.5209937462583267
SW1271,11626560,1.376954486231794,1.8250932592427285
SW48,46943432,0.8743166493146273,2.398414059830725
HEL,3062316,2.2727573444408633,0.23405742521295536
MDST8,JQ-1-carboplatin (1-1 mol-mol),1.720719180230483,2.38190637503146
RCC10RGB,5329102,2.357265375302505,2.2531378359474545
ALL-SIL,9866186,-0.4181259896802407,0.027739860458150422
NCI-H1568,selumetinib-navitoclax (8-1 mol-mol),2.553812274921004,2.180256155009548
HEL,23635314,-2.6594801266287154,-2.555716680645614
Daudi,10074640,1.7373836938395748,2.6052052241587065
RKO,26596,-1.341584325458414,-2.2863891681483235
WM115,11167602,1.5239005360441813,2.7927095470153676
IGROV-1,2746,2.8413672686351212,3.4642868361661185
Daudi,24978538,2.467871482925033,-0.009046598365546728
RKO,2858523,3.1569923390566332,3.063241127723026
LS411N,15983966,2.6804451752833978,-3.379224023925593
SK-OV-3,452548,0.7579906967862455,0.6857814870982887
MOLP-8,25262965,-4.805551534468427,-2.337395639119584
LCLC-97TM1,46215462,1.4949685345148778,1.608352233752833
BICR 22,439501,-2.4052901035443,-1.8582930098688326
SW48,10184653,-2.0074491437034094,1.1171666652184942
P31/FUJ,168313016,4.690131242833582,3.7453862408141303
NCI-H1568,selumetinib-tretinoin (2-1 mol-mol),5.145646184067631,3.601440028827605
SK-OV-3,selumetinib-JQ-1 (4-1 mol-mol),5.055306733015199,2.1123792606975336
LS411N,54613361,3.867376577775082,-0.42222354877521423
COR-L105,24772860,-1.435746068442861,-1.3194228577428013
K-562,11222830,1.892206265748428,1.136422409505837
Daudi,10385095,0.347773175212431,0.9345638930438642
HCC1500,44137675,4.199849963716895,3.3396429415488273
SW1573,11404337,-1.3449252751203844,-0.2538130453794485
SK-HEP-1,46191454,1.8876467264614776,1.7339533429119052
P31/FUJ,135999136,4.068676884464422,2.6348506140695243
RCC10RGB,25150857,2.370598483016253,2.462375819019721
NCI-H2452,57330099,4.302779847582817,4.289434095963041
IGROV-1,10127622,3.2581804056600165,3.5214634094024335
COR-L105,5282054,3.9571885951378505,4.087188849693664
LCLC-97TM1,53481919,3.8027519676947232,3.628911243947809
NCI-H2452,3025986,-0.5496531660815697,-0.5273431429667678
WM115,11955716,-2.4505472507691013,-1.4618307378357498
BFTC-909,637858,2.264716830291231,2.0158643054792686
COR-L105,selumetinib-JQ-1 (4-1 mol-mol),0.4359614379036839,1.602598616865543
Daudi,1641662,2.995591169153073,2.8627430854216773
MOLP-8,446155,0.367312642153156,2.2700149807615455
RERF-LC-MS,135999136,4.400683337930441,4.094972732177843
WM115,5738263,3.851280366828244,3.4978841575658985
MOLM-13,65628,2.9573007313246924,3.279025654298609
HEL,9936388,-3.337900467930123,-5.458700224694775
SW48,104842,-4.777281812432541,-2.6637721480255494
MOLP-8,ISOX-bortezomib (250-1 mol-mol),0.0006851036189058,0.376314979243218
Granta-519,11626560,0.2073830225530282,0.6948698782082191
SK-CO-1,969516,2.7975557975376035,2.9362660170495776
SW948,11640390,3.051257470103826,2.71533742166409
HCC15,10302451,3.767869991537956,3.0742135045695993
MDST8,crizotinib-PLX-4032 (2-1 mol-mol),1.604281792595084,1.735034725805404
PaTu 8988t,46943432,6.478561461465468,2.7018165818962694
K-562,208908,1.7214906675478436,2.1603961050931035
NCI-H1568,11612883,2.467781963295413,2.867600077816369
LCLC-97TM1,9884685,-0.6945268748645868,0.5396992573828103
Granta-519,6918328,-2.2526378564537355,-1.8536926267398375
Granta-519,5470400,-3.2597420844446163,0.1887604697357567
LS180,10231331,0.7625893939503741,1.7102010828263587
SW1271,46199207,3.134892747913181,3.1852480455601158
HEL,11404337,-0.835651629585067,-1.3947445179874984
Daudi,216345,1.872370108624604,2.628072859819776
MOLM-13,decitabine-navitoclax (2-1 mol-mol),-5.337552823003331,-0.7618963055167316
RKN,54613361,0.2026815444056028,-0.18926497010357324
LS180,452548,0.7544699085550369,0.200548086927582
RKN,44493528,4.408823872302737,4.438115618485773
SK-HEP-1,11238147,2.1467729161342524,3.0218609394927456
MOLP-8,tanespimycin-gemcitabine (1-1 mol-mol),-4.944533339092102,-2.0931190852768635
COR-L95,11364421,1.7062947816433405,-2.3377050850549064
KU-19-19,452548,1.4010535434747853,0.23596443395918004
COR-L95,tretinoin-carboplatin (2-1 mol-mol),4.531796019532578,4.159883888790924
IGROV-1,44819697,-0.8326420176056434,-0.40784331568821813
MOLM-13,salermide-PLX-4032 (12-1 mol-mol),4.733891503361179,4.212841935037617
RERF-LC-MS,2729026,3.1361811776879644,2.7141480381664063
RKN,4788,5.902938799554125,5.686544739098312
K-562,216239,1.6121414929675577,1.882409608936305
HARA [Human squamous cell lung carcinoma],2729026,2.992927693558788,2.737433053807743
IGROV-1,2746,2.8413672686351212,3.4642868361661185
IGROV-1,637858,1.814476597989254,2.027751659731456
HuP-T3,11214940,1.8541641961456377,2.0370620414357954
IGROV-1,46907787,2.182756719431072,2.0262298091970137
P31/FUJ,445643,6.117258311867223,3.521279973453346
Granta-519,3854666,0.1662242620713641,1.0473820301636858
MOLM-13,tretinoin-navitoclax (4-1 mol-mol),-1.997886556177749,0.20926355396249163
LCLC-97TM1,135440466,1.105929023295497,2.204607626541363
RERF-LC-MS,56649450,3.38813984116235,3.4490553397292696
SK-CO-1,11612883,2.4661452350243493,2.634148791523422
SK-HEP-1,44137675,4.549525792934436,3.536173986177838
HCC15,72193870,4.3690783386047025,2.174912788003133
HCC1500,2746,2.6069735713089006,3.2644658508836835
MOLM-13,decitabine-carboplatin (1-1 mol-mol),-2.1020710624228833,0.16222796723559418
Daudi,11222830,0.8543881776084605,1.1316760258572522
WM115,2749,6.3303951951253445,2.243573426651251
K-562,9840324,5.675524269237515,5.625804529870557
MDST8,10113978,3.624916965791189,3.1864645221148673
NCI-H2452,44507138,2.753685109279225,2.5986386848539085
MOLM-13,5282054,3.1361279245897857,2.8334503675053524
BICR 31,9911830,2.2138272662609064,2.606836024857502
HEL,6917907,-5.38656193144065,-5.2764173224720885
IGROV-1,2858523,3.196384505087132,3.058384562943074
MOLP-8,322968,-1.2094679469942695,2.342116252598249
BICR 22,3503,2.960513829073252,2.1050107720515157
ALL-SIL,10113978,1.6173510565910796,2.4458629153103164
HARA [Human squamous cell lung carcinoma],navitoclax-sorafenib (1-1 mol-mol),1.2625473684238606,1.5864194324676413
RERF-LC-MS,119182,-0.645974794966856,-0.6748557511617014
LS411N,4261,1.591263829932159,1.1026995629546326
SW948,4096211,1.12279899109382,1.4539555722457471
K-562,11485656,1.7795111963017332,1.6281194694260686
MOLM-13,53232,2.182263698942312,2.491741064835528
ML-1 [Human thyroid carcinoma],44819697,3.711954604060423,-0.45135769989223723
IGROV-1,3689413,-0.3633634632064185,0.02181348394200458
RCC10RGB,12001922,2.277970650057297,2.089396895969114
RERF-LC-MS,246676,4.480243243269967,4.193897769061155
HCC15,374536,0.7951987879889547,2.555888447015331
MOLP-8,11977753,-4.876868381891939,-2.1455847151289307
Panc 02.03,2874250,4.438896474206821,4.5886637214518595
COR-L95,613753,3.031049367391043,3.1194810259547627
SW1573,9840324,5.095993559480237,5.830173572039445
SW48,24901704,1.780712261537264,3.3661720248209237
BICR 22,6918328,0.5113628660513942,0.16446974942686257
Daudi,54613361,-0.5183638298018372,-1.011982125169377
LCLC-97TM1,25102847,2.141917897082315,2.312557987518984
HuP-T3,3081361,3.872954779649628,2.333173569603875
LS180,969516,2.6818241036299275,2.857383912350352
SW1271,2945648,2.4921907486938646,2.8771439115403683
BICR 31,25126798,3.691910729857057,3.8546056106222153
KU-19-19,SNX-2112-bortezomib (250-1 mol-mol),-1.0111363937138018,-1.2136458105933892
Daudi,262093,0.7533038243356376,1.5376313536706272
RKN,20959075,-2.033811748726601,-2.8195256274118945
KU-19-19,702558,5.449368171937104,5.175007921619417
SaOS-2,2842253,6.143936300195383,5.274144967468376
RERF-LC-MS,26596,-1.2372341703529914,-1.086089968583561
PaTu 8988t,5329102,3.3339986936080717,2.1152929534573066
ML-1 [Human thyroid carcinoma],44607531,1.8496707927685447,1.7563389053040352
SaOS-2,73707398,0.8491853151273433,1.197678929719948
K-562,JQ-1-carboplatin (1-1 mol-mol),0.3966707315482991,0.2640326873980402
SaOS-2,984333,4.259432573695519,0.5017483701318642
LCLC-97TM1,53232,3.007779101776312,2.6670607351023996
KU-19-19,3503,3.0769201112014803,2.403134307053485
WM115,57330099,5.984461482923693,4.039733419804591
HARA [Human squamous cell lung carcinoma],82146,4.619283658647928,3.9825677381326234
LCLC-97TM1,44491742,4.237702230509644,4.066338694581421
SK-CO-1,9915743,2.0474134916136184,0.5904629341302922
HCC15,73707398,1.6988346513711203,1.5661690752273778
HCC15,4477,-0.3802251277588812,0.45561965657730086
BICR 22,26596,-1.8883514509946957,-1.026684432720377
SaOS-2,445091,4.479630914494518,4.348769032983025
HCC1500,3503,2.0705498046235817,2.2298378421891396
SK-CO-1,salermide-PLX-4032 (12-1 mol-mol),5.553578625312618,4.666995222395895
RCC10RGB,71304818,3.488257335656729,2.6432030774001576
RKO,241158,4.5302703569847305,2.677824273154877
SW1271,168313016,5.582938604018868,4.858369679472989
SW948,10385095,1.3660359707166476,1.2584194614551374
RERF-LC-MS,3543504,3.1700226881436193,4.394833598092164
LS180,5311,1.1738972820475675,1.4709218084249747
RERF-LC-MS,5291,3.9873816513243785,3.884313359894721
RCC10RGB,53481919,4.9196370953200805,3.8437960957384063
Daudi,44241473,5.233980827552566,4.085549817028759
Panc 02.03,10127622,3.4148938287456776,3.773125970971159
BICR 31,49836020,4.313223650735915,2.1642491009310105
Daudi,54618305,3.9105424608095847,4.1034776835579585
SK-HEP-1,5746,3.319924463812582,1.4254785992909702
ALL-SIL,67156097,-2.3407546390754037,-2.199667671160273
ML-1 [Human thyroid carcinoma],24797083,1.931228349809168,1.4377605803413431
P31/FUJ,613753,2.9305719806169432,2.8121800080584696
PaTu 8988t,1641662,3.634680635371761,3.5790119131066445
SU-DHL-1,15953870,1.992339234699044,2.989557061976167
COR-L95,decitabine-navitoclax (2-1 mol-mol),-0.2234984214129892,0.7571475243430862
SW1573,JQ-1-UNC0638 (2-1 mol-mol),2.8948762578833667,1.5912078969353363
P31/FUJ,navitoclax-PLX-4032 (1-1 mol-mol),0.0164871875305551,-0.4521592889131806
Daudi,vorinostat-carboplatin (1-1 mol-mol),1.6612162447966572,1.6881046624777212
SK-CO-1,11364421,1.7180407971266538,-0.7184628049037731
COR-L105,16722836,1.79329711252707,2.051888338835901
IGROV-1,439501,-2.1510551928674557,-2.2303054243174416
ALL-SIL,50905018,3.9646846974495418,3.287319738714382
SW48,25126798,2.5731969050098993,3.818242370766595
PaTu 8988t,10113978,4.3652834043747335,3.350233630113173
SK-OV-3,12003241,-1.2313805329375749,-1.369196832762396
Daudi,1317464,3.6966432302020817,2.945476586337586
WM115,5978,4.185238310426041,-1.4797758625186879
RKN,carboplatin-etoposide (40-17 mol-mol),3.53893718453625,2.8557158369873044
ALL-SIL,24785538,-0.5874123218373029,0.533581075782213
COR-L105,sirolimus-bortezomib (250-1 mol-mol),-3.794916830429034,1.190703806237368
IGROV-1,9967941,2.9735049794712545,3.5624708858291125
SK-HEP-1,11977753,-1.1270659898133608,-1.3337882041056686
COR-L105,676352,1.9469411585028615,2.245102018140494
MDST8,11485656,2.867381561993162,2.5160570909411835
SW1271,selumetinib-piperlongumine (8-1 mol-mol),2.3808052258502705,2.877677599444383
SW48,6918736,-2.164113269607571,-1.7152299251893819
SK-HEP-1,445455,4.37046727572682,4.753779610145175
Daudi,4096211,1.4831417361144643,1.1702794424836054
LCLC-97TM1,16038120,-0.9192372639718316,0.9850909251013199
BFTC-909,3384730,4.46542670181497,3.4044721886684113
K-562,36462,1.3855340321895664,0.9926036775110814
SK-HEP-1,5329102,2.506246240472525,2.095212394703906
WM115,25161177,2.874219730459086,4.100486060501382
HCC1500,119607,4.730010050453825,5.210919960795109
IGROV-1,24964624,0.5052308994941754,2.4224170459650525
HCC15,421610,3.960173561996767,3.269779465100824
ALL-SIL,4788,4.920956242868583,4.762408162820523
IGROV-1,49766530,-0.195540678413639,-0.5936143478334672
SK-HEP-1,11175137,3.0126176485486114,2.7971074879458677
MOLM-13,selumetinib-piperlongumine (8-1 mol-mol),2.118239948342191,1.2890620173187375
K-562,54678924,1.7343444538293111,1.4738736766125637
ML-1 [Human thyroid carcinoma],5281321,-2.300928121678764,-1.0074781723832167
ML-1 [Human thyroid carcinoma],11167602,2.9640815113410923,2.5241071140799805
COR-L105,6505803,1.059348129706536,-0.23298212262805396
P31/FUJ,25183872,-2.108478877482417,-2.086790449033955
Daudi,navitoclax-birinapant (1-1 mol-mol),2.1928151248147194,0.1234731243148662
NCI-H1568,9444,4.259676436179719,4.2783138000380285
NCI-H2452,selumetinib-MK-2206 (8-1 mol-mol),2.148853035614541,2.407404860059283
KU-19-19,19582717,2.992815973528006,4.363557882209007
RKN,36462,2.460575122343829,2.285078973978482
P31/FUJ,3062316,2.2346133515561415,0.5248549293165855
MOLM-13,36314,-7.769941141611737,-2.554825434062664
HEL,44484440,3.2564839193688524,2.7543556411540937
RERF-LC-MS,168313016,4.277512101574917,4.948740212687628
HCC1500,637858,1.1010846881251866,2.02206612949404
COR-L105,11178236,-3.064044900311784,-3.2296930867222717
IGROV-1,44202524,1.8303703172382677,2.2771775207558638
LS180,alisertib-navitoclax (2-1 mol-mol),1.1962644272537857,0.6155077702322312
MOLP-8,11175137,1.914718066408171,1.9849621072312642
LCLC-97TM1,1641662,3.5570250788057187,3.369246637615673
SK-HEP-1,46199207,3.772137058295689,3.310639439666135
SW1573,6917907,-6.296104468024424,-4.643913685732436
HEL,89183176,1.9576500820122449,3.3108296732412263
SU-DHL-6,49793307,-4.306431914357451,-4.629753635344919
K-562,6918837,-4.262812875828109,-4.012424878168343
Daudi,44493528,3.680262260756896,4.008823059675677
RERF-LC-MS,5311281,3.366561586065275,2.3891393673455004
IGROV-1,675434,4.336225379212549,4.3409686543546036
NCI-H1568,216345,3.8344110950672823,4.002755235183135
SU-DHL-1,9926054,1.6936537424309908,1.6460963083863722
Panc 02.03,9911830,3.8856260346392903,2.552446848858805
HCC1500,2729026,1.749867272011919,2.7942628538813072
ALL-SIL,42642645,-2.33031271995146,-0.05678183231449721
Daudi,9911463,2.4252044126403915,3.078771545210648
NCI-H1568,45279963,3.534456091536717,3.590782189855436
RKO,135999136,6.045591123054076,2.9280582498042054
SW948,JQ-1-UNC0638 (2-1 mol-mol),0.5184819522178918,1.1164897923806345
SW948,9903786,1.6902329933335576,2.6026148739361714
RCC10RGB,9956119,4.44093701823858,3.6753538133143797
SW1271,25154868,5.0403607075499375,4.5175302565716695
K-562,65628,4.517417686157834,3.4666979689825257
SU-DHL-1,613753,2.797885663964736,2.826100892758638
SW48,ISOX-bortezomib (250-1 mol-mol),0.0957852828937709,0.5865442685273268
HCC1500,44566777,0.0909506116020526,0.9250842444736054
NCI-H1568,54454,3.61375646412465,2.604144235016548
SW948,44507138,2.949706410080911,2.5612760982851364
SK-CO-1,17759555,4.047587343089958,3.680979455373997
HEL,568763,0.2288469977463405,-0.38529067474599044
BFTC-909,3815108,3.5118939741133075,3.06972847758123
ALL-SIL,24901704,-0.1489296834412312,2.1913330840601706
MOLP-8,piperlongumine-MST-312 (1-1 mol-mol),0.7424689739493265,1.2844847532465626
KU-19-19,24772860,-1.0696999794461075,-1.8750908523207768
MOLP-8,9866186,-0.5209158528959533,0.32559475026245654
NCI-H1568,JQ-1-MK-0752 (1-1 mol-mol),3.5105249308751363,1.930877952043889
HuP-T3,71304818,3.5647709327393287,2.5472855607117624
MOLM-13,11683005,2.7238157220539345,3.178997936527347
HEL,54618771,0.7283869495698151,0.38821535855761047
RKO,selumetinib-PLX-4032 (8-1 mol-mol),1.8013466074828854,3.249335976962881
WM115,selumetinib-PLX-4032 (8-1 mol-mol),-2.130332393585934,2.338646716809744
NCI-H1568,25150857,2.4294918673251416,2.537060835402411
RKN,6438330,1.1013294242613172,2.055178899031281
HCC15,644241,2.326085716096255,2.2321006775121273
LS180,2708,3.937371430907984,4.86006994513269
LS180,51037431,3.4786862718788747,3.1363872079968145
K-562,16741245,3.9224206604880583,3.6714386369188734
RERF-LC-MS,44185566,3.014427147988128,2.7699971226787965
SW48,navitoclax-MST-312 (1-1 mol-mol),0.8806321220589545,0.7073641794350045
RKN,5566,3.4992110401170944,2.9277255405832814
LS411N,navitoclax-piperlongumine (1-1 mol-mol),2.36008373550467,1.5673189520356674
MOLP-8,216345,2.155670358283386,2.9855688292472444
HCC1500,BRD-A02303741-navitoclax (2-1 mol-mol),0.0071603230581946,1.8079194840611157
HARA [Human squamous cell lung carcinoma],alisertib-navitoclax (2-1 mol-mol),-2.092897901371494,0.5237506531105317
PaTu 8902,46224516,2.4477060426075723,2.766156859113898
RCC10RGB,241158,4.984223152954295,4.114311118070857
HCC15,11612883,1.9950389922708311,2.819439032468349
HCC15,969516,3.14053560758236,2.925459203925413
LS180,9866186,-0.1716689837079009,0.8584701052782628
Granta-519,decitabine-carboplatin (1-1 mol-mol),2.1725621434549582,0.479278990551393
RCC10RGB,24964624,2.93015987785669,2.636930397604614
MDST8,216345,3.5638732818875094,3.6903716533494952
RCC10RGB,10302451,3.839480938635774,3.0123732812057717
HARA [Human squamous cell lung carcinoma],100016,5.315547253627084,6.045100762245056
WM115,44491742,3.78432787650886,4.187497652759128
SU-DHL-1,selumetinib-piperlongumine (8-1 mol-mol),2.378072265787347,3.1342435165517344
KU-19-19,262093,2.7281718696395303,2.9452107105349734
ML-1 [Human thyroid carcinoma],erlotinib-PLX-4032 (2-1 mol-mol),2.7869393467132344,2.9499907162459555
COR-L105,1242560,3.3237423881291233,3.61761263550059
MDST8,16736978,0.980275670291684,1.7595433591288139
NCI-H1568,16722836,1.2045551605263336,1.6423588630452612
WM115,5282054,2.577591804396212,3.948594795533101
IGROV-1,25195348,3.0698662305180275,3.4660747214903127
PaTu 8902,148198,-2.774580136562139,-3.4959773578050317
HEL,26596,-1.8679385890512872,-2.2951051988226157
Daudi,25126798,3.548189682848153,3.5422648600578497
PaTu 8902,selumetinib-piperlongumine (8-1 mol-mol),5.497989392681889,3.04213974599985
SaOS-2,decitabine-navitoclax (2-1 mol-mol),2.350842092351968,1.8920841269477402
PaTu 8988t,56946209,-4.946927234389905,-3.3340330615644183
SK-CO-1,2945648,3.4071568821077993,2.7490786476460913
SK-CO-1,JQ-1-navitoclax (2-1 mol-mol),0.4682346666935782,0.796349885082467
BFTC-909,3136844,3.2427360302120403,4.241546394722047
IA-LM,71304818,3.3887828048220094,2.1954550113856164
NCI-H2452,122327,4.606448802646307,4.586305865208798
LS180,12003241,-0.6460664270988897,-1.1928137994190469
SK-HEP-1,16741245,3.65273757252914,3.8841626097049686
RCC10RGB,6918638,2.235907203261483,0.4291984097284537
WM115,16065773,1.4979025411384967,2.642991138779409
HARA [Human squamous cell lung carcinoma],9825149,2.481612932411,2.0309784951389274
Daudi,54678924,0.8831010429483725,1.2565873523130409
MOLP-8,9903786,1.299688823902182,1.9292598682133715
ML-1 [Human thyroid carcinoma],24180719,3.042356764984187,3.648575184156887
WM115,219104,4.514482202684108,3.7708405888836314
Daudi,25150857,0.8259987709661276,1.5207639727472213
KU-19-19,selumetinib-BRD-A02303741 (4-1 mol-mol),2.399823528664379,3.8887137418043913
BICR 22,25262965,-4.220207088048826,-0.9404400630598906
BICR 22,25126798,3.759096897040898,3.7942685499970192
HCC15,11717001,5.339668805105819,4.0256603511689555
Panc 02.03,JQ-1-MK-0752 (1-1 mol-mol),2.226829891800918,1.6545193162740792
BICR 31,6918328,1.2499033439512497,0.09316151988657743
COR-L95,25150857,1.208080540357677,2.0839951032763016
ALL-SIL,104842,-6.679847729141338,-4.784459591128317
ML-1 [Human thyroid carcinoma],6450551,2.5869852554462622,3.0251313359932324
MOLP-8,crizotinib-PLX-4032 (2-1 mol-mol),0.0452912472141007,1.0950269076674801
IGROV-1,11612883,1.8715405446213529,2.74841496039256
HEL,9926054,1.596813412273358,1.725029135227408
HCC15,11404337,-0.219975280966356,-0.31580845731878765
LS411N,168313047,3.2811764574410893,2.173115854666262
HuP-T3,168313200,4.289513738947004,3.0391128059334824
RKO,216468,3.08027711257304,1.0847370756048003
HCC15,5566,3.133848096057735,3.049950095711487
SaOS-2,2130404,2.752105467907615,3.381190467558488
PaTu 8902,6623618,2.257974787323956,2.187658855605544
Granta-519,45279963,2.8131243875516097,2.675288415503738
BICR 31,6918638,1.4401869695378149,0.5844095527259205
IGROV-1,2729026,2.3541792737160296,2.6182496402533895
SaOS-2,decitabine-carboplatin (1-1 mol-mol),4.9062736540715735,4.490043997151755
PaTu 8988t,126941,-4.347732149803542,-2.397048302738147
BICR 31,44607531,1.4420456412349776,1.4299890692537425
RKO,227681,3.9032876810461814,2.685873603526799
Granta-519,5278396,3.331153353007608,3.0967230193186683
MOLM-13,11214940,0.2452206847669268,0.9663142368426003
Granta-519,6914657,-5.464946920891912,-5.174970346142028
SW1271,72199292,4.741032264194907,0.4964302686297347
LCLC-97TM1,3676137,5.47833794075875,4.406384770339958
BICR 31,6505803,0.2507928346620714,-0.4478311135491914
NCI-H2452,9927531,4.529523169776047,4.895832303700976
HEL,107970,2.2652057864285893,2.090485755395539
P31/FUJ,73707398,-0.9687174770786582,0.3673765624904986
SK-CO-1,3634881,3.2176217097393867,3.287636392339802
ALL-SIL,71680916,4.0231197218666015,3.76174507904128
IA-LM,carboplatin-etoposide (40-17 mol-mol),4.857587432381165,2.745921233544019
NCI-H2452,54678924,3.78052585603054,2.3376311166389483
HARA [Human squamous cell lung carcinoma],20959075,-3.3968163713216657,-2.7156174907654633
RKN,9840324,5.059199694090175,5.529338516634252
LS411N,25195348,3.7393125277208608,3.148857477732394
ML-1 [Human thyroid carcinoma],171352865,2.7298814774275435,3.1946837627405453
BICR 31,11497983,4.106423080888053,4.162899963960523
RKN,3825829,4.2934517576030276,4.0705508114297935
Panc 02.03,104842,-1.6275579890051994,-2.501718834651048
SK-HEP-1,4378219,1.9889575503272792,2.5255668277699335
NCI-H1568,11609586,2.169671625299293,2.849708771026113
NCI-H2452,24772860,-2.067021978185303,-1.4782485774039749
HCC1500,2828334,6.090675120485649,6.122069129523052
ML-1 [Human thyroid carcinoma],15983966,-5.2151360937473,-0.3629806475125904
HCC15,selumetinib-navitoclax (8-1 mol-mol),-1.9070047094364015,2.034388423771459
ML-1 [Human thyroid carcinoma],5291,4.042812106600411,3.845046903458343
SK-CO-1,426756,3.753929508081783,4.28517992575933
SaOS-2,46215462,2.3169135098646483,1.985286564013537
IGROV-1,216468,0.5330864756407336,3.1673782688456855
RERF-LC-MS,25262965,-1.1343637554659964,-1.4854229008253899
NCI-H1568,53392493,1.829675716879907,2.6488323777283242
WM115,6438330,2.009543324889134,2.1844337291051845
P31/FUJ,9908783,6.361014450142155,4.462609461205648
HCC1500,5291,3.388112901698238,3.6258265837478603
HCC1500,216345,2.2086555393223293,3.724960614826618
SK-CO-1,16722836,1.1930735523198912,1.7214497187325621
MDST8,2858523,3.149165485885388,3.081146729858821
IA-LM,44486219,4.346993548383093,4.060973066182527
P31/FUJ,10427712,4.089067276268696,3.665389544077478
K-562,24771867,1.7261535062160185,-0.8513896648359779
SW948,2742550,2.6149964231270166,3.423223148950763
COR-L95,2113511,4.880906118348224,5.155529181416667
BFTC-909,82146,3.493415453952883,3.9109119101787093
BICR 31,4261,2.904745052497421,1.6905480957598602
BFTC-909,119607,6.015893315993201,5.33482941631234
MDST8,JQ-1-MK-0752 (1-1 mol-mol),1.445543393100169,1.6138620217063044
Granta-519,262093,1.5974758737964725,1.447534943384079
COR-L105,4521392,4.261553030698096,4.384394150601143
HuP-T3,52912189,2.4400429797195065,2.621169704579996
HCC15,168313016,4.627209757330862,4.898731766600898
MDST8,15983966,1.9809932367095728,-0.6980568148928805
Granta-519,9866186,-0.14818829969678,0.08143322166501418
SK-HEP-1,462382,1.018219313736715,0.6093111106116497
Daudi,7251185,0.6493905196982933,1.591407865174101
HEL,3385,2.274300648457042,2.599055747430592
NCI-H2452,44185566,2.4757676958398824,2.6981383775329335
SW1573,9884685,-1.2788581073527363,0.9927171074644147
RKN,6505803,1.4092626649390017,-0.19046259584922687
COR-L105,selumetinib-piperlongumine (8-1 mol-mol),1.184006147072735,3.4558587339858002
RERF-LC-MS,11427553,2.91041132641442,2.7929850034318933
SW948,107985,-3.1361927230844255,-3.480181478381338
IGROV-1,24951314,0.9075718706849548,1.5015284915516596
IGROV-1,753704,6.461140333581179,5.155293803208196
LCLC-97TM1,54143018,-1.232378656007133,0.20159624016095445
SU-DHL-1,16038120,-4.191759239414132,0.515428170138795
SK-HEP-1,65064,5.472205201006758,5.096161537327186
COR-L105,2733526,5.6711261994322,3.7210262070541917
HuP-T3,56649450,4.499318873015619,3.2136544143885994
SW48,16741245,3.865069024996995,4.161127197785205
HCC15,89183176,3.7013914070621903,4.348819141071542
SU-DHL-1,135928012,2.7237506411412427,3.9393183579317603
HCC1500,24901704,3.772063812557438,3.397790705352852
K-562,6505803,-1.797722788015983,-0.6533924190115655
P31/FUJ,docetaxel-tanespimycin (2-1 mol-mol),-5.9377835284500895,-4.549148912585671
ALL-SIL,9936388,-6.364749169872344,-4.917855519870631
P31/FUJ,5284616,2.141886646431612,-0.8161577334056476
RKN,654092,-2.299209260296745,-0.45065617170905603
SW48,piperlongumine-MST-312 (1-1 mol-mol),1.3077982167208542,1.8655841410666385
Panc 02.03,462382,1.1832417961450334,0.8227109112833517
P31/FUJ,11609586,2.709581392176905,1.5416889144608215
COR-L105,322968,4.452130073523545,4.014947942147424
RKO,135398516,4.318914396092429,1.336396581076129
Panc 02.03,44185566,3.1312758482446976,2.6409212081367586
NCI-H1568,72376,-1.5373297187690371,-1.8276893877493707
Daudi,11494412,-0.3802447608890573,0.338005134241033
SW48,erlotinib-PLX-4032 (2-1 mol-mol),3.2399078814474924,2.9531358541616974
SW1271,2126,5.27764055734565,4.554310406869182
RERF-LC-MS,10296883,4.230661493555322,3.997917123998613
SK-CO-1,53232,1.9491581074450712,2.95863623054886
HCC1500,11222830,1.0956735100670385,1.6321265826354034
SK-CO-1,vorinostat-navitoclax (4-1 mol-mol),1.5116374119241311,1.0593776476660657
LCLC-97TM1,16219061,3.747043694071086,3.092351654552972
HCC15,3543504,4.297283358198234,4.6227247740661035
SW1271,6918837,-1.9255423784418917,-2.574957085314064
SaOS-2,53301938,5.583232766578932,3.272315930409091
UACC-812,9866186,1.6792636289805696,1.1411744300272295
RKO,5278396,3.510721289362286,2.7776825798751434
K-562,16722836,1.308803334400655,0.9376383733810735
HEL,selumetinib-tretinoin (2-1 mol-mol),7.234386750467808,2.4776466315286223
P31/FUJ,9935249,2.700947453739227,1.0715595826395188
IGROV-1,5351362,1.961059142684053,1.635212412740333
IGROV-1,44819697,-0.8326420176056434,-0.40784331568821813
HCC1500,5746,0.8617369744590151,0.9547021508956646
BICR 31,15547703,3.2095649219178006,3.195712100571044
P31/FUJ,72193861,-0.3659416399435479,0.0034142016977210116
PaTu 8902,24964624,3.11499425545507,2.1408068090917096
BICR 31,vorinostat-navitoclax (4-1 mol-mol),1.4356739307232549,1.0795019668844958
SK-OV-3,24901704,3.989938255280614,3.6708210979694247
LCLC-97TM1,2113511,6.012866888022406,5.434917524250811
SaOS-2,3081361,3.085781742119062,2.28128230742625
IGROV-1,15983966,1.7101486625531308,-0.9147466255119435
MDST8,6852167,1.3374988720553735,2.945759707685346
MOLM-13,67291369,-0.0488061328139809,0.6054444210059311
K-562,JQ-1-vorinostat (2-1 mol-mol),0.1257253367868581,-0.4210424419795147
MOLP-8,9926054,1.7939353525170396,1.6247461103650542
SU-DHL-1,168312962,-2.257405592485961,1.1167226731536841
LCLC-97TM1,219104,3.650486733954163,3.553571347348091
HuP-T3,984333,1.5721860041126483,0.8530469889035394
Panc 02.03,4477,0.984097917718396,0.6332367445229672
Daudi,selumetinib-piperlongumine (8-1 mol-mol),2.587128104626929,2.0552881061039856
IGROV-1,9929138,6.483056540257463,5.679149907283899
SaOS-2,11175137,1.9690729540796783,2.6496315161420374
LCLC-97TM1,9915743,-0.0836077976930932,0.5036818501798137
PaTu 8988t,9907093,4.39010034793255,4.350257278653131
LS180,73707398,1.191690395470446,1.1933661382696044
ML-1 [Human thyroid carcinoma],25102847,2.935986325205898,2.5631508117375397
Daudi,11960529,3.700971671461623,3.2039582578487362
RKO,4259181,-0.4049041326260317,-0.3430301925417222
MOLM-13,31703,-4.683228669920675,-2.6216871098715946
SW1271,4477,0.3648589081307944,0.22897759961015976
HuP-T3,216239,2.9976543037230665,2.2692572697682714
HCC15,9903786,1.5576741113339283,2.83242933471501
IA-LM,selumetinib-JQ-1 (4-1 mol-mol),2.5487957947561544,0.2686752622522197
Daudi,1239801,3.0112900662314717,3.2291623480706506
PaTu 8988t,25126798,4.088623680113087,3.8509894274735017
RKN,227681,3.7901732699912585,3.5030664249893233
K-562,216468,1.7844503846326911,1.3780471984321125
NCI-H1568,11234052,4.07711650557102,4.27237102792252
RERF-LC-MS,17755052,1.8057357372617977,2.0136661716242976
HEL,135999136,1.6019096984193502,2.641422958033234
HEL,9887053,3.0781159437380974,2.893262378993038
RKO,11625818,4.5581118700811105,3.461728741671671
HuP-T3,322968,2.6241189840020787,3.912740610388868
BFTC-909,11317348,4.568727931072339,3.2141566730932074
SW48,selumetinib-BRD-A02303741 (4-1 mol-mol),-1.5460315373913385,3.7649361122730096
MDST8,1716436,1.1500764778734351,2.97818243288592
ALL-SIL,16741245,1.8101156107911176,3.6145672986996074
Granta-519,16722836,1.0937584859115594,0.7863021818556731
PaTu 8902,10385095,2.391345219233966,1.2763049762912309
WM115,3038522,1.9104775831242309,2.9809738982819765
HCC15,decitabine-carboplatin (1-1 mol-mol),4.946381859305088,4.617064111195222
RKO,11497983,5.954072388877685,0.8165730971130496
BICR 31,46174525,4.37434163277974,4.573964991337335
IGROV-1,JQ-1-UNC0638 (2-1 mol-mol),1.7292829396313356,1.701286019602347
PaTu 8902,73707398,2.5949502925816397,1.444707578972795
MOLP-8,1641662,3.485304007232308,2.9640300430684348
HuP-T3,11640390,3.629059315953643,3.524016743155318
HARA [Human squamous cell lung carcinoma],53481919,4.643044937502802,3.96403899117622
LS411N,49850262,4.021647044836445,2.9292632912922545
HARA [Human squamous cell lung carcinoma],9952709,3.695976506837269,3.136635051698461
SW1573,24951314,1.273840217876839,1.480715077884136
RKO,441298,2.3183923582018107,2.409386106779485
COR-L95,5335621,4.389010810876702,4.080280030466616
MOLM-13,selumetinib-UNC0638 (4-1 mol-mol),2.1826018630699746,2.05161139193947
MOLM-13,24785538,0.0261170120397283,0.3477950198333545
Granta-519,374536,-1.3755413186728007,0.7365650863697145
HuP-T3,9911830,2.533690069517969,2.588002336742101
HCC15,11640390,4.25082988279064,3.8609968116010185
Daudi,375860,-0.7416229308895455,-0.6095011324179141
BFTC-909,16722836,1.424017650466323,1.7591661096632896
BICR 31,selumetinib-JQ-1 (4-1 mol-mol),1.6620620003816966,1.3169032553192794
BICR 31,crizotinib-PLX-4032 (2-1 mol-mol),1.5274046089824267,2.1818503405309952
LS411N,46398810,3.253541487295017,1.9948451464075898
SW948,carboplatin-etoposide (40-17 mol-mol),4.008054530018911,2.3753866182846797
HARA [Human squamous cell lung carcinoma],24748573,1.9169510591730587,2.31137057702058
BICR 31,136227924,2.8140968842668923,3.0240159996607603
SK-CO-1,24753719,4.51149350773187,4.362639800359833
LS411N,JQ-1-MK-0752 (1-1 mol-mol),1.615286960946078,1.248984216922086
SW1271,57330099,4.656552081384507,4.298700872160394
ALL-SIL,60750,-4.149254188873004,-3.5466209906502724
MDST8,42642645,1.1052716804296012,1.1488548777252354
ALL-SIL,25062766,1.575972356073685,1.5956838906398922
LCLC-97TM1,salermide-PLX-4032 (12-1 mol-mol),6.666218718302321,4.570634574150952
SW948,11455910,0.6774609071475187,0.7937849256378294
SK-CO-1,11485656,2.076616779710352,2.2769383593639607
P31/FUJ,387447,-5.269499156732966,-5.072591694062193
SaOS-2,54765302,6.138432086002101,4.087667549300786
KU-19-19,3384730,2.4463371108200995,3.2792896546341925
SW48,56946209,-4.8342224094221455,-4.0122232261204145
RERF-LC-MS,71304818,2.1402027844306986,2.6561050097328622
SaOS-2,5351362,1.054118918695375,1.4678067795344
SW1271,60700,-2.0966401571631805,-0.2886883692298928
SK-OV-3,12001922,2.3689117655248197,2.123433615714448
BICR 22,11222830,2.7513096778080293,1.6065046541348127
HEL,637858,1.821308587756956,1.0543174420452062
LS411N,11609586,3.7769222068832384,1.9517515616646985
PaTu 8988t,crizotinib-PLX-4032 (2-1 mol-mol),2.4555083865109197,2.047784527437293
SW1573,53392493,3.256582971351183,2.57156779857355
IGROV-1,71466380,4.863636874274779,4.333575199360522
SK-HEP-1,119607,5.888068080296772,5.349649425206319
K-562,5329102,1.5928854941533903,1.5243770792054605
RERF-LC-MS,24901704,2.6292316786888295,3.5299602914826442
RKO,54649381,4.449908747747005,3.163223116409319
KU-19-19,6438330,3.038685724131264,2.4888070099730006
RERF-LC-MS,6917907,-5.461995819879327,-4.652340670800542
Daudi,6852167,0.8630196090584432,1.286524523865607
RKN,2708,5.19327789915259,4.623246055454452
SK-CO-1,51039095,2.6345691844177006,2.7263063990973455
HEL,9935249,3.1121102066484827,1.426672634121215
Daudi,6184667,1.7615544136572183,2.2056840673113918
ML-1 [Human thyroid carcinoma],24964624,3.117302997790913,2.643800273556689
SK-HEP-1,selumetinib-vorinostat (8-1 mol-mol),2.40344777828312,2.703399736288341
LCLC-97TM1,5978,-5.540378308178224,-1.5307702599788229
SaOS-2,135999136,4.306712196094447,3.789233659609587
IGROV-1,5311,1.0068816368200209,1.466252680129331
PaTu 8902,10184653,3.3664490630517023,1.0593246896257278
IGROV-1,54678924,1.4704159748793169,2.3038434160762593
HARA [Human squamous cell lung carcinoma],54613361,-1.6613115011598742,-0.35022939510240825
IGROV-1,16720766,-0.0562020789376145,0.6697370776661269
RCC10RGB,31703,2.24368059098483,-0.44220614904846917
SW48,4261,1.3708847234833408,1.3442240222830453
LCLC-97TM1,navitoclax-gemcitabine (1-1 mol-mol),-2.1258188281402757,-0.5362455949475453
Granta-519,11494412,-1.422706675432074,0.5611824669862656
BFTC-909,10302451,3.622269240471498,2.9684368956358753
HARA [Human squamous cell lung carcinoma],452548,-0.3270885928487969,0.32947176392458
SU-DHL-1,11497983,5.985793176782232,3.1269965619344697
HEL,44486219,4.241945120616936,3.710903534843819
HuP-T3,9926054,1.9266750805140576,1.8569407394253294
Granta-519,5281672,3.715092894597705,3.928718329857666
NCI-H2452,568763,0.2251625503779925,0.6835956579018508
Daudi,15547703,2.9729250708388815,2.4632864583208116
RERF-LC-MS,1566236,3.687566928717542,2.2715310023664133
SW48,3689413,2.066117060158584,0.13603720327806668
RKN,11396600,3.670395083293249,3.6290042173734713
COR-L95,25227462,1.0954609187473372,0.19351695241163236
P31/FUJ,11497983,-3.9754433923569295,-1.4515611798072008
COR-L105,11977753,-3.381629820862821,-1.098298167503185
SaOS-2,10302451,5.268852772808677,3.1851106055560656
WM115,25126798,4.207732195436686,3.895888604511835
HEL,6918736,-2.4872933380365483,-2.1010720997347483
ALL-SIL,vorinostat-carboplatin (1-1 mol-mol),1.2348853562201922,1.9869290752645277
MDST8,selumetinib-JQ-1 (4-1 mol-mol),-0.5732607032642526,1.0811170019465595
BICR 31,11626560,1.5769037831027732,2.2224201698057295
SaOS-2,53481919,3.9662352208904,3.878781380653459
NCI-H2452,4378219,4.095695943124218,2.4230709142477758
RKO,135440466,3.093117295091816,2.1920547839614577
ALL-SIL,selumetinib-decitabine (4-1 mol-mol),-0.1840409792284095,0.5814593899757307
IGROV-1,4521392,5.131794979216607,4.320720021176094
WM115,6610355,3.646348527159068,4.708460021023899
IA-LM,46199207,3.643614442277753,3.0800640702195734
RERF-LC-MS,navitoclax-MST-312 (1-1 mol-mol),2.0546989000241367,0.9940833070723183
RERF-LC-MS,4259181,-1.273108977623296,0.4915917049180887
COR-L95,selumetinib-PLX-4032 (8-1 mol-mol),5.035796466628604,3.7419450968175183
LCLC-97TM1,9866186,0.636434294421894,0.831381545019017
LS180,selumetinib-BRD-A02303741 (4-1 mol-mol),2.497004756461055,2.931952071879824
BICR 31,285033,-1.6333817403557132,-1.6863707120462863
SW1573,24821094,3.391149888356164,3.0062744666601033
RERF-LC-MS,984333,0.876742343627688,0.9547264851821236
SW1573,2828334,5.538488922798482,6.2795314903967805
BFTC-909,11214940,1.666026285351028,1.8802156247793484
MOLM-13,SNX-2112-bortezomib (250-1 mol-mol),-3.9385993868290665,-2.393371443804395
ML-1 [Human thyroid carcinoma],55508,1.8303716396385248,3.304695735690655
MOLM-13,16722836,-1.8349401857846608,0.7104672148676728
MOLP-8,135398516,0.6877200142840878,1.390308921717225
NCI-H1568,56649450,2.3390116545362956,3.2330620210328624
COR-L105,5329102,2.9490674090485007,2.294229766288262
BICR 22,104842,-5.460039616101889,-2.4009742358911983
ALL-SIL,44507138,0.0905903694215729,1.6387459365671473
COR-L105,navitoclax-piperlongumine (1-1 mol-mol),1.1506089120324992,2.188575584463536
Daudi,252682,5.82526834825694,6.165422303804237
SK-CO-1,24785538,-2.301834394825824,1.685131004684488
HCC15,4788,6.208189927463216,5.6115732279627135
HARA [Human squamous cell lung carcinoma],54686904,4.432396143260886,3.894235547189693
SK-HEP-1,5282054,5.2464488654660935,4.009229116491477
K-562,2729026,2.90327889883348,2.4321271734592043
HEL,docetaxel-tanespimycin (2-1 mol-mol),-3.324993936619335,-3.7469646689142992
IGROV-1,135398744,6.402844237905131,6.377485325732377
Panc 02.03,44819697,-0.6097657869730747,-0.17672525753340826
COR-L95,6252,1.2572884944075156,-0.107426956770254
HARA [Human squamous cell lung carcinoma],613000,1.7145271439199108,2.741354163083679
HARA [Human squamous cell lung carcinoma],54143018,-1.1176720961651934,0.4867436242996364
RKO,135411,0.3039750611139232,0.22635623605193406
SW1271,5284616,3.4240840801047825,2.675832603944268
Daudi,9803433,4.921870042846492,4.203069833511916
HuP-T3,1566236,2.433067651410228,2.1752494430977034
NCI-H1568,11364421,1.3511041801335055,-1.2612220407836825
SaOS-2,54678924,2.353285364311993,2.227225336445338
NCI-H1568,6438330,1.052967118553252,2.2940374814507143
SaOS-2,56946209,-2.927880316628738,-3.875498870169847
MDST8,71304818,3.102141708789901,2.488513752613538
MDST8,16722836,1.8236379945665244,1.6497304723545678
COR-L95,5460769,3.3963309413836815,2.5899122046830887
SW1573,5328940,2.8151731448483424,1.716614768217104
P31/FUJ,44486219,4.066329818545256,3.885771915661846
SK-CO-1,44819697,-0.0659450585917303,-0.012642840714214384
NCI-H1568,3689413,-2.0602171008804935,0.08692439261392013
SW48,4788,5.795432827385499,5.654101531009595
IGROV-1,11625818,2.877471533668122,4.6212406016969405
HEL,5282054,3.8014373831294073,2.678349296948909
Granta-519,2858523,3.0573334835342725,2.6998446833850354
Granta-519,2708,2.6467102550113357,3.235467053210347
SaOS-2,10074640,3.1546787022314264,3.133484046969061
Granta-519,alisertib-navitoclax (2-1 mol-mol),-1.8552810437041576,-1.8595253771970663
NCI-H1568,462382,0.4864277786958156,0.6625254406945735
PaTu 8902,6450551,4.419968438595772,3.013348838526745
NCI-H1568,89183176,4.755399227223714,4.428267158369781
SK-HEP-1,89183176,6.199387598364303,4.591111671110355
COR-L95,3689413,-1.01311028513846,-0.7813563182066641
SW48,322968,2.620984302451229,3.5193963097201713
NCI-H1568,2113511,4.994259934049027,5.62361252400497
RERF-LC-MS,10074640,3.277461458690314,3.0427384051934245
P31/FUJ,11485656,1.9746673234827223,1.3675351183991957
NCI-H2452,24978538,1.4440845227299357,1.5277338274479382
SW948,46398810,1.81837356763434,2.204361569417863
SW948,navitoclax-pluripotin (1-1 mol-mol),-1.6002032912556945,-0.8781372407806198
SW48,5280436,3.9386259808510737,3.2614731554310867
NCI-H1568,16013152,3.794215458313736,4.230370616176255
K-562,JQ-1-navitoclax (2-1 mol-mol),0.4672607120603991,0.21404091484930618
SaOS-2,72193861,0.3662001709486771,1.7027164014258571
SW1271,6623618,2.240401111492455,2.2576744128595845
BICR 31,11964036,0.7129684858082154,1.4351942545179281
MOLM-13,71466445,2.28410988708537,2.3121855453614812
SW1271,5280436,5.166796757102748,3.4215711789724974
Daudi,crizotinib-PLX-4032 (2-1 mol-mol),0.8611087114550048,1.1179856985524277
SK-HEP-1,5470400,0.5577708849126581,0.5017822531028783
SW1271,73707398,1.637161284255629,1.3176888859317983
Panc 02.03,24771867,4.320948526904658,3.051412331534912
K-562,11494412,-0.907204058397288,0.7392808183824117
HuP-T3,4477,0.7500067469313434,0.49988527925536913
WM115,44489675,3.6522428576041888,4.024708084829976
IGROV-1,10074640,3.2681490579824426,3.088121446264488
LCLC-97TM1,387447,-4.752686001320434,-3.980349405829039
NCI-H2452,136227331,4.192235498443636,4.142462738396886
BICR 22,44566777,0.9464577594296588,0.8494476769861353
Daudi,44462760,2.2846011846998184,2.5799690319785276
HuP-T3,11222830,1.7699584455080513,1.7642348200878746
BFTC-909,10184653,1.6906150005550105,1.508914244063747
COR-L105,navitoclax-sorafenib (1-1 mol-mol),1.5234919165461795,2.172432903463777
SK-CO-1,5460769,-0.7722931098274061,2.661096814845541
IGROV-1,9884685,-0.088911709267569,0.5980159059769895
SW948,10074640,3.6458957710098927,3.109328233619237
RCC10RGB,2729026,3.187414345119047,2.894683003503679
SU-DHL-1,25105715,2.6102250612439857,3.187457758184989
SaOS-2,2708,4.307882235107384,4.914103966642426
SW48,11485656,-1.6768123952056315,2.2889105280772473
LS411N,5738263,3.6843208102291127,2.6885358086452515
LCLC-97TM1,89928392,0.9843618500255806,1.28225273891358
IGROV-1,5328940,0.347812751869877,1.864613497105911
BFTC-909,carboplatin-UNC0638 (2-1 mol-mol),3.28125381181505,3.344712948709199
MOLP-8,6184667,3.7618917164892296,2.3140135846423235
HEL,9907093,4.271492923268933,3.175027088983347
SU-DHL-1,409805,5.150132871505728,4.570831885672021
IGROV-1,5287620,-1.5394168430569777,-1.9693459199999703
HCC15,6184667,2.403880665872793,3.0972860695700826
ML-1 [Human thyroid carcinoma],119607,6.010030667993389,5.347715485948357
BFTC-909,11152667,-0.3524603871752078,-0.33318992807686354
BICR 22,10427712,4.255154443676342,4.3259380751265
RCC10RGB,73707398,3.9170227295506304,1.5577161849981616
SK-HEP-1,4788,5.857315027837397,5.762184015243273
SaOS-2,11167602,3.026359974607451,2.616551292932288
IGROV-1,3825829,4.144093606877803,3.9094427401008205
Daudi,53232,2.2893399383043116,2.5530560998847367
HARA [Human squamous cell lung carcinoma],2828334,6.6956020196427115,6.176844839024754
LS180,5470400,-3.6342626980574657,-0.9715591083033087
NCI-H1568,322968,3.6220797151302673,3.9003966317239582
SU-DHL-1,25150857,1.7165355924738273,2.1089748848277234
NCI-H2452,9926054,2.7849990975548726,1.9846908775728656
RKO,5280436,4.655813696583822,2.9086509761374835
Panc 02.03,25126798,4.246913180768056,3.92766640440604
BICR 22,5460769,-1.4539525700949456,2.1579815715292265
RERF-LC-MS,4521392,4.229663793191115,4.329563719132489
COR-L95,65628,4.016533332946612,3.8035216663253455
ML-1 [Human thyroid carcinoma],72199292,2.652505906746634,0.3765161899360364
BFTC-909,11507802,1.7199271215311116,1.7380908576124328
HCC15,16115403,-5.315255617661217,-3.798574665311826
Panc 02.03,24797083,1.7288458125332262,1.5513183208102768
Granta-519,16065773,1.8580334509866892,2.0717567473213987
MOLP-8,67291369,0.6739245689833524,0.7618419624634278
LCLC-97TM1,71304818,2.70820846116735,2.198297340800963
COR-L105,10113978,3.5062120769458907,3.5310556649947595
IA-LM,selumetinib-GDC-0941 (4-1 mol-mol),3.6293192218894017,1.6018596381446886
ALL-SIL,5460769,0.8731159867521163,1.3996862872901479
MOLM-13,89928392,-0.0278317389216686,0.07961634701818944
ALL-SIL,selumetinib-PLX-4032 (8-1 mol-mol),4.528203505983491,3.042079649453567
SaOS-2,6852167,2.181246544986129,2.955699998949936
SK-CO-1,135999136,4.853872243910513,3.9995207043092664
LCLC-97TM1,5329102,1.5800226001590805,2.0923572288273515
RCC10RGB,3825829,4.92777419243283,4.239314121400588
WM115,16722836,2.5522609953991577,1.8042131933158445
KU-19-19,6610355,5.477302473020379,4.6358461887195395
HCC15,5311281,-0.1593612251340344,2.2397859421739588
WM115,11656518,-0.7680829336702796,1.5137688893120957
IGROV-1,675434,4.336225379212549,4.3409686543546036
BICR 31,322968,4.229982613329669,4.036967228483532
LCLC-97TM1,serdemetan-SCH-529074 (1-1 mol-mol),1.7773916595129422,1.8945037947792134
MOLM-13,409805,3.504188648592109,3.6460477241781324
NCI-H2452,68056272,5.088176766324353,3.640880139621193
HuP-T3,JQ-1-vorinostat (2-1 mol-mol),0.3185506624165122,1.13604182806564
RERF-LC-MS,25102847,0.6953191965745218,2.469115699057717
SU-DHL-1,5278396,2.36959409949266,3.3441288012068524
HCC1500,9935249,2.2800833668468266,2.5625003931661916
HEL,46907787,-1.2802643066913908,-0.16768474927764754
Daudi,64971,1.9256728094608813,1.980400385458782
KU-19-19,168313047,3.3084179069540696,2.44851757799197
HCC1500,9903786,4.21203406645071,2.861106241722482
BFTC-909,3689413,0.9841636034152118,-0.3881137435872016
MDST8,9911830,3.786562744766562,2.473987677234863
WM115,262093,2.5199436905866905,2.9870874802118768
IGROV-1,5311281,3.3250623444804206,2.095666863197373
ALL-SIL,4261,-0.4593745111072439,0.18581896576662527
ML-1 [Human thyroid carcinoma],25183872,1.7816002858265556,-0.45924613811900855
NCI-H1568,25105715,3.512540774448481,3.529843432705207
COR-L95,12001922,1.5177554079359803,1.7622572383673392
Granta-519,25154868,5.041568583050757,3.8469513520637757
MOLP-8,navitoclax-piperlongumine (1-1 mol-mol),0.7236562214911971,0.8182286867309364
SK-HEP-1,3503,1.99172511033101,2.40874164082061
BICR 22,2749,1.4483580801045477,2.3419375007040824
SU-DHL-1,10231331,2.149159497852676,1.1459615046903566
SU-DHL-1,132496,3.861580575323874,3.5831867309556498
NCI-H1568,11955716,5.84501437277453,-1.4634114719097386
COR-L105,11647372,1.8386560750541856,1.308823504246154
PaTu 8988t,702558,5.248840045640507,5.188981457631644
RKO,219104,3.7756995047121658,2.4885725201536992
RERF-LC-MS,119607,4.38818595494476,5.382585707524498
SK-OV-3,969516,2.624811361400939,2.9917301390703757
SU-DHL-1,67156097,-2.1897423830418155,-0.2874780617083127
HARA [Human squamous cell lung carcinoma],25262965,-0.7160848382234604,-0.7939644820648742
MDST8,10296883,3.644541291105843,3.7795376261553453
BICR 31,135411,1.1842135795155395,0.9374223214804147
NCI-H1568,17755052,1.5920713080731803,1.8525174663472048
K-562,selumetinib-JQ-1 (4-1 mol-mol),0.1487830644360653,-0.07417214066764738
Granta-519,3062316,1.222650334372554,-0.04014860288226862
MOLM-13,11609586,0.2693262849825738,1.3046794045406773
MDST8,65628,4.39024768664476,4.481961840614612
LS411N,11222830,1.85641131377126,1.102253038884034
P31/FUJ,5278396,3.2564464707559786,2.893565519851525
NCI-H2452,selumetinib-piperlongumine (8-1 mol-mol),3.871574708601934,3.504773415039269
HCC1500,11228183,-3.1075364778620544,2.3154315486122043
Panc 02.03,3503,2.8594786206641514,2.490937259521763
MOLM-13,12001922,1.648284949914827,1.4995130460869055
Daudi,decitabine-navitoclax (2-1 mol-mol),0.1880854613737136,-0.7285105532381008
HEL,tanespimycin-bortezomib (250-1 mol-mol),0.901321339562179,-0.5354354350892873
KU-19-19,selumetinib-UNC0638 (4-1 mol-mol),2.3716952230277313,3.0777115142030165
RCC10RGB,135875424,5.859031260595621,4.2348153090866525
LS180,44491742,4.531352051294965,4.0377234959176835
Daudi,salermide-PLX-4032 (12-1 mol-mol),4.83725960729828,4.739961549125579
SW948,5460769,-0.6640669541383749,2.4946817347039763
BFTC-909,9866186,1.150003196853964,0.7396424812093264
KU-19-19,docetaxel-tanespimycin (2-1 mol-mol),1.4200175787881737,-2.8892134979549913
Daudi,322968,1.8489038189519929,1.8421534145544074
LS180,135999136,4.321194581518088,3.7989319983102465
MOLP-8,4259181,0.2540996075245788,-0.3713544648143696
SaOS-2,UNC0638-navitoclax (1-1 mol-mol),2.2506963685809676,1.5701049113476173
BICR 31,17755052,0.616652074058669,1.8520508526049546
Daudi,10427712,3.475831712716563,3.7052618794183276
ALL-SIL,6252,-2.462384672511242,-1.87072641526151
IGROV-1,57330099,4.391385744785918,4.1882070822513615
ML-1 [Human thyroid carcinoma],5311,0.3887425314777955,1.7060868667805118
LS411N,5746,2.615146419652584,0.9783259542061097
WM115,11625818,2.666283825244439,4.708952501546358
SK-CO-1,17755052,1.6143754050867285,1.7749321672307412
BFTC-909,4788,5.986704833543041,5.655164824503841
BFTC-909,613000,3.1980696015333137,2.7443059120316
RCC10RGB,9933475,1.608288384582936,2.0179262523550547
COR-L95,11964036,1.1862097811542611,1.0777550295744118
IGROV-1,12003241,-2.0122972114546904,-1.278720281219491
ML-1 [Human thyroid carcinoma],67156097,-0.9782117982072136,-0.5038547802989157
SK-CO-1,navitoclax-PLX-4032 (1-1 mol-mol),0.9904814430420492,1.4438405551665474
LS411N,676352,3.0047981548436873,1.970914653103424
NCI-H1568,6918638,-0.3782949656582497,0.6624652988645242
HCC15,654092,-0.5163256778254894,0.017566941036815727
MOLM-13,72193870,3.075841334601934,1.353331756936425
ML-1 [Human thyroid carcinoma],24180125,2.9342502769836263,3.0038713908830346
SK-HEP-1,1716436,3.791424957504218,3.1421267131512747
IGROV-1,637858,1.814476597989254,2.027751659731456
IA-LM,44137675,5.685431340913792,3.17702753457221
RKO,49793307,-1.4433237106321422,-3.8308492517995467
Panc 02.03,1750826,-0.0877771412327358,-1.010103456644259
P31/FUJ,216239,3.114152508734425,1.7620429262478388
BICR 22,9911463,4.403388511465592,3.884246061694418
LS180,3503,2.1233569957286673,2.215527683000195
NCI-H1568,135440466,1.9451121966001212,2.377422579669536
LS180,6917907,-5.898955627831861,-5.352034458808565
NCI-H2452,3503,2.8949427881039367,2.3275957429257854
LCLC-97TM1,9952709,3.284131025623194,2.917802263989799
MOLM-13,168313047,1.872191765635252,1.8934775278953586
RKN,65064,4.855719732775604,4.983605263801767
SK-CO-1,1716436,3.109025551437123,2.919135776154448
Panc 02.03,322968,4.613737356937267,4.014102420281068
SU-DHL-1,16115403,-5.307217729681928,-4.277171707367881
Daudi,5738263,2.220866513982768,2.518707584088702
SW48,10074640,2.891302128524984,3.080213201668086
SW48,3552672,5.820012420560967,2.821234867780404
Daudi,568763,-0.9358982895655849,-0.04208864604537764
HCC1500,11234052,4.300499145525321,3.9409822216079142
WM115,16741245,4.109793610684897,3.9765004408246636
SK-CO-1,6917907,-6.103253673111458,-4.816088896034941
SW48,100016,6.031440310304127,6.020349040153948
SW948,12003241,-1.7903806895013192,-0.4775669758761222
SK-HEP-1,9840324,5.848573782723059,5.736274855690457
ALL-SIL,5328940,-0.9694628184696558,0.9587682162598083
BICR 22,2858523,3.373464702278958,2.9404528522849507
NCI-H2452,17755052,2.4746667711045514,2.0833518857173225
HEL,tanespimycin-gemcitabine (1-1 mol-mol),-4.465092392275179,-2.3138046491911184
P31/FUJ,654092,-2.277731190350674,-0.6473721988754013
HCC15,selumetinib-BRD-A02303741 (4-1 mol-mol),4.266961603535723,3.751414340270519
BICR 22,16736978,1.4452527998079976,1.5634811046741945
HARA [Human squamous cell lung carcinoma],107985,-4.031127583701494,-3.244223343539697
RKN,SNX-2112-bortezomib (250-1 mol-mol),-0.3229299326159797,-1.7828169708133217
ALL-SIL,9843750,4.4328493438561845,3.061590424985008
IGROV-1,168313047,1.93821625738322,2.425602405693409
Panc 02.03,selumetinib-navitoclax (8-1 mol-mol),2.257139592520967,1.9812408812221118
RCC10RGB,24797083,3.688734393817597,1.6989677523086228
IGROV-1,67291369,1.8066430555976296,2.8058755450207546
SK-HEP-1,135875424,4.97106166770821,3.909884308851593
SK-OV-3,676352,2.4999853996447423,2.2947725706023325
IGROV-1,3689413,-0.3633634632064185,0.02181348394200458
MOLM-13,2126,3.944929409626795,3.5874985064618987
SW1271,25150857,2.216244024484901,2.486315389914339
P31/FUJ,piperlongumine-MST-312 (1-1 mol-mol),1.5235846843184453,1.0926536027181648
Granta-519,3689413,-2.6080640580656977,-1.3728053023572264
UACC-812,11955716,-3.4049141440551765,-1.5142689012461228
WM115,6918638,1.2765614986990457,0.5658810685947457
MOLM-13,119182,-3.013346002661584,-2.6932190200866986
HuP-T3,25150857,2.779922499061356,2.5963641025734603
RKN,400769,-0.3685197718994141,-0.6979584598580201
RCC10RGB,navitoclax-birinapant (1-1 mol-mol),2.5525116990099015,1.5981833349797245
COR-L95,9927531,5.207677506691081,4.33910634697305
RKO,439501,-1.8401322759847645,-2.3490879535653617
COR-L105,135875424,4.584511127602178,4.191735534861903
MDST8,67156097,-2.036194319435593,0.23574408072902572
SK-CO-1,11640390,3.1287755311468715,3.115982361779098
NCI-H2452,9915743,1.4140850498548845,1.4071184518927762
COR-L95,54626689,4.626807564914302,4.381063449859553
NCI-H1568,sirolimus-bortezomib (250-1 mol-mol),0.676282688891887,0.9218895169397874
SW48,15983966,-4.810478602921179,-1.592439804670759
RERF-LC-MS,53495165,1.4938275665549956,0.3836738813524606
SW1573,10026128,4.237670104162456,3.6933397025746926
BICR 22,5328940,1.2238467278980267,1.6768547006976156
IGROV-1,25150857,3.031865110078871,2.5292670606946244
SW48,54649381,3.6753624817280706,3.7488116372948763
RKN,11485656,2.343665915939472,2.362625485166241
IGROV-1,216239,2.21703825410177,2.2046778875390554
ALL-SIL,selumetinib-JQ-1 (4-1 mol-mol),0.7996490760807272,-0.18325958333249853
SaOS-2,675434,4.709862103920263,4.526956745507238
WM115,439501,-0.2667789802830004,-2.033716728613598
RKO,11152667,-2.010180339323448,-1.0754733195205588
BICR 22,702558,5.841545864846151,5.215365188882328
SW948,navitoclax-piperlongumine (1-1 mol-mol),1.2480624926894286,0.9958268131392977
IGROV-1,52912189,2.3966568144845666,2.481803248692849
SU-DHL-1,219104,2.7039031158758395,3.036067330617736
SW1271,19582717,5.373754052547774,4.090751656740505
IGROV-1,119182,0.2112476135388779,-0.7593349575503742
SW1573,25150857,3.3863948467965717,2.486043604483319
LCLC-97TM1,1566236,1.804143498427706,2.2090323194505386
SW48,6252,-1.782590172996294,1.1987430662968237
MOLP-8,168313200,3.062868142984741,2.697131923198217
SU-DHL-6,969516,2.321858620209541,1.950493176320943
K-562,44632017,0.5936262556123562,1.0903381456030752
BFTC-909,56973724,3.22598802973391,3.342242326570694
NCI-H1568,24180125,3.319632294157453,3.098865727139634
HCC15,JQ-1-vorinostat (2-1 mol-mol),0.768732947542672,1.1491313787424295
RKO,15547703,3.988071110220001,2.9368151716524324
COR-L105,446155,1.2274898824574871,2.741551769124427
WM115,25062766,1.993857010637035,2.0373331201837526
HCC15,42642645,-0.8684016042996798,0.8819331060450801
IGROV-1,3136844,5.214591389089975,4.378216795386687
COR-L95,16659841,4.2643844802603725,3.379305770869923
NCI-H1568,107985,-3.6136890416333665,-3.275502262341647
HEL,9967941,3.646907071964301,3.106057124662743
NCI-H1568,5311,0.289477139532769,1.6530816919991387
HCC1500,24964624,2.92457410282952,2.3915319991412542
LCLC-97TM1,44185566,1.2712415312804253,2.1719507716368205
HARA [Human squamous cell lung carcinoma],4259181,-0.0825087225465529,0.09551706602865345
RKO,135421197,1.472175761257966,1.336623028572176
BICR 22,UNC0638-navitoclax (1-1 mol-mol),4.356226198213725,1.463212543979206
WM115,vorinostat-carboplatin (1-1 mol-mol),3.7982137973374104,3.1254003643883705
K-562,docetaxel-tanespimycin (2-1 mol-mol),-6.155798984221324,-4.150254335965571
P31/FUJ,119607,5.165578068786105,4.51772328569061
SW1271,44507138,3.04083255973368,2.5442957711176466
MOLP-8,72734382,2.92105223846654,3.5044209920944907
COR-L95,selumetinib-tretinoin (2-1 mol-mol),5.25273224867287,3.660411973437704
RKN,12001922,2.582060834791438,1.982144234194141
MOLM-13,3025986,-2.268401268397509,-1.608497836717855
ML-1 [Human thyroid carcinoma],54613361,1.1529799235720395,0.09314809742048517
HARA [Human squamous cell lung carcinoma],65064,5.174523602274789,5.078962098824266
BICR 22,387447,-3.632542993789297,-4.0948627582954655
SU-DHL-1,navitoclax-pluripotin (1-1 mol-mol),0.447892144567538,-1.2973211072952564
BFTC-909,selumetinib-vorinostat (8-1 mol-mol),1.99531584260594,2.63176153082542
MDST8,44819697,0.5968481057166135,-0.37477105288890983
COR-L95,54613361,1.8571878459944453,-0.20706790231106387
PaTu 8988t,25183872,-1.065851307698322,-0.734652312611125
HCC1500,969516,2.5012208253247374,2.876375636880111
LS411N,51039095,3.380080993968732,2.706675302192329
IA-LM,10385095,1.8174613436578264,1.1157234081144167
Daudi,JQ-1-vorinostat (2-1 mol-mol),-1.994208072819334,-0.6642776083183977
MOLP-8,44589607,1.928632926439859,1.7229761874049416
UACC-812,JQ-1-UNC0638 (2-1 mol-mol),0.7883661966359787,1.4662348446196023
SK-HEP-1,5311,2.3418360503567386,1.7277838243334243
NCI-H2452,24889392,3.037712354939189,4.350499739940401
SU-DHL-1,4378219,1.8683369375684944,2.228620943641004
NCI-H2452,2858523,2.6943426896823284,3.1229285377243157
ML-1 [Human thyroid carcinoma],decitabine-carboplatin (1-1 mol-mol),4.481069697343496,4.628765984602567
IA-LM,119607,5.918153428689206,4.708374079497124
ML-1 [Human thyroid carcinoma],11214940,1.6315509593699482,2.3259581365780333
COR-L105,46224516,3.053099263199949,3.0284936985335116
SW948,3062316,3.151526592835161,1.3670699297108306
BICR 22,6610216,4.672862717569176,4.15581265897731
SW948,16736978,1.371465793072688,1.4758623477490973
IGROV-1,2828334,6.070696247039626,6.122412260371473
RCC10RGB,44185566,3.1564704709707856,2.6716032421839837
Granta-519,135999136,4.28714374371566,2.575147267934974
BFTC-909,654092,0.6323398211983356,-0.02860803797462429
SW48,selumetinib-PLX-4032 (8-1 mol-mol),-2.238777477327049,3.120722645713688
P31/FUJ,17755052,1.7010190253681206,0.7003482814876414
SU-DHL-1,2945648,2.120687124348465,2.726093668136577
LCLC-97TM1,16720766,-2.0806199642234704,0.6500306128391335
HCC15,3025944,3.8616867083103648,4.212770783159102
LCLC-97TM1,53392493,1.9813066602409652,2.3580864445486736
WM115,selumetinib-piperlongumine (8-1 mol-mol),-2.154986024806584,2.708801320261009
COR-L95,675434,4.0325297307826125,4.380499296672038
SaOS-2,11213558,1.0641156085827448,1.5850396019015027
Daudi,JQ-1-carboplatin (1-1 mol-mol),-0.7509851402821236,-0.30353151243242893
KU-19-19,1716436,3.531012736022478,2.983371828903896
SU-DHL-1,11485656,1.6397040363022437,1.9579800434217787
SK-CO-1,16736978,2.1510378918389415,1.5682176912755292
SW1573,selumetinib-JQ-1 (4-1 mol-mol),1.6562897469951037,1.7954124916394678
HCC1500,136227924,2.675203690625814,2.785264200776428
LCLC-97TM1,sirolimus-bortezomib (250-1 mol-mol),0.527232919113557,0.7738244031419786
RKN,BRD-A02303741-carboplatin (1-1 mol-mol),5.528038962892509,4.2178534831880325
PaTu 8902,selumetinib-PLX-4032 (8-1 mol-mol),5.82901614817581,3.3081877899005927
Daudi,219104,1.6178665476553538,2.334873026325572
WM115,5284373,2.6004259651165644,2.846144040200578
SU-DHL-6,216345,3.116690602340157,2.939428691270225
HuP-T3,5460769,4.291069487745317,2.5485191552335236
HARA [Human squamous cell lung carcinoma],54619238,4.4726064543510144,4.742969706795967
Daudi,8515,3.193004700442435,3.34623726111731
HCC15,3815108,3.1337581441750277,2.98763304947325
IGROV-1,5280436,3.2616766817665086,3.4717384785243475
COR-L95,107970,2.0048060228155333,2.199206126825918
BICR 31,25150857,2.3687059872087217,2.4832629502145993
IA-LM,6918837,-2.975709639111599,-3.2957067309378623
WM115,3025986,-1.3268545497049868,-0.8055762607107735
WM115,BRD-A02303741-navitoclax (2-1 mol-mol),3.3998938295257632,2.3945167300005368
SW48,17759555,2.861947497664063,3.4078481613805227
SK-CO-1,selumetinib-vorinostat (8-1 mol-mol),-0.8201042282991368,2.1370870008967584
SW1271,9956119,4.3828310926576375,3.6978508516458395
ML-1 [Human thyroid carcinoma],piperlongumine-MST-312 (1-1 mol-mol),2.022291985496103,2.1555430541398244
MDST8,24772860,-2.900176299695688,-1.2978438004417463
SaOS-2,4259181,-0.1317601722396107,0.17566316643923252
PaTu 8988t,5746,3.0775825889142543,1.3410143106517762
SaOS-2,4521392,4.5837419847316845,4.302594268093087
SaOS-2,445455,5.662681927298568,4.698259483962634
IGROV-1,148198,-2.659972993252853,-3.430739470097038
SK-CO-1,11404337,-0.5084033800481932,-0.2894141110249099
Granta-519,4578,4.680400709321271,3.8271414301954336
RKO,4261,2.924548439505643,1.3062602082194916
MOLP-8,54618164,3.908946135671936,3.6826542325870286
HCC15,24978538,-1.0517559532383662,1.580446679062469
COR-L105,2945648,3.0602962908492386,2.902792737845852
RCC10RGB,salermide-PLX-4032 (12-1 mol-mol),5.5053951487435775,4.949881373760774
NCI-H2452,4705,3.641149380662554,3.3943586896576265
SK-CO-1,54143018,-0.6826828748975821,0.5314103495605628
MDST8,26596,-1.25574590011264,-0.8041575011785214
NCI-H2452,54454,2.511734775409603,2.748089172960383
HARA [Human squamous cell lung carcinoma],selumetinib-GDC-0941 (4-1 mol-mol),2.088944743887487,1.434423174999997
RERF-LC-MS,16038120,1.5599846769821624,1.3182667085455682
SK-OV-3,44185566,3.1295797630764266,2.675126944044664
BICR 31,148124,2.7085675831815292,-1.8448978099655466
P31/FUJ,439501,-2.3575947617146475,-2.57131915718983
BICR 22,11152667,-1.8276171650012312,-0.40804604975170305
COR-L95,56973724,4.268430703602559,2.9900606335724116
RERF-LC-MS,54626689,4.221264321270605,4.490480234058962
IGROV-1,1641662,3.5854177848263675,3.663318950700323
MOLM-13,613753,2.871004682812888,2.739184898719161
IGROV-1,11404337,-0.7659238947812715,-0.16410051103982934
SW48,219104,2.280685064057957,3.7742594439737007
Panc 02.03,crizotinib-PLX-4032 (2-1 mol-mol),2.31663341207245,2.0028110839092883
Granta-519,9935249,0.0212855082517002,0.9126590561292092
MOLM-13,2749,0.3899767988765278,0.9800212311397231
WM115,1750826,-0.9273267035114736,-1.0473570059997863
SK-OV-3,2858523,3.2787147644650716,3.009575925108824
COR-L95,selumetinib-GDC-0941 (4-1 mol-mol),2.521789990361809,1.320258267222229
ML-1 [Human thyroid carcinoma],969516,2.8184901812435923,2.9353047932168868
SW948,25183872,-1.604238480901096,-0.7548311085983079
HARA [Human squamous cell lung carcinoma],decitabine-navitoclax (2-1 mol-mol),1.7884131125603568,2.2329939067519247
IGROV-1,6914657,-4.141311308759326,-4.300150081920091
SW1573,salermide-PLX-4032 (12-1 mol-mol),4.9189296859442315,4.679254174257784
HCC15,6610216,4.23435184261858,4.315873812839994
NCI-H1568,10074640,3.1711026687004855,3.2069913832766526
SW48,4917,2.351047632498956,2.9762682043652533
MOLP-8,46215462,1.266580776259001,1.2803467827399693
WM115,erlotinib-PLX-4032 (2-1 mol-mol),0.1999561238865428,2.758231037161701
COR-L105,387447,-4.5302496546864885,-3.9673695606596193
MOLP-8,44462760,3.111101001788515,2.75321587703952
BICR 31,44819697,0.4590360698509347,-0.2091519148521892
HuP-T3,9956119,4.370077084995815,3.796440433440874
PaTu 8988t,sirolimus-bortezomib (250-1 mol-mol),0.5843474412149585,1.0367168495622983
KU-19-19,66577038,3.864819378735941,3.0855398683722863
BICR 22,5746,-1.0393569299451335,1.1328180499581832
HARA [Human squamous cell lung carcinoma],6438330,2.871193568039211,2.2231201506059453
SW48,67156097,-2.150931452918296,-0.7134403124933105
SaOS-2,25150857,2.491525195617086,2.3879229064329452
NCI-H1568,613753,3.056586098825006,3.1277367851925537
LS180,44137675,2.850653785387247,3.431472761736868
RKN,11364421,-3.590581417405073,-1.2664224397983521
HuP-T3,23582824,1.5911146583975455,0.8498743631351333
SW48,446155,2.2181780639059907,2.616635263622525
SU-DHL-1,44202524,0.8334918459072751,1.7043661467947617
RERF-LC-MS,11404337,1.609147033115388,-0.16336358591589645
K-562,44486219,4.057183894108205,3.9689101646592295
PaTu 8902,serdemetan-SCH-529074 (1-1 mol-mol),2.396607903766339,2.0706375413076734
PaTu 8988t,46199207,3.796589685342678,3.2387821059301136
LS180,11964036,0.9251272605785624,1.2815070542602713
SW948,8515,3.759025323790885,3.504134306970869
SaOS-2,374536,3.743747938767685,2.413052865674895
SW948,135875424,4.663257041681152,3.2628614594050647
SK-HEP-1,72376,-0.6035227354554765,-1.4390518354660207
SK-CO-1,1242560,3.64748499205759,3.4929269592747865
SW48,selumetinib-vorinostat (8-1 mol-mol),-2.7312432821532724,2.1620682664367585
MOLP-8,3025986,-4.599162344151263,-1.459835879718773
SW48,25150857,2.2099211562472125,2.343001231019076
ML-1 [Human thyroid carcinoma],10127622,2.646237824428173,3.687935368541895
LCLC-97TM1,3465537,1.1142431298706064,2.3655357314147243
NCI-H1568,9887053,3.9549233487650666,4.3313448378792865
SW48,5746,-2.6538895977275745,1.121657923489938
LS180,44484440,3.4848015178596343,2.94231729940145
Daudi,25183872,-3.2629659020313393,-1.9127959179396263
IGROV-1,984333,0.6618578113050116,0.764374671670743
COR-L95,135999136,4.28146486500778,3.167349205744601
RERF-LC-MS,4788,5.0822281264538365,5.785970412568121
HuP-T3,2828334,6.159425491986346,6.116656724072806
RKN,3854666,2.132003481112045,2.2076938117440905
HARA [Human squamous cell lung carcinoma],676352,2.7556636695973515,2.101063982739611
PaTu 8902,54639665,4.483683562011812,2.989020806894448
ALL-SIL,24180125,1.6553840753953686,2.0123597789488157
SK-CO-1,12003241,-0.9578793579943758,-0.9947836475496896
BFTC-909,104842,-1.584917163766509,-2.3802492388015635
HARA [Human squamous cell lung carcinoma],60750,0.0702005032300629,-1.7274908050108104
MOLP-8,24772860,-3.493237790177901,-2.768335237115746
SK-OV-3,49836020,-5.2191550029019025,2.7306798385862816
K-562,46199207,1.8646546122938352,2.894674336373553
SaOS-2,BRD9876-MK-1775 (4-1 mol-mol),1.220945840769529,0.667719447828329
MOLM-13,6450551,0.4092106163446157,0.9393301732264662
BICR 31,1566236,4.637821170940002,2.6329202778980663
SW1271,54454,2.1914366041236204,2.442775166121073
HCC1500,selumetinib-PLX-4032 (8-1 mol-mol),4.771751115117369,3.4586597850731793
SaOS-2,9952709,3.1448975558697545,3.1122706768033055
HuP-T3,54618771,0.8132197250487964,1.261064599699153
IGROV-1,6918736,-0.950858733923241,-1.377845060197082
ML-1 [Human thyroid carcinoma],654092,0.5372247724983673,-0.15464308356273793
Granta-519,53392493,1.7904738197895116,1.4953081440270548
NCI-H2452,445643,4.078319116283011,4.00244346314235
HuP-T3,5281321,0.1098786391841839,-0.8136753142527917
NCI-H2452,654092,0.1220899319284023,-0.028620628578217032
ML-1 [Human thyroid carcinoma],135423438,1.332992654992983,2.634221671209568
MOLM-13,56973724,0.5307136138302019,1.3676099840431066
BICR 31,439501,-2.4499261286992007,-1.6876939528661563
MOLP-8,44495899,4.403173191891281,2.1167609945869974
Daudi,44632017,0.5148090574579154,0.9336001237208841
SaOS-2,selumetinib-JQ-1 (4-1 mol-mol),2.075892545487755,1.8984978555072372
SU-DHL-1,10077130,2.6641926349973875,2.508780302027363
SaOS-2,9549297,2.000544043325996,2.5336207400446646
LCLC-97TM1,24785538,-0.7280489014481334,0.8690130670983275
HuP-T3,10302451,3.3244038223924868,2.880599702426281
Panc 02.03,73707398,1.687012904299387,1.4174112528404041
SW948,25161177,4.032512886861284,3.449464502875226
COR-L105,17755052,1.2153053156846572,2.156983428326191
HCC1500,11719255,2.4435237001116685,3.572607939315317
RERF-LC-MS,5287620,-3.2415128958876123,-1.720905178299002
WM115,72193861,3.0084505907765795,1.9923383423257517
K-562,2113511,5.3605896450220785,4.979282265388122
RERF-LC-MS,24772860,-2.3078196081029136,-1.9720981275677516
SK-CO-1,navitoclax-gemcitabine (1-1 mol-mol),-3.3609230620799595,-0.2435704357726656
HCC15,piperlongumine-MST-312 (1-1 mol-mol),2.732022929511258,1.8342696664170361
MOLP-8,15547703,2.3372930335131663,2.627683515899206
LS180,4378219,2.066313424484697,2.254225450108211
SW1271,168313047,1.8206519834924395,2.239784726614879
RKO,123631,2.6120370559458155,2.130126626773532
NCI-H2452,3011155,5.255477653901917,4.315278786007266
Daudi,16722836,0.8830828668869325,0.8179883005964531
PaTu 8988t,6505803,-0.6279165545759258,-0.48536685083577263
SW1573,5280436,3.0542460563059253,3.7021261470416547
MOLM-13,262093,0.9014616367149992,1.7177903157498267
IGROV-1,BRD-K55473186,4.387806234483854,3.958810810442612
SU-DHL-1,selumetinib-MK-2206 (8-1 mol-mol),2.1944562589821226,1.8800591036159784
SW948,5287969,-2.4513180825948515,-1.7951006234831763
P31/FUJ,54619267,3.5260071244925575,3.5559092938979755
IGROV-1,navitoclax-sorafenib (1-1 mol-mol),2.116164500809202,1.7349156816775826
SW1271,11396600,3.626770708484224,3.6680112822086146
IA-LM,676352,2.5463710414635696,2.1077505724680687
SW48,148198,-2.7635683141359277,-3.3546372892343244
K-562,6918328,-1.3297822316036851,-0.8635111717195262
HARA [Human squamous cell lung carcinoma],25105715,3.4880191589222966,3.489434499253523
Daudi,135423438,1.6157885595086947,1.2116628399171452
Daudi,6438330,0.2626238759101729,1.0379094709610235
Daudi,44543605,5.193449926403497,3.6466716637774432
SaOS-2,71751553,4.337892909522829,4.634038727326496
MOLP-8,23939,4.352572888875192,3.2437758346680603
SW48,2858523,2.8468158768410965,2.989157096922363
SK-HEP-1,selumetinib-piperlongumine (8-1 mol-mol),4.719630045140052,3.353131895090091
COR-L105,9911463,4.222864246171191,4.00495167501813
SW1271,11167602,2.369450835450289,2.513825824984643
SW48,135928012,3.696922095661256,4.084686962581634
Granta-519,53232,4.0944047749373915,2.4930512521771955
COR-L95,2871966,-0.8178907803151099,-0.00616839519676603
MOLM-13,17759555,3.648246486561575,3.1155849251254426
COR-L95,tretinoin-navitoclax (4-1 mol-mol),0.626714074175952,0.9960685594205572
SK-OV-3,44589607,4.1377534493712265,2.99834430543702
RERF-LC-MS,44543605,4.169252612552019,4.241338852829968
Granta-519,49836020,3.8229564713378057,2.8091490131963535
SW948,5278396,3.777624651516773,3.1898187755735075
HCC15,400769,-0.8695567043490428,-0.40161009908809164
ALL-SIL,3038522,2.34327176020718,2.425463663302896
SW948,135440466,1.4177296224023617,2.1861756077420336
PaTu 8902,400769,0.6580342998730634,-0.6227934092481943
IGROV-1,5746,1.9055212643377857,1.038827917962998
COR-L95,25195348,4.044301101066811,2.9571727488790946
BICR 22,24180125,3.296229177015365,2.993261069297323
SW1271,carboplatin-UNC0638 (2-1 mol-mol),2.98870654666586,3.562479630174238
RKO,73707398,0.9128481241529548,0.6138566971974648
BICR 22,selumetinib-vorinostat (8-1 mol-mol),2.1163342168700936,2.1875732556874095
HCC1500,decitabine-navitoclax (2-1 mol-mol),-0.2719438923490784,1.2271750474576346
IGROV-1,15953870,2.712793598656007,3.610482035026306
WM115,71466445,4.303064097958205,3.998481518367241
COR-L105,9956119,4.279642090153805,3.955060585374341
BICR 22,168312962,0.5954564951508424,1.6375033396535843
SK-OV-3,navitoclax-piperlongumine (1-1 mol-mol),3.1171344026711147,1.4569560632094787
LCLC-97TM1,46843906,2.6060669508648675,2.5519620146449813
HCC15,9840324,6.2076616503129,5.828924224852975
RKN,24964624,2.2448388370498704,2.453414366343743
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,2.0505748414707954
K-562,10410894,3.650757753763785,2.9696936057246335
SW48,124202324,1.4616392816877528,2.379028511167727
IA-LM,15547703,3.104636726250569,2.7363844519823486
SU-DHL-1,decitabine-navitoclax (2-1 mol-mol),1.6803027957585963,0.32567857086500324
ML-1 [Human thyroid carcinoma],15547703,3.133536230544004,3.230125824367749
MDST8,49850262,3.692937134795778,3.6511227824582293
UACC-812,52947716,-6.767186414102593,-1.2044871426245933
ML-1 [Human thyroid carcinoma],9911830,3.383108057822615,2.5361170813331553
HEL,11427553,2.263048189869726,1.2087797736817933
IGROV-1,5281321,-1.4962463697398798,-1.0168400256543133
IGROV-1,135421197,1.96820638017286,2.0761162754660805
LCLC-97TM1,104842,-3.469971777740615,-2.7733696567284403
RCC10RGB,374536,3.743226525407361,2.742896558817468
COR-L95,107985,-2.989419812710682,-3.585572585476103
RCC10RGB,72199289,4.762339751475906,3.496404218256205
NCI-H1568,11485656,1.8106242285910237,2.4371504282553667
MOLP-8,9549297,1.4376511571672042,1.8915476623212146
Daudi,24951314,0.2263717121921743,0.1609335808565686
BFTC-909,7326481,3.4905195575106527,3.00203468686618
BFTC-909,6623618,2.802037410677928,2.326955817163547
HuP-T3,5287620,-3.5836939395445913,-2.0586890359275456
COR-L95,568763,-0.4949329271490838,0.2755495101908695
SaOS-2,216239,3.028726771334262,2.417113961086682
RKN,navitoclax-piperlongumine (1-1 mol-mol),2.28018118974292,1.8369535359855902
Daudi,5311281,1.0302556341787754,1.7906190187190816
LS411N,3503,3.033347172376105,2.056140306217681
BICR 22,4705,3.4365696424802477,2.8577884324672085
Granta-519,6918638,-1.0102021398050984,-0.7178248759453203
HARA [Human squamous cell lung carcinoma],11175137,1.814800704414418,2.6760489362421604
SW48,54618164,3.7830586534540616,3.7728813944092696
MOLM-13,25105715,3.5182090361281326,3.0857117481502754
Daudi,11175137,1.084300991963852,1.7127339623882962
SW1573,42642645,1.1024283721976142,0.7300172421685521
P31/FUJ,11364421,-5.080526011220062,-4.323249261652398
MOLP-8,12003241,-1.4499361325619826,-1.3200140108105427
Granta-519,10410894,1.4137063553430784,2.624365964274755
RCC10RGB,57519531,5.003664553369681,3.0872991292844945
HEL,11625818,4.404342627749774,3.2650715015852336
SK-HEP-1,1242560,3.752923936287399,3.5879919510911646
SW48,3062316,-0.5038339303633423,1.3461875779367671
HEL,219104,3.0071408108258253,2.410301579843538
SK-CO-1,3025944,4.807689572392986,4.119420643832923
SK-OV-3,52912189,0.2062426244094619,2.515413915223549
COR-L105,51039095,3.4251018662752073,3.0162192202145115
HEL,65064,3.1933308972510113,3.7819638268614244
Daudi,9929138,3.458684768924583,5.061331524530554
SK-OV-3,11404337,1.4011927232423718,-0.2166148989224745
ML-1 [Human thyroid carcinoma],7326481,3.5221044039257037,3.2045301470574103
MDST8,11178236,-3.494725666780331,-3.100661629531635
HCC1500,ISOX-bortezomib (250-1 mol-mol),0.4566996929358766,0.5532444397458193
WM115,119182,-0.4924283039006125,-0.9012492431653341
COR-L95,56649450,4.0191520211736895,2.9097598525757298
HCC15,5278396,3.283293724206623,3.612426532966655
LS180,54143018,-0.5111931850291043,0.5281567252937607
MOLM-13,10427712,3.427914513597021,3.501188313992131
NCI-H2452,1566236,3.5735792412039022,2.3854519585381793
ALL-SIL,452548,-3.3771532504793194,-3.004051726058648
KU-19-19,409805,5.730069773001202,4.921743893223799
SK-CO-1,sirolimus-bortezomib (250-1 mol-mol),-0.6660837723392407,0.802025795179608
HARA [Human squamous cell lung carcinoma],17759555,3.7036804092868847,3.5606373133329416
SW948,11955716,-2.1355637415890323,-1.3297471749906362
RERF-LC-MS,11609586,3.546222239883878,3.030735221214783
IGROV-1,selumetinib-tretinoin (2-1 mol-mol),4.176281087704045,3.2399625664763825
WM115,5311,1.988201906885666,1.449411228246097
HCC1500,5311,1.250436307916732,1.3089423372438396
KU-19-19,5282054,4.451216911386669,3.7409209694195753
PaTu 8902,4788,6.453607861068675,5.626490924654778
PaTu 8902,4261,2.3507697687761224,1.5930474070024818
SW48,68056272,2.992212540747962,3.4837248226522464
HCC1500,56963564,1.3630245510511625,0.4932585622244064
Panc 02.03,25183872,-0.079390979301081,-0.6146459436377889
LS411N,11964036,1.3999141622104765,0.7736019603545912
BFTC-909,135440466,2.535274686795805,2.309435096136337
SW48,selumetinib-UNC0638 (4-1 mol-mol),-2.2763178570350857,2.8176827077268074
ML-1 [Human thyroid carcinoma],54619267,4.278122085164484,4.195122945689118
LS180,25183872,-0.6080839156226316,-0.7833393004044517
PaTu 8902,71304818,2.9919229428361263,2.4793685790118696
BICR 22,216345,4.525930969601246,4.084949967618709
NCI-H1568,374536,1.2941902477204823,2.5996008435445903
LCLC-97TM1,135423438,1.8911988038183152,2.3876217773890445
NCI-H1568,56963564,0.2273202395709376,0.6874964319591207
K-562,9927531,3.3022164605184763,4.267698885669757
SW948,2858523,3.1308292618704905,2.9960261160158606
COR-L95,ISOX-bortezomib (250-1 mol-mol),0.3297770164947888,-0.11705130550540283
SK-OV-3,5287620,-0.5544150043477152,-1.9812001967317823
ML-1 [Human thyroid carcinoma],3676137,5.53606210778591,4.671730494392944
NCI-H1568,5311037,3.1621369524545155,3.745292893499808
WM115,15953870,3.7155207356015207,3.7575760343752256
Daudi,445643,2.8458589584694307,3.4974814107318117
BICR 22,navitoclax-piperlongumine (1-1 mol-mol),2.368049525679639,1.1867182576713582
HARA [Human squamous cell lung carcinoma],49766530,5.57937649881164,-0.4250108010485269
NCI-H2452,156414,1.7996451609117237,1.7278599167566446
Daudi,53301938,4.372641532954565,0.11920526786475572
PaTu 8902,9907093,4.385383441203628,4.324812893437795
SW48,136227924,1.7122170056378203,3.0120845984126112
P31/FUJ,4096211,0.7441609883240002,0.8759164193917692
IGROV-1,6610355,3.969940996770339,4.321252789305607
PaTu 8902,4917,3.0649190232675525,3.12123610323424
IGROV-1,613753,3.483244781428779,3.303667729086631
SU-DHL-1,3136844,3.883215489826005,4.109534827817325
HEL,446155,2.11086977892158,2.3596242158980876
HuP-T3,46907787,1.2763139172323097,2.2858679255829633
ALL-SIL,2729026,2.163276094007301,2.2307955312186167
NCI-H2452,54613361,3.2620625907056744,0.0806164563769158
BICR 22,448949,3.2035793217055124,2.011836119973316
SW948,5280436,1.724516723779293,3.0247974207400445
BICR 31,25154868,5.458998944130281,4.691761117466524
LCLC-97TM1,44632017,0.6758650901814578,1.1939098708949756
PaTu 8988t,docetaxel-tanespimycin (2-1 mol-mol),-5.646992799561264,-2.937254560988238
SK-HEP-1,selumetinib-BRD-A02303741 (4-1 mol-mol),5.819431075997551,3.6293061035193905
HARA [Human squamous cell lung carcinoma],4261,3.400371454492322,1.8020348035977645
HARA [Human squamous cell lung carcinoma],salermide-PLX-4032 (12-1 mol-mol),5.233652502193764,4.781602422661218
ML-1 [Human thyroid carcinoma],9866186,0.3108629746931657,1.1020883153417709
SW948,409805,5.995103866916248,4.033199420551066
P31/FUJ,16736978,2.2012912480094444,0.9016017371381148
SK-CO-1,crizotinib-PLX-4032 (2-1 mol-mol),1.4696043946454187,1.931891672699968
PaTu 8902,19582717,4.67665303596855,4.2081651379309974
SaOS-2,24775005,3.5680490412807555,3.5483197039609906
Granta-519,327653,2.833903719231272,2.3864449652707957
ALL-SIL,446155,2.369103686447931,2.3235585513632437
HCC1500,445643,3.796669497386567,3.78194686058579
COR-L95,7326481,3.0640813007839105,2.899658387658086
Granta-519,selumetinib-navitoclax (8-1 mol-mol),0.4649117531552323,0.21125692356003
LS180,53232,2.536426383073758,2.950884465203811
P31/FUJ,10127622,1.4388313131004449,2.445832809272413
HARA [Human squamous cell lung carcinoma],vorinostat-carboplatin (1-1 mol-mol),4.151404263307493,3.2221249125473936
WM115,alisertib-navitoclax (2-1 mol-mol),1.935725956121268,0.29063045637951324
SaOS-2,11214940,4.2656495802712735,1.943269476816316
RKO,637858,2.400395947377078,1.0957490523529452
NCI-H2452,3552672,4.527548939486843,2.7986348217011336
Daudi,168312962,0.2834059413422853,0.7155156118779052
P31/FUJ,216468,2.1049028903625673,0.8253261677207476
MOLP-8,11656518,1.844531268869525,1.0452079839962054
MOLP-8,5426,4.334733303826167,1.7007356050705442
SW48,54454,2.31662951125423,2.862928735113063
K-562,4521392,4.220123235241678,4.083356420182577
SU-DHL-1,selumetinib-PLX-4032 (8-1 mol-mol),2.801448892460394,3.198503640904061
RKO,1641662,3.3091455873155367,2.931865808985719
BICR 31,135875424,5.0736941678127945,3.885799868618765
SW1573,BRD-K27188169-navitoclax (2-1 mol-mol),1.518643472033959,2.2586039969461438
Daudi,44607530,0.9746569917988196,1.4057903541166048
SK-HEP-1,25150857,3.0587845310763297,2.4133860929571727
COR-L105,tanespimycin-gemcitabine (1-1 mol-mol),0.318019061549867,-0.5753482077404503
Granta-519,23635314,-4.977140911540282,-2.8893070426335243
LCLC-97TM1,24753719,4.6973214087473405,4.08744942579656
P31/FUJ,11640390,3.1324724534083277,2.39508816844447
HCC15,navitoclax-MST-312 (1-1 mol-mol),-0.227842438558318,1.1266710825199069
K-562,6450551,-0.0734681627771844,1.3054133830965864
Daudi,56946209,-7.191237665956405,-5.028113735462726
Panc 02.03,25154868,5.464083731960118,4.503836831063998
P31/FUJ,5311,0.3390662723443479,0.5463127650975954
SaOS-2,11485656,2.155652122560971,2.437565808900925
IGROV-1,3025944,3.9702787396819503,4.264316707727756
COR-L95,docetaxel-tanespimycin (2-1 mol-mol),-3.340788273550256,-3.691236763823197
PaTu 8988t,11494412,2.1257430484232525,1.740321332937193
IGROV-1,53495165,1.3981720287668329,0.4043244085774363
LCLC-97TM1,42642645,0.0997949580151915,0.8282037019490981
HCC1500,36314,3.7134374865247017,-0.6779071141785877
NCI-H2452,3815108,3.5712952235347455,2.9227556775072907
WM115,11214940,3.8761690772861126,1.8535185573304938
SW48,676352,1.4830170410483523,2.0106138004106335
MOLM-13,25262965,-3.0495150612642465,-2.451025888875918
ALL-SIL,tanespimycin-gemcitabine (1-1 mol-mol),-4.457360880270642,-2.5050859205060605
Panc 02.03,148198,-4.053337817942692,-3.3567930460396953
SW1573,71466380,3.629171273590213,4.7901043522353755
SU-DHL-1,151289,-1.0536473601541108,1.213638647129486
SK-OV-3,JQ-1-vorinostat (2-1 mol-mol),1.4863340037373012,1.1537195452901146
COR-L105,285033,-1.0049053408998423,-1.5358047284553076
SU-DHL-1,SNX-2112-bortezomib (250-1 mol-mol),-2.738100295775396,-2.146517966513602
Daudi,135440466,1.490781603812653,1.9274027316392914
NCI-H2452,6918878,3.5446658281374277,3.066084097685341
PaTu 8902,123631,3.453096327622384,2.1627220239511127
COR-L95,15547703,3.222652754514603,3.0684931070528596
NCI-H1568,123631,1.2596294102093508,2.430987234873495
P31/FUJ,216345,2.9363986514954203,2.7521307441472733
HEL,4261,0.4865008011530605,0.7819449963321377
SK-HEP-1,5280436,-0.1709015599208282,3.5581405823750747
SaOS-2,25062766,1.5016836694759386,2.13988773892196
RERF-LC-MS,51037431,2.0455212647735364,3.423961193360758
HCC15,11656518,2.9308462534519024,2.0850636584598554
RKO,10127622,3.209405126939437,3.1057628729168534
COR-L105,9927531,5.197941564874311,5.11816489906213
NCI-H2452,6623618,2.534886377212576,2.369448668440223
SK-HEP-1,16725315,5.326615386804391,4.2768356956559135
SW1271,11152667,-1.5987482479879582,-0.2733299669757393
PaTu 8902,selumetinib-GDC-0941 (4-1 mol-mol),3.4038309056959424,0.8070623645833552
SU-DHL-6,3825829,3.5283611337160155,3.3665118748337846
RCC10RGB,11656518,3.9855029209510215,1.9073607037641813
SaOS-2,67156097,-1.585481519484996,-0.3955711760754756
BFTC-909,5566,2.8568699448622263,3.1275091435487092
SW948,4788,6.033471365822279,5.540127674509249
LCLC-97TM1,1750826,-2.0890062190589544,-1.2987142407723902
MDST8,3689413,-1.6812703512916511,0.05411831843473548
SW48,9926054,0.5681768331785455,1.9379343889010312
MOLP-8,selumetinib-JQ-1 (4-1 mol-mol),-0.4981022967817401,-0.2985622812343033
SU-DHL-1,262093,1.7952973078733698,2.322514828729661
BFTC-909,439501,-2.4866456286351095,-2.008860757255134
HCC15,123631,2.7523193051058974,2.503666848825329
P31/FUJ,60750,-3.4241008025920396,-3.1602843655779522
Daudi,9927531,3.2507934675389447,3.9273586771622586
MOLM-13,5281672,4.456656164404507,3.9945199066035517
IGROV-1,11222830,1.5703285223102077,1.752875663732775
SK-CO-1,5311,2.0479844637297617,1.653435916277643
COR-L105,15953870,3.0827686267342957,3.6539293722036694
PaTu 8988t,9866186,1.4965239773376473,0.8113454381808212
IGROV-1,124202324,2.2563058955522157,2.6103596601172416
PaTu 8988t,9936388,-7.900053622036252,-0.46067419713073476
HCC1500,11152667,3.4439033763408644,0.17248970945796255
MDST8,54618305,4.422279328619345,4.582825858988915
MOLM-13,3825829,3.189823245525434,2.8951429054282674
BICR 22,3081361,1.798482521796042,1.5209325088132823
SW1271,3854666,4.252835819462087,2.2791090099270574
HuP-T3,285033,-3.1273004056463916,-1.6175970481009712
COR-L105,navitoclax-birinapant (1-1 mol-mol),1.1502985438361142,1.7731236921452165
SK-OV-3,6610216,4.5015440272840275,4.228850194184418
ML-1 [Human thyroid carcinoma],56946209,-4.214217670545523,-3.5557635822067715
SU-DHL-1,10090485,4.45721233802345,3.234198223287432
COR-L105,54765302,4.547071050564395,4.365911100961925
SaOS-2,44491742,4.263847553999534,4.323328716677361
RCC10RGB,BRD-K55473186,4.42890698658841,4.112485805314924
SW1271,2742550,3.530952260660614,3.9827515757166965
Daudi,148198,-7.679285276133229,-3.9566133909508614
RKN,104842,-2.3241286690000265,-2.6563248119074996
SK-CO-1,3689413,1.2567954519757167,0.3395961233185571
Panc 02.03,24180719,3.694319415808187,3.4290713613109163
MDST8,637858,1.7716899628344815,2.050194457642028
BICR 22,11404337,-1.5250786338229352,-0.3999993494640926
NCI-H1568,82146,4.486561599154294,3.7510834621028963
LCLC-97TM1,52912189,1.3140510236946998,1.6209865282934333
BFTC-909,6918328,0.6354681535452512,0.048448530996837456
IGROV-1,selumetinib-navitoclax (8-1 mol-mol),2.4437934407587907,2.0505748414707954
SW48,10385095,0.7767009249070084,1.3038977343682856
RKO,56649450,4.8662264096692684,2.7949904232808755
SW948,45279963,3.8052773477912782,2.872926033436095
RCC10RGB,3038522,2.595581097335362,3.357815058262953
BICR 31,3689413,0.760898743899782,0.15358878449392424
RERF-LC-MS,5282054,4.065617468844444,4.010617814619716
K-562,selumetinib-PLX-4032 (8-1 mol-mol),4.219594820991848,3.523242606074328
K-562,25161177,2.405708421255354,3.6790401904696837
ALL-SIL,11497983,-4.396279985993102,-1.243722749059376
SW1271,446155,1.3369653200346725,2.5366377548777774
HARA [Human squamous cell lung carcinoma],568763,1.3363257274557196,0.5769387607561209
Daudi,10296883,2.545577320776033,3.159180951797057
COR-L105,52912189,0.1952406080619365,2.6959463244141966
RERF-LC-MS,36314,3.6884025033565897,-0.7700935517747152
SU-DHL-1,25062766,2.372674975426994,1.9482889257609293
BICR 22,126941,-2.054722221433598,-2.356909598109502
P31/FUJ,46398810,1.6622931867453647,1.7327613368936465
K-562,15953870,3.5143251027161613,2.931664580120609
MOLP-8,89183176,2.6780353354925706,3.14757906856096
MOLM-13,9967941,3.903949930542719,3.0425427394257243
ML-1 [Human thyroid carcinoma],57519531,1.467564757525082,2.7669674519558516
SW1271,5291,3.239071539524422,3.777521832745679
K-562,56963564,-0.0263606087054764,-0.34332309291588126
LCLC-97TM1,54613361,-0.0023609252607709,0.11683485642499784
Granta-519,24771867,-1.6352261980607803,-1.8438234330788228
RERF-LC-MS,5287969,-2.0564845219287555,-1.7633123162025448
SW48,alisertib-navitoclax (2-1 mol-mol),-4.705705243079418,0.3431860685577363
IGROV-1,168312962,3.022863957843741,1.8401221727298573
SaOS-2,6505803,-1.001039194104569,-0.3034337902927321
Panc 02.03,5460769,1.6540560754425335,2.406607268205746
RCC10RGB,vorinostat-navitoclax (4-1 mol-mol),1.2015093799520282,1.005955466116706
ML-1 [Human thyroid carcinoma],11175137,2.0792526924223735,2.788933213985069
Granta-519,crizotinib-PLX-4032 (2-1 mol-mol),0.3086247100875356,1.0738945782506595
HCC15,135440466,1.473766152733558,2.122603644689354
Panc 02.03,448949,3.46549633046868,2.1482443022429467
SW48,119182,-2.1563748503052103,-0.5496314920726967
SK-OV-3,36462,2.5052417836250496,2.2759074636986965
LS411N,46199207,3.2917214979820506,3.1959860383236793
Daudi,71466380,2.956949879575845,3.743241900065156
RCC10RGB,44566777,1.0790521939265936,1.1164494019703581
P31/FUJ,446155,2.867326521256313,2.475768571851335
SW948,navitoclax-PLX-4032 (1-1 mol-mol),3.63435849770784,1.4061639036125197
SW1271,sirolimus-bortezomib (250-1 mol-mol),1.1899864031488736,0.9352177975658514
BICR 31,71576739,4.400142576070014,3.9474941670873176
SW1573,6623618,2.3278245092002936,2.063040960093649
ALL-SIL,969516,2.19071597716798,2.0314854615693476
COR-L105,241158,4.618729119434587,4.072875606887855
Daudi,24797083,-0.0937737057199073,1.045634130712444
HEL,5566,2.9283259495001133,2.834032766038218
BICR 22,44137675,4.05989667865121,3.3544740721455573
Granta-519,3503,1.8528122642218805,2.1528007270013587
WM115,5287969,-2.3112325385791093,-1.7573858475654267
NCI-H2452,3062316,-0.5574526988915461,1.3219196567027691
PaTu 8988t,12003241,-0.7673639150441187,-0.9623807084239018
SK-CO-1,44589607,2.7511810771029213,3.085626754226376
RKN,23939,4.640348748177221,4.090893873160069
IGROV-1,72734382,4.633226130326536,4.619740043142407
BICR 22,46215462,1.5294433170369757,2.1420320511022903
MOLM-13,2949965,3.7040534246432624,2.1817322786202538
HCC1500,46215462,1.5254849350202837,2.1797900077727115
K-562,25183872,-1.1768480549542706,-1.8175710815970958
HARA [Human squamous cell lung carcinoma],5470400,2.3733756266777037,-0.1634775849271983
IGROV-1,3081361,0.99973562532788,2.17246431964548
NCI-H1568,9908783,4.863315848037401,4.91630659259232
HEL,vorinostat-carboplatin (1-1 mol-mol),1.771793472925216,1.8456075190520371
SW48,25195348,3.355247289110599,3.2904847079324515
HCC1500,135411,2.801194317933856,0.6930824167169715
BFTC-909,10410894,3.671861694905457,3.3401321495571854
COR-L105,2708,5.5167338716905885,5.159226790799819
SW1271,9927531,4.558020454092029,4.820642618541836
NCI-H1568,44462760,4.02669785413772,3.9485426386322784
COR-L95,11612883,2.9601999054336106,2.5463771017408603
KU-19-19,selumetinib-tretinoin (2-1 mol-mol),2.7257099010203047,3.450370831961733
SaOS-2,46199207,3.779046434903352,3.151618700965638
MDST8,15547703,1.8320295844693912,3.0143137689341377
SK-HEP-1,23725625,4.972795252846745,5.176871396915115
HuP-T3,JQ-1-MK-0752 (1-1 mol-mol),1.9324342474715044,1.8385823076233874
SaOS-2,doxorubicin-navitoclax (2-1 mol-mol),-1.9339656168793864,-1.5706988922591671
HCC1500,24797083,1.1358144177435396,1.3329770484768195
MOLM-13,11647372,-0.8512376057901615,0.3189971936117219
Daudi,navitoclax-sorafenib (1-1 mol-mol),1.4462190868370148,0.4417957916768952
K-562,5335621,4.97915810125604,3.967979327140096
COR-L95,2858523,3.028185885315027,3.0217040440034215
HCC1500,9911463,3.4774936591741703,3.8960001993656177
RKO,452548,0.942587279069954,-1.175515368289136
MOLP-8,126941,4.086011311839599,-3.0270676385953443
P31/FUJ,3384730,-0.5934712638177775,1.3661934835777632
LCLC-97TM1,16725315,3.732120983026874,4.086828944807495
HuP-T3,60700,1.2793809884126126,-0.1198642508743302
SaOS-2,9956119,4.053594307296879,3.650611190737255
HEL,alisertib-navitoclax (2-1 mol-mol),-1.6663288612486489,-1.338316798936593
SK-CO-1,46199207,2.9466484543003197,3.22903342477691
SK-OV-3,11175137,3.182781765506491,2.740969460003171
LS180,11222830,1.8684195070218452,1.5977599890890435
SW1573,selumetinib-MK-2206 (8-1 mol-mol),4.390623431255029,2.2196692739301684
K-562,23582824,1.4169931108164455,0.787255700178243
COR-L95,3025986,-1.3264557881304966,-1.1002020511306958
NCI-H2452,16065773,1.9140766169124153,2.6306068920082333
MOLM-13,54454,1.7928295036604598,2.21155322944502
LS180,119607,5.442141379439383,5.072502574442037
Granta-519,644241,4.377614733152813,0.6422589104077383
IGROV-1,46199207,3.293579955374855,3.2915593550911275
IGROV-1,3038522,3.6829378423722416,3.148271322095571
HuP-T3,135875424,4.261865095251217,4.045877261362043
IGROV-1,89928392,1.4824233552493276,1.4487890830188563
KU-19-19,5280436,3.7375704611092657,3.6561683921467703
SW1573,54678924,1.9184875438403524,2.4135193938621047
K-562,selumetinib-MK-2206 (8-1 mol-mol),2.367030654184624,1.848122981961505
SK-HEP-1,11364421,3.0648019303900624,-1.2273704145539626
P31/FUJ,11507802,-0.4015560413947272,0.532051632112728
MDST8,selumetinib-PLX-4032 (8-1 mol-mol),6.148002129111475,2.9365381241775923
NCI-H1568,89928392,1.1949851991515912,1.6894861994311432
WM115,11222830,1.2308018153574234,1.7439112845203892
SU-DHL-6,9908783,5.938767725153886,4.531374926890646
HCC1500,25150857,1.1801270031504156,2.3477800711503543
ML-1 [Human thyroid carcinoma],9915743,-0.6180546405493912,1.228042754680605
NCI-H1568,4521392,3.7910777113602303,4.326804424105197
COR-L95,25183872,0.0728708482253017,-0.9467242748765494
IGROV-1,227681,3.5439813498262347,3.366154483027893
PaTu 8902,6918878,3.691618711508776,2.9804215476942897
K-562,1242560,3.4884556471232293,3.034618705327917
BICR 31,53495165,2.344314514368125,0.24180176263890282
BFTC-909,tretinoin-navitoclax (4-1 mol-mol),5.193173988671874,2.7066598802800756
BICR 22,17755052,1.4011116930942769,1.267333882289189
Daudi,17755052,0.1512024273398794,0.7712288075488775
HEL,67156097,-1.6398778776875675,-2.092011713598188
BICR 31,44486219,4.3544536670303025,4.2835528932686175
SU-DHL-1,119182,-1.9070320733957784,-0.6477376070557506
WM115,135440466,3.0586385090162085,2.2404962904258054
IGROV-1,11152667,-1.4116509977729443,-0.2500706814436021
BICR 31,10385095,1.3759128494100044,1.4372359399487116
RKO,969516,2.537841036798478,2.172614308586039
Granta-519,123631,2.886011281362197,2.0189004392685757
HEL,4477,0.140225607998234,0.37203725727582915
HCC15,568763,0.562622735167329,0.6273398886932139
HCC1500,9926054,1.7367797854287812,1.8073701788321583
HCC15,vorinostat-navitoclax (4-1 mol-mol),-0.4329287763165494,1.4248547908760123
SW948,444795,4.960330673315111,3.6453202344969355
SW948,119607,5.410714093672246,4.58303387073954
RERF-LC-MS,9936388,-8.273067767637817,-0.5956958622825531
SW1271,alisertib-navitoclax (2-1 mol-mol),1.9083065334137317,0.5298263362157671
KU-19-19,4261,0.7367611445661113,1.9006653971262741
SU-DHL-6,387447,-5.553627026103078,-5.206157323736736
SK-HEP-1,3825829,4.395950359013269,4.117777054682265
COR-L95,9903786,3.7357721387912513,2.567573062542126
SK-HEP-1,44185566,3.236949395761265,2.618170878559159
COR-L95,73707398,1.0347493154641954,1.0145479864203415
SW1271,66577038,2.7134536861777807,3.0238732850464327
RERF-LC-MS,36462,1.1230283698314445,2.327433848093545
LS180,5278396,3.460947025625347,3.445970788752034
Daudi,3062316,-6.775500959037878,0.4259101389020804
K-562,107970,1.9304513771469212,2.0665395211785595
HCC1500,3854666,1.4433352503078565,2.230032036094985
LCLC-97TM1,JQ-1-navitoclax (2-1 mol-mol),0.3092105032557149,1.023282737261446
HCC1500,11455910,0.2448151005088887,1.3842875795069571
MOLP-8,46907787,-2.434163875600539,-0.7956469039023805
LS180,crizotinib-PLX-4032 (2-1 mol-mol),2.1034358212812867,1.7516667168206483
RERF-LC-MS,53392493,1.949934555719578,2.7270407756890376
MDST8,6610216,4.3863838734153,4.223842927973632
COR-L105,navitoclax-MST-312 (1-1 mol-mol),1.0518954464197996,1.1979852423811816
LS411N,216345,4.369072592416217,3.246407209930032
SW948,JQ-1-carboplatin (1-1 mol-mol),1.423261364200352,0.6835650679744039
SW48,2841722,4.762546821441249,4.27534543080196
SW48,9956119,3.393025538441131,3.8191762445802446
PaTu 8988t,44607531,1.764787957031886,1.8097782239327356
HCC15,16741245,4.574628343563009,4.004991386640213
SW948,89928392,1.4444572178844948,0.7807811509323325
SK-OV-3,25126798,3.9960730178767,3.966940726724669
RKN,54143018,1.3184566027416504,0.614686475150851
NCI-H2452,24180719,2.8480667171601852,3.524026152915889
COR-L95,9915743,0.942320604231091,0.4968781435518544
LCLC-97TM1,decitabine-navitoclax (2-1 mol-mol),2.9245922441873717,2.325331464962927
LS411N,selumetinib-PLX-4032 (8-1 mol-mol),1.7092095935664802,2.5992239418484684
ALL-SIL,387447,-4.904935645240703,-5.20013369724512
SW1271,54649381,4.56488530045006,4.098717499037006
KU-19-19,4259181,2.3072251676522835,0.1477573399032461
SW948,25105715,3.628389782970242,3.4640472406713867
SK-CO-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.470227169685732,-0.7881611262672926
LS180,19582717,2.9052461851112565,4.044617251928696
Daudi,676352,1.3635905677607614,1.911616053353079
SW948,SNX-2112-bortezomib (250-1 mol-mol),-2.424265268462928,-1.7450660825499096
ML-1 [Human thyroid carcinoma],375860,0.003862862725961,-0.14136739192004252
SW48,9915743,2.691515978939234,1.1561675309554054
MDST8,BRD-A02303741-navitoclax (2-1 mol-mol),1.0671280155352338,2.2911738565076543
P31/FUJ,navitoclax-piperlongumine (1-1 mol-mol),-0.4738069202441977,-0.4844060557428866
SK-CO-1,navitoclax-piperlongumine (1-1 mol-mol),0.7177098692298883,1.3323359728212003
Granta-519,3025944,4.149663954634143,3.8784032159461135
ML-1 [Human thyroid carcinoma],46174525,4.296155307906125,4.568720459640146
SW1271,2841722,4.036476035404804,4.308073519326808
SW948,53232,2.3961531254319466,2.87882583037247
SK-CO-1,25183872,-2.2315902989777725,-0.635543566942808
KU-19-19,vorinostat-navitoclax (4-1 mol-mol),1.414230786423441,1.2483226232628375
SK-CO-1,selumetinib-MK-2206 (8-1 mol-mol),-0.5781899978856783,1.7516488447829761
P31/FUJ,6918328,-1.424420935100909,-1.4828864442346776
HuP-T3,71680916,4.329506074723249,4.829371148168264
P31/FUJ,262093,1.035147161622815,1.780436480305401
SaOS-2,11228183,2.7080984165628754,2.4747264047797035
NCI-H1568,6852167,2.376266672184036,3.087233766793167
RKO,4477,1.7070595719756474,0.3961138173065573
Granta-519,46199207,2.493616790778817,2.620481014880534
IGROV-1,5470400,-0.2457809435208252,-0.497139583851838
IGROV-1,409805,5.990596261907717,4.89259548539791
PaTu 8902,15983966,2.4191743534269463,-1.0970784884910503
RERF-LC-MS,31703,0.0184985959907658,-0.46515393518395426
NCI-H2452,SNX-2112-bortezomib (250-1 mol-mol),-1.5822620251622193,-1.406918879492493
P31/FUJ,46224516,2.421293495972869,2.01971363647554
BFTC-909,10127622,5.216996592058982,3.6920417130008714
HuP-T3,55508,4.397520768584908,3.4964419658405625
HuP-T3,10385095,0.7178899916931367,1.2620373148482593
RKO,16013152,4.038378204585466,3.226099481247874
RCC10RGB,6918328,1.0053978601828475,0.5653138649216732
SW948,9444,4.221430823371368,3.90623302193162
WM115,53392493,1.845382538513501,2.6770693701077666
HCC15,44185566,3.08334642122707,2.618267448452215
LS180,JQ-1-navitoclax (2-1 mol-mol),0.8160001924760493,0.9579539692365914
UACC-812,25262965,-4.249514707304517,-1.1466479614202016
WM115,51037431,2.6247692404465868,3.3055089421510258
SW948,5311281,0.0185560472432188,2.5011890058292887
HCC15,44607531,1.6724658843452191,1.453507474854817
MOLP-8,6450551,1.973885798572914,1.5888159493847878
MOLP-8,7251185,0.7855879803762651,1.8211710701080828
SaOS-2,5479543,4.655800274360292,3.5543776434520593
IGROV-1,4917,2.985904350427039,3.2258012285826676
Daudi,3825829,3.2006002080342544,3.33188507717744
UACC-812,148198,-2.7739066615342236,-3.5488693771246305
Granta-519,1242560,3.55554960326222,2.8972468133922296
HARA [Human squamous cell lung carcinoma],60700,-1.6734694813518207,-0.41015343140938754
HEL,17759555,4.966386069896687,3.3701016722631003
SW1271,119607,6.141140067390372,5.332217503131862
Daudi,3038522,1.648170780235362,2.8791911602135114
PaTu 8988t,969516,4.442820223092304,2.972447237807481
HuP-T3,4521392,4.351966444408677,4.2859765681932
BFTC-909,2113511,5.65564772398506,5.371086059868032
ML-1 [Human thyroid carcinoma],9903786,1.6234934744716731,2.8173146439338486
SW1271,24856436,1.0602186643720275,0.3285602581009005
HEL,24180125,3.3188099636510495,2.555448812169467
WM115,10077130,4.784184630126653,3.0338790392997725
SK-HEP-1,5281321,-2.075735756673856,-1.1962323760550644
UACC-812,10184653,-4.111635019949291,0.587558786966377
BICR 31,55283,4.60336009153674,2.7639129160116407
MOLM-13,11178236,-3.317575610691226,-3.9996825001892216
COR-L105,57519531,4.553300256365288,2.9461634752375523
ML-1 [Human thyroid carcinoma],3815108,2.9979183689426723,2.9234750230093294
ML-1 [Human thyroid carcinoma],sirolimus-bortezomib (250-1 mol-mol),0.5199068018007997,1.1908561934124764
ML-1 [Human thyroid carcinoma],vorinostat-carboplatin (1-1 mol-mol),2.0705525470951587,3.2981855642080915
ALL-SIL,11317348,-1.373590167325895,1.0770333827623035
LS411N,6914657,-4.299110458286086,-4.198430216585206
ML-1 [Human thyroid carcinoma],12003241,-1.866080903179476,-1.1131569107966743
HARA [Human squamous cell lung carcinoma],1716436,3.773793106717324,2.88324218531704
LS180,57519531,1.9809210286085912,2.4260212025762717
LCLC-97TM1,60750,-0.9490237417659374,-1.9011986211764762
SU-DHL-1,49850262,3.2383746822480384,2.9852147150753114
SK-OV-3,9911830,2.8997016876614863,2.717059565767138
PaTu 8988t,alisertib-navitoclax (2-1 mol-mol),4.265397677389301,0.4150625305493566
RERF-LC-MS,15983966,-4.090154567310139,-0.5613312368263137
SK-HEP-1,selumetinib-MK-2206 (8-1 mol-mol),4.11054762578972,2.145054887059905
RERF-LC-MS,24951314,1.4075693116182684,1.4493423297038575
SK-HEP-1,11494412,3.332434654266433,1.851374814995508
BICR 31,51039095,3.0794813668201546,3.073244274185362
Panc 02.03,11178236,-2.8028080099743624,-2.956239076369704
SU-DHL-1,24772860,-2.736237819232434,-2.02604857420674
Daudi,6610216,3.2134188501838494,3.880408765914358
NCI-H2452,53392493,2.782389188766079,2.779945607745828
NCI-H1568,445091,4.097432324473231,4.4105229731728075
K-562,9926054,1.8612748023096723,1.6663165478799582
HCC1500,24978538,-1.6021545775061432,0.6713831469156776
COR-L95,25126798,4.203058281978897,3.6835234485895114
LS180,44819697,-0.9723932292423276,-0.6074856812171772
BICR 22,5281321,-1.7077192732848236,-1.0011214667672566
PaTu 8902,656346,4.145274855759625,0.8351711533718315
BFTC-909,42642645,1.561027146692027,0.8078016394690904
IGROV-1,49836020,5.658436828096057,2.5484006334699942
Daudi,168313200,1.4988300519601074,2.685146514938503
MOLM-13,24779724,4.7751629548446894,3.0361903473446876
IA-LM,docetaxel-tanespimycin (2-1 mol-mol),3.5360773084497494,-3.599690675733141
K-562,doxorubicin-navitoclax (2-1 mol-mol),-1.4702798280033291,-1.7468560267871707
RKN,2828334,5.965623907482328,6.113334240812344
NCI-H2452,5280436,4.838161671645799,3.476166558677288
HARA [Human squamous cell lung carcinoma],25062766,2.285935640348263,2.203225578502255
BICR 22,637858,2.779101364791116,2.1181341206353257
RERF-LC-MS,56963564,0.3267097404636779,0.5158045971559385
RCC10RGB,2949965,2.9970768068045577,3.1486086266415807
WM115,10074640,2.7921613557017473,3.2412606638875183
KU-19-19,25154868,3.204596310046931,4.637214646472059
BICR 22,49793307,-5.020228152199773,-2.3736832952971487
SU-DHL-1,5460769,-0.475427190707336,1.9253020484342613
NCI-H2452,9868037,3.199558399493599,3.4535948748163054
SaOS-2,9823820,4.1201217228566565,4.226025487731904
SU-DHL-1,9444,2.825333870881758,3.6448962625822103
HCC1500,53495165,1.6495193303321407,0.6764731706421756
RCC10RGB,9952709,4.37754893062567,3.3028674132422746
Granta-519,73707398,-0.348610297970246,0.3961698247672405
HARA [Human squamous cell lung carcinoma],44632017,0.7187380309890276,1.2671942110407446
MOLM-13,26596,-2.2068545341754295,-2.7426250760648747
K-562,52912189,0.5484446218637569,0.27514243955950846
MOLP-8,doxorubicin-navitoclax (2-1 mol-mol),-3.5664947897809207,-2.0572215157606295
IGROV-1,375860,0.7731558163124775,0.10756673440962744
IA-LM,11964036,4.998383188027045,0.5108380893803612
MDST8,387447,-2.914953377887094,-3.567840893133137
IA-LM,9915743,1.455667571666015,1.0568653860045463
LS180,6918328,-0.1069758097146191,0.008628081741155688
PaTu 8988t,6610216,5.064895456595333,4.346526386500611
SU-DHL-1,104842,-6.410970225096146,-3.4729563345217334
P31/FUJ,56946209,-4.67609529352027,-4.897676710743216
SW948,6917907,-5.884345700630281,-4.979905745194634
BICR 22,53232,4.030024483575548,2.5093890456041437
PaTu 8902,568763,1.8312011651342244,0.6043033991685791
ALL-SIL,6505803,0.7073572306495796,-0.685705523772688
SW1271,selumetinib-JQ-1 (4-1 mol-mol),-0.3516238001186607,1.9556392904905968
LS411N,10302451,4.220534629483678,2.8146619525119627
RKN,11238147,3.9265768628415487,2.800890683782752
PaTu 8902,135440466,3.176809791892748,2.2097651770257465
MOLM-13,119607,3.836878131829583,4.471949597465611
HEL,11612883,1.9962168488272864,1.9259038621963722
COR-L95,11485656,1.8696119642586884,2.029992253924678
MDST8,675434,4.4652962141660595,4.661145076643509
IGROV-1,11507802,1.5049911819213722,1.6132953549846087
SK-HEP-1,2708,5.260013220141412,4.934384067660075
LCLC-97TM1,BRD-K27188169-navitoclax (2-1 mol-mol),5.367919613117806,2.188563013587192
SU-DHL-1,5738263,2.757121948334044,3.183471642847781
Granta-519,54626689,4.523537450364534,4.2520733539837146
SW948,135421197,1.7477185084776832,1.4991084979838671
SW1573,ISOX-bortezomib (250-1 mol-mol),0.8486273919193054,0.6440010490313807
BFTC-909,tanespimycin-gemcitabine (1-1 mol-mol),0.2587370636739561,-0.8227623261367354
BICR 22,4917,3.6655313291566327,2.863381902970714
HARA [Human squamous cell lung carcinoma],2130404,2.6459509712703246,3.294204545497642
MOLP-8,16736978,0.6033273838828506,0.9695285627668704
SW948,11396600,3.556168564723583,2.6334677647556908
IGROV-1,2113511,5.982902824257526,5.555446635169906
Panc 02.03,16725315,5.289216895099664,4.235219144646224
K-562,9549297,1.810271401171294,1.5495037715913158
SU-DHL-1,60700,-3.861884777487788,-1.413380328078301
MDST8,89183176,5.515733421140453,4.058076407693462
PaTu 8988t,selumetinib-decitabine (4-1 mol-mol),5.718429611668687,3.9682183702940774
WM115,10113978,3.3670712397266698,3.4162587214394478
SW48,25154868,5.084018259884556,4.186753107788935
Granta-519,107985,-5.079154139769343,-4.007368576657889
IA-LM,15953870,4.160803294534019,3.5291185990985063
RKO,19582717,4.345992572306107,3.1255317228020902
WM115,selumetinib-decitabine (4-1 mol-mol),-1.8184529973078083,2.9180992054734314
ALL-SIL,2742550,3.1857763586562577,3.2706390596616246
COR-L95,375860,0.21091681928276,-0.02249996536219715
Daudi,JQ-1-MK-0752 (1-1 mol-mol),-0.2875395851345496,0.2758095499495651
COR-L95,702558,5.203109308170341,4.8424413220712035
ALL-SIL,5329102,0.5818325089631969,1.288017650996104
MDST8,9911463,4.372295154952754,3.7387978302671576
LS411N,44607531,1.9881484499388475,1.4697481078182497
Daudi,68056272,2.8001037652797818,2.96410914934081
MOLP-8,4521392,3.737637773211522,3.9766540896672495
MDST8,20959075,-2.855250986095604,-2.703427110422701
IA-LM,400769,-0.2498086542393983,-0.49688737878705835
IA-LM,16722836,2.5380745713557893,1.21322388460259
HCC15,445091,5.451686926059382,4.510465499578958
HCC15,11507802,1.1916077520331714,1.9823327737235616
MOLM-13,9903786,0.7109980532390177,1.8133876595124065
SW948,24901704,3.213341299668661,2.605748988562478
ML-1 [Human thyroid carcinoma],46224516,1.5473988782080883,2.5510097518275856
SU-DHL-1,10427712,3.576020229714379,4.106560332201068
ML-1 [Human thyroid carcinoma],107985,-3.3059977696559204,-3.2095326305156395
SK-CO-1,piperlongumine-MST-312 (1-1 mol-mol),2.091052840490691,1.90731981798794
Granta-519,51039095,1.7779321154646133,2.1651162999200846
RERF-LC-MS,65628,5.693639897620667,4.246851933773203
SaOS-2,2828334,6.074749772556143,6.278257368238425
SW48,3815108,2.5063295630391806,2.7760673826384146
SK-CO-1,11626560,0.3943389380121196,1.7953180144008685
HEL,107985,-3.965696416470184,-3.7428271904896544
KU-19-19,60700,0.8700483452505813,0.036665492572685275
Daudi,5280436,1.0789231424034973,2.541728873265362
MOLP-8,54613361,-0.8734170036218252,-0.735901245519601
HARA [Human squamous cell lung carcinoma],439501,-2.358364257130844,-1.982303426829763
SK-CO-1,24978538,-0.5683899539074425,1.1930469396388033
SU-DHL-1,54649381,3.644517842316546,3.662669558282285
SU-DHL-1,44493528,3.922242735424854,4.27470457457154
P31/FUJ,5282054,2.945149434876345,2.7523996370081405
SK-OV-3,49850262,4.3958011115665006,3.8481109006722662
IA-LM,10184653,0.8510906912410041,1.295728834424851
NCI-H1568,36314,4.092621701538515,-0.9250896180735717
BICR 22,46843906,2.889476079217857,3.1041855875020836
SU-DHL-6,9444,3.111459322097769,3.579708839860327
ALL-SIL,10410894,2.969142576372873,2.7086306325506886
ALL-SIL,9549297,0.2429486516660708,1.5056566404592677
Daudi,46926350,-6.041265180126537,-4.626818208106072
RKO,1750826,1.760307875609834,-2.2274314982417875
PaTu 8988t,4477,0.4312443696129938,0.05569205094199048
Granta-519,5282054,2.5814189459390957,2.571043361251021
SaOS-2,carboplatin-UNC0638 (2-1 mol-mol),3.570952437368873,3.3195073337578496
IA-LM,16065773,2.795317455347302,2.274486279017326
RCC10RGB,156422,4.423389512885201,4.093130652746554
IGROV-1,11214940,1.360660548899077,2.1697628768355823
Panc 02.03,16720766,4.473005389666903,0.7353704322496561
Granta-519,3081361,1.7559432073327723,1.6721800915452152
MOLP-8,52947716,-7.872176911001468,-2.1899311052211172
KU-19-19,5281321,2.871465791170073,-0.8129857309388514
IGROV-1,5282054,3.614574021382022,3.7632632060097833
MDST8,4261,1.8348924416255383,1.6594706041090452
MOLP-8,100016,7.090961588333011,4.794301542361492
Granta-519,168313200,2.290121636997186,2.693569944035701
HCC1500,462382,0.0787876699821948,0.8352391200361099
IGROV-1,10113978,2.874171865860951,3.63545771313453
IGROV-1,BRD-K55473186,4.387806234483854,3.958810810442612
HARA [Human squamous cell lung carcinoma],5291,4.037970789679042,3.7158466192663115
P31/FUJ,10410894,5.368264014178215,2.811646326836885
BFTC-909,3025986,-2.0399601309440336,-0.98673199867183
MOLP-8,24771867,-5.187641849515016,-0.8966191820408445
BICR 31,11214940,4.966543096658616,2.011416954738456
Panc 02.03,selumetinib-JQ-1 (4-1 mol-mol),2.589155616289617,1.4748971747918902
UACC-812,9936388,-5.022392750910281,-1.1114396287097146
ALL-SIL,24772860,-3.38763553354356,-2.8070276526191993
MOLP-8,11626560,-0.689912231097504,0.6311222621153941
HARA [Human squamous cell lung carcinoma],selumetinib-JQ-1 (4-1 mol-mol),3.6659251122276015,1.4519821310959387
BICR 22,navitoclax-PLX-4032 (1-1 mol-mol),4.097608134933257,1.8836463270531618
SW948,262093,3.1804911198162036,2.0812450131428912
SW948,216239,1.8650010893863176,2.0496673477790206
SW948,11364421,-5.809742751249139,-3.037510907139948
HEL,10302451,3.814274659252608,2.6943142346805997
K-562,46398810,1.812730009869126,1.8429655100125857
Daudi,216239,1.5780166370194677,1.8047936062394803
LS411N,10231331,0.2083934704449227,1.3816003325947266
MOLP-8,46926350,-5.986975596425451,-4.563450713822838
SK-HEP-1,11964036,3.325100881793091,1.6459879605914427
Granta-519,11485656,1.6660529916447626,1.5942451594597566
K-562,2871966,0.96376622724181,-0.11940628143040005
P31/FUJ,54454,2.7341923640247123,2.269973830247913
SW48,54613361,-1.8010952783890095,-0.2895834512682185
NCI-H2452,46843906,4.012061875028764,3.264513650379027
HEL,135875424,2.9448279330391927,3.192184296856264
HARA [Human squamous cell lung carcinoma],16725315,4.551171651287005,4.307110046249912
SW1573,serdemetan-SCH-529074 (1-1 mol-mol),2.68378670703322,2.174681123499947
ML-1 [Human thyroid carcinoma],51039095,1.326261900002616,2.8948238706877207
P31/FUJ,decitabine-navitoclax (2-1 mol-mol),-1.2834649241305407,-1.2870344723492215
HCC1500,54678924,1.846277418486191,2.245661971502809
SU-DHL-1,UNC0638-navitoclax (1-1 mol-mol),-6.722227351020971,0.4765968325987176
MOLP-8,9927531,5.438833274000949,4.191245632757815
PaTu 8902,selumetinib-vorinostat (8-1 mol-mol),2.5580221704247403,2.5932746905204285
HCC15,9952709,3.084010703088348,3.149977725576656
K-562,3503,1.244026999465694,2.0368321203828192
SaOS-2,3689413,0.0712794264513353,-0.04858083487286523
MDST8,10427712,3.921886084986449,4.414524176830813
HARA [Human squamous cell lung carcinoma],11238147,2.905443405294126,3.030800870342622
SU-DHL-1,1716436,3.093009546519781,2.4575409864842537
PaTu 8902,25105715,3.5553172149604375,3.4229404185588703
HuP-T3,24771867,4.228511460696379,3.1583062998206084
RKN,31703,-0.7196573309741882,-1.0011717307360632
MDST8,60700,1.1908209554887386,-0.18554953890089454
SW948,carboplatin-UNC0638 (2-1 mol-mol),3.7515115045005913,3.3140914326942585
HEL,54454,2.1583735480761437,2.661703292141529
NCI-H1568,UNC0638-navitoclax (1-1 mol-mol),3.297813275168301,1.8492670534928728
BICR 31,alisertib-navitoclax (2-1 mol-mol),3.3923193563221257,1.0482785203791876
SU-DHL-1,135875424,2.8587183873170847,3.492420222735031
SU-DHL-1,36462,-1.6063137198477124,0.9666865949059936
MOLM-13,73707386,2.881964792667641,2.3623982790094304
P31/FUJ,3854666,0.6136756098719494,0.7462985002678134
ML-1 [Human thyroid carcinoma],6505803,-0.5261965004955029,-0.05614998356318458
MOLM-13,159324,-0.2587959593058327,1.110085680217314
SW948,19582717,2.742329976582949,3.2886067192733233
SK-CO-1,444795,5.109688629113172,4.778183134376694
Daudi,400769,-1.3686052359334673,-1.4627306693537283
SK-HEP-1,10296883,4.4971190241998835,3.833467167952215
HARA [Human squamous cell lung carcinoma],12003241,-0.2443339656532688,-1.2758273425799855
LS180,17759555,2.746757712453425,3.302998254230184
MOLM-13,156414,-0.1970532812518614,0.9095005528524668
ALL-SIL,72376,-2.2514410459425043,-3.609415595445812
BICR 31,selumetinib-MK-2206 (8-1 mol-mol),1.335551689205146,2.2789361483178716
HARA [Human squamous cell lung carcinoma],tanespimycin-bortezomib (250-1 mol-mol),0.1045864370631683,-0.8148999358260663
HCC1500,51039095,2.9997605815390935,2.646962000924473
WM115,44185566,3.0030021210520794,2.6413861251059996
COR-L105,4705,0.5312031062005766,3.382060261434973
Granta-519,8515,3.731909716775835,3.1976927025904507
ALL-SIL,11234052,3.5011978223530926,2.973501932538626
COR-L95,tanespimycin-bortezomib (250-1 mol-mol),-0.3690826099539636,-0.44421554562917814
ML-1 [Human thyroid carcinoma],44632017,3.256506939906626,1.3739214458817168
Granta-519,613753,3.0344429390603493,2.8253277297371664
HuP-T3,5329102,2.4996480668272527,2.0524455132237076
SU-DHL-1,2828334,5.462697908299577,5.975333005750374
SK-OV-3,51039095,2.3576173335626147,2.9351624357611636
UACC-812,5470400,-2.2578344499942418,0.07556763573002055
HCC15,9935249,4.091947122155354,3.173301625127343
UACC-812,JQ-1-vorinostat (2-1 mol-mol),-0.5213031534169104,1.2163963208459065
SW1271,322968,3.7653444240208263,3.7513031438215534
COR-L105,54678924,1.4327429630461548,2.4921293000255718
Panc 02.03,31703,0.91391851070637,-0.3985449226436073
NCI-H1568,5329102,1.5348278867114138,2.284710753640167
Granta-519,9887053,0.035640336798207,2.282569165877929
IA-LM,6610216,4.173583896241699,3.9188818638402747
NCI-H1568,119182,-0.8732650634834633,-0.4094283964078658
IGROV-1,159324,2.8766947154825044,3.054280232946636
NCI-H1568,5566,2.911706555521376,3.0975047714909727
Granta-519,ISOX-bortezomib (250-1 mol-mol),-0.0076351128807997,-0.21737237987828822
NCI-H2452,10385095,2.425738192808243,1.3310620506110515
HuP-T3,16065773,2.155269900494742,2.5354618816952956
SW948,448949,1.5714288146717783,1.7974467206162728
NCI-H2452,107985,-2.625758680845612,-3.4450689126453384
RCC10RGB,1750826,-3.277944046627699,-2.4845808174768234
Granta-519,16736978,1.0160166250823044,0.8563858834127163
HEL,104842,-4.135712202151618,-4.065673216917991
MOLP-8,71466445,1.892906464336944,2.4288028608369987
MDST8,262093,2.389063867163299,2.751421400911077
COR-L95,4259181,0.8580425806970188,-0.10766352498098185
Daudi,45279963,2.6753649589319854,2.699643180618948
IGROV-1,656346,1.6285470744333117,1.0817481698496154
SK-HEP-1,10427712,4.527720982072863,4.4194275111622385
SaOS-2,11647372,0.6261520317366223,1.343820061219663
COR-L105,53495165,0.9627099148057476,0.5137938201778721
Granta-519,11404337,-2.8078628280004048,-1.2423171849611356
SW1573,25154868,3.281093993360062,4.378266389947158
RCC10RGB,crizotinib-PLX-4032 (2-1 mol-mol),2.89623675646366,2.072019173407563
BICR 31,3503,3.4488620791118993,2.3136705777160547
SK-CO-1,3062316,0.5910144260309655,0.9543104042674325
RKN,6917907,-6.438038185084336,-4.7646618766350315
LS411N,23635314,4.011909681168236,-2.814835314710267
WM115,11234052,4.1182935305671435,4.190913797577819
Granta-519,tanespimycin-gemcitabine (1-1 mol-mol),-7.490554088908799,-2.2375351172115345
SW948,JQ-1-navitoclax (2-1 mol-mol),0.5901277786092829,0.2809484771640557
RERF-LC-MS,11485656,1.5190166417661397,2.5420798354366
PaTu 8988t,46224516,2.924922546378164,2.6527230216218154
Granta-519,JQ-1-vorinostat (2-1 mol-mol),0.0738956362017292,-0.6952881624699734
SK-CO-1,5287620,-2.837552470898679,-2.0662194417812683
PaTu 8988t,24772860,-1.5593380796956875,-1.5635983142134007
PaTu 8988t,6184667,3.5063575702163345,2.9697030080479037
BICR 22,36462,0.4717839486114671,1.8872782091558002
RKN,16722836,2.340122812915413,1.6051581576333902
Panc 02.03,54618164,4.482290203520866,4.262507369751032
BFTC-909,2841722,4.3094465275997536,4.277051591821606
COR-L105,2746,3.1035280268076217,3.5012421674372285
IGROV-1,9929138,6.483056540257463,5.679149907283899
HCC1500,2708,5.151987441269929,5.119669686496996
MOLM-13,11238147,1.4582306649534449,2.138027862793654
RERF-LC-MS,11364421,-3.8493036468537265,-1.4268122112483783
ML-1 [Human thyroid carcinoma],100016,6.6260589736745015,6.302509870798819
RERF-LC-MS,16736978,2.30801467798398,1.8684624798859033
LS180,44241473,4.435457667187811,4.697047735553964
SW48,16722836,0.2197322523934369,1.6871822459795098
NCI-H2452,9444,3.5242093703527697,4.334277252466242
SU-DHL-1,5284616,2.4488241799592143,0.219361632376448
K-562,54454,3.689215856042272,2.3238740580944723
HEL,2945648,2.719646445320408,2.1766238758928016
ML-1 [Human thyroid carcinoma],selumetinib-JQ-1 (4-1 mol-mol),1.6383064835611996,1.53824595280424
HuP-T3,9936388,0.6940852338085793,-0.4302330947071495
LCLC-97TM1,10427712,4.124790087544491,4.066228109038043
SK-CO-1,navitoclax-sorafenib (1-1 mol-mol),1.5561836215711824,1.421905405762918
SW1271,135398738,5.657599080768866,4.1457642178353
RKN,216468,4.351451769225332,3.576429455301433
SW1271,46224516,1.263100640010589,2.56232755008963
SK-OV-3,60750,-4.210978436614257,-2.093655554488415
SU-DHL-1,11455910,0.1271925880707346,1.182094450642627
Granta-519,25161177,3.429453868131532,3.337255559625731
PaTu 8902,SNX-2112-bortezomib (250-1 mol-mol),1.6303309640570394,-1.119100164910117
COR-L105,erlotinib-PLX-4032 (2-1 mol-mol),-0.0740461614956173,3.1767546291573154
UACC-812,16065773,1.9582746458630844,2.469932528966208
MOLP-8,2858523,3.112163707938977,2.802523746560811
ML-1 [Human thyroid carcinoma],6252,2.036085666454029,1.3362240987369716
IGROV-1,6505803,-0.2382223795960626,-0.6184853298068745
HEL,24772860,-2.0205510075596425,-2.759724116954449
HCC15,4917,3.2753021602409267,3.08736829376497
HEL,ISOX-bortezomib (250-1 mol-mol),0.0125517502363375,-0.09451335019108757
P31/FUJ,6184667,2.9500590386465393,2.0019537946085113
MOLP-8,46843906,0.174682801852784,1.6340026408156327
NCI-H2452,54618305,4.302077073898344,4.569922111326517
BICR 22,8515,4.348804794701894,3.8414616550343754
COR-L105,24821094,-1.121187296223131,3.1506511854185932
HCC1500,4788,5.676843976237076,5.426265284739193
SK-HEP-1,2746,4.04921422913523,3.41754224911139
Granta-519,tanespimycin-bortezomib (250-1 mol-mol),-0.1680583743842791,-0.6064217104429797
COR-L95,46199207,3.11604668311128,2.8124167876648336
MOLM-13,1641662,2.418131669664625,2.696979236019441
WM115,135984461,4.094268409164816,3.848599930257972
LS411N,10127622,0.4126946340819594,2.6970306156068995
HARA [Human squamous cell lung carcinoma],11497983,-2.5330413808054333,4.3958867984251135
ALL-SIL,11364421,-5.245070547120315,-3.8493145293674704
NCI-H1568,44607531,1.2688225542701184,1.7135341219618019
SW1573,navitoclax-pluripotin (1-1 mol-mol),-0.8972243214684317,-0.6352170556637482
SW948,104842,-0.6555530305877334,-2.630575573299356
SK-CO-1,46907787,4.316773762169295,2.0506475871749523
HuP-T3,104842,-2.1883971380944054,-2.7759249598700153
IGROV-1,11178236,-2.8618715106425725,-3.006036807187512
HCC1500,71751553,4.671922723370954,4.391079603127792
SW1271,54618771,-0.1319273231055389,1.5059503583306957
ML-1 [Human thyroid carcinoma],9952709,4.669340472029816,3.326262454733994
IGROV-1,654092,-1.340387623873854,0.007952728577717512
HCC1500,44819697,2.691999336982048,0.12378980283554145
HEL,44137675,4.224171499328968,2.762053240822348
MOLM-13,tanespimycin-gemcitabine (1-1 mol-mol),-4.499081483016427,-1.9015251703219707
COR-L95,5328940,2.113977806947162,1.6048882253740937
SK-OV-3,3825829,4.139200001280225,4.062505567508437
Panc 02.03,216468,3.8655539989600176,3.518257620481963
SW948,25195348,3.534636067330416,3.050975961612479
MOLM-13,9444,3.2439366633039426,3.438194629773551
NCI-H1568,24821094,1.7576462865100984,2.9181542189056255
MOLP-8,1566236,0.7132031003128095,1.5414253227982346
HuP-T3,11455910,1.0919804440303738,1.3216125014061546
MDST8,44185566,3.0590843033834116,2.6665257168493883
NCI-H2452,216345,4.1608899350266615,4.151392966522636
SaOS-2,23635314,-2.530968731721941,-2.213399648718664
MOLP-8,selumetinib-MK-2206 (8-1 mol-mol),0.6863734484808788,1.711448064712891
LS180,168312962,-1.039638615515642,1.923544907588487
BFTC-909,crizotinib-PLX-4032 (2-1 mol-mol),2.7598509436067906,1.9235308447702533
BICR 22,322968,4.6496227244818416,3.816793709067486
NCI-H1568,vorinostat-carboplatin (1-1 mol-mol),1.5719417416558872,3.3051343396059467
RKO,6918837,-1.4612228483082623,-3.804413497725942
MDST8,selumetinib-navitoclax (8-1 mol-mol),0.5901837965573531,1.7751745668854693
SW48,613753,3.5910736246612323,3.1496892685083804
IGROV-1,44507138,2.359177395411688,2.477946883719173
WM115,52947716,-6.8465929822900815,-0.1798583860590094
RKN,73707398,1.136221501718042,1.3557635375335735
HCC1500,4477,0.2789780560390432,0.4493980594666455
Granta-519,11719255,2.4006867045586953,2.1585802378367718
HCC1500,6918736,0.2919336581768246,-1.1828019590729255
IGROV-1,4477,1.1767656777594142,0.39078778011898635
IA-LM,11609586,4.073174168632335,2.1104471175736474
NCI-H2452,11404337,-0.3859535574072682,-0.19314331200904086
Daudi,136227924,1.3476403322374937,2.1801171163576987
SK-OV-3,387447,-3.0618968905277164,-3.9170817241995786
MOLM-13,3854666,0.5101644656521153,0.6511958645221145
RKN,46843906,3.906010302389018,3.0180239342983466
ALL-SIL,1641662,2.105441320822025,2.791850992490365
MOLP-8,46199207,3.622115707782432,2.6898325659463223
HEL,17755052,2.5427584711612554,0.8258519473951675
MOLP-8,9915743,0.5160575940701332,0.19650914428728838
NCI-H2452,135398516,0.2354885350790482,2.5517389989114476
NCI-H2452,JQ-1-vorinostat (2-1 mol-mol),1.361868366541758,1.4097513940933881
SW1573,9911463,3.734935340044018,3.929268756335416
P31/FUJ,selumetinib-vorinostat (8-1 mol-mol),0.1511350548351421,1.822218688269766
IGROV-1,23725625,5.712368491237602,5.043773980853625
IGROV-1,54143018,0.8385018685685798,0.4981759568908861
WM115,135875424,2.968517855352779,3.988619337405422
SW948,16659841,2.968981271202921,2.8295364732071793
SW48,25183872,-1.521332471338628,-0.688974208012127
ALL-SIL,selumetinib-GDC-0941 (4-1 mol-mol),1.4850584156304236,0.3965481104950346
RKN,selumetinib-JQ-1 (4-1 mol-mol),2.2117221190324323,1.8142571606969775
COR-L105,UNC0638-navitoclax (1-1 mol-mol),1.0855753959105363,1.8195620831447012
WM115,5284616,2.9108529677003565,1.9885994543274124
SW948,4705,1.720002028261835,2.9165190540387487
HCC1500,71680916,4.362866442203444,4.873359885047348
PaTu 8902,17755052,3.1533076581920936,1.275684128871469
COR-L95,11427553,2.745819698220539,2.185154942902199
MOLP-8,11707110,-0.9708482925672104,1.2720974916001035
HCC15,5351362,1.1207822529279785,1.769375996240624
SaOS-2,11234052,4.364959006359101,3.8203188167972013
SK-OV-3,6918837,-1.7709381590236568,-2.563487353542601
RKN,10113978,4.430129932581481,3.4326622520253434
Panc 02.03,5566,2.8367562997211815,3.1244279892162297
IGROV-1,crizotinib-PLX-4032 (2-1 mol-mol),2.0296160065449858,2.0805385282103837
Granta-519,4096211,0.4087245803445845,0.8069062616780077
SK-HEP-1,72193861,3.0367238048594603,1.7244381452190536
SW948,9933475,1.7222383900333498,1.8082456772311954
SW48,9936388,-6.68623848822316,-1.6901330939087
NCI-H1568,11222830,1.5738139714037271,1.6663597167699087
IGROV-1,24856436,0.4840146383282276,0.3765565035795004
SW1271,25105715,2.9104912505007143,3.411210990079892
IA-LM,11238147,3.064975348903814,2.2887899852614804
PaTu 8988t,23635314,0.3317794086663004,-1.3038698573157028
Granta-519,3136844,3.153984140395424,3.8093444483350942
COR-L105,24951314,2.139685821030411,1.780443285196662
IGROV-1,135398744,6.402844237905131,6.377485325732377
LCLC-97TM1,156414,1.5907536031970133,1.127867230529824
BICR 22,46926350,-6.042960620867506,-4.001404354218226
Granta-519,387447,-5.4996124066637435,-5.14953802464019
BFTC-909,51039095,2.7594177275421403,2.595349291213282
Panc 02.03,5746,2.615751109567445,0.8843702337072264
SW948,71466380,3.8629020707603914,4.39360313850295
SW1573,tanespimycin-gemcitabine (1-1 mol-mol),5.2364436023498815,-0.7054898958951896
COR-L105,24856436,1.5602990639828938,0.9888973524533253
K-562,327653,3.3038748071855175,2.8263198108237555
Daudi,16725315,3.035985748437892,3.369660004196808
LCLC-97TM1,6917907,-8.098980466082804,-4.904959701277242
NCI-H2452,4261,1.8682088943565944,1.9478012444329278
SU-DHL-6,241158,1.5794519300851928,2.580292913259866
IGROV-1,9840324,5.720969888694302,5.6485769189635935
COR-L95,10074640,3.0551355702246292,3.028479202150392
ALL-SIL,navitoclax-birinapant (1-1 mol-mol),-2.9890180212020265,-0.9610198862235887
BICR 31,5460769,3.9433617709959696,2.6699134800837445
WM115,navitoclax-pluripotin (1-1 mol-mol),-1.858334672155358,-0.8517746465573104
ALL-SIL,171352865,4.1926931777749346,2.204887395868647
PaTu 8988t,5351362,2.286773409161727,1.6206079167656804
COR-L105,54618164,4.149947168538197,4.085133512329382
K-562,168312962,1.3008721680360658,0.973485573282766
NCI-H2452,3634881,3.1517111283550854,3.3184387813456975
SW48,crizotinib-PLX-4032 (2-1 mol-mol),0.8715368349247399,1.855827461369494
LS411N,2858523,3.1062955336512603,3.025097665355249
NCI-H1568,65628,3.926137474064237,4.292241216076949
SW1573,25126798,4.147065453172024,3.923724526372287
SU-DHL-1,9868037,1.568771805047012,2.89310028371815
HCC15,46174525,4.292402667650191,4.4393961988723945
HCC15,54626689,4.436341034968849,4.6201906891795295
K-562,241158,3.183928650435804,2.752494861645717
HEL,400769,-1.0010167847558078,-1.241189272154147
MOLP-8,24180125,2.8280981087253605,2.1963652379056926
LCLC-97TM1,6918837,-2.241539398034031,-2.829821406075533
SW948,52947716,2.6983492764143984,-1.2748773698699314
HuP-T3,11609586,3.0975126346448056,2.8264392050139673
ML-1 [Human thyroid carcinoma],44589607,3.064794245292079,3.209774434230758
K-562,9911830,-1.954559593888618,1.7851984578494255
Panc 02.03,54454,5.027619058009229,2.7285587643807103
Daudi,9967941,1.9498714635628245,2.9701418363012015
SK-CO-1,46224516,2.9108482414820833,2.6673639639716957
IGROV-1,56963564,1.8260986108097368,0.7341950430361617
PaTu 8902,119607,6.110313748168657,5.325278949830834
SK-OV-3,1750826,-0.3132155362058529,-1.303643126912933
NCI-H1568,11507802,1.223292685938289,1.846318360725944
SU-DHL-1,6918736,-2.1290482192432396,-1.5311792417610062
MOLM-13,6252,-1.803091878000868,-1.643651906845222
HuP-T3,16659841,4.694527425679891,4.196985976486135
COR-L105,135440466,2.282908830244017,2.515491092618848
COR-L105,36462,5.237060103367249,2.5397996478029894
LS180,16038120,0.768362963165676,1.1501823534343771
COR-L95,11719255,2.8113582651389684,2.9557171355536913
K-562,71466380,4.109476883218819,4.072809956633532
LS411N,selumetinib-GDC-0941 (4-1 mol-mol),0.0319239505994205,1.14494339911262
LCLC-97TM1,65064,4.239331302053654,4.9176335135153995
ALL-SIL,11626560,-1.2475078800938888,0.5902328969499728
IGROV-1,9903786,1.7387584479757865,2.975138443999421
HARA [Human squamous cell lung carcinoma],119607,5.240910567943734,5.269093991135461
UACC-812,3025944,3.7003704595595894,4.3096799216450625
HCC15,52912189,2.9796194932949875,2.349561164446624
SK-CO-1,24951314,2.193758155281627,1.604525977858587
IGROV-1,208908,2.822483792004996,1.977071922207451
BICR 31,2945648,3.0787524499283023,3.0940117227625343
WM115,11485656,3.738489726762909,2.649825885783969
IGROV-1,126941,-2.246216453812328,-2.5834810706469953
KU-19-19,135411,0.3258457054887789,1.0301084589263743
PaTu 8988t,tanespimycin-gemcitabine (1-1 mol-mol),0.132721029617077,-0.5590306631979194
P31/FUJ,BRD-K27188169-navitoclax (2-1 mol-mol),0.0086353275600694,0.860517071214668
MOLP-8,25105715,3.7016775455761968,3.1547114440156356
IGROV-1,doxorubicin-navitoclax (2-1 mol-mol),-1.0361645465839266,-1.2974237520868712
NCI-H1568,25126798,3.633705991567496,3.8799021570684458
LCLC-97TM1,3689413,0.1289764847745495,-0.5695810963955097
SW48,5311,0.4861581581750583,1.488502534782031
LS180,409805,6.164182483443964,4.920819806323982
ALL-SIL,17759555,3.7861470032844418,3.3551318876170946
K-562,7326481,2.6072018104551824,2.7080961311046376
SK-CO-1,8515,5.207883928071115,3.771001308892574
NCI-H1568,439501,-2.6831567396736022,-2.139473708434283
BICR 31,3634881,3.594506321194918,3.392578573851633
KU-19-19,656346,4.826208082880011,1.1567788059650292
SW1271,10410894,3.9794007270318903,3.2236770172812186
ML-1 [Human thyroid carcinoma],3689413,0.6725245747839163,-0.24694029678432922
SK-HEP-1,16722836,2.576451725849178,1.7898219562781852
RERF-LC-MS,10113978,3.210216765519601,3.3911023536640266
LS180,54454,2.0147485365690945,2.6266140269699885
NCI-H1568,9866186,-0.23967308205821,0.9945655987431397
IGROV-1,10302451,0.4135234554742116,3.035197704696989
PaTu 8988t,9935249,3.4642640806067897,3.050156488343486
HuP-T3,65064,5.168937665689206,5.0998026829112915
UACC-812,JQ-1-carboplatin (1-1 mol-mol),1.7132070182589942,2.4241713442273247
LCLC-97TM1,44543605,5.020704141539917,3.6099494606080027
KU-19-19,3062316,3.300727237006398,1.0395123495679632
IA-LM,54143018,6.360653223606267,0.025407865741645698
HCC15,JQ-1-carboplatin (1-1 mol-mol),2.0328384477438477,2.2695389871462184
PaTu 8988t,11497983,4.771256524847766,4.122863510033518
IA-LM,7326481,3.2597510497719964,3.0886742153800437
MOLP-8,57519531,1.794840771759573,1.7246804093284245
Panc 02.03,387447,-4.21908064053878,-4.014371240702808
Panc 02.03,9866186,1.4364847380387245,0.7885723041382758
BFTC-909,56946209,-2.8280109825858943,-4.02468026642908
K-562,46843906,1.6079735978006011,1.5637463368391809
IGROV-1,3038522,3.6829378423722416,3.148271322095571
COR-L95,9933475,1.8209744616881691,1.9661248586244409
NCI-H1568,54613361,-1.9115789745186575,-0.060319752607573
PaTu 8988t,11178236,-5.843883599227575,-2.9506796777087736
IGROV-1,24856436,0.4840146383282276,0.3765565035795004
HEL,5746,-1.0378501544368317,-0.33204422652889
LS180,216345,2.343571728213523,3.6345202992078494
MOLM-13,11234052,1.8885372726820036,2.658131912474029
IGROV-1,656346,1.6285470744333117,1.0817481698496154
IGROV-1,613753,3.483244781428779,3.303667729086631
RERF-LC-MS,44632017,0.7768655843829712,1.2992551435154687
LCLC-97TM1,10113978,4.598206277837053,3.124439034144844
LS180,136227924,2.415770069388299,3.0546546997774073
Granta-519,5978,-7.678617575463935,-3.6075819550292847
MOLM-13,2828334,5.861258184508348,5.536693738615708
ALL-SIL,3815108,1.81429533281988,2.0651895068666564
NCI-H2452,serdemetan-SCH-529074 (1-1 mol-mol),2.3569369644908535,2.2414833166513257
LS180,10385095,1.937933801431244,1.3559249478568183
SW1271,7326481,3.1173859417421985,3.075123065597648
COR-L105,176870,-0.2151307909405896,3.3622907235016153
IGROV-1,selumetinib-BRD-A02303741 (4-1 mol-mol),3.1366391073371296,3.98415301918012
HEL,6918878,-0.4197772532459504,0.6919314637540442
RCC10RGB,44589607,3.0966280095343777,3.1401376632221156
RKN,ISOX-bortezomib (250-1 mol-mol),1.0286936108605995,0.8077355468293571
SW48,89183176,5.513741245898386,3.7306319103688907
KU-19-19,168312962,-2.211081322704064,2.0104666603040315
LCLC-97TM1,11656518,-4.424964199082896,1.6034478664072618
ML-1 [Human thyroid carcinoma],426756,5.157831333984941,4.443470267415065
SW48,decitabine-carboplatin (1-1 mol-mol),4.347409294464919,4.398740220651161
WM115,6918328,0.4200257259119496,0.2268855337552642
RKO,44491742,4.905526099010324,4.04357393150226
SU-DHL-1,5280436,3.4353188558540895,2.947551104406389
SW1271,BRD-K27188169-navitoclax (2-1 mol-mol),3.98136464619854,2.333170769435867
P31/FUJ,702558,3.294053878414949,3.7158635245376503
MDST8,322968,3.292336134337166,3.8951327186182225
MOLP-8,66577038,2.4807994544381997,2.74013960860574
NCI-H2452,216239,2.289885444542123,2.3532432370536944
LS411N,24951314,1.1768436480242177,0.5328598230373008
HCC15,5291,3.948819619575577,3.6976908271179787
RERF-LC-MS,11152667,0.0782441689403026,-0.28268485070522936
NCI-H1568,285033,-1.965656578387781,-1.6226475213471747
K-562,119607,4.708269214175102,4.499805362769169
MOLM-13,6918328,-1.6668605659600593,-1.6237100868820473
HuP-T3,51039095,3.318948357155543,3.0456444821982966
COR-L105,3025944,3.915005293474353,4.348436009081865
SK-CO-1,carboplatin-UNC0638 (2-1 mol-mol),2.9632424574107157,3.1560769937427176
NCI-H2452,42642645,0.8357005775142816,0.9785720493006431
PaTu 8988t,67156097,0.822255948885768,-0.5189196119857401
P31/FUJ,44507138,1.0120664141515707,1.7433021143656864
SK-OV-3,sirolimus-bortezomib (250-1 mol-mol),1.4473324892897623,0.9902821388655307
COR-L95,vorinostat-navitoclax (4-1 mol-mol),-0.3281165082224372,0.30289012596925496
HCC15,10074640,3.1199478074334106,3.2480746774146256
IGROV-1,53392493,2.352084848618059,2.4268433311077287
SK-HEP-1,135398516,1.8011759760648425,2.212465354844854
HCC1500,tretinoin-navitoclax (4-1 mol-mol),-0.6846797821009611,1.4678223047249472
IGROV-1,1242560,3.902441161940491,3.4067179832826615
IGROV-1,24901704,3.0789156375765936,3.402002404617141
RERF-LC-MS,23635314,-3.639251677232653,-1.578910170305057
KU-19-19,56946209,-3.434845070293707,-3.678194407465028
SK-CO-1,11427553,2.3636745936222177,2.9896177575374345
SU-DHL-1,erlotinib-PLX-4032 (2-1 mol-mol),3.622151043319632,2.476797260961439
Panc 02.03,6852167,4.143336119644561,3.0092481163469444
NCI-H1568,26596,-1.690126811671561,-0.7967542951125789
ALL-SIL,100016,4.099229681419155,4.899195619974536
SW1271,navitoclax-pluripotin (1-1 mol-mol),-0.6532328489926583,-1.1896569849311789
BICR 22,219104,4.618531153522784,3.756191367718632
HuP-T3,4378219,2.0668857590794767,2.2655068009729713
IGROV-1,11647372,-0.6595372928368528,1.0746870496139285
BICR 31,46843906,2.802485697538939,3.2295809676430935
SW1573,navitoclax-piperlongumine (1-1 mol-mol),1.792577527221854,1.4580009150995858
HARA [Human squamous cell lung carcinoma],44202524,1.300312464104863,2.0177953422934456
PaTu 8902,65064,4.553320484088526,4.961839547056451
NCI-H1568,10410894,1.924104691976128,3.3713645286878635
SU-DHL-1,72376,-3.386078956410557,-2.2149936976806286
BFTC-909,JQ-1-UNC0638 (2-1 mol-mol),2.2684379316791112,1.8032655043988708
NCI-H1568,16659841,3.88074746768202,3.8299326696417793
LS180,selumetinib-vorinostat (8-1 mol-mol),0.5678514609289822,2.0309164060085805
LS411N,54618164,4.167426775220608,4.002555616343586
MOLP-8,5287969,-2.4943575090146903,-2.2345064615657937
Granta-519,24856436,-2.399051702227432,-0.7642294268861016
SK-OV-3,JQ-1-navitoclax (2-1 mol-mol),0.6239682404577798,0.9661013264095222
BICR 22,3689413,1.1307119933583345,0.06173616857000306
SW948,11494412,0.3616963479580831,1.184655796664236
RCC10RGB,3552672,3.073432883089278,2.7586799166231315
LCLC-97TM1,72376,-4.375427192181232,-1.9131065422651625
SW948,11234052,4.776317924055416,3.4792919093723897
P31/FUJ,89928392,-0.2575535361410093,0.5762410508374707
SK-HEP-1,ISOX-bortezomib (250-1 mol-mol),0.2987916672751671,0.6345223350243814
MDST8,piperlongumine-MST-312 (1-1 mol-mol),2.167739236118489,2.140162072180836
HuP-T3,selumetinib-JQ-1 (4-1 mol-mol),1.2883856318712232,1.3344888670184099
NCI-H2452,2742550,5.209305166760603,4.13450983881804
SW48,9884685,-1.5395746259931604,0.5710204003450852
SU-DHL-1,16722836,1.4294085247204618,1.5094192728158249
MOLP-8,11640390,2.6566405323234057,2.584282368724962
RKN,5113032,5.131058822839954,4.932930912127817
Panc 02.03,5311,2.7910052639268415,1.6392281846066665
HuP-T3,36462,3.380707637397105,2.4513300351047516
IGROV-1,tanespimycin-gemcitabine (1-1 mol-mol),-0.5447128478899342,-0.8212174742821865
K-562,6852167,3.2696177089982807,2.063038613522666
KU-19-19,16725315,4.810213458660102,4.16666557835513
Daudi,44819697,-3.048561633253287,-1.7601694419687548
NCI-H2452,73707398,1.4673083704761625,1.475819729118877
SU-DHL-1,6438330,0.8462618394668467,1.5748670528558903
PaTu 8902,carboplatin-etoposide (40-17 mol-mol),6.0931927841576385,2.5929590005872587
IGROV-1,400769,-0.5589612210030486,-0.6852695928865862
PaTu 8988t,6918736,-0.015847459349983,-1.385548649198499
NCI-H2452,12003241,-1.7557808561862691,-1.183986503612227
SW48,89928392,0.7467993581529679,1.613370453762821
HARA [Human squamous cell lung carcinoma],135875424,5.177992671051203,4.119202912039405
NCI-H2452,71466380,5.164331301376758,4.473167804773438
Panc 02.03,4917,3.7856869354758342,3.145284623632076
SW48,25062766,1.0755009410821956,2.2128773754851223
IGROV-1,4259181,0.1937358171291443,0.20438500229701473
BICR 31,46926350,-4.294934659479777,-3.8812905863556044
Granta-519,72199292,2.8103945289975623,0.5524222992775608
HARA [Human squamous cell lung carcinoma],216239,2.4828561148565256,2.288666032586257
MOLM-13,11222830,0.9845802392597008,0.9375852319090313
SK-HEP-1,676352,1.798347685811885,2.1777540112514164
SK-CO-1,36314,-5.371942323616045,-0.8577611130922719
P31/FUJ,71466380,4.574945433624961,3.8117665513360577
PaTu 8988t,11427553,3.005069211450264,2.9026690342353447
ML-1 [Human thyroid carcinoma],1566236,3.1920996771286783,2.809957722834164
NCI-H1568,151289,0.8908355813530987,1.025093949957168
SW48,216345,1.323366684487305,3.666880022460165
SK-HEP-1,44819697,-0.1381867301228731,-0.32838673887728964
BFTC-909,24951314,2.3445794180209565,1.5077923561252544
SK-CO-1,107985,-2.728069079888901,-3.3468874971361915
BICR 22,168313016,4.910867780923905,4.728327620475502
SW48,3025986,-2.1875732043663048,-0.9084663206671414
HEL,SNX-2112-bortezomib (250-1 mol-mol),-2.046606544409741,-2.4957182856242377
UACC-812,erlotinib-PLX-4032 (2-1 mol-mol),1.674253271447935,2.6459586691164088
HCC15,446155,0.1844871361320988,2.6939676731008833
LS180,sirolimus-bortezomib (250-1 mol-mol),1.3360442889009512,0.6356111580661984
BFTC-909,56963564,-0.1720168824982637,0.5811233595966558
MOLP-8,151289,0.9447515089929442,0.5819840103799604
HEL,11609586,2.7821230127549663,1.792472193078544
ML-1 [Human thyroid carcinoma],66577038,3.490614785347513,3.0768327099301116
SW948,46174525,3.747184504681747,3.6794094254531937
HCC15,11964036,0.8100768326008368,1.4805890187806385
SK-OV-3,53232,3.610813443380856,2.930518876978969
NCI-H2452,9884685,3.2183676658345868,0.7685293092032403
RKO,navitoclax-MST-312 (1-1 mol-mol),1.4157691797100402,0.6574631738189738
K-562,44241473,4.342180714885996,4.320737226581019
HCC1500,65628,4.452955395596753,4.306497815402124
MOLM-13,24771867,-2.755307399303063,-1.6938675106533965
RERF-LC-MS,168312962,0.3496483928324376,2.098917596352168
SU-DHL-1,carboplatin-UNC0638 (2-1 mol-mol),2.541711165237938,3.067993452655857
NCI-H1568,44589607,2.521775448277625,2.910130170346454
ALL-SIL,selumetinib-UNC0638 (4-1 mol-mol),2.881146238835363,2.1682150664804993
Granta-519,5280436,1.7342596657129103,2.3938094443423767
NCI-H1568,72199292,0.3941551729128716,0.5143676723438572
SK-CO-1,439501,-2.410857533331093,-1.739881646130701
Daudi,selumetinib-decitabine (4-1 mol-mol),-0.4974612156096017,0.20345246933073205
PaTu 8902,3038522,3.855914834510199,3.054934696729043
SU-DHL-1,159324,0.2044468524757833,2.364815303344527
BFTC-909,46398810,2.674147192871529,2.566013714929693
LCLC-97TM1,148198,-1.8422045751990368,-3.2271658395024416
MOLM-13,selumetinib-MK-2206 (8-1 mol-mol),0.4118015123896347,0.9607844877164581
LS180,5351362,1.0497784443121565,1.4159788181968798
NCI-H1568,5311281,2.6261557759532974,2.5116464931193003
SW1271,44589607,3.6432775089048888,2.920077480109049
RKO,54143018,-0.3751060369564643,-0.12844709350666184
COR-L105,44607530,0.5885750535327339,1.8067522398099327
RKO,navitoclax-pluripotin (1-1 mol-mol),0.0128409422156563,-1.0192130395433505
Granta-519,serdemetan-SCH-529074 (1-1 mol-mol),-1.751418488769959,1.4276587877775648
SW948,387447,-4.931777613053621,-4.390639701946133
BICR 31,168313016,4.3680397842259095,5.001609911084873
LS411N,36314,3.823716751686664,-1.721423895622087
IA-LM,JQ-1-vorinostat (2-1 mol-mol),1.5927237168826456,0.10088976235403196
MDST8,67291369,1.5579520311273356,2.8760557265577047
RERF-LC-MS,3062316,3.070306969339253,1.0593770201545814
COR-L95,doxorubicin-navitoclax (2-1 mol-mol),-3.6271325367233977,-1.9439661295265906
ML-1 [Human thyroid carcinoma],navitoclax-gemcitabine (1-1 mol-mol),0.4874661343054459,-0.7683773281924831
WM115,JQ-1-vorinostat (2-1 mol-mol),1.1090035526940631,1.1374430790740395
MOLP-8,11964036,0.2292639686830329,0.36932175800590444
RKN,66577038,3.4891743358782104,3.0800974502577425
PaTu 8988t,5978,-2.779195325360685,-1.753878818325983
RKO,8515,4.32265921632429,3.3070002362582045
SU-DHL-1,46907787,0.92481130470373,1.6183341829510847
COR-L95,216468,4.837628080392179,2.209106044137484
SW948,462382,0.505941174695894,0.7894119674146484
NCI-H1568,448949,1.6827994040181535,1.968641827209284
ML-1 [Human thyroid carcinoma],11626560,2.2482240841306123,1.8660248019398185
NCI-H2452,10184653,1.4868368660739673,1.8004777150755304
NCI-H2452,1285940,4.318373702463549,3.7853108874737917
SW48,52912189,0.0060801339095902,2.157664182045884
RERF-LC-MS,46926350,-4.177207395055215,-3.8910113154871833
P31/FUJ,5978,-3.805650321394954,-3.2740832631542305
Daudi,4917,1.6956741153412938,2.7060540680057
LS411N,44507138,1.8249335905604152,2.4415830983349602
RERF-LC-MS,10231331,0.9954911948227504,2.05778099331977
HCC15,4261,-0.2961876318733478,1.8758200722207186
P31/FUJ,16722836,0.3472605187822769,0.7286089017075652
MOLP-8,45279963,3.839697844480557,2.881517833345088
NCI-H2452,446155,1.665772886963468,2.644810521076305
NCI-H2452,11609586,3.752552997604344,3.0259207985803265
ML-1 [Human thyroid carcinoma],54618771,2.3801125351223105,1.5150857355573024
IA-LM,9933475,1.89794527933904,1.9069612651491277
MOLP-8,4477,0.6768027916096236,0.5181331183293709
IGROV-1,42642645,0.3750175292659389,0.9552733376567114
IGROV-1,6852167,1.5305143027352028,3.019065602990417
Daudi,5287969,-2.32062356362434,-2.0265118326857627
WM115,44607530,1.3586937130527126,1.8158722099825968
SU-DHL-6,5291,3.0098231219330422,3.1957470804788826
IA-LM,53392493,3.818463276064527,2.046547815537846
MOLP-8,5328940,1.3442597724286955,1.0897994012098393
NCI-H1568,11626560,1.7284579168385834,2.2753560792702214
NCI-H1568,9967941,2.084939505363619,3.5433352265192415
BICR 31,24856436,1.9770307243044476,0.5507937358677019
LS411N,6918289,4.168112514533401,2.1048101785215456
SK-CO-1,49766530,2.416603727276247,0.040992463039937116
LS180,15547703,3.0095925001469577,3.117480045596863
SK-CO-1,24771867,2.6665073598645086,2.4487010393412607
MOLP-8,17755052,-0.3093261728985458,1.102207243282549
HARA [Human squamous cell lung carcinoma],SNX-2112-bortezomib (250-1 mol-mol),-1.7614271905544292,-1.454439247724485
NCI-H2452,6610216,4.12804282735119,4.440133688201237
RERF-LC-MS,16065773,2.958049600168222,2.6011785088565365
SaOS-2,6610216,4.351676798413151,4.287460814211997
RERF-LC-MS,navitoclax-sorafenib (1-1 mol-mol),1.552996311194731,2.0140644176021234
COR-L95,BRD-A02303741-carboplatin (1-1 mol-mol),4.777626447761979,3.8243671259283207
NCI-H1568,3854666,0.7326561551321923,2.0864096110076105
SU-DHL-1,11404337,-0.9851913382580488,-1.0774262845435871
HARA [Human squamous cell lung carcinoma],2708,4.268843127757034,4.958362660333319
K-562,2746,2.4328857060914797,2.0006624686682666
Daudi,16038120,0.2901991168563289,0.08048500399550963
MOLM-13,71466380,3.777949844495899,3.824407429960739
Panc 02.03,11955716,-1.8470517927785437,-1.778826035819556
LCLC-97TM1,2858523,3.382646598163124,3.0556244473155094
SK-HEP-1,11234052,4.66363668535284,4.215314448035766
HCC1500,322968,2.559368987278369,3.409975802133054
COR-L95,24772860,-0.7858558168975444,-1.91308849929506
RKN,selumetinib-navitoclax (8-1 mol-mol),4.166323835760914,2.0900728901928165
SW1271,89928392,3.428275427880058,1.6953839576875007
RCC10RGB,24821094,3.8097926200280225,2.977976618286829
HEL,24753719,3.7144242054355985,3.360082726156936
K-562,445091,4.14956176193418,3.8344278180356595
HEL,136227924,2.725456875957553,2.368167437381714
IGROV-1,carboplatin-etoposide (40-17 mol-mol),3.2860353297411256,2.4796146082385224
LCLC-97TM1,159324,3.194316902825419,2.596620215608516
RERF-LC-MS,57519531,1.5399611647939,2.78564919585993
RKO,JQ-1-navitoclax (2-1 mol-mol),1.6431758808285295,0.5326388394622098
SW1573,navitoclax-birinapant (1-1 mol-mol),1.5026164736180645,1.4396435507721423
HCC1500,51037431,2.242858518427135,3.4844444981027296
ALL-SIL,12003241,-5.746631994241774,-2.119703223868495
P31/FUJ,44819697,-1.8374306821299025,-1.8163644178490284
SU-DHL-1,tanespimycin-gemcitabine (1-1 mol-mol),-4.4382165085850405,-1.9383025064386985
MDST8,107970,2.8941750874079744,2.368331439104173
SK-OV-3,3503,3.0304882575129497,2.3366758434552035
HuP-T3,selumetinib-piperlongumine (8-1 mol-mol),4.093853736240695,3.292257290397331
HCC1500,9927531,5.051014893697188,4.72020677885132
NCI-H2452,selumetinib-tretinoin (2-1 mol-mol),6.004763322543325,3.5710528362703102
HCC15,5328940,2.162982624771584,1.7228454693181203
Panc 02.03,11626927,4.481877662185247,2.8594377231144783
SU-DHL-1,navitoclax-gemcitabine (1-1 mol-mol),-3.283553666087357,-1.8008620958646728
SU-DHL-6,2749,-0.5951367082815587,0.812803509777567
HARA [Human squamous cell lung carcinoma],15547703,3.5023955614710633,3.090102398030842
MDST8,135398516,1.8788362071916904,1.8922715296848507
MOLM-13,5328940,0.1532905912336842,0.9137361570976928
WM115,4477,-0.2872762876800434,0.5816623788093231
ALL-SIL,5746,-1.6673474530311534,-0.5457669367712045
PaTu 8902,25150857,2.644837375624729,2.5448597225038454
MDST8,219104,3.7181204954875864,3.995940742959891
Daudi,11228183,2.4864875823277557,0.4517512509518816
ML-1 [Human thyroid carcinoma],613753,2.773006926215127,3.3082476423861866
Daudi,984333,-2.2486456844128333,-0.3022714786064075
Granta-519,12003241,-2.1147517064841925,-1.6889695225347066
Granta-519,BRD-A02303741-carboplatin (1-1 mol-mol),4.5159158584764745,4.010614464884506
SW48,387447,-4.885505238560258,-4.163187819457685
COR-L105,36314,4.185071185075879,-0.1297656211917781
HuP-T3,4705,2.7233440783632608,3.1314285632612933
Panc 02.03,54678924,2.4878586568917536,2.373214723731549
SW1573,16065773,3.287625611468905,2.4960763573852307
ML-1 [Human thyroid carcinoma],15953870,3.8046885468141016,3.821292683288864
COR-L95,10385095,1.3959867651371194,0.9745670496632242
P31/FUJ,2945648,2.3869646223252365,2.2531024334175793
PaTu 8902,55283,3.4956890773009097,2.6180966821410676
COR-L105,89183176,5.033590250009003,4.512058049292283
HEL,navitoclax-MST-312 (1-1 mol-mol),-0.4450786060493964,0.14138103318227138
HCC1500,445091,4.393350110080019,4.432911289679842
SK-CO-1,11175137,2.477148698701912,2.7207206794482697
SK-CO-1,navitoclax-MST-312 (1-1 mol-mol),0.863563965470539,0.9291512673867718
BFTC-909,54618771,2.8225313881877545,1.2955044363102612
HCC1500,73707398,0.9868057798362108,1.229389509389858
WM115,135398516,0.1940094116062491,2.2065007950702484
SW948,11977753,-4.015233583581633,-1.9082575874425318
KU-19-19,446155,2.785852834205258,2.810457214903995
BFTC-909,3854666,1.1654585644167257,2.093753227081877
ALL-SIL,327653,2.0915878780614623,2.4485603650856738
RERF-LC-MS,2749,2.1448012118135176,2.0945547621812803
SK-CO-1,3503,2.662166466999906,2.256115633693449
IA-LM,60700,0.8821511316384938,0.07430005357579872
Panc 02.03,10302451,3.706546166543765,2.5532135490449392
SaOS-2,45279963,3.893370234288743,3.6543414636430454
HARA [Human squamous cell lung carcinoma],2858523,2.980861882613042,3.005504017085422
RKO,tanespimycin-gemcitabine (1-1 mol-mol),-1.448163850865836,-1.3529972905637253
K-562,11626560,-0.7477726232652755,0.8091247164839567
PaTu 8902,252682,7.782026892174048,6.5485105681739215
HARA [Human squamous cell lung carcinoma],24856436,-1.2762108597510684,0.8946732651938768
HCC1500,9887053,4.8738692747205175,3.826646306403832
IGROV-1,11717001,4.394306548697183,4.1731764480174744
NCI-H2452,9911463,3.657985193851277,4.064997968697976
HuP-T3,11707110,2.782188957571083,-0.21603696226971839
COR-L105,5287620,-2.2558017577268665,-1.8991660456124935
K-562,9907093,4.115761716505682,3.527807536498792
SW1573,53245473,3.5468633352222287,2.8748105566707753
COR-L95,100016,6.620829555802918,5.862395467903601
Granta-519,11178236,-5.517610268531398,-3.8916033594569863
IA-LM,3503,2.293282991199797,2.1956351284053066
BFTC-909,tanespimycin-bortezomib (250-1 mol-mol),0.7192435114334943,-0.31754040713579346
IGROV-1,navitoclax-gemcitabine (1-1 mol-mol),-2.4690208522715005,-1.0164784418249224
MOLM-13,23635314,-2.1464398793300408,-2.9919323664754747
WM115,45100481,5.666571363096329,4.280602354729261
ALL-SIL,doxorubicin-navitoclax (2-1 mol-mol),-2.2880067679034526,-2.6985540376916544
COR-L105,5351362,1.5942690709113274,1.8050063410259998
IGROV-1,6610216,4.310938387105607,4.401258219080982
SK-CO-1,4521392,4.292734672993078,4.285822872328131
RERF-LC-MS,53232,1.207294902086358,2.83321207935935
NCI-H2452,16038120,1.767482091574877,1.3354524043158926
LS180,107985,-4.080313435814333,-3.4469392683883715
SU-DHL-1,24785538,0.8988368126388477,1.291167183437732
IGROV-1,11977753,-2.2284230058029433,-1.260215750356114
ML-1 [Human thyroid carcinoma],6623618,2.7004595127938686,2.493275907822198
SW48,24964624,1.8073600797801577,2.1843652791456027
RKO,9911830,2.9376280530386123,1.7033824357082903
SU-DHL-1,navitoclax-PLX-4032 (1-1 mol-mol),4.469831301175806,1.457262476896239
Panc 02.03,navitoclax-pluripotin (1-1 mol-mol),3.190516365419919,-0.7544269064871508
HEL,5287620,-1.51108604946339,-2.336175989719693
MDST8,11964036,-0.5107320494490124,1.522887600157578
HCC1500,10385095,0.8648832931247582,1.4110177084534874
SW48,702558,4.851481027043998,5.067386622465026
BICR 22,15547703,3.054989624104991,3.0980748387926935
LCLC-97TM1,375860,-0.9613247940016756,-0.18700341980774177
BICR 22,5566,3.0896765386345244,2.793101631822771
SW948,36462,2.9711779559511604,1.794374458088753
SaOS-2,135411,0.7043200334589346,0.757211015239312
SW1271,24889392,3.729104653817525,4.051713947481623
K-562,4917,1.7461656699737091,2.8869556413480653
MOLM-13,11964036,-0.3903680086882432,0.008602771589267266
SU-DHL-1,9907093,3.802209526559384,4.034295904197278
MOLP-8,44507138,3.0437239609683515,1.6600791434728395
HCC15,441298,2.404091830829315,2.6170323324377716
IGROV-1,246676,4.485924799339535,4.155398797077951
IGROV-1,3136844,5.214591389089975,4.378216795386687
Daudi,119182,-1.0022442636317743,-3.267089314175158
SK-CO-1,2742550,3.074063089907043,3.8593890520352385
COR-L95,5291,3.794551144961864,3.5796400202906544
ML-1 [Human thyroid carcinoma],6184667,3.426764234055379,3.0802750001439936
WM115,16219061,2.9198343751130036,3.5526381127783786
RERF-LC-MS,2871966,0.0193381278585586,0.8239042893831996
SW1271,44607531,2.0262821909932964,1.6855260729183674
NCI-H2452,53495165,2.6100799702143824,0.6175781258746746
SaOS-2,3825829,3.573326366415088,4.042004994373651
HEL,1242560,2.170830105823081,3.0475853630526495
SU-DHL-1,selumetinib-tretinoin (2-1 mol-mol),1.6823534410792318,2.6048421890026656
MOLM-13,135423438,-5.2048777869707035,1.146430181192011
RKO,3815108,2.4813915623878264,2.5469356118297624
SK-CO-1,57519531,1.3464743023672243,2.77145374997495
SU-DHL-1,2729026,1.1961155288156848,2.532025315589802
MOLP-8,57330099,4.408814311331857,3.907751144230498
SK-HEP-1,25262965,-1.9202339310426983,-1.0653141484257458
HCC15,71466445,3.952377160133232,4.163179838324684
Daudi,49793307,-5.375388093698208,-4.096012983116971
RCC10RGB,52947716,3.397847809230189,0.10019442622129582
COR-L95,selumetinib-vorinostat (8-1 mol-mol),2.598334256861724,2.1309496886269397
MOLM-13,10074640,2.6694741782411975,1.9651870223247017
HCC1500,16736978,0.2362509616809698,1.606902676216282
WM115,11228183,1.7654096487865938,2.3248773185261284
Granta-519,25150857,0.8022216450857215,1.5014763043973993
RERF-LC-MS,2858523,3.0171071482923826,2.8043067136427013
K-562,71466578,3.85538032532176,2.8129509013146397
RKO,135875424,3.829354185480349,3.172184607727299
HEL,4096211,2.9626104821001524,0.9731363183757277
LCLC-97TM1,67156097,-2.339870774569048,-1.1290318871871934
COR-L95,3503,2.5200783295079834,2.259783360034661
SW48,11609586,2.634017068041322,2.912187173885999
SU-DHL-1,375860,-0.8487932986720208,0.06339927999825216
SU-DHL-1,5351362,0.9282229173955964,1.767864708970863
SK-OV-3,6917907,1.1533351492785058,-4.761243828255358
PaTu 8988t,65064,5.1728218990125,4.993847865950251
RKN,3503,2.6546301780010144,2.3689799411154864
IA-LM,23582824,0.7235929041173603,0.8272365576786863
IGROV-1,54143018,0.8385018685685798,0.4981759568908861
Daudi,11214940,1.5157277988308535,1.196034586581476
SW948,4261,0.2066749270482282,1.2102713557903937
HuP-T3,15547703,4.355520728687953,3.1120792970110034
NCI-H2452,24748573,1.1942514329138498,2.5267289177772314
IGROV-1,159324,2.8766947154825044,3.054280232946636
MOLP-8,JQ-1-vorinostat (2-1 mol-mol),-1.65297675500665,-0.6939063463442728
MOLP-8,navitoclax-birinapant (1-1 mol-mol),3.3062400198752195,0.6305202582858656
SU-DHL-1,3465537,3.713885766889003,2.5278584236709913
NCI-H1568,60700,-0.8736945480852499,-0.31384838799363907
P31/FUJ,3689413,-2.495432751898851,-1.313448903307378
PaTu 8902,16722836,2.3982166809874768,1.6650346737212252
SW1271,452548,-0.0979853591066759,0.15963606974039565
HCC1500,9444,4.370086947523025,3.9370935401973806
IA-LM,navitoclax-pluripotin (1-1 mol-mol),-1.626939018948189,-1.1074823517375922
MDST8,44137675,1.8173250203578384,3.5059860026171634
IGROV-1,5460769,1.6083174601829917,2.2094040803833557
SK-CO-1,10302451,2.4520332675877605,2.8097381684540603
IA-LM,sirolimus-bortezomib (250-1 mol-mol),1.6120597722062386,0.5488981119922576
SU-DHL-1,3384730,1.173741268518712,2.7014879445352324
LS411N,11178236,-2.533537215148808,-3.4266421317531486
COR-L105,216239,2.81147830727615,2.3724943787549897
MDST8,1750826,-3.2078848487443716,-1.265181615120241
HARA [Human squamous cell lung carcinoma],tanespimycin-gemcitabine (1-1 mol-mol),0.469334809183726,-0.678341048945747
SW1573,3025986,2.659291536752942,-0.6092876781688142
SK-OV-3,73707398,1.4890038437616029,1.2210612079903909
LCLC-97TM1,12003241,-0.8351557307101188,-1.1975088288056692
BFTC-909,1750826,-0.1726466566192349,-2.0036007353662555
WM115,44819697,0.4217395821242636,-0.26430884925608994
Daudi,57330099,4.348234162675926,3.8424515063833335
HCC15,6852167,3.485797740848402,2.9402909459425732
IGROV-1,23939,4.412541857664819,3.8804120946264167
Daudi,carboplatin-UNC0638 (2-1 mol-mol),1.637238274504332,2.7622926464148976
MDST8,159324,4.143261975826356,2.8943004457150585
IGROV-1,9840324,5.720969888694302,5.6485769189635935
LCLC-97TM1,36314,-6.600382606146434,-0.9570180849312868
UACC-812,11494412,1.976870257251046,1.8459282898675717
LS180,24785538,2.36344296814186,1.2690070134320128
SW1271,46398810,2.1181317502001864,2.5974863331401985
COR-L95,8515,4.297389552329342,3.477021698362447
HEL,67291369,-0.0398574366947598,1.264006579180836
WM115,65064,5.519507799834776,4.73348273955766
K-562,11178236,-5.937287665657859,-3.5580595889352646
MOLM-13,46398810,-0.3461491770759903,1.7829004905584624
Daudi,49836020,3.49644839546437,2.7297996874477803
SaOS-2,135659046,3.828911922642458,3.713205313860863
MOLM-13,156422,2.6570896066322054,2.730300551244338
IGROV-1,11222830,1.5703285223102077,1.752875663732775
MOLM-13,3062316,-0.5121609334560062,0.21151693040022615
RCC10RGB,24775005,3.7293513155953737,3.894426300207625
Daudi,135411,0.411387979123234,0.0442913326848252
HEL,6623618,1.8836955043929509,1.9515990823205167
IGROV-1,5702613,4.420745339537274,2.8418352495255594
BICR 31,3025986,-1.7152493432112506,-0.6206514172006369
ALL-SIL,crizotinib-PLX-4032 (2-1 mol-mol),-0.8453908934030238,1.0719422886094603
HuP-T3,46926350,-3.9956296104835447,-3.9399502635093104
SW948,11964036,0.9329377934210036,0.4987009465542968
HEL,navitoclax-pluripotin (1-1 mol-mol),-0.6457207254934652,-2.1196042137441817
BICR 31,168313200,4.293337148285007,2.9878431582443428
LCLC-97TM1,613753,3.2994086878019693,3.0652719574150824
NCI-H1568,2858523,2.9099207435493306,3.09219657578535
K-562,selumetinib-piperlongumine (8-1 mol-mol),3.695022326832345,2.1269045603779655
WM115,168312962,-0.8720769549309708,2.1950248971791044
COR-L105,3136844,4.323289843330604,4.470916110514512
SaOS-2,24964624,2.194529135867758,2.466373495302975
IGROV-1,322968,4.140599241163106,3.654466365130304
SU-DHL-1,44259,0.9870469643742532,0.8133083962554248
HuP-T3,erlotinib-PLX-4032 (2-1 mol-mol),4.371591161861475,2.6292370724279333
Daudi,7326481,2.37278983949268,2.6067723701306047
HCC1500,5284616,3.2143502285360395,1.8556770095511346
Granta-519,6918736,-3.0470654964091346,-2.1659402800768555
K-562,53232,2.317344808959498,2.4799935256335393
KU-19-19,6914657,-4.990300196809823,-3.794313562509844
Granta-519,72376,-3.0273971733074463,-3.6010884389094393
SW948,54678924,1.3690911042909353,1.4914217931817213
HARA [Human squamous cell lung carcinoma],135999136,4.433628677785179,3.705838480409392
SU-DHL-1,2858523,2.096941494706986,2.870384845317976
HCC15,11427553,0.4296382841284133,2.7579984141131497
HCC1500,UNC0638-navitoclax (1-1 mol-mol),-0.3841073877308503,1.1161041357538353
PaTu 8902,9444,4.223556509018044,4.1218624516685365
Granta-519,10074640,3.4462174196318864,2.5222451934340047
NCI-H2452,11213558,2.927858740250081,1.8081773926699938
HARA [Human squamous cell lung carcinoma],10302451,4.803964333247322,3.139105169493797
SU-DHL-1,17755052,1.573040093702568,1.3231294505313673
HCC1500,44185566,2.7833515387265435,2.5209634001685575
BFTC-909,107970,2.2861723254681774,2.448410628565112
WM115,46191454,1.770414974730312,1.8629204414100686
Panc 02.03,selumetinib-decitabine (4-1 mol-mol),4.111945447475948,3.862467645917005
SW948,JQ-1-vorinostat (2-1 mol-mol),0.5761489017255973,0.057087905852590756
SW48,984333,0.702746968378095,0.6494995180471957
MOLM-13,4378219,1.3750720877022855,1.7287364686833184
SK-CO-1,104842,-6.47047720162668,-2.0740830482625223
HARA [Human squamous cell lung carcinoma],135440466,2.4398826683273165,2.2465015014711507
SU-DHL-1,753704,3.8222320630358344,4.510135455863686
NCI-H2452,11640390,3.686004280320225,3.859761066315303
IA-LM,44185566,3.1900951690600596,2.1457943626408835
SW948,24748573,3.0928652753553685,1.7169901318446779
HCC15,16722836,0.9313515315756092,1.7226161248484928
SK-CO-1,2858523,3.0692168261278345,3.1013373842183944
BICR 22,984333,1.5288435331300914,0.4648016925679483
WM115,46907787,1.8634039559333693,2.627717255842058
K-562,135398516,2.1877631842117315,1.4192844747972952
PaTu 8988t,navitoclax-pluripotin (1-1 mol-mol),-0.085365931635351,-0.6208598376347895
SW1271,56649450,5.123918884487689,3.2381886335350156
MOLM-13,73707438,4.222752629567675,3.626843936863645
BICR 31,navitoclax-PLX-4032 (1-1 mol-mol),3.597223758742863,2.0863345889599407
IGROV-1,9908783,5.873270433212515,4.998055912604027
COR-L105,100016,7.1590039780101895,6.2763812826469065
MOLP-8,2733487,6.371854996101937,5.635184458205191
HuP-T3,40482356,5.071639396405957,4.29605610765331
Daudi,10231331,6.134507235467236,0.7864784188927731
IGROV-1,JQ-1-navitoclax (2-1 mol-mol),1.1306356566784013,0.8903437817407316
ALL-SIL,135398738,2.8388897343309214,2.3585298103724766
Granta-519,15953870,3.078322892664931,3.000195294324931
SW1573,16722836,2.4665820842388606,1.5378376128653286
RKN,262093,2.5285063130840344,2.918849204881573
COR-L105,16736978,0.0668136597141226,1.7116085313235758
SU-DHL-1,3854666,0.5155348387571919,1.856599550583863
SaOS-2,docetaxel-tanespimycin (2-1 mol-mol),-4.954749121249774,-3.223057056215812
HCC15,1242560,4.141842055686159,3.655015127056465
Daudi,227681,2.3413610492173533,2.443623834235056
BICR 22,9825149,1.9632507246672848,2.06755418804404
KU-19-19,57519531,2.7709295903751987,2.6809167658547977
HEL,675434,4.82305615478698,3.9380756896533478
LCLC-97TM1,9927531,5.703886109604247,4.593617279520303
HCC1500,60700,0.3261825799377537,-0.23091469922984564
SK-HEP-1,3025986,-0.7748266135658505,-0.8516652396984494
LS180,5281321,-2.3743222213125703,-0.8558008644235771
RERF-LC-MS,11234052,4.094456859515875,4.2443678944994065
COR-L95,JQ-1-navitoclax (2-1 mol-mol),-0.0986281743436248,0.22695318803576822
RERF-LC-MS,753704,5.128075002459309,5.06823528544621
ALL-SIL,71304818,1.8469641946240791,1.8897266329025668
LCLC-97TM1,2733526,4.142341185184233,3.770933159414913
SW1271,6918328,0.5991052607451842,-0.26866372661734483
SW1271,24901704,3.681572165465946,3.3622245572996174
Granta-519,11656518,1.6452745070498538,0.4298831145914099
NCI-H2452,3025944,3.797054601848671,4.3379480031504665
COR-L95,navitoclax-sorafenib (1-1 mol-mol),-0.3721439158461418,0.9182415584618675
RKN,24951314,1.3743916622304369,1.4425448441641586
SW1271,25126798,3.686543071113652,3.756002447948416
IGROV-1,6450551,2.579641476451469,2.791652771434821
IGROV-1,54454,2.453541831966438,2.6891884160166946
COR-L95,9936388,1.0197606854481494,-3.5827198355986023
Daudi,42611257,3.0497080994784307,3.0795084824504486
BICR 22,54618771,-1.5156377594303725,0.9821980931418086
LCLC-97TM1,23939,4.339779460008714,3.6854808768480507
NCI-H2452,46191454,2.4313233431346366,1.9170206624141455
COR-L105,42642645,1.1549939076973508,1.285195172110268
MOLP-8,11609586,0.3617141221652126,1.7775470035701821
BICR 31,613753,3.1747241586791772,3.294836318624693
SU-DHL-1,5328940,1.3431964509037,1.5762223178258319
HARA [Human squamous cell lung carcinoma],5287620,-1.762699468398793,-1.8552804093717459
SW48,carboplatin-UNC0638 (2-1 mol-mol),2.888292790339682,3.2791631019892176
BFTC-909,11455910,1.958059547603208,1.3557793410255423
RERF-LC-MS,322968,4.758979615786181,3.9195077550465443
KU-19-19,5351362,1.814646406429004,1.6582047353833531
MOLM-13,54649381,3.864277780400009,2.882974929630773
RKO,selumetinib-MK-2206 (8-1 mol-mol),2.0156387563640337,1.1392240402582128
NCI-H2452,72199292,1.1345413256627164,0.15662082574439246
MOLP-8,676352,1.5936675202889017,1.844314929846533
HCC1500,676352,1.5631676801704226,1.9212233183478529
COR-L95,51037431,4.395819234826154,3.239524002934027
Daudi,5328940,0.4604914818199462,1.1802244713770123
SU-DHL-1,ISOX-bortezomib (250-1 mol-mol),0.1782734065105105,0.250779922456691
IA-LM,168313200,3.804941602819176,2.7718431712634475
RERF-LC-MS,navitoclax-gemcitabine (1-1 mol-mol),-4.0027913936317026,-1.0927782058070645
RKO,119182,-2.4803685643523,-1.327063741388467
Panc 02.03,selumetinib-vorinostat (8-1 mol-mol),2.158693436679715,2.2987481479917347
PaTu 8988t,25227462,0.2940996568558364,0.46001473384196573
SU-DHL-1,9929138,3.6810672504095385,4.4996115222476245
SU-DHL-1,12003241,0.0778318253848937,-1.3332938608818665
RKN,15547703,3.1395613683678287,3.2356661313451935
MDST8,selumetinib-vorinostat (8-1 mol-mol),1.0590621941896752,2.2051186194433687
MOLP-8,375860,-0.9263291950812266,-0.4958181449769825
PaTu 8988t,11234052,5.58672838892775,4.271560004917576
LS411N,piperlongumine-MST-312 (1-1 mol-mol),2.10220496247882,1.535761098551384
SK-CO-1,126941,-2.257482818819106,-2.0282983428804537
KU-19-19,selumetinib-GDC-0941 (4-1 mol-mol),1.3867335606828617,1.5946462414977025
LS180,3038522,3.8311766422201727,3.0030720346777224
SW948,1566236,2.0550116218076235,1.9367820686258517
Granta-519,89928392,0.2978525114312038,0.40898659162260964
MOLP-8,19582717,2.2376953494036624,2.739220598215492
HCC1500,vorinostat-navitoclax (4-1 mol-mol),-0.8820209164506474,0.5130508745277281
K-562,2874250,4.395305106833161,4.614622002072172
SU-DHL-1,11234052,1.0073590907004168,3.5950355905450313
BICR 22,73707398,1.4183060149157571,1.367550573402579
COR-L95,46926350,-4.41571269577794,-4.2193181985614805
Daudi,25154868,2.925803317483448,3.8724842523425154
HEL,16725315,4.4825385691379145,3.5940576085335705
IGROV-1,67291369,1.8066430555976296,2.8058755450207546
PaTu 8988t,11404337,-0.5897258437911538,-0.2550297984779594
SK-CO-1,9911463,3.850014047184169,3.631178031493522
LS411N,89928392,2.6081309937571655,0.8716166706078206
SW948,374536,1.478775672326772,1.3078360443126587
Daudi,3543504,2.1992036346279997,3.513448250008174
NCI-H2452,5746,2.2152642195731818,1.4505879516933493
K-562,451668,2.928523807666895,-0.1534752018791474
RERF-LC-MS,71680916,4.2559060280924665,4.880944203747697
BFTC-909,5311281,3.2468587214362175,2.230349741090704
HCC15,54649381,3.779002151510325,3.820377212134698
SaOS-2,6252,5.899001284083339,1.2090412161233688
SK-CO-1,2828334,6.603893313093487,6.039332655097416
HARA [Human squamous cell lung carcinoma],8515,3.1956320485149265,3.9326164044102883
RKN,56946209,-4.407104587623599,-3.9014335865490937
P31/FUJ,54618164,3.783909273991047,3.6605267327258146
P31/FUJ,46943432,0.8368365469264624,0.5777524057253115
SU-DHL-1,24180719,4.350105317542874,2.9424071996615866
SK-CO-1,10113978,3.831664495659769,3.2325922097381117
Granta-519,16659841,3.0104726191973756,2.339853880481069
HCC15,5329102,1.9423862085433257,2.2003017365804762
RKO,9903786,4.184024439899693,2.3599322619597176
Daudi,76446078,6.274042769130843,2.8772693620463046
SU-DHL-1,5113032,6.615586057729586,4.589606593934731
ML-1 [Human thyroid carcinoma],carboplatin-etoposide (40-17 mol-mol),0.3624432437862623,3.013921030565299
IA-LM,219104,4.299166533144503,2.615090312318888
P31/FUJ,5329102,0.6917422477571054,1.275934697508512
PaTu 8988t,5278396,4.086122365965545,3.6587484538707917
LCLC-97TM1,8515,3.105500626842055,3.537569098097565
ALL-SIL,36314,-6.574209880787115,-3.8033306082653793
HEL,JQ-1-MK-0752 (1-1 mol-mol),-0.9106796249442436,0.4066210372828947
SU-DHL-1,252682,6.908372017357921,6.347594197396777
MOLM-13,24753719,4.086009941734247,3.3354506163158586
LS411N,119607,5.818355117504778,4.569082275681305
MOLM-13,66577038,2.3893764671204853,2.57206534492865
HCC1500,25183872,-1.4621663438631347,-1.0081066785148833
KU-19-19,6917907,-4.52253618895935,-4.9490042921990645
MOLM-13,11396600,-0.7885098330267027,2.3565766040129863
SW1271,25195348,2.4923805554625407,3.2071948653301825
NCI-H2452,15983966,-3.826639310361129,-1.6996177009845042
BICR 22,6184667,3.547514920621151,3.138803140184166
IGROV-1,11396600,3.99372654279783,3.748066213082582
PaTu 8902,24748573,3.607230896648149,2.218085277750855
MDST8,54613361,0.3905773320508885,0.3973712326657774
SW948,136227924,2.9576701343794145,2.6785275647064686
HEL,135411,-2.1892340188273836,0.16758866474534811
RKN,322968,3.2277505791227776,3.9665935531027667
HARA [Human squamous cell lung carcinoma],15953870,3.428154571209005,3.575143437992762
RCC10RGB,alisertib-navitoclax (2-1 mol-mol),1.3902469753656497,0.7793309611733933
COR-L105,444795,5.02091820523187,4.7180528562055075
RERF-LC-MS,11175137,3.6286013190581503,2.618522464683067
RKN,54619267,4.894700718514424,4.0489178791446925
MDST8,54143018,0.2489025697900608,0.8267259434994269
LCLC-97TM1,4917,2.8423920861921803,2.908597730996509
Granta-519,60700,-4.015034522335836,-1.9142693480755526
MOLP-8,56649450,1.2499213171679169,2.709995054487556
RERF-LC-MS,11719255,3.775646564562419,3.495917507781733
BFTC-909,12001922,1.803559970478093,2.0110990436773215
MOLP-8,3384730,1.892166165987978,1.6293132119274778
RKO,176870,5.862868084879783,2.421481688897885
HCC1500,SNX-2112-bortezomib (250-1 mol-mol),0.5561082321817433,-1.3024924484831126
PaTu 8988t,navitoclax-MST-312 (1-1 mol-mol),1.1129030049458837,1.03058580208104
IGROV-1,24772860,-3.2892316801587835,-1.651278373614719
IA-LM,6450551,2.2909353415785403,1.5959862924825665
HARA [Human squamous cell lung carcinoma],441298,0.3301976976056055,2.537297142190798
BFTC-909,6252,5.031852570794812,1.4912101852664754
BICR 31,9907093,4.585915925811977,4.282835101141659
MDST8,285033,-1.9150900594470792,-1.5946431401913157
MOLM-13,375860,-1.005106987112833,-0.594477117249881
P31/FUJ,16725315,4.109597365862544,3.5093229542586983
IGROV-1,216345,3.498629789107092,3.901190610975039
SW1271,208908,1.7498569635536685,2.1050955503399185
COR-L95,11507802,0.9381723124038672,1.1479469799270658
RERF-LC-MS,6918328,0.3946668064090056,0.15136548518201526
NCI-H1568,426756,4.294080241318686,4.236243243549234
K-562,67156097,-2.769244311294464,-2.1785459879622473
LS411N,2729026,2.9791300415919646,2.438305395488228
SK-HEP-1,2729026,3.094345392685322,2.8527257176135983
Panc 02.03,54618771,1.0884531427161812,1.3629459937791677
MDST8,5282054,3.0885738072945776,3.6112017391089823
HARA [Human squamous cell lung carcinoma],31703,-1.5277652674394486,-0.8539476565976513
HEL,54143018,-0.2807045945993052,-0.5130332379119474
COR-L105,5278396,3.038896363429305,3.735685958784569
SU-DHL-6,6450551,1.9173550036200224,1.2381481933656229
LCLC-97TM1,1716436,2.9898763561132276,2.7810777929730532
K-562,54619267,3.679496217482672,3.7945221383214984
Granta-519,1641662,2.857235389717828,2.5759622284357557
PaTu 8902,219104,4.25826825351418,4.0094357197352055
NCI-H2452,24779724,6.409137734448782,4.485785194528248
RCC10RGB,2126,5.809199309072596,4.715428861457091
HuP-T3,24753719,4.122061219367772,4.378635386513373
RKN,44197249,3.9607888926275217,4.254236637343972
SU-DHL-1,44543605,4.013392575246718,3.7798610795564334
HEL,11455910,0.7002369428142345,0.47024454149445605
SK-HEP-1,5281672,4.68841423543723,4.622358399858556
SW1271,navitoclax-gemcitabine (1-1 mol-mol),-0.9038417813496232,-1.0306916200272729
BICR 31,23582824,0.6119811525421108,0.7147347898394858
SW48,57330099,4.121753491452113,4.119518878920661
MOLP-8,3825829,4.0673932001437,3.292930552980222
Granta-519,5746,-3.467826904777232,-0.3288530039072046
K-562,46215462,1.6076592131491731,1.3181463075584263
Daudi,alisertib-navitoclax (2-1 mol-mol),-1.1022910082635888,-1.425434451224053
MOLM-13,6852167,0.0474303723036755,1.3736373231211396
PaTu 8902,44819697,-0.6077719001286086,-0.18458128469589383
P31/FUJ,selumetinib-BRD-A02303741 (4-1 mol-mol),2.927335699972257,3.2057368430981485
HCC15,135875424,4.57405525423842,3.9042600222128674
BFTC-909,6918736,-1.9066217610366931,-1.4085464350505845
MOLP-8,25195348,2.8158250690550215,2.3723321925330523
KU-19-19,11175137,2.6409229524549858,2.7327572243745744
MOLP-8,selumetinib-vorinostat (8-1 mol-mol),0.5192774432453199,1.6240656972210323
SU-DHL-1,15983966,-4.109397573586815,-1.4485321605922805
Granta-519,4705,3.4024179319436483,2.8273663291539406
SaOS-2,6450551,2.5324870379200113,2.768287603282887
SU-DHL-1,6918837,-2.995399398295858,-3.5154157965717756
RKN,selumetinib-BRD-A02303741 (4-1 mol-mol),7.036223119013143,3.6970046409441544
SW1573,159324,2.9705070550476274,3.1275222703262346
LS180,11625818,4.457813695022962,4.213282818640259
Granta-519,10296883,3.749738066673353,3.0298167978365114
Panc 02.03,285033,-1.023489563814438,-1.6847098307718602
SU-DHL-1,11175137,1.828860424721981,2.4650181051836793
HEL,124202324,1.0355607531680788,1.1789094990215012
NCI-H1568,702558,5.469457182473135,5.312291170021139
IGROV-1,46191454,1.3777495915525844,1.7199957899440679
WM115,55283,3.7426713954425415,2.9303314478992313
SW948,7251185,1.827873481109932,2.031843541058971
MDST8,4521392,4.294685623216763,4.260830120272836
HuP-T3,selumetinib-GDC-0941 (4-1 mol-mol),0.9673243203252392,1.0663460866161771
LS180,11455910,2.088798844266998,1.1646390006015046
NCI-H2452,151289,3.721937933525537,1.0501513692796025
LCLC-97TM1,11214940,1.4536772193180694,1.6495078423525786
RKO,25062766,2.7314931301361476,1.490169210953419
SU-DHL-1,navitoclax-piperlongumine (1-1 mol-mol),1.5701555779120346,0.9896704882187711
COR-L105,3385,6.244906352702261,4.206300598223922
IGROV-1,375860,0.7731558163124775,0.10756673440962744
SU-DHL-1,9936388,0.846879508636978,-2.2860682526053013
MOLP-8,11955716,-2.2423093620343666,-2.020511708220459
IGROV-1,11455910,-0.2792640061206097,1.0193202880748053
HEL,216468,1.594172428774628,1.2081289402220325
K-562,216345,3.9110155346915088,3.2111675161325373
SK-HEP-1,6450551,3.663777137244395,3.0156189114340908
Daudi,5460769,0.2326576177581661,1.679570312446003
BICR 22,1750826,0.8880077925102622,-1.3019363208455297
RERF-LC-MS,11238147,2.4729298726299147,3.025510886715081
BFTC-909,54649381,4.487285574329416,3.9626453161748056
RERF-LC-MS,9926054,1.8051014319834384,2.009680541154394
IA-LM,1750826,-4.675530321169698,-2.310253091658831
BICR 22,46398810,2.733805979632988,2.4909517361246776
WM115,445643,3.76443753653658,3.926349967829961
LS411N,3689413,2.701640891749041,-0.997835387645013
SW48,71304818,2.1411626536950323,2.432100037787925
HuP-T3,5291,4.150853397708747,3.8217419808015736
SW48,9911463,3.374803590447597,3.7692538954644776
Daudi,16219061,1.2860438148144782,2.1969359936561896
SaOS-2,9911830,2.995519789289086,2.509381695473556
BFTC-909,5329102,1.9658448878596055,2.084144323104365
NCI-H1568,53495165,-0.6133813456223128,0.7020632238079361
BICR 22,6918878,1.3704913724877863,3.07103475813056
SK-OV-3,4259181,0.9080230343390464,0.26758967232027786
HCC15,BRD-A02303741-navitoclax (2-1 mol-mol),0.3796712498058268,2.630534676824455
BFTC-909,445091,4.3207806819680625,4.432202925557605
WM115,2130404,3.451007656106494,3.3791802196901806
RCC10RGB,11152667,2.8531679730856268,-0.1882047702111022
HEL,5460769,3.63888115942649,2.202159907493175
HEL,969516,2.4495484774391296,2.2471283707326166
MDST8,11152667,-1.6082048518025778,-0.3470687226584755
WM115,54596490,4.400808012137458,4.522258252731152
NCI-H2452,1716436,2.783046357832639,3.012860271593017
MOLM-13,4917,2.9272389210025955,2.67375187496427
ALL-SIL,119182,-4.503247338331098,-2.765955214206977
MDST8,3552672,1.9687663546279843,2.7291672232666233
HCC15,16720766,-0.3160262480808965,0.7810514928011074
ML-1 [Human thyroid carcinoma],12001922,2.2640831281012916,2.031765501912104
MOLM-13,12003241,-3.578107028375036,-1.8954420898060362
SW948,24856436,-0.402936098482521,0.3541273521655885
HCC1500,44202524,3.676243999694772,1.8631287912227688
Daudi,4261,-0.6156785773872924,0.5570813291613271
MDST8,11507802,0.9258202338292296,1.7147913375522181
BFTC-909,54626689,4.365294423210906,4.675444930449188
NCI-H1568,16741245,4.262204040009308,4.065059806417787
HCC1500,25154868,1.8923567203600569,4.3388254535852795
HCC15,navitoclax-piperlongumine (1-1 mol-mol),-0.4364560874228035,1.8693643786024927
COR-L105,3825829,4.424164708702568,4.18461197565486
HEL,10074640,3.098757234686198,1.8241261265695405
RKO,44202524,1.4476976505001866,1.6486102736780124
SK-HEP-1,6852167,5.53454213252302,3.0792256170105134
